data_2h25_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2h25 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.81 0.338 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -120.97 178.24 4.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.917 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -93.04 168.73 10.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.79 36.43 87.12 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.481 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.8 170.32 21.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.848 0.356 . . . . 0.0 110.949 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.6 mt -140.38 124.51 17.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.88 106.97 21.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.059 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.0 mp -99.26 121.23 49.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.428 ' CZ3' ' HB2' ' A' ' 43' ' ' LEU . 1.4 m0 -91.23 133.7 35.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.984 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.414 HG13 ' N ' ' A' ' 12' ' ' ASN . 9.4 tp -125.01 159.56 31.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.962 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.414 ' N ' HG13 ' A' ' 11' ' ' ILE . 26.6 m-20 -93.49 31.71 1.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.159 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 47.46 37.77 12.97 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.06 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -178.64 53.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.846 0.355 . . . . 0.0 111.004 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.75 78.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.865 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.47 49.8 73.17 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.534 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 36.3 p90 -78.99 -38.83 35.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.813 0.339 . . . . 0.0 110.919 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.438 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 2.6 t30 -86.92 -31.68 20.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.949 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.57 -37.44 68.41 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.531 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.9 tp -63.75 -32.23 73.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.856 0.36 . . . . 0.0 110.949 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.67 -31.23 72.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.081 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -63.51 -43.64 96.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.912 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.87 -35.44 60.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.109 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.96 -43.73 93.05 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.445 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -59.73 -25.62 64.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.772 0.32 . . . . 0.0 111.002 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -82.58 -38.95 22.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.991 0.424 . . . . 0.0 110.882 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.34 -50.13 73.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.029 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -38.39 81.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.93 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.06 -25.12 64.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.095 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -88.38 -32.49 18.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.372 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.0 p -136.65 -44.14 0.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.375 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.67 20.61 4.94 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.657 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.436 HG23 HD11 ' A' ' 33' ' ' ILE . 32.9 mm -85.78 126.72 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.852 0.358 . . . . 0.0 111.043 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -65.45 148.68 51.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.38 104.36 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.09 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.6 m -109.54 150.6 27.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.999 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.15 127.83 55.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.064 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -126.26 155.56 41.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.91 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -135.96 70.22 63.92 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.851 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.77 170.27 15.73 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.584 2.189 . . . . 0.0 112.468 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -108.34 141.42 40.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.717 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.98 32.94 19.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.663 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.428 ' HB2' ' CZ3' ' A' ' 10' ' ' TRP . 2.3 pp -77.34 -0.78 26.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.699 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -56.98 -57.09 14.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.784 0.326 . . . . 0.0 111.16 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -88.41 -25.64 22.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.185 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.0 -18.97 60.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.295 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.445 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 78.4 t80 -74.07 -56.33 2.72 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.504 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 40.6 Cg_endo -67.0 -23.91 46.05 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.298 1.998 . . . . 0.0 112.883 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -65.12 -46.03 82.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.873 0.368 . . . . 0.0 111.155 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.8 m -87.06 -28.99 5.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.314 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.9 -29.61 63.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.261 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.59 -33.37 71.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.13 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.2 p -93.87 -30.78 14.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.949 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.73 25.61 24.77 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.59 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -94.44 -32.97 13.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.869 0.366 . . . . 0.0 110.867 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.27 -143.94 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.534 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.422 ' HG3' ' CD2' ' A' ' 10' ' ' TRP . 43.6 Cg_endo -68.09 -167.78 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.538 2.159 . . . . 0.0 112.329 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -123.75 -51.9 1.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.0 mt -109.77 138.46 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.092 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.469 ' CG1' ' N ' ' A' ' 61' ' ' PHE . 3.0 tt -125.82 159.72 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.069 0.461 . . . . 0.0 111.029 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.469 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 46.4 m-85 -135.08 125.63 26.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.932 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.411 ' CD1' ' HG3' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -160.27 175.95 12.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.52 157.01 37.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.142 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.428 ' CG ' ' HB1' ' A' ' 96' ' ' ALA . 32.2 p80 -57.98 -34.11 69.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.994 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -60.59 -48.82 80.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.08 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.411 ' HG3' ' CD1' ' A' ' 62' ' ' TRP . 30.5 mmm180 -74.87 -27.85 60.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.021 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.412 ' CE2' ' HB2' ' A' ' 263' ' ' SER . 1.0 OUTLIER -57.65 -22.37 45.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.147 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -94.6 33.7 5.18 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.576 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -118.4 -32.49 1.35 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.51 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -88.41 -27.52 21.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.775 0.322 . . . . 0.0 110.98 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.33 -30.72 38.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.053 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.411 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 3.5 pt20 -61.05 -36.4 79.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.962 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 m -89.75 -23.06 21.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.126 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.74 59.2 0.87 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.452 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.0 mt -138.31 31.69 2.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.362 . . . . 0.0 110.961 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.1 mt -138.88 161.45 37.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -97.8 151.21 20.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.058 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.06 -165.37 0.55 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.93 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.4 pt -157.64 171.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.085 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.8 p -158.1 77.42 3.52 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.741 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.48 160.16 47.39 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.631 2.221 . . . . 0.0 112.347 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.35 -176.94 3.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.753 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.3 mttp -59.89 -38.94 83.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.81 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.18 -28.04 61.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.075 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -79.19 -37.69 37.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.935 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -82.14 -25.95 33.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.085 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -79.19 -40.83 29.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.163 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.5 pttt -58.37 -39.45 79.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.083 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.412 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 24.9 mt -83.01 162.1 21.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.872 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.438 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . 26.1 m-85 -88.26 147.63 40.72 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.03 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -54.21 -55.71 3.18 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.567 2.178 . . . . 0.0 112.736 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.447 ' CE1' ' CG2' ' A' ' 93' ' ' THR . 40.2 p90 -54.09 -39.62 66.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.808 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.447 ' CG2' ' CE1' ' A' ' 92' ' ' PHE . 27.8 p -61.42 -32.98 72.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.745 0.307 . . . . 0.0 110.826 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.412 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 45.3 m95 -67.75 -32.0 72.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.793 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -60.35 -26.98 67.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.055 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.428 ' HB1' ' CG ' ' A' ' 64' ' ' HIS . . . -73.12 -28.67 62.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.258 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 m -104.05 56.24 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.936 0.398 . . . . 0.0 111.245 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -156.08 130.45 8.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.411 ' CE2' ' HB3' ' A' ' 72' ' ' GLN . 1.8 t80 -96.23 -64.74 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.838 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -127.69 45.78 2.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.795 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.16 -26.8 19.4 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.526 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.2 141.8 33.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.841 0.353 . . . . 0.0 110.88 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 32.1 mt -97.01 132.05 43.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.843 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.6 pp -138.31 30.47 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.196 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -173.8 178.73 2.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.152 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -155.74 96.09 2.4 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.807 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.54 144.99 39.39 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.504 2.136 . . . . 0.0 112.424 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.4 mt -128.31 -59.3 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.047 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -105.86 145.75 30.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.096 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 32.7 t -121.18 138.36 51.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.136 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -139.47 160.08 40.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.863 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -172.31 152.74 2.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.083 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.3 mt -71.02 101.94 2.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.44 -176.52 3.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.6 tp -96.81 114.61 26.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.919 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.7 mt -108.9 114.01 45.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.004 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -124.88 165.53 17.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.906 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.39 144.51 34.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.926 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.5 mtmm -98.5 33.39 2.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.961 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -93.13 -48.12 6.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.949 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.96 -35.26 5.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.008 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.6 tt -108.53 95.32 15.95 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.979 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.48 -45.24 1.26 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.484 2.123 . . . . 0.0 112.353 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -100.34 114.71 65.81 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.51 153.01 39.11 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.416 2.077 . . . . 0.0 112.364 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.52 116.24 4.64 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.576 2.184 . . . . 0.0 112.289 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.93 -23.73 38.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.027 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 73.2 p -118.01 149.7 40.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.895 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.459 ' CE3' ' CD1' ' A' ' 132' ' ' ILE . 26.5 m95 -69.63 -31.27 69.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.854 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -68.8 -15.65 63.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.427 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -85.5 -16.95 37.87 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.517 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 24.0 mt -71.78 -49.42 10.78 Favored Pre-proline 0 C--N 1.331 -0.204 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.517 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 83.3 Cg_exo -44.99 -46.58 12.96 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.499 2.132 . . . . 0.0 112.509 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.07 -40.07 92.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.997 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.73 -36.84 85.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.797 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.76 -27.51 63.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.067 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.422 ' HE2' ' CE1' ' A' ' 203' ' ' HIS . 50.1 mttm -85.6 -31.6 22.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.069 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -85.1 -56.46 3.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.171 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.42 -26.77 43.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.272 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -77.67 -28.26 51.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.804 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.42 -38.28 83.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.951 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 41.3 mttt -73.64 -27.12 61.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.073 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.2 32.4 1.83 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.599 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.2 mtmt -149.82 159.7 44.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 0.0 110.874 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 84.7 p -82.33 170.11 15.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.975 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -102.67 -56.69 2.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.169 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.0 tp -153.54 136.32 15.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.92 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.87 -177.91 4.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.82 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -177.25 -172.78 0.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.416 ' HB3' ' CD1' ' A' ' 156' ' ' PHE . 60.2 t-20 -83.59 114.21 21.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.941 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.4 mt -98.57 30.8 3.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.911 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -127.54 30.33 5.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -168.49 111.42 0.55 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.26 -25.74 14.07 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.453 2.102 . . . . 0.0 112.353 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.494 ' CZ ' ' CE1' ' A' ' 258' ' ' PHE . 0.8 OUTLIER -58.4 -31.5 67.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.416 ' CD1' ' HB3' ' A' ' 150' ' ' ASN . 13.6 m-85 -74.43 -30.53 61.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 21.1 p -102.56 30.34 4.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.067 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.468 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 1.4 t-105 -83.59 -48.45 0.73 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.093 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 32.4 Cg_exo -58.13 -18.83 38.49 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.417 2.078 . . . . 0.0 112.497 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 15.6 tp -92.66 -32.13 14.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.155 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 15.6 mt -95.79 -58.02 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.222 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -56.15 -31.1 63.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.252 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -59.08 -44.82 91.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.135 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -63.73 -20.08 65.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.185 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 131.71 71.26 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.56 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -158.2 142.9 8.84 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.493 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -147.48 179.47 7.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.332 . . . . 0.0 110.999 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.413 ' HB1' ' CE1' ' A' ' 339' ' ' PHE . . . -103.55 -33.01 9.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.983 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -141.25 155.31 46.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.793 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 9.1 tttm -103.35 111.32 23.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.057 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.437 ' CD1' ' CZ ' ' A' ' 176' ' ' TYR . 57.4 t80 -73.81 110.91 8.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.412 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -158.76 150.92 21.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.08 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 61.51 29.93 18.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.059 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 90.78 -38.54 3.2 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.014 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -108.05 -177.11 3.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.918 0.389 . . . . 0.0 111.079 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.437 ' CZ ' ' CD1' ' A' ' 171' ' ' TYR . 4.9 m-85 -108.1 121.14 44.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.921 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -58.75 132.5 54.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.7 pt -91.02 -23.63 5.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.385 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.39 26.05 4.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.15 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -141.53 90.12 2.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.919 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 16.2 t -100.75 146.01 10.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.079 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -111.0 66.55 0.23 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.652 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.423 HG12 ' HA ' ' A' ' 361' ' ' LEU . 1.5 t -103.13 -60.52 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.91 0.386 . . . . 0.0 111.064 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -83.46 56.7 3.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.11 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -95.77 168.43 10.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.814 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -59.83 -34.17 72.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.113 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -85.93 -45.51 5.67 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.611 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.9 -38.69 79.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.785 0.326 . . . . 0.0 111.17 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -60.07 -34.7 73.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -87.55 -30.99 20.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.168 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -58.45 -50.5 66.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.57 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.77 -43.08 98.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.806 0.336 . . . . 0.0 110.931 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 9.9 m -50.19 -27.37 5.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.252 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -67.93 -58.67 4.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.811 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.1 tp -64.76 -30.1 71.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.18 -56.92 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.062 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.84 -28.41 61.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.146 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 26.2 mt -59.69 -58.22 9.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.012 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 9.0 mt -61.39 -28.8 44.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.057 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.33 -35.4 66.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -90.2 16.46 8.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.44 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.84 39.12 27.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.821 0.343 . . . . 0.0 111.216 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . 0.422 ' CE1' ' HE2' ' A' ' 137' ' ' LYS . 2.8 m-70 -90.2 -23.86 21.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.888 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 13.9 mtt -132.91 -177.51 4.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.777 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -115.59 147.86 40.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.918 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -78.8 -30.52 45.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.041 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . 0.407 ' O ' HD11 ' A' ' 212' ' ' ILE . 0.9 OUTLIER -91.37 60.04 4.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.783 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.453 ' HA ' HD11 ' A' ' 212' ' ' ILE . 0.2 OUTLIER -117.43 138.55 51.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.928 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.423 ' HB2' ' CG1' ' A' ' 212' ' ' ILE . 57.3 m-20 -154.19 176.16 12.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.732 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -64.68 -39.84 94.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.231 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.03 -59.08 3.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.876 0.369 . . . . 0.0 110.988 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.453 HD11 ' HA ' ' A' ' 208' ' ' THR . 0.3 OUTLIER -57.63 -29.11 33.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.656 179.805 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -80.61 -22.63 40.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.961 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -77.88 -36.62 49.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.866 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -72.47 -38.2 68.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.037 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.66 -30.8 67.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.121 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.421 ' CD1' HG21 ' A' ' 225' ' ' THR . 58.2 t80 -81.71 -36.88 28.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.93 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -68.28 -46.85 69.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.52 -30.1 71.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.13 43.79 1.99 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.49 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -100.3 -74.49 0.6 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.882 0.373 . . . . 0.0 110.903 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 11.3 t -74.34 142.81 45.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.72 -30.98 46.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.049 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.1 mpp? -128.34 156.24 43.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.929 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.421 HG21 ' CD1' ' A' ' 217' ' ' PHE . 9.4 t -166.64 147.36 6.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.5 mt -109.85 126.51 67.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.029 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -144.92 165.43 28.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.418 ' HA3' ' CZ3' ' A' ' 230' ' ' TRP . . . -80.96 -169.44 41.46 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.533 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.423 ' HD2' ' CE3' ' A' ' 230' ' ' TRP . 55.1 Cg_endo -69.81 -8.98 24.99 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.562 2.175 . . . . 0.0 112.699 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . 0.423 ' CE3' ' HD2' ' A' ' 229' ' ' PRO . 41.0 p90 -94.36 39.25 1.09 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.758 0.314 . . . . 0.0 111.09 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -113.47 -33.19 5.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.129 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 22.4 m0 -63.14 -31.42 72.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.862 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 49.6 m -60.8 -33.69 73.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.96 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.35 -50.89 72.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 18.1 pt -75.58 134.81 28.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.123 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -176.26 -40.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.69 -36.05 9.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.35 -32.69 58.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.923 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt 60.06 74.65 0.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.27 122.0 56.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.063 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -63.18 107.3 1.02 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -98.13 157.65 16.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.3 120.68 2.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.463 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.5 t -94.39 123.04 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 111.1 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 58.9 m -143.52 136.18 27.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.409 ' CG2' ' N ' ' A' ' 247' ' ' LEU . 0.7 OUTLIER -54.62 152.34 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.241 0.543 . . . . 0.0 111.328 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.409 ' N ' ' CG2' ' A' ' 246' ' ' VAL . 4.7 mt -59.62 139.47 89.5 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.884 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.42 ' HB2' ' CD1' ' A' ' 129' ' ' TRP . 51.2 Cg_exo -54.0 -172.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.504 2.136 . . . . 0.0 112.276 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 2.7 p -122.65 165.48 16.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.883 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.416 ' CD2' ' HG3' ' A' ' 251' ' ' LYS . 14.6 t80 -129.0 117.54 21.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.416 ' HG3' ' CD2' ' A' ' 250' ' ' PHE . 6.2 mtpp 59.96 31.99 20.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 73.8 27.02 67.81 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.564 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -118.85 147.81 43.16 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.7 0.286 . . . . 0.0 110.859 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.7 149.89 55.53 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.538 2.159 . . . . 0.0 112.286 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 66.9 p -73.81 159.19 33.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.39 54.59 4.56 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.876 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.19 155.27 64.92 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.575 2.183 . . . . 0.0 112.281 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . 0.494 ' CE1' ' CZ ' ' A' ' 155' ' ' TYR . 67.0 m-85 -74.17 166.21 23.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.894 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 22.0 t -116.7 134.95 58.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.24 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -128.93 96.24 0.4 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.388 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 10.2 p -98.8 159.96 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.819 0.342 . . . . 0.0 111.216 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 12.2 tp -122.21 104.67 9.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.903 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.412 ' HB2' ' CE2' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -109.07 170.3 8.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.924 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -101.95 143.6 31.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.058 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -116.05 152.43 17.97 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.56 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 30.2 mt -135.15 144.37 34.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.833 0.349 . . . . 0.0 110.983 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -82.49 153.69 25.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -84.08 -22.8 31.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.355 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -53.66 -82.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.226 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' SER . . . . . 0.419 ' N ' ' HD3' ' A' ' 271' ' ' PRO . 0.3 OUTLIER 179.58 65.56 0.13 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.94 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' A' ' 270' ' ' SER . 4.9 Cg_exo -76.67 -71.44 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.812 2.341 . . . . 0.0 112.088 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 174.88 68.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.625 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.26 -28.13 69.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.086 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -77.07 -49.35 15.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.146 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 99.3 mt -76.04 -44.44 39.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.096 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -58.46 -53.38 59.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.155 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 24.6 tttp -59.97 -30.67 69.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.959 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -81.04 -38.51 27.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.943 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.41 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 49.8 t80 -72.55 -34.93 67.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.951 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 7.8 mt -81.46 -20.77 39.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.396 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -91.08 -48.7 6.81 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.434 ' O ' ' CG ' ' A' ' 283' ' ' TYR . 0.0 OUTLIER -114.16 28.37 8.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.073 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.434 ' CG ' ' O ' ' A' ' 282' ' ' ASN . 32.3 m-85 -164.39 32.75 0.07 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.856 0.36 . . . . 0.0 111.005 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 10.6 tp -168.66 -42.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.898 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 1.9 mt -98.16 30.38 3.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.897 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 65.8 p -138.95 164.52 29.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.853 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.27 -27.81 62.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.077 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -67.03 -41.88 85.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.022 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -92.41 -46.47 3.5 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.678 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.422 ' HB3' ' CE2' ' A' ' 307' ' ' TYR . 0.6 OUTLIER -57.67 -53.61 56.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.801 0.334 . . . . 0.0 111.09 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -58.83 -32.49 69.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.965 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -66.6 -42.51 86.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.141 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.8 t -81.84 -30.3 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.175 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -69.83 -30.78 68.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 7.9 mtpp -63.58 -33.6 75.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.952 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -98.3 -39.99 8.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.99 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -144.25 89.17 7.1 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.856 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.47 98.08 0.83 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.523 2.149 . . . . 0.0 112.34 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 1.7 mp -58.78 -22.88 59.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.094 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 110.04 -118.16 4.98 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.45 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -81.22 163.26 23.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 111.038 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 15.5 m -141.59 176.04 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.142 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -87.49 -30.32 20.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.16 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 5.4 tp -58.1 122.22 12.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.975 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -64.51 -41.45 96.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.947 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.5 m -60.01 -53.3 59.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.93 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.422 ' CE2' ' HB3' ' A' ' 290' ' ' LEU . 2.5 t80 -67.4 -23.2 65.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.162 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.03 -31.24 66.81 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 110.85 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -76.24 -58.04 3.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -50.11 -32.44 15.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 32.9 mt -85.76 -26.63 25.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.704 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -74.89 -6.05 47.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.515 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.47 -31.76 4.51 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.986 0.422 . . . . 0.0 110.82 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.87 134.8 24.39 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.317 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.15 -27.14 54.48 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.42 2.08 . . . . 0.0 112.373 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -49.82 -42.02 46.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.037 0.446 . . . . 0.0 110.294 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 30.8 mt -85.63 -33.55 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.851 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.8 -30.71 67.81 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.129 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.59 -31.98 70.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.082 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 25.3 m -62.49 -51.15 68.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.911 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 5.6 tpt -61.5 -37.51 83.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -64.77 -31.87 73.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -67.01 -38.28 85.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -78.7 -35.35 45.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -67.07 -43.65 82.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.928 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.31 -31.35 26.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.84 -164.07 1.82 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.528 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -137.34 129.11 28.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.37 . . . . 0.0 110.892 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.424 HG21 ' CE1' ' A' ' 64' ' ' HIS . 31.2 mt -77.22 138.98 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.113 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 30.4 mtm -76.77 130.47 76.11 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.919 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.44 175.55 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.378 2.052 . . . . 0.0 112.271 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -114.17 32.1 6.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.819 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 42.3 pt -99.63 153.59 37.7 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.2 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.66 -25.2 34.44 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.583 2.188 . . . . 0.0 112.382 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -58.62 -25.16 62.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.096 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 23.3 mmm -56.19 -32.47 64.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.052 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.3 m -59.52 -48.68 80.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.0 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -59.14 -31.55 69.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.06 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.437 ' CE1' ' CG2' ' A' ' 343' ' ' VAL . 85.0 t80 -69.34 -32.25 71.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . 0.489 ' CZ2' ' CZ ' ' A' ' 155' ' ' TYR . 68.9 m95 -66.38 -30.63 71.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.961 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -84.71 -51.73 6.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.178 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -55.23 -54.41 43.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.43 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.437 ' CG2' ' CE1' ' A' ' 339' ' ' PHE . 28.8 t -59.03 -30.66 44.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.228 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.44 -57.48 12.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.975 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 3.6 m -68.66 -27.29 65.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.108 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -57.14 -61.74 2.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.397 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 23.3 t -61.8 -43.15 96.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.309 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 27.7 mt -63.56 -44.98 98.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.109 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -59.79 -30.95 69.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -77.96 -51.06 10.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.108 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -60.17 -40.15 88.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.087 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 14.9 m -71.65 -22.42 61.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.122 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 86.5 27.52 29.74 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.453 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -89.59 -30.39 18.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.784 0.326 . . . . 0.0 110.9 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -145.37 145.07 31.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.888 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.7 p -62.37 169.51 2.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.795 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.481 ' CG1' ' N ' ' A' ' 358' ' ' ASP . 1.5 p -62.51 -47.3 93.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.893 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . 0.481 ' N ' ' CG1' ' A' ' 357' ' ' VAL . 3.2 m-20 -66.78 -31.42 72.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.987 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -72.19 -43.13 64.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.975 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -60.59 -40.6 92.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.162 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.423 ' HA ' HG12 ' A' ' 183' ' ' VAL . 0.5 OUTLIER -77.35 -31.82 54.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.806 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.6 -52.88 40.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -61.17 -47.28 86.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -57.96 -37.73 74.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.072 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.67 -42.15 96.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.794 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 31.6 m -71.68 -31.5 66.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.862 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 36.1 mtt180 -69.41 -42.02 75.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 4.8 mt -67.19 -51.96 47.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 9.8 t -95.44 43.59 1.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.994 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 1.2 tttm . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.245 -0.884 . . . . 0.0 110.92 179.986 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.773 0.321 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -151.64 154.34 36.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -83.62 139.89 32.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.925 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.38 26.51 43.16 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.539 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.0 159.74 32.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.78 0.324 . . . . 0.0 110.915 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.4 mt -128.09 109.98 12.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.5 t -83.6 147.01 6.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.15 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.474 HG21 HD11 ' A' ' 9' ' ' ILE . 29.6 mt -127.42 107.5 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.949 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.45 ' CE3' ' CD1' ' A' ' 43' ' ' LEU . 3.6 m0 -97.98 106.76 19.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.798 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.7 tt -140.67 158.19 24.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.085 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -59.1 146.51 38.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.26 -26.13 74.16 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.598 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.24 46.45 1.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.914 0.388 . . . . 0.0 111.006 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -141.34 -176.13 4.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.833 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.78 80.33 0.12 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.516 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 19.2 p90 -83.65 -35.61 24.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.868 0.366 . . . . 0.0 110.942 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.4 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 6.9 t-20 -60.31 -31.17 70.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.61 -58.1 8.17 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.476 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.79 -30.41 70.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.81 0.338 . . . . 0.0 110.885 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.51 -43.89 95.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.059 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -75.64 -51.96 11.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.9 t -59.05 -31.21 45.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.055 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.42 -34.41 84.73 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.424 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.8 mmtm -72.46 -28.16 62.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.824 0.345 . . . . 0.0 110.957 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -46.1 89.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.989 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -62.48 -41.21 98.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.956 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -69.79 -30.89 68.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.941 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.8 mttp -82.66 -26.66 31.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.086 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -91.78 -24.98 19.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.726 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.6 p -125.4 -44.19 1.87 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.692 0.282 . . . . 0.0 111.59 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.3 -26.82 5.17 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.585 -0.816 . . . . 0.0 112.467 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.6 mm -59.96 124.33 14.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.826 0.346 . . . . 0.0 111.058 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.3 mtmt -72.23 153.7 41.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.948 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.5 t -140.54 110.58 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.106 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.4 m -105.53 130.25 53.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.933 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t -97.94 110.52 25.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.051 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -103.35 141.18 36.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.974 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -136.57 70.17 59.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.813 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.63 156.06 40.16 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.629 2.219 . . . . 0.0 112.503 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.69 140.69 37.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.506 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? 56.39 41.72 28.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.675 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.45 ' CD1' ' CE3' ' A' ' 10' ' ' TRP . 0.9 OUTLIER -89.1 16.87 6.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.554 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -60.99 -42.18 97.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.876 0.369 . . . . 0.0 110.694 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -85.45 -6.3 59.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.252 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.85 -20.07 36.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.376 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.422 ' CZ ' ' HG2' ' A' ' 57' ' ' PRO . 0.4 OUTLIER -78.86 -52.58 1.25 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.617 0.246 . . . . 0.0 111.224 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.413 ' HD3' ' CB ' ' A' ' 47' ' ' PHE . 35.2 Cg_exo -59.94 -40.07 65.56 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.47 2.113 . . . . 0.0 112.366 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.442 ' CG ' ' N ' ' A' ' 50' ' ' VAL . 1.7 pt20 -60.12 -49.08 79.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.01 0.433 . . . . 0.0 111.058 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.442 ' N ' ' CG ' ' A' ' 49' ' ' GLN . 34.2 m -79.28 -23.92 12.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.212 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.14 -27.79 48.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.19 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.13 -34.85 75.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.197 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.8 t -69.52 -26.8 64.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.972 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.34 32.52 4.87 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.602 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.32 -81.25 0.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.789 0.328 . . . . 0.0 110.933 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 54.3 -170.85 1.11 Allowed Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.605 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.422 ' HG2' ' CZ ' ' A' ' 47' ' ' PHE . 55.2 Cg_endo -69.59 -179.57 2.93 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.577 2.185 . . . . 0.0 112.253 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -110.2 -31.3 7.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.976 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.8 mt -143.75 137.41 24.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.235 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.48 ' CG1' ' N ' ' A' ' 61' ' ' PHE . 2.6 tt -142.36 159.72 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.887 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.48 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 41.7 m-85 -130.46 135.83 48.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.065 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -176.04 161.79 2.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.863 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.92 148.97 28.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.201 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.414 ' CG ' ' HB2' ' A' ' 96' ' ' ALA . 45.4 p-80 -60.7 -36.03 77.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.867 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -60.34 -30.28 69.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -93.85 17.17 12.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.208 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -112.2 29.24 8.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.854 0.359 . . . . 0.0 110.87 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.83 25.35 6.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.535 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -120.53 -36.4 0.79 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.483 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -83.07 -27.59 30.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.745 0.307 . . . . 0.0 111.036 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.03 -36.88 22.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.165 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -59.19 -32.54 70.02 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.078 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 m -90.1 -23.14 21.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.141 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.96 57.87 0.76 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.45 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.2 mt -139.25 32.36 2.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.793 0.33 . . . . 0.0 110.916 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.0 mt -144.4 160.57 40.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.56 163.28 12.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.066 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -93.56 -165.48 1.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.409 HG23 ' CZ ' ' A' ' 106' ' ' TYR . 44.6 pt -157.49 172.87 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.957 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 48.1 p -156.54 77.48 4.24 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.802 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.42 134.29 26.27 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.641 2.227 . . . . 0.0 112.348 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.71 174.26 10.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.758 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -59.66 -37.05 77.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.825 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.72 -30.05 69.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.064 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -77.58 -47.72 18.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.895 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -65.64 -30.89 71.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.954 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.04 -27.07 64.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.053 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -95.94 39.83 1.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.03 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.422 HD11 ' CZ2' ' A' ' 94' ' ' TRP . 8.3 mt -157.99 173.74 16.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.861 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.442 ' CZ ' ' CE ' ' A' ' 321' ' ' MET . 27.2 m-85 -89.34 150.78 45.38 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.057 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -67.79 -56.39 0.21 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.454 2.103 . . . . 0.0 112.441 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' A' ' 93' ' ' THR . 44.2 p90 -55.68 -41.01 73.09 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.4 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.443 ' N ' ' CD1' ' A' ' 92' ' ' PHE . 13.8 p -56.89 -29.62 63.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.068 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.422 ' CZ2' HD11 ' A' ' 89' ' ' LEU . 55.0 m95 -74.52 -30.85 61.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.914 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.85 -28.43 64.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.0 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.414 ' HB2' ' CG ' ' A' ' 64' ' ' HIS . . . -72.26 -29.57 64.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.226 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.0 m -100.46 50.82 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.259 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -156.08 142.27 18.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -93.69 -47.97 6.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.927 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -151.48 58.71 0.88 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.842 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.08 -27.88 14.96 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.611 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.22 152.47 21.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 110.891 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.417 HD12 ' CE3' ' A' ' 94' ' ' TRP . 13.7 mt -110.59 150.38 29.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.2 pp -146.68 30.37 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.221 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -164.34 -176.87 4.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.168 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.409 ' CZ ' HG23 ' A' ' 79' ' ' ILE . 81.8 m-85 -142.02 89.35 8.85 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.922 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.86 129.92 35.12 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.551 2.167 . . . . 0.0 112.214 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.4 mt -112.91 -61.34 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.226 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -127.34 150.6 49.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.175 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.72 137.39 54.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.033 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -116.36 161.66 18.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.952 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -169.17 158.44 8.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.098 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.8 mt -67.71 -178.28 0.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.936 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.95 169.27 8.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.929 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.4 tp -101.24 142.8 32.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.7 mt -127.72 131.94 69.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.077 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -134.97 161.18 36.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -115.74 117.76 31.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.024 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -66.64 -28.46 68.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -56.82 -40.78 76.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.928 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 81.7 mt -88.06 -80.15 0.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.83 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.21 144.46 54.24 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.84 -43.06 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.477 2.118 . . . . 0.0 112.295 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -139.42 142.77 33.36 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.853 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.61 150.94 36.25 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.566 2.177 . . . . 0.0 112.337 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.28 120.02 6.32 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.56 2.173 . . . . 0.0 112.309 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -94.88 20.59 8.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.95 142.0 29.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.914 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -72.54 -25.95 61.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.017 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.1 -21.93 56.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.213 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -77.5 -26.28 51.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.203 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.524 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 36.8 mt -62.26 -54.45 49.26 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.534 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 18.7 Cg_endo -60.23 -28.32 86.67 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.185 1.923 . . . . 0.0 112.131 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.59 -30.21 41.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.74 -35.78 65.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.814 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.37 -27.92 39.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -85.65 -28.21 24.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.072 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -84.45 -37.27 21.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.11 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.4 -17.21 60.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.487 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.09 -29.54 57.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.876 0.369 . . . . 0.0 110.656 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.46 -37.12 82.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.928 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -78.46 -27.11 46.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.022 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 113.66 45.11 0.73 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.509 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -162.03 -178.24 6.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.814 0.34 . . . . 0.0 110.937 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.2 t -112.0 176.99 4.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.848 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -101.96 -68.42 0.82 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.199 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.3 tp -140.42 145.72 37.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.963 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.21 -177.82 5.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.805 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.434 ' CZ ' ' CE ' ' A' ' 204' ' ' MET . 22.6 p90 -179.4 170.93 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.818 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.405 ' OD1' ' CG ' ' A' ' 156' ' ' PHE . 4.4 p-10 -79.47 131.06 35.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.2 mt -105.91 29.13 6.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.992 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -104.41 -30.48 10.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.944 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -119.78 120.69 30.3 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.935 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.05 -21.94 29.18 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.509 2.139 . . . . 0.0 112.434 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.5 ' CD1' ' CE2' ' A' ' 258' ' ' PHE . 2.5 m-85 -53.91 -30.02 44.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.129 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.405 ' CG ' ' OD1' ' A' ' 150' ' ' ASN . 4.3 m-85 -89.81 -30.24 18.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.902 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.3 p -95.03 18.42 12.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.263 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.471 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 13.4 t-105 -87.44 -46.86 0.49 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.313 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 59.2 Cg_exo -51.72 -25.38 20.39 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.329 2.02 . . . . 0.0 112.438 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 49.6 tp -76.73 -61.95 1.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.001 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 4.3 mt -69.33 -46.42 76.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.224 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -57.65 -34.05 68.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.25 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.09 -41.33 92.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -68.21 -20.09 64.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.187 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 121.44 41.72 0.49 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.467 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -119.54 103.6 0.98 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.507 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.425 ' CD2' ' HA3' ' A' ' 182' ' ' GLY . 30.3 p90 -114.15 -177.4 3.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.796 0.332 . . . . 0.0 110.882 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -108.19 -35.09 6.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.087 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -136.39 152.97 51.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.88 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.27 118.93 37.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.061 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.404 ' CE1' ' HA ' ' A' ' 175' ' ' LYS . 6.5 t80 -79.53 121.24 24.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.489 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -170.41 147.32 2.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.969 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 63.4 42.36 6.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.863 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.4 ' O ' ' CZ ' ' A' ' 171' ' ' TYR . . . 102.83 -63.16 0.44 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.694 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.404 ' HA ' ' CE1' ' A' ' 171' ' ' TYR . 35.9 pttt -128.7 -166.92 1.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.805 0.336 . . . . 0.0 110.994 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -94.09 174.0 7.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -131.31 158.61 40.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.975 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 44.9 pt -92.76 -6.44 10.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.601 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.33 25.89 4.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.755 0.312 . . . . 0.0 111.073 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -152.91 102.53 2.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.859 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 24.2 t -93.96 145.95 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.104 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . 0.425 ' HA3' ' CD2' ' A' ' 167' ' ' TYR . . . -96.88 -20.46 23.88 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.734 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.429 HG13 ' CD2' ' A' ' 361' ' ' LEU . 21.4 t -55.17 -40.76 56.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.822 0.344 . . . . 0.0 111.346 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -84.29 57.19 4.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.974 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -118.82 168.56 10.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.834 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.59 -32.97 70.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.133 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -83.47 -38.41 10.87 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.534 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.16 -34.35 72.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.866 0.365 . . . . 0.0 111.168 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -59.95 -54.54 44.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -60.89 -30.14 69.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.177 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -57.9 -54.23 39.04 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.557 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.26 -44.86 86.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.1 m -53.5 -25.22 15.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.203 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -69.49 -60.59 2.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.801 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.1 tp -62.3 -33.2 74.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.662 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 47.3 t -69.04 -34.57 64.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.975 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -74.06 -38.34 63.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 5.5 mt -57.94 -54.15 50.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.001 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 8.6 mt -68.38 -24.86 30.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.135 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -64.35 -40.89 96.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.022 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -95.81 22.07 7.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.232 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.03 79.22 0.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.844 0.354 . . . . 0.0 111.027 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -149.82 25.44 0.84 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.886 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' MET . . . . . 0.434 ' CE ' ' CZ ' ' A' ' 149' ' ' PHE . 23.1 mtp -160.77 -178.78 7.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.822 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -130.05 114.01 15.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.842 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -67.66 -32.58 73.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.89 46.75 1.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.976 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 57.2 m -98.41 138.17 36.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.923 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -106.15 176.05 5.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.828 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -75.77 -33.56 60.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.938 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.4 m -82.79 -28.18 30.47 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.092 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -45.66 -47.47 4.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.218 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -71.73 -28.09 63.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.16 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.416 ' HA ' ' CE2' ' A' ' 217' ' ' PHE . 0.4 OUTLIER -61.86 -63.0 1.4 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.937 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.77 -21.45 66.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.365 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.09 -61.11 2.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.274 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.431 ' CD1' ' N ' ' A' ' 218' ' ' ASN . 11.2 p90 -68.8 -30.72 69.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.925 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . 0.431 ' N ' ' CD1' ' A' ' 217' ' ' PHE . 5.5 t-20 -60.18 -30.68 69.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.28 28.76 7.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.921 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 58.57 95.92 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.53 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -150.46 -46.89 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.337 . . . . 0.0 110.88 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.3 t -124.71 171.97 9.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -93.12 -54.05 3.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.084 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -111.08 163.53 13.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 78.4 m -163.99 152.62 13.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.8 mt -126.7 129.56 71.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.018 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -145.43 159.31 43.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -75.86 -156.44 6.21 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.54 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.419 ' HD2' ' CZ3' ' A' ' 230' ' ' TRP . 43.3 Cg_endo -68.14 -24.22 38.71 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.554 2.169 . . . . 0.0 112.473 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . 0.419 ' CZ3' ' HD2' ' A' ' 229' ' ' PRO . 44.9 p90 -84.06 57.02 3.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.403 . . . . 0.0 110.92 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -143.0 -44.79 0.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.199 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 20.3 m0 -52.98 -40.84 64.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.058 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 13.0 m -61.71 -30.85 71.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.864 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -64.78 -31.71 73.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.929 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.419 HG22 ' CD1' ' A' ' 242' ' ' TYR . 4.8 mt -84.23 57.77 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.056 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.67 -48.51 2.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.816 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 2.5 m -108.98 31.23 5.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.888 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 3.4 t -100.37 -29.73 12.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp 64.04 40.57 7.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.07 117.62 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.042 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -62.02 124.19 20.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.419 ' CD1' HG22 ' A' ' 235' ' ' ILE . 21.1 p90 -118.94 132.04 56.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.876 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -109.14 131.3 10.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.517 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.3 t -99.21 117.42 44.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.809 0.338 . . . . 0.0 111.085 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.7 t -135.8 149.66 49.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.414 ' CG2' ' N ' ' A' ' 247' ' ' LEU . 0.7 OUTLIER -55.09 152.22 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.257 0.551 . . . . 0.0 111.311 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.414 ' N ' ' CG2' ' A' ' 246' ' ' VAL . 40.7 mt -72.35 152.15 92.1 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.077 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.73 177.15 2.43 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.619 2.213 . . . . 0.0 112.258 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 57.5 p -115.57 152.76 32.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -100.37 116.48 32.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.76 25.97 15.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.038 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 93.64 -21.09 43.04 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.695 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -87.74 142.18 32.38 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.685 0.278 . . . . 0.0 110.901 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.8 163.26 33.87 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.578 2.185 . . . . 0.0 112.339 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.4 p -88.18 179.52 6.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.892 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.409 ' N ' ' HD3' ' A' ' 257' ' ' PRO . 5.5 mtmm -136.55 62.86 44.92 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.939 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.409 ' HD3' ' N ' ' A' ' 256' ' ' LYS . 32.3 Cg_exo -57.94 -173.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.537 2.158 . . . . 0.0 112.242 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . 0.5 ' CE2' ' CD1' ' A' ' 155' ' ' TYR . 43.4 m-85 -103.91 126.22 50.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.729 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.2 t -108.63 138.53 35.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.378 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -119.78 156.3 15.89 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.258 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 10.9 p -139.65 152.2 22.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.819 0.342 . . . . 0.0 111.238 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 20.3 tp -105.25 110.28 22.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.74 155.95 40.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.933 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -100.85 133.46 45.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.113 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -101.38 161.74 18.05 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.489 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 31.5 mt -135.14 152.0 31.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.822 0.344 . . . . 0.0 111.146 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -91.47 149.27 21.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.952 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.98 -28.38 68.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.189 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -55.82 -30.0 60.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.268 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 5.9 t 59.09 62.5 4.11 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.55 -32.84 14.6 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.583 2.188 . . . . 0.0 112.297 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -162.33 46.86 0.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 34.0 mttt -59.62 -31.83 69.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -60.15 -54.97 39.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.897 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 77.8 mt -75.24 -31.06 60.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -59.87 -45.86 91.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.34 -51.26 70.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.906 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -61.81 -45.39 94.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -66.09 -37.85 86.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.972 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 55.3 mt -81.33 -21.01 39.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.376 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -93.52 -43.32 8.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.796 0.331 . . . . 0.0 111.334 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -92.08 -48.92 6.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.211 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -96.96 38.56 1.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.166 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.96 38.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.888 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -177.77 37.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.825 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 38.3 p -140.79 167.28 22.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.921 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -64.91 -30.43 71.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.969 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -76.24 -30.64 57.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.981 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -90.71 -50.76 2.83 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.588 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 3.5 mt -59.28 -41.1 88.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.991 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -62.37 -37.06 84.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.959 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.41 -47.57 83.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.043 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 25.3 t -72.94 -30.92 33.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.027 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -71.81 -31.25 66.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 9.9 mtmt -63.41 -34.84 78.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.99 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -99.53 -34.74 10.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.078 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.4 tptt -148.43 91.33 4.76 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.98 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.5 108.54 2.24 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.495 2.13 . . . . 0.0 112.296 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 4.9 mt -59.53 -28.4 67.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.013 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 107.37 -125.83 8.15 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.461 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.83 94.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.846 0.355 . . . . 0.0 111.039 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 30.1 m -67.65 158.08 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.184 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -87.94 -26.45 22.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.141 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 10.0 tp -55.97 127.63 31.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.963 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -67.31 -29.49 69.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.048 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.26 -26.09 36.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.226 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.54 -22.98 16.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.396 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.38 -33.4 69.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.859 0.362 . . . . 0.0 110.948 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -75.48 -53.49 8.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.907 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -49.66 -34.13 17.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.767 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 12.4 mt -85.8 -26.46 25.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.641 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -71.56 -14.12 61.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.433 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -48.0 -34.1 8.85 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.965 0.412 . . . . 0.0 110.83 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.52 138.1 21.34 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.381 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.3 -23.56 38.23 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.407 2.071 . . . . 0.0 112.432 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.05 -41.58 59.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.961 0.41 . . . . 0.0 110.34 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 33.8 mm -85.57 -33.65 7.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.952 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.67 -30.08 68.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.223 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -73.64 -51.71 15.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.178 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 8.8 t -58.94 -30.73 68.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.995 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.442 ' CE ' ' CZ ' ' A' ' 90' ' ' TYR . 4.9 ttt -85.47 -31.03 23.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.983 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -59.27 -46.96 87.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.912 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -66.05 -31.52 72.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -72.06 -49.21 38.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.088 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -59.97 -35.64 75.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.919 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -96.27 21.07 9.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.085 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -133.3 -179.11 16.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.514 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.09 137.2 42.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.819 0.343 . . . . 0.0 110.929 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 12.2 mt -80.29 144.28 10.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.055 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 15.1 ttm -57.21 113.32 5.95 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.941 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.83 -172.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.459 2.106 . . . . 0.0 112.315 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -152.76 38.6 0.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.923 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 10.2 pt -107.2 155.75 38.8 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.129 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.34 -27.75 47.42 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.535 2.157 . . . . 0.0 112.336 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -59.44 -22.59 61.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.091 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 9.5 mtp -54.63 -28.3 45.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.127 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.1 m -56.91 -53.96 52.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.014 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -59.66 -30.29 68.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.041 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.441 ' CE1' ' CG2' ' A' ' 343' ' ' VAL . 51.6 t80 -58.95 -34.11 71.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.885 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . 0.497 ' CH2' ' CE1' ' A' ' 155' ' ' TYR . 97.3 m95 -76.24 -21.86 55.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.175 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -84.83 -34.74 22.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.419 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -87.05 -57.95 2.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.85 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.441 ' CG2' ' CE1' ' A' ' 339' ' ' PHE . 47.3 t -48.98 -56.55 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.804 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -52.89 -29.98 31.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.394 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 10.7 m -84.1 -55.71 4.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.113 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -51.44 -26.47 8.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.615 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 31.3 t -82.75 -55.32 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.234 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 59.4 mt -64.94 -41.85 93.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.335 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -57.59 -39.29 76.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.001 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -86.32 -30.55 22.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.108 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -76.18 -29.03 57.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.233 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 72.7 m -95.6 20.74 9.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.175 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 56.04 25.39 46.12 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.644 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.82 -31.55 20.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.87 0.366 . . . . 0.0 110.869 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -144.71 -168.82 3.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.859 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 19.3 p -121.52 160.4 24.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 30.2 t -58.06 -56.31 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.063 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.49 -29.71 1.88 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.185 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -84.25 -42.75 15.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -60.3 -59.72 4.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.736 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.429 ' CD2' HG13 ' A' ' 183' ' ' VAL . 3.3 mt -58.39 -26.77 63.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.03 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 30.9 tttt -80.89 -59.18 2.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.782 0.325 . . . . 0.0 110.965 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -61.16 -44.76 96.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.83 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -52.49 -37.8 58.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.253 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -59.42 -43.36 93.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 69.3 m -63.57 -39.92 95.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.984 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 31.9 mtt180 -67.06 -42.51 84.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.991 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 19.0 mt -75.45 -31.37 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.174 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 63.6 p -81.91 -31.42 31.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.877 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 3.5 mtpp . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.889 -179.963 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.7 t . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.822 0.344 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -133.81 87.63 2.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.921 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -133.42 20.2 3.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.188 0.518 . . . . 0.0 111.207 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.52 34.61 49.44 Favored Glycine 0 C--N 1.317 -0.503 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.509 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.78 -177.23 4.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.832 0.349 . . . . 0.0 110.931 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.3 mt -133.51 118.2 18.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.94 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.49 147.0 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.193 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.4 mt -132.59 107.44 12.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.947 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.416 ' CZ3' ' HG3' ' A' ' 57' ' ' PRO . 19.7 m0 -92.95 106.65 18.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.873 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.8 tt -137.97 158.98 33.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.046 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -54.84 174.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.049 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.22 -23.99 49.53 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.68 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -137.6 81.42 1.86 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.849 0.357 . . . . 0.0 110.961 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.81 36.71 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.811 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.58 43.37 4.88 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.504 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -85.22 -31.33 23.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 0.0 110.904 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -32.58 70.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.923 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.83 -38.69 15.39 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.501 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.48 -30.65 70.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.808 0.337 . . . . 0.0 110.896 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.36 -42.98 99.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -68.2 -44.18 76.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.03 -33.46 58.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.213 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.11 -27.86 73.56 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.558 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -83.21 -27.74 29.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.759 0.314 . . . . 0.0 111.011 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -45.5 89.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.947 0.403 . . . . 0.0 110.956 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.421 ' CD2' ' HB ' ' A' ' 33' ' ' ILE . 10.4 t80 -61.51 -38.87 88.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.016 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.409 ' O ' ' HA2' ' A' ' 32' ' ' GLY . 28.3 mt-10 -60.75 -32.57 71.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.877 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.4 tttm -82.67 -24.36 33.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.918 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -90.8 -26.14 19.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.68 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.1 p -137.29 -44.28 0.56 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 28' ' ' GLU . . . 121.23 -17.82 9.01 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.687 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.421 ' HB ' ' CD2' ' A' ' 27' ' ' PHE . 37.3 mm -59.94 105.43 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.872 0.368 . . . . 0.0 110.96 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -58.67 141.89 51.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.95 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.6 130.12 74.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.117 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.0 m -121.94 150.61 41.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.5 t -133.73 116.55 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.156 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -104.37 161.94 13.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.49 70.29 32.17 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.951 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.16 168.55 24.48 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.56 2.173 . . . . 0.0 112.215 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -89.94 140.13 29.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.935 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.424 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 12.8 mmtt 74.91 -57.2 0.61 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.98 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 42' ' ' LYS . 0.4 OUTLIER 51.17 18.41 0.58 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.051 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.22 -57.03 3.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.796 0.331 . . . . 0.0 110.949 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -83.17 -6.84 59.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.45 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.54 -20.08 65.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.325 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.494 ' CB ' ' HD3' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -87.21 -58.43 0.29 Allowed Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.189 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.494 ' HD3' ' CB ' ' A' ' 47' ' ' PHE . 52.0 Cg_exo -55.24 -30.71 73.05 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.33 2.02 . . . . 0.0 112.412 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.447 ' CG ' ' N ' ' A' ' 50' ' ' VAL . 5.9 pt20 -60.08 -48.99 79.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.984 0.421 . . . . 0.0 111.084 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.447 ' N ' ' CG ' ' A' ' 49' ' ' GLN . 5.5 m -93.18 17.63 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.762 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.06 -35.63 14.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.826 0.346 . . . . 0.0 111.164 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.21 -26.66 26.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.213 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t -59.96 -27.54 66.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.005 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.75 36.29 5.35 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.492 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.53 -78.2 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.894 0.378 . . . . 0.0 110.863 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.41 173.74 26.91 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.475 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.428 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 44.4 Cg_endo -68.49 -167.55 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.542 2.161 . . . . 0.0 112.242 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.75 -45.72 3.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.027 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.3 mt -149.39 159.06 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.29 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.478 ' CG1' ' N ' ' A' ' 61' ' ' PHE . 2.4 tt -159.02 159.47 2.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.866 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.478 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 4.1 m-85 -128.59 137.96 51.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.914 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.412 ' CZ3' HD11 ' A' ' 43' ' ' LEU . 2.9 t-105 -176.03 163.31 2.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.854 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.24 140.16 53.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.11 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -57.62 -30.9 65.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.963 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.67 -42.05 98.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.958 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.06 17.27 12.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.291 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.45 -26.02 13.03 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.735 0.302 . . . . 0.0 110.992 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.29 49.61 3.75 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.54 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -120.96 -34.08 0.93 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.583 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -93.38 -23.48 18.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.715 0.293 . . . . 0.0 111.096 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.59 -24.66 56.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.121 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -56.75 -38.18 72.05 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.033 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.4 t -90.52 -23.08 21.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.016 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.23 34.57 3.13 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.487 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.2 mt -85.57 -46.11 11.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 0.0 110.847 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.2 mt -74.1 170.64 15.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.834 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.7 155.03 18.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.032 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.12 -165.02 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.845 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.423 HG23 ' CE1' ' A' ' 106' ' ' TYR . 37.6 pt -157.02 166.82 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.044 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.0 p -156.53 77.45 4.25 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.779 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.39 154.53 60.85 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.641 2.228 . . . . 0.0 112.314 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.7 175.94 8.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.793 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 28.2 mttm -59.59 -45.34 92.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.85 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.08 -30.51 69.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.01 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -73.41 -35.15 65.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -81.6 -29.86 33.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.944 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.57 -40.2 70.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.012 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -59.22 -35.2 73.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.004 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.416 HD11 ' CZ2' ' A' ' 94' ' ' TRP . 4.0 mt -90.6 148.84 22.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.865 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.433 ' CB ' ' CE2' ' A' ' 92' ' ' PHE . 83.2 m-85 -78.42 144.61 66.32 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.966 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -49.35 -55.71 3.87 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.695 2.263 . . . . 0.0 112.844 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 93' ' ' THR . 21.7 p90 -49.33 -37.28 23.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.436 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.446 ' N ' ' CD1' ' A' ' 92' ' ' PHE . 0.3 OUTLIER -59.71 -42.22 92.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.896 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.416 ' CZ2' HD11 ' A' ' 89' ' ' LEU . 61.4 m95 -69.65 -34.81 74.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.905 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.98 -25.82 67.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.007 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.67 -33.9 62.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.16 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.6 m -103.52 64.2 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.198 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -156.01 123.64 5.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.32 -52.95 6.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.81 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -143.38 48.69 1.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.73 -25.34 25.42 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.597 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -91.24 135.12 34.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.366 . . . . 0.0 110.95 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 78.7 mt -88.71 150.46 22.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.83 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.8 pp -157.14 34.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.193 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.54 174.23 14.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.11 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.423 ' CE1' HG23 ' A' ' 79' ' ' ILE . 72.3 m-85 -133.42 82.24 52.85 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.807 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.65 119.39 4.64 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.625 2.216 . . . . 0.0 112.392 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.5 mt -101.69 -66.56 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.146 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -108.58 148.94 29.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.096 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.77 125.26 66.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.141 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.67 148.9 24.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.908 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -169.94 153.77 4.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.049 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.2 mt -65.22 164.98 12.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.1 178.91 8.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.3 tp -137.62 114.22 10.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.939 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.1 mt -106.97 150.1 9.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.067 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.403 ' CE2' ' O ' ' A' ' 243' ' ' GLY . 45.1 p90 -148.55 165.45 31.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.955 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -91.58 121.26 33.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.59 -17.42 61.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.171 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.24 -50.84 68.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.76 0.314 . . . . 0.0 111.132 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.89 -31.06 7.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.086 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.5 tp -104.39 89.35 2.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.964 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.13 -46.94 1.93 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.563 2.175 . . . . 0.0 112.295 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -119.24 128.92 25.67 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.826 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.58 147.76 28.62 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.424 2.083 . . . . 0.0 112.38 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.33 120.47 5.98 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.546 2.164 . . . . 0.0 112.335 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.96 20.57 8.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.1 p -136.5 141.96 43.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.93 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.419 ' CE3' HD13 ' A' ' 132' ' ' ILE . 12.6 m95 -81.68 -29.27 33.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -74.87 -15.84 60.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.378 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.79 -14.84 33.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.531 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.479 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 25.4 mt -65.88 -46.3 65.14 Favored Pre-proline 0 C--N 1.331 -0.214 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 50.9 Cg_exo -53.95 -49.98 15.27 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.293 1.995 . . . . 0.0 112.304 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.0 -35.28 76.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.134 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.3 mt -63.97 -46.05 86.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.96 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -52.08 -29.56 22.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.983 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -85.53 -27.76 25.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.044 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -85.05 -31.64 23.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.087 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.0 mt -83.87 -17.25 41.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.375 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -76.66 -29.11 56.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.808 0.337 . . . . 0.0 110.607 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.4 -37.35 85.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.892 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -80.57 -27.02 37.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.973 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 117.48 33.92 1.26 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.579 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.71 172.56 13.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.826 0.346 . . . . 0.0 110.882 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.3 t -107.37 172.68 6.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.926 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -73.19 -78.18 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.111 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.2 tp -137.86 115.98 11.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.922 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.55 158.2 21.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.229 0.538 . . . . 0.0 111.539 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.422 ' CE1' ' HE2' ' A' ' 204' ' ' MET . 38.1 p90 178.35 144.06 0.12 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.876 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -59.38 121.2 10.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.065 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.2 mt -107.32 32.94 4.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.891 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -95.61 -69.82 0.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.97 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -77.27 149.36 79.03 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.002 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.16 -9.0 22.91 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.652 2.235 . . . . 0.0 112.618 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 258' ' ' PHE . 5.2 t80 -59.67 -26.51 65.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.746 0.308 . . . . 0.0 111.117 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -91.17 -36.1 14.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.056 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 43.9 p -81.48 -22.22 38.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.226 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.549 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 64.9 t-105 -53.03 -54.36 45.09 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.642 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 12.7 Cg_endo -56.29 -21.02 34.46 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.233 1.955 . . . . 0.0 112.431 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.9 tp -87.67 -42.57 12.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.853 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 20.0 mt -77.9 -46.21 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.147 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -59.98 -27.85 67.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.237 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -56.65 -39.12 73.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.236 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.83 -20.14 55.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.162 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 136.02 -28.31 2.95 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.49 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -59.61 151.07 37.36 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.413 ' CG ' ' HA3' ' A' ' 182' ' ' GLY . 41.6 p90 -141.58 -176.16 4.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 110.916 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -97.75 -49.0 4.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.053 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.42 ' CE2' HD11 ' A' ' 333' ' ' ILE . 92.1 m-85 -133.22 154.77 50.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.914 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.13 134.13 40.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -101.14 110.88 22.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.657 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -162.79 146.19 11.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.867 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 61.46 30.38 18.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 64.84 13.7 57.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.009 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.96 160.08 38.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.848 0.356 . . . . 0.0 111.01 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -101.5 102.11 12.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.816 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -59.01 136.63 58.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.986 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.0 pt -93.59 -29.05 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.186 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -69.44 -16.44 63.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.296 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -102.43 150.32 23.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.783 0.325 . . . . 0.0 111.01 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.81 146.05 33.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.048 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . 0.413 ' HA3' ' CG ' ' A' ' 167' ' ' TYR . . . -103.06 -18.3 15.59 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.783 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.42 HG12 ' CD2' ' A' ' 361' ' ' LEU . 21.3 t -56.65 -44.38 81.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.81 0.338 . . . . 0.0 111.25 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -84.16 57.38 4.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.906 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -120.25 -177.3 3.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.868 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -76.21 -29.61 57.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.191 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -82.26 -47.19 6.2 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.556 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.31 -29.97 64.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.82 0.343 . . . . 0.0 111.197 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -67.92 -49.28 62.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.906 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -74.22 -30.15 62.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.163 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -58.85 -53.91 42.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.557 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.43 -43.96 92.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.86 0.362 . . . . 0.0 110.997 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 61.0 m -57.39 -21.79 38.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.257 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.49 ' CZ ' ' CE1' ' A' ' 250' ' ' PHE . 14.2 t80 -68.21 -60.53 2.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.824 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.2 tp -63.11 -35.59 80.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.626 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 43.8 t -66.19 -56.81 12.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.983 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -67.63 -26.83 66.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.999 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.41 HD13 ' CZ ' ' A' ' 194' ' ' PHE . 4.9 mt -61.26 -58.42 8.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.003 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 5.6 mt -57.65 -21.24 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.439 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -84.86 -35.71 22.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.407 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -113.08 19.43 17.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.703 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.34 -17.21 3.81 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 14.1 m80 64.22 43.8 4.72 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.884 0.373 . . . . 0.0 110.671 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' MET . . . . . 0.422 ' HE2' ' CE1' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -82.89 146.68 28.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.85 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -81.99 116.77 21.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.96 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.16 -10.15 59.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.413 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.6 56.93 4.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.875 0.369 . . . . 0.0 111.008 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.0 133.08 56.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.802 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.424 ' N ' HD12 ' A' ' 212' ' ' ILE . 55.0 m-20 -154.11 176.1 12.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.029 0.442 . . . . 0.0 111.106 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.401 ' CD2' ' OE2' ' A' ' 214' ' ' GLU . 1.1 t80 -41.87 -61.64 1.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.81 -59.21 3.24 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.424 HD12 ' N ' ' A' ' 209' ' ' ASP . 0.2 OUTLIER -53.81 -34.03 24.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.507 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . -81.78 -24.14 36.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.712 0.291 . . . . 0.0 110.915 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.401 ' OE2' ' CD2' ' A' ' 210' ' ' TYR . 4.0 mt-10 -82.29 -46.08 14.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.939 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.13 -31.22 66.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.131 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.33 -35.74 78.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.023 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -82.24 -36.53 27.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -59.11 -46.77 87.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.973 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -76.41 -27.98 56.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.958 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.35 31.2 6.58 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.521 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -77.94 -71.33 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.808 0.337 . . . . 0.0 110.86 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.4 t -68.0 129.0 38.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -59.18 -36.81 75.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.14 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 9.7 ptt? -141.37 153.89 45.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 9.0 t -151.42 157.89 42.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 30.2 mt -94.97 121.82 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.109 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.84 165.44 26.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.822 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -124.39 -162.31 11.37 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.617 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.81 -10.28 26.14 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.846 2.364 . . . . 0.0 112.71 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -92.56 28.28 2.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.651 0.262 . . . . 0.0 111.386 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.05 19.18 1.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.371 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 9.6 m95 -81.2 -55.84 4.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.851 0.358 . . . . 0.0 110.919 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.7 m -57.3 -26.5 60.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.177 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -54.66 -29.27 52.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.092 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.419 HG21 ' CD1' ' A' ' 242' ' ' TYR . 3.2 mt -86.71 98.53 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.046 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -169.98 -49.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.1 t -73.35 -33.51 65.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 71.1 m -90.88 -30.26 17.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt 62.13 31.4 17.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.43 124.2 31.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.083 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -61.93 94.24 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.827 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.419 ' CD1' HG21 ' A' ' 235' ' ' ILE . 50.3 p90 -89.99 123.02 33.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.924 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.403 ' O ' ' CE2' ' A' ' 117' ' ' TYR . . . -108.99 95.32 0.9 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.469 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 27.0 t -68.95 127.96 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.815 0.34 . . . . 0.0 111.088 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.9 t -134.0 159.33 41.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.7 t -66.65 152.02 9.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.97 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.2 mp -67.63 151.19 97.39 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.944 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.14 162.98 35.92 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.543 2.162 . . . . 0.0 112.211 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 36.9 p -102.14 144.99 30.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.968 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.49 ' CE1' ' CZ ' ' A' ' 194' ' ' PHE . 26.9 t80 -129.31 132.06 47.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.06 18.44 8.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.282 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 91.21 -21.27 35.48 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.942 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.66 145.74 31.19 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.701 0.286 . . . . 0.0 110.926 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.66 164.04 34.58 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.589 2.192 . . . . 0.0 112.299 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.15 -176.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 15.7 mttp -137.0 66.61 54.91 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.7 176.19 9.21 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.561 2.174 . . . . 0.0 112.324 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 155' ' ' TYR . 95.1 m-85 -95.26 166.12 12.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.99 136.4 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.293 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -131.15 121.68 3.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.349 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.67 133.64 58.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 111.233 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 12.9 tp -92.07 90.17 7.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.568 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.87 167.01 16.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.08 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -98.97 114.99 27.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.997 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -81.92 149.8 28.59 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.529 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 31.3 mt -142.41 152.0 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 0.0 111.098 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -98.93 149.93 22.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.962 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.6 -36.68 79.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.065 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -97.35 36.54 1.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.14 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.3 m -69.27 146.5 96.77 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.888 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.51 -49.32 17.76 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.524 2.149 . . . . 0.0 112.264 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -141.76 83.4 1.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.82 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? -63.08 -34.33 77.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.82 -53.94 52.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.876 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 68.7 mt -59.78 -32.52 70.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.9 -40.69 96.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -52.3 25.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.9 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -60.34 -42.35 95.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.406 ' CE2' ' HB2' ' A' ' 27' ' ' PHE . 11.9 t80 -60.26 -64.28 1.01 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.123 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.403 ' CD2' ' CD2' ' A' ' 284' ' ' LEU . 26.2 mt -57.25 -21.65 35.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.411 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -90.48 -32.93 16.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.704 0.288 . . . . 0.0 111.375 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.402 ' O ' ' CD1' ' A' ' 283' ' ' TYR . 35.2 m-80 -104.34 20.39 18.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.285 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 282' ' ' ASN . 96.1 m-85 -157.75 -66.25 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.825 0.345 . . . . 0.0 111.042 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.403 ' CD2' ' CD2' ' A' ' 280' ' ' LEU . 17.6 tp -60.84 -30.14 69.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.935 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 99.6 mt -121.89 82.28 1.93 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.964 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -160.96 170.01 21.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.835 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.2 -57.07 8.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -69.26 -42.77 75.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.049 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -57.77 -57.2 21.03 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.615 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.406 ' HB2' ' CE2' ' A' ' 307' ' ' TYR . 30.4 mt -58.59 -29.85 66.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.802 0.334 . . . . 0.0 110.976 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -60.05 -43.82 95.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.001 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -59.53 -53.67 55.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.142 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.1 t -59.65 -32.17 48.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.22 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -71.68 -31.21 66.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.944 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 49.1 mttm -65.69 -34.66 78.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.955 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.62 -35.04 11.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.5 90.71 4.55 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.889 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.91 112.61 2.75 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.548 2.165 . . . . 0.0 112.238 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 1.2 mt -97.4 25.82 5.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.003 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 58.29 -125.5 39.66 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.553 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.97 156.05 32.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.78 0.324 . . . . 0.0 111.099 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 9.6 m -128.36 24.89 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.234 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . 52.92 27.37 5.45 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.343 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.0 125.24 52.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.862 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -67.01 -31.78 72.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.01 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.8 m -81.2 -29.8 34.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.164 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.406 ' CE2' ' HB2' ' A' ' 290' ' ' LEU . 1.9 t80 -87.91 -28.24 21.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.202 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.09 -29.63 45.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.814 0.34 . . . . 0.0 111.062 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -67.79 -61.51 1.85 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -50.86 -33.7 24.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.77 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 46.9 mt -85.76 -25.83 26.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.781 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -73.39 -7.44 51.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.558 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -47.21 -30.59 3.06 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.95 0.405 . . . . 0.0 110.895 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.33 133.81 24.31 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.283 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.55 -29.04 58.27 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.421 2.081 . . . . 0.0 112.422 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -49.35 -41.76 39.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.095 0.474 . . . . 0.0 110.296 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 27.8 mt -85.6 -33.26 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.939 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -62.66 -30.83 71.67 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.11 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -79.31 -31.38 43.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.118 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.37 -35.47 80.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 45.8 mtp -81.88 -32.79 30.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.933 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.24 -31.34 70.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.943 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -67.99 -38.77 83.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -71.17 -39.89 71.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.132 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -59.85 -35.03 73.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.957 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 6.7 mmtm -117.81 21.11 13.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.033 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -114.03 142.27 17.42 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.501 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -75.61 135.57 40.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.791 0.329 . . . . 0.0 110.884 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.404 HG22 HD13 ' A' ' 329' ' ' ILE . 30.8 mt -79.19 148.96 5.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.14 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 6.6 mtp -76.51 113.49 29.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.37 152.5 15.43 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.489 2.126 . . . . 0.0 112.312 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -106.01 39.15 1.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.854 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.42 HD11 ' CE2' ' A' ' 169' ' ' PHE . 22.7 pt -108.15 148.87 38.37 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.177 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.95 -27.71 30.08 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.559 2.172 . . . . 0.0 112.339 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -59.33 -24.14 63.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.055 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 1.7 tpt -54.53 -26.8 34.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.188 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 38.3 m -58.23 -55.26 37.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.015 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -60.43 -29.61 69.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.166 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.429 ' CE1' ' CG2' ' A' ' 343' ' ' VAL . 68.7 t80 -58.98 -51.71 68.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.026 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 40.3 m95 -56.47 -23.52 39.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.356 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -79.38 -61.38 2.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.125 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -59.63 -48.32 82.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.404 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.429 ' CG2' ' CE1' ' A' ' 339' ' ' PHE . 31.7 t -58.18 -32.52 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.292 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 -68.11 -57.46 6.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.914 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 30.9 m -65.83 -28.32 68.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.137 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -60.09 -51.39 69.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.342 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 32.8 t -70.83 -47.31 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.272 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 57.8 mt -59.31 -43.29 89.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.054 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -60.36 -30.61 69.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.012 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -79.31 -52.51 8.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.34 -38.72 90.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.03 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 16.8 m -70.98 -22.35 62.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.139 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 87.5 26.79 29.18 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.589 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 30.4 mtt180 -91.27 -30.74 16.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.854 0.359 . . . . 0.0 110.915 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -146.45 -176.51 5.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.846 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 19.8 p -116.28 170.74 8.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 47.9 t -59.5 -55.29 24.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.005 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -47.42 -29.83 2.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.157 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -84.29 -41.97 16.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.965 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -60.08 -60.46 3.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.931 0.395 . . . . 0.0 110.765 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.42 ' CD2' HG12 ' A' ' 183' ' ' VAL . 3.1 mt -58.29 -27.02 63.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.978 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.94 -53.46 6.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.831 0.348 . . . . 0.0 111.007 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -59.36 -48.55 81.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.857 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.57 -36.42 73.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.994 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.78 -45.24 92.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.831 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -52.32 66.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.002 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -59.05 -48.38 81.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.998 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 10.6 mt -65.88 -28.96 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.188 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 32.6 p -83.37 -31.3 26.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.922 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.884 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.821 0.343 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -98.75 31.76 2.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.413 ' HB3' ' CD ' ' A' ' 6' ' ' LYS . 2.2 tt0 -92.83 -163.87 1.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.794 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -134.15 52.47 0.81 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.771 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.413 ' CD ' ' HB3' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -146.25 -174.93 4.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.793 0.33 . . . . 0.0 110.94 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 21.6 mt -130.56 123.62 29.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.5 t -91.27 142.04 13.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.156 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.5 mm -119.66 107.53 21.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.952 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.404 ' CD2' ' HG3' ' A' ' 57' ' ' PRO . 5.2 m0 -104.07 106.74 17.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.6 tt -150.84 150.52 13.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.11 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -64.36 158.91 22.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.916 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.87 57.74 3.68 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.522 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -125.86 -44.51 1.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.862 0.363 . . . . 0.0 110.912 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.75 -179.29 6.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.874 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.18 83.83 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.486 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -71.91 -35.5 69.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.809 0.338 . . . . 0.0 110.902 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -72.31 -31.18 65.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.85 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.25 -41.49 96.75 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.495 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.4 tp -67.23 -29.52 69.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.0 110.952 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.74 -42.29 79.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.101 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.67 -26.14 68.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.019 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.5 t -76.71 -25.94 16.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -81.39 -42.54 9.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.599 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -27.69 69.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.767 0.318 . . . . 0.0 110.988 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -73.9 -41.52 62.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -60.43 -57.15 14.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.931 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.32 -21.19 48.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.295 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.42 -25.81 33.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.334 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -102.48 -33.74 9.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.583 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.68 -44.15 3.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.766 0.317 . . . . 0.0 111.402 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.31 -26.4 7.04 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.528 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.7 mm -62.25 122.65 13.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.338 . . . . 0.0 111.108 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -70.71 166.77 20.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.967 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.2 t -147.45 102.57 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.087 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.8 m -98.29 144.67 27.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.5 t -114.53 110.18 31.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.113 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -97.56 176.46 5.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.789 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -159.32 70.24 3.36 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.018 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.29 144.41 46.0 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.549 2.166 . . . . 0.0 112.171 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.21 139.13 48.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.966 0.412 . . . . 0.0 111.04 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.416 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 4.4 mtmt 73.48 -58.39 0.6 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.873 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 42' ' ' LYS . 0.5 OUTLIER 49.18 18.69 0.25 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.114 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -83.29 -57.02 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -91.57 -7.4 50.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.354 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -67.75 -25.1 65.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.264 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.462 ' CB ' ' HD3' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -85.16 -57.68 0.36 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.179 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.462 ' HD3' ' CB ' ' A' ' 47' ' ' PHE . 54.0 Cg_exo -52.07 -35.8 63.2 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.416 2.077 . . . . 0.0 112.531 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.454 ' CG ' ' N ' ' A' ' 50' ' ' VAL . 11.5 pt20 -60.09 -49.64 76.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.01 0.433 . . . . 0.0 111.053 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.454 ' N ' ' CG ' ' A' ' 49' ' ' GLN . 6.2 m -96.68 27.0 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.418 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -88.55 -42.15 12.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.107 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.33 -33.65 76.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.098 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.5 t -88.12 -31.31 19.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.52 39.61 68.38 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.518 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -97.73 -29.58 13.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.98 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.52 -160.5 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.551 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.426 ' HG2' ' CZ ' ' A' ' 47' ' ' PHE . 41.4 Cg_endo -67.54 -167.79 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.549 2.166 . . . . 0.0 112.263 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -124.12 -42.48 2.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.006 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.7 mt -102.1 158.29 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.242 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.477 ' CG1' ' N ' ' A' ' 61' ' ' PHE . 2.4 tt -166.86 159.48 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.811 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.477 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 73.6 m-85 -119.85 140.58 50.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.987 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.417 ' CD1' ' HB3' ' A' ' 66' ' ' ARG . 4.9 t-105 -174.07 151.11 1.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.64 134.54 57.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.091 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -53.26 -28.37 27.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.195 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -64.55 -35.06 79.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.005 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.417 ' HB3' ' CD1' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -94.41 17.18 13.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.296 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -106.84 30.62 5.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.827 0.346 . . . . 0.0 110.907 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -122.29 35.91 3.34 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.544 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -128.43 -41.7 0.27 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.51 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -80.62 -9.03 59.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.608 0.242 . . . . 0.0 111.364 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.22 -25.98 47.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.728 0.299 . . . . 0.0 111.144 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -60.72 -51.05 71.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.948 0.404 . . . . 0.0 110.661 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.7 m -72.04 -23.1 61.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.047 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.4 31.63 9.43 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.526 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.7 mt -72.5 -37.97 68.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.785 0.326 . . . . 0.0 110.952 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.7 mt -77.35 146.28 36.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.986 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -93.08 116.39 28.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.078 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.429 ' HG2' ' N ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -60.79 155.83 18.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.833 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.429 ' N ' ' HG2' ' A' ' 78' ' ' GLU . 42.6 pt -124.68 179.19 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.131 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -159.82 77.81 2.79 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.893 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.31 163.45 34.42 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.613 2.209 . . . . 0.0 112.207 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -94.8 -179.43 4.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -59.18 -48.92 79.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.883 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.51 -31.16 72.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.104 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -74.59 -35.73 62.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.917 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.417 ' HA ' ' CZ2' ' A' ' 94' ' ' TRP . 15.5 mt-30 -79.87 -30.13 40.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.947 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -74.05 -39.26 63.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.985 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.83 -36.21 76.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.978 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.451 ' CD1' ' CZ2' ' A' ' 94' ' ' TRP . 0.4 OUTLIER -84.48 178.07 7.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.834 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.419 ' HB3' ' CE1' ' A' ' 92' ' ' PHE . 24.4 m-85 -86.79 142.38 34.4 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.039 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -54.27 -55.85 3.03 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.581 2.188 . . . . 0.0 112.657 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.452 ' CE2' ' CG2' ' A' ' 93' ' ' THR . 50.0 p90 -60.32 -46.63 89.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.429 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.452 ' CG2' ' CE2' ' A' ' 92' ' ' PHE . 70.9 p -53.21 -27.6 22.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.797 0.332 . . . . 0.0 111.233 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.451 ' CZ2' ' CD1' ' A' ' 89' ' ' LEU . 22.8 m95 -74.68 -36.44 62.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.822 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -74.56 -7.7 53.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.342 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.76 -27.9 22.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.822 0.344 . . . . 0.0 111.183 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.5 m -93.0 47.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.288 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.9 124.31 13.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -108.94 -65.2 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.844 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -98.59 30.66 3.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.808 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.92 -25.96 21.1 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.558 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -92.17 170.55 9.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.333 . . . . 0.0 110.99 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.9 mt -96.17 141.11 29.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.79 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 pp -158.08 58.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.239 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -177.33 172.25 1.89 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.229 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.443 ' CE1' ' CD1' ' A' ' 266' ' ' ILE . 26.0 m-85 -138.53 94.01 10.82 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.821 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.52 116.96 3.65 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.648 2.232 . . . . 0.0 112.381 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.0 mt -119.06 -64.39 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.118 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.7 142.84 45.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.147 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.5 t -106.86 151.88 8.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.116 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -130.94 149.14 52.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -171.72 146.36 2.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.2 mt -66.53 114.87 5.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.915 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.3 m -93.72 163.23 13.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.925 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 50.1 tp -100.72 101.54 12.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.416 HG21 ' CZ ' ' A' ' 217' ' ' PHE . 28.7 mt -86.16 119.91 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.119 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -137.84 148.9 45.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.943 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -81.42 156.75 25.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.6 mtmm -110.88 -30.25 7.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.978 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -61.17 -31.61 71.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.035 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.8 pp -111.6 -33.71 6.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.974 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.3 tp -119.25 88.98 38.83 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.995 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.26 -28.42 33.65 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.535 2.157 . . . . 0.0 112.283 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -140.26 112.58 7.31 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.836 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -78.82 167.59 22.05 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.586 2.191 . . . . 0.0 112.422 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.34 111.81 3.02 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.603 2.202 . . . . 0.0 112.322 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.45 -27.1 65.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.963 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 29.5 p -120.34 158.53 26.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.964 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.425 ' CE3' HD11 ' A' ' 132' ' ' ILE . 34.5 m95 -72.44 -30.06 64.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.967 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -72.2 -16.05 61.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.405 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -89.76 0.05 57.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.581 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.48 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 12.2 mt -85.44 -46.5 0.62 Allowed Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 73.2 Cg_exo -49.25 -28.35 14.76 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.378 2.052 . . . . 0.0 112.44 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.27 -34.61 28.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.197 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.23 -42.55 99.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.092 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.5 p30 -57.09 -22.24 38.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.216 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -85.62 -33.71 21.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.079 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -85.1 -61.74 1.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.296 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.6 mt -53.79 -24.85 16.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.545 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.87 -24.77 52.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.742 0.306 . . . . 0.0 110.959 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.12 -33.75 69.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.903 0.383 . . . . 0.0 110.97 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.08 -27.12 39.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.029 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.44 42.16 0.77 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.491 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -144.99 -177.3 5.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 0.0 110.861 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.57 147.82 40.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.868 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -68.33 -68.82 0.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.201 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.8 tp -148.79 132.92 17.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.043 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.17 179.61 5.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.712 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.42 ' HB2' ' CD2' ' A' ' 156' ' ' PHE . 50.6 p90 -178.28 -176.04 0.49 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.018 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -79.37 118.8 21.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.905 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.4 mt -98.93 29.2 3.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -112.09 -33.34 6.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.842 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -101.04 135.27 19.99 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.56 -13.36 18.3 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.532 2.155 . . . . 0.0 112.612 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.495 ' CZ ' ' CH2' ' A' ' 340' ' ' TRP . 3.0 m-85 -57.37 -32.62 66.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.12 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.42 ' CD2' ' HB2' ' A' ' 149' ' ' PHE . 1.8 m-85 -77.44 -36.72 52.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.896 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 40.1 p -81.55 -23.07 37.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.045 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.537 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 64.5 t-105 -50.9 -54.15 40.03 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.572 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 14.9 Cg_endo -57.24 -22.02 46.61 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.196 1.931 . . . . 0.0 112.3 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.4 tp -80.44 -54.48 5.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.813 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.401 HD12 ' CE3' ' A' ' 158' ' ' TRP . 12.3 pt -71.16 -34.03 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.08 -28.9 60.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.175 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -56.5 -28.87 60.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.233 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -76.16 -20.04 57.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.222 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 139.55 -26.37 2.67 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.658 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -57.0 145.32 37.64 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.565 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -134.81 -176.35 4.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.801 0.334 . . . . 0.0 110.986 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -107.58 -49.64 3.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.12 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.414 ' CE2' HD11 ' A' ' 333' ' ' ILE . 24.9 m-85 -127.83 158.73 36.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -99.44 118.58 36.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.017 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.404 ' CE1' ' O ' ' A' ' 174' ' ' GLY . 7.7 t80 -85.59 111.15 19.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.487 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.04 146.33 23.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.153 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 63.11 29.45 16.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.095 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 171' ' ' TYR . . . 90.55 -37.0 3.44 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.021 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.91 -177.24 3.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 0.0 111.067 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -98.92 -177.48 3.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.954 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -133.46 134.76 43.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.8 pt -87.12 -29.68 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.119 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -74.54 -16.33 60.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.219 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -104.96 117.35 33.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.807 0.337 . . . . 0.0 110.976 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.409 ' CG1' ' CG2' ' A' ' 183' ' ' VAL . 16.9 t -124.51 146.05 30.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.006 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -117.04 61.37 0.42 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.782 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.409 ' CG2' ' CG1' ' A' ' 181' ' ' VAL . 2.3 t -96.55 -61.58 2.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.846 0.355 . . . . 0.0 110.973 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -84.4 57.23 4.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.922 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -95.74 167.84 11.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.849 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -58.64 -31.14 67.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.178 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -85.98 -49.13 4.38 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.55 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.0 -31.59 68.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 0.0 111.182 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -60.02 -45.81 91.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.834 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -86.95 -28.2 22.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.154 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -57.81 -53.61 43.96 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.608 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -32.65 72.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.339 . . . . 0.0 110.981 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.3 m -53.67 -25.15 16.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.091 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -65.89 -59.08 4.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.786 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.0 tt -64.78 -29.78 70.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.735 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 41.2 t -69.49 -59.84 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.062 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -58.48 -29.55 66.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.051 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 12.5 mt -60.06 -47.88 84.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 22.4 mt -76.53 -28.41 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.167 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -62.06 -30.48 71.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.966 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -91.07 13.58 16.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.423 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt 56.13 44.04 25.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.956 0.407 . . . . 0.0 111.028 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.83 -28.1 12.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.904 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' MET . . . . . 0.407 ' HE2' ' CE1' ' A' ' 149' ' ' PHE . 87.7 mtp -113.69 176.74 4.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.932 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 19.8 m-20 -124.22 133.57 53.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -79.77 -38.99 31.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.094 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -59.25 -27.39 65.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.982 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 1.6 m -49.45 146.74 3.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.227 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -154.23 176.08 12.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.858 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -61.08 -29.02 69.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.257 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.13 -59.36 2.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.84 0.352 . . . . 0.0 110.986 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -28.65 44.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.309 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.74 -21.75 51.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.769 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.16 -50.2 11.36 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.835 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.76 -30.61 68.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.127 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.3 -32.98 70.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.144 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.416 ' CZ ' HG21 ' A' ' 116' ' ' ILE . 19.4 t80 -79.42 -41.1 28.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.961 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -67.12 -36.11 81.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.5 mttm -83.73 -34.0 24.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.863 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.12 59.33 0.94 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.491 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -109.27 -72.69 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.803 0.335 . . . . 0.0 110.825 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 10.6 t -74.36 169.12 18.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.924 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -81.53 -54.66 5.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.171 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -125.78 163.59 22.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.004 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 66.3 m -159.83 137.75 10.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 29.3 mt -112.98 135.22 53.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.163 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -150.47 155.78 40.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -62.47 -162.25 0.27 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.551 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.431 ' HD2' ' CZ3' ' A' ' 230' ' ' TRP . 34.5 Cg_endo -64.56 -23.09 64.48 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.649 2.233 . . . . 0.0 112.499 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . 0.431 ' CZ3' ' HD2' ' A' ' 229' ' ' PRO . 46.6 p90 -84.5 57.31 4.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.958 0.409 . . . . 0.0 110.875 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -141.76 -44.94 0.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.18 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 20.8 m0 -54.26 -30.59 51.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.086 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.5 m -62.71 -36.58 83.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.944 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -60.39 -34.39 73.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.919 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 10.6 mt -74.96 70.4 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.03 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -153.28 -46.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.871 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 62.4 m -61.29 -44.1 97.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.84 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 2.7 t -101.58 -34.13 9.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.93 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.97 104.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.6 t -135.01 142.32 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.122 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.05 95.66 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -100.54 135.6 41.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -100.53 148.16 18.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.466 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.3 t -128.55 123.27 59.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.838 0.351 . . . . 0.0 111.119 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 10.0 t -143.45 153.78 43.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.864 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.412 ' CG2' ' N ' ' A' ' 247' ' ' LEU . 0.8 OUTLIER -54.85 152.35 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.245 0.545 . . . . 0.0 111.381 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.412 ' N ' ' CG2' ' A' ' 246' ' ' VAL . 89.9 mt -67.68 136.24 92.68 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.855 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.424 ' HB2' ' CD1' ' A' ' 129' ' ' TRP . 52.3 Cg_exo -54.58 -170.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.412 2.075 . . . . 0.0 112.279 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 1.3 p -127.89 163.04 25.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -111.05 108.24 17.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.93 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 17.1 mttt 59.44 30.72 20.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.958 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 83.1 27.03 42.06 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.541 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -122.22 141.27 34.14 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.59 0.233 . . . . 0.0 110.852 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.37 145.34 26.82 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.544 2.163 . . . . 0.0 112.42 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.22 -172.64 1.77 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.769 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.417 ' N ' ' HD3' ' A' ' 257' ' ' PRO . 12.3 mmmt -132.88 58.69 37.45 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.128 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.417 ' HD3' ' N ' ' A' ' 256' ' ' LYS . 62.3 Cg_exo -50.9 -179.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.406 2.071 . . . . 0.0 112.291 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . 0.494 ' CE2' ' CD2' ' A' ' 155' ' ' TYR . 10.9 m-85 -110.53 134.9 51.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.826 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 23.8 t -97.17 132.13 42.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.203 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -145.57 106.13 0.37 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.307 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.21 149.53 9.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.881 0.372 . . . . 0.0 111.323 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 11.9 tp -85.75 80.88 8.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.975 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.1 m -75.81 137.44 40.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.033 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -82.04 114.98 20.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.053 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -83.38 117.82 4.51 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.565 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.443 ' CD1' ' CE1' ' A' ' 106' ' ' TYR . 29.2 mt -119.48 121.94 67.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.818 0.342 . . . . 0.0 110.998 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -79.59 148.64 31.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.953 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.51 -27.13 66.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.176 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -90.98 48.81 1.56 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.152 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 58.5 p -116.45 108.11 45.93 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.794 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.73 -24.37 47.54 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.418 2.079 . . . . 0.0 112.312 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -97.64 37.21 1.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.841 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -66.36 -41.09 89.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -59.58 -56.15 25.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.961 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 19.1 mt -60.32 -35.04 74.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.81 -50.72 40.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.075 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -44.62 95.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.873 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -63.07 -61.97 2.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -55.09 -27.18 43.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.143 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 24.8 mt -76.95 -37.83 54.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.109 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -93.62 -7.32 44.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.643 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -103.29 -35.8 8.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.653 0.263 . . . . 0.0 111.367 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -116.96 -35.77 4.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.406 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.5 tp -95.21 41.1 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.799 0.333 . . . . 0.0 111.134 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 2.7 mt -177.18 37.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.878 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.2 p -142.91 164.49 29.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -72.28 -30.21 64.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -79.45 -30.49 42.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.004 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -89.63 -50.92 3.01 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.589 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 87.2 mt -59.68 -31.0 69.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.363 . . . . 0.0 111.021 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -69.64 -31.21 69.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.46 -30.73 67.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.164 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.12 -30.02 9.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.39 -30.71 71.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.959 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -68.99 -33.62 73.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.027 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.55 -36.69 12.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.015 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -169.2 100.3 0.49 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.922 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.28 115.12 3.69 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.428 2.085 . . . . 0.0 112.32 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.9 -24.63 53.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.026 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 109.76 -32.66 6.58 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.573 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -157.36 176.83 12.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 0.0 111.126 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 5.8 m -152.92 156.08 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.089 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -84.42 -30.32 25.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.135 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 14.0 tp -59.67 123.97 18.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.908 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -72.66 -24.14 60.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.12 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.6 m -81.27 -24.13 37.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.179 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.414 ' CE2' HD13 ' A' ' 311' ' ' LEU . 26.3 t80 -95.33 -31.97 13.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.306 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -57.23 -29.72 63.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.343 . . . . 0.0 110.948 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -64.27 -59.87 3.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -50.89 -33.26 23.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.827 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.414 HD13 ' CE2' ' A' ' 307' ' ' TYR . 7.8 mt -85.76 -24.99 26.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.798 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -67.13 -13.82 62.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.494 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -47.48 -32.16 4.91 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.972 0.415 . . . . 0.0 110.941 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -112.69 140.65 24.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.37 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.76 -26.99 59.59 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.425 2.083 . . . . 0.0 112.341 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -50.51 -41.24 53.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.079 0.466 . . . . 0.0 110.313 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 32.2 mm -85.58 -32.0 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.957 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -69.39 -30.69 68.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.171 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -74.42 -46.18 41.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.204 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 63.4 m -59.7 -31.35 69.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.925 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.91 -41.82 25.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.946 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -60.0 -47.06 87.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.958 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -60.14 -54.27 47.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.966 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.79 -50.55 73.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.148 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -59.71 -33.29 71.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -96.59 21.15 9.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.123 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -128.18 161.88 21.97 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.521 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.58 156.24 27.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.804 0.335 . . . . 0.0 110.873 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 25.3 mt -88.02 138.39 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.141 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.417 ' HG2' ' CD1' ' A' ' 258' ' ' PHE . 12.8 mtm -60.35 140.27 91.74 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.41 138.79 20.1 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.549 2.166 . . . . 0.0 112.333 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -101.87 30.98 4.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.414 HD11 ' CE2' ' A' ' 169' ' ' PHE . 9.4 pt -107.2 148.52 37.23 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.108 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.56 -24.47 18.77 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.584 2.19 . . . . 0.0 112.446 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.15 -26.34 38.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.184 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 17.3 ptm -57.31 -22.27 40.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.215 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 67.1 m -50.24 -48.8 54.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.175 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.52 -28.02 60.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.15 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.414 ' CZ ' HG23 ' A' ' 343' ' ' VAL . 78.0 t80 -58.25 -29.1 65.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.009 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . 0.495 ' CH2' ' CZ ' ' A' ' 155' ' ' TYR . 94.2 m95 -60.28 -61.06 2.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.034 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.86 -30.72 71.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.091 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -62.04 -56.28 20.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.339 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.414 HG23 ' CZ ' ' A' ' 339' ' ' PHE . 21.4 t -78.62 -33.76 17.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.417 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -57.16 -57.45 12.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.15 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 21.0 m -66.71 -29.53 69.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.01 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -59.78 -56.84 16.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.24 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.05 -40.57 81.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.284 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 26.2 mt -68.22 -41.6 84.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.064 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -59.58 -30.2 68.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.967 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -91.1 -34.84 14.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.236 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -76.52 -33.33 58.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.228 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 5.6 t -66.27 -22.42 66.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.118 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 80.0 61.7 2.22 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.539 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 18.9 mtt-85 -140.29 -79.33 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.83 0.348 . . . . 0.0 110.836 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -77.55 177.55 7.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.758 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 65.8 p -106.57 145.13 32.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.776 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 40.3 t -51.44 -40.14 23.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.108 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -50.73 -38.51 47.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.62 -30.65 29.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -65.96 -58.17 6.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.062 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.401 ' CD2' HG13 ' A' ' 183' ' ' VAL . 12.1 mt -60.04 -25.29 65.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.037 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -72.83 -51.07 20.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.834 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -57.76 -48.46 79.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.85 -39.19 80.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.073 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -58.86 -33.99 71.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.963 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 90.0 m -87.11 -40.36 14.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.925 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -59.07 -44.87 91.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 17.1 mt -69.45 -30.4 45.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.175 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 76.2 p -82.97 -29.64 28.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.942 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 26.3 tttm . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.918 179.998 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.813 0.34 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -105.21 99.45 9.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 58.87 162.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.967 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.59 -58.4 0.53 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.506 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -142.14 174.6 10.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.815 0.34 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 33.7 mt -128.69 133.8 48.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.7 t -109.6 147.05 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.115 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 28.7 mm -120.49 107.51 20.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.968 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.43 ' CG ' ' HG3' ' A' ' 57' ' ' PRO . 0.5 OUTLIER -93.41 106.77 18.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.3 tt -163.15 123.02 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.006 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -142.53 162.68 34.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.928 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 109.57 58.81 0.52 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.984 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.6 t70 59.48 28.9 18.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.96 0.409 . . . . 0.0 110.556 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -83.16 173.56 11.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.8 54.67 4.62 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.527 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -72.62 -31.05 64.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.827 0.346 . . . . 0.0 110.909 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -74.53 -32.3 62.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.39 -37.85 8.67 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.512 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.2 tp -65.77 -31.22 72.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.783 0.325 . . . . 0.0 110.92 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.92 -31.02 70.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.128 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -66.59 -36.65 83.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 25.4 t -65.38 -31.39 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.074 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.97 -27.63 73.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.512 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.3 mmtt -59.24 -30.55 68.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.776 0.322 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.3 -40.48 58.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.881 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.419 ' CE1' HG22 ' A' ' 31' ' ' THR . 38.5 t80 -57.98 -52.89 63.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.017 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -68.94 -23.91 64.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.174 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -78.84 -25.83 44.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.22 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -103.89 -36.98 7.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.41 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.419 HG22 ' CE1' ' A' ' 27' ' ' PHE . 8.9 p -99.98 -44.11 6.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.225 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.06 -27.09 8.38 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.45 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.413 ' HB ' ' CE2' ' A' ' 27' ' ' PHE . 35.8 mm -64.32 118.83 7.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.779 0.323 . . . . 0.0 111.091 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -59.71 152.37 22.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.914 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.29 108.78 12.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.045 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.5 m -115.36 144.67 43.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.6 t -118.98 119.07 59.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.052 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -100.85 151.4 21.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -117.21 73.41 7.1 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.973 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.95 -179.99 5.51 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.646 2.231 . . . . 0.0 112.359 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -60.3 -158.88 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.416 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.424 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -47.13 -27.39 1.4 Allowed 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.598 0.237 . . . . 0.0 111.485 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 42' ' ' LYS . 0.3 OUTLIER 52.45 17.95 0.86 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.979 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -83.19 -57.04 3.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 0.0 110.972 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -92.77 -5.62 50.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.44 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.1 -18.94 29.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.557 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.524 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 13.3 t80 -83.37 -47.92 0.77 Allowed Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 116.762 -0.199 . . . . 0.0 111.49 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 41.9 Cg_exo -57.11 -38.23 96.14 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.336 2.024 . . . . 0.0 112.327 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.441 ' CG ' ' N ' ' A' ' 50' ' ' VAL . 4.6 pt20 -60.9 -47.31 86.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.044 0.45 . . . . 0.0 110.923 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.441 ' N ' ' CG ' ' A' ' 49' ' ' GLN . 20.3 m -76.99 -27.95 16.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.229 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.7 -26.78 57.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.39 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.76 -35.73 71.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.237 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.0 t -110.8 -29.65 7.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.031 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.39 35.53 6.56 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.536 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.27 -27.45 20.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.785 0.326 . . . . 0.0 111.029 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.73 -156.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.544 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.43 ' HG3' ' CG ' ' A' ' 10' ' ' TRP . 46.0 Cg_endo -68.06 -167.84 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.623 2.215 . . . . 0.0 112.301 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -109.45 -31.27 7.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.2 mt -136.81 129.03 44.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.135 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.47 ' CG1' ' N ' ' A' ' 61' ' ' PHE . 2.3 tt -114.88 159.07 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.093 0.473 . . . . 0.0 111.018 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.47 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 6.2 m-85 -130.56 113.14 13.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.784 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.3 t-105 -152.71 173.73 14.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.959 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.45 139.27 58.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -58.0 -33.69 69.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.038 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -59.67 -39.39 84.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.981 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -94.14 17.18 13.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.273 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.43 -4.71 37.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.416 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -94.82 26.4 18.74 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.56 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -124.5 4.42 8.74 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.84 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.411 ' CE1' ' HG3' ' A' ' 48' ' ' PRO . 4.7 m-85 -112.59 -32.32 6.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.845 0.355 . . . . 0.0 110.998 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.51 -26.07 50.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.09 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -32.82 70.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.963 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.57 24.95 6.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.079 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 54.84 40.48 72.3 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.756 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.0 mt -100.32 -48.19 4.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.808 0.337 . . . . 0.0 110.934 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 20.5 mt -73.35 142.0 47.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.987 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.6 169.77 10.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.095 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.35 -164.9 1.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.942 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.419 HG23 ' CE1' ' A' ' 106' ' ' TYR . 35.8 pt -157.02 168.82 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.089 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 48.9 p -156.65 77.49 4.17 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.831 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.77 154.59 63.67 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.603 2.202 . . . . 0.0 112.315 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -78.08 164.77 24.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.813 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -59.74 -38.48 81.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.815 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.94 -44.39 85.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.005 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.415 ' CE1' ' HG2' ' A' ' 281' ' ' GLU . 31.4 t80 -66.44 -37.37 85.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -69.07 -30.48 68.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.51 -28.32 62.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.969 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.66 43.19 1.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.024 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.418 HD13 ' CZ2' ' A' ' 94' ' ' TRP . 8.1 mt -151.93 139.04 19.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.876 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.438 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . 12.9 m-85 -73.31 129.77 85.39 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -49.06 -55.54 4.05 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.657 2.238 . . . . 0.0 112.996 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.455 ' CE1' ' CG2' ' A' ' 93' ' ' THR . 10.7 p90 -49.78 -25.13 2.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.077 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.455 ' CG2' ' CE1' ' A' ' 92' ' ' PHE . 10.4 p -74.73 -30.57 61.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.819 0.342 . . . . 0.0 110.804 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.419 ' CZ3' HD11 ' A' ' 103' ' ' LEU . 12.2 m95 -73.1 -39.48 65.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.922 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -62.09 -27.34 68.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.999 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.98 -25.67 67.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.332 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.6 m -121.09 72.81 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.911 0.386 . . . . 0.0 111.266 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -156.06 144.2 19.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.874 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -106.09 -64.53 1.15 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -123.8 41.76 3.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.824 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.84 25.58 29.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.522 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.99 145.35 49.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.765 0.317 . . . . 0.0 110.896 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.419 HD11 ' CZ3' ' A' ' 94' ' ' TRP . 13.4 mt -87.93 140.41 29.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.939 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.0 pt -144.86 29.87 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.227 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -166.68 -177.11 3.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.153 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.419 ' CE1' HG23 ' A' ' 79' ' ' ILE . 5.9 m-85 -135.31 85.97 31.47 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.89 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.32 97.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.584 2.19 . . . . 0.0 112.321 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.431 HD11 HG22 ' A' ' 108' ' ' ILE . 24.7 mm -75.31 -66.16 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.204 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -112.74 164.41 13.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.181 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.3 t -130.51 106.96 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.07 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -91.44 163.55 14.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.933 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -163.02 144.3 9.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.061 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.8 mt -62.05 145.22 53.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.1 p -140.35 -177.19 4.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.942 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 35.2 tp -122.48 129.38 51.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.871 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.1 mp -110.51 125.83 67.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.064 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.42 ' CG ' ' HB3' ' A' ' 125' ' ' PRO . 28.2 p90 -125.72 160.42 29.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -92.38 -176.36 4.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.886 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.9 mttm -125.13 -45.31 1.86 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.869 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.16 -31.65 72.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 70.6 mt -98.98 -31.06 12.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.957 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 9.9 tp -132.53 108.0 13.23 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.853 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.63 -45.84 3.1 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.377 2.051 . . . . 0.0 112.263 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -128.17 128.95 23.68 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.83 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.42 ' HB3' ' CG ' ' A' ' 117' ' ' TYR . 66.8 Cg_endo -74.11 144.18 33.36 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.448 2.099 . . . . 0.0 112.416 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.54 123.07 7.33 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.52 2.147 . . . . 0.0 112.315 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.0 mmtp -93.42 17.87 10.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.105 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.41 149.93 51.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.846 0.355 . . . . 0.0 110.795 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.421 ' CD1' ' HG2' ' A' ' 248' ' ' PRO . 3.7 m95 -78.52 -22.47 47.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.111 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.26 -18.4 36.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.362 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.54 -30.68 52.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.8 0.334 . . . . 0.0 111.113 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.54 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 24.5 mt -63.68 -54.79 39.41 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.673 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 12.2 Cg_endo -55.98 -30.63 78.8 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.205 1.937 . . . . 0.0 112.084 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.2 -29.16 57.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.808 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.9 mt -72.74 -33.14 66.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.762 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.69 -22.9 38.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.202 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -85.35 -32.31 22.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.026 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -85.09 -48.44 9.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.138 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.2 mt -63.33 -17.45 62.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.403 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.42 -29.9 42.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.845 0.355 . . . . 0.0 110.814 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.34 -34.39 78.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.91 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -75.9 -27.09 57.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.97 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 113.11 40.21 1.08 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.48 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.66 -175.97 5.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.787 0.327 . . . . 0.0 110.862 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.9 t -115.34 159.12 21.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -84.57 -66.08 0.94 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.128 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.0 tp -154.02 141.62 19.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.939 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.46 -177.86 4.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.409 ' CE1' HD11 ' A' ' 195' ' ' LEU . 8.2 p90 -177.22 175.0 1.57 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.867 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -69.0 111.17 4.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.851 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.6 mt -98.0 27.02 4.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.057 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -119.83 -40.0 2.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.822 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -99.37 146.42 31.73 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.813 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.08 9.45 3.96 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.722 2.281 . . . . 0.0 113.028 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -75.41 -32.3 60.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.739 0.304 . . . . 0.0 111.13 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -94.98 -16.58 22.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.437 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 30.8 p -92.42 -24.41 18.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.69 0.281 . . . . 0.0 111.28 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.489 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 27.3 t-105 -53.4 -45.78 98.33 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.526 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 52.6 Cg_exo -52.67 -25.61 26.85 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.334 2.022 . . . . 0.0 112.28 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.409 HD11 ' CD1' ' A' ' 250' ' ' PHE . 4.8 tp -92.56 -42.96 9.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.933 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 21.0 mt -72.79 -54.66 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.419 ' HB1' ' CD2' ' A' ' 158' ' ' TRP . . . -60.2 -33.21 71.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.176 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.07 -33.48 74.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.142 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.28 -20.14 57.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.153 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 141.09 -26.9 2.45 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.561 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.7 158.01 53.35 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.537 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -146.8 171.26 15.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.327 . . . . 0.0 110.85 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -90.96 -67.55 0.85 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.078 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -120.83 121.14 37.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.788 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -63.69 123.99 20.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.931 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -86.36 115.28 23.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.483 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -165.04 148.38 8.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.106 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 64.73 29.22 12.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.162 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.7 -37.25 3.37 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.087 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.73 -173.35 2.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.886 0.374 . . . . 0.0 111.063 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -105.25 173.98 6.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.85 127.85 49.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.1 pt -79.34 -22.55 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.349 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.34 26.02 4.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.132 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -145.06 94.2 2.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.836 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.27 131.75 65.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.163 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -87.88 -9.04 71.82 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.853 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 184' ' ' ASP . 0.3 OUTLIER -48.47 -41.8 11.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.892 0.377 . . . . 0.0 111.332 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.416 ' N ' ' CG1' ' A' ' 183' ' ' VAL . 25.8 t0 -84.61 57.17 4.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.915 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -118.26 -173.75 2.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.944 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.07 -34.77 57.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.113 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.57 -43.74 84.9 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.569 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.43 -30.62 67.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.833 0.349 . . . . 0.0 111.189 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.86 -38.68 82.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.869 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -86.96 -28.51 22.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.199 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -57.47 -54.62 35.79 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.607 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.63 -53.11 61.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.829 0.347 . . . . 0.0 110.932 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 62.1 m -54.1 -24.93 19.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.121 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -70.86 -59.99 2.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.815 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.409 HD11 ' CE1' ' A' ' 149' ' ' PHE . 2.6 tp -58.73 -33.07 69.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.669 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 49.5 t -63.43 -54.52 31.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.902 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -66.06 -32.69 74.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.735 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 14.5 mt -57.11 -19.27 18.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.224 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 4.7 mt -88.99 -60.11 2.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.803 0.335 . . . . 0.0 111.565 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -85.19 -47.27 10.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.008 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -71.0 -10.0 58.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.014 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.71 -82.98 0.61 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.808 0.337 . . . . 0.0 111.189 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 171.01 16.27 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.374 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -82.96 146.12 28.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.784 0.326 . . . . 0.0 110.77 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -102.04 137.42 40.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.031 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -79.99 -25.28 40.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.259 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -55.09 -31.1 60.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.132 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 3.8 m -49.89 147.23 3.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.174 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.414 ' HB2' ' CG1' ' A' ' 212' ' ' ILE . 69.8 m-20 -154.15 176.22 12.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.015 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -41.59 -61.66 1.03 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.77 -59.26 3.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.833 0.349 . . . . 0.0 111.921 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.414 ' CG1' ' HB2' ' A' ' 209' ' ' ASP . 0.2 OUTLIER -53.88 -30.67 19.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.342 -179.357 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -81.89 -25.76 34.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.801 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -82.31 -53.0 6.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.71 -25.75 63.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.323 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.86 -32.27 65.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.239 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.401 ' CD1' HG23 ' A' ' 225' ' ' THR . 58.2 t80 -82.15 -34.0 29.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -75.46 -40.39 57.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -77.64 -31.92 53.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.928 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 103.01 72.13 0.91 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.546 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -128.39 -62.92 1.01 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.835 0.35 . . . . 0.0 110.893 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.9 t -93.5 135.88 34.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.939 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.92 -31.25 70.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.06 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -120.8 151.21 39.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.942 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.401 HG23 ' CD1' ' A' ' 217' ' ' PHE . 9.0 t -157.67 159.58 37.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 24.8 mt -120.46 130.35 74.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.174 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -160.95 165.34 30.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -105.99 -153.16 20.6 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.566 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.98 -26.19 24.38 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.629 2.22 . . . . 0.0 112.364 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 41.1 p90 -84.87 57.51 4.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.839 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -156.45 -44.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.166 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -54.88 -48.01 73.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.021 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.3 m -66.77 -31.7 72.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.01 -32.2 73.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 4.8 mt -94.13 113.66 29.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.031 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -165.46 -49.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 7.0 m -65.87 -39.98 91.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.923 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 1.9 t -69.25 -29.5 67.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.921 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt 61.82 36.55 16.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.918 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 26.8 t -79.01 108.29 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.043 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.42 92.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.924 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -97.58 160.05 14.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.23 137.86 9.43 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.445 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.28 124.15 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.784 0.326 . . . . 0.0 111.155 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.1 t -130.52 159.3 37.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.5 t -73.61 151.92 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.001 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.2 mt -74.22 149.82 87.22 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.884 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.421 ' HG2' ' CD1' ' A' ' 129' ' ' TRP . 50.9 Cg_endo -69.14 165.97 28.44 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.554 2.169 . . . . 0.0 112.341 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 4.0 p -92.33 163.64 13.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.963 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.409 ' CD1' HD11 ' A' ' 160' ' ' LEU . 8.3 t80 -128.89 111.12 12.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 8.8 mttt 60.28 28.23 17.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.023 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 93.79 -21.16 42.99 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.731 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -94.3 148.99 36.01 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.704 0.288 . . . . 0.0 110.945 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.2 154.36 66.06 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.594 2.196 . . . . 0.0 112.334 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.16 -174.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.837 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 2.0 mmtt -135.04 63.83 59.02 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.973 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -56.19 -177.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.532 2.154 . . . . 0.0 112.251 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -118.83 116.59 26.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.766 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.2 t -85.8 123.4 39.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.288 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -121.92 117.64 3.45 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.271 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.48 127.47 66.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.37 . . . . 0.0 111.318 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 29.3 tp -91.11 85.38 5.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.297 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 1.4 m -86.33 175.19 8.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.134 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -107.06 114.99 29.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.006 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -85.9 128.8 8.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.553 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 28.0 mt -115.63 135.18 56.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.361 . . . . 0.0 111.08 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -85.49 140.62 30.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -70.39 -41.57 72.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.081 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -61.85 -28.95 69.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.149 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 3.7 m -58.17 109.48 1.85 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.979 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.57 -18.2 43.06 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.467 2.112 . . . . 0.0 112.499 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -92.88 46.27 1.22 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.03 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 16.3 mtmt -84.05 -31.96 25.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -62.11 -57.44 11.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 50.1 mt -62.51 -31.53 72.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.85 -46.62 65.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.68 -29.12 64.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.012 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -73.7 -52.96 11.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.043 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.412 ' CD1' ' HB2' ' A' ' 283' ' ' TYR . 79.1 t80 -59.93 -28.21 67.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.325 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 5.1 mt -80.31 -30.7 38.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.182 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.415 ' HG2' ' CE1' ' A' ' 85' ' ' PHE . 7.3 tt0 -93.65 -24.46 17.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.449 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -97.51 -50.16 4.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.445 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.423 ' N ' ' CD1' ' A' ' 283' ' ' TYR . 4.4 m-85 -117.47 71.41 0.81 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.37 . . . . 0.0 111.296 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 5.6 tp -178.54 -39.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.91 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.404 HD21 ' CZ ' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -115.26 38.35 3.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.869 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.19 -176.38 2.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -80.87 -38.7 27.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -82.68 -36.28 26.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -65.67 -44.19 92.96 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.519 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 9.2 mt -70.14 -31.08 68.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 0.0 110.915 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -70.33 -36.96 74.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.994 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -59.27 -38.22 79.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.131 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.56 -29.45 20.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.111 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -74.06 -30.92 62.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.983 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 33.1 mttt -65.87 -35.41 80.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.959 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -99.0 -30.96 12.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.969 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -152.97 95.18 3.02 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.931 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -62.29 119.52 6.66 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.513 2.142 . . . . 0.0 112.248 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.72 22.01 8.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.963 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 58.37 -133.96 52.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.664 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -58.71 174.68 0.31 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.816 0.341 . . . . 0.0 111.223 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 14.2 m -143.18 -179.7 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.07 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -93.86 -29.55 15.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.146 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.5 tp -58.89 152.27 19.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.916 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -77.01 -61.19 2.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.019 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 7.2 p -57.17 -49.79 74.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.079 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.81 -25.04 60.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.027 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.46 -31.78 71.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.736 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -83.83 -42.1 16.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.865 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -52.44 -33.22 43.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.774 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 83.7 mt -85.74 -21.37 28.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.919 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -76.47 -2.65 33.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.711 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 22.1 mmtt -47.26 -31.83 4.09 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 121.043 0.449 . . . . 0.0 110.856 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -117.41 140.22 27.08 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.309 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.46 -32.4 94.01 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.349 2.033 . . . . 0.0 112.416 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 11.2 mtm-85 -48.58 -42.57 34.14 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.116 0.484 . . . . 0.0 110.243 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.454 HD12 HG23 ' A' ' 317' ' ' ILE . 34.4 mt -85.56 -30.78 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.791 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.66 -33.92 77.07 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.125 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -74.97 -31.46 61.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.152 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 7.1 m -64.05 -48.48 76.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 10.8 tpt -60.96 -31.62 71.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -61.11 -43.77 98.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -62.35 -41.91 98.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.03 -55.0 39.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.082 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -60.1 -30.03 68.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.931 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -95.84 21.08 8.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.145 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -131.38 -179.6 16.28 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.486 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.1 133.77 52.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.825 0.345 . . . . 0.0 110.906 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 22.9 mt -81.53 133.53 29.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.107 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 10.7 mtm -62.41 137.42 96.15 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.92 -172.38 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.522 2.148 . . . . 0.0 112.326 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -110.05 -26.07 9.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.027 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 33.5 pt -56.25 147.99 44.31 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.319 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.26 -8.91 22.65 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.636 2.224 . . . . 0.0 112.645 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -54.53 -26.18 30.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.741 0.305 . . . . 0.0 111.103 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.404 ' O ' ' CD1' ' A' ' 340' ' ' TRP . 0.7 OUTLIER -56.8 -30.91 64.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.934 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.5 m -60.75 -57.31 13.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.971 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.97 -30.35 71.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.133 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -59.73 -36.76 77.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.977 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . 0.404 ' CD1' ' O ' ' A' ' 336' ' ' MET . 25.8 m95 -66.28 -51.01 61.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.945 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.89 -47.84 84.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.074 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -57.22 -44.63 83.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.301 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 23.9 t -77.39 -28.55 16.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.27 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -57.43 13.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.945 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 3.7 m -60.57 -41.37 94.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -57.29 -34.92 69.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.23 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 28.7 t -82.69 -45.91 19.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.188 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 9.4 mt -61.26 -57.59 11.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.162 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -58.77 -43.66 90.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.971 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.39 -29.87 70.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.082 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -78.51 -29.45 46.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.174 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 10.6 m -95.75 20.74 9.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.18 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 56.32 27.02 52.24 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.617 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 6.8 mtt-85 -89.86 -29.69 18.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.79 0.329 . . . . 0.0 110.963 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -143.86 162.27 36.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.899 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 30.6 p -97.96 156.85 16.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.844 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 25.6 t -56.88 -28.66 28.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.159 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -70.26 -56.5 6.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -61.88 -46.08 90.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.021 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -60.02 -50.37 73.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.139 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 28.0 mt -62.04 -30.18 70.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.47 -45.44 25.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.961 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -69.13 -45.59 69.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.99 -46.03 89.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -59.8 -43.25 94.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 10.0 m -64.66 -31.53 72.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.92 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 13.6 mtp85 -68.57 -35.71 77.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.943 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 19.3 mt -73.26 -28.86 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.177 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 2.2 p -82.62 -31.47 28.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.899 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.901 179.969 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.809 0.337 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.2 165.24 12.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -82.59 154.85 24.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 113.26 -35.9 4.33 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.455 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -113.76 169.86 8.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 0.0 110.871 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.7 mt -124.24 118.78 27.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.9 147.05 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.208 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.8 mt -137.32 107.34 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.927 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -96.81 109.36 22.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.84 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.9 tt -123.52 158.14 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.029 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -60.56 166.58 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.19 43.36 2.39 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.498 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -161.18 31.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.46 177.67 7.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.94 73.49 0.27 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.52 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -86.02 -33.06 21.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 0.0 110.947 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -60.43 -33.17 72.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.96 -28.46 60.61 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.531 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.7 tp -72.66 -30.99 64.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.811 0.338 . . . . 0.0 110.932 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.52 -37.94 83.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.103 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -70.39 -32.23 69.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.413 HG13 ' CZ ' ' A' ' 279' ' ' PHE . 26.8 t -72.2 -30.72 36.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.104 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.32 -38.6 33.4 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.538 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -59.88 -29.51 68.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.817 0.341 . . . . 0.0 110.94 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -74.78 -41.19 60.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.937 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.484 ' CD2' ' CE1' ' A' ' 283' ' ' TYR . 1.5 t80 -59.75 -52.62 64.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.907 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -58.53 -43.13 89.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.902 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -71.83 -25.39 61.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.83 -32.85 40.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.371 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.53 -44.23 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.473 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.16 -23.27 2.58 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.762 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.411 ' HB ' ' CD1' ' A' ' 27' ' ' PHE . 33.1 mm -59.92 110.16 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.828 0.347 . . . . 0.0 111.037 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.6 mtmt -78.63 156.75 28.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.955 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.4 t -134.82 117.96 24.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.091 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.0 m -99.5 143.86 29.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.4 t -137.84 110.71 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.139 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -110.28 176.21 5.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.86 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -133.11 74.31 73.44 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.86 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.18 -179.13 4.07 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.64 2.227 . . . . 0.0 112.415 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -60.05 -159.43 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.53 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.464 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -46.46 -27.45 1.1 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.604 0.24 . . . . 0.0 111.53 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 42' ' ' LYS . 0.3 OUTLIER 52.44 19.68 1.23 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.852 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.73 -57.12 4.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.829 0.347 . . . . 0.0 110.655 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -95.49 -7.72 37.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.002 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.87 -19.24 57.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.256 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.444 ' CE2' ' CG ' ' A' ' 57' ' ' PRO . 0.3 OUTLIER -85.58 -55.94 0.39 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.045 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.429 ' HD3' ' CB ' ' A' ' 47' ' ' PHE . 72.6 Cg_exo -50.54 -35.63 46.79 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.589 2.193 . . . . 0.0 112.61 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.454 ' CG ' ' N ' ' A' ' 50' ' ' VAL . 11.2 pt20 -59.49 -49.68 76.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.947 0.403 . . . . 0.0 111.004 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.454 ' N ' ' CG ' ' A' ' 49' ' ' GLN . 6.6 m -95.29 18.05 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.552 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.09 -38.01 13.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.825 0.345 . . . . 0.0 111.216 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.51 -33.77 68.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.164 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.3 t -96.43 -29.53 13.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.934 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.53 28.1 72.71 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.431 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -94.5 -28.26 15.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.74 0.305 . . . . 0.0 111.01 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.97 -105.11 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.597 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.444 ' CG ' ' CE2' ' A' ' 47' ' ' PHE . 61.4 Cg_endo -73.18 -169.12 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.49 2.127 . . . . 0.0 112.407 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -150.55 -46.86 0.12 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.813 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.2 mt -127.19 133.37 68.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.058 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.477 ' CG1' ' N ' ' A' ' 61' ' ' PHE . 1.9 tt -139.49 159.69 28.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.111 0.481 . . . . 0.0 110.942 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.477 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 65.2 m-85 -138.1 122.35 18.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.873 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -158.26 169.26 24.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.882 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.13 143.87 47.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -60.49 -31.52 70.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -59.74 -36.04 75.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.902 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.3 mmt-85 -94.69 17.18 13.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.231 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -105.71 -31.14 9.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.849 0.357 . . . . 0.0 110.858 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.5 -28.14 64.53 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.555 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.34 -28.83 74.01 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.559 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -91.89 -27.91 17.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.73 0.3 . . . . 0.0 110.982 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.53 -28.03 41.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.244 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.36 -31.71 69.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.063 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.6 m -88.09 -23.17 23.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.09 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.4 27.98 10.17 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.442 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.9 mt -81.25 -34.25 32.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.77 0.319 . . . . 0.0 110.868 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.5 mt -81.86 146.55 29.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.29 135.27 33.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.068 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.443 ' HG3' ' N ' ' A' ' 79' ' ' ILE . 17.5 tp10 -69.57 159.72 32.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.09 0.472 . . . . 0.0 110.739 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.443 ' N ' ' HG3' ' A' ' 78' ' ' GLU . 35.4 pt -135.29 -178.57 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.176 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 t -163.22 78.0 1.75 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.804 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.08 123.4 11.83 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.643 2.229 . . . . 0.0 112.282 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.5 -177.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.852 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -60.09 -40.56 90.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.913 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.79 -50.5 73.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.094 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -66.28 -35.31 80.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.46 -31.14 63.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.794 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -75.64 -36.51 60.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 57.19 4.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.885 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.422 HD11 ' CZ2' ' A' ' 94' ' ' TRP . 0.1 OUTLIER -173.61 162.02 4.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.774 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.48 ' CD1' ' CZ ' ' A' ' 92' ' ' PHE . 22.0 m-85 -78.51 136.22 60.09 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.077 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -55.24 -55.72 2.91 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.526 2.15 . . . . 0.0 112.662 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.48 ' CZ ' ' CD1' ' A' ' 90' ' ' TYR . 25.0 p90 -54.87 -44.83 74.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.549 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.431 ' CG2' ' CE1' ' A' ' 92' ' ' PHE . 40.2 p -61.31 -27.6 68.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.189 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.422 ' CZ2' HD11 ' A' ' 89' ' ' LEU . 8.4 m95 -69.52 -29.29 66.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.941 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -93.66 17.32 11.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.362 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -101.89 -29.69 11.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.76 0.314 . . . . 0.0 111.214 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.0 m -90.63 -35.73 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.446 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.95 132.37 48.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.012 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.407 ' CE1' ' OD1' ' A' ' 332' ' ' ASN . 0.4 OUTLIER -82.0 -49.59 10.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.865 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -148.6 54.67 1.01 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.929 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.12 -27.27 20.01 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.645 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.51 158.9 20.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.782 0.325 . . . . 0.0 110.965 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 54.9 mt -117.5 131.03 56.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.884 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.8 pp -142.65 27.21 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.342 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.25 179.33 9.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.869 0.366 . . . . 0.0 111.173 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.404 ' CE1' HD12 ' A' ' 266' ' ' ILE . 39.2 m-85 -140.87 89.49 9.96 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.833 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.09 99.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.57 2.18 . . . . 0.0 112.269 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.443 HD11 HG21 ' A' ' 108' ' ' ILE . 25.2 mm -74.01 -66.23 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.161 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -120.8 166.36 13.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.066 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.9 p -123.22 139.07 51.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.092 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -116.74 147.93 41.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -161.85 149.62 14.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.141 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.9 mt -68.27 126.02 28.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.9 m -124.9 147.29 48.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 tp -82.94 136.0 34.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.898 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.3 mt -116.4 131.38 69.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.049 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -122.24 154.95 36.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.32 144.31 31.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.36 29.77 3.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.959 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -97.39 -61.17 1.44 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.895 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.33 -32.83 6.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.849 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.1 tp -93.39 104.16 11.62 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.821 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.83 -47.21 2.0 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.405 2.07 . . . . 0.0 112.275 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -123.38 135.44 26.04 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.822 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.09 139.11 21.21 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.529 2.152 . . . . 0.0 112.32 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.2 116.77 4.65 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.447 2.098 . . . . 0.0 112.394 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.01 23.41 6.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.03 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.5 p -134.77 141.95 46.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.865 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.422 ' CD1' ' HB2' ' A' ' 248' ' ' PRO . 2.4 m95 -79.94 -22.56 42.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.103 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.52 -24.72 53.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.181 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -81.18 -26.56 35.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.143 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.532 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 31.7 mt -57.28 -54.56 53.49 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.625 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 15.6 Cg_endo -57.47 -27.32 75.75 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.239 1.959 . . . . 0.0 112.089 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.0 -29.31 35.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.5 mt -73.92 -39.68 63.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.859 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.12 -26.35 11.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.058 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -85.58 -27.86 25.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.122 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.98 -48.62 9.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.153 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.89 -17.32 61.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.411 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -28.11 55.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.845 0.355 . . . . 0.0 110.847 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.88 -41.64 87.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.02 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 46.7 mttt -77.22 -27.01 53.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.02 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 116.07 31.48 1.88 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.488 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.72 -178.31 5.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 0.0 110.868 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.2 t -115.65 171.76 7.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.861 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -87.28 -57.59 2.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.155 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.2 tp -161.21 143.83 12.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.987 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.29 -178.99 5.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -179.29 151.73 0.5 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -62.52 121.33 13.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.857 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.4 mt -98.26 28.6 3.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.938 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -112.63 -33.59 6.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.24 107.51 60.54 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.887 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -51.32 -24.13 15.14 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.485 2.123 . . . . 0.0 112.398 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.483 ' CE1' ' CD2' ' A' ' 258' ' ' PHE . 54.0 t80 -52.33 -27.79 16.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.199 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -87.11 -35.1 18.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.9 p -94.86 18.3 12.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.2 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.535 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 27.4 t-105 -73.76 -50.51 5.65 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.531 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 43.2 Cg_endo -68.2 -24.79 37.67 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.116 1.878 . . . . 0.0 112.508 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.412 HD13 ' CZ2' ' A' ' 129' ' ' TRP . 52.1 tp -59.23 -37.47 77.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.841 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 4.8 mp -105.06 -33.28 2.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.991 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.52 -29.15 70.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.241 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -56.64 -46.77 80.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.144 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -61.06 -20.07 62.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.124 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 125.63 53.55 0.17 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.489 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -134.53 123.64 3.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.512 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.419 ' CD2' ' HA3' ' A' ' 182' ' ' GLY . 20.7 p90 -117.99 -178.25 3.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.848 0.356 . . . . 0.0 110.871 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -100.07 -44.48 5.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.083 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -131.87 141.95 49.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.7 tptp -68.38 137.24 54.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.976 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.428 ' CE1' ' HA2' ' A' ' 174' ' ' GLY . 19.8 t80 -128.11 110.7 12.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.74 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.407 ' CG ' ' N ' ' A' ' 173' ' ' ASN . 9.7 pt-20 -139.01 -47.24 0.48 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.308 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.407 ' N ' ' CG ' ' A' ' 172' ' ' GLU . 49.4 m-80 -95.72 41.85 1.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.073 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.428 ' HA2' ' CE1' ' A' ' 171' ' ' TYR . . . 57.78 20.55 40.54 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.706 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.406 ' O ' ' CD2' ' A' ' 171' ' ' TYR . 11.3 mttt -133.3 -171.37 2.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.337 . . . . 0.0 110.866 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -126.44 86.81 2.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.59 127.67 33.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.911 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.9 pt -81.46 -12.3 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.472 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -96.01 26.0 4.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.719 0.295 . . . . 0.0 111.149 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -148.4 116.16 6.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.935 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 21.3 t -104.53 146.08 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.042 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . 0.419 ' HA3' ' CD2' ' A' ' 167' ' ' TYR . . . -96.97 -12.64 49.08 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.029 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 6.1 t -62.89 -43.5 98.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.815 0.34 . . . . 0.0 111.18 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -83.85 57.23 4.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.07 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -110.74 -172.78 2.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.12 -44.78 29.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.171 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.16 -34.78 28.84 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.583 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.62 -30.16 68.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.337 . . . . 0.0 111.179 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -60.51 -56.62 19.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.32 -26.53 55.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.225 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -56.14 -40.7 84.29 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.706 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.77 -30.13 56.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.752 0.311 . . . . 0.0 110.94 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 66.2 m -56.35 -23.27 36.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.943 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -65.58 -60.53 2.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.791 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 5.2 tp -60.31 -30.96 69.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.703 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 40.0 t -66.07 -48.41 81.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.007 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -82.43 -23.12 34.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.095 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 6.3 mt -64.25 -24.38 67.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.228 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 13.5 mt -88.96 -42.22 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.646 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 23.4 mtpt -85.02 -29.35 25.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.829 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -91.65 -10.18 41.28 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.424 ' O ' ' CG ' ' A' ' 203' ' ' HIS . 13.4 mmtt -133.96 9.71 3.86 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.191 -0.204 . . . . 0.0 111.516 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . 0.424 ' CG ' ' O ' ' A' ' 202' ' ' LYS . 56.2 p-80 43.89 53.15 6.38 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.942 0.401 . . . . 0.0 111.376 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.84 128.42 34.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.844 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -59.94 119.89 8.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.991 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -80.04 -28.06 39.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.077 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -56.47 -24.36 45.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.182 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 7.6 m -36.29 145.91 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.94 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -153.55 176.21 12.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.75 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -34.84 79.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.032 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.99 -59.13 2.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 0.0 111.226 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.88 -29.59 41.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.848 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -81.75 -21.23 37.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.995 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -75.47 -56.9 4.25 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.837 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.37 -29.53 68.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.136 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.94 -41.91 88.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.141 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.42 ' CG ' HG23 ' A' ' 225' ' ' THR . 19.1 t80 -75.65 -33.16 60.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -74.9 -38.39 61.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.956 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.35 -31.55 33.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.894 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.66 63.8 0.72 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.48 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -111.07 -32.99 6.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.342 . . . . 0.0 110.949 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.6 t -121.05 162.26 20.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -84.08 -39.86 19.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.102 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -126.71 165.81 18.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.897 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.42 HG23 ' CG ' ' A' ' 217' ' ' PHE . 9.8 t -166.65 139.52 3.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 22.9 mt -101.08 128.27 53.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -165.3 144.74 6.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -63.84 -175.05 3.5 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.508 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.52 -20.91 35.34 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.662 2.241 . . . . 0.0 112.457 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . 0.428 ' CD1' ' N ' ' A' ' 231' ' ' ALA . 5.4 p90 -56.3 -30.7 62.86 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.001 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.428 ' N ' ' CD1' ' A' ' 230' ' ' TRP . . . -72.92 -32.78 65.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.102 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 50.6 m0 -57.29 -27.42 62.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.074 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.3 m -59.59 -55.42 34.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.024 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -62.59 -30.63 71.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.011 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.416 HG22 ' CE1' ' A' ' 242' ' ' TYR . 23.2 mt -70.78 96.69 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.085 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -160.48 -53.2 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.77 -33.92 74.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.917 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 99.1 p -60.19 -32.84 71.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm 60.69 33.34 20.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.5 t -91.44 131.18 39.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.12 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.97 93.52 3.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.416 ' CE1' HG22 ' A' ' 235' ' ' ILE . 52.7 p90 -103.43 135.13 45.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.967 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -101.97 -164.55 26.84 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.5 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.4 t -148.19 133.99 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 111.128 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 63.3 m -143.5 159.3 42.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.86 151.88 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.971 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 9.9 mt -59.64 141.05 88.94 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.874 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.422 ' HB2' ' CD1' ' A' ' 129' ' ' TRP . 50.3 Cg_exo -53.67 146.1 45.78 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.506 2.137 . . . . 0.0 112.242 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 67.6 p -81.19 -177.3 6.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -156.8 109.95 2.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 24.1 mtpt 59.57 31.04 20.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 83.84 27.12 39.1 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.549 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -138.16 142.2 34.69 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.667 0.27 . . . . 0.0 110.915 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.09 163.88 34.29 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.572 2.181 . . . . 0.0 112.342 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 8.5 m -74.25 153.05 39.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.845 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.35 72.62 0.93 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.868 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.8 -168.26 0.31 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.597 2.198 . . . . 0.0 112.335 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . 0.496 ' CE2' ' CD1' ' A' ' 158' ' ' TRP . 13.9 m-85 -101.99 165.6 11.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.924 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 26.5 t -127.98 126.4 66.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.103 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -126.92 116.9 2.59 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.386 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.6 130.56 66.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.824 0.345 . . . . 0.0 111.078 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 7.3 tp -90.58 84.01 5.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.791 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.53 166.27 18.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.966 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -99.51 131.38 45.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.068 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -95.53 103.04 2.92 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.507 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.404 HD12 ' CE1' ' A' ' 106' ' ' TYR . 32.8 mt -100.5 103.05 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.797 0.332 . . . . 0.0 111.098 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -62.07 165.49 5.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.997 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -84.02 -24.97 30.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.279 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -96.4 30.25 2.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.301 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.44 125.05 90.59 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.83 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.23 -27.71 39.25 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.385 2.057 . . . . 0.0 112.339 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -145.9 85.51 1.69 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.883 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -64.85 -36.32 83.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.855 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.25 -57.69 9.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 10.1 mt -60.01 -31.53 70.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.957 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.92 -60.4 3.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.099 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.86 -29.16 70.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.964 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -59.47 -60.91 3.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.021 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.413 ' CZ ' HG13 ' A' ' 23' ' ' VAL . 52.6 t80 -54.12 -24.27 17.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.403 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 95.1 mt -76.74 -40.72 47.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.265 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -93.56 -16.38 24.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.601 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.42 ' HB3' ' CD1' ' A' ' 283' ' ' TYR . 2.8 m-80 -91.91 -58.06 2.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.639 0.257 . . . . 0.0 111.362 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.484 ' CE1' ' CD2' ' A' ' 27' ' ' PHE . 7.0 m-85 -126.83 75.86 1.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.37 . . . . 0.0 111.227 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 5.1 tp -177.99 -57.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.924 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 13.7 mt -94.41 47.29 1.18 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.891 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 18.0 p -128.53 176.98 7.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.891 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.418 ' HA ' ' CD1' ' A' ' 307' ' ' TYR . 9.2 p-10 -81.0 -34.98 32.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.933 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -82.69 -31.21 28.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.929 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.79 -56.64 5.8 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.583 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.83 -30.7 69.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.76 0.314 . . . . 0.0 110.97 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -59.76 -41.06 90.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.036 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.72 -54.44 47.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.143 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.3 t -58.4 -28.31 35.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.282 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -71.08 -27.16 63.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.046 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 18.5 mttm -60.28 -34.19 73.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.189 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -110.73 -34.68 6.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.207 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 2.8 tppt? -133.41 83.71 48.73 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.062 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.42 119.32 6.26 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.579 2.186 . . . . 0.0 112.284 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 4.6 mp -95.71 20.95 9.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.07 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 57.09 -106.56 0.74 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.603 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -71.59 175.29 5.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 111.12 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 15.4 m -143.14 160.12 17.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.165 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -79.96 -34.51 38.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.072 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 2.7 tp -71.37 110.65 6.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.891 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -60.59 -31.54 70.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.861 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.4 m -70.21 -33.23 71.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.418 ' CD1' ' HA ' ' A' ' 287' ' ' ASP . 12.5 t80 -83.78 -27.14 29.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.024 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -58.75 -30.62 67.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.878 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -63.19 -55.32 26.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.809 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.94 -35.25 45.31 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.749 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.413 HD12 ' CE2' ' A' ' 307' ' ' TYR . 15.8 mt -85.73 -23.97 27.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.756 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.46 -14.74 61.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.457 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -46.66 -31.37 2.85 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 120.921 0.391 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -116.64 137.89 24.05 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.302 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.77 -28.48 67.09 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.432 2.088 . . . . 0.0 112.459 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -51.72 -36.31 46.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.001 0.429 . . . . 0.0 110.37 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 35.7 mm -85.43 -35.45 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.85 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -69.83 -29.69 67.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.189 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -70.66 -56.01 7.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.148 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 8.7 m -60.1 -37.23 79.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.954 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 7.0 tpt -63.98 -31.34 72.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.951 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -69.45 -53.65 18.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.992 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.2 -31.34 70.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.887 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.68 -31.33 72.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.14 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -75.43 -55.02 6.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.94 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -68.55 -30.29 69.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -58.43 142.56 45.05 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.529 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -74.53 154.12 38.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.869 0.366 . . . . 0.0 110.872 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 23.3 mt -101.69 132.52 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.064 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.407 ' HG3' ' CD1' ' A' ' 258' ' ' PHE . 29.5 mtm -69.58 135.87 88.3 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.49 168.55 24.26 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.501 2.134 . . . . 0.0 112.347 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . 0.407 ' OD1' ' CE1' ' A' ' 99' ' ' TYR . 9.3 p30 -113.03 36.81 3.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.839 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 2.1 pt -105.98 154.29 39.59 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.158 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.26 -28.1 28.08 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.564 2.176 . . . . 0.0 112.308 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -58.86 -26.26 64.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.047 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.4 ' O ' ' CD1' ' A' ' 340' ' ' TRP . 0.0 OUTLIER -56.08 -29.9 61.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.04 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.8 m -66.66 -41.65 87.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.936 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.85 -26.09 60.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.233 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -57.95 -30.43 65.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.07 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . 0.4 ' CD1' ' O ' ' A' ' 336' ' ' MET . 89.0 m95 -67.43 -53.28 30.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.004 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.89 -24.75 59.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.172 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -84.77 -29.13 25.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.397 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 25.4 t -91.97 -50.27 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.259 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.66 -28.5 21.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.281 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 19.5 m -85.72 -48.67 8.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.077 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -58.78 -29.12 66.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.388 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 24.8 t -77.13 -52.26 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.293 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 40.4 mt -61.38 -50.92 78.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.127 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -58.57 -30.18 66.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.925 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -82.68 -29.42 29.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.207 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -76.44 -27.08 56.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.272 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 3.3 m -95.83 20.77 9.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.224 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 55.75 24.7 41.65 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.703 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.87 -29.72 18.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.832 0.349 . . . . 0.0 110.887 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -138.69 153.26 48.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.817 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.14 165.08 20.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.805 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 358' ' ' ASP . 1.6 p -63.97 -45.4 96.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.154 0.502 . . . . 0.0 110.774 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . 0.468 ' N ' ' CG1' ' A' ' 357' ' ' VAL . 66.4 m-20 -60.02 -53.87 52.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.172 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -57.18 -31.24 65.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.177 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -61.07 -60.41 3.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.973 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.31 -32.93 74.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.606 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.65 -59.05 3.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -59.17 -46.37 88.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.795 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -57.13 -37.16 71.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.076 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -60.59 -45.4 94.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 6.5 m -61.03 -40.61 94.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.956 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 44.4 mtm180 -62.95 -43.52 98.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.937 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 15.8 mt -72.47 -32.19 40.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.047 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 4.8 t -160.76 91.83 0.92 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.912 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.802 0.334 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -72.73 149.96 43.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.911 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -69.46 137.23 52.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 107.76 29.4 4.4 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.474 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -157.14 -177.94 6.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.817 0.341 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 mt -150.09 112.49 4.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.8 t -100.58 131.07 48.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.162 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.412 ' N ' ' CD1' ' A' ' 9' ' ' ILE . 3.3 mp -113.2 107.36 22.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.817 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.432 ' CD2' ' CG ' ' A' ' 57' ' ' PRO . 0.3 OUTLIER -95.22 106.7 18.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.842 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.9 tt -137.12 157.22 35.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.104 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -69.45 -179.59 1.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.51 61.02 0.31 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.558 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.41 31.11 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.815 0.34 . . . . 0.0 110.917 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -150.37 -176.73 5.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.854 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.75 64.79 1.84 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.536 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -78.92 -31.56 45.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.824 0.345 . . . . 0.0 110.921 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -63.1 -32.04 73.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.844 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.85 -30.82 57.14 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.46 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.1 tp -60.98 -30.68 70.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 110.887 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.89 -48.62 80.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.131 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -59.03 -30.66 68.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.966 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 36.5 t -69.04 -34.89 66.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.029 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.3 -35.71 83.1 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.465 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -59.63 -27.82 66.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.81 0.338 . . . . 0.0 111.014 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.42 -41.58 76.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.894 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.84 -51.26 67.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.0 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -64.66 -23.1 67.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.158 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -82.64 -25.45 33.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.309 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -101.22 -32.58 10.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.629 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.8 p -119.0 -44.18 2.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.781 0.325 . . . . 0.0 111.446 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.93 27.23 6.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.526 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.9 mm -94.19 130.49 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.761 0.315 . . . . 0.0 111.104 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -59.64 152.16 23.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.942 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.33 104.64 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.115 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.0 m -103.41 147.87 26.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -141.16 110.63 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -115.61 161.11 19.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.928 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -132.51 70.3 79.6 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.865 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.13 161.14 45.71 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.59 2.193 . . . . 0.0 112.362 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -103.36 141.01 36.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.651 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.09 37.57 24.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.817 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 pp -79.07 5.57 11.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.747 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.4 -46.69 66.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.795 0.331 . . . . 0.0 111.173 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -90.03 -9.84 47.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.478 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.03 -18.91 26.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.649 0.261 . . . . 0.0 111.338 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.441 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -78.18 -50.86 1.71 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.682 0.277 . . . . 0.0 111.317 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 52.7 Cg_exo -55.31 -20.43 25.31 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.632 2.221 . . . . 0.0 112.944 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.429 ' CG ' ' N ' ' A' ' 50' ' ' VAL . 0.9 OUTLIER -85.71 -47.95 9.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.896 0.379 . . . . 0.0 111.327 -179.61 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.429 ' N ' ' CG ' ' A' ' 49' ' ' GLN . 11.2 m -79.57 -28.6 13.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.304 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.28 -41.69 89.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.88 -32.21 73.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.148 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.2 p -83.52 -30.83 26.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.937 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.5 25.85 66.97 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.559 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.26 -31.07 10.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.864 0.364 . . . . 0.0 110.892 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.38 -147.72 2.29 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.523 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.432 ' CG ' ' CD2' ' A' ' 10' ' ' TRP . 52.9 Cg_exo -52.57 -175.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.56 2.173 . . . . 0.0 112.314 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -135.25 -46.77 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.957 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.4 HG23 HD13 ' A' ' 59' ' ' ILE . 6.7 pt -117.24 130.65 71.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.25 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.482 ' CG1' ' N ' ' A' ' 61' ' ' PHE . 2.8 tt -127.4 159.84 37.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.83 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.482 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 6.2 m-85 -119.65 140.52 50.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.139 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.424 ' CE3' HD12 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -176.07 153.76 1.34 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.724 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.89 158.44 6.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.09 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -55.99 -36.23 67.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.127 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -65.03 -29.68 70.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.066 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.7 17.25 12.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.365 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.453 ' CD2' ' CB ' ' A' ' 105' ' ' ALA . 2.6 m-85 -110.99 -31.8 7.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.8 0.333 . . . . 0.0 110.909 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.33 -28.3 61.68 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.519 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.06 -25.9 63.24 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.61 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -85.42 -19.32 31.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.627 0.251 . . . . 0.0 111.279 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.53 -39.47 16.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.759 0.314 . . . . 0.0 111.166 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -30.63 71.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.012 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.1 m -73.64 -23.09 59.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.08 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.81 26.79 30.96 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.561 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 mt -94.59 -30.12 14.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.84 0.353 . . . . 0.0 110.976 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 80.5 mt -83.09 160.86 21.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.032 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.17 -172.69 2.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.04 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.408 ' O ' ' CG2' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -88.57 -168.16 2.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.002 0.429 . . . . 0.0 110.958 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.44 HG23 ' CE1' ' A' ' 106' ' ' TYR . 7.6 pt -158.53 179.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.851 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 61.7 p -157.46 78.74 3.59 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.138 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.22 113.2 1.8 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.575 2.183 . . . . 0.0 112.128 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.54 176.98 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.965 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -50.05 75.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.863 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 88' ' ' LYS . . . -56.66 -22.06 31.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.405 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.423 ' CD2' ' CD1' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -83.75 -54.52 4.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.898 0.38 . . . . 0.0 111.006 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.453 ' HG2' ' CZ2' ' A' ' 94' ' ' TRP . 17.3 mt-30 -69.79 -21.18 63.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.539 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -91.62 -9.07 45.39 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.412 ' HE2' ' CD1' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -117.07 -23.01 8.13 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.497 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.423 ' CD1' ' CD2' ' A' ' 85' ' ' PHE . 0.4 OUTLIER -82.72 135.13 35.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.868 0.366 . . . . 0.0 110.988 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.442 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . 33.1 m-85 -63.25 131.97 94.95 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.073 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.13 -55.57 3.74 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.682 2.255 . . . . 0.0 112.867 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.442 ' CE2' ' HB3' ' A' ' 90' ' ' TYR . 10.5 p90 -46.35 -28.02 1.21 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.908 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.432 HG21 ' CE1' ' A' ' 92' ' ' PHE . 11.7 p -72.95 -31.28 64.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.83 0.348 . . . . 0.0 110.858 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.466 ' CZ3' ' CD1' ' A' ' 103' ' ' LEU . 6.6 m95 -63.57 -31.42 72.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.817 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.26 -18.21 64.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.359 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -88.77 -18.11 28.44 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.406 ' CG2' ' CD2' ' A' ' 103' ' ' LEU . 4.8 m -103.82 -36.0 3.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.653 0.263 . . . . 0.0 111.541 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.9 116.92 7.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.885 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -99.85 -33.33 10.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.809 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -155.23 40.68 0.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.767 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.73 -22.37 40.78 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.658 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.7 pttp -104.21 179.77 4.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 111.018 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.466 ' CD1' ' CZ3' ' A' ' 94' ' ' TRP . 17.6 mt -124.96 169.36 12.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.022 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 pp -156.61 -41.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.393 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.453 ' CB ' ' CD2' ' A' ' 67' ' ' PHE . . . -89.8 162.84 15.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 111.301 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.44 ' CE1' HG23 ' A' ' 79' ' ' ILE . 58.9 m-85 -120.14 79.93 27.0 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.19 137.47 70.51 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.607 2.205 . . . . 0.0 112.352 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.1 mp -118.51 -60.15 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.126 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -125.37 150.42 47.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.141 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.02 101.15 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.33 174.69 9.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.974 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -169.97 124.59 0.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.07 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 mt -64.35 96.59 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.962 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.2 t -100.3 154.17 18.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.3 tt -83.24 128.57 34.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.907 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.1 mt -114.53 130.52 68.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.096 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -109.79 165.55 11.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -106.68 154.05 21.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.94 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -98.92 31.07 3.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -94.06 -45.78 7.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.89 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -144.04 38.96 1.32 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 20.1 tp -172.5 89.35 0.41 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.07 -44.79 2.31 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.527 2.151 . . . . 0.0 112.29 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -108.91 120.45 45.96 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.834 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.92 151.1 44.83 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.408 2.072 . . . . 0.0 112.389 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.63 119.03 5.71 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.587 2.192 . . . . 0.0 112.344 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.24 21.69 7.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.036 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.38 141.94 25.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.838 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.409 ' CE3' HD12 ' A' ' 132' ' ' ILE . 45.9 m95 -68.29 -27.99 66.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.001 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -73.47 -15.75 61.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.402 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.12 -3.91 59.1 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.501 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 11.3 mt -85.47 -48.13 0.59 Allowed Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.501 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 71.5 Cg_exo -48.51 -49.83 13.7 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.383 2.055 . . . . 0.0 112.411 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.45 -42.83 98.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.088 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.19 -48.61 79.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -53.4 -27.8 26.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -85.71 -28.91 24.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -84.96 -52.01 6.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.331 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.1 mt -58.88 -19.75 44.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.493 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.19 -29.56 48.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.823 0.344 . . . . 0.0 110.803 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.74 -36.72 77.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.66 -27.04 40.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.878 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.45 31.26 2.03 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.508 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -140.27 173.57 11.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.751 0.31 . . . . 0.0 110.924 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.1 t -101.21 171.99 7.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -101.33 -68.4 0.82 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.267 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.0 tp -148.42 143.25 26.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.034 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.78 -177.81 5.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.808 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.416 ' CE2' ' HG ' ' A' ' 151' ' ' LEU . 32.1 p90 -178.54 -178.52 0.6 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -84.92 111.9 20.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.972 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.416 ' HG ' ' CE2' ' A' ' 149' ' ' PHE . 9.9 mt -99.91 41.67 1.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.779 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -104.25 -32.5 9.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.06 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -134.59 143.92 48.64 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.018 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -57.55 -19.47 37.01 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.577 2.185 . . . . 0.0 112.491 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -48.13 -28.24 2.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.428 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -100.57 -29.95 12.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.081 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 16.2 p -96.83 17.66 16.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.354 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.522 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 11.8 t-105 -73.63 -50.37 5.9 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.538 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 47.2 Cg_endo -68.79 -15.82 41.05 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.153 1.902 . . . . 0.0 112.535 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 23.0 tp -77.27 -35.2 55.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 0.0 110.809 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 10.2 mt -105.1 -47.27 9.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.144 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -57.94 -28.68 64.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.312 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -56.51 -28.85 60.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.27 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -74.58 -20.1 60.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.212 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 139.01 -24.42 2.85 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.694 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -56.52 144.65 36.94 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.663 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.426 ' CD2' ' HA3' ' A' ' 182' ' ' GLY . 25.7 p90 -140.96 -177.01 4.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.337 . . . . 0.0 110.84 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -101.26 -34.49 9.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.14 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.418 ' CD2' HD11 ' A' ' 333' ' ' ILE . 90.0 m-85 -144.37 153.67 42.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.933 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.5 140.01 39.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.976 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.436 ' CZ ' ' HA2' ' A' ' 174' ' ' GLY . 57.7 t80 -143.99 110.81 5.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.685 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -135.03 -47.54 0.72 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.385 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -103.21 50.24 0.81 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 0.0 111.123 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.436 ' HA2' ' CZ ' ' A' ' 171' ' ' TYR . . . 57.71 19.77 36.91 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.735 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -125.22 170.79 10.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.793 0.33 . . . . 0.0 110.969 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -128.17 95.87 4.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.871 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.03 129.45 42.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.942 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.1 pt -82.75 -26.34 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.254 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.8 25.97 4.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.144 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -130.52 108.04 9.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.916 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.88 146.06 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.089 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . 0.426 ' HA3' ' CD2' ' A' ' 167' ' ' TYR . . . -117.17 33.2 5.13 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.738 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.408 HG13 ' CD2' ' A' ' 361' ' ' LEU . 3.4 t -92.5 -50.52 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.345 . . . . 0.0 110.92 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -83.98 57.06 3.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.963 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -102.98 -178.92 3.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.766 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -74.06 -32.1 63.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.019 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -85.96 -42.61 6.67 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.571 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.33 -39.88 80.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.817 0.342 . . . . 0.0 111.227 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -59.25 -31.25 68.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.864 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -87.48 -30.25 20.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.096 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.73 -49.01 66.17 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.544 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.43 -43.57 96.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.834 0.35 . . . . 0.0 110.848 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 17.0 m -58.13 -27.43 63.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.928 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -60.27 -60.58 3.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.766 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.8 tp -60.56 -31.65 70.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.541 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 45.6 t -65.03 -61.64 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.936 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.61 -28.28 69.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.778 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.3 mt -58.57 -55.59 33.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.953 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 4.7 mt -55.26 -30.01 24.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.072 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -82.16 -34.09 29.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.937 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -106.49 29.98 6.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -144.92 -36.06 0.31 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.275 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 10.4 m80 76.28 41.64 0.21 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.925 0.393 . . . . 0.0 110.811 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.97 -175.38 5.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.759 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -108.16 126.76 53.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.963 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -79.44 -30.22 42.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.012 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.96 -15.98 62.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.22 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 30.0 m -36.81 148.43 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.974 0.416 . . . . 0.0 111.878 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -154.05 176.19 12.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.808 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -64.79 -28.73 69.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.47 -59.17 2.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.812 0.339 . . . . 0.0 111.12 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.18 -27.48 36.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.833 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -80.1 -20.43 45.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.838 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.59 -49.99 13.47 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.885 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.89 -32.44 69.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.104 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.68 -30.19 68.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.077 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -75.24 -47.73 26.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -59.54 -44.9 93.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -61.65 -29.0 69.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.826 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.59 37.67 5.49 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.473 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -94.52 -76.43 0.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 110.923 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 10.5 t -70.07 123.39 21.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.46 -31.71 68.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.047 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 1.5 mpp? -119.87 151.16 39.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.88 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 6.6 t -166.69 147.56 6.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 24.0 mt -95.66 116.81 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.085 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -119.26 165.43 14.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.852 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -119.64 -175.14 15.79 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.548 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.1 -20.29 30.22 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.648 2.232 . . . . 0.0 112.533 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 36.5 p90 -94.31 26.02 3.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.284 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.62 -1.66 7.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.685 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -81.02 -21.73 39.95 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.763 0.316 . . . . 0.0 111.226 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.6 m -72.97 -28.86 62.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.113 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -78.98 -32.88 45.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.075 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 2.1 pt -88.91 87.32 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.125 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -171.23 -46.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.862 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 63.3 p -93.54 -30.97 14.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.91 -26.3 64.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.023 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 62.68 67.21 0.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.87 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.97 128.6 56.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.013 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -62.01 104.88 0.51 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -106.49 148.73 27.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -137.85 113.71 1.01 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.499 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 26.9 t -78.68 120.49 29.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.791 0.329 . . . . 0.0 111.119 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 5.6 t -131.18 159.29 38.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.65 151.91 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.019 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 11.4 mt -72.21 152.75 92.46 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.881 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.44 164.34 31.2 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.508 2.139 . . . . 0.0 112.274 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 18.8 p -106.52 152.07 24.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.963 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -102.55 111.74 24.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt 60.42 28.1 17.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.971 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 93.83 -21.04 43.73 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.671 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -83.67 149.12 56.47 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.689 0.281 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.6 154.92 64.11 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.544 2.162 . . . . 0.0 112.304 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 91.1 p -65.29 166.33 10.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.417 ' N ' ' CD ' ' A' ' 257' ' ' PRO . 0.1 OUTLIER -133.59 52.8 8.95 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.951 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 256' ' ' LYS . 73.2 Cg_endo -76.28 -172.98 1.52 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.583 2.189 . . . . 0.0 112.385 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . 0.429 ' CD1' ' CG ' ' A' ' 330' ' ' MET . 13.5 m-85 -92.22 158.44 16.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.81 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 20.4 t -144.01 119.28 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.227 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -99.16 155.53 19.95 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.297 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 14.9 p -144.0 116.74 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.815 0.34 . . . . 0.0 111.286 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 52.0 tp -68.42 127.03 31.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.794 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 79.6 p -140.93 154.56 46.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.056 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -102.07 138.65 38.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.958 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -109.59 130.2 9.83 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.598 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.421 HD12 ' CE1' ' A' ' 106' ' ' TYR . 23.4 mt -109.58 119.01 58.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.754 0.312 . . . . 0.0 111.02 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -76.91 150.45 35.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.965 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -60.28 -31.65 70.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.027 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -92.55 48.02 1.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.083 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.0 t -108.89 97.39 24.19 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.869 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.57 -30.2 21.0 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.537 2.158 . . . . 0.0 112.38 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -101.19 56.87 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.82 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 9.2 tptp -70.55 -55.08 9.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -62.25 -34.36 76.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.939 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 20.6 mt -73.66 -31.75 63.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.02 -48.42 81.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.102 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -60.54 -56.33 22.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.814 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -57.19 -22.12 38.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.136 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -86.63 -60.65 1.93 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.165 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 2.3 mt -81.46 -56.39 4.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.433 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.28 -18.2 47.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.917 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -120.11 -58.2 1.88 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.668 0.271 . . . . 0.0 111.609 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -86.97 57.54 4.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.954 0.406 . . . . 0.0 111.143 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 7.1 tp -172.51 -41.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.964 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 1.9 mp -97.62 38.21 1.3 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.926 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.8 p -117.83 165.42 13.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.853 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -62.38 -30.4 71.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.934 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -82.46 -49.62 9.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -59.34 -49.56 77.16 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.572 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 2.8 mt -60.1 -30.89 69.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.815 0.34 . . . . 0.0 110.916 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -64.09 -41.89 97.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.951 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.08 -58.15 9.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.147 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.39 -29.45 42.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.204 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -70.51 -31.88 69.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.899 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -65.66 -34.63 78.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.954 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.61 -31.39 12.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.951 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.9 95.56 1.98 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.935 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.53 108.98 1.95 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.455 2.104 . . . . 0.0 112.291 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 5.0 mt -58.96 -28.26 66.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.003 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 99.64 -109.37 3.73 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.56 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -75.23 93.73 2.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.82 0.343 . . . . 0.0 111.072 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.2 134.0 30.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -65.6 -27.4 68.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.023 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 24.6 tp -59.25 111.16 1.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.432 ' CG ' ' CE2' ' A' ' 90' ' ' TYR . 3.9 mttm -64.98 -45.07 87.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.974 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 17.2 m -54.74 -27.12 38.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.102 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.433 ' CE2' ' CD1' ' A' ' 311' ' ' LEU . 4.9 t80 -99.95 -25.31 14.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.12 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.11 -34.4 70.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.86 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.41 -62.8 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.863 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -52.18 -31.8 33.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.789 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.433 ' CD1' ' CE2' ' A' ' 307' ' ' TYR . 12.3 mt -85.7 -25.05 26.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.793 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -67.25 -13.47 62.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.526 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 4.3 mtmm -46.51 -32.91 3.65 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.906 0.384 . . . . 0.0 110.925 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.64 140.16 24.95 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.354 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.02 -25.59 54.71 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.393 2.062 . . . . 0.0 112.352 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -50.87 -40.21 55.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.038 0.447 . . . . 0.0 110.316 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 32.1 mm -85.5 -33.79 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.014 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -69.29 -29.72 67.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.241 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -72.08 -48.97 40.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.205 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 1.7 m -59.98 -38.62 83.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 5.3 tpt -72.58 -43.09 63.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.948 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -60.77 -31.87 71.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -69.5 -31.84 70.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.932 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -73.16 -50.18 24.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.143 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -61.39 -51.47 68.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 29.5 mtpt -59.97 -30.72 69.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.993 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -97.19 164.34 22.38 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.493 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -97.56 150.59 20.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.775 0.321 . . . . 0.0 110.897 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 32.1 mt -84.37 142.77 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.429 ' CG ' ' CD1' ' A' ' 258' ' ' PHE . 32.4 mtm -58.85 131.81 86.47 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.894 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.65 -174.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.367 2.045 . . . . 0.0 112.305 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -132.65 30.76 4.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.878 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.418 HD11 ' CD2' ' A' ' 169' ' ' PHE . 27.2 pt -106.11 147.31 34.6 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.35 -25.56 21.56 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.56 2.174 . . . . 0.0 112.437 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 -55.15 -29.5 57.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.071 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 13.9 ttt -58.75 -24.49 61.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.055 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' SER . . . . . 0.402 ' O ' ' CE2' ' A' ' 341' ' ' TYR . 8.0 m -56.66 -38.93 72.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.047 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -86.16 -33.3 20.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.1 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.417 ' CZ ' HG21 ' A' ' 343' ' ' VAL . 48.6 t80 -59.76 -26.29 65.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.115 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 20.8 m95 -56.36 -52.45 64.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.17 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . 0.402 ' CE2' ' O ' ' A' ' 337' ' ' SER . 0.2 OUTLIER -84.89 -31.79 23.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.666 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -50.49 -40.16 50.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.478 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.417 HG21 ' CZ ' ' A' ' 339' ' ' PHE . 17.5 t -95.93 -26.19 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.259 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -52.37 -56.35 15.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.162 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 12.4 m -64.3 -29.63 70.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.011 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -67.14 -55.32 14.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.248 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.9 t -57.24 -43.2 81.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.278 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 22.7 mt -67.04 -53.74 31.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.089 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -59.95 -30.69 69.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -82.91 -38.38 22.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.131 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -67.84 -30.57 69.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.094 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 17.4 t -71.18 -22.38 62.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.111 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 96.24 -21.6 44.43 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.66 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -57.76 -31.34 66.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.856 0.36 . . . . 0.0 110.928 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -122.46 151.57 41.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 30.2 p -85.44 169.36 13.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.772 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 29.2 t -72.55 -51.68 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.969 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -47.1 -32.53 4.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.353 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.22 -44.69 14.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.996 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -56.45 -60.46 3.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.061 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.408 ' CD2' HG13 ' A' ' 183' ' ' VAL . 7.9 mt -56.98 -26.13 59.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.813 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.6 -35.92 33.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.85 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -57.85 -49.4 76.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.948 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -59.3 -39.11 81.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.082 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -41.9 89.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.96 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 28.3 m -63.38 -49.59 73.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -43.44 94.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.998 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 13.9 mt -73.81 -40.4 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.082 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 13.1 p -98.26 30.72 3.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.952 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.88 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.808 0.337 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -136.12 32.32 2.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -151.09 166.33 31.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.8 -16.49 76.29 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.718 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 pptp? -69.87 153.45 43.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.807 0.337 . . . . 0.0 110.935 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 mt -102.28 138.8 38.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.953 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 t -106.94 147.03 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.168 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 25.8 mt -125.43 107.51 18.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.967 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.416 ' CG ' ' HG3' ' A' ' 57' ' ' PRO . 0.9 OUTLIER -92.27 109.67 21.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.83 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.3 tt -153.89 148.02 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.05 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -60.4 170.29 1.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.927 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.16 29.56 9.9 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.566 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -90.88 -52.97 4.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.361 . . . . 0.0 110.943 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -79.9 -175.61 5.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -59.06 87.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.516 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 36.9 p90 -83.57 -44.24 14.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.343 . . . . 0.0 110.867 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.428 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 12.9 t30 -70.62 -31.72 68.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.1 -32.77 51.73 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.525 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.18 -41.86 93.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.861 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.81 -30.22 68.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.089 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -59.5 -33.99 72.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.985 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.1 t -62.22 -31.26 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.11 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.57 -29.56 72.91 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.517 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 mmtt -59.85 -33.35 71.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.331 . . . . 0.0 110.944 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -42.04 72.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.854 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.417 ' CE1' HG23 ' A' ' 31' ' ' THR . 12.7 t80 -59.37 -59.22 5.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.939 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -57.8 -21.92 44.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.35 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -69.5 -26.31 64.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.512 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -117.74 -39.01 3.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.78 0.324 . . . . 0.0 111.49 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.417 HG23 ' CE1' ' A' ' 27' ' ' PHE . 15.1 p -90.68 -32.99 15.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.183 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.67 -22.39 35.98 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.663 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.425 HD13 HG22 ' A' ' 33' ' ' ILE . 38.8 mt -66.17 139.34 21.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.821 0.343 . . . . 0.0 111.046 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.0 170.01 17.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.982 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.6 t -146.99 111.06 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.042 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.1 m -101.85 150.63 22.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.948 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.9 t -130.14 110.19 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.117 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -96.52 165.7 12.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -149.6 72.31 9.79 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.843 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.62 -179.75 3.54 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.601 2.201 . . . . 0.0 112.347 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -118.58 143.77 46.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.74 28.95 18.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.27 -26.92 65.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.099 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.447 ' CG ' ' CH2' ' A' ' 62' ' ' TRP . 26.1 mt-10 -56.99 -30.59 64.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.013 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -95.89 -19.02 19.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.203 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -88.68 -29.6 19.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.803 0.335 . . . . 0.0 111.16 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.434 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -52.83 -50.63 80.27 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.344 -179.803 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 38.4 Cg_exo -61.1 -23.64 77.73 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.573 2.182 . . . . 0.0 112.741 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.28 -40.38 11.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.835 0.35 . . . . 0.0 111.278 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.9 m -80.45 -28.02 11.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.133 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.31 -22.53 59.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.303 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.3 -28.35 41.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.406 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.2 t -135.29 24.01 3.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.175 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 53.31 24.54 22.99 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.729 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -74.67 -30.14 61.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.885 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.67 -150.47 0.64 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.543 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.416 ' HG3' ' CG ' ' A' ' 10' ' ' TRP . 59.2 Cg_endo -71.97 177.69 6.78 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.597 2.198 . . . . 0.0 112.36 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.58 -31.57 7.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.804 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.3 mt -128.32 139.83 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.048 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.482 ' CG1' ' N ' ' A' ' 61' ' ' PHE . 2.5 tt -140.34 160.14 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.062 0.458 . . . . 0.0 110.962 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.482 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 9.0 m-85 -132.58 136.02 46.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.078 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.447 ' CH2' ' CG ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -176.08 152.01 1.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.756 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.61 157.76 3.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.231 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -54.89 -29.65 56.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.085 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -58.86 -34.33 71.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.099 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.81 17.14 12.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.345 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -113.29 -24.23 9.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.655 0.264 . . . . 0.0 111.28 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -83.05 55.49 5.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.466 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -153.15 -42.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.574 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -82.86 -14.4 54.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.628 0.251 . . . . 0.0 111.258 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.47 -35.35 24.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.78 0.324 . . . . 0.0 111.205 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -62.28 -30.02 70.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.9 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.4 t -83.61 -23.12 32.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.057 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.5 28.26 13.21 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.479 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.0 mt -88.81 -34.3 17.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.801 0.334 . . . . 0.0 110.955 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 27.6 mt -79.11 167.01 21.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.7 126.23 52.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.083 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.457 ' CG ' ' N ' ' A' ' 79' ' ' ILE . 19.2 tt0 -65.42 164.05 14.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.795 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.457 ' N ' ' CG ' ' A' ' 78' ' ' GLU . 40.6 pt -139.8 -179.65 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.208 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -158.89 77.86 3.11 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.421 ' HG3' ' CH2' ' A' ' 94' ' ' TRP . 37.2 Cg_endo -65.61 119.17 6.15 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.593 2.196 . . . . 0.0 112.27 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.35 177.92 0.33 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.824 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 11.2 mtmm -60.21 -45.45 93.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.52 -31.56 69.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.001 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -72.26 -52.21 17.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.871 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -64.37 -25.88 68.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.951 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.8 -28.36 67.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.157 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.86 34.26 1.93 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.118 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.423 HD11 ' CZ2' ' A' ' 94' ' ' TRP . 94.2 mt -153.37 174.22 14.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.91 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.435 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . 44.7 m-85 -99.83 142.25 24.27 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.989 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -56.17 -55.88 2.53 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.617 2.211 . . . . 0.0 112.932 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.457 ' CE1' ' CG2' ' A' ' 93' ' ' THR . 38.2 p90 -52.98 -37.86 61.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.892 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.457 ' CG2' ' CE1' ' A' ' 92' ' ' PHE . 30.0 p -64.25 -27.88 69.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.722 0.296 . . . . 0.0 111.115 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.423 ' CZ2' HD11 ' A' ' 89' ' ' LEU . 11.2 m95 -73.26 -24.52 60.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.218 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.42 11.31 19.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.466 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -101.83 -31.39 10.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.812 0.339 . . . . 0.0 111.257 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.0 m -87.92 -35.5 8.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.312 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.93 117.98 9.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.926 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -97.93 -67.24 0.86 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -99.62 30.74 3.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.922 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.02 -24.63 27.75 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.564 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.4 133.04 42.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 0.0 110.944 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.8 mt -66.35 150.0 49.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.868 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.5 pp -155.02 36.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.145 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -172.73 157.43 3.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.131 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.421 ' CE1' HG22 ' A' ' 79' ' ' ILE . 72.8 m-85 -118.01 80.85 15.3 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -55.98 138.79 83.46 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.564 2.176 . . . . 0.0 112.233 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.444 HG22 HD11 ' A' ' 108' ' ' ILE . 24.7 mt -134.46 -51.73 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.121 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -108.67 171.56 7.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.123 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.5 t -141.5 129.05 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.126 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.97 144.59 43.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -162.79 151.78 14.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 13.8 mt -61.22 124.56 20.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.1 m -115.66 165.28 13.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.0 tp -105.47 101.26 10.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.858 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 32.8 mt -91.45 119.77 39.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.109 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -118.79 148.1 43.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.931 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -73.68 165.23 25.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.881 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.32 -31.13 6.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.02 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -74.8 -39.4 61.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.023 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.7 mt -109.53 28.61 8.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.076 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.8 tp -176.96 89.44 0.25 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.97 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -69.03 -30.51 25.56 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.516 2.144 . . . . 0.0 112.248 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -133.99 120.98 15.49 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.22 153.84 41.05 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.47 2.113 . . . . 0.0 112.379 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.05 122.11 8.15 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.587 2.191 . . . . 0.0 112.289 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -93.75 18.13 10.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.4 p -156.99 141.96 17.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.8 0.334 . . . . 0.0 110.81 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.419 ' CE3' HD13 ' A' ' 132' ' ' ILE . 27.9 m95 -61.77 -31.78 72.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -68.89 -15.88 63.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.336 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.98 0.52 57.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.551 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.485 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 16.6 mt -85.37 -46.24 0.63 Allowed Pre-proline 0 C--N 1.332 -0.184 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 72.0 Cg_exo -48.74 -57.49 2.33 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.369 2.046 . . . . 0.0 112.447 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.28 -36.97 83.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.995 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.2 mt -58.39 -52.29 66.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.997 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -46.08 -31.75 2.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.436 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -85.61 -27.02 25.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.232 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -57.93 -64.18 1.0 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.289 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.413 HD22 ' N ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -68.49 -16.32 63.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.567 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.413 ' N ' HD22 ' A' ' 139' ' ' LEU . 2.6 ttmt -63.4 -21.57 66.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.884 0.373 . . . . 0.0 110.461 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.51 -41.74 81.39 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.672 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.85 -26.28 34.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.784 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 119.52 21.48 3.63 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.615 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -116.0 -174.98 2.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.775 0.322 . . . . 0.0 110.943 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.2 p -130.17 158.38 39.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.913 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -76.76 -62.72 1.54 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.179 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.0 tp -148.66 143.44 26.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.015 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.26 -177.83 4.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.778 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.9 p90 179.63 145.99 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.9 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -62.9 126.97 29.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.952 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.7 mt -98.48 31.62 2.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.848 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -101.51 -31.33 10.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -119.71 146.5 41.76 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.905 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.1 -3.41 13.71 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.553 2.168 . . . . 0.0 112.677 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.5 ' CZ ' ' CH2' ' A' ' 340' ' ' TRP . 0.4 OUTLIER -57.8 -32.12 67.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.826 0.346 . . . . 0.0 110.954 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -94.69 4.04 54.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.544 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 55.8 p -106.77 -28.12 10.35 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.796 0.332 . . . . 0.0 111.049 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.483 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 11.7 t-105 -55.94 -46.66 99.73 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.308 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 77.2 Cg_exo -50.35 -25.51 13.95 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.377 2.051 . . . . 0.0 112.479 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.6 tp -94.06 -38.84 10.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.018 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 21.4 mt -76.04 -55.45 11.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.179 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.09 -25.97 68.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.243 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -57.17 -56.09 26.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.239 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -96.05 -20.1 18.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.231 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -77.06 -104.65 0.15 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.525 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -150.49 -86.98 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.531 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -172.83 -179.6 2.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.837 0.351 . . . . 0.0 110.897 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.02 -48.8 6.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.066 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -141.86 140.61 32.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.965 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -77.5 136.83 38.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.848 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.487 ' CE2' ' CE2' ' A' ' 176' ' ' TYR . 0.3 OUTLIER -101.69 110.64 22.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.779 179.834 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -133.96 145.02 49.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.126 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 48.69 32.09 3.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.249 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 68.0 26.61 73.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.424 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.23 -171.32 2.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.359 . . . . 0.0 110.839 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.487 ' CE2' ' CE2' ' A' ' 171' ' ' TYR . 1.1 m-85 -130.54 131.7 45.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.848 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.73 139.4 32.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 19.9 pt -95.03 -18.4 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.334 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.91 26.01 4.37 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.113 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -140.52 78.58 1.66 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.882 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 21.7 t -94.24 137.71 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.162 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.29 0.3 40.6 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.857 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.418 ' CG1' ' N ' ' A' ' 184' ' ' ASP . 0.3 OUTLIER -54.05 -42.67 55.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.921 0.391 . . . . 0.0 111.31 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.418 ' N ' ' CG1' ' A' ' 183' ' ' VAL . 22.9 t0 -96.09 61.51 2.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.971 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -91.57 165.47 13.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.84 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -59.87 -38.71 82.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.14 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -85.92 -25.11 38.93 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.565 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.15 -30.56 66.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 0.0 111.163 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -61.03 -38.2 85.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -87.56 -30.06 20.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -59.31 -51.05 61.44 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.555 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -41.01 92.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.805 0.336 . . . . 0.0 110.904 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.8 m -54.07 -25.5 22.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.161 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -65.28 -60.57 2.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.784 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.9 tp -63.86 -33.47 75.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.68 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 46.2 t -65.9 -44.68 92.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.941 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.5 -28.11 60.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.938 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 16.6 mt -57.82 -53.72 55.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.005 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 14.9 mt -68.81 -29.86 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.003 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 24.1 mtpt -75.8 -29.86 58.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.968 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -95.32 22.76 6.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.177 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.49 75.27 0.33 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.931 0.396 . . . . 0.0 111.156 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.4 -41.97 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.74 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.01 145.56 29.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.846 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -90.03 113.96 25.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.867 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.19 -26.72 66.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.154 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -92.98 46.49 1.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.931 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 51.9 m -113.36 138.75 49.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.784 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.464 ' HB2' HD11 ' A' ' 212' ' ' ILE . 1.8 m-20 -151.35 176.3 11.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.945 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -42.67 -62.98 0.86 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.38 -59.25 4.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.004 0.43 . . . . 0.0 111.591 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.464 HD11 ' HB2' ' A' ' 209' ' ' ASP . 0.0 OUTLIER -52.96 -31.9 17.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.183 -179.53 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -81.98 -28.3 32.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.763 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -82.36 -56.15 4.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.026 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.08 -31.26 61.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.334 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.46 -36.0 73.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.122 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.448 ' CG ' ' CG2' ' A' ' 225' ' ' THR . 29.0 t80 -82.24 -31.75 30.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.994 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -63.97 -46.94 82.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.99 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.09 -36.76 58.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.95 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 110.33 56.92 0.51 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.506 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -108.66 -29.71 8.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.801 0.334 . . . . 0.0 110.949 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.8 t -117.38 140.1 50.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.937 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.06 -31.14 68.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.095 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 9.8 mtp -134.43 163.29 30.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.448 ' CG2' ' CG ' ' A' ' 217' ' ' PHE . 4.7 t -166.62 132.49 2.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 25.6 mt -96.62 116.81 39.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.087 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -156.29 165.3 36.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.416 ' HA3' ' CZ3' ' A' ' 230' ' ' TRP . . . -82.53 170.77 50.77 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.478 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.81 -25.59 27.64 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.661 2.241 . . . . 0.0 112.325 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . 0.416 ' CZ3' ' HA3' ' A' ' 228' ' ' GLY . 28.5 p90 -59.29 -30.97 68.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.965 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -59.46 -29.95 68.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.152 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 27.9 m0 -59.61 -28.91 67.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.049 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.9 m -57.81 -31.07 66.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.003 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -72.16 -59.61 2.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 4.5 mt -78.49 116.66 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.082 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -168.66 -47.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.934 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 22.2 p -76.48 -38.71 54.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 11.8 t -66.16 -29.41 69.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.957 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 62.16 81.72 0.19 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.35 143.8 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.104 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -85.25 87.47 7.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.932 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -104.64 167.61 9.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.06 174.28 21.99 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.523 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 20.9 t -140.01 127.52 24.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.793 0.33 . . . . 0.0 111.076 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.7 t -143.53 151.34 40.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.967 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.417 ' CG2' ' N ' ' A' ' 247' ' ' LEU . 0.7 OUTLIER -54.51 152.3 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.292 0.568 . . . . 0.0 111.295 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.417 ' N ' ' CG2' ' A' ' 246' ' ' VAL . 9.2 mt -71.45 146.6 91.87 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.977 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.418 ' HG2' ' CD1' ' A' ' 129' ' ' TRP . 50.8 Cg_endo -69.18 177.17 5.44 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.541 2.16 . . . . 0.0 112.265 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 44.6 p -121.12 175.47 6.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -142.85 121.94 12.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 20.7 mttm 60.1 31.67 20.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 74.35 27.03 66.62 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.52 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -136.48 128.99 17.43 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.554 0.216 . . . . 0.0 110.821 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.07 163.09 35.86 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.505 2.137 . . . . 0.0 112.354 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.82 -172.95 3.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.786 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -134.72 63.87 60.77 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.952 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -56.88 127.78 27.25 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.554 2.169 . . . . 0.0 112.182 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . 0.425 ' CD2' ' CD1' ' A' ' 155' ' ' TYR . 98.5 m-85 -60.65 139.96 57.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.739 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 25.5 t -120.32 146.25 25.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.294 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -134.65 86.57 0.26 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.294 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 7.5 p -60.52 128.85 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.843 0.354 . . . . 0.0 111.326 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.3 tp -89.9 106.9 18.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.56 174.32 6.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.961 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -109.44 154.51 22.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.03 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.0 129.77 8.11 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.515 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.404 HD11 ' CE1' ' A' ' 106' ' ' TYR . 4.4 mt -125.74 100.53 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.803 0.335 . . . . 0.0 110.998 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.19 162.63 4.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.956 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -70.78 -28.36 64.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -90.51 49.94 1.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.132 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.5 m -109.1 102.76 50.17 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.782 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.81 -23.91 47.51 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.419 2.079 . . . . 0.0 112.366 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -98.37 31.11 2.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.934 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.99 -38.35 90.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.886 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -61.7 -49.52 76.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.96 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 78.2 mt -77.7 -31.02 52.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.942 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.67 -55.4 20.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.178 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -44.82 74.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.045 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -63.89 -43.38 96.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -66.83 -37.11 83.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 2.8 mt -78.71 -22.24 46.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.445 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.55 -29.94 15.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.505 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -94.67 -58.09 2.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.728 0.299 . . . . 0.0 111.494 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -106.49 58.12 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.94 0.4 . . . . 0.0 111.319 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.0 tp 177.64 38.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.942 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.4 ' CD2' ' CD1' ' A' ' 304' ' ' LEU . 0.4 OUTLIER 179.3 38.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.872 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 44.7 p -153.48 172.37 17.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.947 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -63.15 -29.28 70.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.018 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -78.22 -30.15 48.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.019 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -92.2 -51.8 2.33 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.624 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.417 ' HB3' ' CE2' ' A' ' 307' ' ' TYR . 1.5 mt -59.03 -30.59 68.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.764 0.316 . . . . 0.0 110.999 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -72.81 -31.45 64.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.937 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -59.25 -40.49 86.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.138 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.2 t -83.53 -30.81 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.138 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -63.31 -29.72 70.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.977 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -58.77 -33.66 70.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.96 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -102.61 -35.82 8.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.0 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 4.2 mmtm -146.61 90.36 5.57 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.932 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.2 104.79 1.44 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.53 2.154 . . . . 0.0 112.265 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 2.2 mp -58.42 -26.75 63.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.994 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 90.13 -94.72 2.01 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.523 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -79.05 122.01 25.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.784 0.326 . . . . 0.0 111.073 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 21.3 m -111.59 165.98 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.18 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -92.13 -29.24 16.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.167 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.4 ' CD1' ' CD2' ' A' ' 285' ' ' LEU . 5.0 tp -58.16 120.91 9.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.936 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -65.22 -31.63 72.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.9 -31.75 51.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.418 ' CD2' HD13 ' A' ' 311' ' ' LEU . 5.4 t80 -84.68 -28.26 26.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.021 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -59.4 -31.79 69.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.84 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -73.08 -58.91 2.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.853 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -51.53 -32.21 27.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.771 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.418 HD13 ' CD2' ' A' ' 307' ' ' TYR . 13.3 mt -85.78 -26.14 25.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.667 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.7 -16.48 62.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.343 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -47.82 -32.62 6.29 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.931 0.396 . . . . 0.0 110.832 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -108.67 138.53 20.3 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.345 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.89 -30.67 78.26 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.418 2.078 . . . . 0.0 112.374 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -49.68 -39.32 36.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.001 0.429 . . . . 0.0 110.299 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 18.5 mm -85.57 -33.58 7.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.964 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -69.2 -57.48 5.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.205 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.19 -49.58 75.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.258 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 73.8 m -58.73 -31.02 67.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.987 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 9.1 tpt -79.98 -32.13 39.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -61.43 -56.13 23.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.94 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -65.12 -30.44 71.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.942 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.09 -56.54 20.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.134 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -64.09 -37.52 87.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.875 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 12.0 tttp -67.52 -31.92 72.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -76.97 -162.02 14.3 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.501 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -129.27 160.46 32.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.762 0.315 . . . . 0.0 110.949 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 29.8 mt -86.78 158.81 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.127 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 6.1 mtp -80.13 131.07 63.83 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.899 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.419 ' HA ' ' CE2' ' A' ' 176' ' ' TYR . 36.3 Cg_exo -57.3 158.36 18.82 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.392 2.061 . . . . 0.0 112.181 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -110.23 -26.53 9.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.087 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 34.9 pt -55.59 150.44 25.49 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.248 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.71 -25.42 24.22 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.594 2.196 . . . . 0.0 112.417 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.57 -28.36 60.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.062 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.419 ' HE2' ' CD1' ' A' ' 339' ' ' PHE . 0.0 OUTLIER -59.3 -27.86 66.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.061 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 4.9 m -55.87 -56.2 23.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.01 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.59 -30.8 71.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.09 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.426 ' CE1' HG22 ' A' ' 343' ' ' VAL . 47.1 t80 -59.7 -40.49 88.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.946 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . 0.5 ' CH2' ' CZ ' ' A' ' 155' ' ' TYR . 96.7 m95 -63.6 -55.75 21.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.024 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -58.8 -44.3 90.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.082 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -59.17 -58.73 7.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.19 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.426 HG22 ' CE1' ' A' ' 339' ' ' PHE . 24.4 t -59.21 -28.43 39.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.228 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.71 -53.89 49.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.073 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.67 -30.61 68.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.959 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -59.26 -52.83 63.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.212 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.19 -36.74 64.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.198 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 29.3 mt -76.37 -37.15 30.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.158 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -58.93 -30.95 68.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.95 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -87.6 -46.68 9.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.053 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.13 -40.53 96.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.123 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 8.1 m -67.92 -22.43 65.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.104 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 85.12 27.6 33.3 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.564 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.19 -30.28 21.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.852 0.358 . . . . 0.0 110.918 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -146.09 -173.92 4.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 4.4 p -104.48 156.12 18.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.951 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 43.1 t -59.12 -29.93 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.977 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.12 -49.29 70.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 360' ' ' ALA . 0.1 OUTLIER -71.23 -34.88 71.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.995 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.406 ' N ' ' HG3' ' A' ' 359' ' ' GLU . . . -65.98 -52.85 45.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.98 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 89.9 mt -61.75 -28.72 69.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -81.19 -41.16 22.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.871 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -73.72 -46.98 42.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.14 -43.65 87.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.145 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -62.95 -36.17 82.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.933 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 21.3 m -60.34 -42.99 96.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -59.71 -29.82 68.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.924 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.414 HD13 HG23 ' A' ' 368' ' ' ILE . 26.2 mm -71.02 -35.66 60.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.076 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 1.4 t -152.77 78.64 1.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.92 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.798 0.332 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.26 173.54 10.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.883 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 58.24 174.63 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.983 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -84.98 55.92 4.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.494 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -125.15 173.29 8.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.861 0.362 . . . . 0.0 110.887 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.1 mt -141.9 115.82 9.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.2 t -89.61 146.99 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.212 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.4 mt -128.16 107.47 16.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.925 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.426 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 8.6 m0 -93.78 106.7 18.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.854 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.3 tt -123.29 145.81 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.081 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -60.13 170.56 1.22 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.79 47.91 2.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.52 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -157.23 31.4 0.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.856 0.36 . . . . 0.0 110.907 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.33 -172.3 3.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.92 93.84 1.53 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.501 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -85.97 -37.5 18.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.816 0.341 . . . . 0.0 110.923 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -75.73 -32.72 60.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.976 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.9 -28.21 59.22 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.507 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.5 tp -80.05 -32.4 39.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.76 0.314 . . . . 0.0 110.931 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.77 -31.81 71.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.175 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -60.23 -31.05 69.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.965 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.8 t -64.62 -41.14 91.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.088 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.99 -34.96 88.64 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.499 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.0 mttp -60.03 -28.59 67.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.826 0.346 . . . . 0.0 110.934 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -83.0 -38.5 22.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.849 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -55.82 -45.69 78.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.096 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -60.36 -38.35 83.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.937 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.39 -28.81 66.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.901 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -83.76 -32.66 25.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.311 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -139.06 -44.15 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.391 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.98 20.9 5.5 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.721 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.458 HD12 HG23 ' A' ' 33' ' ' ILE . 29.4 mm -80.67 114.9 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.814 0.34 . . . . 0.0 110.985 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -57.65 145.48 33.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.003 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.4 t -138.96 109.31 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.111 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.2 m -104.14 128.54 51.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.911 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.5 t -114.74 113.86 44.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.149 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -114.78 156.8 24.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.9 p-80 -122.47 71.49 37.22 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.855 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.413 ' HG3' ' CD2' ' A' ' 10' ' ' TRP . 57.1 Cg_endo -70.77 165.84 30.82 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.603 2.202 . . . . 0.0 112.377 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -126.0 141.21 52.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.815 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.5 mmtm 59.68 36.96 22.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.839 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.19 -3.51 42.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.48 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -58.29 -36.91 74.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.84 0.352 . . . . 0.0 110.964 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.47 -19.75 23.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.172 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -87.41 -19.0 28.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.344 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.451 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 7.0 t80 -70.91 -48.52 14.41 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.361 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 2.9 Cg_exo -76.04 -31.32 5.02 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.791 2.327 . . . . 0.0 112.688 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.448 ' CG ' ' N ' ' A' ' 50' ' ' VAL . 7.8 pt20 -60.28 -50.69 72.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.834 0.35 . . . . 0.0 111.239 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.448 ' N ' ' CG ' ' A' ' 49' ' ' GLN . 7.4 m -97.17 27.09 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.434 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.19 -29.98 31.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.184 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.55 -32.49 25.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.207 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.2 t -82.75 -29.65 29.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.944 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.71 26.96 23.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.517 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.42 -26.02 24.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.829 0.347 . . . . 0.0 111.009 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.4 -178.52 0.4 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.554 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.426 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 60.9 Cg_endo -72.59 -168.23 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.609 2.206 . . . . 0.0 112.364 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.29 -46.22 3.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.814 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.9 mt -117.88 138.88 47.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.481 ' CG1' ' N ' ' A' ' 61' ' ' PHE . 2.6 tt -139.02 159.69 29.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.12 0.486 . . . . 0.0 110.952 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.481 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 28.1 m-85 -127.62 136.17 51.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.942 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.41 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -172.01 157.69 4.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.913 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.36 156.1 30.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.094 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -56.48 -41.93 77.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.085 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -59.26 -31.35 69.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.08 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.41 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 8.6 mmm180 -94.25 17.19 13.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.334 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.402 ' CE2' ' O ' ' A' ' 62' ' ' TRP . 0.8 OUTLIER -109.65 -13.33 14.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.285 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -92.5 21.89 35.93 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.739 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.42 -23.83 4.65 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.559 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -100.47 -28.08 13.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.737 0.303 . . . . 0.0 110.972 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.0 -25.78 53.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.11 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -59.29 -29.3 67.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.155 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 m -96.65 24.99 5.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.13 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.49 29.46 39.31 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.791 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.3 mt -87.81 -40.61 13.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 0.0 110.944 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.4 mt -83.33 148.52 27.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.931 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.31 165.33 20.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.128 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.03 -165.63 1.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.935 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.8 pt -157.33 164.62 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.968 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 47.0 p -156.31 77.43 4.36 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.837 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.64 161.16 46.15 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.646 2.231 . . . . 0.0 112.269 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.38 165.07 16.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.809 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.35 -38.28 76.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.884 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.37 -29.31 61.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.063 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.417 ' CZ ' HD13 ' A' ' 285' ' ' LEU . 7.4 t80 -78.54 -32.01 47.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.42 ' HG2' ' CE2' ' A' ' 94' ' ' TRP . 0.0 OUTLIER -82.21 -29.62 31.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.994 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -73.74 -36.42 65.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.048 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -59.87 -30.28 68.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.012 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.1 mp -88.45 162.54 16.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.849 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.428 ' HB3' ' CE1' ' A' ' 92' ' ' PHE . 15.2 m-85 -75.09 141.09 74.07 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.064 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -54.31 -55.88 3.0 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.658 2.239 . . . . 0.0 113.022 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.44 ' CE2' ' CG2' ' A' ' 93' ' ' THR . 42.4 p90 -56.16 -42.21 76.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.734 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.44 ' CG2' ' CE2' ' A' ' 92' ' ' PHE . 30.6 p -59.46 -28.06 66.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.754 0.312 . . . . 0.0 111.103 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.42 ' CE2' ' HG2' ' A' ' 86' ' ' GLN . 7.2 m95 -75.01 -25.82 59.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.113 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -90.55 12.42 18.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.398 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -101.9 -48.26 4.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.779 0.324 . . . . 0.0 111.289 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.2 m -78.98 -33.14 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.387 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.09 121.17 14.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.99 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -122.96 142.68 50.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.727 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 69.59 25.31 5.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.071 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.57 7.27 88.13 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.109 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.04 141.64 47.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.846 0.355 . . . . 0.0 111.006 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.2 mp -75.85 149.82 37.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.953 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.5 pp -157.14 26.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.387 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.59 179.09 8.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.073 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -137.66 89.97 14.99 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.939 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -56.23 131.47 46.06 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.524 2.149 . . . . 0.0 112.228 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.0 mt -127.24 -48.06 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.34 138.44 50.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.089 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.34 128.92 67.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.1 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -109.2 148.17 31.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -157.93 137.05 11.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.6 mt -66.85 109.08 2.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.864 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.85 161.14 14.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.931 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.8 tp -96.78 111.79 23.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.8 mt -97.98 132.09 43.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.1 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.415 ' CD1' ' HB3' ' A' ' 125' ' ' PRO . 34.7 p90 -129.74 159.33 36.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.001 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -86.39 120.93 28.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.0 mtpp -77.93 -27.97 49.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.037 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -65.46 -30.48 71.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.1 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.9 mp -110.42 -35.7 5.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.114 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 16.2 tp -110.43 101.92 49.98 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.97 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.82 -27.79 37.08 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.37 2.047 . . . . 0.0 112.303 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -137.98 130.34 16.33 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.415 ' HB3' ' CD1' ' A' ' 117' ' ' TYR . 71.7 Cg_endo -76.99 151.55 30.94 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.538 2.159 . . . . 0.0 112.326 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.26 103.03 1.68 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.54 2.16 . . . . 0.0 112.328 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -24.28 59.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.092 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.39 143.69 35.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.902 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.42 ' CE3' HG13 ' A' ' 132' ' ' ILE . 18.4 m95 -78.1 -30.82 49.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -67.64 -15.82 63.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.314 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.81 -11.11 43.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.609 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.468 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 25.6 mm -70.96 -46.56 15.15 Favored Pre-proline 0 CA--C 1.53 0.197 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 75.3 Cg_exo -48.12 -57.94 2.04 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.396 2.064 . . . . 0.0 112.489 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.32 -35.18 79.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.061 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.2 mt -58.44 -51.02 71.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.052 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -46.74 -28.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.508 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -85.58 -27.97 25.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.312 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.56 -63.71 1.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.302 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.415 HD23 ' N ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -68.96 -16.4 63.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.646 -179.597 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.415 ' N ' HD23 ' A' ' 139' ' ' LEU . 0.0 OUTLIER -64.54 -21.58 66.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.804 0.335 . . . . 0.0 110.495 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.44 -41.61 80.82 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.126 0.489 . . . . 0.0 110.581 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.01 -26.75 30.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.784 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.34 18.6 3.36 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.76 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -111.4 -174.96 2.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.826 0.345 . . . . 0.0 110.893 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.6 t -132.12 163.9 27.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.878 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -79.26 -64.47 1.18 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.303 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -153.28 148.44 26.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.102 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.05 -177.87 4.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.754 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -179.26 152.74 0.55 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.954 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.405 ' OD1' ' CD2' ' A' ' 156' ' ' PHE . 12.9 p-10 -67.95 113.11 5.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 8.8 mt -94.1 45.26 1.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.854 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -110.44 -30.29 7.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.008 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -125.14 125.86 25.24 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.885 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.84 -22.32 29.32 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.446 2.098 . . . . 0.0 112.341 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -54.19 -31.1 51.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.091 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.405 ' CD2' ' OD1' ' A' ' 150' ' ' ASN . 0.2 OUTLIER -89.16 -31.25 18.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.93 12.43 28.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.241 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.537 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 29.7 t-105 -68.23 -54.85 14.04 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.433 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 17.4 Cg_endo -57.82 -20.26 42.88 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.238 1.959 . . . . 0.0 112.413 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 21.3 tp -78.8 -27.41 44.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.945 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 18.3 mt -101.67 -47.72 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.127 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -60.07 -36.48 77.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.214 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.42 84.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.232 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.05 -20.16 56.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.252 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 130.9 71.74 0.11 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.509 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -171.77 172.67 44.78 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.489 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -162.39 173.57 13.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.82 0.343 . . . . 0.0 110.946 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.71 -53.34 4.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.052 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -127.72 146.22 50.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.784 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.85 108.12 17.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.049 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -73.51 110.95 8.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.577 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -159.38 145.6 16.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.935 0.398 . . . . 0.0 111.099 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 62.11 29.19 17.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.18 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.41 -37.27 3.36 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.14 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 5.1 pttm -102.04 179.61 4.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 111.139 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 176' ' ' TYR . 1.3 m-85 -110.19 115.21 29.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.801 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -58.45 134.83 57.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.899 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.8 pt -95.05 -16.63 7.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.415 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.04 25.96 4.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.024 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -150.13 110.05 4.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.817 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 22.0 t -124.49 139.67 50.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.173 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -96.5 -5.58 58.93 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.831 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.417 ' CG1' ' N ' ' A' ' 184' ' ' ASP . 0.3 OUTLIER -51.85 -42.6 33.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.927 0.394 . . . . 0.0 111.36 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.417 ' N ' ' CG1' ' A' ' 183' ' ' VAL . 37.2 t0 -105.2 65.55 0.73 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.91 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.11 -168.84 1.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -74.81 -39.22 61.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.142 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -85.89 -37.85 9.05 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.468 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.21 -30.61 69.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.809 0.337 . . . . 0.0 111.163 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.44 -49.82 76.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.919 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.23 -27.88 66.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.201 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -58.18 -56.59 24.36 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.545 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 6.9 tp -59.57 -50.44 73.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.77 0.319 . . . . 0.0 110.893 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.39 -24.72 57.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.07 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -66.84 -60.5 2.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.824 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.8 tp -57.55 -31.85 66.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.657 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.8 t -61.73 -61.58 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.983 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.62 -27.73 68.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.848 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mt -60.28 -46.6 89.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.99 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 5.1 mt -64.35 -30.02 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.171 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.87 -30.33 26.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.367 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -98.65 -6.44 29.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.8 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -117.58 -9.82 10.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.588 0.232 . . . . 0.0 111.546 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 24.9 m80 62.96 41.48 8.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.873 0.368 . . . . 0.0 110.61 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.96 134.73 35.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.88 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -74.47 122.73 23.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -73.09 -13.84 61.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.449 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -83.93 3.96 31.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.537 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 56.5 m -52.53 144.6 13.2 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.769 0.319 . . . . 0.0 111.12 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.405 ' HB2' ' CG1' ' A' ' 212' ' ' ILE . 1.5 m-20 -153.65 176.39 12.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.048 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.409 ' OH ' ' CZ2' ' A' ' 230' ' ' TRP . 0.8 OUTLIER -46.0 -62.95 1.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.406 -179.506 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.23 -59.04 6.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.599 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.456 HD13 HG21 ' A' ' 212' ' ' ILE . 0.0 OUTLIER -55.81 -33.46 34.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.21 -179.428 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -81.91 -25.54 34.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.779 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.34 -47.2 12.62 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.975 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.23 -32.16 62.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.253 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.47 -25.18 50.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.217 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.446 ' CD2' ' CG2' ' A' ' 225' ' ' THR . 1.1 t80 -69.3 -62.66 1.29 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.991 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -68.94 -45.57 70.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.03 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.41 -29.4 66.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.959 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.57 41.28 10.04 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.514 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -89.19 -31.31 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.794 0.33 . . . . 0.0 110.893 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 11.0 t -124.64 163.17 22.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.934 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -90.26 -35.24 15.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.032 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -130.5 163.22 27.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.818 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.446 ' CG2' ' CD2' ' A' ' 217' ' ' PHE . 1.8 t -166.72 162.67 16.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.97 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.9 mt -111.61 118.8 58.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.021 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -144.27 165.42 27.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.924 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -98.59 -174.76 32.46 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.536 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.12 -24.67 27.77 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.562 2.175 . . . . 0.0 112.415 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . 0.409 ' CZ2' ' OH ' ' A' ' 210' ' ' TYR . 24.7 p90 -59.03 -30.83 68.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.91 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -71.33 -26.68 62.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.191 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 27.6 m0 -55.83 -39.62 71.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.981 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.6 m -69.47 -31.7 70.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -69.67 -35.85 75.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.924 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 22.7 mt -75.83 116.52 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.079 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -173.31 -42.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.933 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.41 -55.51 13.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 20.9 t -63.67 -28.68 70.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.941 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt 60.84 76.01 0.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.902 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 22.6 t -121.08 112.21 34.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.045 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.04 108.87 1.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.942 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -117.3 145.13 44.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.844 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -117.63 179.15 17.22 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.513 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.56 128.84 74.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 0.0 111.13 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.9 t -143.03 159.28 42.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.956 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.62 152.06 7.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.01 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.85 145.25 91.68 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.833 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.418 ' HB2' ' CD1' ' A' ' 129' ' ' TRP . 51.0 Cg_exo -53.7 137.29 66.91 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.477 2.118 . . . . 0.0 112.267 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 1.3 p -77.08 160.6 28.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -145.37 126.62 14.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt 62.26 18.01 9.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.287 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.24 38.66 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.888 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.84 149.29 37.01 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.731 0.3 . . . . 0.0 110.873 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.66 162.07 42.62 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.509 2.139 . . . . 0.0 112.229 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 39.7 p -71.14 179.59 2.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.832 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -128.84 58.07 33.91 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.84 136.47 32.88 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.548 2.165 . . . . 0.0 112.316 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . 0.497 ' CZ ' ' CD1' ' A' ' 158' ' ' TRP . 85.9 m-85 -59.51 140.1 56.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.978 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.68 145.76 12.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -134.81 108.42 0.71 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.469 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 7.4 p -88.74 160.84 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 0.0 111.152 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 9.6 tp -121.62 131.43 54.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.77 169.43 19.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.964 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -105.4 127.36 52.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.058 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -90.44 148.21 19.5 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.537 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 31.3 mt -127.3 115.76 41.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.861 0.362 . . . . 0.0 111.125 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -77.05 135.88 38.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.912 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.77 -30.43 71.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.132 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -58.98 -30.98 68.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.7 111.18 8.12 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.87 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -68.27 -14.05 39.39 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.402 2.068 . . . . 0.0 112.583 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -84.47 57.22 4.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.939 0.4 . . . . 0.0 110.942 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.6 tppm? -82.77 -36.75 25.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -59.95 -49.18 78.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 37.4 mt -71.08 -33.33 70.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.968 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.34 93.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.044 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -63.14 -54.17 41.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -62.9 -33.28 74.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -69.64 -46.74 65.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.047 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 79.9 mt -81.42 -21.67 38.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.383 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -93.66 -48.21 6.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.765 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -103.77 18.05 22.77 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.605 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -163.47 52.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.879 0.371 . . . . 0.0 111.213 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 7.1 tp -174.83 -65.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.897 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.417 HD13 ' CZ ' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -84.95 58.41 5.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.947 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.23 -179.09 5.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.881 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.75 -36.97 31.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -75.76 -31.05 59.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.907 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -79.42 -52.1 4.95 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.532 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.411 HD11 ' CD2' ' A' ' 307' ' ' TYR . 10.1 mt -60.04 -35.35 74.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.819 0.342 . . . . 0.0 110.958 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -59.96 -44.02 94.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.29 -53.68 51.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.12 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.8 t -59.64 -47.14 92.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.128 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -66.44 -31.6 72.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.914 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 2.4 mtmm -63.1 -33.9 76.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.942 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -98.82 -32.43 11.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.024 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -154.49 95.12 2.72 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.915 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.81 123.65 11.63 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.488 2.125 . . . . 0.0 112.314 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.38 17.44 11.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.133 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 81.78 -142.8 22.87 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.59 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -58.41 174.94 0.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 111.192 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 13.4 m -140.47 133.14 32.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.111 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -59.46 -33.79 71.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.208 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 14.0 tp -60.16 114.86 3.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -60.14 -30.67 69.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.951 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 32.6 m -70.36 -39.39 74.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.935 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.411 ' CD2' HD11 ' A' ' 290' ' ' LEU . 1.0 OUTLIER -86.22 -26.76 24.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.014 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -59.89 -31.7 70.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.807 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -69.76 -54.51 13.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.862 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.73 -34.74 19.82 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.788 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.3 mt -85.72 -26.63 25.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.697 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -70.53 -12.3 61.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.439 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -47.76 -31.77 5.21 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.925 0.393 . . . . 0.0 110.81 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -116.11 140.26 26.13 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.35 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.52 -24.82 55.25 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.384 2.056 . . . . 0.0 112.414 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -50.96 -41.48 59.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.008 0.433 . . . . 0.0 110.302 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 30.1 mm -85.55 -32.72 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.882 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -69.11 -29.63 67.74 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.233 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.33 -30.65 66.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.151 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 56.6 m -84.61 -36.35 22.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 6.8 tpt -64.41 -40.21 95.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -59.92 -43.73 94.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.931 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -79.26 -29.13 42.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.023 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.6 -39.96 94.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.19 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -71.65 -55.01 8.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.994 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.13 -47.33 74.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.836 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -58.99 147.71 40.9 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.482 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -86.22 149.85 24.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.337 . . . . 0.0 110.911 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.408 HD12 HG21 ' A' ' 329' ' ' ILE . 28.4 mt -87.98 141.96 13.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.085 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 71.6 mtm -63.84 124.16 84.06 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.944 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -56.38 -164.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.38 2.053 . . . . 0.0 112.261 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -150.61 30.82 0.66 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 31.5 pt -117.86 153.73 51.01 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.108 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.51 -20.36 70.38 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.606 2.204 . . . . 0.0 112.445 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -60.39 -27.46 67.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.099 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.418 ' HE1' ' CH2' ' A' ' 340' ' ' TRP . 1.4 tpt -74.78 -30.21 61.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.074 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.84 -44.98 86.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.001 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -63.52 -29.93 71.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.108 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.439 ' CE1' ' CG2' ' A' ' 343' ' ' VAL . 11.9 t80 -59.45 -48.6 81.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.973 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . 0.418 ' CH2' ' HE1' ' A' ' 336' ' ' MET . 24.2 m95 -59.01 -30.27 67.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.044 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -81.31 -44.17 18.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.046 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -61.83 -61.66 2.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.269 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.439 ' CG2' ' CE1' ' A' ' 339' ' ' PHE . 21.9 t -58.39 -23.73 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.427 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.84 -57.41 12.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.093 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 26.4 m -72.18 -30.27 64.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.107 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.27 -50.79 66.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.289 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 33.3 t -62.91 -45.27 99.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.249 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 27.6 mt -67.85 -42.59 86.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.113 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -58.13 -45.71 86.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.985 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -74.57 -28.71 61.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.197 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.19 -35.98 76.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.268 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.09 20.76 9.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.185 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 55.82 26.0 46.11 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.602 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -82.03 -30.44 31.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.866 0.365 . . . . 0.0 110.941 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -145.42 174.75 10.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 41.0 p -100.47 151.64 21.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 40.5 t -55.91 -27.41 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.053 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -73.81 -47.71 36.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.82 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -35.4 62.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.051 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.0 -56.7 13.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.971 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 92.1 mt -61.63 -29.81 70.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.818 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -56.14 25.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.887 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -63.78 -47.62 80.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.932 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -61.61 -52.84 62.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.151 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 15.6 tm0? -57.36 -30.49 64.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.005 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 60.5 m -82.62 -33.41 27.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.952 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -66.99 -33.81 76.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.936 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.428 HD13 ' CE2' ' A' ' 339' ' ' PHE . 5.2 mt -65.92 -30.13 49.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.04 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.7 p -80.14 -29.94 38.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 34.3 mttp . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.895 180.0 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.5 t . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.832 0.348 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -170.68 35.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.914 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -143.9 -166.37 2.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.785 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -84.91 56.02 5.0 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.463 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.08 -178.38 5.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.754 0.312 . . . . 0.0 110.938 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.2 mt -145.83 118.38 8.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.1 t -92.2 132.46 36.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.118 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.3 mt -121.56 107.2 19.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.446 ' CG ' ' CG ' ' A' ' 57' ' ' PRO . 0.9 OUTLIER -94.89 112.98 24.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.871 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.8 tt -144.93 146.16 20.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.105 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -66.26 161.57 21.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.858 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.13 55.99 4.97 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.512 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -153.34 36.03 0.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.795 0.331 . . . . 0.0 110.897 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.44 179.94 7.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.92 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.2 66.92 3.11 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.505 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 12.2 p90 -79.47 -31.4 42.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.821 0.344 . . . . 0.0 110.911 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.445 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 51.7 t-20 -60.49 -32.92 71.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.944 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.65 -28.59 51.06 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.493 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.0 tp -69.27 -33.46 73.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.865 0.364 . . . . 0.0 110.906 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.23 -40.83 91.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.119 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.4 -33.1 70.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.035 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.1 t -70.91 -32.74 49.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.11 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.63 -33.07 63.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.489 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -66.86 -29.44 69.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.845 0.355 . . . . 0.0 110.937 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.14 -40.13 46.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -58.3 -54.67 44.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.959 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -37.56 77.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.941 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -72.01 -26.3 62.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.975 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -82.95 -31.79 27.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.523 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 17.3 p -138.14 -44.22 0.51 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.611 0.243 . . . . 0.0 111.594 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.53 -20.2 2.95 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.689 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.3 mm -59.94 114.68 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.807 0.337 . . . . 0.0 111.047 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.3 mttp -82.69 170.13 15.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.988 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.28 125.51 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.104 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 m -116.6 125.1 51.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -105.15 127.95 59.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -115.49 153.68 30.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.861 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -117.83 70.27 7.19 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.409 ' HG3' ' CD2' ' A' ' 10' ' ' TRP . 88.0 Cg_endo -77.07 174.53 12.68 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.685 2.256 . . . . 0.0 112.475 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -60.94 -156.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.474 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.429 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -46.95 -26.49 1.01 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.516 0.198 . . . . 0.0 111.457 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 42' ' ' LYS . 0.3 OUTLIER 54.77 18.11 2.0 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.879 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -79.17 -55.78 4.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.834 0.349 . . . . 0.0 110.782 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -93.67 -7.8 42.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.363 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.71 -19.17 45.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.385 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.416 ' CB ' ' HD3' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -84.46 -53.36 0.51 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.197 -179.762 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.416 ' HD3' ' CB ' ' A' ' 47' ' ' PHE . 32.6 Cg_exo -57.84 -32.44 94.97 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.485 2.123 . . . . 0.0 112.37 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.428 ' CG ' ' N ' ' A' ' 50' ' ' VAL . 11.4 pt20 -61.31 -47.07 87.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.058 0.456 . . . . 0.0 111.016 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.428 ' N ' ' CG ' ' A' ' 49' ' ' GLN . 4.1 m -95.1 27.05 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.484 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.16 -32.18 30.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.348 . . . . 0.0 111.2 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.52 -32.82 19.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.171 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 51.6 p -72.73 -31.4 64.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.93 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.89 26.08 46.79 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.563 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -96.24 -28.66 14.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.808 0.337 . . . . 0.0 110.895 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.97 166.14 3.98 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.665 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.446 ' CG ' ' CG ' ' A' ' 10' ' ' TRP . 50.0 Cg_exo -53.38 -172.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.681 2.254 . . . . 0.0 112.38 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 p30 -109.48 -29.02 8.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.953 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.9 mt -132.13 157.08 43.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.205 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.481 ' CG1' ' N ' ' A' ' 61' ' ' PHE . 2.0 tt -163.35 159.36 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.133 0.492 . . . . 0.0 110.897 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.481 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 3.9 m-85 -132.73 124.95 29.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.835 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.6 t-105 -159.41 171.43 19.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.851 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.7 134.04 55.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.163 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -58.56 -31.0 67.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.97 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -59.89 -29.97 68.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.988 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -88.48 -30.27 19.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.923 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -58.36 -30.12 66.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.968 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.81 -27.47 61.83 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.578 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.33 -28.45 71.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.488 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -87.22 -30.16 21.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.815 0.34 . . . . 0.0 110.947 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.18 -29.08 42.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.123 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -57.91 -29.55 65.19 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.063 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.55 -23.15 17.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.085 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.02 28.4 9.36 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.515 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.5 mt -81.81 -32.63 31.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.852 0.358 . . . . 0.0 110.913 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 38.5 mt -76.0 160.68 29.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.896 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.77 133.0 47.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.453 ' CG ' ' N ' ' A' ' 79' ' ' ILE . 19.3 tt0 -61.36 164.01 6.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.722 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.453 ' N ' ' CG ' ' A' ' 78' ' ' GLU . 43.1 pt -141.22 177.6 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.145 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -162.03 77.9 2.08 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.802 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.51 135.92 41.02 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.555 2.17 . . . . 0.0 112.318 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.39 173.42 0.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -62.39 -48.47 79.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.64 -31.3 69.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.121 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -71.08 -44.26 66.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.89 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -64.08 -44.76 91.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.904 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -65.8 -29.75 70.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.94 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -59.62 -45.35 92.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.945 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.422 HD13 ' CZ2' ' A' ' 94' ' ' TRP . 46.3 mt -88.23 173.64 8.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.879 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.432 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . 10.6 m-85 -81.57 149.55 64.83 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.063 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.33 -55.93 2.45 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.637 2.225 . . . . 0.0 112.706 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.454 ' CE1' ' CG2' ' A' ' 93' ' ' THR . 50.8 p90 -56.55 -44.12 80.58 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.771 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.454 ' CG2' ' CE1' ' A' ' 92' ' ' PHE . 39.3 p -54.49 -28.07 42.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.74 0.305 . . . . 0.0 111.116 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.422 ' CZ2' HD13 ' A' ' 89' ' ' LEU . 49.6 m95 -76.83 -46.09 26.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.821 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.73 -26.53 67.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.069 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.71 -28.74 63.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.279 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.2 m -107.42 64.58 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.22 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -156.06 120.07 4.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.98 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -118.93 136.48 54.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.781 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 62.64 17.94 10.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.18 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.79 21.9 56.75 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.947 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.05 156.43 48.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.832 0.349 . . . . 0.0 110.994 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 mt -93.8 142.67 27.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.6 pp -159.0 36.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.206 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.79 176.91 10.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.186 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -139.34 87.4 13.63 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.81 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -51.77 102.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.571 2.18 . . . . 0.0 112.327 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.7 mm -76.67 -64.27 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.095 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -131.88 171.63 13.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.078 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.28 148.11 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.055 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.77 159.8 37.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.961 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -169.07 145.25 3.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.107 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.2 mt -62.56 108.39 1.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.1 m -92.56 161.83 14.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.0 tp -109.3 102.12 11.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.907 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.7 mp -91.94 131.46 38.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.131 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.419 ' CD1' ' HG2' ' A' ' 125' ' ' PRO . 46.1 p90 -113.51 165.51 12.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.949 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -109.84 106.16 15.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.821 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -58.58 -22.86 57.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -55.04 -32.81 62.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.113 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.86 -42.03 1.43 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.201 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.4 tp -104.85 90.67 3.68 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.009 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.84 -43.83 2.37 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.532 2.155 . . . . 0.0 112.283 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -126.51 91.37 47.69 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.419 ' HG2' ' CD1' ' A' ' 117' ' ' TYR . 75.6 Cg_exo -50.58 151.83 9.9 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.586 2.191 . . . . 0.0 112.357 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.76 119.5 5.46 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.566 2.178 . . . . 0.0 112.366 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.05 -21.22 62.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.036 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 12.0 p -100.86 146.1 27.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.903 0.382 . . . . 0.0 111.058 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.42 ' CZ3' HD12 ' A' ' 132' ' ' ILE . 4.4 m95 -77.36 -28.44 52.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.958 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.96 -15.74 60.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.526 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -89.19 -21.94 23.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.528 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.49 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 41.4 mt -59.76 -46.99 98.44 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.49 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 75.7 Cg_exo -49.5 -45.17 32.06 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.412 2.075 . . . . 0.0 112.416 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.26 -38.71 92.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.05 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.34 -33.59 76.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.865 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -63.77 -24.4 67.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.1 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -85.53 -31.67 22.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.115 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -85.01 -47.11 10.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.208 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.14 -17.87 59.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.394 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.32 -27.92 53.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.736 0.303 . . . . 0.0 110.879 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.6 -41.69 90.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.05 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.7 mtpt -72.59 -27.11 61.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.017 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 114.51 29.4 2.71 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.504 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt -141.75 166.99 23.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.844 0.354 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.0 t -97.71 159.13 15.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.871 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -85.45 -32.07 22.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.17 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.404 ' CD1' ' CB ' ' A' ' 224' ' ' MET . 1.0 OUTLIER -169.98 124.1 0.75 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.018 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -129.43 166.65 19.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.59 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.8 p90 179.01 -170.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.803 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -89.14 109.64 20.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.905 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 13.7 mt -88.97 -29.13 19.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.952 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -59.17 -31.46 69.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.885 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.38 111.28 59.45 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.6 -23.48 19.8 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.428 2.085 . . . . 0.0 112.318 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.496 ' CE1' ' CD1' ' A' ' 258' ' ' PHE . 0.3 OUTLIER -50.6 -27.41 6.78 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.232 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -96.81 -22.47 16.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.219 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.2 p -92.35 11.75 24.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.398 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.462 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 22.8 t-105 -87.58 -47.45 0.48 Allowed Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.309 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 53.7 Cg_exo -52.52 -23.32 18.95 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.374 2.049 . . . . 0.0 112.574 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.6 tp -86.02 -67.38 0.81 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.103 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 5.4 mt -57.73 -41.69 80.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.237 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -59.8 -38.27 81.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.197 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -57.79 -36.17 71.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.229 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.94 -20.18 56.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.169 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 130.04 -22.0 4.86 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.636 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -69.32 154.65 53.25 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.496 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.433 ' CD1' ' HA3' ' A' ' 182' ' ' GLY . 25.6 p90 -148.85 -175.13 4.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 0.0 110.926 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.425 ' HB2' ' CE1' ' A' ' 339' ' ' PHE . . . -111.31 -48.9 3.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.024 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -130.28 127.53 39.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.828 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 167' ' ' TYR . 11.1 tttm -94.65 112.79 24.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.092 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -68.93 110.89 4.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.544 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -172.48 156.06 3.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.961 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 62.73 46.23 5.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.007 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 104.09 -62.27 0.4 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.723 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -151.09 -171.47 3.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 111.009 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -59.49 125.9 25.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.9 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -82.19 127.51 33.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.876 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.2 pt -73.18 -27.6 24.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.202 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -97.25 26.04 5.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.052 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -125.44 96.35 4.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.921 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 23.5 t -96.29 146.01 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.111 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' A' ' 167' ' ' TYR . . . -114.71 -7.04 18.57 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.995 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.432 HG12 ' CD2' ' A' ' 361' ' ' LEU . 11.1 t -56.51 -43.31 77.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.866 0.333 . . . . 0.0 111.181 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.06 57.26 4.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.919 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -104.61 -178.87 3.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.75 -52.15 22.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.108 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -76.82 -29.59 57.2 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.561 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.29 -33.93 69.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.829 0.347 . . . . 0.0 111.122 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.59 -31.2 72.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -87.47 -36.86 17.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.137 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -60.29 -46.85 93.52 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.461 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.33 -45.93 91.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.831 0.348 . . . . 0.0 110.854 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 91.7 m -67.02 -24.28 66.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.977 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.404 ' CE2' HD12 ' A' ' 198' ' ' LEU . 24.7 t80 -59.27 -60.67 3.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.812 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.7 tp -61.18 -30.29 70.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.554 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 49.1 t -69.86 -43.28 79.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.005 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.34 -24.32 34.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.133 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.404 HD12 ' CE2' ' A' ' 194' ' ' PHE . 0.7 OUTLIER -63.87 -35.21 79.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.033 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 12.4 mt -77.75 -33.74 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.3 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 4.0 mtpp -85.07 -28.99 25.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.146 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -91.39 -10.18 42.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.558 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.424 ' O ' ' CG ' ' A' ' 203' ' ' HIS . 13.1 mmtm -130.83 9.02 4.9 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.5 0.191 . . . . 0.0 111.49 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . 0.424 ' CG ' ' O ' ' A' ' 202' ' ' LYS . 40.1 p-80 43.67 52.96 6.16 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.888 0.375 . . . . 0.0 111.426 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 48.0 mtp -82.76 133.51 35.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -59.37 119.75 8.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.073 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -80.07 -29.77 39.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.059 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.74 -20.85 52.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.222 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 7.2 m -45.16 149.31 0.5 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.916 0.388 . . . . 0.0 111.398 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -154.07 176.28 12.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.661 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 211' ' ' SER . 0.3 OUTLIER -62.96 -30.48 71.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.93 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.454 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 0.7 OUTLIER -68.78 -59.21 3.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.953 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -28.85 38.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.358 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -74.07 -33.61 63.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.781 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.75 -28.63 30.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.53 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.37 -36.42 83.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.474 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.433 ' HA ' ' HA3' ' A' ' 220' ' ' GLY . . . -52.46 -25.22 9.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.307 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -66.92 -53.9 27.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.979 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -90.06 -13.96 34.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.03 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -176.84 101.85 0.05 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.979 0.419 . . . . 0.0 111.275 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 216' ' ' ALA . . . 149.73 -46.85 0.64 Allowed Glycine 0 N--CA 1.453 -0.229 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.049 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 63.97 101.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.944 0.402 . . . . 0.0 111.561 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 13.3 t -116.05 124.89 51.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.374 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -45.92 -32.64 2.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.604 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.404 ' CB ' ' CD1' ' A' ' 147' ' ' LEU . 26.3 mtm -156.89 142.54 17.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.914 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 4.1 t -164.3 126.24 2.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.0 mt -95.71 126.99 48.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.096 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -141.28 165.49 27.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -82.48 -170.94 46.06 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.496 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.414 ' HD2' ' CE3' ' A' ' 230' ' ' TRP . 74.1 Cg_endo -74.99 -2.89 13.13 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.638 2.225 . . . . 0.0 112.751 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . 0.414 ' CE3' ' HD2' ' A' ' 229' ' ' PRO . 39.0 p90 -95.97 34.08 1.6 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.694 0.283 . . . . 0.0 111.104 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -136.86 11.29 3.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.557 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 8.7 m0 -81.19 -39.43 25.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.808 0.337 . . . . 0.0 110.965 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.45 -29.92 68.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.024 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.71 -30.45 65.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.993 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.409 HG23 ' CE1' ' A' ' 242' ' ' TYR . 4.4 mt -88.63 84.67 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.071 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -160.76 37.19 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.915 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -165.71 -43.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.957 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 82.8 p -63.08 -30.68 71.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.964 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 7.4 mmtm 61.09 36.05 18.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 20.8 t -95.41 121.73 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.105 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -61.98 111.97 2.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.868 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.409 ' CE1' HG23 ' A' ' 235' ' ' ILE . 50.8 p90 -109.26 146.96 33.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.91 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -126.14 147.19 16.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.492 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 20.8 t -110.18 127.05 67.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.814 0.34 . . . . 0.0 111.126 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.3 t -143.61 146.81 33.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.419 ' CG2' ' N ' ' A' ' 247' ' ' LEU . 0.7 OUTLIER -55.17 152.31 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.217 0.532 . . . . 0.0 111.32 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.419 ' N ' ' CG2' ' A' ' 246' ' ' VAL . 13.5 mt -72.08 147.62 91.04 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.946 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.43 166.45 19.47 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.535 2.157 . . . . 0.0 112.282 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 4.5 p -110.32 162.2 14.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.943 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -117.24 110.58 18.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.913 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 9.1 mttm 59.84 25.3 14.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.042 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 92.93 -21.07 41.61 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.714 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -80.48 126.59 78.26 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.539 0.209 . . . . 0.0 110.832 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.76 143.88 30.5 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.433 2.089 . . . . 0.0 112.34 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 89.7 p -60.64 -178.29 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.777 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.406 ' N ' ' HD3' ' A' ' 257' ' ' PRO . 11.6 mttp -136.99 62.25 38.82 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.014 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 256' ' ' LYS . 35.7 Cg_exo -57.43 -161.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.497 2.131 . . . . 0.0 112.207 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . 0.496 ' CD1' ' CE1' ' A' ' 155' ' ' TYR . 63.1 m-85 -122.3 136.89 54.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.821 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 25.8 t -97.15 117.82 42.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.178 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -114.61 114.23 3.2 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.405 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.84 142.34 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.849 0.357 . . . . 0.0 111.151 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 14.8 tp -101.76 81.44 2.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.724 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 14.9 p -85.32 166.2 16.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.971 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -99.72 148.37 24.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.055 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -125.26 131.4 7.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.521 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 3.9 mp -124.13 102.4 10.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.789 0.328 . . . . 0.0 111.064 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -59.59 148.33 33.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.993 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -60.74 -30.55 70.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.092 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.83 57.1 4.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.014 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 8.0 m -145.56 93.29 5.35 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.84 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -48.64 -26.72 9.67 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.585 2.19 . . . . 0.0 112.464 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -86.21 56.24 3.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.835 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.27 -49.64 9.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.905 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -60.04 -43.72 95.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.864 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 46.6 mt -66.06 -32.18 73.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.8 -44.27 86.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.074 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.11 -49.39 74.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -63.05 -32.31 73.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.89 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -69.57 -47.59 63.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.97 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.6 mt -81.49 -21.17 38.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.383 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -93.61 -48.25 6.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.793 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -102.99 17.72 23.39 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.519 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -163.81 44.59 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.884 0.373 . . . . 0.0 111.193 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.1 tp -177.95 -55.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 3.0 mt -89.99 52.56 2.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.7 p -138.31 -178.17 5.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -71.54 -43.27 66.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.888 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -82.72 -33.62 27.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -60.55 -61.88 6.59 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.563 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.41 ' HB3' ' CE2' ' A' ' 307' ' ' TYR . 2.8 mt -60.96 -34.27 74.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.333 . . . . 0.0 110.917 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.94 -41.99 93.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.94 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -59.5 -36.4 75.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.14 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.6 t -85.4 -30.67 6.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -59.77 -36.0 75.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -66.88 -32.72 74.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -89.46 -32.75 17.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.961 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -162.65 91.53 1.27 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.983 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.66 123.68 10.72 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.499 2.133 . . . . 0.0 112.315 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 3.1 mp -93.33 16.87 12.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.11 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 59.09 -116.93 9.51 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.542 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -59.58 155.71 14.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.861 0.362 . . . . 0.0 111.093 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.412 HG22 ' CD2' ' A' ' 307' ' ' TYR . 16.7 m -141.1 156.16 21.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.162 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -69.87 -36.2 75.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.098 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 9.2 tp -61.35 122.32 14.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -70.05 -27.28 64.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.009 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 69.0 m -81.25 -27.61 35.11 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.149 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.412 ' CD2' HG22 ' A' ' 302' ' ' VAL . 8.3 t80 -83.06 -31.24 27.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.24 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -30.71 69.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.881 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -69.8 -50.23 45.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.891 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -51.22 -39.46 56.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.75 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 72.4 mt -85.68 -23.05 27.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.866 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.99 -14.95 61.66 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.491 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -46.41 -30.61 2.22 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.891 0.377 . . . . 0.0 110.912 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.89 142.04 27.79 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.339 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.42 -33.52 96.43 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.476 2.117 . . . . 0.0 112.521 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -49.18 -37.15 21.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.007 0.432 . . . . 0.0 110.364 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 33.1 mm -85.56 -34.33 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.876 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.3 -31.81 72.84 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.154 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.09 -45.75 83.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.175 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 60.3 m -61.34 -35.24 76.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 2.9 tpt -66.38 -46.62 76.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -62.76 -33.68 75.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -75.33 -32.19 60.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.45 -45.38 72.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.045 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -59.67 -31.54 69.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.854 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -96.59 21.12 9.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.145 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -117.15 135.95 12.29 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.524 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -79.27 143.03 35.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.781 0.324 . . . . 0.0 110.886 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 26.0 mt -75.76 133.88 30.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.142 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 27.4 mtm -60.29 125.63 82.16 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.778 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.77 172.06 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.352 2.035 . . . . 0.0 112.245 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -132.35 41.03 3.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.432 HG23 HD12 ' A' ' 333' ' ' ILE . 31.7 pt -117.56 143.98 33.29 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.108 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.49 -23.84 49.91 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.595 2.196 . . . . 0.0 112.426 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.13 -22.46 40.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.203 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 37.8 mtp -54.66 -24.2 20.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.288 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 44.7 m -57.14 -36.89 71.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.085 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -82.41 -28.19 31.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.189 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.442 ' CE1' ' CG2' ' A' ' 343' ' ' VAL . 79.7 t80 -57.4 -31.22 65.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.979 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -62.74 -61.0 2.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.018 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -63.2 -27.96 69.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.131 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -73.44 -38.24 65.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.351 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.442 ' CG2' ' CE1' ' A' ' 339' ' ' PHE . 25.9 t -88.58 -46.35 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.299 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 7.1 ttt180 -55.75 -57.36 12.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.129 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 29.8 m -61.97 -27.25 68.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.115 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -76.3 -32.66 58.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.322 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 33.0 t -82.71 -42.68 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.282 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 17.4 mt -62.31 -59.05 4.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.125 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -59.6 -30.36 68.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.935 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -73.56 -52.06 14.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.112 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.26 -32.2 72.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.137 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.25 -22.4 64.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.092 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 103.45 -27.21 20.85 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.573 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -58.97 -77.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.882 0.372 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -65.55 140.89 58.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.844 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 78.2 p -87.92 178.02 6.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.787 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 23.3 t -77.62 -55.11 11.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.945 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -47.69 -33.0 6.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.319 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -82.08 -45.79 14.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.143 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -57.43 -60.46 3.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.052 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.432 ' CD2' HG12 ' A' ' 183' ' ' VAL . 7.3 mt -58.7 -27.29 64.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.074 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -81.2 -37.06 29.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.955 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -70.36 -45.53 65.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.863 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.2 -30.78 66.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.11 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -69.39 -30.46 68.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 7.0 m -85.05 -30.14 24.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.051 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -74.19 -41.99 60.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.0 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 12.4 mt -73.48 -28.92 26.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.218 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 79.6 p -90.98 -46.09 8.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.867 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.932 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 40.4 tttt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.796 0.331 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.7 t -80.45 166.42 21.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -120.97 178.24 4.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.917 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -93.04 168.73 10.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.79 36.43 87.12 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.481 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.8 170.32 21.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.848 0.356 . . . . 0.0 110.949 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.6 mt -140.38 124.51 17.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.88 106.97 21.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.059 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.0 mp -99.26 121.23 49.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.428 ' CZ3' ' HB2' ' A' ' 43' ' ' LEU . 1.4 m0 -91.23 133.7 35.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.984 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.414 HG13 ' N ' ' A' ' 12' ' ' ASN . 9.4 tp -125.01 159.56 31.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.962 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.414 ' N ' HG13 ' A' ' 11' ' ' ILE . 26.6 m-20 -93.49 31.71 1.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.159 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 47.46 37.77 12.97 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.06 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -178.64 53.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.846 0.355 . . . . 0.0 111.004 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.75 78.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.865 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.47 49.8 73.17 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.534 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 36.3 p90 -78.99 -38.83 35.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.813 0.339 . . . . 0.0 110.919 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.438 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 2.6 t30 -86.92 -31.68 20.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.949 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.57 -37.44 68.41 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.531 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.9 tp -63.75 -32.23 73.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.856 0.36 . . . . 0.0 110.949 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.67 -31.23 72.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.081 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -63.51 -43.64 96.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.912 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.87 -35.44 60.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.109 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.96 -43.73 93.05 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.445 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -59.73 -25.62 64.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.772 0.32 . . . . 0.0 111.002 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -82.58 -38.95 22.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.991 0.424 . . . . 0.0 110.882 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.34 -50.13 73.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.029 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -38.39 81.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.93 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.06 -25.12 64.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.095 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -88.38 -32.49 18.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.372 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.0 p -136.65 -44.14 0.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.375 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.67 20.61 4.94 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.657 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.436 HG23 HD11 ' A' ' 33' ' ' ILE . 32.9 mm -85.78 126.72 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.852 0.358 . . . . 0.0 111.043 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -65.45 148.68 51.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.38 104.36 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.09 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.6 m -109.54 150.6 27.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.999 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.15 127.83 55.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.064 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -126.26 155.56 41.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.91 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -135.96 70.22 63.92 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.851 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.77 170.27 15.73 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.584 2.189 . . . . 0.0 112.468 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -108.34 141.42 40.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.717 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.98 32.94 19.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.663 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.428 ' HB2' ' CZ3' ' A' ' 10' ' ' TRP . 2.3 pp -77.34 -0.78 26.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.699 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -56.98 -57.09 14.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.784 0.326 . . . . 0.0 111.16 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -88.41 -25.64 22.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.185 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.0 -18.97 60.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.295 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.445 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 78.4 t80 -74.07 -56.33 2.72 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.504 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 40.6 Cg_endo -67.0 -23.91 46.05 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.298 1.998 . . . . 0.0 112.883 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -65.12 -46.03 82.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.873 0.368 . . . . 0.0 111.155 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.8 m -87.06 -28.99 5.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.314 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.9 -29.61 63.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.261 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.59 -33.37 71.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.13 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.2 p -93.87 -30.78 14.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.949 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.73 25.61 24.77 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.59 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -94.44 -32.97 13.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.869 0.366 . . . . 0.0 110.867 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.27 -143.94 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.534 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.422 ' HG3' ' CD2' ' A' ' 10' ' ' TRP . 43.6 Cg_endo -68.09 -167.78 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.538 2.159 . . . . 0.0 112.329 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -123.75 -51.9 1.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.0 mt -109.77 138.46 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.092 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.469 ' CG1' ' N ' ' A' ' 61' ' ' PHE . 3.0 tt -125.82 159.72 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.069 0.461 . . . . 0.0 111.029 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.469 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 46.4 m-85 -135.08 125.63 26.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.932 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.411 ' CD1' ' HG3' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -160.27 175.95 12.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.52 157.01 37.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.142 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.428 ' CG ' ' HB1' ' A' ' 96' ' ' ALA . 32.2 p80 -57.98 -34.11 69.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.994 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -60.59 -48.82 80.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.08 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.411 ' HG3' ' CD1' ' A' ' 62' ' ' TRP . 30.5 mmm180 -74.87 -27.85 60.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.021 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.412 ' CE2' ' HB2' ' A' ' 263' ' ' SER . 1.0 OUTLIER -57.65 -22.37 45.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.147 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -94.6 33.7 5.18 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.576 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -118.4 -32.49 1.35 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.51 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -88.41 -27.52 21.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.775 0.322 . . . . 0.0 110.98 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.33 -30.72 38.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.053 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.411 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 3.5 pt20 -61.05 -36.4 79.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.962 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 m -89.75 -23.06 21.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.126 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.74 59.2 0.87 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.452 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.0 mt -138.31 31.69 2.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.362 . . . . 0.0 110.961 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.1 mt -138.88 161.45 37.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -97.8 151.21 20.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.058 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.06 -165.37 0.55 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.93 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.4 pt -157.64 171.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.085 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.8 p -158.1 77.42 3.52 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.741 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.48 160.16 47.39 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.631 2.221 . . . . 0.0 112.347 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.35 -176.94 3.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.753 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.3 mttp -59.89 -38.94 83.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.81 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.18 -28.04 61.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.075 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -79.19 -37.69 37.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.935 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -82.14 -25.95 33.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.085 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -79.19 -40.83 29.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.163 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.5 pttt -58.37 -39.45 79.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.083 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.412 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 24.9 mt -83.01 162.1 21.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.872 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.438 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . 26.1 m-85 -88.26 147.63 40.72 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.03 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -54.21 -55.71 3.18 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.567 2.178 . . . . 0.0 112.736 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.447 ' CE1' ' CG2' ' A' ' 93' ' ' THR . 40.2 p90 -54.09 -39.62 66.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.808 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.447 ' CG2' ' CE1' ' A' ' 92' ' ' PHE . 27.8 p -61.42 -32.98 72.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.745 0.307 . . . . 0.0 110.826 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.412 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 45.3 m95 -67.75 -32.0 72.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.793 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -60.35 -26.98 67.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.055 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.428 ' HB1' ' CG ' ' A' ' 64' ' ' HIS . . . -73.12 -28.67 62.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.258 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 m -104.05 56.24 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.936 0.398 . . . . 0.0 111.245 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -156.08 130.45 8.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.411 ' CE2' ' HB3' ' A' ' 72' ' ' GLN . 1.8 t80 -96.23 -64.74 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.838 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -127.69 45.78 2.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.795 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.16 -26.8 19.4 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.526 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.2 141.8 33.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.841 0.353 . . . . 0.0 110.88 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 32.1 mt -97.01 132.05 43.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.843 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.6 pp -138.31 30.47 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.196 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -173.8 178.73 2.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.152 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -155.74 96.09 2.4 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.807 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.54 144.99 39.39 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.504 2.136 . . . . 0.0 112.424 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.4 mt -128.31 -59.3 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.047 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -105.86 145.75 30.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.096 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 32.7 t -121.18 138.36 51.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.136 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -139.47 160.08 40.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.863 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -172.31 152.74 2.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.083 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.3 mt -71.02 101.94 2.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.44 -176.52 3.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.6 tp -96.81 114.61 26.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.919 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.7 mt -108.9 114.01 45.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.004 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -124.88 165.53 17.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.906 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.39 144.51 34.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.926 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.5 mtmm -98.5 33.39 2.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.961 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -93.13 -48.12 6.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.949 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.96 -35.26 5.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.008 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.6 tt -108.53 95.32 15.95 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.979 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.48 -45.24 1.26 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.484 2.123 . . . . 0.0 112.353 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -100.34 114.71 65.81 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.51 153.01 39.11 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.416 2.077 . . . . 0.0 112.364 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.52 116.24 4.64 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.576 2.184 . . . . 0.0 112.289 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.93 -23.73 38.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.027 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 73.2 p -118.01 149.7 40.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.895 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.459 ' CE3' ' CD1' ' A' ' 132' ' ' ILE . 26.5 m95 -69.63 -31.27 69.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.854 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -68.8 -15.65 63.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.427 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -85.5 -16.95 37.87 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.517 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 24.0 mt -71.78 -49.42 10.78 Favored Pre-proline 0 C--N 1.331 -0.204 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.517 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 83.3 Cg_exo -44.99 -46.58 12.96 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.499 2.132 . . . . 0.0 112.509 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.07 -40.07 92.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.997 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.73 -36.84 85.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.797 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.76 -27.51 63.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.067 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.422 ' HE2' ' CE1' ' A' ' 203' ' ' HIS . 50.1 mttm -85.6 -31.6 22.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.069 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -85.1 -56.46 3.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.171 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.42 -26.77 43.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.272 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -77.67 -28.26 51.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.804 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.42 -38.28 83.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.951 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 41.3 mttt -73.64 -27.12 61.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.073 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.2 32.4 1.83 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.599 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.2 mtmt -149.82 159.7 44.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 0.0 110.874 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 84.7 p -82.33 170.11 15.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.975 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -102.67 -56.69 2.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.169 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.0 tp -153.54 136.32 15.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.92 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.87 -177.91 4.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.82 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -177.25 -172.78 0.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.416 ' HB3' ' CD1' ' A' ' 156' ' ' PHE . 60.2 t-20 -83.59 114.21 21.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.941 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.4 mt -98.57 30.8 3.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.911 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -127.54 30.33 5.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -168.49 111.42 0.55 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.26 -25.74 14.07 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.453 2.102 . . . . 0.0 112.353 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.494 ' CZ ' ' CE1' ' A' ' 258' ' ' PHE . 0.8 OUTLIER -58.4 -31.5 67.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.416 ' CD1' ' HB3' ' A' ' 150' ' ' ASN . 13.6 m-85 -74.43 -30.53 61.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 21.1 p -102.56 30.34 4.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.067 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.468 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 1.4 t-105 -83.59 -48.45 0.73 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.093 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 32.4 Cg_exo -58.13 -18.83 38.49 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.417 2.078 . . . . 0.0 112.497 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 15.6 tp -92.66 -32.13 14.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.155 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 15.6 mt -95.79 -58.02 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.222 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -56.15 -31.1 63.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.252 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -59.08 -44.82 91.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.135 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -63.73 -20.08 65.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.185 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 131.71 71.26 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.56 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -158.2 142.9 8.84 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.493 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -147.48 179.47 7.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.332 . . . . 0.0 110.999 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.413 ' HB1' ' CE1' ' A' ' 339' ' ' PHE . . . -103.55 -33.01 9.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.983 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -141.25 155.31 46.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.793 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 9.1 tttm -103.35 111.32 23.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.057 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.437 ' CD1' ' CZ ' ' A' ' 176' ' ' TYR . 57.4 t80 -73.81 110.91 8.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.412 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -158.76 150.92 21.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.08 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 61.51 29.93 18.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.059 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 90.78 -38.54 3.2 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.014 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -108.05 -177.11 3.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.918 0.389 . . . . 0.0 111.079 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.437 ' CZ ' ' CD1' ' A' ' 171' ' ' TYR . 4.9 m-85 -108.1 121.14 44.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.921 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -58.75 132.5 54.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.7 pt -91.02 -23.63 5.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.385 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.39 26.05 4.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.15 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -141.53 90.12 2.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.919 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 16.2 t -100.75 146.01 10.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.079 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -111.0 66.55 0.23 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.652 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.423 HG12 ' HA ' ' A' ' 361' ' ' LEU . 1.5 t -103.13 -60.52 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.91 0.386 . . . . 0.0 111.064 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -83.46 56.7 3.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.11 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -95.77 168.43 10.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.814 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -59.83 -34.17 72.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.113 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -85.93 -45.51 5.67 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.611 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.9 -38.69 79.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.785 0.326 . . . . 0.0 111.17 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -60.07 -34.7 73.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -87.55 -30.99 20.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.168 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -58.45 -50.5 66.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.57 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.77 -43.08 98.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.806 0.336 . . . . 0.0 110.931 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 9.9 m -50.19 -27.37 5.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.252 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -67.93 -58.67 4.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.811 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.1 tp -64.76 -30.1 71.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.18 -56.92 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.062 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.84 -28.41 61.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.146 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 26.2 mt -59.69 -58.22 9.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.012 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 9.0 mt -61.39 -28.8 44.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.057 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.33 -35.4 66.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -90.2 16.46 8.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.44 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.84 39.12 27.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.821 0.343 . . . . 0.0 111.216 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . 0.422 ' CE1' ' HE2' ' A' ' 137' ' ' LYS . 2.8 m-70 -90.2 -23.86 21.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.888 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 13.9 mtt -132.91 -177.51 4.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.777 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -115.59 147.86 40.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.918 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -78.8 -30.52 45.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.041 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.407 ' O ' HD11 ' A' ' 212' ' ' ILE . 0.9 OUTLIER -91.37 60.04 4.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.783 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.453 ' HA ' HD11 ' A' ' 212' ' ' ILE . 0.2 OUTLIER -117.43 138.55 51.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.928 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.423 ' HB2' ' CG1' ' A' ' 212' ' ' ILE . 57.3 m-20 -154.19 176.16 12.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.732 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -64.68 -39.84 94.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.231 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.03 -59.08 3.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.876 0.369 . . . . 0.0 110.988 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.453 HD11 ' HA ' ' A' ' 208' ' ' THR . 0.3 OUTLIER -57.63 -29.11 33.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.656 179.805 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -80.61 -22.63 40.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.961 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -77.88 -36.62 49.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.866 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -72.47 -38.2 68.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.037 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.66 -30.8 67.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.121 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.421 ' CD1' HG21 ' A' ' 225' ' ' THR . 58.2 t80 -81.71 -36.88 28.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.93 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -68.28 -46.85 69.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.52 -30.1 71.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.13 43.79 1.99 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.49 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -100.3 -74.49 0.6 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.882 0.373 . . . . 0.0 110.903 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 11.3 t -74.34 142.81 45.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.72 -30.98 46.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.049 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.1 mpp? -128.34 156.24 43.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.929 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.421 HG21 ' CD1' ' A' ' 217' ' ' PHE . 9.4 t -166.64 147.36 6.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.5 mt -109.85 126.51 67.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.029 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -144.92 165.43 28.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.418 ' HA3' ' CZ3' ' A' ' 230' ' ' TRP . . . -80.96 -169.44 41.46 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.533 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.423 ' HD2' ' CE3' ' A' ' 230' ' ' TRP . 55.1 Cg_endo -69.81 -8.98 24.99 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.562 2.175 . . . . 0.0 112.699 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.423 ' CE3' ' HD2' ' A' ' 229' ' ' PRO . 41.0 p90 -94.36 39.25 1.09 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.758 0.314 . . . . 0.0 111.09 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -113.47 -33.19 5.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.129 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 22.4 m0 -63.14 -31.42 72.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.862 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 49.6 m -60.8 -33.69 73.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.96 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.35 -50.89 72.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 18.1 pt -75.58 134.81 28.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.123 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -176.26 -40.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.69 -36.05 9.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.35 -32.69 58.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.923 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt 60.06 74.65 0.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.27 122.0 56.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.063 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -63.18 107.3 1.02 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -98.13 157.65 16.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.3 120.68 2.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.463 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.5 t -94.39 123.04 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 111.1 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 58.9 m -143.52 136.18 27.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.409 ' CG2' ' N ' ' A' ' 247' ' ' LEU . 0.7 OUTLIER -54.62 152.34 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.241 0.543 . . . . 0.0 111.328 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.409 ' N ' ' CG2' ' A' ' 246' ' ' VAL . 4.7 mt -59.62 139.47 89.5 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.884 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.42 ' HB2' ' CD1' ' A' ' 129' ' ' TRP . 51.2 Cg_exo -54.0 -172.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.504 2.136 . . . . 0.0 112.276 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 2.7 p -122.65 165.48 16.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.883 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.416 ' CD2' ' HG3' ' A' ' 251' ' ' LYS . 14.6 t80 -129.0 117.54 21.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.416 ' HG3' ' CD2' ' A' ' 250' ' ' PHE . 6.2 mtpp 59.96 31.99 20.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 73.8 27.02 67.81 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.564 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -118.85 147.81 43.16 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.7 0.286 . . . . 0.0 110.859 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.7 149.89 55.53 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.538 2.159 . . . . 0.0 112.286 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 66.9 p -73.81 159.19 33.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.39 54.59 4.56 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.876 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.19 155.27 64.92 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.575 2.183 . . . . 0.0 112.281 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.494 ' CE1' ' CZ ' ' A' ' 155' ' ' TYR . 67.0 m-85 -74.17 166.21 23.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.894 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 22.0 t -116.7 134.95 58.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.24 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -128.93 96.24 0.4 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.388 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 10.2 p -98.8 159.96 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.819 0.342 . . . . 0.0 111.216 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 12.2 tp -122.21 104.67 9.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.903 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.412 ' HB2' ' CE2' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -109.07 170.3 8.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.924 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -101.95 143.6 31.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.058 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -116.05 152.43 17.97 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.56 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 30.2 mt -135.15 144.37 34.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.833 0.349 . . . . 0.0 110.983 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -82.49 153.69 25.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -84.08 -22.8 31.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.355 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -53.66 -82.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.226 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' SER . . . . . 0.419 ' N ' ' HD3' ' A' ' 271' ' ' PRO . 0.3 OUTLIER 179.58 65.56 0.13 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.94 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' A' ' 270' ' ' SER . 4.9 Cg_exo -76.67 -71.44 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.812 2.341 . . . . 0.0 112.088 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 174.88 68.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.625 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.26 -28.13 69.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.086 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -77.07 -49.35 15.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.146 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 99.3 mt -76.04 -44.44 39.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.096 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -58.46 -53.38 59.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.155 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 24.6 tttp -59.97 -30.67 69.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.959 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -81.04 -38.51 27.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.943 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.41 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 49.8 t80 -72.55 -34.93 67.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.951 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 7.8 mt -81.46 -20.77 39.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.396 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -91.08 -48.7 6.81 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.434 ' O ' ' CG ' ' A' ' 283' ' ' TYR . 0.0 OUTLIER -114.16 28.37 8.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.073 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.434 ' CG ' ' O ' ' A' ' 282' ' ' ASN . 32.3 m-85 -164.39 32.75 0.07 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.856 0.36 . . . . 0.0 111.005 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 10.6 tp -168.66 -42.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.898 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 1.9 mt -98.16 30.38 3.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.897 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 65.8 p -138.95 164.52 29.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.853 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.27 -27.81 62.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.077 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -67.03 -41.88 85.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.022 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -92.41 -46.47 3.5 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.678 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.422 ' HB3' ' CE2' ' A' ' 307' ' ' TYR . 0.6 OUTLIER -57.67 -53.61 56.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.801 0.334 . . . . 0.0 111.09 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -58.83 -32.49 69.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.965 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -66.6 -42.51 86.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.141 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.8 t -81.84 -30.3 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.175 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -69.83 -30.78 68.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 7.9 mtpp -63.58 -33.6 75.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.952 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -98.3 -39.99 8.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.99 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -144.25 89.17 7.1 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.856 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.47 98.08 0.83 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.523 2.149 . . . . 0.0 112.34 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 1.7 mp -58.78 -22.88 59.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.094 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 110.04 -118.16 4.98 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.45 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -81.22 163.26 23.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 111.038 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 15.5 m -141.59 176.04 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.142 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -87.49 -30.32 20.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.16 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 5.4 tp -58.1 122.22 12.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.975 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -64.51 -41.45 96.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.947 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.5 m -60.01 -53.3 59.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.93 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.422 ' CE2' ' HB3' ' A' ' 290' ' ' LEU . 2.5 t80 -67.4 -23.2 65.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.162 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.03 -31.24 66.81 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 110.85 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -76.24 -58.04 3.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -50.11 -32.44 15.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 32.9 mt -85.76 -26.63 25.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.704 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -74.89 -6.05 47.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.515 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.47 -31.76 4.51 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.986 0.422 . . . . 0.0 110.82 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.87 134.8 24.39 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.317 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.15 -27.14 54.48 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.42 2.08 . . . . 0.0 112.373 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -49.82 -42.02 46.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.037 0.446 . . . . 0.0 110.294 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 30.8 mt -85.63 -33.55 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.851 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.8 -30.71 67.81 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.129 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.59 -31.98 70.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.082 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 25.3 m -62.49 -51.15 68.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.911 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 5.6 tpt -61.5 -37.51 83.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -64.77 -31.87 73.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -67.01 -38.28 85.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -78.7 -35.35 45.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -67.07 -43.65 82.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.928 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.31 -31.35 26.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.84 -164.07 1.82 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.528 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -137.34 129.11 28.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.37 . . . . 0.0 110.892 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.424 HG21 ' CE1' ' A' ' 64' ' ' HIS . 31.2 mt -77.22 138.98 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.113 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 30.4 mtm -76.77 130.47 76.11 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.919 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.44 175.55 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.378 2.052 . . . . 0.0 112.271 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -114.17 32.1 6.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.819 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 42.3 pt -99.63 153.59 37.7 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.2 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.66 -25.2 34.44 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.583 2.188 . . . . 0.0 112.382 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -58.62 -25.16 62.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.096 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 23.3 mmm -56.19 -32.47 64.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.052 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.3 m -59.52 -48.68 80.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.0 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -59.14 -31.55 69.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.06 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.437 ' CE1' ' CG2' ' A' ' 343' ' ' VAL . 85.0 t80 -69.34 -32.25 71.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . 0.489 ' CZ2' ' CZ ' ' A' ' 155' ' ' TYR . 68.9 m95 -66.38 -30.63 71.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.961 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -84.71 -51.73 6.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.178 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -55.23 -54.41 43.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.43 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.437 ' CG2' ' CE1' ' A' ' 339' ' ' PHE . 28.8 t -59.03 -30.66 44.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.228 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.44 -57.48 12.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.975 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 3.6 m -68.66 -27.29 65.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.108 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -57.14 -61.74 2.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.397 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 23.3 t -61.8 -43.15 96.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.309 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 27.7 mt -63.56 -44.98 98.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.109 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -59.79 -30.95 69.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -77.96 -51.06 10.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.108 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -60.17 -40.15 88.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.087 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 14.9 m -71.65 -22.42 61.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.122 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 86.5 27.52 29.74 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.453 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -89.59 -30.39 18.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.784 0.326 . . . . 0.0 110.9 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -145.37 145.07 31.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.888 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.7 p -62.37 169.51 2.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.795 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.481 ' CG1' ' N ' ' A' ' 358' ' ' ASP . 1.5 p -62.51 -47.3 93.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.893 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . 0.481 ' N ' ' CG1' ' A' ' 357' ' ' VAL . 3.2 m-20 -66.78 -31.42 72.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.987 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -72.19 -43.13 64.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.975 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -60.59 -40.6 92.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.162 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.423 ' HA ' HG12 ' A' ' 183' ' ' VAL . 0.5 OUTLIER -77.35 -31.82 54.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.806 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.6 -52.88 40.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -61.17 -47.28 86.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -57.96 -37.73 74.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.072 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.67 -42.15 96.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.794 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 31.6 m -71.68 -31.5 66.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.862 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 36.1 mtt180 -69.41 -42.02 75.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 4.8 mt -67.19 -51.96 47.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 9.8 t -95.44 43.59 1.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.994 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 1.2 tttm . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.245 -0.884 . . . . 0.0 110.92 179.986 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 47.3 mttt . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.838 0.351 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.47 -175.75 4.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -151.64 154.34 36.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -83.62 139.89 32.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.925 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.38 26.51 43.16 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.539 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.0 159.74 32.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.78 0.324 . . . . 0.0 110.915 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.4 mt -128.09 109.98 12.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.5 t -83.6 147.01 6.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.15 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.474 HG21 HD11 ' A' ' 9' ' ' ILE . 29.6 mt -127.42 107.5 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.949 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.45 ' CE3' ' CD1' ' A' ' 43' ' ' LEU . 3.6 m0 -97.98 106.76 19.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.798 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.7 tt -140.67 158.19 24.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.085 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -59.1 146.51 38.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.26 -26.13 74.16 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.598 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.24 46.45 1.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.914 0.388 . . . . 0.0 111.006 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -141.34 -176.13 4.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.833 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.78 80.33 0.12 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.516 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 19.2 p90 -83.65 -35.61 24.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.868 0.366 . . . . 0.0 110.942 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.4 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 6.9 t-20 -60.31 -31.17 70.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.61 -58.1 8.17 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.476 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.79 -30.41 70.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.81 0.338 . . . . 0.0 110.885 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.51 -43.89 95.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.059 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -75.64 -51.96 11.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.9 t -59.05 -31.21 45.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.055 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.42 -34.41 84.73 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.424 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.8 mmtm -72.46 -28.16 62.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.824 0.345 . . . . 0.0 110.957 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -46.1 89.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.989 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -62.48 -41.21 98.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.956 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -69.79 -30.89 68.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.941 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.8 mttp -82.66 -26.66 31.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.086 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -91.78 -24.98 19.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.726 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.6 p -125.4 -44.19 1.87 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.692 0.282 . . . . 0.0 111.59 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.3 -26.82 5.17 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.585 -0.816 . . . . 0.0 112.467 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.6 mm -59.96 124.33 14.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.826 0.346 . . . . 0.0 111.058 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.3 mtmt -72.23 153.7 41.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.948 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.5 t -140.54 110.58 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.106 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.4 m -105.53 130.25 53.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.933 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t -97.94 110.52 25.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.051 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -103.35 141.18 36.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.974 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -136.57 70.17 59.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.813 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.63 156.06 40.16 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.629 2.219 . . . . 0.0 112.503 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.69 140.69 37.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.506 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? 56.39 41.72 28.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.675 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.45 ' CD1' ' CE3' ' A' ' 10' ' ' TRP . 0.9 OUTLIER -89.1 16.87 6.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.554 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -60.99 -42.18 97.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.876 0.369 . . . . 0.0 110.694 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -85.45 -6.3 59.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.252 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.85 -20.07 36.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.376 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.422 ' CZ ' ' HG2' ' A' ' 57' ' ' PRO . 0.4 OUTLIER -78.86 -52.58 1.25 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.617 0.246 . . . . 0.0 111.224 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.413 ' HD3' ' CB ' ' A' ' 47' ' ' PHE . 35.2 Cg_exo -59.94 -40.07 65.56 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.47 2.113 . . . . 0.0 112.366 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.442 ' CG ' ' N ' ' A' ' 50' ' ' VAL . 1.7 pt20 -60.12 -49.08 79.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.01 0.433 . . . . 0.0 111.058 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.442 ' N ' ' CG ' ' A' ' 49' ' ' GLN . 34.2 m -79.28 -23.92 12.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.212 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.14 -27.79 48.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.19 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.13 -34.85 75.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.197 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.8 t -69.52 -26.8 64.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.972 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.34 32.52 4.87 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.602 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.32 -81.25 0.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.789 0.328 . . . . 0.0 110.933 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 54.3 -170.85 1.11 Allowed Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.605 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.422 ' HG2' ' CZ ' ' A' ' 47' ' ' PHE . 55.2 Cg_endo -69.59 -179.57 2.93 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.577 2.185 . . . . 0.0 112.253 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -110.2 -31.3 7.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.976 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.8 mt -143.75 137.41 24.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.235 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.48 ' CG1' ' N ' ' A' ' 61' ' ' PHE . 2.6 tt -142.36 159.72 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.887 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.48 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 41.7 m-85 -130.46 135.83 48.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.065 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -176.04 161.79 2.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.863 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.92 148.97 28.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.201 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.414 ' CG ' ' HB2' ' A' ' 96' ' ' ALA . 45.4 p-80 -60.7 -36.03 77.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.867 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -60.34 -30.28 69.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -93.85 17.17 12.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.208 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -112.2 29.24 8.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.854 0.359 . . . . 0.0 110.87 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.83 25.35 6.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.535 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -120.53 -36.4 0.79 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.483 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -83.07 -27.59 30.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.745 0.307 . . . . 0.0 111.036 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.03 -36.88 22.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.165 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -59.19 -32.54 70.02 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.078 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 m -90.1 -23.14 21.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.141 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.96 57.87 0.76 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.45 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.2 mt -139.25 32.36 2.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.793 0.33 . . . . 0.0 110.916 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.0 mt -144.4 160.57 40.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.56 163.28 12.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.066 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -93.56 -165.48 1.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.409 HG23 ' CZ ' ' A' ' 106' ' ' TYR . 44.6 pt -157.49 172.87 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.957 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 48.1 p -156.54 77.48 4.24 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.802 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.42 134.29 26.27 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.641 2.227 . . . . 0.0 112.348 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.71 174.26 10.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.758 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -59.66 -37.05 77.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.825 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.72 -30.05 69.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.064 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -77.58 -47.72 18.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.895 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -65.64 -30.89 71.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.954 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.04 -27.07 64.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.053 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -95.94 39.83 1.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.03 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.422 HD11 ' CZ2' ' A' ' 94' ' ' TRP . 8.3 mt -157.99 173.74 16.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.861 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.442 ' CZ ' ' CE ' ' A' ' 321' ' ' MET . 27.2 m-85 -89.34 150.78 45.38 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.057 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -67.79 -56.39 0.21 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.454 2.103 . . . . 0.0 112.441 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' A' ' 93' ' ' THR . 44.2 p90 -55.68 -41.01 73.09 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.4 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.443 ' N ' ' CD1' ' A' ' 92' ' ' PHE . 13.8 p -56.89 -29.62 63.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.068 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.422 ' CZ2' HD11 ' A' ' 89' ' ' LEU . 55.0 m95 -74.52 -30.85 61.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.914 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.85 -28.43 64.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.0 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.414 ' HB2' ' CG ' ' A' ' 64' ' ' HIS . . . -72.26 -29.57 64.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.226 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.0 m -100.46 50.82 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.259 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -156.08 142.27 18.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -93.69 -47.97 6.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.927 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -151.48 58.71 0.88 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.842 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.08 -27.88 14.96 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.611 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.22 152.47 21.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 110.891 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.417 HD12 ' CE3' ' A' ' 94' ' ' TRP . 13.7 mt -110.59 150.38 29.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.2 pp -146.68 30.37 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.221 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -164.34 -176.87 4.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.168 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.409 ' CZ ' HG23 ' A' ' 79' ' ' ILE . 81.8 m-85 -142.02 89.35 8.85 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.922 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.86 129.92 35.12 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.551 2.167 . . . . 0.0 112.214 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.4 mt -112.91 -61.34 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.226 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -127.34 150.6 49.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.175 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.72 137.39 54.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.033 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -116.36 161.66 18.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.952 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -169.17 158.44 8.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.098 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.8 mt -67.71 -178.28 0.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.936 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.95 169.27 8.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.929 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.4 tp -101.24 142.8 32.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.7 mt -127.72 131.94 69.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.077 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -134.97 161.18 36.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -115.74 117.76 31.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.024 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -66.64 -28.46 68.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -56.82 -40.78 76.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.928 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 81.7 mt -88.06 -80.15 0.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.83 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.21 144.46 54.24 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.84 -43.06 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.477 2.118 . . . . 0.0 112.295 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -139.42 142.77 33.36 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.853 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.61 150.94 36.25 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.566 2.177 . . . . 0.0 112.337 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.28 120.02 6.32 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.56 2.173 . . . . 0.0 112.309 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -94.88 20.59 8.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.95 142.0 29.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.914 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -72.54 -25.95 61.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.017 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.1 -21.93 56.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.213 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -77.5 -26.28 51.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.203 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.524 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 36.8 mt -62.26 -54.45 49.26 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.534 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 18.7 Cg_endo -60.23 -28.32 86.67 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.185 1.923 . . . . 0.0 112.131 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.59 -30.21 41.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.74 -35.78 65.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.814 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.37 -27.92 39.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -85.65 -28.21 24.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.072 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -84.45 -37.27 21.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.11 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.4 -17.21 60.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.487 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.09 -29.54 57.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.876 0.369 . . . . 0.0 110.656 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.46 -37.12 82.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.928 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -78.46 -27.11 46.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.022 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 113.66 45.11 0.73 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.509 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -162.03 -178.24 6.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.814 0.34 . . . . 0.0 110.937 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.2 t -112.0 176.99 4.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.848 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -101.96 -68.42 0.82 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.199 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.3 tp -140.42 145.72 37.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.963 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.21 -177.82 5.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.805 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.434 ' CZ ' ' CE ' ' A' ' 204' ' ' MET . 22.6 p90 -179.4 170.93 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.818 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.405 ' OD1' ' CG ' ' A' ' 156' ' ' PHE . 4.4 p-10 -79.47 131.06 35.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.2 mt -105.91 29.13 6.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.992 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -104.41 -30.48 10.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.944 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -119.78 120.69 30.3 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.935 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.05 -21.94 29.18 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.509 2.139 . . . . 0.0 112.434 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.5 ' CD1' ' CE2' ' A' ' 258' ' ' PHE . 2.5 m-85 -53.91 -30.02 44.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.129 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.405 ' CG ' ' OD1' ' A' ' 150' ' ' ASN . 4.3 m-85 -89.81 -30.24 18.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.902 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.3 p -95.03 18.42 12.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.263 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.471 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 13.4 t-105 -87.44 -46.86 0.49 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.313 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 59.2 Cg_exo -51.72 -25.38 20.39 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.329 2.02 . . . . 0.0 112.438 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 49.6 tp -76.73 -61.95 1.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.001 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 4.3 mt -69.33 -46.42 76.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.224 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -57.65 -34.05 68.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.25 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.09 -41.33 92.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -68.21 -20.09 64.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.187 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 121.44 41.72 0.49 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.467 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -119.54 103.6 0.98 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.507 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.425 ' CD2' ' HA3' ' A' ' 182' ' ' GLY . 30.3 p90 -114.15 -177.4 3.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.796 0.332 . . . . 0.0 110.882 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -108.19 -35.09 6.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.087 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -136.39 152.97 51.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.88 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.27 118.93 37.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.061 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.404 ' CE1' ' HA ' ' A' ' 175' ' ' LYS . 6.5 t80 -79.53 121.24 24.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.489 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -170.41 147.32 2.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.969 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 63.4 42.36 6.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.863 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.4 ' O ' ' CZ ' ' A' ' 171' ' ' TYR . . . 102.83 -63.16 0.44 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.694 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.404 ' HA ' ' CE1' ' A' ' 171' ' ' TYR . 35.9 pttt -128.7 -166.92 1.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.805 0.336 . . . . 0.0 110.994 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -94.09 174.0 7.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -131.31 158.61 40.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.975 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 44.9 pt -92.76 -6.44 10.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.601 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.33 25.89 4.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.755 0.312 . . . . 0.0 111.073 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -152.91 102.53 2.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.859 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 24.2 t -93.96 145.95 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.104 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 0.425 ' HA3' ' CD2' ' A' ' 167' ' ' TYR . . . -96.88 -20.46 23.88 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.734 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.429 HG13 ' CD2' ' A' ' 361' ' ' LEU . 21.4 t -55.17 -40.76 56.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.822 0.344 . . . . 0.0 111.346 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -84.29 57.19 4.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.974 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -118.82 168.56 10.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.834 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.59 -32.97 70.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.133 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -83.47 -38.41 10.87 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.534 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.16 -34.35 72.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.866 0.365 . . . . 0.0 111.168 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -59.95 -54.54 44.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -60.89 -30.14 69.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.177 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -57.9 -54.23 39.04 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.557 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.26 -44.86 86.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.1 m -53.5 -25.22 15.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.203 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -69.49 -60.59 2.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.801 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.1 tp -62.3 -33.2 74.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.662 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 47.3 t -69.04 -34.57 64.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.975 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -74.06 -38.34 63.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 5.5 mt -57.94 -54.15 50.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.001 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 8.6 mt -68.38 -24.86 30.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.135 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -64.35 -40.89 96.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.022 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -95.81 22.07 7.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.232 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.03 79.22 0.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.844 0.354 . . . . 0.0 111.027 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -149.82 25.44 0.84 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.886 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' MET . . . . . 0.434 ' CE ' ' CZ ' ' A' ' 149' ' ' PHE . 23.1 mtp -160.77 -178.78 7.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.822 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -130.05 114.01 15.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.842 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -67.66 -32.58 73.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.89 46.75 1.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.976 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 57.2 m -98.41 138.17 36.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.923 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -106.15 176.05 5.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.828 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -75.77 -33.56 60.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.938 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.4 m -82.79 -28.18 30.47 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.092 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -45.66 -47.47 4.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.218 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -71.73 -28.09 63.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.16 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.416 ' HA ' ' CE2' ' A' ' 217' ' ' PHE . 0.4 OUTLIER -61.86 -63.0 1.4 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.937 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.77 -21.45 66.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.365 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.09 -61.11 2.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.274 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.431 ' CD1' ' N ' ' A' ' 218' ' ' ASN . 11.2 p90 -68.8 -30.72 69.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.925 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.431 ' N ' ' CD1' ' A' ' 217' ' ' PHE . 5.5 t-20 -60.18 -30.68 69.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.28 28.76 7.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.921 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 58.57 95.92 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.53 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -150.46 -46.89 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.337 . . . . 0.0 110.88 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.3 t -124.71 171.97 9.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -93.12 -54.05 3.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.084 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -111.08 163.53 13.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 78.4 m -163.99 152.62 13.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.8 mt -126.7 129.56 71.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.018 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -145.43 159.31 43.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -75.86 -156.44 6.21 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.54 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.419 ' HD2' ' CZ3' ' A' ' 230' ' ' TRP . 43.3 Cg_endo -68.14 -24.22 38.71 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.554 2.169 . . . . 0.0 112.473 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.419 ' CZ3' ' HD2' ' A' ' 229' ' ' PRO . 44.9 p90 -84.06 57.02 3.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.403 . . . . 0.0 110.92 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -143.0 -44.79 0.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.199 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 20.3 m0 -52.98 -40.84 64.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.058 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 13.0 m -61.71 -30.85 71.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.864 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -64.78 -31.71 73.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.929 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.419 HG22 ' CD1' ' A' ' 242' ' ' TYR . 4.8 mt -84.23 57.77 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.056 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.67 -48.51 2.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.816 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 2.5 m -108.98 31.23 5.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.888 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 3.4 t -100.37 -29.73 12.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp 64.04 40.57 7.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.07 117.62 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.042 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -62.02 124.19 20.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.419 ' CD1' HG22 ' A' ' 235' ' ' ILE . 21.1 p90 -118.94 132.04 56.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.876 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -109.14 131.3 10.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.517 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.3 t -99.21 117.42 44.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.809 0.338 . . . . 0.0 111.085 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.7 t -135.8 149.66 49.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.414 ' CG2' ' N ' ' A' ' 247' ' ' LEU . 0.7 OUTLIER -55.09 152.22 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.257 0.551 . . . . 0.0 111.311 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.414 ' N ' ' CG2' ' A' ' 246' ' ' VAL . 40.7 mt -72.35 152.15 92.1 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.077 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.73 177.15 2.43 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.619 2.213 . . . . 0.0 112.258 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 57.5 p -115.57 152.76 32.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -100.37 116.48 32.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.76 25.97 15.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.038 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 93.64 -21.09 43.04 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.695 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -87.74 142.18 32.38 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.685 0.278 . . . . 0.0 110.901 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.8 163.26 33.87 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.578 2.185 . . . . 0.0 112.339 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.4 p -88.18 179.52 6.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.892 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.409 ' N ' ' HD3' ' A' ' 257' ' ' PRO . 5.5 mtmm -136.55 62.86 44.92 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.939 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.409 ' HD3' ' N ' ' A' ' 256' ' ' LYS . 32.3 Cg_exo -57.94 -173.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.537 2.158 . . . . 0.0 112.242 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.5 ' CE2' ' CD1' ' A' ' 155' ' ' TYR . 43.4 m-85 -103.91 126.22 50.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.729 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.2 t -108.63 138.53 35.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.378 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -119.78 156.3 15.89 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.258 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 10.9 p -139.65 152.2 22.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.819 0.342 . . . . 0.0 111.238 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 20.3 tp -105.25 110.28 22.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.74 155.95 40.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.933 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -100.85 133.46 45.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.113 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -101.38 161.74 18.05 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.489 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 31.5 mt -135.14 152.0 31.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.822 0.344 . . . . 0.0 111.146 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -91.47 149.27 21.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.952 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.98 -28.38 68.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.189 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -55.82 -30.0 60.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.268 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 5.9 t 59.09 62.5 4.11 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.55 -32.84 14.6 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.583 2.188 . . . . 0.0 112.297 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -162.33 46.86 0.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 34.0 mttt -59.62 -31.83 69.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -60.15 -54.97 39.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.897 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 77.8 mt -75.24 -31.06 60.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -59.87 -45.86 91.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.34 -51.26 70.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.906 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -61.81 -45.39 94.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -66.09 -37.85 86.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.972 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 55.3 mt -81.33 -21.01 39.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.376 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -93.52 -43.32 8.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.796 0.331 . . . . 0.0 111.334 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -92.08 -48.92 6.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.211 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -96.96 38.56 1.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.166 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.96 38.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.888 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -177.77 37.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.825 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 38.3 p -140.79 167.28 22.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.921 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -64.91 -30.43 71.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.969 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -76.24 -30.64 57.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.981 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -90.71 -50.76 2.83 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.588 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 3.5 mt -59.28 -41.1 88.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.991 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -62.37 -37.06 84.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.959 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.41 -47.57 83.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.043 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 25.3 t -72.94 -30.92 33.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.027 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -71.81 -31.25 66.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 9.9 mtmt -63.41 -34.84 78.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.99 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -99.53 -34.74 10.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.078 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.4 tptt -148.43 91.33 4.76 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.98 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.5 108.54 2.24 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.495 2.13 . . . . 0.0 112.296 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 4.9 mt -59.53 -28.4 67.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.013 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 107.37 -125.83 8.15 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.461 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.83 94.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.846 0.355 . . . . 0.0 111.039 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 30.1 m -67.65 158.08 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.184 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -87.94 -26.45 22.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.141 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 10.0 tp -55.97 127.63 31.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.963 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -67.31 -29.49 69.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.048 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.26 -26.09 36.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.226 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.54 -22.98 16.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.396 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.38 -33.4 69.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.859 0.362 . . . . 0.0 110.948 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -75.48 -53.49 8.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.907 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -49.66 -34.13 17.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.767 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 12.4 mt -85.8 -26.46 25.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.641 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -71.56 -14.12 61.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.433 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -48.0 -34.1 8.85 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.965 0.412 . . . . 0.0 110.83 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.52 138.1 21.34 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.381 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.3 -23.56 38.23 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.407 2.071 . . . . 0.0 112.432 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.05 -41.58 59.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.961 0.41 . . . . 0.0 110.34 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 33.8 mm -85.57 -33.65 7.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.952 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.67 -30.08 68.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.223 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -73.64 -51.71 15.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.178 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 8.8 t -58.94 -30.73 68.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.995 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.442 ' CE ' ' CZ ' ' A' ' 90' ' ' TYR . 4.9 ttt -85.47 -31.03 23.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.983 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -59.27 -46.96 87.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.912 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -66.05 -31.52 72.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -72.06 -49.21 38.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.088 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -59.97 -35.64 75.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.919 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -96.27 21.07 9.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.085 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -133.3 -179.11 16.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.514 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.09 137.2 42.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.819 0.343 . . . . 0.0 110.929 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 12.2 mt -80.29 144.28 10.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.055 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 15.1 ttm -57.21 113.32 5.95 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.941 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.83 -172.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.459 2.106 . . . . 0.0 112.315 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -152.76 38.6 0.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.923 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 10.2 pt -107.2 155.75 38.8 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.129 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.34 -27.75 47.42 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.535 2.157 . . . . 0.0 112.336 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -59.44 -22.59 61.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.091 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 9.5 mtp -54.63 -28.3 45.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.127 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.1 m -56.91 -53.96 52.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.014 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -59.66 -30.29 68.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.041 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.441 ' CE1' ' CG2' ' A' ' 343' ' ' VAL . 51.6 t80 -58.95 -34.11 71.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.885 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . 0.497 ' CH2' ' CE1' ' A' ' 155' ' ' TYR . 97.3 m95 -76.24 -21.86 55.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.175 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -84.83 -34.74 22.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.419 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -87.05 -57.95 2.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.85 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.441 ' CG2' ' CE1' ' A' ' 339' ' ' PHE . 47.3 t -48.98 -56.55 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.804 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -52.89 -29.98 31.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.394 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 10.7 m -84.1 -55.71 4.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.113 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -51.44 -26.47 8.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.615 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 31.3 t -82.75 -55.32 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.234 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 59.4 mt -64.94 -41.85 93.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.335 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -57.59 -39.29 76.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.001 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -86.32 -30.55 22.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.108 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -76.18 -29.03 57.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.233 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 72.7 m -95.6 20.74 9.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.175 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 56.04 25.39 46.12 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.644 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.82 -31.55 20.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.87 0.366 . . . . 0.0 110.869 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -144.71 -168.82 3.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.859 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 19.3 p -121.52 160.4 24.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 30.2 t -58.06 -56.31 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.063 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.49 -29.71 1.88 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.185 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -84.25 -42.75 15.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -60.3 -59.72 4.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.736 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.429 ' CD2' HG13 ' A' ' 183' ' ' VAL . 3.3 mt -58.39 -26.77 63.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.03 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 30.9 tttt -80.89 -59.18 2.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.782 0.325 . . . . 0.0 110.965 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -61.16 -44.76 96.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.83 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -52.49 -37.8 58.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.253 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -59.42 -43.36 93.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 69.3 m -63.57 -39.92 95.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.984 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 31.9 mtt180 -67.06 -42.51 84.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.991 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 19.0 mt -75.45 -31.37 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.174 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 63.6 p -81.91 -31.42 31.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.877 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 3.5 mtpp . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.889 -179.963 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.821 0.343 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.7 t -150.52 91.23 1.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -133.81 87.63 2.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.921 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -133.42 20.2 3.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.188 0.518 . . . . 0.0 111.207 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.52 34.61 49.44 Favored Glycine 0 C--N 1.317 -0.503 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.509 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.78 -177.23 4.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.832 0.349 . . . . 0.0 110.931 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.3 mt -133.51 118.2 18.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.94 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.49 147.0 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.193 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.4 mt -132.59 107.44 12.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.947 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.416 ' CZ3' ' HG3' ' A' ' 57' ' ' PRO . 19.7 m0 -92.95 106.65 18.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.873 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.8 tt -137.97 158.98 33.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.046 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -54.84 174.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.049 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.22 -23.99 49.53 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.68 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -137.6 81.42 1.86 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.849 0.357 . . . . 0.0 110.961 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.81 36.71 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.811 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.58 43.37 4.88 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.504 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -85.22 -31.33 23.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 0.0 110.904 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -32.58 70.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.923 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.83 -38.69 15.39 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.501 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.48 -30.65 70.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.808 0.337 . . . . 0.0 110.896 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.36 -42.98 99.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -68.2 -44.18 76.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.03 -33.46 58.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.213 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.11 -27.86 73.56 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.558 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -83.21 -27.74 29.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.759 0.314 . . . . 0.0 111.011 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -45.5 89.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.947 0.403 . . . . 0.0 110.956 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.421 ' CD2' ' HB ' ' A' ' 33' ' ' ILE . 10.4 t80 -61.51 -38.87 88.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.016 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.409 ' O ' ' HA2' ' A' ' 32' ' ' GLY . 28.3 mt-10 -60.75 -32.57 71.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.877 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.4 tttm -82.67 -24.36 33.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.918 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -90.8 -26.14 19.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.68 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.1 p -137.29 -44.28 0.56 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 28' ' ' GLU . . . 121.23 -17.82 9.01 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.687 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.421 ' HB ' ' CD2' ' A' ' 27' ' ' PHE . 37.3 mm -59.94 105.43 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.872 0.368 . . . . 0.0 110.96 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -58.67 141.89 51.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.95 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.6 130.12 74.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.117 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.0 m -121.94 150.61 41.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.5 t -133.73 116.55 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.156 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -104.37 161.94 13.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.49 70.29 32.17 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.951 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.16 168.55 24.48 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.56 2.173 . . . . 0.0 112.215 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -89.94 140.13 29.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.935 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.424 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 12.8 mmtt 74.91 -57.2 0.61 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.98 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 42' ' ' LYS . 0.4 OUTLIER 51.17 18.41 0.58 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.051 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.22 -57.03 3.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.796 0.331 . . . . 0.0 110.949 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -83.17 -6.84 59.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.45 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.54 -20.08 65.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.325 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.494 ' CB ' ' HD3' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -87.21 -58.43 0.29 Allowed Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.189 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.494 ' HD3' ' CB ' ' A' ' 47' ' ' PHE . 52.0 Cg_exo -55.24 -30.71 73.05 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.33 2.02 . . . . 0.0 112.412 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.447 ' CG ' ' N ' ' A' ' 50' ' ' VAL . 5.9 pt20 -60.08 -48.99 79.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.984 0.421 . . . . 0.0 111.084 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.447 ' N ' ' CG ' ' A' ' 49' ' ' GLN . 5.5 m -93.18 17.63 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.762 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.06 -35.63 14.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.826 0.346 . . . . 0.0 111.164 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.21 -26.66 26.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.213 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t -59.96 -27.54 66.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.005 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.75 36.29 5.35 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.492 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.53 -78.2 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.894 0.378 . . . . 0.0 110.863 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.41 173.74 26.91 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.475 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.428 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 44.4 Cg_endo -68.49 -167.55 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.542 2.161 . . . . 0.0 112.242 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.75 -45.72 3.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.027 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.3 mt -149.39 159.06 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.29 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.478 ' CG1' ' N ' ' A' ' 61' ' ' PHE . 2.4 tt -159.02 159.47 2.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.866 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.478 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 4.1 m-85 -128.59 137.96 51.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.914 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.412 ' CZ3' HD11 ' A' ' 43' ' ' LEU . 2.9 t-105 -176.03 163.31 2.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.854 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.24 140.16 53.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.11 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -57.62 -30.9 65.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.963 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.67 -42.05 98.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.958 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.06 17.27 12.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.291 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.45 -26.02 13.03 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.735 0.302 . . . . 0.0 110.992 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.29 49.61 3.75 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.54 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -120.96 -34.08 0.93 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.583 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -93.38 -23.48 18.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.715 0.293 . . . . 0.0 111.096 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.59 -24.66 56.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.121 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -56.75 -38.18 72.05 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.033 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.4 t -90.52 -23.08 21.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.016 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.23 34.57 3.13 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.487 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.2 mt -85.57 -46.11 11.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 0.0 110.847 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.2 mt -74.1 170.64 15.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.834 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.7 155.03 18.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.032 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.12 -165.02 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.845 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.423 HG23 ' CE1' ' A' ' 106' ' ' TYR . 37.6 pt -157.02 166.82 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.044 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.0 p -156.53 77.45 4.25 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.779 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.39 154.53 60.85 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.641 2.228 . . . . 0.0 112.314 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.7 175.94 8.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.793 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 28.2 mttm -59.59 -45.34 92.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.85 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.08 -30.51 69.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.01 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -73.41 -35.15 65.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -81.6 -29.86 33.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.944 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.57 -40.2 70.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.012 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -59.22 -35.2 73.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.004 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.416 HD11 ' CZ2' ' A' ' 94' ' ' TRP . 4.0 mt -90.6 148.84 22.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.865 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.433 ' CB ' ' CE2' ' A' ' 92' ' ' PHE . 83.2 m-85 -78.42 144.61 66.32 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.966 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -49.35 -55.71 3.87 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.695 2.263 . . . . 0.0 112.844 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 93' ' ' THR . 21.7 p90 -49.33 -37.28 23.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.436 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.446 ' N ' ' CD1' ' A' ' 92' ' ' PHE . 0.3 OUTLIER -59.71 -42.22 92.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.896 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.416 ' CZ2' HD11 ' A' ' 89' ' ' LEU . 61.4 m95 -69.65 -34.81 74.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.905 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.98 -25.82 67.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.007 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.67 -33.9 62.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.16 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.6 m -103.52 64.2 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.198 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -156.01 123.64 5.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.32 -52.95 6.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.81 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -143.38 48.69 1.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.73 -25.34 25.42 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.597 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -91.24 135.12 34.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.366 . . . . 0.0 110.95 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 78.7 mt -88.71 150.46 22.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.83 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.8 pp -157.14 34.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.193 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.54 174.23 14.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.11 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.423 ' CE1' HG23 ' A' ' 79' ' ' ILE . 72.3 m-85 -133.42 82.24 52.85 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.807 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.65 119.39 4.64 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.625 2.216 . . . . 0.0 112.392 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.5 mt -101.69 -66.56 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.146 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -108.58 148.94 29.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.096 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.77 125.26 66.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.141 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.67 148.9 24.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.908 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -169.94 153.77 4.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.049 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.2 mt -65.22 164.98 12.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.1 178.91 8.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.3 tp -137.62 114.22 10.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.939 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.1 mt -106.97 150.1 9.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.067 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.403 ' CE2' ' O ' ' A' ' 243' ' ' GLY . 45.1 p90 -148.55 165.45 31.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.955 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -91.58 121.26 33.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.59 -17.42 61.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.171 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.24 -50.84 68.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.76 0.314 . . . . 0.0 111.132 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.89 -31.06 7.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.086 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.5 tp -104.39 89.35 2.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.964 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.13 -46.94 1.93 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.563 2.175 . . . . 0.0 112.295 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -119.24 128.92 25.67 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.826 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.58 147.76 28.62 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.424 2.083 . . . . 0.0 112.38 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.33 120.47 5.98 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.546 2.164 . . . . 0.0 112.335 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.96 20.57 8.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.1 p -136.5 141.96 43.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.93 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.419 ' CE3' HD13 ' A' ' 132' ' ' ILE . 12.6 m95 -81.68 -29.27 33.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -74.87 -15.84 60.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.378 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.79 -14.84 33.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.531 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.479 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 25.4 mt -65.88 -46.3 65.14 Favored Pre-proline 0 C--N 1.331 -0.214 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 50.9 Cg_exo -53.95 -49.98 15.27 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.293 1.995 . . . . 0.0 112.304 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.0 -35.28 76.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.134 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.3 mt -63.97 -46.05 86.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.96 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -52.08 -29.56 22.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.983 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -85.53 -27.76 25.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.044 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -85.05 -31.64 23.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.087 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.0 mt -83.87 -17.25 41.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.375 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -76.66 -29.11 56.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.808 0.337 . . . . 0.0 110.607 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.4 -37.35 85.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.892 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -80.57 -27.02 37.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.973 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 117.48 33.92 1.26 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.579 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.71 172.56 13.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.826 0.346 . . . . 0.0 110.882 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.3 t -107.37 172.68 6.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.926 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -73.19 -78.18 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.111 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.2 tp -137.86 115.98 11.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.922 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.55 158.2 21.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.229 0.538 . . . . 0.0 111.539 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.422 ' CE1' ' HE2' ' A' ' 204' ' ' MET . 38.1 p90 178.35 144.06 0.12 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.876 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -59.38 121.2 10.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.065 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.2 mt -107.32 32.94 4.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.891 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -95.61 -69.82 0.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.97 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -77.27 149.36 79.03 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.002 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.16 -9.0 22.91 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.652 2.235 . . . . 0.0 112.618 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 258' ' ' PHE . 5.2 t80 -59.67 -26.51 65.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.746 0.308 . . . . 0.0 111.117 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -91.17 -36.1 14.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.056 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 43.9 p -81.48 -22.22 38.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.226 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.549 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 64.9 t-105 -53.03 -54.36 45.09 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.642 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 12.7 Cg_endo -56.29 -21.02 34.46 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.233 1.955 . . . . 0.0 112.431 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.9 tp -87.67 -42.57 12.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.853 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 20.0 mt -77.9 -46.21 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.147 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -59.98 -27.85 67.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.237 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -56.65 -39.12 73.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.236 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.83 -20.14 55.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.162 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 136.02 -28.31 2.95 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.49 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -59.61 151.07 37.36 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.413 ' CG ' ' HA3' ' A' ' 182' ' ' GLY . 41.6 p90 -141.58 -176.16 4.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 110.916 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -97.75 -49.0 4.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.053 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.42 ' CE2' HD11 ' A' ' 333' ' ' ILE . 92.1 m-85 -133.22 154.77 50.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.914 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.13 134.13 40.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -101.14 110.88 22.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.657 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -162.79 146.19 11.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.867 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 61.46 30.38 18.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 64.84 13.7 57.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.009 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.96 160.08 38.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.848 0.356 . . . . 0.0 111.01 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -101.5 102.11 12.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.816 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -59.01 136.63 58.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.986 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.0 pt -93.59 -29.05 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.186 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -69.44 -16.44 63.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.296 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -102.43 150.32 23.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.783 0.325 . . . . 0.0 111.01 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.81 146.05 33.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.048 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 0.413 ' HA3' ' CG ' ' A' ' 167' ' ' TYR . . . -103.06 -18.3 15.59 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.783 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.42 HG12 ' CD2' ' A' ' 361' ' ' LEU . 21.3 t -56.65 -44.38 81.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.81 0.338 . . . . 0.0 111.25 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -84.16 57.38 4.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.906 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -120.25 -177.3 3.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.868 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -76.21 -29.61 57.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.191 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -82.26 -47.19 6.2 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.556 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.31 -29.97 64.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.82 0.343 . . . . 0.0 111.197 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -67.92 -49.28 62.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.906 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -74.22 -30.15 62.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.163 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -58.85 -53.91 42.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.557 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.43 -43.96 92.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.86 0.362 . . . . 0.0 110.997 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 61.0 m -57.39 -21.79 38.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.257 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.49 ' CZ ' ' CE1' ' A' ' 250' ' ' PHE . 14.2 t80 -68.21 -60.53 2.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.824 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.2 tp -63.11 -35.59 80.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.626 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 43.8 t -66.19 -56.81 12.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.983 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -67.63 -26.83 66.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.999 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.41 HD13 ' CZ ' ' A' ' 194' ' ' PHE . 4.9 mt -61.26 -58.42 8.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.003 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 5.6 mt -57.65 -21.24 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.439 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -84.86 -35.71 22.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.407 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -113.08 19.43 17.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.703 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.34 -17.21 3.81 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 14.1 m80 64.22 43.8 4.72 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.884 0.373 . . . . 0.0 110.671 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' MET . . . . . 0.422 ' HE2' ' CE1' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -82.89 146.68 28.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.85 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -81.99 116.77 21.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.96 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.16 -10.15 59.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.413 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.6 56.93 4.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.875 0.369 . . . . 0.0 111.008 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.0 133.08 56.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.802 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.424 ' N ' HD12 ' A' ' 212' ' ' ILE . 55.0 m-20 -154.11 176.1 12.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.029 0.442 . . . . 0.0 111.106 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.401 ' CD2' ' OE2' ' A' ' 214' ' ' GLU . 1.1 t80 -41.87 -61.64 1.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.81 -59.21 3.24 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.424 HD12 ' N ' ' A' ' 209' ' ' ASP . 0.2 OUTLIER -53.81 -34.03 24.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.507 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 209' ' ' ASP . . . -81.78 -24.14 36.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.712 0.291 . . . . 0.0 110.915 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.401 ' OE2' ' CD2' ' A' ' 210' ' ' TYR . 4.0 mt-10 -82.29 -46.08 14.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.939 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.13 -31.22 66.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.131 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.33 -35.74 78.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.023 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -82.24 -36.53 27.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -59.11 -46.77 87.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.973 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -76.41 -27.98 56.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.958 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.35 31.2 6.58 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.521 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -77.94 -71.33 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.808 0.337 . . . . 0.0 110.86 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.4 t -68.0 129.0 38.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -59.18 -36.81 75.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.14 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 9.7 ptt? -141.37 153.89 45.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 9.0 t -151.42 157.89 42.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 30.2 mt -94.97 121.82 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.109 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.84 165.44 26.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.822 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -124.39 -162.31 11.37 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.617 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.81 -10.28 26.14 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.846 2.364 . . . . 0.0 112.71 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -92.56 28.28 2.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.651 0.262 . . . . 0.0 111.386 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.05 19.18 1.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.371 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 9.6 m95 -81.2 -55.84 4.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.851 0.358 . . . . 0.0 110.919 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.7 m -57.3 -26.5 60.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.177 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -54.66 -29.27 52.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.092 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.419 HG21 ' CD1' ' A' ' 242' ' ' TYR . 3.2 mt -86.71 98.53 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.046 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -169.98 -49.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.1 t -73.35 -33.51 65.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 71.1 m -90.88 -30.26 17.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt 62.13 31.4 17.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.43 124.2 31.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.083 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -61.93 94.24 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.827 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.419 ' CD1' HG21 ' A' ' 235' ' ' ILE . 50.3 p90 -89.99 123.02 33.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.924 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.403 ' O ' ' CE2' ' A' ' 117' ' ' TYR . . . -108.99 95.32 0.9 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.469 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 27.0 t -68.95 127.96 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.815 0.34 . . . . 0.0 111.088 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.9 t -134.0 159.33 41.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.7 t -66.65 152.02 9.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.97 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.2 mp -67.63 151.19 97.39 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.944 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.14 162.98 35.92 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.543 2.162 . . . . 0.0 112.211 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 36.9 p -102.14 144.99 30.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.968 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.49 ' CE1' ' CZ ' ' A' ' 194' ' ' PHE . 26.9 t80 -129.31 132.06 47.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.06 18.44 8.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.282 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 91.21 -21.27 35.48 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.942 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.66 145.74 31.19 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.701 0.286 . . . . 0.0 110.926 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.66 164.04 34.58 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.589 2.192 . . . . 0.0 112.299 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.15 -176.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 15.7 mttp -137.0 66.61 54.91 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.7 176.19 9.21 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.561 2.174 . . . . 0.0 112.324 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 155' ' ' TYR . 95.1 m-85 -95.26 166.12 12.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.99 136.4 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.293 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -131.15 121.68 3.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.349 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.67 133.64 58.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 111.233 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 12.9 tp -92.07 90.17 7.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.568 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.87 167.01 16.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.08 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -98.97 114.99 27.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.997 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -81.92 149.8 28.59 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.529 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 31.3 mt -142.41 152.0 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 0.0 111.098 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -98.93 149.93 22.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.962 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.6 -36.68 79.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.065 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -97.35 36.54 1.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.14 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.3 m -69.27 146.5 96.77 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.888 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.51 -49.32 17.76 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.524 2.149 . . . . 0.0 112.264 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -141.76 83.4 1.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.82 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? -63.08 -34.33 77.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.82 -53.94 52.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.876 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 68.7 mt -59.78 -32.52 70.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.9 -40.69 96.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -52.3 25.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.9 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -60.34 -42.35 95.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.406 ' CE2' ' HB2' ' A' ' 27' ' ' PHE . 11.9 t80 -60.26 -64.28 1.01 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.123 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.403 ' CD2' ' CD2' ' A' ' 284' ' ' LEU . 26.2 mt -57.25 -21.65 35.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.411 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -90.48 -32.93 16.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.704 0.288 . . . . 0.0 111.375 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.402 ' O ' ' CD1' ' A' ' 283' ' ' TYR . 35.2 m-80 -104.34 20.39 18.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.285 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 282' ' ' ASN . 96.1 m-85 -157.75 -66.25 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.825 0.345 . . . . 0.0 111.042 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.403 ' CD2' ' CD2' ' A' ' 280' ' ' LEU . 17.6 tp -60.84 -30.14 69.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.935 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 99.6 mt -121.89 82.28 1.93 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.964 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -160.96 170.01 21.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.835 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.2 -57.07 8.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -69.26 -42.77 75.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.049 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -57.77 -57.2 21.03 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.615 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.406 ' HB2' ' CE2' ' A' ' 307' ' ' TYR . 30.4 mt -58.59 -29.85 66.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.802 0.334 . . . . 0.0 110.976 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -60.05 -43.82 95.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.001 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -59.53 -53.67 55.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.142 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.1 t -59.65 -32.17 48.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.22 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -71.68 -31.21 66.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.944 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 49.1 mttm -65.69 -34.66 78.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.955 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.62 -35.04 11.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.5 90.71 4.55 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.889 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.91 112.61 2.75 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.548 2.165 . . . . 0.0 112.238 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 1.2 mt -97.4 25.82 5.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.003 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 58.29 -125.5 39.66 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.553 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.97 156.05 32.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.78 0.324 . . . . 0.0 111.099 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 9.6 m -128.36 24.89 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.234 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . 52.92 27.37 5.45 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.343 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.0 125.24 52.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.862 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -67.01 -31.78 72.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.01 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.8 m -81.2 -29.8 34.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.164 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.406 ' CE2' ' HB2' ' A' ' 290' ' ' LEU . 1.9 t80 -87.91 -28.24 21.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.202 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.09 -29.63 45.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.814 0.34 . . . . 0.0 111.062 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -67.79 -61.51 1.85 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -50.86 -33.7 24.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.77 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 46.9 mt -85.76 -25.83 26.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.781 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -73.39 -7.44 51.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.558 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -47.21 -30.59 3.06 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.95 0.405 . . . . 0.0 110.895 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.33 133.81 24.31 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.283 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.55 -29.04 58.27 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.421 2.081 . . . . 0.0 112.422 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -49.35 -41.76 39.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.095 0.474 . . . . 0.0 110.296 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 27.8 mt -85.6 -33.26 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.939 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -62.66 -30.83 71.67 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.11 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -79.31 -31.38 43.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.118 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.37 -35.47 80.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 45.8 mtp -81.88 -32.79 30.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.933 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.24 -31.34 70.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.943 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -67.99 -38.77 83.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -71.17 -39.89 71.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.132 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -59.85 -35.03 73.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.957 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 6.7 mmtm -117.81 21.11 13.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.033 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -114.03 142.27 17.42 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.501 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -75.61 135.57 40.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.791 0.329 . . . . 0.0 110.884 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.404 HG22 HD13 ' A' ' 329' ' ' ILE . 30.8 mt -79.19 148.96 5.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.14 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 6.6 mtp -76.51 113.49 29.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.37 152.5 15.43 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.489 2.126 . . . . 0.0 112.312 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -106.01 39.15 1.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.854 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.42 HD11 ' CE2' ' A' ' 169' ' ' PHE . 22.7 pt -108.15 148.87 38.37 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.177 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.95 -27.71 30.08 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.559 2.172 . . . . 0.0 112.339 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -59.33 -24.14 63.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.055 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 1.7 tpt -54.53 -26.8 34.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.188 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 38.3 m -58.23 -55.26 37.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.015 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -60.43 -29.61 69.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.166 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.429 ' CE1' ' CG2' ' A' ' 343' ' ' VAL . 68.7 t80 -58.98 -51.71 68.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.026 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 40.3 m95 -56.47 -23.52 39.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.356 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -79.38 -61.38 2.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.125 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -59.63 -48.32 82.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.404 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.429 ' CG2' ' CE1' ' A' ' 339' ' ' PHE . 31.7 t -58.18 -32.52 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.292 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 -68.11 -57.46 6.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.914 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 30.9 m -65.83 -28.32 68.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.137 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -60.09 -51.39 69.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.342 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 32.8 t -70.83 -47.31 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.272 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 57.8 mt -59.31 -43.29 89.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.054 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -60.36 -30.61 69.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.012 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -79.31 -52.51 8.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.34 -38.72 90.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.03 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 16.8 m -70.98 -22.35 62.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.139 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 87.5 26.79 29.18 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.589 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 30.4 mtt180 -91.27 -30.74 16.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.854 0.359 . . . . 0.0 110.915 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -146.45 -176.51 5.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.846 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 19.8 p -116.28 170.74 8.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 47.9 t -59.5 -55.29 24.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.005 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -47.42 -29.83 2.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.157 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -84.29 -41.97 16.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.965 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -60.08 -60.46 3.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.931 0.395 . . . . 0.0 110.765 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.42 ' CD2' HG12 ' A' ' 183' ' ' VAL . 3.1 mt -58.29 -27.02 63.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.978 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.94 -53.46 6.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.831 0.348 . . . . 0.0 111.007 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -59.36 -48.55 81.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.857 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.57 -36.42 73.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.994 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.78 -45.24 92.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.831 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -52.32 66.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.002 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -59.05 -48.38 81.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.998 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 10.6 mt -65.88 -28.96 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.188 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 32.6 p -83.37 -31.3 26.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.922 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.884 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 32.2 mttt . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.788 0.327 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.7 t -80.12 98.07 7.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.91 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -98.75 31.76 2.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.413 ' HB3' ' CD ' ' A' ' 6' ' ' LYS . 2.2 tt0 -92.83 -163.87 1.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.794 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -134.15 52.47 0.81 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.771 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.413 ' CD ' ' HB3' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -146.25 -174.93 4.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.793 0.33 . . . . 0.0 110.94 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 21.6 mt -130.56 123.62 29.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.5 t -91.27 142.04 13.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.156 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.5 mm -119.66 107.53 21.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.952 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.404 ' CD2' ' HG3' ' A' ' 57' ' ' PRO . 5.2 m0 -104.07 106.74 17.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.6 tt -150.84 150.52 13.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.11 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -64.36 158.91 22.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.916 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.87 57.74 3.68 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.522 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -125.86 -44.51 1.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.862 0.363 . . . . 0.0 110.912 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.75 -179.29 6.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.874 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.18 83.83 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.486 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -71.91 -35.5 69.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.809 0.338 . . . . 0.0 110.902 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -72.31 -31.18 65.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.85 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.25 -41.49 96.75 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.495 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.4 tp -67.23 -29.52 69.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.0 110.952 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.74 -42.29 79.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.101 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.67 -26.14 68.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.019 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.5 t -76.71 -25.94 16.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -81.39 -42.54 9.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.599 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -27.69 69.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.767 0.318 . . . . 0.0 110.988 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -73.9 -41.52 62.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -60.43 -57.15 14.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.931 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.32 -21.19 48.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.295 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.42 -25.81 33.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.334 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -102.48 -33.74 9.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.583 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.68 -44.15 3.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.766 0.317 . . . . 0.0 111.402 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.31 -26.4 7.04 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.528 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.7 mm -62.25 122.65 13.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.338 . . . . 0.0 111.108 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -70.71 166.77 20.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.967 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.2 t -147.45 102.57 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.087 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.8 m -98.29 144.67 27.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.5 t -114.53 110.18 31.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.113 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -97.56 176.46 5.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.789 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -159.32 70.24 3.36 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.018 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.29 144.41 46.0 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.549 2.166 . . . . 0.0 112.171 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.21 139.13 48.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.966 0.412 . . . . 0.0 111.04 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.416 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 4.4 mtmt 73.48 -58.39 0.6 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.873 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 42' ' ' LYS . 0.5 OUTLIER 49.18 18.69 0.25 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.114 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -83.29 -57.02 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -91.57 -7.4 50.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.354 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -67.75 -25.1 65.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.264 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.462 ' CB ' ' HD3' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -85.16 -57.68 0.36 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.179 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.462 ' HD3' ' CB ' ' A' ' 47' ' ' PHE . 54.0 Cg_exo -52.07 -35.8 63.2 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.416 2.077 . . . . 0.0 112.531 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.454 ' CG ' ' N ' ' A' ' 50' ' ' VAL . 11.5 pt20 -60.09 -49.64 76.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.01 0.433 . . . . 0.0 111.053 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.454 ' N ' ' CG ' ' A' ' 49' ' ' GLN . 6.2 m -96.68 27.0 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.418 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -88.55 -42.15 12.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.107 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.33 -33.65 76.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.098 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.5 t -88.12 -31.31 19.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.52 39.61 68.38 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.518 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -97.73 -29.58 13.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.98 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.52 -160.5 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.551 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.426 ' HG2' ' CZ ' ' A' ' 47' ' ' PHE . 41.4 Cg_endo -67.54 -167.79 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.549 2.166 . . . . 0.0 112.263 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -124.12 -42.48 2.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.006 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.7 mt -102.1 158.29 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.242 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.477 ' CG1' ' N ' ' A' ' 61' ' ' PHE . 2.4 tt -166.86 159.48 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.811 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.477 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 73.6 m-85 -119.85 140.58 50.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.987 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.417 ' CD1' ' HB3' ' A' ' 66' ' ' ARG . 4.9 t-105 -174.07 151.11 1.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.64 134.54 57.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.091 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -53.26 -28.37 27.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.195 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -64.55 -35.06 79.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.005 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.417 ' HB3' ' CD1' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -94.41 17.18 13.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.296 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -106.84 30.62 5.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.827 0.346 . . . . 0.0 110.907 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -122.29 35.91 3.34 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.544 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -128.43 -41.7 0.27 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.51 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -80.62 -9.03 59.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.608 0.242 . . . . 0.0 111.364 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.22 -25.98 47.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.728 0.299 . . . . 0.0 111.144 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -60.72 -51.05 71.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.948 0.404 . . . . 0.0 110.661 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.7 m -72.04 -23.1 61.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.047 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.4 31.63 9.43 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.526 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.7 mt -72.5 -37.97 68.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.785 0.326 . . . . 0.0 110.952 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.7 mt -77.35 146.28 36.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.986 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -93.08 116.39 28.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.078 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.429 ' HG2' ' N ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -60.79 155.83 18.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.833 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.429 ' N ' ' HG2' ' A' ' 78' ' ' GLU . 42.6 pt -124.68 179.19 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.131 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -159.82 77.81 2.79 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.893 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.31 163.45 34.42 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.613 2.209 . . . . 0.0 112.207 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -94.8 -179.43 4.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -59.18 -48.92 79.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.883 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.51 -31.16 72.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.104 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -74.59 -35.73 62.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.917 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.417 ' HA ' ' CZ2' ' A' ' 94' ' ' TRP . 15.5 mt-30 -79.87 -30.13 40.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.947 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -74.05 -39.26 63.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.985 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.83 -36.21 76.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.978 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.451 ' CD1' ' CZ2' ' A' ' 94' ' ' TRP . 0.4 OUTLIER -84.48 178.07 7.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.834 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.419 ' HB3' ' CE1' ' A' ' 92' ' ' PHE . 24.4 m-85 -86.79 142.38 34.4 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.039 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -54.27 -55.85 3.03 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.581 2.188 . . . . 0.0 112.657 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.452 ' CE2' ' CG2' ' A' ' 93' ' ' THR . 50.0 p90 -60.32 -46.63 89.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.429 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.452 ' CG2' ' CE2' ' A' ' 92' ' ' PHE . 70.9 p -53.21 -27.6 22.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.797 0.332 . . . . 0.0 111.233 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.451 ' CZ2' ' CD1' ' A' ' 89' ' ' LEU . 22.8 m95 -74.68 -36.44 62.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.822 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -74.56 -7.7 53.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.342 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.76 -27.9 22.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.822 0.344 . . . . 0.0 111.183 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.5 m -93.0 47.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.288 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.9 124.31 13.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -108.94 -65.2 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.844 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -98.59 30.66 3.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.808 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.92 -25.96 21.1 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.558 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -92.17 170.55 9.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.333 . . . . 0.0 110.99 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.9 mt -96.17 141.11 29.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.79 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 pp -158.08 58.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.239 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -177.33 172.25 1.89 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.229 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.443 ' CE1' ' CD1' ' A' ' 266' ' ' ILE . 26.0 m-85 -138.53 94.01 10.82 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.821 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.52 116.96 3.65 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.648 2.232 . . . . 0.0 112.381 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.0 mt -119.06 -64.39 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.118 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.7 142.84 45.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.147 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.5 t -106.86 151.88 8.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.116 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -130.94 149.14 52.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -171.72 146.36 2.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.2 mt -66.53 114.87 5.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.915 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.3 m -93.72 163.23 13.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.925 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 50.1 tp -100.72 101.54 12.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.416 HG21 ' CZ ' ' A' ' 217' ' ' PHE . 28.7 mt -86.16 119.91 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.119 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -137.84 148.9 45.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.943 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -81.42 156.75 25.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.6 mtmm -110.88 -30.25 7.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.978 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -61.17 -31.61 71.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.035 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.8 pp -111.6 -33.71 6.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.974 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.3 tp -119.25 88.98 38.83 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.995 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.26 -28.42 33.65 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.535 2.157 . . . . 0.0 112.283 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -140.26 112.58 7.31 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.836 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -78.82 167.59 22.05 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.586 2.191 . . . . 0.0 112.422 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.34 111.81 3.02 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.603 2.202 . . . . 0.0 112.322 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.45 -27.1 65.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.963 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 29.5 p -120.34 158.53 26.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.964 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.425 ' CE3' HD11 ' A' ' 132' ' ' ILE . 34.5 m95 -72.44 -30.06 64.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.967 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -72.2 -16.05 61.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.405 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -89.76 0.05 57.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.581 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.48 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 12.2 mt -85.44 -46.5 0.62 Allowed Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 73.2 Cg_exo -49.25 -28.35 14.76 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.378 2.052 . . . . 0.0 112.44 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.27 -34.61 28.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.197 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.23 -42.55 99.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.092 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.5 p30 -57.09 -22.24 38.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.216 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -85.62 -33.71 21.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.079 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -85.1 -61.74 1.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.296 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.6 mt -53.79 -24.85 16.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.545 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.87 -24.77 52.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.742 0.306 . . . . 0.0 110.959 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.12 -33.75 69.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.903 0.383 . . . . 0.0 110.97 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.08 -27.12 39.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.029 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.44 42.16 0.77 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.491 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -144.99 -177.3 5.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 0.0 110.861 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.57 147.82 40.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.868 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -68.33 -68.82 0.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.201 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.8 tp -148.79 132.92 17.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.043 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.17 179.61 5.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.712 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.42 ' HB2' ' CD2' ' A' ' 156' ' ' PHE . 50.6 p90 -178.28 -176.04 0.49 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.018 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -79.37 118.8 21.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.905 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.4 mt -98.93 29.2 3.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -112.09 -33.34 6.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.842 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -101.04 135.27 19.99 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.56 -13.36 18.3 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.532 2.155 . . . . 0.0 112.612 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.495 ' CZ ' ' CH2' ' A' ' 340' ' ' TRP . 3.0 m-85 -57.37 -32.62 66.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.12 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.42 ' CD2' ' HB2' ' A' ' 149' ' ' PHE . 1.8 m-85 -77.44 -36.72 52.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.896 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 40.1 p -81.55 -23.07 37.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.045 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.537 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 64.5 t-105 -50.9 -54.15 40.03 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.572 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 14.9 Cg_endo -57.24 -22.02 46.61 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.196 1.931 . . . . 0.0 112.3 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.4 tp -80.44 -54.48 5.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.813 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.401 HD12 ' CE3' ' A' ' 158' ' ' TRP . 12.3 pt -71.16 -34.03 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.08 -28.9 60.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.175 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -56.5 -28.87 60.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.233 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -76.16 -20.04 57.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.222 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 139.55 -26.37 2.67 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.658 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -57.0 145.32 37.64 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.565 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -134.81 -176.35 4.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.801 0.334 . . . . 0.0 110.986 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -107.58 -49.64 3.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.12 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.414 ' CE2' HD11 ' A' ' 333' ' ' ILE . 24.9 m-85 -127.83 158.73 36.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -99.44 118.58 36.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.017 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.404 ' CE1' ' O ' ' A' ' 174' ' ' GLY . 7.7 t80 -85.59 111.15 19.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.487 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.04 146.33 23.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.153 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 63.11 29.45 16.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.095 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 171' ' ' TYR . . . 90.55 -37.0 3.44 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.021 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.91 -177.24 3.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 0.0 111.067 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -98.92 -177.48 3.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.954 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -133.46 134.76 43.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.8 pt -87.12 -29.68 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.119 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -74.54 -16.33 60.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.219 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -104.96 117.35 33.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.807 0.337 . . . . 0.0 110.976 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.409 ' CG1' ' CG2' ' A' ' 183' ' ' VAL . 16.9 t -124.51 146.05 30.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.006 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -117.04 61.37 0.42 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.782 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.409 ' CG2' ' CG1' ' A' ' 181' ' ' VAL . 2.3 t -96.55 -61.58 2.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.846 0.355 . . . . 0.0 110.973 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -84.4 57.23 4.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.922 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -95.74 167.84 11.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.849 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -58.64 -31.14 67.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.178 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -85.98 -49.13 4.38 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.55 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.0 -31.59 68.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 0.0 111.182 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -60.02 -45.81 91.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.834 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -86.95 -28.2 22.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.154 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -57.81 -53.61 43.96 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.608 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -32.65 72.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.339 . . . . 0.0 110.981 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.3 m -53.67 -25.15 16.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.091 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -65.89 -59.08 4.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.786 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.0 tt -64.78 -29.78 70.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.735 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 41.2 t -69.49 -59.84 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.062 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -58.48 -29.55 66.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.051 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 12.5 mt -60.06 -47.88 84.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 22.4 mt -76.53 -28.41 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.167 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -62.06 -30.48 71.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.966 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -91.07 13.58 16.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.423 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt 56.13 44.04 25.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.956 0.407 . . . . 0.0 111.028 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.83 -28.1 12.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.904 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' MET . . . . . 0.407 ' HE2' ' CE1' ' A' ' 149' ' ' PHE . 87.7 mtp -113.69 176.74 4.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.932 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 19.8 m-20 -124.22 133.57 53.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -79.77 -38.99 31.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.094 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -59.25 -27.39 65.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.982 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 1.6 m -49.45 146.74 3.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.227 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -154.23 176.08 12.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.858 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -61.08 -29.02 69.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.257 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.13 -59.36 2.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.84 0.352 . . . . 0.0 110.986 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -28.65 44.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.309 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.74 -21.75 51.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.769 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.16 -50.2 11.36 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.835 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.76 -30.61 68.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.127 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.3 -32.98 70.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.144 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.416 ' CZ ' HG21 ' A' ' 116' ' ' ILE . 19.4 t80 -79.42 -41.1 28.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.961 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -67.12 -36.11 81.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.5 mttm -83.73 -34.0 24.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.863 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.12 59.33 0.94 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.491 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -109.27 -72.69 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.803 0.335 . . . . 0.0 110.825 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 10.6 t -74.36 169.12 18.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.924 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -81.53 -54.66 5.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.171 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -125.78 163.59 22.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.004 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 66.3 m -159.83 137.75 10.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 29.3 mt -112.98 135.22 53.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.163 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -150.47 155.78 40.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -62.47 -162.25 0.27 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.551 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.431 ' HD2' ' CZ3' ' A' ' 230' ' ' TRP . 34.5 Cg_endo -64.56 -23.09 64.48 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.649 2.233 . . . . 0.0 112.499 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.431 ' CZ3' ' HD2' ' A' ' 229' ' ' PRO . 46.6 p90 -84.5 57.31 4.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.958 0.409 . . . . 0.0 110.875 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -141.76 -44.94 0.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.18 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 20.8 m0 -54.26 -30.59 51.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.086 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.5 m -62.71 -36.58 83.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.944 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -60.39 -34.39 73.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.919 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 10.6 mt -74.96 70.4 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.03 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -153.28 -46.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.871 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 62.4 m -61.29 -44.1 97.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.84 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 2.7 t -101.58 -34.13 9.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.93 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.97 104.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.6 t -135.01 142.32 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.122 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.05 95.66 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -100.54 135.6 41.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -100.53 148.16 18.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.466 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.3 t -128.55 123.27 59.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.838 0.351 . . . . 0.0 111.119 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 10.0 t -143.45 153.78 43.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.864 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.412 ' CG2' ' N ' ' A' ' 247' ' ' LEU . 0.8 OUTLIER -54.85 152.35 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.245 0.545 . . . . 0.0 111.381 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.412 ' N ' ' CG2' ' A' ' 246' ' ' VAL . 89.9 mt -67.68 136.24 92.68 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.855 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.424 ' HB2' ' CD1' ' A' ' 129' ' ' TRP . 52.3 Cg_exo -54.58 -170.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.412 2.075 . . . . 0.0 112.279 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 1.3 p -127.89 163.04 25.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -111.05 108.24 17.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.93 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 17.1 mttt 59.44 30.72 20.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.958 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 83.1 27.03 42.06 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.541 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -122.22 141.27 34.14 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.59 0.233 . . . . 0.0 110.852 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.37 145.34 26.82 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.544 2.163 . . . . 0.0 112.42 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.22 -172.64 1.77 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.769 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.417 ' N ' ' HD3' ' A' ' 257' ' ' PRO . 12.3 mmmt -132.88 58.69 37.45 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.128 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.417 ' HD3' ' N ' ' A' ' 256' ' ' LYS . 62.3 Cg_exo -50.9 -179.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.406 2.071 . . . . 0.0 112.291 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.494 ' CE2' ' CD2' ' A' ' 155' ' ' TYR . 10.9 m-85 -110.53 134.9 51.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.826 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 23.8 t -97.17 132.13 42.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.203 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -145.57 106.13 0.37 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.307 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.21 149.53 9.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.881 0.372 . . . . 0.0 111.323 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 11.9 tp -85.75 80.88 8.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.975 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.1 m -75.81 137.44 40.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.033 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -82.04 114.98 20.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.053 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -83.38 117.82 4.51 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.565 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.443 ' CD1' ' CE1' ' A' ' 106' ' ' TYR . 29.2 mt -119.48 121.94 67.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.818 0.342 . . . . 0.0 110.998 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -79.59 148.64 31.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.953 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.51 -27.13 66.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.176 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -90.98 48.81 1.56 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.152 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 58.5 p -116.45 108.11 45.93 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.794 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.73 -24.37 47.54 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.418 2.079 . . . . 0.0 112.312 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -97.64 37.21 1.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.841 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -66.36 -41.09 89.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -59.58 -56.15 25.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.961 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 19.1 mt -60.32 -35.04 74.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.81 -50.72 40.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.075 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -44.62 95.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.873 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -63.07 -61.97 2.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -55.09 -27.18 43.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.143 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 24.8 mt -76.95 -37.83 54.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.109 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -93.62 -7.32 44.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.643 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -103.29 -35.8 8.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.653 0.263 . . . . 0.0 111.367 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -116.96 -35.77 4.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.406 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.5 tp -95.21 41.1 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.799 0.333 . . . . 0.0 111.134 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 2.7 mt -177.18 37.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.878 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.2 p -142.91 164.49 29.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -72.28 -30.21 64.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -79.45 -30.49 42.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.004 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -89.63 -50.92 3.01 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.589 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 87.2 mt -59.68 -31.0 69.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.363 . . . . 0.0 111.021 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -69.64 -31.21 69.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.46 -30.73 67.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.164 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.12 -30.02 9.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.39 -30.71 71.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.959 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -68.99 -33.62 73.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.027 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.55 -36.69 12.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.015 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -169.2 100.3 0.49 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.922 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.28 115.12 3.69 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.428 2.085 . . . . 0.0 112.32 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.9 -24.63 53.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.026 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 109.76 -32.66 6.58 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.573 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -157.36 176.83 12.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 0.0 111.126 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 5.8 m -152.92 156.08 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.089 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -84.42 -30.32 25.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.135 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 14.0 tp -59.67 123.97 18.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.908 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -72.66 -24.14 60.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.12 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.6 m -81.27 -24.13 37.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.179 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.414 ' CE2' HD13 ' A' ' 311' ' ' LEU . 26.3 t80 -95.33 -31.97 13.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.306 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -57.23 -29.72 63.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.343 . . . . 0.0 110.948 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -64.27 -59.87 3.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -50.89 -33.26 23.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.827 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.414 HD13 ' CE2' ' A' ' 307' ' ' TYR . 7.8 mt -85.76 -24.99 26.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.798 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -67.13 -13.82 62.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.494 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -47.48 -32.16 4.91 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.972 0.415 . . . . 0.0 110.941 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -112.69 140.65 24.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.37 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.76 -26.99 59.59 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.425 2.083 . . . . 0.0 112.341 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -50.51 -41.24 53.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.079 0.466 . . . . 0.0 110.313 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 32.2 mm -85.58 -32.0 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.957 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -69.39 -30.69 68.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.171 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -74.42 -46.18 41.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.204 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 63.4 m -59.7 -31.35 69.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.925 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.91 -41.82 25.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.946 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -60.0 -47.06 87.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.958 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -60.14 -54.27 47.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.966 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.79 -50.55 73.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.148 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -59.71 -33.29 71.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -96.59 21.15 9.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.123 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -128.18 161.88 21.97 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.521 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.58 156.24 27.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.804 0.335 . . . . 0.0 110.873 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 25.3 mt -88.02 138.39 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.141 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.417 ' HG2' ' CD1' ' A' ' 258' ' ' PHE . 12.8 mtm -60.35 140.27 91.74 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.41 138.79 20.1 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.549 2.166 . . . . 0.0 112.333 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -101.87 30.98 4.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.414 HD11 ' CE2' ' A' ' 169' ' ' PHE . 9.4 pt -107.2 148.52 37.23 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.108 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.56 -24.47 18.77 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.584 2.19 . . . . 0.0 112.446 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.15 -26.34 38.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.184 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 17.3 ptm -57.31 -22.27 40.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.215 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 67.1 m -50.24 -48.8 54.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.175 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.52 -28.02 60.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.15 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.414 ' CZ ' HG23 ' A' ' 343' ' ' VAL . 78.0 t80 -58.25 -29.1 65.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.009 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . 0.495 ' CH2' ' CZ ' ' A' ' 155' ' ' TYR . 94.2 m95 -60.28 -61.06 2.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.034 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.86 -30.72 71.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.091 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -62.04 -56.28 20.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.339 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.414 HG23 ' CZ ' ' A' ' 339' ' ' PHE . 21.4 t -78.62 -33.76 17.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.417 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -57.16 -57.45 12.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.15 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 21.0 m -66.71 -29.53 69.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.01 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -59.78 -56.84 16.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.24 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.05 -40.57 81.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.284 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 26.2 mt -68.22 -41.6 84.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.064 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -59.58 -30.2 68.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.967 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -91.1 -34.84 14.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.236 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -76.52 -33.33 58.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.228 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 5.6 t -66.27 -22.42 66.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.118 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 80.0 61.7 2.22 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.539 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 18.9 mtt-85 -140.29 -79.33 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.83 0.348 . . . . 0.0 110.836 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -77.55 177.55 7.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.758 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 65.8 p -106.57 145.13 32.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.776 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 40.3 t -51.44 -40.14 23.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.108 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -50.73 -38.51 47.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.62 -30.65 29.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -65.96 -58.17 6.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.062 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.401 ' CD2' HG13 ' A' ' 183' ' ' VAL . 12.1 mt -60.04 -25.29 65.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.037 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -72.83 -51.07 20.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.834 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -57.76 -48.46 79.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.85 -39.19 80.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.073 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -58.86 -33.99 71.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.963 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 90.0 m -87.11 -40.36 14.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.925 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -59.07 -44.87 91.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 17.1 mt -69.45 -30.4 45.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.175 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 76.2 p -82.97 -29.64 28.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.942 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 26.3 tttm . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.918 179.998 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 22.2 tttt . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.826 0.346 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.3 t -102.17 125.78 48.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.894 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -105.21 99.45 9.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 58.87 162.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.967 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.59 -58.4 0.53 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.506 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -142.14 174.6 10.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.815 0.34 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 33.7 mt -128.69 133.8 48.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.7 t -109.6 147.05 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.115 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 28.7 mm -120.49 107.51 20.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.968 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.43 ' CG ' ' HG3' ' A' ' 57' ' ' PRO . 0.5 OUTLIER -93.41 106.77 18.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.3 tt -163.15 123.02 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.006 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -142.53 162.68 34.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.928 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 109.57 58.81 0.52 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.984 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.6 t70 59.48 28.9 18.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.96 0.409 . . . . 0.0 110.556 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -83.16 173.56 11.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.8 54.67 4.62 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.527 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -72.62 -31.05 64.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.827 0.346 . . . . 0.0 110.909 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -74.53 -32.3 62.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.39 -37.85 8.67 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.512 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.2 tp -65.77 -31.22 72.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.783 0.325 . . . . 0.0 110.92 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.92 -31.02 70.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.128 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -66.59 -36.65 83.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 25.4 t -65.38 -31.39 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.074 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.97 -27.63 73.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.512 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.3 mmtt -59.24 -30.55 68.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.776 0.322 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.3 -40.48 58.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.881 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.419 ' CE1' HG22 ' A' ' 31' ' ' THR . 38.5 t80 -57.98 -52.89 63.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.017 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -68.94 -23.91 64.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.174 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -78.84 -25.83 44.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.22 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -103.89 -36.98 7.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.41 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.419 HG22 ' CE1' ' A' ' 27' ' ' PHE . 8.9 p -99.98 -44.11 6.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.225 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.06 -27.09 8.38 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.45 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.413 ' HB ' ' CE2' ' A' ' 27' ' ' PHE . 35.8 mm -64.32 118.83 7.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.779 0.323 . . . . 0.0 111.091 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -59.71 152.37 22.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.914 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.29 108.78 12.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.045 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.5 m -115.36 144.67 43.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.6 t -118.98 119.07 59.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.052 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -100.85 151.4 21.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -117.21 73.41 7.1 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.973 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.95 -179.99 5.51 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.646 2.231 . . . . 0.0 112.359 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -60.3 -158.88 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.416 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.424 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -47.13 -27.39 1.4 Allowed 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.598 0.237 . . . . 0.0 111.485 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 42' ' ' LYS . 0.3 OUTLIER 52.45 17.95 0.86 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.979 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -83.19 -57.04 3.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 0.0 110.972 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -92.77 -5.62 50.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.44 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.1 -18.94 29.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.557 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.524 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 13.3 t80 -83.37 -47.92 0.77 Allowed Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 116.762 -0.199 . . . . 0.0 111.49 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 41.9 Cg_exo -57.11 -38.23 96.14 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.336 2.024 . . . . 0.0 112.327 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.441 ' CG ' ' N ' ' A' ' 50' ' ' VAL . 4.6 pt20 -60.9 -47.31 86.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.044 0.45 . . . . 0.0 110.923 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.441 ' N ' ' CG ' ' A' ' 49' ' ' GLN . 20.3 m -76.99 -27.95 16.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.229 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.7 -26.78 57.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.39 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.76 -35.73 71.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.237 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.0 t -110.8 -29.65 7.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.031 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.39 35.53 6.56 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.536 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.27 -27.45 20.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.785 0.326 . . . . 0.0 111.029 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.73 -156.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.544 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.43 ' HG3' ' CG ' ' A' ' 10' ' ' TRP . 46.0 Cg_endo -68.06 -167.84 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.623 2.215 . . . . 0.0 112.301 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -109.45 -31.27 7.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.2 mt -136.81 129.03 44.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.135 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.47 ' CG1' ' N ' ' A' ' 61' ' ' PHE . 2.3 tt -114.88 159.07 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.093 0.473 . . . . 0.0 111.018 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.47 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 6.2 m-85 -130.56 113.14 13.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.784 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.3 t-105 -152.71 173.73 14.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.959 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.45 139.27 58.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -58.0 -33.69 69.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.038 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -59.67 -39.39 84.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.981 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -94.14 17.18 13.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.273 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.43 -4.71 37.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.416 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -94.82 26.4 18.74 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.56 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -124.5 4.42 8.74 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.84 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.411 ' CE1' ' HG3' ' A' ' 48' ' ' PRO . 4.7 m-85 -112.59 -32.32 6.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.845 0.355 . . . . 0.0 110.998 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.51 -26.07 50.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.09 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -32.82 70.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.963 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.57 24.95 6.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.079 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 54.84 40.48 72.3 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.756 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.0 mt -100.32 -48.19 4.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.808 0.337 . . . . 0.0 110.934 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 20.5 mt -73.35 142.0 47.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.987 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.6 169.77 10.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.095 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.35 -164.9 1.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.942 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.419 HG23 ' CE1' ' A' ' 106' ' ' TYR . 35.8 pt -157.02 168.82 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.089 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 48.9 p -156.65 77.49 4.17 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.831 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.77 154.59 63.67 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.603 2.202 . . . . 0.0 112.315 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -78.08 164.77 24.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.813 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -59.74 -38.48 81.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.815 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.94 -44.39 85.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.005 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.415 ' CE1' ' HG2' ' A' ' 281' ' ' GLU . 31.4 t80 -66.44 -37.37 85.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -69.07 -30.48 68.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.51 -28.32 62.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.969 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.66 43.19 1.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.024 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.418 HD13 ' CZ2' ' A' ' 94' ' ' TRP . 8.1 mt -151.93 139.04 19.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.876 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.438 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . 12.9 m-85 -73.31 129.77 85.39 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -49.06 -55.54 4.05 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.657 2.238 . . . . 0.0 112.996 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.455 ' CE1' ' CG2' ' A' ' 93' ' ' THR . 10.7 p90 -49.78 -25.13 2.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.077 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.455 ' CG2' ' CE1' ' A' ' 92' ' ' PHE . 10.4 p -74.73 -30.57 61.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.819 0.342 . . . . 0.0 110.804 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.419 ' CZ3' HD11 ' A' ' 103' ' ' LEU . 12.2 m95 -73.1 -39.48 65.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.922 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -62.09 -27.34 68.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.999 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.98 -25.67 67.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.332 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.6 m -121.09 72.81 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.911 0.386 . . . . 0.0 111.266 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -156.06 144.2 19.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.874 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -106.09 -64.53 1.15 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -123.8 41.76 3.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.824 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.84 25.58 29.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.522 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.99 145.35 49.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.765 0.317 . . . . 0.0 110.896 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.419 HD11 ' CZ3' ' A' ' 94' ' ' TRP . 13.4 mt -87.93 140.41 29.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.939 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.0 pt -144.86 29.87 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.227 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -166.68 -177.11 3.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.153 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.419 ' CE1' HG23 ' A' ' 79' ' ' ILE . 5.9 m-85 -135.31 85.97 31.47 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.89 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.32 97.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.584 2.19 . . . . 0.0 112.321 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.431 HD11 HG22 ' A' ' 108' ' ' ILE . 24.7 mm -75.31 -66.16 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.204 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -112.74 164.41 13.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.181 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.3 t -130.51 106.96 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.07 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -91.44 163.55 14.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.933 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -163.02 144.3 9.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.061 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.8 mt -62.05 145.22 53.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.1 p -140.35 -177.19 4.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.942 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 35.2 tp -122.48 129.38 51.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.871 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.1 mp -110.51 125.83 67.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.064 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.42 ' CG ' ' HB3' ' A' ' 125' ' ' PRO . 28.2 p90 -125.72 160.42 29.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -92.38 -176.36 4.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.886 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.9 mttm -125.13 -45.31 1.86 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.869 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.16 -31.65 72.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 70.6 mt -98.98 -31.06 12.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.957 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 9.9 tp -132.53 108.0 13.23 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.853 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.63 -45.84 3.1 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.377 2.051 . . . . 0.0 112.263 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -128.17 128.95 23.68 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.83 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.42 ' HB3' ' CG ' ' A' ' 117' ' ' TYR . 66.8 Cg_endo -74.11 144.18 33.36 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.448 2.099 . . . . 0.0 112.416 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.54 123.07 7.33 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.52 2.147 . . . . 0.0 112.315 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.0 mmtp -93.42 17.87 10.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.105 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.41 149.93 51.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.846 0.355 . . . . 0.0 110.795 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.421 ' CD1' ' HG2' ' A' ' 248' ' ' PRO . 3.7 m95 -78.52 -22.47 47.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.111 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.26 -18.4 36.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.362 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.54 -30.68 52.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.8 0.334 . . . . 0.0 111.113 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.54 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 24.5 mt -63.68 -54.79 39.41 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.673 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 12.2 Cg_endo -55.98 -30.63 78.8 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.205 1.937 . . . . 0.0 112.084 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.2 -29.16 57.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.808 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.9 mt -72.74 -33.14 66.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.762 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.69 -22.9 38.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.202 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -85.35 -32.31 22.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.026 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -85.09 -48.44 9.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.138 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.2 mt -63.33 -17.45 62.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.403 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.42 -29.9 42.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.845 0.355 . . . . 0.0 110.814 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.34 -34.39 78.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.91 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -75.9 -27.09 57.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.97 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 113.11 40.21 1.08 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.48 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.66 -175.97 5.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.787 0.327 . . . . 0.0 110.862 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.9 t -115.34 159.12 21.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -84.57 -66.08 0.94 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.128 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.0 tp -154.02 141.62 19.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.939 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.46 -177.86 4.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.409 ' CE1' HD11 ' A' ' 195' ' ' LEU . 8.2 p90 -177.22 175.0 1.57 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.867 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -69.0 111.17 4.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.851 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.6 mt -98.0 27.02 4.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.057 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -119.83 -40.0 2.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.822 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -99.37 146.42 31.73 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.813 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.08 9.45 3.96 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.722 2.281 . . . . 0.0 113.028 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -75.41 -32.3 60.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.739 0.304 . . . . 0.0 111.13 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -94.98 -16.58 22.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.437 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 30.8 p -92.42 -24.41 18.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.69 0.281 . . . . 0.0 111.28 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.489 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 27.3 t-105 -53.4 -45.78 98.33 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.526 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 52.6 Cg_exo -52.67 -25.61 26.85 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.334 2.022 . . . . 0.0 112.28 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.409 HD11 ' CD1' ' A' ' 250' ' ' PHE . 4.8 tp -92.56 -42.96 9.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.933 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 21.0 mt -72.79 -54.66 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.419 ' HB1' ' CD2' ' A' ' 158' ' ' TRP . . . -60.2 -33.21 71.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.176 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.07 -33.48 74.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.142 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.28 -20.14 57.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.153 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 141.09 -26.9 2.45 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.561 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.7 158.01 53.35 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.537 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -146.8 171.26 15.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.327 . . . . 0.0 110.85 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -90.96 -67.55 0.85 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.078 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -120.83 121.14 37.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.788 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -63.69 123.99 20.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.931 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -86.36 115.28 23.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.483 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -165.04 148.38 8.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.106 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 64.73 29.22 12.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.162 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.7 -37.25 3.37 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.087 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.73 -173.35 2.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.886 0.374 . . . . 0.0 111.063 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -105.25 173.98 6.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.85 127.85 49.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.1 pt -79.34 -22.55 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.349 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.34 26.02 4.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.132 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -145.06 94.2 2.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.836 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.27 131.75 65.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.163 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -87.88 -9.04 71.82 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.853 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 184' ' ' ASP . 0.3 OUTLIER -48.47 -41.8 11.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.892 0.377 . . . . 0.0 111.332 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.416 ' N ' ' CG1' ' A' ' 183' ' ' VAL . 25.8 t0 -84.61 57.17 4.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.915 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -118.26 -173.75 2.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.944 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.07 -34.77 57.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.113 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.57 -43.74 84.9 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.569 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.43 -30.62 67.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.833 0.349 . . . . 0.0 111.189 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.86 -38.68 82.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.869 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -86.96 -28.51 22.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.199 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -57.47 -54.62 35.79 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.607 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.63 -53.11 61.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.829 0.347 . . . . 0.0 110.932 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 62.1 m -54.1 -24.93 19.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.121 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -70.86 -59.99 2.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.815 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.409 HD11 ' CE1' ' A' ' 149' ' ' PHE . 2.6 tp -58.73 -33.07 69.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.669 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 49.5 t -63.43 -54.52 31.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.902 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -66.06 -32.69 74.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.735 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 14.5 mt -57.11 -19.27 18.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.224 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 4.7 mt -88.99 -60.11 2.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.803 0.335 . . . . 0.0 111.565 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -85.19 -47.27 10.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.008 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -71.0 -10.0 58.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.014 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.71 -82.98 0.61 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.808 0.337 . . . . 0.0 111.189 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 171.01 16.27 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.374 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -82.96 146.12 28.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.784 0.326 . . . . 0.0 110.77 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -102.04 137.42 40.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.031 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -79.99 -25.28 40.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.259 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -55.09 -31.1 60.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.132 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 3.8 m -49.89 147.23 3.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.174 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.414 ' HB2' ' CG1' ' A' ' 212' ' ' ILE . 69.8 m-20 -154.15 176.22 12.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.015 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -41.59 -61.66 1.03 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.77 -59.26 3.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.833 0.349 . . . . 0.0 111.921 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.414 ' CG1' ' HB2' ' A' ' 209' ' ' ASP . 0.2 OUTLIER -53.88 -30.67 19.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.342 -179.357 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -81.89 -25.76 34.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.801 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -82.31 -53.0 6.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.71 -25.75 63.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.323 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.86 -32.27 65.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.239 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.401 ' CD1' HG23 ' A' ' 225' ' ' THR . 58.2 t80 -82.15 -34.0 29.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -75.46 -40.39 57.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -77.64 -31.92 53.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.928 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 103.01 72.13 0.91 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.546 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -128.39 -62.92 1.01 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.835 0.35 . . . . 0.0 110.893 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.9 t -93.5 135.88 34.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.939 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.92 -31.25 70.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.06 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -120.8 151.21 39.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.942 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.401 HG23 ' CD1' ' A' ' 217' ' ' PHE . 9.0 t -157.67 159.58 37.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 24.8 mt -120.46 130.35 74.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.174 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -160.95 165.34 30.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -105.99 -153.16 20.6 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.566 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.98 -26.19 24.38 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.629 2.22 . . . . 0.0 112.364 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 41.1 p90 -84.87 57.51 4.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.839 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -156.45 -44.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.166 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -54.88 -48.01 73.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.021 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.3 m -66.77 -31.7 72.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.01 -32.2 73.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 4.8 mt -94.13 113.66 29.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.031 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -165.46 -49.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 7.0 m -65.87 -39.98 91.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.923 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 1.9 t -69.25 -29.5 67.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.921 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt 61.82 36.55 16.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.918 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 26.8 t -79.01 108.29 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.043 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.42 92.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.924 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -97.58 160.05 14.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.23 137.86 9.43 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.445 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.28 124.15 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.784 0.326 . . . . 0.0 111.155 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.1 t -130.52 159.3 37.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.5 t -73.61 151.92 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.001 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.2 mt -74.22 149.82 87.22 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.884 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.421 ' HG2' ' CD1' ' A' ' 129' ' ' TRP . 50.9 Cg_endo -69.14 165.97 28.44 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.554 2.169 . . . . 0.0 112.341 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 4.0 p -92.33 163.64 13.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.963 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.409 ' CD1' HD11 ' A' ' 160' ' ' LEU . 8.3 t80 -128.89 111.12 12.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 8.8 mttt 60.28 28.23 17.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.023 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 93.79 -21.16 42.99 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.731 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -94.3 148.99 36.01 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.704 0.288 . . . . 0.0 110.945 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.2 154.36 66.06 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.594 2.196 . . . . 0.0 112.334 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.16 -174.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.837 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 2.0 mmtt -135.04 63.83 59.02 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.973 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -56.19 -177.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.532 2.154 . . . . 0.0 112.251 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -118.83 116.59 26.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.766 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.2 t -85.8 123.4 39.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.288 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -121.92 117.64 3.45 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.271 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.48 127.47 66.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.37 . . . . 0.0 111.318 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 29.3 tp -91.11 85.38 5.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.297 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 1.4 m -86.33 175.19 8.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.134 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -107.06 114.99 29.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.006 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -85.9 128.8 8.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.553 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 28.0 mt -115.63 135.18 56.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.361 . . . . 0.0 111.08 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -85.49 140.62 30.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -70.39 -41.57 72.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.081 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -61.85 -28.95 69.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.149 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 3.7 m -58.17 109.48 1.85 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.979 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.57 -18.2 43.06 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.467 2.112 . . . . 0.0 112.499 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -92.88 46.27 1.22 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.03 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 16.3 mtmt -84.05 -31.96 25.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -62.11 -57.44 11.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 50.1 mt -62.51 -31.53 72.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.85 -46.62 65.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.68 -29.12 64.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.012 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -73.7 -52.96 11.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.043 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.412 ' CD1' ' HB2' ' A' ' 283' ' ' TYR . 79.1 t80 -59.93 -28.21 67.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.325 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 5.1 mt -80.31 -30.7 38.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.182 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.415 ' HG2' ' CE1' ' A' ' 85' ' ' PHE . 7.3 tt0 -93.65 -24.46 17.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.449 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -97.51 -50.16 4.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.445 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.423 ' N ' ' CD1' ' A' ' 283' ' ' TYR . 4.4 m-85 -117.47 71.41 0.81 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.37 . . . . 0.0 111.296 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 5.6 tp -178.54 -39.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.91 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.404 HD21 ' CZ ' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -115.26 38.35 3.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.869 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.19 -176.38 2.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -80.87 -38.7 27.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -82.68 -36.28 26.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -65.67 -44.19 92.96 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.519 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 9.2 mt -70.14 -31.08 68.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 0.0 110.915 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -70.33 -36.96 74.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.994 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -59.27 -38.22 79.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.131 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.56 -29.45 20.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.111 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -74.06 -30.92 62.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.983 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 33.1 mttt -65.87 -35.41 80.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.959 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -99.0 -30.96 12.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.969 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -152.97 95.18 3.02 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.931 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -62.29 119.52 6.66 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.513 2.142 . . . . 0.0 112.248 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.72 22.01 8.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.963 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 58.37 -133.96 52.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.664 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -58.71 174.68 0.31 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.816 0.341 . . . . 0.0 111.223 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 14.2 m -143.18 -179.7 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.07 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -93.86 -29.55 15.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.146 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.5 tp -58.89 152.27 19.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.916 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -77.01 -61.19 2.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.019 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 7.2 p -57.17 -49.79 74.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.079 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.81 -25.04 60.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.027 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.46 -31.78 71.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.736 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -83.83 -42.1 16.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.865 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -52.44 -33.22 43.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.774 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 83.7 mt -85.74 -21.37 28.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.919 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -76.47 -2.65 33.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.711 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 22.1 mmtt -47.26 -31.83 4.09 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 121.043 0.449 . . . . 0.0 110.856 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -117.41 140.22 27.08 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.309 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.46 -32.4 94.01 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.349 2.033 . . . . 0.0 112.416 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 11.2 mtm-85 -48.58 -42.57 34.14 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.116 0.484 . . . . 0.0 110.243 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.454 HD12 HG23 ' A' ' 317' ' ' ILE . 34.4 mt -85.56 -30.78 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.791 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.66 -33.92 77.07 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.125 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -74.97 -31.46 61.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.152 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 7.1 m -64.05 -48.48 76.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 10.8 tpt -60.96 -31.62 71.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -61.11 -43.77 98.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -62.35 -41.91 98.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.03 -55.0 39.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.082 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -60.1 -30.03 68.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.931 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -95.84 21.08 8.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.145 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -131.38 -179.6 16.28 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.486 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.1 133.77 52.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.825 0.345 . . . . 0.0 110.906 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 22.9 mt -81.53 133.53 29.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.107 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 10.7 mtm -62.41 137.42 96.15 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.92 -172.38 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.522 2.148 . . . . 0.0 112.326 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -110.05 -26.07 9.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.027 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 33.5 pt -56.25 147.99 44.31 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.319 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.26 -8.91 22.65 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.636 2.224 . . . . 0.0 112.645 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -54.53 -26.18 30.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.741 0.305 . . . . 0.0 111.103 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.404 ' O ' ' CD1' ' A' ' 340' ' ' TRP . 0.7 OUTLIER -56.8 -30.91 64.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.934 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.5 m -60.75 -57.31 13.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.971 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.97 -30.35 71.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.133 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -59.73 -36.76 77.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.977 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . 0.404 ' CD1' ' O ' ' A' ' 336' ' ' MET . 25.8 m95 -66.28 -51.01 61.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.945 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.89 -47.84 84.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.074 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -57.22 -44.63 83.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.301 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 23.9 t -77.39 -28.55 16.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.27 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -57.43 13.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.945 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 3.7 m -60.57 -41.37 94.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -57.29 -34.92 69.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.23 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 28.7 t -82.69 -45.91 19.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.188 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 9.4 mt -61.26 -57.59 11.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.162 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -58.77 -43.66 90.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.971 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.39 -29.87 70.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.082 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -78.51 -29.45 46.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.174 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 10.6 m -95.75 20.74 9.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.18 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 56.32 27.02 52.24 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.617 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 6.8 mtt-85 -89.86 -29.69 18.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.79 0.329 . . . . 0.0 110.963 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -143.86 162.27 36.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.899 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 30.6 p -97.96 156.85 16.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.844 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 25.6 t -56.88 -28.66 28.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.159 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -70.26 -56.5 6.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -61.88 -46.08 90.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.021 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -60.02 -50.37 73.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.139 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 28.0 mt -62.04 -30.18 70.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.47 -45.44 25.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.961 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -69.13 -45.59 69.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.99 -46.03 89.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -59.8 -43.25 94.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 10.0 m -64.66 -31.53 72.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.92 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 13.6 mtp85 -68.57 -35.71 77.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.943 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 19.3 mt -73.26 -28.86 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.177 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 2.2 p -82.62 -31.47 28.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.899 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.901 179.969 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.804 0.335 . . . . 0.0 111.254 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.0 t -154.27 146.66 23.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.2 165.24 12.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -82.59 154.85 24.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 113.26 -35.9 4.33 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.455 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -113.76 169.86 8.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 0.0 110.871 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.7 mt -124.24 118.78 27.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.9 147.05 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.208 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.8 mt -137.32 107.34 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.927 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -96.81 109.36 22.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.84 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.9 tt -123.52 158.14 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.029 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -60.56 166.58 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.19 43.36 2.39 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.498 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -161.18 31.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.46 177.67 7.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.94 73.49 0.27 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.52 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -86.02 -33.06 21.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 0.0 110.947 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -60.43 -33.17 72.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.96 -28.46 60.61 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.531 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.7 tp -72.66 -30.99 64.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.811 0.338 . . . . 0.0 110.932 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.52 -37.94 83.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.103 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -70.39 -32.23 69.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.413 HG13 ' CZ ' ' A' ' 279' ' ' PHE . 26.8 t -72.2 -30.72 36.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.104 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.32 -38.6 33.4 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.538 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -59.88 -29.51 68.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.817 0.341 . . . . 0.0 110.94 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -74.78 -41.19 60.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.937 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.484 ' CD2' ' CE1' ' A' ' 283' ' ' TYR . 1.5 t80 -59.75 -52.62 64.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.907 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -58.53 -43.13 89.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.902 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -71.83 -25.39 61.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.83 -32.85 40.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.371 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.53 -44.23 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.473 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.16 -23.27 2.58 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.762 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.411 ' HB ' ' CD1' ' A' ' 27' ' ' PHE . 33.1 mm -59.92 110.16 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.828 0.347 . . . . 0.0 111.037 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.6 mtmt -78.63 156.75 28.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.955 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.4 t -134.82 117.96 24.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.091 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.0 m -99.5 143.86 29.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.4 t -137.84 110.71 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.139 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -110.28 176.21 5.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.86 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -133.11 74.31 73.44 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.86 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.18 -179.13 4.07 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.64 2.227 . . . . 0.0 112.415 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -60.05 -159.43 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.53 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.464 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -46.46 -27.45 1.1 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.604 0.24 . . . . 0.0 111.53 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 42' ' ' LYS . 0.3 OUTLIER 52.44 19.68 1.23 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.852 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.73 -57.12 4.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.829 0.347 . . . . 0.0 110.655 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -95.49 -7.72 37.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.002 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.87 -19.24 57.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.256 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.444 ' CE2' ' CG ' ' A' ' 57' ' ' PRO . 0.3 OUTLIER -85.58 -55.94 0.39 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.045 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.429 ' HD3' ' CB ' ' A' ' 47' ' ' PHE . 72.6 Cg_exo -50.54 -35.63 46.79 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.589 2.193 . . . . 0.0 112.61 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.454 ' CG ' ' N ' ' A' ' 50' ' ' VAL . 11.2 pt20 -59.49 -49.68 76.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.947 0.403 . . . . 0.0 111.004 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.454 ' N ' ' CG ' ' A' ' 49' ' ' GLN . 6.6 m -95.29 18.05 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.552 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.09 -38.01 13.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.825 0.345 . . . . 0.0 111.216 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.51 -33.77 68.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.164 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.3 t -96.43 -29.53 13.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.934 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.53 28.1 72.71 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.431 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -94.5 -28.26 15.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.74 0.305 . . . . 0.0 111.01 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.97 -105.11 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.597 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.444 ' CG ' ' CE2' ' A' ' 47' ' ' PHE . 61.4 Cg_endo -73.18 -169.12 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.49 2.127 . . . . 0.0 112.407 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -150.55 -46.86 0.12 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.813 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.2 mt -127.19 133.37 68.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.058 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.477 ' CG1' ' N ' ' A' ' 61' ' ' PHE . 1.9 tt -139.49 159.69 28.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.111 0.481 . . . . 0.0 110.942 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.477 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 65.2 m-85 -138.1 122.35 18.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.873 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -158.26 169.26 24.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.882 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.13 143.87 47.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -60.49 -31.52 70.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -59.74 -36.04 75.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.902 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.3 mmt-85 -94.69 17.18 13.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.231 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -105.71 -31.14 9.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.849 0.357 . . . . 0.0 110.858 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.5 -28.14 64.53 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.555 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.34 -28.83 74.01 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.559 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -91.89 -27.91 17.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.73 0.3 . . . . 0.0 110.982 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.53 -28.03 41.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.244 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.36 -31.71 69.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.063 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.6 m -88.09 -23.17 23.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.09 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.4 27.98 10.17 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.442 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.9 mt -81.25 -34.25 32.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.77 0.319 . . . . 0.0 110.868 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.5 mt -81.86 146.55 29.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.29 135.27 33.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.068 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.443 ' HG3' ' N ' ' A' ' 79' ' ' ILE . 17.5 tp10 -69.57 159.72 32.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.09 0.472 . . . . 0.0 110.739 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.443 ' N ' ' HG3' ' A' ' 78' ' ' GLU . 35.4 pt -135.29 -178.57 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.176 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 t -163.22 78.0 1.75 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.804 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.08 123.4 11.83 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.643 2.229 . . . . 0.0 112.282 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.5 -177.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.852 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -60.09 -40.56 90.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.913 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.79 -50.5 73.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.094 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -66.28 -35.31 80.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.46 -31.14 63.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.794 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -75.64 -36.51 60.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 57.19 4.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.885 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.422 HD11 ' CZ2' ' A' ' 94' ' ' TRP . 0.1 OUTLIER -173.61 162.02 4.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.774 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.48 ' CD1' ' CZ ' ' A' ' 92' ' ' PHE . 22.0 m-85 -78.51 136.22 60.09 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.077 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -55.24 -55.72 2.91 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.526 2.15 . . . . 0.0 112.662 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.48 ' CZ ' ' CD1' ' A' ' 90' ' ' TYR . 25.0 p90 -54.87 -44.83 74.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.549 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.431 ' CG2' ' CE1' ' A' ' 92' ' ' PHE . 40.2 p -61.31 -27.6 68.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.189 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.422 ' CZ2' HD11 ' A' ' 89' ' ' LEU . 8.4 m95 -69.52 -29.29 66.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.941 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -93.66 17.32 11.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.362 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -101.89 -29.69 11.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.76 0.314 . . . . 0.0 111.214 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.0 m -90.63 -35.73 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.446 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.95 132.37 48.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.012 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.407 ' CE1' ' OD1' ' A' ' 332' ' ' ASN . 0.4 OUTLIER -82.0 -49.59 10.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.865 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -148.6 54.67 1.01 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.929 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.12 -27.27 20.01 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.645 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.51 158.9 20.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.782 0.325 . . . . 0.0 110.965 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 54.9 mt -117.5 131.03 56.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.884 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.8 pp -142.65 27.21 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.342 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.25 179.33 9.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.869 0.366 . . . . 0.0 111.173 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.404 ' CE1' HD12 ' A' ' 266' ' ' ILE . 39.2 m-85 -140.87 89.49 9.96 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.833 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.09 99.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.57 2.18 . . . . 0.0 112.269 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.443 HD11 HG21 ' A' ' 108' ' ' ILE . 25.2 mm -74.01 -66.23 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.161 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -120.8 166.36 13.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.066 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.9 p -123.22 139.07 51.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.092 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -116.74 147.93 41.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -161.85 149.62 14.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.141 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.9 mt -68.27 126.02 28.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.9 m -124.9 147.29 48.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 tp -82.94 136.0 34.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.898 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.3 mt -116.4 131.38 69.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.049 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -122.24 154.95 36.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.32 144.31 31.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.36 29.77 3.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.959 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -97.39 -61.17 1.44 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.895 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.33 -32.83 6.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.849 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.1 tp -93.39 104.16 11.62 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.821 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.83 -47.21 2.0 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.405 2.07 . . . . 0.0 112.275 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -123.38 135.44 26.04 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.822 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.09 139.11 21.21 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.529 2.152 . . . . 0.0 112.32 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.2 116.77 4.65 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.447 2.098 . . . . 0.0 112.394 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.01 23.41 6.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.03 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.5 p -134.77 141.95 46.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.865 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.422 ' CD1' ' HB2' ' A' ' 248' ' ' PRO . 2.4 m95 -79.94 -22.56 42.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.103 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.52 -24.72 53.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.181 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -81.18 -26.56 35.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.143 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.532 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 31.7 mt -57.28 -54.56 53.49 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.625 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 15.6 Cg_endo -57.47 -27.32 75.75 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.239 1.959 . . . . 0.0 112.089 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.0 -29.31 35.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.5 mt -73.92 -39.68 63.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.859 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.12 -26.35 11.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.058 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -85.58 -27.86 25.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.122 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.98 -48.62 9.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.153 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.89 -17.32 61.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.411 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -28.11 55.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.845 0.355 . . . . 0.0 110.847 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.88 -41.64 87.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.02 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 46.7 mttt -77.22 -27.01 53.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.02 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 116.07 31.48 1.88 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.488 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.72 -178.31 5.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 0.0 110.868 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.2 t -115.65 171.76 7.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.861 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -87.28 -57.59 2.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.155 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.2 tp -161.21 143.83 12.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.987 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.29 -178.99 5.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -179.29 151.73 0.5 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -62.52 121.33 13.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.857 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.4 mt -98.26 28.6 3.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.938 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -112.63 -33.59 6.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.24 107.51 60.54 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.887 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -51.32 -24.13 15.14 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.485 2.123 . . . . 0.0 112.398 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.483 ' CE1' ' CD2' ' A' ' 258' ' ' PHE . 54.0 t80 -52.33 -27.79 16.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.199 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -87.11 -35.1 18.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.9 p -94.86 18.3 12.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.2 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.535 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 27.4 t-105 -73.76 -50.51 5.65 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.531 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 43.2 Cg_endo -68.2 -24.79 37.67 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.116 1.878 . . . . 0.0 112.508 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.412 HD13 ' CZ2' ' A' ' 129' ' ' TRP . 52.1 tp -59.23 -37.47 77.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.841 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 4.8 mp -105.06 -33.28 2.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.991 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.52 -29.15 70.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.241 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -56.64 -46.77 80.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.144 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -61.06 -20.07 62.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.124 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 125.63 53.55 0.17 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.489 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -134.53 123.64 3.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.512 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.419 ' CD2' ' HA3' ' A' ' 182' ' ' GLY . 20.7 p90 -117.99 -178.25 3.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.848 0.356 . . . . 0.0 110.871 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -100.07 -44.48 5.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.083 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -131.87 141.95 49.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.7 tptp -68.38 137.24 54.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.976 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.428 ' CE1' ' HA2' ' A' ' 174' ' ' GLY . 19.8 t80 -128.11 110.7 12.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.74 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.407 ' CG ' ' N ' ' A' ' 173' ' ' ASN . 9.7 pt-20 -139.01 -47.24 0.48 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.308 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.407 ' N ' ' CG ' ' A' ' 172' ' ' GLU . 49.4 m-80 -95.72 41.85 1.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.073 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.428 ' HA2' ' CE1' ' A' ' 171' ' ' TYR . . . 57.78 20.55 40.54 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.706 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.406 ' O ' ' CD2' ' A' ' 171' ' ' TYR . 11.3 mttt -133.3 -171.37 2.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.337 . . . . 0.0 110.866 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -126.44 86.81 2.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.59 127.67 33.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.911 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.9 pt -81.46 -12.3 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.472 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -96.01 26.0 4.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.719 0.295 . . . . 0.0 111.149 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -148.4 116.16 6.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.935 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 21.3 t -104.53 146.08 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.042 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 0.419 ' HA3' ' CD2' ' A' ' 167' ' ' TYR . . . -96.97 -12.64 49.08 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.029 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 6.1 t -62.89 -43.5 98.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.815 0.34 . . . . 0.0 111.18 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -83.85 57.23 4.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.07 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -110.74 -172.78 2.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.12 -44.78 29.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.171 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.16 -34.78 28.84 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.583 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.62 -30.16 68.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.337 . . . . 0.0 111.179 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -60.51 -56.62 19.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.32 -26.53 55.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.225 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -56.14 -40.7 84.29 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.706 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.77 -30.13 56.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.752 0.311 . . . . 0.0 110.94 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 66.2 m -56.35 -23.27 36.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.943 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -65.58 -60.53 2.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.791 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 5.2 tp -60.31 -30.96 69.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.703 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 40.0 t -66.07 -48.41 81.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.007 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -82.43 -23.12 34.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.095 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 6.3 mt -64.25 -24.38 67.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.228 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 13.5 mt -88.96 -42.22 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.646 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 23.4 mtpt -85.02 -29.35 25.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.829 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -91.65 -10.18 41.28 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.424 ' O ' ' CG ' ' A' ' 203' ' ' HIS . 13.4 mmtt -133.96 9.71 3.86 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.191 -0.204 . . . . 0.0 111.516 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . 0.424 ' CG ' ' O ' ' A' ' 202' ' ' LYS . 56.2 p-80 43.89 53.15 6.38 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.942 0.401 . . . . 0.0 111.376 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.84 128.42 34.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.844 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -59.94 119.89 8.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.991 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -80.04 -28.06 39.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.077 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -56.47 -24.36 45.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.182 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 7.6 m -36.29 145.91 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.94 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -153.55 176.21 12.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.75 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -34.84 79.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.032 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.99 -59.13 2.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 0.0 111.226 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.88 -29.59 41.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.848 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -81.75 -21.23 37.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.995 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -75.47 -56.9 4.25 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.837 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.37 -29.53 68.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.136 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.94 -41.91 88.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.141 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.42 ' CG ' HG23 ' A' ' 225' ' ' THR . 19.1 t80 -75.65 -33.16 60.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -74.9 -38.39 61.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.956 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.35 -31.55 33.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.894 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.66 63.8 0.72 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.48 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -111.07 -32.99 6.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.342 . . . . 0.0 110.949 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.6 t -121.05 162.26 20.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -84.08 -39.86 19.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.102 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -126.71 165.81 18.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.897 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.42 HG23 ' CG ' ' A' ' 217' ' ' PHE . 9.8 t -166.65 139.52 3.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 22.9 mt -101.08 128.27 53.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -165.3 144.74 6.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -63.84 -175.05 3.5 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.508 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.52 -20.91 35.34 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.662 2.241 . . . . 0.0 112.457 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.428 ' CD1' ' N ' ' A' ' 231' ' ' ALA . 5.4 p90 -56.3 -30.7 62.86 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.001 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.428 ' N ' ' CD1' ' A' ' 230' ' ' TRP . . . -72.92 -32.78 65.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.102 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 50.6 m0 -57.29 -27.42 62.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.074 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.3 m -59.59 -55.42 34.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.024 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -62.59 -30.63 71.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.011 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.416 HG22 ' CE1' ' A' ' 242' ' ' TYR . 23.2 mt -70.78 96.69 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.085 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -160.48 -53.2 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.77 -33.92 74.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.917 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 99.1 p -60.19 -32.84 71.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm 60.69 33.34 20.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.5 t -91.44 131.18 39.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.12 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.97 93.52 3.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.416 ' CE1' HG22 ' A' ' 235' ' ' ILE . 52.7 p90 -103.43 135.13 45.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.967 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -101.97 -164.55 26.84 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.5 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.4 t -148.19 133.99 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 111.128 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 63.3 m -143.5 159.3 42.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.86 151.88 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.971 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 9.9 mt -59.64 141.05 88.94 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.874 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.422 ' HB2' ' CD1' ' A' ' 129' ' ' TRP . 50.3 Cg_exo -53.67 146.1 45.78 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.506 2.137 . . . . 0.0 112.242 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 67.6 p -81.19 -177.3 6.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -156.8 109.95 2.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 24.1 mtpt 59.57 31.04 20.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 83.84 27.12 39.1 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.549 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -138.16 142.2 34.69 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.667 0.27 . . . . 0.0 110.915 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.09 163.88 34.29 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.572 2.181 . . . . 0.0 112.342 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 8.5 m -74.25 153.05 39.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.845 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.35 72.62 0.93 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.868 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.8 -168.26 0.31 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.597 2.198 . . . . 0.0 112.335 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.496 ' CE2' ' CD1' ' A' ' 158' ' ' TRP . 13.9 m-85 -101.99 165.6 11.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.924 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 26.5 t -127.98 126.4 66.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.103 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -126.92 116.9 2.59 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.386 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.6 130.56 66.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.824 0.345 . . . . 0.0 111.078 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 7.3 tp -90.58 84.01 5.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.791 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.53 166.27 18.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.966 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -99.51 131.38 45.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.068 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -95.53 103.04 2.92 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.507 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.404 HD12 ' CE1' ' A' ' 106' ' ' TYR . 32.8 mt -100.5 103.05 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.797 0.332 . . . . 0.0 111.098 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -62.07 165.49 5.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.997 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -84.02 -24.97 30.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.279 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -96.4 30.25 2.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.301 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.44 125.05 90.59 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.83 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.23 -27.71 39.25 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.385 2.057 . . . . 0.0 112.339 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -145.9 85.51 1.69 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.883 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -64.85 -36.32 83.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.855 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.25 -57.69 9.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 10.1 mt -60.01 -31.53 70.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.957 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.92 -60.4 3.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.099 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.86 -29.16 70.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.964 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -59.47 -60.91 3.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.021 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.413 ' CZ ' HG13 ' A' ' 23' ' ' VAL . 52.6 t80 -54.12 -24.27 17.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.403 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 95.1 mt -76.74 -40.72 47.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.265 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -93.56 -16.38 24.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.601 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.42 ' HB3' ' CD1' ' A' ' 283' ' ' TYR . 2.8 m-80 -91.91 -58.06 2.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.639 0.257 . . . . 0.0 111.362 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.484 ' CE1' ' CD2' ' A' ' 27' ' ' PHE . 7.0 m-85 -126.83 75.86 1.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.37 . . . . 0.0 111.227 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 5.1 tp -177.99 -57.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.924 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 13.7 mt -94.41 47.29 1.18 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.891 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 18.0 p -128.53 176.98 7.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.891 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.418 ' HA ' ' CD1' ' A' ' 307' ' ' TYR . 9.2 p-10 -81.0 -34.98 32.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.933 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -82.69 -31.21 28.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.929 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.79 -56.64 5.8 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.583 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.83 -30.7 69.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.76 0.314 . . . . 0.0 110.97 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -59.76 -41.06 90.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.036 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.72 -54.44 47.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.143 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.3 t -58.4 -28.31 35.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.282 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -71.08 -27.16 63.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.046 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 18.5 mttm -60.28 -34.19 73.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.189 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -110.73 -34.68 6.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.207 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 2.8 tppt? -133.41 83.71 48.73 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.062 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.42 119.32 6.26 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.579 2.186 . . . . 0.0 112.284 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 4.6 mp -95.71 20.95 9.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.07 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 57.09 -106.56 0.74 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.603 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -71.59 175.29 5.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 111.12 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 15.4 m -143.14 160.12 17.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.165 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -79.96 -34.51 38.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.072 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 2.7 tp -71.37 110.65 6.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.891 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -60.59 -31.54 70.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.861 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.4 m -70.21 -33.23 71.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.418 ' CD1' ' HA ' ' A' ' 287' ' ' ASP . 12.5 t80 -83.78 -27.14 29.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.024 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -58.75 -30.62 67.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.878 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -63.19 -55.32 26.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.809 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.94 -35.25 45.31 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.749 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.413 HD12 ' CE2' ' A' ' 307' ' ' TYR . 15.8 mt -85.73 -23.97 27.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.756 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.46 -14.74 61.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.457 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -46.66 -31.37 2.85 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 120.921 0.391 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -116.64 137.89 24.05 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.302 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.77 -28.48 67.09 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.432 2.088 . . . . 0.0 112.459 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -51.72 -36.31 46.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.001 0.429 . . . . 0.0 110.37 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 35.7 mm -85.43 -35.45 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.85 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -69.83 -29.69 67.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.189 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -70.66 -56.01 7.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.148 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 8.7 m -60.1 -37.23 79.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.954 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 7.0 tpt -63.98 -31.34 72.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.951 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -69.45 -53.65 18.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.992 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.2 -31.34 70.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.887 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.68 -31.33 72.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.14 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -75.43 -55.02 6.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.94 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -68.55 -30.29 69.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -58.43 142.56 45.05 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.529 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -74.53 154.12 38.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.869 0.366 . . . . 0.0 110.872 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 23.3 mt -101.69 132.52 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.064 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.407 ' HG3' ' CD1' ' A' ' 258' ' ' PHE . 29.5 mtm -69.58 135.87 88.3 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.49 168.55 24.26 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.501 2.134 . . . . 0.0 112.347 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.407 ' OD1' ' CE1' ' A' ' 99' ' ' TYR . 9.3 p30 -113.03 36.81 3.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.839 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 2.1 pt -105.98 154.29 39.59 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.158 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.26 -28.1 28.08 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.564 2.176 . . . . 0.0 112.308 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -58.86 -26.26 64.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.047 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.4 ' O ' ' CD1' ' A' ' 340' ' ' TRP . 0.0 OUTLIER -56.08 -29.9 61.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.04 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.8 m -66.66 -41.65 87.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.936 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.85 -26.09 60.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.233 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -57.95 -30.43 65.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.07 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . 0.4 ' CD1' ' O ' ' A' ' 336' ' ' MET . 89.0 m95 -67.43 -53.28 30.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.004 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.89 -24.75 59.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.172 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -84.77 -29.13 25.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.397 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 25.4 t -91.97 -50.27 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.259 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.66 -28.5 21.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.281 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 19.5 m -85.72 -48.67 8.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.077 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -58.78 -29.12 66.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.388 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 24.8 t -77.13 -52.26 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.293 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 40.4 mt -61.38 -50.92 78.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.127 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -58.57 -30.18 66.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.925 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -82.68 -29.42 29.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.207 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -76.44 -27.08 56.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.272 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 3.3 m -95.83 20.77 9.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.224 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 55.75 24.7 41.65 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.703 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.87 -29.72 18.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.832 0.349 . . . . 0.0 110.887 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -138.69 153.26 48.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.817 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.14 165.08 20.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.805 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 358' ' ' ASP . 1.6 p -63.97 -45.4 96.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.154 0.502 . . . . 0.0 110.774 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . 0.468 ' N ' ' CG1' ' A' ' 357' ' ' VAL . 66.4 m-20 -60.02 -53.87 52.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.172 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -57.18 -31.24 65.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.177 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -61.07 -60.41 3.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.973 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.31 -32.93 74.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.606 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.65 -59.05 3.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -59.17 -46.37 88.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.795 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -57.13 -37.16 71.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.076 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -60.59 -45.4 94.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 6.5 m -61.03 -40.61 94.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.956 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 44.4 mtm180 -62.95 -43.52 98.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.937 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 15.8 mt -72.47 -32.19 40.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.047 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 4.8 t -160.76 91.83 0.92 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.912 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.827 0.346 . . . . 0.0 111.172 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.5 m -79.11 104.81 9.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -72.73 149.96 43.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.911 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -69.46 137.23 52.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 107.76 29.4 4.4 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.474 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -157.14 -177.94 6.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.817 0.341 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 mt -150.09 112.49 4.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.8 t -100.58 131.07 48.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.162 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.412 ' N ' ' CD1' ' A' ' 9' ' ' ILE . 3.3 mp -113.2 107.36 22.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.817 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.432 ' CD2' ' CG ' ' A' ' 57' ' ' PRO . 0.3 OUTLIER -95.22 106.7 18.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.842 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.9 tt -137.12 157.22 35.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.104 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -69.45 -179.59 1.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.51 61.02 0.31 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.558 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.41 31.11 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.815 0.34 . . . . 0.0 110.917 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -150.37 -176.73 5.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.854 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.75 64.79 1.84 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.536 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -78.92 -31.56 45.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.824 0.345 . . . . 0.0 110.921 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -63.1 -32.04 73.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.844 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.85 -30.82 57.14 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.46 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.1 tp -60.98 -30.68 70.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 110.887 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.89 -48.62 80.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.131 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -59.03 -30.66 68.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.966 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 36.5 t -69.04 -34.89 66.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.029 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.3 -35.71 83.1 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.465 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -59.63 -27.82 66.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.81 0.338 . . . . 0.0 111.014 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.42 -41.58 76.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.894 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.84 -51.26 67.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.0 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -64.66 -23.1 67.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.158 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -82.64 -25.45 33.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.309 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -101.22 -32.58 10.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.629 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.8 p -119.0 -44.18 2.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.781 0.325 . . . . 0.0 111.446 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.93 27.23 6.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.526 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.9 mm -94.19 130.49 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.761 0.315 . . . . 0.0 111.104 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -59.64 152.16 23.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.942 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.33 104.64 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.115 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.0 m -103.41 147.87 26.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -141.16 110.63 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -115.61 161.11 19.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.928 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -132.51 70.3 79.6 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.865 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.13 161.14 45.71 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.59 2.193 . . . . 0.0 112.362 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -103.36 141.01 36.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.651 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.09 37.57 24.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.817 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 pp -79.07 5.57 11.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.747 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.4 -46.69 66.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.795 0.331 . . . . 0.0 111.173 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -90.03 -9.84 47.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.478 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.03 -18.91 26.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.649 0.261 . . . . 0.0 111.338 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.441 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -78.18 -50.86 1.71 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.682 0.277 . . . . 0.0 111.317 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 52.7 Cg_exo -55.31 -20.43 25.31 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.632 2.221 . . . . 0.0 112.944 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.429 ' CG ' ' N ' ' A' ' 50' ' ' VAL . 0.9 OUTLIER -85.71 -47.95 9.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.896 0.379 . . . . 0.0 111.327 -179.61 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.429 ' N ' ' CG ' ' A' ' 49' ' ' GLN . 11.2 m -79.57 -28.6 13.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.304 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.28 -41.69 89.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.88 -32.21 73.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.148 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.2 p -83.52 -30.83 26.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.937 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.5 25.85 66.97 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.559 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.26 -31.07 10.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.864 0.364 . . . . 0.0 110.892 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.38 -147.72 2.29 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.523 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.432 ' CG ' ' CD2' ' A' ' 10' ' ' TRP . 52.9 Cg_exo -52.57 -175.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.56 2.173 . . . . 0.0 112.314 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -135.25 -46.77 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.957 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.4 HG23 HD13 ' A' ' 59' ' ' ILE . 6.7 pt -117.24 130.65 71.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.25 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.482 ' CG1' ' N ' ' A' ' 61' ' ' PHE . 2.8 tt -127.4 159.84 37.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.83 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.482 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 6.2 m-85 -119.65 140.52 50.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.139 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.424 ' CE3' HD12 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -176.07 153.76 1.34 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.724 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.89 158.44 6.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.09 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -55.99 -36.23 67.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.127 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -65.03 -29.68 70.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.066 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.7 17.25 12.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.365 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.453 ' CD2' ' CB ' ' A' ' 105' ' ' ALA . 2.6 m-85 -110.99 -31.8 7.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.8 0.333 . . . . 0.0 110.909 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.33 -28.3 61.68 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.519 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.06 -25.9 63.24 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.61 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -85.42 -19.32 31.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.627 0.251 . . . . 0.0 111.279 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.53 -39.47 16.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.759 0.314 . . . . 0.0 111.166 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -30.63 71.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.012 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.1 m -73.64 -23.09 59.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.08 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.81 26.79 30.96 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.561 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 mt -94.59 -30.12 14.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.84 0.353 . . . . 0.0 110.976 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 80.5 mt -83.09 160.86 21.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.032 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.17 -172.69 2.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.04 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.408 ' O ' ' CG2' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -88.57 -168.16 2.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.002 0.429 . . . . 0.0 110.958 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.44 HG23 ' CE1' ' A' ' 106' ' ' TYR . 7.6 pt -158.53 179.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.851 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 61.7 p -157.46 78.74 3.59 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.138 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.22 113.2 1.8 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.575 2.183 . . . . 0.0 112.128 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.54 176.98 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.965 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -50.05 75.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.863 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 88' ' ' LYS . . . -56.66 -22.06 31.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.405 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.423 ' CD2' ' CD1' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -83.75 -54.52 4.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.898 0.38 . . . . 0.0 111.006 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.453 ' HG2' ' CZ2' ' A' ' 94' ' ' TRP . 17.3 mt-30 -69.79 -21.18 63.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.539 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -91.62 -9.07 45.39 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.412 ' HE2' ' CD1' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -117.07 -23.01 8.13 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.497 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.423 ' CD1' ' CD2' ' A' ' 85' ' ' PHE . 0.4 OUTLIER -82.72 135.13 35.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.868 0.366 . . . . 0.0 110.988 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.442 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . 33.1 m-85 -63.25 131.97 94.95 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.073 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.13 -55.57 3.74 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.682 2.255 . . . . 0.0 112.867 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.442 ' CE2' ' HB3' ' A' ' 90' ' ' TYR . 10.5 p90 -46.35 -28.02 1.21 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.908 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.432 HG21 ' CE1' ' A' ' 92' ' ' PHE . 11.7 p -72.95 -31.28 64.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.83 0.348 . . . . 0.0 110.858 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.466 ' CZ3' ' CD1' ' A' ' 103' ' ' LEU . 6.6 m95 -63.57 -31.42 72.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.817 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.26 -18.21 64.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.359 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -88.77 -18.11 28.44 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.406 ' CG2' ' CD2' ' A' ' 103' ' ' LEU . 4.8 m -103.82 -36.0 3.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.653 0.263 . . . . 0.0 111.541 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.9 116.92 7.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.885 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -99.85 -33.33 10.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.809 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -155.23 40.68 0.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.767 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.73 -22.37 40.78 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.658 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.7 pttp -104.21 179.77 4.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 111.018 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.466 ' CD1' ' CZ3' ' A' ' 94' ' ' TRP . 17.6 mt -124.96 169.36 12.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.022 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 pp -156.61 -41.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.393 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.453 ' CB ' ' CD2' ' A' ' 67' ' ' PHE . . . -89.8 162.84 15.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 111.301 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.44 ' CE1' HG23 ' A' ' 79' ' ' ILE . 58.9 m-85 -120.14 79.93 27.0 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.19 137.47 70.51 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.607 2.205 . . . . 0.0 112.352 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.1 mp -118.51 -60.15 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.126 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -125.37 150.42 47.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.141 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.02 101.15 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.33 174.69 9.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.974 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -169.97 124.59 0.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.07 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 mt -64.35 96.59 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.962 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.2 t -100.3 154.17 18.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.3 tt -83.24 128.57 34.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.907 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.1 mt -114.53 130.52 68.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.096 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -109.79 165.55 11.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -106.68 154.05 21.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.94 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -98.92 31.07 3.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -94.06 -45.78 7.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.89 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -144.04 38.96 1.32 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 20.1 tp -172.5 89.35 0.41 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.07 -44.79 2.31 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.527 2.151 . . . . 0.0 112.29 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -108.91 120.45 45.96 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.834 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.92 151.1 44.83 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.408 2.072 . . . . 0.0 112.389 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.63 119.03 5.71 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.587 2.192 . . . . 0.0 112.344 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.24 21.69 7.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.036 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.38 141.94 25.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.838 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.409 ' CE3' HD12 ' A' ' 132' ' ' ILE . 45.9 m95 -68.29 -27.99 66.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.001 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -73.47 -15.75 61.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.402 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.12 -3.91 59.1 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.501 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 11.3 mt -85.47 -48.13 0.59 Allowed Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.501 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 71.5 Cg_exo -48.51 -49.83 13.7 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.383 2.055 . . . . 0.0 112.411 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.45 -42.83 98.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.088 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.19 -48.61 79.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -53.4 -27.8 26.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -85.71 -28.91 24.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -84.96 -52.01 6.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.331 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.1 mt -58.88 -19.75 44.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.493 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.19 -29.56 48.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.823 0.344 . . . . 0.0 110.803 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.74 -36.72 77.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.66 -27.04 40.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.878 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.45 31.26 2.03 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.508 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -140.27 173.57 11.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.751 0.31 . . . . 0.0 110.924 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.1 t -101.21 171.99 7.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -101.33 -68.4 0.82 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.267 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.0 tp -148.42 143.25 26.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.034 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.78 -177.81 5.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.808 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.416 ' CE2' ' HG ' ' A' ' 151' ' ' LEU . 32.1 p90 -178.54 -178.52 0.6 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -84.92 111.9 20.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.972 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.416 ' HG ' ' CE2' ' A' ' 149' ' ' PHE . 9.9 mt -99.91 41.67 1.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.779 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -104.25 -32.5 9.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.06 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -134.59 143.92 48.64 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.018 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -57.55 -19.47 37.01 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.577 2.185 . . . . 0.0 112.491 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -48.13 -28.24 2.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.428 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -100.57 -29.95 12.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.081 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 16.2 p -96.83 17.66 16.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.354 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.522 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 11.8 t-105 -73.63 -50.37 5.9 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.538 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 47.2 Cg_endo -68.79 -15.82 41.05 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.153 1.902 . . . . 0.0 112.535 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 23.0 tp -77.27 -35.2 55.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 0.0 110.809 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 10.2 mt -105.1 -47.27 9.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.144 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -57.94 -28.68 64.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.312 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -56.51 -28.85 60.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.27 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -74.58 -20.1 60.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.212 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 139.01 -24.42 2.85 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.694 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -56.52 144.65 36.94 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.663 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.426 ' CD2' ' HA3' ' A' ' 182' ' ' GLY . 25.7 p90 -140.96 -177.01 4.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.337 . . . . 0.0 110.84 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -101.26 -34.49 9.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.14 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.418 ' CD2' HD11 ' A' ' 333' ' ' ILE . 90.0 m-85 -144.37 153.67 42.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.933 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.5 140.01 39.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.976 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.436 ' CZ ' ' HA2' ' A' ' 174' ' ' GLY . 57.7 t80 -143.99 110.81 5.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.685 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -135.03 -47.54 0.72 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.385 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -103.21 50.24 0.81 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 0.0 111.123 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.436 ' HA2' ' CZ ' ' A' ' 171' ' ' TYR . . . 57.71 19.77 36.91 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.735 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -125.22 170.79 10.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.793 0.33 . . . . 0.0 110.969 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -128.17 95.87 4.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.871 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.03 129.45 42.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.942 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.1 pt -82.75 -26.34 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.254 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.8 25.97 4.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.144 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -130.52 108.04 9.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.916 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.88 146.06 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.089 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 0.426 ' HA3' ' CD2' ' A' ' 167' ' ' TYR . . . -117.17 33.2 5.13 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.738 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.408 HG13 ' CD2' ' A' ' 361' ' ' LEU . 3.4 t -92.5 -50.52 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.345 . . . . 0.0 110.92 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -83.98 57.06 3.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.963 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -102.98 -178.92 3.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.766 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -74.06 -32.1 63.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.019 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -85.96 -42.61 6.67 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.571 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.33 -39.88 80.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.817 0.342 . . . . 0.0 111.227 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -59.25 -31.25 68.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.864 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -87.48 -30.25 20.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.096 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.73 -49.01 66.17 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.544 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.43 -43.57 96.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.834 0.35 . . . . 0.0 110.848 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 17.0 m -58.13 -27.43 63.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.928 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -60.27 -60.58 3.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.766 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.8 tp -60.56 -31.65 70.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.541 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 45.6 t -65.03 -61.64 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.936 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.61 -28.28 69.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.778 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.3 mt -58.57 -55.59 33.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.953 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 4.7 mt -55.26 -30.01 24.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.072 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -82.16 -34.09 29.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.937 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -106.49 29.98 6.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -144.92 -36.06 0.31 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.275 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 10.4 m80 76.28 41.64 0.21 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.925 0.393 . . . . 0.0 110.811 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.97 -175.38 5.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.759 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -108.16 126.76 53.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.963 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -79.44 -30.22 42.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.012 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.96 -15.98 62.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.22 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 30.0 m -36.81 148.43 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.974 0.416 . . . . 0.0 111.878 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -154.05 176.19 12.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.808 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -64.79 -28.73 69.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.47 -59.17 2.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.812 0.339 . . . . 0.0 111.12 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.18 -27.48 36.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.833 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -80.1 -20.43 45.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.838 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.59 -49.99 13.47 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.885 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.89 -32.44 69.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.104 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.68 -30.19 68.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.077 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -75.24 -47.73 26.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -59.54 -44.9 93.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -61.65 -29.0 69.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.826 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.59 37.67 5.49 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.473 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -94.52 -76.43 0.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 110.923 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 10.5 t -70.07 123.39 21.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.46 -31.71 68.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.047 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 1.5 mpp? -119.87 151.16 39.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.88 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 6.6 t -166.69 147.56 6.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 24.0 mt -95.66 116.81 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.085 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -119.26 165.43 14.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.852 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -119.64 -175.14 15.79 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.548 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.1 -20.29 30.22 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.648 2.232 . . . . 0.0 112.533 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 36.5 p90 -94.31 26.02 3.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.284 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.62 -1.66 7.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.685 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -81.02 -21.73 39.95 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.763 0.316 . . . . 0.0 111.226 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.6 m -72.97 -28.86 62.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.113 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -78.98 -32.88 45.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.075 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 2.1 pt -88.91 87.32 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.125 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -171.23 -46.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.862 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 63.3 p -93.54 -30.97 14.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.91 -26.3 64.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.023 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 62.68 67.21 0.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.87 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.97 128.6 56.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.013 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -62.01 104.88 0.51 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -106.49 148.73 27.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -137.85 113.71 1.01 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.499 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 26.9 t -78.68 120.49 29.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.791 0.329 . . . . 0.0 111.119 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 5.6 t -131.18 159.29 38.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.65 151.91 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.019 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 11.4 mt -72.21 152.75 92.46 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.881 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.44 164.34 31.2 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.508 2.139 . . . . 0.0 112.274 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 18.8 p -106.52 152.07 24.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.963 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -102.55 111.74 24.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt 60.42 28.1 17.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.971 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 93.83 -21.04 43.73 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.671 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -83.67 149.12 56.47 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.689 0.281 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.6 154.92 64.11 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.544 2.162 . . . . 0.0 112.304 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 91.1 p -65.29 166.33 10.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.417 ' N ' ' CD ' ' A' ' 257' ' ' PRO . 0.1 OUTLIER -133.59 52.8 8.95 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.951 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 256' ' ' LYS . 73.2 Cg_endo -76.28 -172.98 1.52 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.583 2.189 . . . . 0.0 112.385 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.429 ' CD1' ' CG ' ' A' ' 330' ' ' MET . 13.5 m-85 -92.22 158.44 16.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.81 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 20.4 t -144.01 119.28 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.227 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -99.16 155.53 19.95 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.297 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 14.9 p -144.0 116.74 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.815 0.34 . . . . 0.0 111.286 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 52.0 tp -68.42 127.03 31.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.794 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 79.6 p -140.93 154.56 46.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.056 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -102.07 138.65 38.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.958 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -109.59 130.2 9.83 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.598 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.421 HD12 ' CE1' ' A' ' 106' ' ' TYR . 23.4 mt -109.58 119.01 58.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.754 0.312 . . . . 0.0 111.02 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -76.91 150.45 35.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.965 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -60.28 -31.65 70.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.027 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -92.55 48.02 1.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.083 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.0 t -108.89 97.39 24.19 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.869 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.57 -30.2 21.0 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.537 2.158 . . . . 0.0 112.38 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -101.19 56.87 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.82 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 9.2 tptp -70.55 -55.08 9.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -62.25 -34.36 76.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.939 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 20.6 mt -73.66 -31.75 63.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.02 -48.42 81.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.102 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -60.54 -56.33 22.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.814 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -57.19 -22.12 38.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.136 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -86.63 -60.65 1.93 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.165 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 2.3 mt -81.46 -56.39 4.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.433 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.28 -18.2 47.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.917 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -120.11 -58.2 1.88 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.668 0.271 . . . . 0.0 111.609 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -86.97 57.54 4.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.954 0.406 . . . . 0.0 111.143 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 7.1 tp -172.51 -41.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.964 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 1.9 mp -97.62 38.21 1.3 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.926 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.8 p -117.83 165.42 13.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.853 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -62.38 -30.4 71.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.934 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -82.46 -49.62 9.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -59.34 -49.56 77.16 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.572 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 2.8 mt -60.1 -30.89 69.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.815 0.34 . . . . 0.0 110.916 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -64.09 -41.89 97.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.951 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.08 -58.15 9.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.147 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.39 -29.45 42.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.204 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -70.51 -31.88 69.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.899 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -65.66 -34.63 78.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.954 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.61 -31.39 12.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.951 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.9 95.56 1.98 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.935 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.53 108.98 1.95 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.455 2.104 . . . . 0.0 112.291 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 5.0 mt -58.96 -28.26 66.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.003 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 99.64 -109.37 3.73 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.56 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -75.23 93.73 2.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.82 0.343 . . . . 0.0 111.072 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.2 134.0 30.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -65.6 -27.4 68.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.023 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 24.6 tp -59.25 111.16 1.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.432 ' CG ' ' CE2' ' A' ' 90' ' ' TYR . 3.9 mttm -64.98 -45.07 87.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.974 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 17.2 m -54.74 -27.12 38.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.102 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.433 ' CE2' ' CD1' ' A' ' 311' ' ' LEU . 4.9 t80 -99.95 -25.31 14.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.12 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.11 -34.4 70.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.86 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.41 -62.8 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.863 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -52.18 -31.8 33.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.789 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.433 ' CD1' ' CE2' ' A' ' 307' ' ' TYR . 12.3 mt -85.7 -25.05 26.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.793 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -67.25 -13.47 62.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.526 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 4.3 mtmm -46.51 -32.91 3.65 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.906 0.384 . . . . 0.0 110.925 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.64 140.16 24.95 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.354 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.02 -25.59 54.71 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.393 2.062 . . . . 0.0 112.352 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -50.87 -40.21 55.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.038 0.447 . . . . 0.0 110.316 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 32.1 mm -85.5 -33.79 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.014 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -69.29 -29.72 67.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.241 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -72.08 -48.97 40.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.205 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 1.7 m -59.98 -38.62 83.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 5.3 tpt -72.58 -43.09 63.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.948 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -60.77 -31.87 71.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -69.5 -31.84 70.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.932 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -73.16 -50.18 24.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.143 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -61.39 -51.47 68.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 29.5 mtpt -59.97 -30.72 69.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.993 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -97.19 164.34 22.38 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.493 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -97.56 150.59 20.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.775 0.321 . . . . 0.0 110.897 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 32.1 mt -84.37 142.77 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.429 ' CG ' ' CD1' ' A' ' 258' ' ' PHE . 32.4 mtm -58.85 131.81 86.47 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.894 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.65 -174.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.367 2.045 . . . . 0.0 112.305 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -132.65 30.76 4.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.878 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.418 HD11 ' CD2' ' A' ' 169' ' ' PHE . 27.2 pt -106.11 147.31 34.6 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.35 -25.56 21.56 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.56 2.174 . . . . 0.0 112.437 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 -55.15 -29.5 57.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.071 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 13.9 ttt -58.75 -24.49 61.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.055 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' SER . . . . . 0.402 ' O ' ' CE2' ' A' ' 341' ' ' TYR . 8.0 m -56.66 -38.93 72.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.047 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -86.16 -33.3 20.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.1 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.417 ' CZ ' HG21 ' A' ' 343' ' ' VAL . 48.6 t80 -59.76 -26.29 65.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.115 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 20.8 m95 -56.36 -52.45 64.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.17 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . 0.402 ' CE2' ' O ' ' A' ' 337' ' ' SER . 0.2 OUTLIER -84.89 -31.79 23.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.666 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -50.49 -40.16 50.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.478 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.417 HG21 ' CZ ' ' A' ' 339' ' ' PHE . 17.5 t -95.93 -26.19 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.259 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -52.37 -56.35 15.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.162 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 12.4 m -64.3 -29.63 70.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.011 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -67.14 -55.32 14.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.248 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.9 t -57.24 -43.2 81.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.278 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 22.7 mt -67.04 -53.74 31.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.089 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -59.95 -30.69 69.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -82.91 -38.38 22.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.131 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -67.84 -30.57 69.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.094 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 17.4 t -71.18 -22.38 62.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.111 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 96.24 -21.6 44.43 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.66 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -57.76 -31.34 66.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.856 0.36 . . . . 0.0 110.928 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -122.46 151.57 41.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 30.2 p -85.44 169.36 13.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.772 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 29.2 t -72.55 -51.68 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.969 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -47.1 -32.53 4.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.353 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.22 -44.69 14.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.996 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -56.45 -60.46 3.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.061 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.408 ' CD2' HG13 ' A' ' 183' ' ' VAL . 7.9 mt -56.98 -26.13 59.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.813 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.6 -35.92 33.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.85 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -57.85 -49.4 76.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.948 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -59.3 -39.11 81.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.082 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -41.9 89.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.96 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 28.3 m -63.38 -49.59 73.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -43.44 94.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.998 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 13.9 mt -73.81 -40.4 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.082 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 13.1 p -98.26 30.72 3.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.952 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.88 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.827 0.346 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.72 125.3 25.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.917 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -136.12 32.32 2.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -151.09 166.33 31.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.8 -16.49 76.29 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.718 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 pptp? -69.87 153.45 43.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.807 0.337 . . . . 0.0 110.935 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 mt -102.28 138.8 38.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.953 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 t -106.94 147.03 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.168 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 25.8 mt -125.43 107.51 18.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.967 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.416 ' CG ' ' HG3' ' A' ' 57' ' ' PRO . 0.9 OUTLIER -92.27 109.67 21.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.83 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.3 tt -153.89 148.02 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.05 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -60.4 170.29 1.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.927 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.16 29.56 9.9 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.566 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -90.88 -52.97 4.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.361 . . . . 0.0 110.943 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -79.9 -175.61 5.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -59.06 87.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.516 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 36.9 p90 -83.57 -44.24 14.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.343 . . . . 0.0 110.867 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.428 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 12.9 t30 -70.62 -31.72 68.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.1 -32.77 51.73 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.525 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.18 -41.86 93.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.861 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.81 -30.22 68.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.089 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -59.5 -33.99 72.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.985 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.1 t -62.22 -31.26 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.11 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.57 -29.56 72.91 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.517 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 mmtt -59.85 -33.35 71.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.331 . . . . 0.0 110.944 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -42.04 72.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.854 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.417 ' CE1' HG23 ' A' ' 31' ' ' THR . 12.7 t80 -59.37 -59.22 5.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.939 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -57.8 -21.92 44.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.35 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -69.5 -26.31 64.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.512 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -117.74 -39.01 3.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.78 0.324 . . . . 0.0 111.49 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.417 HG23 ' CE1' ' A' ' 27' ' ' PHE . 15.1 p -90.68 -32.99 15.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.183 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.67 -22.39 35.98 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.663 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.425 HD13 HG22 ' A' ' 33' ' ' ILE . 38.8 mt -66.17 139.34 21.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.821 0.343 . . . . 0.0 111.046 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.0 170.01 17.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.982 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.6 t -146.99 111.06 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.042 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.1 m -101.85 150.63 22.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.948 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.9 t -130.14 110.19 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.117 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -96.52 165.7 12.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -149.6 72.31 9.79 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.843 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.62 -179.75 3.54 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.601 2.201 . . . . 0.0 112.347 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -118.58 143.77 46.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.74 28.95 18.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.27 -26.92 65.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.099 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.447 ' CG ' ' CH2' ' A' ' 62' ' ' TRP . 26.1 mt-10 -56.99 -30.59 64.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.013 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -95.89 -19.02 19.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.203 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -88.68 -29.6 19.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.803 0.335 . . . . 0.0 111.16 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.434 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -52.83 -50.63 80.27 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.344 -179.803 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 38.4 Cg_exo -61.1 -23.64 77.73 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.573 2.182 . . . . 0.0 112.741 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.28 -40.38 11.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.835 0.35 . . . . 0.0 111.278 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.9 m -80.45 -28.02 11.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.133 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.31 -22.53 59.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.303 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.3 -28.35 41.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.406 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.2 t -135.29 24.01 3.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.175 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 53.31 24.54 22.99 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.729 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -74.67 -30.14 61.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.885 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.67 -150.47 0.64 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.543 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.416 ' HG3' ' CG ' ' A' ' 10' ' ' TRP . 59.2 Cg_endo -71.97 177.69 6.78 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.597 2.198 . . . . 0.0 112.36 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.58 -31.57 7.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.804 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.3 mt -128.32 139.83 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.048 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.482 ' CG1' ' N ' ' A' ' 61' ' ' PHE . 2.5 tt -140.34 160.14 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.062 0.458 . . . . 0.0 110.962 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.482 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 9.0 m-85 -132.58 136.02 46.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.078 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.447 ' CH2' ' CG ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -176.08 152.01 1.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.756 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.61 157.76 3.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.231 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -54.89 -29.65 56.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.085 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -58.86 -34.33 71.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.099 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.81 17.14 12.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.345 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -113.29 -24.23 9.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.655 0.264 . . . . 0.0 111.28 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -83.05 55.49 5.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.466 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -153.15 -42.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.574 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -82.86 -14.4 54.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.628 0.251 . . . . 0.0 111.258 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.47 -35.35 24.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.78 0.324 . . . . 0.0 111.205 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -62.28 -30.02 70.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.9 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.4 t -83.61 -23.12 32.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.057 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.5 28.26 13.21 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.479 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.0 mt -88.81 -34.3 17.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.801 0.334 . . . . 0.0 110.955 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 27.6 mt -79.11 167.01 21.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.7 126.23 52.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.083 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.457 ' CG ' ' N ' ' A' ' 79' ' ' ILE . 19.2 tt0 -65.42 164.05 14.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.795 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.457 ' N ' ' CG ' ' A' ' 78' ' ' GLU . 40.6 pt -139.8 -179.65 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.208 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -158.89 77.86 3.11 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.421 ' HG3' ' CH2' ' A' ' 94' ' ' TRP . 37.2 Cg_endo -65.61 119.17 6.15 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.593 2.196 . . . . 0.0 112.27 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.35 177.92 0.33 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.824 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 11.2 mtmm -60.21 -45.45 93.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.52 -31.56 69.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.001 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -72.26 -52.21 17.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.871 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -64.37 -25.88 68.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.951 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.8 -28.36 67.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.157 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.86 34.26 1.93 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.118 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.423 HD11 ' CZ2' ' A' ' 94' ' ' TRP . 94.2 mt -153.37 174.22 14.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.91 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.435 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . 44.7 m-85 -99.83 142.25 24.27 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.989 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -56.17 -55.88 2.53 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.617 2.211 . . . . 0.0 112.932 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.457 ' CE1' ' CG2' ' A' ' 93' ' ' THR . 38.2 p90 -52.98 -37.86 61.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.892 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.457 ' CG2' ' CE1' ' A' ' 92' ' ' PHE . 30.0 p -64.25 -27.88 69.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.722 0.296 . . . . 0.0 111.115 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.423 ' CZ2' HD11 ' A' ' 89' ' ' LEU . 11.2 m95 -73.26 -24.52 60.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.218 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.42 11.31 19.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.466 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -101.83 -31.39 10.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.812 0.339 . . . . 0.0 111.257 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.0 m -87.92 -35.5 8.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.312 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.93 117.98 9.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.926 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -97.93 -67.24 0.86 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -99.62 30.74 3.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.922 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.02 -24.63 27.75 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.564 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.4 133.04 42.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 0.0 110.944 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.8 mt -66.35 150.0 49.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.868 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.5 pp -155.02 36.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.145 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -172.73 157.43 3.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.131 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.421 ' CE1' HG22 ' A' ' 79' ' ' ILE . 72.8 m-85 -118.01 80.85 15.3 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -55.98 138.79 83.46 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.564 2.176 . . . . 0.0 112.233 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.444 HG22 HD11 ' A' ' 108' ' ' ILE . 24.7 mt -134.46 -51.73 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.121 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -108.67 171.56 7.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.123 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.5 t -141.5 129.05 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.126 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.97 144.59 43.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -162.79 151.78 14.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 13.8 mt -61.22 124.56 20.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.1 m -115.66 165.28 13.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.0 tp -105.47 101.26 10.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.858 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 32.8 mt -91.45 119.77 39.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.109 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -118.79 148.1 43.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.931 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -73.68 165.23 25.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.881 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.32 -31.13 6.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.02 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -74.8 -39.4 61.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.023 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.7 mt -109.53 28.61 8.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.076 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.8 tp -176.96 89.44 0.25 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.97 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -69.03 -30.51 25.56 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.516 2.144 . . . . 0.0 112.248 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -133.99 120.98 15.49 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.22 153.84 41.05 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.47 2.113 . . . . 0.0 112.379 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.05 122.11 8.15 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.587 2.191 . . . . 0.0 112.289 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -93.75 18.13 10.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.4 p -156.99 141.96 17.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.8 0.334 . . . . 0.0 110.81 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.419 ' CE3' HD13 ' A' ' 132' ' ' ILE . 27.9 m95 -61.77 -31.78 72.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -68.89 -15.88 63.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.336 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.98 0.52 57.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.551 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.485 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 16.6 mt -85.37 -46.24 0.63 Allowed Pre-proline 0 C--N 1.332 -0.184 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 72.0 Cg_exo -48.74 -57.49 2.33 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.369 2.046 . . . . 0.0 112.447 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.28 -36.97 83.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.995 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.2 mt -58.39 -52.29 66.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.997 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -46.08 -31.75 2.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.436 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -85.61 -27.02 25.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.232 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -57.93 -64.18 1.0 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.289 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.413 HD22 ' N ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -68.49 -16.32 63.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.567 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.413 ' N ' HD22 ' A' ' 139' ' ' LEU . 2.6 ttmt -63.4 -21.57 66.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.884 0.373 . . . . 0.0 110.461 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.51 -41.74 81.39 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.672 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.85 -26.28 34.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.784 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 119.52 21.48 3.63 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.615 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -116.0 -174.98 2.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.775 0.322 . . . . 0.0 110.943 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.2 p -130.17 158.38 39.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.913 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -76.76 -62.72 1.54 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.179 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.0 tp -148.66 143.44 26.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.015 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.26 -177.83 4.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.778 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.9 p90 179.63 145.99 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.9 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -62.9 126.97 29.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.952 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.7 mt -98.48 31.62 2.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.848 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -101.51 -31.33 10.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -119.71 146.5 41.76 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.905 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.1 -3.41 13.71 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.553 2.168 . . . . 0.0 112.677 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.5 ' CZ ' ' CH2' ' A' ' 340' ' ' TRP . 0.4 OUTLIER -57.8 -32.12 67.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.826 0.346 . . . . 0.0 110.954 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -94.69 4.04 54.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.544 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 55.8 p -106.77 -28.12 10.35 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.796 0.332 . . . . 0.0 111.049 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.483 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 11.7 t-105 -55.94 -46.66 99.73 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.308 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 77.2 Cg_exo -50.35 -25.51 13.95 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.377 2.051 . . . . 0.0 112.479 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.6 tp -94.06 -38.84 10.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.018 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 21.4 mt -76.04 -55.45 11.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.179 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.09 -25.97 68.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.243 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -57.17 -56.09 26.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.239 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -96.05 -20.1 18.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.231 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -77.06 -104.65 0.15 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.525 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -150.49 -86.98 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.531 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -172.83 -179.6 2.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.837 0.351 . . . . 0.0 110.897 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.02 -48.8 6.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.066 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -141.86 140.61 32.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.965 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -77.5 136.83 38.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.848 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.487 ' CE2' ' CE2' ' A' ' 176' ' ' TYR . 0.3 OUTLIER -101.69 110.64 22.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.779 179.834 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -133.96 145.02 49.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.126 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 48.69 32.09 3.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.249 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 68.0 26.61 73.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.424 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.23 -171.32 2.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.359 . . . . 0.0 110.839 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.487 ' CE2' ' CE2' ' A' ' 171' ' ' TYR . 1.1 m-85 -130.54 131.7 45.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.848 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.73 139.4 32.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 19.9 pt -95.03 -18.4 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.334 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.91 26.01 4.37 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.113 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -140.52 78.58 1.66 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.882 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 21.7 t -94.24 137.71 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.162 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.29 0.3 40.6 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.857 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.418 ' CG1' ' N ' ' A' ' 184' ' ' ASP . 0.3 OUTLIER -54.05 -42.67 55.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.921 0.391 . . . . 0.0 111.31 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.418 ' N ' ' CG1' ' A' ' 183' ' ' VAL . 22.9 t0 -96.09 61.51 2.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.971 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -91.57 165.47 13.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.84 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -59.87 -38.71 82.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.14 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -85.92 -25.11 38.93 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.565 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.15 -30.56 66.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 0.0 111.163 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -61.03 -38.2 85.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -87.56 -30.06 20.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -59.31 -51.05 61.44 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.555 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -41.01 92.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.805 0.336 . . . . 0.0 110.904 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.8 m -54.07 -25.5 22.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.161 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -65.28 -60.57 2.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.784 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.9 tp -63.86 -33.47 75.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.68 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 46.2 t -65.9 -44.68 92.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.941 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.5 -28.11 60.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.938 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 16.6 mt -57.82 -53.72 55.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.005 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 14.9 mt -68.81 -29.86 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.003 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 24.1 mtpt -75.8 -29.86 58.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.968 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -95.32 22.76 6.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.177 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.49 75.27 0.33 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.931 0.396 . . . . 0.0 111.156 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.4 -41.97 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.74 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.01 145.56 29.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.846 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -90.03 113.96 25.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.867 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.19 -26.72 66.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.154 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -92.98 46.49 1.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.931 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 51.9 m -113.36 138.75 49.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.784 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.464 ' HB2' HD11 ' A' ' 212' ' ' ILE . 1.8 m-20 -151.35 176.3 11.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.945 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -42.67 -62.98 0.86 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.38 -59.25 4.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.004 0.43 . . . . 0.0 111.591 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.464 HD11 ' HB2' ' A' ' 209' ' ' ASP . 0.0 OUTLIER -52.96 -31.9 17.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.183 -179.53 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -81.98 -28.3 32.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.763 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -82.36 -56.15 4.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.026 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.08 -31.26 61.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.334 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.46 -36.0 73.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.122 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.448 ' CG ' ' CG2' ' A' ' 225' ' ' THR . 29.0 t80 -82.24 -31.75 30.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.994 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -63.97 -46.94 82.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.99 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.09 -36.76 58.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.95 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 110.33 56.92 0.51 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.506 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -108.66 -29.71 8.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.801 0.334 . . . . 0.0 110.949 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.8 t -117.38 140.1 50.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.937 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.06 -31.14 68.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.095 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 9.8 mtp -134.43 163.29 30.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.448 ' CG2' ' CG ' ' A' ' 217' ' ' PHE . 4.7 t -166.62 132.49 2.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 25.6 mt -96.62 116.81 39.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.087 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -156.29 165.3 36.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.416 ' HA3' ' CZ3' ' A' ' 230' ' ' TRP . . . -82.53 170.77 50.77 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.478 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.81 -25.59 27.64 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.661 2.241 . . . . 0.0 112.325 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.416 ' CZ3' ' HA3' ' A' ' 228' ' ' GLY . 28.5 p90 -59.29 -30.97 68.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.965 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -59.46 -29.95 68.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.152 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 27.9 m0 -59.61 -28.91 67.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.049 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.9 m -57.81 -31.07 66.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.003 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -72.16 -59.61 2.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 4.5 mt -78.49 116.66 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.082 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -168.66 -47.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.934 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 22.2 p -76.48 -38.71 54.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 11.8 t -66.16 -29.41 69.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.957 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 62.16 81.72 0.19 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.35 143.8 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.104 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -85.25 87.47 7.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.932 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -104.64 167.61 9.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.06 174.28 21.99 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.523 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 20.9 t -140.01 127.52 24.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.793 0.33 . . . . 0.0 111.076 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.7 t -143.53 151.34 40.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.967 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.417 ' CG2' ' N ' ' A' ' 247' ' ' LEU . 0.7 OUTLIER -54.51 152.3 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.292 0.568 . . . . 0.0 111.295 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.417 ' N ' ' CG2' ' A' ' 246' ' ' VAL . 9.2 mt -71.45 146.6 91.87 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.977 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.418 ' HG2' ' CD1' ' A' ' 129' ' ' TRP . 50.8 Cg_endo -69.18 177.17 5.44 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.541 2.16 . . . . 0.0 112.265 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 44.6 p -121.12 175.47 6.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -142.85 121.94 12.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 20.7 mttm 60.1 31.67 20.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 74.35 27.03 66.62 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.52 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -136.48 128.99 17.43 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.554 0.216 . . . . 0.0 110.821 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.07 163.09 35.86 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.505 2.137 . . . . 0.0 112.354 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.82 -172.95 3.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.786 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -134.72 63.87 60.77 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.952 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -56.88 127.78 27.25 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.554 2.169 . . . . 0.0 112.182 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.425 ' CD2' ' CD1' ' A' ' 155' ' ' TYR . 98.5 m-85 -60.65 139.96 57.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.739 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 25.5 t -120.32 146.25 25.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.294 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -134.65 86.57 0.26 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.294 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 7.5 p -60.52 128.85 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.843 0.354 . . . . 0.0 111.326 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.3 tp -89.9 106.9 18.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.56 174.32 6.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.961 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -109.44 154.51 22.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.03 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.0 129.77 8.11 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.515 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.404 HD11 ' CE1' ' A' ' 106' ' ' TYR . 4.4 mt -125.74 100.53 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.803 0.335 . . . . 0.0 110.998 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.19 162.63 4.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.956 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -70.78 -28.36 64.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -90.51 49.94 1.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.132 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.5 m -109.1 102.76 50.17 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.782 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.81 -23.91 47.51 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.419 2.079 . . . . 0.0 112.366 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -98.37 31.11 2.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.934 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.99 -38.35 90.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.886 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -61.7 -49.52 76.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.96 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 78.2 mt -77.7 -31.02 52.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.942 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.67 -55.4 20.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.178 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -44.82 74.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.045 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -63.89 -43.38 96.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -66.83 -37.11 83.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 2.8 mt -78.71 -22.24 46.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.445 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.55 -29.94 15.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.505 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -94.67 -58.09 2.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.728 0.299 . . . . 0.0 111.494 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -106.49 58.12 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.94 0.4 . . . . 0.0 111.319 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.0 tp 177.64 38.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.942 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.4 ' CD2' ' CD1' ' A' ' 304' ' ' LEU . 0.4 OUTLIER 179.3 38.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.872 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 44.7 p -153.48 172.37 17.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.947 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -63.15 -29.28 70.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.018 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -78.22 -30.15 48.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.019 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -92.2 -51.8 2.33 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.624 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.417 ' HB3' ' CE2' ' A' ' 307' ' ' TYR . 1.5 mt -59.03 -30.59 68.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.764 0.316 . . . . 0.0 110.999 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -72.81 -31.45 64.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.937 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -59.25 -40.49 86.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.138 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.2 t -83.53 -30.81 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.138 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -63.31 -29.72 70.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.977 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -58.77 -33.66 70.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.96 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -102.61 -35.82 8.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.0 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 4.2 mmtm -146.61 90.36 5.57 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.932 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.2 104.79 1.44 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.53 2.154 . . . . 0.0 112.265 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 2.2 mp -58.42 -26.75 63.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.994 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 90.13 -94.72 2.01 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.523 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -79.05 122.01 25.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.784 0.326 . . . . 0.0 111.073 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 21.3 m -111.59 165.98 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.18 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -92.13 -29.24 16.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.167 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.4 ' CD1' ' CD2' ' A' ' 285' ' ' LEU . 5.0 tp -58.16 120.91 9.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.936 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -65.22 -31.63 72.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.9 -31.75 51.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.418 ' CD2' HD13 ' A' ' 311' ' ' LEU . 5.4 t80 -84.68 -28.26 26.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.021 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -59.4 -31.79 69.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.84 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -73.08 -58.91 2.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.853 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -51.53 -32.21 27.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.771 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.418 HD13 ' CD2' ' A' ' 307' ' ' TYR . 13.3 mt -85.78 -26.14 25.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.667 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.7 -16.48 62.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.343 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -47.82 -32.62 6.29 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.931 0.396 . . . . 0.0 110.832 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -108.67 138.53 20.3 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.345 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.89 -30.67 78.26 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.418 2.078 . . . . 0.0 112.374 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -49.68 -39.32 36.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.001 0.429 . . . . 0.0 110.299 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 18.5 mm -85.57 -33.58 7.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.964 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -69.2 -57.48 5.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.205 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.19 -49.58 75.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.258 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 73.8 m -58.73 -31.02 67.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.987 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 9.1 tpt -79.98 -32.13 39.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -61.43 -56.13 23.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.94 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -65.12 -30.44 71.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.942 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.09 -56.54 20.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.134 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -64.09 -37.52 87.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.875 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 12.0 tttp -67.52 -31.92 72.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -76.97 -162.02 14.3 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.501 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -129.27 160.46 32.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.762 0.315 . . . . 0.0 110.949 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 29.8 mt -86.78 158.81 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.127 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 6.1 mtp -80.13 131.07 63.83 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.899 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.419 ' HA ' ' CE2' ' A' ' 176' ' ' TYR . 36.3 Cg_exo -57.3 158.36 18.82 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.392 2.061 . . . . 0.0 112.181 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -110.23 -26.53 9.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.087 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 34.9 pt -55.59 150.44 25.49 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.248 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.71 -25.42 24.22 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.594 2.196 . . . . 0.0 112.417 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.57 -28.36 60.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.062 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.419 ' HE2' ' CD1' ' A' ' 339' ' ' PHE . 0.0 OUTLIER -59.3 -27.86 66.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.061 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 4.9 m -55.87 -56.2 23.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.01 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.59 -30.8 71.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.09 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.426 ' CE1' HG22 ' A' ' 343' ' ' VAL . 47.1 t80 -59.7 -40.49 88.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.946 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . 0.5 ' CH2' ' CZ ' ' A' ' 155' ' ' TYR . 96.7 m95 -63.6 -55.75 21.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.024 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -58.8 -44.3 90.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.082 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -59.17 -58.73 7.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.19 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.426 HG22 ' CE1' ' A' ' 339' ' ' PHE . 24.4 t -59.21 -28.43 39.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.228 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.71 -53.89 49.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.073 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.67 -30.61 68.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.959 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -59.26 -52.83 63.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.212 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.19 -36.74 64.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.198 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 29.3 mt -76.37 -37.15 30.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.158 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -58.93 -30.95 68.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.95 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -87.6 -46.68 9.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.053 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.13 -40.53 96.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.123 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 8.1 m -67.92 -22.43 65.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.104 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 85.12 27.6 33.3 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.564 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.19 -30.28 21.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.852 0.358 . . . . 0.0 110.918 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -146.09 -173.92 4.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 4.4 p -104.48 156.12 18.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.951 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 43.1 t -59.12 -29.93 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.977 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.12 -49.29 70.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 360' ' ' ALA . 0.1 OUTLIER -71.23 -34.88 71.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.995 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.406 ' N ' ' HG3' ' A' ' 359' ' ' GLU . . . -65.98 -52.85 45.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.98 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 89.9 mt -61.75 -28.72 69.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -81.19 -41.16 22.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.871 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -73.72 -46.98 42.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.14 -43.65 87.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.145 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -62.95 -36.17 82.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.933 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 21.3 m -60.34 -42.99 96.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -59.71 -29.82 68.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.924 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.414 HD13 HG23 ' A' ' 368' ' ' ILE . 26.2 mm -71.02 -35.66 60.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.076 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 1.4 t -152.77 78.64 1.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.92 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.799 0.333 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.5 t -58.93 99.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.94 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.26 173.54 10.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.883 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 58.24 174.63 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.983 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -84.98 55.92 4.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.494 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -125.15 173.29 8.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.861 0.362 . . . . 0.0 110.887 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.1 mt -141.9 115.82 9.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.2 t -89.61 146.99 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.212 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.4 mt -128.16 107.47 16.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.925 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.426 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 8.6 m0 -93.78 106.7 18.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.854 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.3 tt -123.29 145.81 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.081 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -60.13 170.56 1.22 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.79 47.91 2.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.52 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -157.23 31.4 0.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.856 0.36 . . . . 0.0 110.907 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.33 -172.3 3.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.92 93.84 1.53 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.501 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -85.97 -37.5 18.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.816 0.341 . . . . 0.0 110.923 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -75.73 -32.72 60.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.976 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.9 -28.21 59.22 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.507 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.5 tp -80.05 -32.4 39.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.76 0.314 . . . . 0.0 110.931 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.77 -31.81 71.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.175 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -60.23 -31.05 69.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.965 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.8 t -64.62 -41.14 91.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.088 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.99 -34.96 88.64 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.499 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.0 mttp -60.03 -28.59 67.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.826 0.346 . . . . 0.0 110.934 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -83.0 -38.5 22.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.849 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -55.82 -45.69 78.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.096 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -60.36 -38.35 83.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.937 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.39 -28.81 66.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.901 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -83.76 -32.66 25.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.311 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -139.06 -44.15 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.391 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.98 20.9 5.5 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.721 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.458 HD12 HG23 ' A' ' 33' ' ' ILE . 29.4 mm -80.67 114.9 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.814 0.34 . . . . 0.0 110.985 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -57.65 145.48 33.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.003 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.4 t -138.96 109.31 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.111 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.2 m -104.14 128.54 51.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.911 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.5 t -114.74 113.86 44.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.149 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -114.78 156.8 24.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.9 p-80 -122.47 71.49 37.22 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.855 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.413 ' HG3' ' CD2' ' A' ' 10' ' ' TRP . 57.1 Cg_endo -70.77 165.84 30.82 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.603 2.202 . . . . 0.0 112.377 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -126.0 141.21 52.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.815 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.5 mmtm 59.68 36.96 22.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.839 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.19 -3.51 42.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.48 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -58.29 -36.91 74.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.84 0.352 . . . . 0.0 110.964 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.47 -19.75 23.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.172 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -87.41 -19.0 28.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.344 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.451 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 7.0 t80 -70.91 -48.52 14.41 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.361 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 2.9 Cg_exo -76.04 -31.32 5.02 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.791 2.327 . . . . 0.0 112.688 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.448 ' CG ' ' N ' ' A' ' 50' ' ' VAL . 7.8 pt20 -60.28 -50.69 72.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.834 0.35 . . . . 0.0 111.239 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.448 ' N ' ' CG ' ' A' ' 49' ' ' GLN . 7.4 m -97.17 27.09 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.434 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.19 -29.98 31.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.184 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.55 -32.49 25.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.207 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.2 t -82.75 -29.65 29.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.944 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.71 26.96 23.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.517 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.42 -26.02 24.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.829 0.347 . . . . 0.0 111.009 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.4 -178.52 0.4 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.554 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.426 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 60.9 Cg_endo -72.59 -168.23 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.609 2.206 . . . . 0.0 112.364 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.29 -46.22 3.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.814 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.9 mt -117.88 138.88 47.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.481 ' CG1' ' N ' ' A' ' 61' ' ' PHE . 2.6 tt -139.02 159.69 29.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.12 0.486 . . . . 0.0 110.952 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.481 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 28.1 m-85 -127.62 136.17 51.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.942 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.41 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -172.01 157.69 4.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.913 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.36 156.1 30.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.094 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -56.48 -41.93 77.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.085 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -59.26 -31.35 69.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.08 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.41 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 8.6 mmm180 -94.25 17.19 13.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.334 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.402 ' CE2' ' O ' ' A' ' 62' ' ' TRP . 0.8 OUTLIER -109.65 -13.33 14.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.285 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -92.5 21.89 35.93 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.739 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.42 -23.83 4.65 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.559 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -100.47 -28.08 13.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.737 0.303 . . . . 0.0 110.972 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.0 -25.78 53.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.11 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -59.29 -29.3 67.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.155 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 m -96.65 24.99 5.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.13 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.49 29.46 39.31 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.791 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.3 mt -87.81 -40.61 13.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 0.0 110.944 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.4 mt -83.33 148.52 27.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.931 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.31 165.33 20.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.128 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.03 -165.63 1.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.935 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.8 pt -157.33 164.62 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.968 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 47.0 p -156.31 77.43 4.36 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.837 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.64 161.16 46.15 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.646 2.231 . . . . 0.0 112.269 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.38 165.07 16.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.809 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.35 -38.28 76.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.884 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.37 -29.31 61.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.063 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.417 ' CZ ' HD13 ' A' ' 285' ' ' LEU . 7.4 t80 -78.54 -32.01 47.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.42 ' HG2' ' CE2' ' A' ' 94' ' ' TRP . 0.0 OUTLIER -82.21 -29.62 31.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.994 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -73.74 -36.42 65.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.048 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -59.87 -30.28 68.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.012 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.1 mp -88.45 162.54 16.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.849 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.428 ' HB3' ' CE1' ' A' ' 92' ' ' PHE . 15.2 m-85 -75.09 141.09 74.07 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.064 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -54.31 -55.88 3.0 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.658 2.239 . . . . 0.0 113.022 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.44 ' CE2' ' CG2' ' A' ' 93' ' ' THR . 42.4 p90 -56.16 -42.21 76.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.734 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.44 ' CG2' ' CE2' ' A' ' 92' ' ' PHE . 30.6 p -59.46 -28.06 66.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.754 0.312 . . . . 0.0 111.103 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.42 ' CE2' ' HG2' ' A' ' 86' ' ' GLN . 7.2 m95 -75.01 -25.82 59.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.113 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -90.55 12.42 18.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.398 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -101.9 -48.26 4.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.779 0.324 . . . . 0.0 111.289 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.2 m -78.98 -33.14 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.387 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.09 121.17 14.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.99 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -122.96 142.68 50.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.727 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 69.59 25.31 5.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.071 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.57 7.27 88.13 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.109 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.04 141.64 47.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.846 0.355 . . . . 0.0 111.006 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.2 mp -75.85 149.82 37.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.953 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.5 pp -157.14 26.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.387 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.59 179.09 8.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.073 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -137.66 89.97 14.99 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.939 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -56.23 131.47 46.06 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.524 2.149 . . . . 0.0 112.228 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.0 mt -127.24 -48.06 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.34 138.44 50.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.089 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.34 128.92 67.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.1 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -109.2 148.17 31.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -157.93 137.05 11.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.6 mt -66.85 109.08 2.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.864 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.85 161.14 14.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.931 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.8 tp -96.78 111.79 23.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.8 mt -97.98 132.09 43.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.1 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.415 ' CD1' ' HB3' ' A' ' 125' ' ' PRO . 34.7 p90 -129.74 159.33 36.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.001 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -86.39 120.93 28.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.0 mtpp -77.93 -27.97 49.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.037 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -65.46 -30.48 71.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.1 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.9 mp -110.42 -35.7 5.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.114 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 16.2 tp -110.43 101.92 49.98 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.97 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.82 -27.79 37.08 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.37 2.047 . . . . 0.0 112.303 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -137.98 130.34 16.33 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.415 ' HB3' ' CD1' ' A' ' 117' ' ' TYR . 71.7 Cg_endo -76.99 151.55 30.94 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.538 2.159 . . . . 0.0 112.326 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.26 103.03 1.68 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.54 2.16 . . . . 0.0 112.328 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -24.28 59.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.092 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.39 143.69 35.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.902 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.42 ' CE3' HG13 ' A' ' 132' ' ' ILE . 18.4 m95 -78.1 -30.82 49.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -67.64 -15.82 63.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.314 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.81 -11.11 43.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.609 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.468 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 25.6 mm -70.96 -46.56 15.15 Favored Pre-proline 0 CA--C 1.53 0.197 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 75.3 Cg_exo -48.12 -57.94 2.04 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.396 2.064 . . . . 0.0 112.489 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.32 -35.18 79.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.061 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.2 mt -58.44 -51.02 71.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.052 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -46.74 -28.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.508 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -85.58 -27.97 25.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.312 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.56 -63.71 1.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.302 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.415 HD23 ' N ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -68.96 -16.4 63.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.646 -179.597 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.415 ' N ' HD23 ' A' ' 139' ' ' LEU . 0.0 OUTLIER -64.54 -21.58 66.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.804 0.335 . . . . 0.0 110.495 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.44 -41.61 80.82 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.126 0.489 . . . . 0.0 110.581 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.01 -26.75 30.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.784 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.34 18.6 3.36 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.76 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -111.4 -174.96 2.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.826 0.345 . . . . 0.0 110.893 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.6 t -132.12 163.9 27.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.878 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -79.26 -64.47 1.18 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.303 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -153.28 148.44 26.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.102 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.05 -177.87 4.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.754 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -179.26 152.74 0.55 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.954 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.405 ' OD1' ' CD2' ' A' ' 156' ' ' PHE . 12.9 p-10 -67.95 113.11 5.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 8.8 mt -94.1 45.26 1.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.854 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -110.44 -30.29 7.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.008 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -125.14 125.86 25.24 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.885 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.84 -22.32 29.32 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.446 2.098 . . . . 0.0 112.341 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -54.19 -31.1 51.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.091 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.405 ' CD2' ' OD1' ' A' ' 150' ' ' ASN . 0.2 OUTLIER -89.16 -31.25 18.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.93 12.43 28.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.241 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.537 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 29.7 t-105 -68.23 -54.85 14.04 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.433 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 17.4 Cg_endo -57.82 -20.26 42.88 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.238 1.959 . . . . 0.0 112.413 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 21.3 tp -78.8 -27.41 44.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.945 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 18.3 mt -101.67 -47.72 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.127 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -60.07 -36.48 77.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.214 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.42 84.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.232 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.05 -20.16 56.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.252 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 130.9 71.74 0.11 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.509 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -171.77 172.67 44.78 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.489 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -162.39 173.57 13.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.82 0.343 . . . . 0.0 110.946 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.71 -53.34 4.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.052 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -127.72 146.22 50.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.784 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.85 108.12 17.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.049 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -73.51 110.95 8.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.577 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -159.38 145.6 16.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.935 0.398 . . . . 0.0 111.099 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 62.11 29.19 17.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.18 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.41 -37.27 3.36 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.14 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 5.1 pttm -102.04 179.61 4.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 111.139 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 176' ' ' TYR . 1.3 m-85 -110.19 115.21 29.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.801 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -58.45 134.83 57.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.899 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.8 pt -95.05 -16.63 7.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.415 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.04 25.96 4.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.024 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -150.13 110.05 4.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.817 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 22.0 t -124.49 139.67 50.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.173 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -96.5 -5.58 58.93 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.831 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.417 ' CG1' ' N ' ' A' ' 184' ' ' ASP . 0.3 OUTLIER -51.85 -42.6 33.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.927 0.394 . . . . 0.0 111.36 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.417 ' N ' ' CG1' ' A' ' 183' ' ' VAL . 37.2 t0 -105.2 65.55 0.73 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.91 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.11 -168.84 1.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -74.81 -39.22 61.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.142 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -85.89 -37.85 9.05 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.468 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.21 -30.61 69.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.809 0.337 . . . . 0.0 111.163 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.44 -49.82 76.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.919 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.23 -27.88 66.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.201 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -58.18 -56.59 24.36 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.545 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 6.9 tp -59.57 -50.44 73.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.77 0.319 . . . . 0.0 110.893 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.39 -24.72 57.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.07 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -66.84 -60.5 2.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.824 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.8 tp -57.55 -31.85 66.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.657 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.8 t -61.73 -61.58 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.983 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.62 -27.73 68.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.848 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mt -60.28 -46.6 89.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.99 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 5.1 mt -64.35 -30.02 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.171 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.87 -30.33 26.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.367 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -98.65 -6.44 29.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.8 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -117.58 -9.82 10.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.588 0.232 . . . . 0.0 111.546 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 24.9 m80 62.96 41.48 8.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.873 0.368 . . . . 0.0 110.61 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.96 134.73 35.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.88 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -74.47 122.73 23.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -73.09 -13.84 61.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.449 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -83.93 3.96 31.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.537 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 56.5 m -52.53 144.6 13.2 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.769 0.319 . . . . 0.0 111.12 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.405 ' HB2' ' CG1' ' A' ' 212' ' ' ILE . 1.5 m-20 -153.65 176.39 12.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.048 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.409 ' OH ' ' CZ2' ' A' ' 230' ' ' TRP . 0.8 OUTLIER -46.0 -62.95 1.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.406 -179.506 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.23 -59.04 6.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.599 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.456 HD13 HG21 ' A' ' 212' ' ' ILE . 0.0 OUTLIER -55.81 -33.46 34.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.21 -179.428 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -81.91 -25.54 34.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.779 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.34 -47.2 12.62 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.975 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.23 -32.16 62.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.253 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.47 -25.18 50.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.217 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.446 ' CD2' ' CG2' ' A' ' 225' ' ' THR . 1.1 t80 -69.3 -62.66 1.29 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.991 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -68.94 -45.57 70.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.03 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.41 -29.4 66.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.959 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.57 41.28 10.04 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.514 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -89.19 -31.31 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.794 0.33 . . . . 0.0 110.893 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 11.0 t -124.64 163.17 22.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.934 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -90.26 -35.24 15.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.032 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -130.5 163.22 27.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.818 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.446 ' CG2' ' CD2' ' A' ' 217' ' ' PHE . 1.8 t -166.72 162.67 16.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.97 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.9 mt -111.61 118.8 58.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.021 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -144.27 165.42 27.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.924 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -98.59 -174.76 32.46 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.536 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.12 -24.67 27.77 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.562 2.175 . . . . 0.0 112.415 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.409 ' CZ2' ' OH ' ' A' ' 210' ' ' TYR . 24.7 p90 -59.03 -30.83 68.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.91 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -71.33 -26.68 62.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.191 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 27.6 m0 -55.83 -39.62 71.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.981 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.6 m -69.47 -31.7 70.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -69.67 -35.85 75.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.924 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 22.7 mt -75.83 116.52 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.079 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -173.31 -42.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.933 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.41 -55.51 13.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 20.9 t -63.67 -28.68 70.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.941 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt 60.84 76.01 0.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.902 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 22.6 t -121.08 112.21 34.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.045 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.04 108.87 1.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.942 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -117.3 145.13 44.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.844 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -117.63 179.15 17.22 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.513 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.56 128.84 74.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 0.0 111.13 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.9 t -143.03 159.28 42.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.956 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.62 152.06 7.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.01 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.85 145.25 91.68 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.833 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.418 ' HB2' ' CD1' ' A' ' 129' ' ' TRP . 51.0 Cg_exo -53.7 137.29 66.91 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.477 2.118 . . . . 0.0 112.267 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 1.3 p -77.08 160.6 28.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -145.37 126.62 14.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt 62.26 18.01 9.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.287 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.24 38.66 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.888 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.84 149.29 37.01 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.731 0.3 . . . . 0.0 110.873 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.66 162.07 42.62 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.509 2.139 . . . . 0.0 112.229 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 39.7 p -71.14 179.59 2.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.832 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -128.84 58.07 33.91 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.84 136.47 32.88 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.548 2.165 . . . . 0.0 112.316 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.497 ' CZ ' ' CD1' ' A' ' 158' ' ' TRP . 85.9 m-85 -59.51 140.1 56.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.978 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.68 145.76 12.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -134.81 108.42 0.71 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.469 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 7.4 p -88.74 160.84 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 0.0 111.152 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 9.6 tp -121.62 131.43 54.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.77 169.43 19.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.964 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -105.4 127.36 52.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.058 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -90.44 148.21 19.5 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.537 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 31.3 mt -127.3 115.76 41.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.861 0.362 . . . . 0.0 111.125 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -77.05 135.88 38.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.912 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.77 -30.43 71.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.132 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -58.98 -30.98 68.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.7 111.18 8.12 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.87 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -68.27 -14.05 39.39 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.402 2.068 . . . . 0.0 112.583 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -84.47 57.22 4.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.939 0.4 . . . . 0.0 110.942 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.6 tppm? -82.77 -36.75 25.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -59.95 -49.18 78.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 37.4 mt -71.08 -33.33 70.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.968 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.34 93.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.044 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -63.14 -54.17 41.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -62.9 -33.28 74.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -69.64 -46.74 65.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.047 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 79.9 mt -81.42 -21.67 38.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.383 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -93.66 -48.21 6.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.765 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -103.77 18.05 22.77 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.605 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -163.47 52.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.879 0.371 . . . . 0.0 111.213 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 7.1 tp -174.83 -65.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.897 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.417 HD13 ' CZ ' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -84.95 58.41 5.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.947 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.23 -179.09 5.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.881 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.75 -36.97 31.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -75.76 -31.05 59.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.907 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -79.42 -52.1 4.95 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.532 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.411 HD11 ' CD2' ' A' ' 307' ' ' TYR . 10.1 mt -60.04 -35.35 74.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.819 0.342 . . . . 0.0 110.958 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -59.96 -44.02 94.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.29 -53.68 51.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.12 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.8 t -59.64 -47.14 92.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.128 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -66.44 -31.6 72.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.914 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 2.4 mtmm -63.1 -33.9 76.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.942 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -98.82 -32.43 11.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.024 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -154.49 95.12 2.72 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.915 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.81 123.65 11.63 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.488 2.125 . . . . 0.0 112.314 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.38 17.44 11.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.133 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 81.78 -142.8 22.87 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.59 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -58.41 174.94 0.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 111.192 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 13.4 m -140.47 133.14 32.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.111 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -59.46 -33.79 71.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.208 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 14.0 tp -60.16 114.86 3.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -60.14 -30.67 69.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.951 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 32.6 m -70.36 -39.39 74.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.935 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.411 ' CD2' HD11 ' A' ' 290' ' ' LEU . 1.0 OUTLIER -86.22 -26.76 24.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.014 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -59.89 -31.7 70.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.807 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -69.76 -54.51 13.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.862 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.73 -34.74 19.82 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.788 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.3 mt -85.72 -26.63 25.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.697 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -70.53 -12.3 61.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.439 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -47.76 -31.77 5.21 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.925 0.393 . . . . 0.0 110.81 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -116.11 140.26 26.13 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.35 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.52 -24.82 55.25 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.384 2.056 . . . . 0.0 112.414 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -50.96 -41.48 59.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.008 0.433 . . . . 0.0 110.302 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 30.1 mm -85.55 -32.72 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.882 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -69.11 -29.63 67.74 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.233 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.33 -30.65 66.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.151 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 56.6 m -84.61 -36.35 22.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 6.8 tpt -64.41 -40.21 95.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -59.92 -43.73 94.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.931 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -79.26 -29.13 42.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.023 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.6 -39.96 94.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.19 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -71.65 -55.01 8.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.994 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.13 -47.33 74.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.836 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -58.99 147.71 40.9 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.482 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -86.22 149.85 24.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.337 . . . . 0.0 110.911 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.408 HD12 HG21 ' A' ' 329' ' ' ILE . 28.4 mt -87.98 141.96 13.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.085 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 71.6 mtm -63.84 124.16 84.06 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.944 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -56.38 -164.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.38 2.053 . . . . 0.0 112.261 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -150.61 30.82 0.66 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 31.5 pt -117.86 153.73 51.01 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.108 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.51 -20.36 70.38 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.606 2.204 . . . . 0.0 112.445 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -60.39 -27.46 67.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.099 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.418 ' HE1' ' CH2' ' A' ' 340' ' ' TRP . 1.4 tpt -74.78 -30.21 61.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.074 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.84 -44.98 86.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.001 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -63.52 -29.93 71.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.108 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.439 ' CE1' ' CG2' ' A' ' 343' ' ' VAL . 11.9 t80 -59.45 -48.6 81.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.973 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . 0.418 ' CH2' ' HE1' ' A' ' 336' ' ' MET . 24.2 m95 -59.01 -30.27 67.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.044 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -81.31 -44.17 18.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.046 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -61.83 -61.66 2.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.269 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.439 ' CG2' ' CE1' ' A' ' 339' ' ' PHE . 21.9 t -58.39 -23.73 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.427 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.84 -57.41 12.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.093 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 26.4 m -72.18 -30.27 64.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.107 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.27 -50.79 66.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.289 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 33.3 t -62.91 -45.27 99.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.249 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 27.6 mt -67.85 -42.59 86.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.113 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -58.13 -45.71 86.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.985 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -74.57 -28.71 61.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.197 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.19 -35.98 76.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.268 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.09 20.76 9.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.185 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 55.82 26.0 46.11 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.602 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -82.03 -30.44 31.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.866 0.365 . . . . 0.0 110.941 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -145.42 174.75 10.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 41.0 p -100.47 151.64 21.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 40.5 t -55.91 -27.41 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.053 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -73.81 -47.71 36.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.82 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -35.4 62.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.051 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.0 -56.7 13.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.971 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 92.1 mt -61.63 -29.81 70.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.818 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -56.14 25.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.887 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -63.78 -47.62 80.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.932 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -61.61 -52.84 62.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.151 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 15.6 tm0? -57.36 -30.49 64.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.005 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 60.5 m -82.62 -33.41 27.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.952 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -66.99 -33.81 76.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.936 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.428 HD13 ' CE2' ' A' ' 339' ' ' PHE . 5.2 mt -65.92 -30.13 49.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.04 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.7 p -80.14 -29.94 38.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 34.3 mttp . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.895 180.0 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.86 0.362 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.5 t -118.24 133.31 56.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.94 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -170.68 35.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.914 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -143.9 -166.37 2.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.785 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -84.91 56.02 5.0 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.463 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.08 -178.38 5.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.754 0.312 . . . . 0.0 110.938 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.2 mt -145.83 118.38 8.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.1 t -92.2 132.46 36.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.118 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.3 mt -121.56 107.2 19.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.446 ' CG ' ' CG ' ' A' ' 57' ' ' PRO . 0.9 OUTLIER -94.89 112.98 24.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.871 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.8 tt -144.93 146.16 20.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.105 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -66.26 161.57 21.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.858 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.13 55.99 4.97 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.512 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -153.34 36.03 0.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.795 0.331 . . . . 0.0 110.897 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.44 179.94 7.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.92 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.2 66.92 3.11 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.505 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 12.2 p90 -79.47 -31.4 42.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.821 0.344 . . . . 0.0 110.911 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.445 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 51.7 t-20 -60.49 -32.92 71.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.944 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.65 -28.59 51.06 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.493 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.0 tp -69.27 -33.46 73.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.865 0.364 . . . . 0.0 110.906 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.23 -40.83 91.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.119 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.4 -33.1 70.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.035 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.1 t -70.91 -32.74 49.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.11 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.63 -33.07 63.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.489 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -66.86 -29.44 69.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.845 0.355 . . . . 0.0 110.937 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.14 -40.13 46.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -58.3 -54.67 44.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.959 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -37.56 77.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.941 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -72.01 -26.3 62.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.975 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -82.95 -31.79 27.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.523 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 17.3 p -138.14 -44.22 0.51 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.611 0.243 . . . . 0.0 111.594 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.53 -20.2 2.95 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.689 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.3 mm -59.94 114.68 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.807 0.337 . . . . 0.0 111.047 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.3 mttp -82.69 170.13 15.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.988 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.28 125.51 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.104 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 m -116.6 125.1 51.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -105.15 127.95 59.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -115.49 153.68 30.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.861 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -117.83 70.27 7.19 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.409 ' HG3' ' CD2' ' A' ' 10' ' ' TRP . 88.0 Cg_endo -77.07 174.53 12.68 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.685 2.256 . . . . 0.0 112.475 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -60.94 -156.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.474 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.429 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -46.95 -26.49 1.01 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.516 0.198 . . . . 0.0 111.457 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 42' ' ' LYS . 0.3 OUTLIER 54.77 18.11 2.0 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.879 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -79.17 -55.78 4.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.834 0.349 . . . . 0.0 110.782 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -93.67 -7.8 42.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.363 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.71 -19.17 45.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.385 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.416 ' CB ' ' HD3' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -84.46 -53.36 0.51 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.197 -179.762 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.416 ' HD3' ' CB ' ' A' ' 47' ' ' PHE . 32.6 Cg_exo -57.84 -32.44 94.97 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.485 2.123 . . . . 0.0 112.37 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.428 ' CG ' ' N ' ' A' ' 50' ' ' VAL . 11.4 pt20 -61.31 -47.07 87.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.058 0.456 . . . . 0.0 111.016 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.428 ' N ' ' CG ' ' A' ' 49' ' ' GLN . 4.1 m -95.1 27.05 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.484 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.16 -32.18 30.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.348 . . . . 0.0 111.2 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.52 -32.82 19.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.171 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 51.6 p -72.73 -31.4 64.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.93 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.89 26.08 46.79 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.563 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -96.24 -28.66 14.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.808 0.337 . . . . 0.0 110.895 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.97 166.14 3.98 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.665 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.446 ' CG ' ' CG ' ' A' ' 10' ' ' TRP . 50.0 Cg_exo -53.38 -172.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.681 2.254 . . . . 0.0 112.38 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 p30 -109.48 -29.02 8.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.953 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.9 mt -132.13 157.08 43.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.205 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.481 ' CG1' ' N ' ' A' ' 61' ' ' PHE . 2.0 tt -163.35 159.36 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.133 0.492 . . . . 0.0 110.897 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.481 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 3.9 m-85 -132.73 124.95 29.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.835 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.6 t-105 -159.41 171.43 19.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.851 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.7 134.04 55.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.163 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -58.56 -31.0 67.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.97 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -59.89 -29.97 68.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.988 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -88.48 -30.27 19.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.923 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -58.36 -30.12 66.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.968 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.81 -27.47 61.83 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.578 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.33 -28.45 71.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.488 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -87.22 -30.16 21.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.815 0.34 . . . . 0.0 110.947 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.18 -29.08 42.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.123 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -57.91 -29.55 65.19 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.063 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.55 -23.15 17.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.085 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.02 28.4 9.36 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.515 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.5 mt -81.81 -32.63 31.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.852 0.358 . . . . 0.0 110.913 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 38.5 mt -76.0 160.68 29.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.896 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.77 133.0 47.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.453 ' CG ' ' N ' ' A' ' 79' ' ' ILE . 19.3 tt0 -61.36 164.01 6.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.722 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.453 ' N ' ' CG ' ' A' ' 78' ' ' GLU . 43.1 pt -141.22 177.6 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.145 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -162.03 77.9 2.08 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.802 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.51 135.92 41.02 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.555 2.17 . . . . 0.0 112.318 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.39 173.42 0.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -62.39 -48.47 79.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.64 -31.3 69.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.121 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -71.08 -44.26 66.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.89 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -64.08 -44.76 91.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.904 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -65.8 -29.75 70.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.94 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -59.62 -45.35 92.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.945 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.422 HD13 ' CZ2' ' A' ' 94' ' ' TRP . 46.3 mt -88.23 173.64 8.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.879 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.432 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . 10.6 m-85 -81.57 149.55 64.83 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.063 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.33 -55.93 2.45 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.637 2.225 . . . . 0.0 112.706 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.454 ' CE1' ' CG2' ' A' ' 93' ' ' THR . 50.8 p90 -56.55 -44.12 80.58 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.771 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.454 ' CG2' ' CE1' ' A' ' 92' ' ' PHE . 39.3 p -54.49 -28.07 42.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.74 0.305 . . . . 0.0 111.116 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.422 ' CZ2' HD13 ' A' ' 89' ' ' LEU . 49.6 m95 -76.83 -46.09 26.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.821 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.73 -26.53 67.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.069 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.71 -28.74 63.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.279 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.2 m -107.42 64.58 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.22 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -156.06 120.07 4.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.98 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -118.93 136.48 54.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.781 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 62.64 17.94 10.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.18 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.79 21.9 56.75 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.947 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.05 156.43 48.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.832 0.349 . . . . 0.0 110.994 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 mt -93.8 142.67 27.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.6 pp -159.0 36.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.206 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.79 176.91 10.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.186 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -139.34 87.4 13.63 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.81 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -51.77 102.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.571 2.18 . . . . 0.0 112.327 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.7 mm -76.67 -64.27 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.095 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -131.88 171.63 13.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.078 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.28 148.11 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.055 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.77 159.8 37.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.961 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -169.07 145.25 3.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.107 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.2 mt -62.56 108.39 1.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.1 m -92.56 161.83 14.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.0 tp -109.3 102.12 11.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.907 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.7 mp -91.94 131.46 38.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.131 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.419 ' CD1' ' HG2' ' A' ' 125' ' ' PRO . 46.1 p90 -113.51 165.51 12.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.949 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -109.84 106.16 15.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.821 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -58.58 -22.86 57.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -55.04 -32.81 62.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.113 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.86 -42.03 1.43 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.201 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.4 tp -104.85 90.67 3.68 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.009 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.84 -43.83 2.37 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.532 2.155 . . . . 0.0 112.283 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -126.51 91.37 47.69 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.419 ' HG2' ' CD1' ' A' ' 117' ' ' TYR . 75.6 Cg_exo -50.58 151.83 9.9 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.586 2.191 . . . . 0.0 112.357 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.76 119.5 5.46 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.566 2.178 . . . . 0.0 112.366 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.05 -21.22 62.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.036 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 12.0 p -100.86 146.1 27.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.903 0.382 . . . . 0.0 111.058 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.42 ' CZ3' HD12 ' A' ' 132' ' ' ILE . 4.4 m95 -77.36 -28.44 52.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.958 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.96 -15.74 60.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.526 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -89.19 -21.94 23.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.528 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.49 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 41.4 mt -59.76 -46.99 98.44 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.49 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 75.7 Cg_exo -49.5 -45.17 32.06 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.412 2.075 . . . . 0.0 112.416 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.26 -38.71 92.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.05 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.34 -33.59 76.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.865 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -63.77 -24.4 67.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.1 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -85.53 -31.67 22.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.115 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -85.01 -47.11 10.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.208 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.14 -17.87 59.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.394 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.32 -27.92 53.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.736 0.303 . . . . 0.0 110.879 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.6 -41.69 90.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.05 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.7 mtpt -72.59 -27.11 61.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.017 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 114.51 29.4 2.71 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.504 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt -141.75 166.99 23.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.844 0.354 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.0 t -97.71 159.13 15.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.871 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -85.45 -32.07 22.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.17 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.404 ' CD1' ' CB ' ' A' ' 224' ' ' MET . 1.0 OUTLIER -169.98 124.1 0.75 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.018 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -129.43 166.65 19.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.59 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.8 p90 179.01 -170.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.803 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -89.14 109.64 20.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.905 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 13.7 mt -88.97 -29.13 19.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.952 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -59.17 -31.46 69.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.885 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.38 111.28 59.45 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.6 -23.48 19.8 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.428 2.085 . . . . 0.0 112.318 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.496 ' CE1' ' CD1' ' A' ' 258' ' ' PHE . 0.3 OUTLIER -50.6 -27.41 6.78 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.232 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -96.81 -22.47 16.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.219 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.2 p -92.35 11.75 24.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.398 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.462 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 22.8 t-105 -87.58 -47.45 0.48 Allowed Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.309 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 53.7 Cg_exo -52.52 -23.32 18.95 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.374 2.049 . . . . 0.0 112.574 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.6 tp -86.02 -67.38 0.81 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.103 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 5.4 mt -57.73 -41.69 80.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.237 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -59.8 -38.27 81.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.197 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -57.79 -36.17 71.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.229 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.94 -20.18 56.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.169 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 130.04 -22.0 4.86 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.636 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -69.32 154.65 53.25 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.496 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.433 ' CD1' ' HA3' ' A' ' 182' ' ' GLY . 25.6 p90 -148.85 -175.13 4.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 0.0 110.926 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.425 ' HB2' ' CE1' ' A' ' 339' ' ' PHE . . . -111.31 -48.9 3.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.024 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -130.28 127.53 39.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.828 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 167' ' ' TYR . 11.1 tttm -94.65 112.79 24.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.092 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -68.93 110.89 4.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.544 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -172.48 156.06 3.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.961 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 62.73 46.23 5.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.007 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 104.09 -62.27 0.4 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.723 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -151.09 -171.47 3.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 111.009 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -59.49 125.9 25.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.9 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -82.19 127.51 33.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.876 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.2 pt -73.18 -27.6 24.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.202 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -97.25 26.04 5.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.052 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -125.44 96.35 4.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.921 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 23.5 t -96.29 146.01 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.111 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' A' ' 167' ' ' TYR . . . -114.71 -7.04 18.57 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.995 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.432 HG12 ' CD2' ' A' ' 361' ' ' LEU . 11.1 t -56.51 -43.31 77.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.866 0.333 . . . . 0.0 111.181 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.06 57.26 4.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.919 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -104.61 -178.87 3.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.75 -52.15 22.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.108 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -76.82 -29.59 57.2 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.561 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.29 -33.93 69.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.829 0.347 . . . . 0.0 111.122 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.59 -31.2 72.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -87.47 -36.86 17.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.137 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -60.29 -46.85 93.52 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.461 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.33 -45.93 91.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.831 0.348 . . . . 0.0 110.854 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 91.7 m -67.02 -24.28 66.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.977 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.404 ' CE2' HD12 ' A' ' 198' ' ' LEU . 24.7 t80 -59.27 -60.67 3.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.812 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.7 tp -61.18 -30.29 70.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.554 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 49.1 t -69.86 -43.28 79.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.005 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.34 -24.32 34.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.133 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.404 HD12 ' CE2' ' A' ' 194' ' ' PHE . 0.7 OUTLIER -63.87 -35.21 79.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.033 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 12.4 mt -77.75 -33.74 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.3 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 4.0 mtpp -85.07 -28.99 25.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.146 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -91.39 -10.18 42.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.558 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.424 ' O ' ' CG ' ' A' ' 203' ' ' HIS . 13.1 mmtm -130.83 9.02 4.9 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.5 0.191 . . . . 0.0 111.49 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . 0.424 ' CG ' ' O ' ' A' ' 202' ' ' LYS . 40.1 p-80 43.67 52.96 6.16 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.888 0.375 . . . . 0.0 111.426 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 48.0 mtp -82.76 133.51 35.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -59.37 119.75 8.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.073 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -80.07 -29.77 39.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.059 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.74 -20.85 52.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.222 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 7.2 m -45.16 149.31 0.5 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.916 0.388 . . . . 0.0 111.398 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -154.07 176.28 12.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.661 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 211' ' ' SER . 0.3 OUTLIER -62.96 -30.48 71.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.93 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.454 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 0.7 OUTLIER -68.78 -59.21 3.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.953 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -28.85 38.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.358 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -74.07 -33.61 63.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.781 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.75 -28.63 30.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.53 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.37 -36.42 83.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.474 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.433 ' HA ' ' HA3' ' A' ' 220' ' ' GLY . . . -52.46 -25.22 9.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.307 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -66.92 -53.9 27.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.979 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -90.06 -13.96 34.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.03 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -176.84 101.85 0.05 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.979 0.419 . . . . 0.0 111.275 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 216' ' ' ALA . . . 149.73 -46.85 0.64 Allowed Glycine 0 N--CA 1.453 -0.229 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.049 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 63.97 101.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.944 0.402 . . . . 0.0 111.561 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 13.3 t -116.05 124.89 51.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.374 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -45.92 -32.64 2.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.604 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.404 ' CB ' ' CD1' ' A' ' 147' ' ' LEU . 26.3 mtm -156.89 142.54 17.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.914 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 4.1 t -164.3 126.24 2.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.0 mt -95.71 126.99 48.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.096 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -141.28 165.49 27.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -82.48 -170.94 46.06 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.496 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.414 ' HD2' ' CE3' ' A' ' 230' ' ' TRP . 74.1 Cg_endo -74.99 -2.89 13.13 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.638 2.225 . . . . 0.0 112.751 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.414 ' CE3' ' HD2' ' A' ' 229' ' ' PRO . 39.0 p90 -95.97 34.08 1.6 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.694 0.283 . . . . 0.0 111.104 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -136.86 11.29 3.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.557 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 8.7 m0 -81.19 -39.43 25.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.808 0.337 . . . . 0.0 110.965 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.45 -29.92 68.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.024 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.71 -30.45 65.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.993 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.409 HG23 ' CE1' ' A' ' 242' ' ' TYR . 4.4 mt -88.63 84.67 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.071 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -160.76 37.19 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.915 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -165.71 -43.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.957 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 82.8 p -63.08 -30.68 71.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.964 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 7.4 mmtm 61.09 36.05 18.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 20.8 t -95.41 121.73 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.105 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -61.98 111.97 2.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.868 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.409 ' CE1' HG23 ' A' ' 235' ' ' ILE . 50.8 p90 -109.26 146.96 33.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.91 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -126.14 147.19 16.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.492 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 20.8 t -110.18 127.05 67.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.814 0.34 . . . . 0.0 111.126 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.3 t -143.61 146.81 33.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.419 ' CG2' ' N ' ' A' ' 247' ' ' LEU . 0.7 OUTLIER -55.17 152.31 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.217 0.532 . . . . 0.0 111.32 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.419 ' N ' ' CG2' ' A' ' 246' ' ' VAL . 13.5 mt -72.08 147.62 91.04 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.946 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.43 166.45 19.47 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.535 2.157 . . . . 0.0 112.282 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 4.5 p -110.32 162.2 14.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.943 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -117.24 110.58 18.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.913 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 9.1 mttm 59.84 25.3 14.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.042 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 92.93 -21.07 41.61 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.714 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -80.48 126.59 78.26 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.539 0.209 . . . . 0.0 110.832 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.76 143.88 30.5 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.433 2.089 . . . . 0.0 112.34 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 89.7 p -60.64 -178.29 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.777 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.406 ' N ' ' HD3' ' A' ' 257' ' ' PRO . 11.6 mttp -136.99 62.25 38.82 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.014 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 256' ' ' LYS . 35.7 Cg_exo -57.43 -161.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.497 2.131 . . . . 0.0 112.207 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.496 ' CD1' ' CE1' ' A' ' 155' ' ' TYR . 63.1 m-85 -122.3 136.89 54.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.821 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 25.8 t -97.15 117.82 42.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.178 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -114.61 114.23 3.2 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.405 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.84 142.34 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.849 0.357 . . . . 0.0 111.151 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 14.8 tp -101.76 81.44 2.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.724 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 14.9 p -85.32 166.2 16.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.971 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -99.72 148.37 24.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.055 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -125.26 131.4 7.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.521 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 3.9 mp -124.13 102.4 10.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.789 0.328 . . . . 0.0 111.064 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -59.59 148.33 33.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.993 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -60.74 -30.55 70.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.092 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.83 57.1 4.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.014 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 8.0 m -145.56 93.29 5.35 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.84 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -48.64 -26.72 9.67 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.585 2.19 . . . . 0.0 112.464 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -86.21 56.24 3.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.835 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.27 -49.64 9.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.905 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -60.04 -43.72 95.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.864 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 46.6 mt -66.06 -32.18 73.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.8 -44.27 86.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.074 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.11 -49.39 74.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -63.05 -32.31 73.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.89 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -69.57 -47.59 63.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.97 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.6 mt -81.49 -21.17 38.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.383 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -93.61 -48.25 6.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.793 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -102.99 17.72 23.39 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.519 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -163.81 44.59 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.884 0.373 . . . . 0.0 111.193 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.1 tp -177.95 -55.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 3.0 mt -89.99 52.56 2.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.7 p -138.31 -178.17 5.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -71.54 -43.27 66.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.888 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -82.72 -33.62 27.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -60.55 -61.88 6.59 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.563 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.41 ' HB3' ' CE2' ' A' ' 307' ' ' TYR . 2.8 mt -60.96 -34.27 74.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.333 . . . . 0.0 110.917 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.94 -41.99 93.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.94 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -59.5 -36.4 75.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.14 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.6 t -85.4 -30.67 6.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -59.77 -36.0 75.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -66.88 -32.72 74.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -89.46 -32.75 17.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.961 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -162.65 91.53 1.27 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.983 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.66 123.68 10.72 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.499 2.133 . . . . 0.0 112.315 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 3.1 mp -93.33 16.87 12.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.11 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 59.09 -116.93 9.51 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.542 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -59.58 155.71 14.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.861 0.362 . . . . 0.0 111.093 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.412 HG22 ' CD2' ' A' ' 307' ' ' TYR . 16.7 m -141.1 156.16 21.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.162 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -69.87 -36.2 75.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.098 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 9.2 tp -61.35 122.32 14.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -70.05 -27.28 64.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.009 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 69.0 m -81.25 -27.61 35.11 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.149 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.412 ' CD2' HG22 ' A' ' 302' ' ' VAL . 8.3 t80 -83.06 -31.24 27.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.24 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -30.71 69.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.881 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -69.8 -50.23 45.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.891 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -51.22 -39.46 56.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.75 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 72.4 mt -85.68 -23.05 27.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.866 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.99 -14.95 61.66 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.491 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -46.41 -30.61 2.22 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.891 0.377 . . . . 0.0 110.912 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.89 142.04 27.79 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.339 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.42 -33.52 96.43 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.476 2.117 . . . . 0.0 112.521 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -49.18 -37.15 21.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.007 0.432 . . . . 0.0 110.364 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 33.1 mm -85.56 -34.33 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.876 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.3 -31.81 72.84 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.154 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.09 -45.75 83.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.175 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 60.3 m -61.34 -35.24 76.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 2.9 tpt -66.38 -46.62 76.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -62.76 -33.68 75.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -75.33 -32.19 60.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.45 -45.38 72.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.045 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -59.67 -31.54 69.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.854 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -96.59 21.12 9.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.145 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -117.15 135.95 12.29 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.524 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -79.27 143.03 35.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.781 0.324 . . . . 0.0 110.886 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 26.0 mt -75.76 133.88 30.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.142 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 27.4 mtm -60.29 125.63 82.16 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.778 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.77 172.06 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.352 2.035 . . . . 0.0 112.245 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -132.35 41.03 3.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.432 HG23 HD12 ' A' ' 333' ' ' ILE . 31.7 pt -117.56 143.98 33.29 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.108 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.49 -23.84 49.91 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.595 2.196 . . . . 0.0 112.426 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.13 -22.46 40.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.203 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 37.8 mtp -54.66 -24.2 20.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.288 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 44.7 m -57.14 -36.89 71.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.085 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -82.41 -28.19 31.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.189 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.442 ' CE1' ' CG2' ' A' ' 343' ' ' VAL . 79.7 t80 -57.4 -31.22 65.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.979 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -62.74 -61.0 2.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.018 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -63.2 -27.96 69.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.131 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -73.44 -38.24 65.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.351 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.442 ' CG2' ' CE1' ' A' ' 339' ' ' PHE . 25.9 t -88.58 -46.35 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.299 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 7.1 ttt180 -55.75 -57.36 12.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.129 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 29.8 m -61.97 -27.25 68.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.115 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -76.3 -32.66 58.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.322 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 33.0 t -82.71 -42.68 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.282 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 17.4 mt -62.31 -59.05 4.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.125 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -59.6 -30.36 68.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.935 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -73.56 -52.06 14.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.112 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.26 -32.2 72.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.137 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.25 -22.4 64.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.092 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 103.45 -27.21 20.85 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.573 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -58.97 -77.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.882 0.372 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -65.55 140.89 58.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.844 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 78.2 p -87.92 178.02 6.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.787 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 23.3 t -77.62 -55.11 11.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.945 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -47.69 -33.0 6.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.319 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -82.08 -45.79 14.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.143 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -57.43 -60.46 3.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.052 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.432 ' CD2' HG12 ' A' ' 183' ' ' VAL . 7.3 mt -58.7 -27.29 64.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.074 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -81.2 -37.06 29.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.955 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -70.36 -45.53 65.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.863 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.2 -30.78 66.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.11 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -69.39 -30.46 68.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 7.0 m -85.05 -30.14 24.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.051 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -74.19 -41.99 60.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.0 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 12.4 mt -73.48 -28.92 26.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.218 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 79.6 p -90.98 -46.09 8.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.867 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.932 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.81 0.338 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -120.97 178.24 4.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.917 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -93.04 168.73 10.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.79 36.43 87.12 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.481 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.8 170.32 21.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.848 0.356 . . . . 0.0 110.949 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.6 mt -140.38 124.51 17.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.88 106.97 21.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.059 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.706 HG21 HD21 ' A' ' 20' ' ' LEU . 4.0 mp -99.26 121.23 49.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.578 ' CE3' HD13 ' A' ' 43' ' ' LEU . 1.4 m0 -91.23 133.7 35.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.984 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.535 HG23 ' HB3' ' A' ' 39' ' ' HIS . 9.4 tp -125.01 159.56 31.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.962 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.404 ' N ' HG13 ' A' ' 11' ' ' ILE . 26.6 m-20 -93.49 31.71 1.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.159 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.45 ' H ' HG23 ' A' ' 11' ' ' ILE . . . 47.46 37.77 12.97 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.06 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -178.64 53.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.846 0.355 . . . . 0.0 111.004 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.401 ' CB ' HD11 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -179.75 78.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.865 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.47 49.8 73.17 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.534 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 36.3 p90 -78.99 -38.83 35.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.813 0.339 . . . . 0.0 110.919 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.438 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 2.6 t30 -86.92 -31.68 20.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.949 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.57 -37.44 68.41 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.531 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.706 HD21 HG21 ' A' ' 9' ' ' ILE . 4.9 tp -63.75 -32.23 73.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.856 0.36 . . . . 0.0 110.949 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.67 -31.23 72.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.081 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -63.51 -43.64 96.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.912 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.87 -35.44 60.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.109 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.412 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . -65.96 -43.73 93.05 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.445 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -59.73 -25.62 64.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.772 0.32 . . . . 0.0 111.002 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -82.58 -38.95 22.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.991 0.424 . . . . 0.0 110.882 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.34 -50.13 73.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.029 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -38.39 81.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.93 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.06 -25.12 64.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.095 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -88.38 -32.49 18.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.372 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.0 p -136.65 -44.14 0.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.375 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.67 20.61 4.94 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.657 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.56 HG21 HD13 ' A' ' 275' ' ' LEU . 32.9 mm -85.78 126.72 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.852 0.358 . . . . 0.0 111.043 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -65.45 148.68 51.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.412 HG21 ' HA2' ' A' ' 24' ' ' GLY . 21.5 t -143.38 104.36 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.09 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.6 m -109.54 150.6 27.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.999 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 9' ' ' ILE . 21.6 t -133.15 127.83 55.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.064 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -126.26 155.56 41.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.91 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.535 ' HB3' HG23 ' A' ' 11' ' ' ILE . 7.6 p80 -135.96 70.22 63.92 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.851 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.523 ' HG2' HD22 ' A' ' 43' ' ' LEU . 44.4 Cg_endo -68.77 170.27 15.73 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.584 2.189 . . . . 0.0 112.468 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -108.34 141.42 40.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.717 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.98 32.94 19.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.663 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.623 HD11 ' HZ3' ' A' ' 62' ' ' TRP . 2.3 pp -77.34 -0.78 26.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.699 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -56.98 -57.09 14.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.784 0.326 . . . . 0.0 111.16 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -88.41 -25.64 22.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.185 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.532 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -74.0 -18.97 60.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.295 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.462 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 78.4 t80 -74.07 -56.33 2.72 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.504 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 40.6 Cg_endo -67.0 -23.91 46.05 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.298 1.998 . . . . 0.0 112.883 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -65.12 -46.03 82.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.873 0.368 . . . . 0.0 111.155 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.532 HG22 ' O ' ' A' ' 46' ' ' LYS . 5.8 m -87.06 -28.99 5.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.314 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.463 ' HB1' ' OD1' ' A' ' 267' ' ' ASN . . . -56.9 -29.61 63.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.261 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.59 -33.37 71.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.13 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.2 p -93.87 -30.78 14.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.949 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.73 25.61 24.77 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.59 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -94.44 -32.97 13.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.869 0.366 . . . . 0.0 110.867 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.27 -143.94 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.534 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.422 ' HG3' ' CD2' ' A' ' 10' ' ' TRP . 43.6 Cg_endo -68.09 -167.78 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.538 2.159 . . . . 0.0 112.329 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -123.75 -51.9 1.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.0 mt -109.77 138.46 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.092 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.469 ' CG1' ' N ' ' A' ' 61' ' ' PHE . 3.0 tt -125.82 159.72 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.069 0.461 . . . . 0.0 111.029 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.469 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 46.4 m-85 -135.08 125.63 26.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.932 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.623 ' HZ3' HD11 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -160.27 175.95 12.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.52 157.01 37.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.142 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.661 ' CE1' HG23 ' A' ' 329' ' ' ILE . 15.8 p-80 -57.98 -34.11 69.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.994 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.419 ' N ' ' CD2' ' A' ' 64' ' ' HIS . 16.0 t70 -60.59 -48.82 80.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.08 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.416 ' HG3' ' CD1' ' A' ' 62' ' ' TRP . 30.5 mmm180 -74.87 -27.85 60.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.021 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.402 ' CE2' ' HB2' ' A' ' 263' ' ' SER . 1.0 OUTLIER -57.65 -22.37 45.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.147 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -94.6 33.7 5.18 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.576 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -118.4 -32.49 1.35 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.51 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -88.41 -27.52 21.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.775 0.322 . . . . 0.0 110.98 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.33 -30.72 38.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.053 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.422 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 3.5 pt20 -61.05 -36.4 79.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.962 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 m -89.75 -23.06 21.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.126 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.74 59.2 0.87 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.452 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.0 mt -138.31 31.69 2.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.362 . . . . 0.0 110.961 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' A' ' 268' ' ' ALA . 14.1 mt -138.88 161.45 37.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.792 ' HB2' ' O ' ' A' ' 267' ' ' ASN . . . -97.8 151.21 20.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.058 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.469 ' CD ' HG22 ' A' ' 104' ' ' ILE . 1.0 OUTLIER -77.06 -165.37 0.55 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.93 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.441 HD13 ' N ' ' A' ' 105' ' ' ALA . 33.4 pt -157.64 171.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.085 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 79' ' ' ILE . 41.8 p -158.1 77.42 3.52 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.741 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.48 160.16 47.39 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.631 2.221 . . . . 0.0 112.347 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.35 -176.94 3.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.753 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.3 mttp -59.89 -38.94 83.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.81 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.18 -28.04 61.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.075 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -79.19 -37.69 37.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.935 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -82.14 -25.95 33.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.085 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -79.19 -40.83 29.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.163 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.452 ' NZ ' HD13 ' A' ' 285' ' ' LEU . 32.5 pttt -58.37 -39.45 79.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.083 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.707 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 24.9 mt -83.01 162.1 21.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.872 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.499 ' HB2' HG23 ' A' ' 93' ' ' THR . 26.1 m-85 -88.26 147.63 40.72 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.03 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -54.21 -55.71 3.18 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.567 2.178 . . . . 0.0 112.736 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.547 ' CE1' HG22 ' A' ' 93' ' ' THR . 40.2 p90 -54.09 -39.62 66.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.808 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.547 HG22 ' CE1' ' A' ' 92' ' ' PHE . 27.8 p -61.42 -32.98 72.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.745 0.307 . . . . 0.0 110.826 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.707 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 45.3 m95 -67.75 -32.0 72.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.793 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -60.35 -26.98 67.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.055 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.622 ' HB1' ' CB ' ' A' ' 64' ' ' HIS . . . -73.12 -28.67 62.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.258 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.612 ' CG1' ' HB3' ' A' ' 105' ' ' ALA . 3.8 m -104.05 56.24 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.936 0.398 . . . . 0.0 111.245 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -156.08 130.45 8.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.422 ' CE2' ' HB3' ' A' ' 72' ' ' GLN . 1.8 t80 -96.23 -64.74 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.838 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -127.69 45.78 2.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.795 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.16 -26.8 19.4 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.526 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.2 141.8 33.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.841 0.353 . . . . 0.0 110.88 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 32.1 mt -97.01 132.05 43.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.843 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.547 ' O ' HD12 ' A' ' 104' ' ' ILE . 2.6 pp -138.31 30.47 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.196 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.612 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . . . -173.8 178.73 2.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.152 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.806 ' OH ' HD11 ' A' ' 266' ' ' ILE . 1.1 p90 -155.74 96.09 2.4 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.807 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.63 ' HB3' HG21 ' A' ' 261' ' ' VAL . 54.0 Cg_exo -52.54 144.99 39.39 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.504 2.136 . . . . 0.0 112.424 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.612 HG23 ' CD2' ' A' ' 285' ' ' LEU . 5.4 mt -128.31 -59.3 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.047 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.526 ' HA ' HG12 ' A' ' 302' ' ' VAL . . . -105.86 145.75 30.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.096 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.478 HG22 HG23 ' A' ' 261' ' ' VAL . 32.7 t -121.18 138.36 51.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.136 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -139.47 160.08 40.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.863 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -172.31 152.74 2.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.083 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.512 HD23 ' HA2' ' A' ' 228' ' ' GLY . 5.3 mt -71.02 101.94 2.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.44 -176.52 3.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.6 tp -96.81 114.61 26.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.919 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.7 mt -108.9 114.01 45.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.004 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -124.88 165.53 17.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.906 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.39 144.51 34.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.926 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.5 mtmm -98.5 33.39 2.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.961 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -93.13 -48.12 6.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.949 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.96 -35.26 5.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.008 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.464 HD21 ' O ' ' A' ' 124' ' ' ASN . 1.6 tt -108.53 95.32 15.95 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.979 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.48 -45.24 1.26 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.484 2.123 . . . . 0.0 112.353 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.464 ' O ' HD21 ' A' ' 122' ' ' LEU . 6.3 m120 -100.34 114.71 65.81 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.51 153.01 39.11 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.416 2.077 . . . . 0.0 112.364 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.52 116.24 4.64 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.576 2.184 . . . . 0.0 112.289 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.93 -23.73 38.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.027 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 73.2 p -118.01 149.7 40.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.895 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.895 ' CE3' HD12 ' A' ' 132' ' ' ILE . 26.5 m95 -69.63 -31.27 69.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.854 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -68.8 -15.65 63.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.427 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -85.5 -16.95 37.87 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.895 HD12 ' CE3' ' A' ' 129' ' ' TRP . 24.0 mt -71.78 -49.42 10.78 Favored Pre-proline 0 C--N 1.331 -0.204 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.53 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 83.3 Cg_exo -44.99 -46.58 12.96 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.499 2.132 . . . . 0.0 112.509 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.07 -40.07 92.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.997 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.926 HD23 HD12 ' A' ' 139' ' ' LEU . 0.2 OUTLIER -64.73 -36.84 85.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.797 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.706 ' OD1' ' HB3' ' A' ' 146' ' ' ALA . 1.6 m-20 -57.76 -27.51 63.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.067 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.433 ' HE2' ' CE1' ' A' ' 203' ' ' HIS . 50.1 mttm -85.6 -31.6 22.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.069 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -85.1 -56.46 3.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.171 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.926 HD12 HD23 ' A' ' 135' ' ' LEU . 0.2 OUTLIER -55.42 -26.77 43.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.272 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -77.67 -28.26 51.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.804 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.42 -38.28 83.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.951 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 41.3 mttt -73.64 -27.12 61.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.073 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.2 32.4 1.83 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.599 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.2 mtmt -149.82 159.7 44.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 0.0 110.874 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.608 ' O ' HD22 ' A' ' 139' ' ' LEU . 84.7 p -82.33 170.11 15.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.975 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.72 ' HA ' HD13 ' A' ' 139' ' ' LEU . . . -102.67 -56.69 2.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.169 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.666 HD22 HD13 ' A' ' 132' ' ' ILE . 4.0 tp -153.54 136.32 15.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.92 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.588 ' SD ' HG21 ' A' ' 222' ' ' THR . 0.0 OUTLIER -133.87 -177.91 4.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.82 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.518 ' HZ ' HD11 ' A' ' 195' ' ' LEU . 51.1 p90 -177.25 -172.78 0.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.875 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.424 ' HB3' ' CD1' ' A' ' 156' ' ' PHE . 60.2 t-20 -83.59 114.21 21.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.941 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.4 mt -98.57 30.8 3.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.911 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -127.54 30.33 5.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -168.49 111.42 0.55 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.627 ' CB ' HG12 ' A' ' 343' ' ' VAL . 78.0 Cg_exo -50.26 -25.74 14.07 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.453 2.102 . . . . 0.0 112.353 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.494 ' CD2' ' CD2' ' A' ' 258' ' ' PHE . 0.8 OUTLIER -58.4 -31.5 67.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.424 ' CD1' ' HB3' ' A' ' 150' ' ' ASN . 13.6 m-85 -74.43 -30.53 61.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.44 ' O ' HD12 ' A' ' 161' ' ' ILE . 21.1 p -102.56 30.34 4.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.067 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.468 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 1.4 t-105 -83.59 -48.45 0.73 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.093 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.512 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 32.4 Cg_exo -58.13 -18.83 38.49 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.417 2.078 . . . . 0.0 112.497 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 15.6 tp -92.66 -32.13 14.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.155 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.661 HD13 HD12 ' A' ' 192' ' ' LEU . 15.6 mt -95.79 -58.02 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.222 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.463 ' HB1' ' HE3' ' A' ' 256' ' ' LYS . . . -56.15 -31.1 63.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.252 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -59.08 -44.82 91.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.135 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -63.73 -20.08 65.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.185 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 131.71 71.26 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.56 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -158.2 142.9 8.84 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.493 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -147.48 179.47 7.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.332 . . . . 0.0 110.999 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.635 ' HB2' ' CZ ' ' A' ' 339' ' ' PHE . . . -103.55 -33.01 9.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.983 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -141.25 155.31 46.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.793 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 9.1 tttm -103.35 111.32 23.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.057 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.437 ' CD1' ' CZ ' ' A' ' 176' ' ' TYR . 57.4 t80 -73.81 110.91 8.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.412 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -158.76 150.92 21.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.08 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 61.51 29.93 18.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.059 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 90.78 -38.54 3.2 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.014 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -108.05 -177.11 3.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.918 0.389 . . . . 0.0 111.079 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.437 ' CZ ' ' CD1' ' A' ' 171' ' ' TYR . 4.9 m-85 -108.1 121.14 44.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.921 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -58.75 132.5 54.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.7 pt -91.02 -23.63 5.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.385 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.39 26.05 4.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.15 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -141.53 90.12 2.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.919 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.72 HG11 HD13 ' A' ' 368' ' ' ILE . 16.2 t -100.75 146.01 10.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.079 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -111.0 66.55 0.23 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.652 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.947 HG12 ' CD2' ' A' ' 361' ' ' LEU . 1.5 t -103.13 -60.52 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.91 0.386 . . . . 0.0 111.064 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.498 ' HA ' HD13 ' A' ' 361' ' ' LEU . 35.1 p-10 -83.46 56.7 3.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.11 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -95.77 168.43 10.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.814 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -59.83 -34.17 72.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.113 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -85.93 -45.51 5.67 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.611 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 183' ' ' VAL . . . -58.9 -38.69 79.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.785 0.326 . . . . 0.0 111.17 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -60.07 -34.7 73.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -87.55 -30.99 20.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.168 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -58.45 -50.5 66.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.57 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.888 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.2 OUTLIER -60.77 -43.08 98.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.806 0.336 . . . . 0.0 110.931 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 9.9 m -50.19 -27.37 5.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.252 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -67.93 -58.67 4.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.811 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.518 HD11 ' HZ ' ' A' ' 149' ' ' PHE . 4.1 tp -64.76 -30.1 71.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 192' ' ' LEU . 47.6 t -66.18 -56.92 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.062 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.84 -28.41 61.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.146 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 195' ' ' LEU . 26.2 mt -59.69 -58.22 9.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.012 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 9.0 mt -61.39 -28.8 44.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.057 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.33 -35.4 66.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -90.2 16.46 8.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.44 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.84 39.12 27.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.821 0.343 . . . . 0.0 111.216 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' HIS . . . . . 0.433 ' CE1' ' HE2' ' A' ' 137' ' ' LYS . 2.8 m-70 -90.2 -23.86 21.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.888 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 13.9 mtt -132.91 -177.51 4.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.777 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -115.59 147.86 40.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.918 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -78.8 -30.52 45.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.041 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.37 60.04 4.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.783 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.587 ' HA ' HD12 ' A' ' 212' ' ' ILE . 0.2 OUTLIER -117.43 138.55 51.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.928 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.444 ' OD2' HD11 ' A' ' 212' ' ' ILE . 57.3 m-20 -154.19 176.16 12.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.732 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -64.68 -39.84 94.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.231 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.03 -59.08 3.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.876 0.369 . . . . 0.0 110.988 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.587 HD12 ' HA ' ' A' ' 208' ' ' THR . 0.3 OUTLIER -57.63 -29.11 33.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.656 179.805 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.405 ' CB ' ' HG3' ' A' ' 148' ' ' MET . . . -80.61 -22.63 40.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.961 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -77.88 -36.62 49.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.866 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -72.47 -38.2 68.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.037 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.66 -30.8 67.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.121 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -81.71 -36.88 28.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.93 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -68.28 -46.85 69.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.52 -30.1 71.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.13 43.79 1.99 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.49 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -100.3 -74.49 0.6 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.882 0.373 . . . . 0.0 110.903 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.588 HG21 ' SD ' ' A' ' 148' ' ' MET . 11.3 t -74.34 142.81 45.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.72 -30.98 46.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.049 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.422 ' SD ' HD13 ' A' ' 122' ' ' LEU . 2.1 mpp? -128.34 156.24 43.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.929 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 9.4 t -166.64 147.36 6.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.47 HD12 ' HB3' ' A' ' 149' ' ' PHE . 4.5 mt -109.85 126.51 67.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.029 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -144.92 165.43 28.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.512 ' HA2' HD23 ' A' ' 113' ' ' LEU . . . -80.96 -169.44 41.46 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.533 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.419 ' HD2' ' CZ3' ' A' ' 230' ' ' TRP . 55.1 Cg_endo -69.81 -8.98 24.99 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.562 2.175 . . . . 0.0 112.699 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' TRP . . . . . 0.427 ' CZ3' ' HA3' ' A' ' 228' ' ' GLY . 41.0 p90 -94.36 39.25 1.09 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.758 0.314 . . . . 0.0 111.09 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -113.47 -33.19 5.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.129 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 22.4 m0 -63.14 -31.42 72.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.862 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 49.6 m -60.8 -33.69 73.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.96 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.35 -50.89 72.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 18.1 pt -75.58 134.81 28.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.123 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -176.26 -40.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.69 -36.05 9.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.35 -32.69 58.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.923 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt 60.06 74.65 0.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.27 122.0 56.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.063 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -63.18 107.3 1.02 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -98.13 157.65 16.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.3 120.68 2.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.463 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.5 t -94.39 123.04 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 111.1 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 58.9 m -143.52 136.18 27.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.409 ' CG2' ' N ' ' A' ' 247' ' ' LEU . 0.7 OUTLIER -54.62 152.34 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.241 0.543 . . . . 0.0 111.328 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.409 ' N ' ' CG2' ' A' ' 246' ' ' VAL . 4.7 mt -59.62 139.47 89.5 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.884 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.423 ' HB2' ' CD1' ' A' ' 129' ' ' TRP . 51.2 Cg_exo -54.0 -172.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.504 2.136 . . . . 0.0 112.276 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 2.7 p -122.65 165.48 16.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.883 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.416 ' CD2' ' HG3' ' A' ' 251' ' ' LYS . 14.6 t80 -129.0 117.54 21.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.416 ' HG3' ' CD2' ' A' ' 250' ' ' PHE . 6.2 mtpp 59.96 31.99 20.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 73.8 27.02 67.81 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.564 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -118.85 147.81 43.16 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.7 0.286 . . . . 0.0 110.859 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.7 149.89 55.53 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.538 2.159 . . . . 0.0 112.286 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 66.9 p -73.81 159.19 33.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.463 ' HE3' ' HB1' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -121.39 54.59 4.56 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.876 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.19 155.27 64.92 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.575 2.183 . . . . 0.0 112.281 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' PHE . . . . . 0.494 ' CD2' ' CD2' ' A' ' 155' ' ' TYR . 67.0 m-85 -74.17 166.21 23.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.894 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.488 HG23 ' C ' ' A' ' 328' ' ' GLU . 22.0 t -116.7 134.95 58.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.24 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -128.93 96.24 0.4 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.388 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.63 HG21 ' HB3' ' A' ' 107' ' ' PRO . 10.2 p -98.8 159.96 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.819 0.342 . . . . 0.0 111.216 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.464 ' N ' HG22 ' A' ' 261' ' ' VAL . 12.2 tp -122.21 104.67 9.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.903 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.402 ' HB2' ' CE2' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -109.07 170.3 8.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.924 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.555 ' HB3' ' CE1' ' A' ' 106' ' ' TYR . . . -101.95 143.6 31.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.058 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -116.05 152.43 17.97 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.56 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.806 HD11 ' OH ' ' A' ' 106' ' ' TYR . 30.2 mt -135.15 144.37 34.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.833 0.349 . . . . 0.0 110.983 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.792 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -82.49 153.69 25.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 76' ' ' LEU . . . -84.08 -22.8 31.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.355 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -53.66 -82.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.226 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' SER . . . . . 0.418 ' N ' ' HD3' ' A' ' 271' ' ' PRO . 0.3 OUTLIER 179.58 65.56 0.13 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.94 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' A' ' 270' ' ' SER . 4.9 Cg_exo -76.67 -71.44 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.812 2.341 . . . . 0.0 112.088 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.635 ' ND2' HD12 ' A' ' 275' ' ' LEU . 0.6 OUTLIER 174.88 68.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.625 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.26 -28.13 69.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.086 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -77.07 -49.35 15.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.146 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.635 HD12 ' ND2' ' A' ' 272' ' ' ASN . 99.3 mt -76.04 -44.44 39.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.096 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -58.46 -53.38 59.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.155 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 24.6 tttp -59.97 -30.67 69.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.959 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -81.04 -38.51 27.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.943 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.431 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 49.8 t80 -72.55 -34.93 67.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.951 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.987 HD23 HD22 ' A' ' 284' ' ' LEU . 7.8 mt -81.46 -20.77 39.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.396 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -91.08 -48.7 6.81 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.434 ' O ' ' CG ' ' A' ' 283' ' ' TYR . 0.0 OUTLIER -114.16 28.37 8.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.073 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.434 ' CG ' ' O ' ' A' ' 282' ' ' ASN . 32.3 m-85 -164.39 32.75 0.07 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.856 0.36 . . . . 0.0 111.005 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.987 HD22 HD23 ' A' ' 280' ' ' LEU . 10.6 tp -168.66 -42.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.898 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.612 ' CD2' HG23 ' A' ' 108' ' ' ILE . 1.9 mt -98.16 30.38 3.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.897 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 65.8 p -138.95 164.52 29.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.853 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.27 -27.81 62.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.077 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -67.03 -41.88 85.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.022 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.4 ' O ' HG23 ' A' ' 293' ' ' VAL . . . -92.41 -46.47 3.5 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.678 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.505 ' CD2' HG11 ' A' ' 302' ' ' VAL . 0.6 OUTLIER -57.67 -53.61 56.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.801 0.334 . . . . 0.0 111.09 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -58.83 -32.49 69.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.965 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -66.6 -42.51 86.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.141 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 289' ' ' GLY . 21.8 t -81.84 -30.3 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.175 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -69.83 -30.78 68.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 7.9 mtpp -63.58 -33.6 75.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.952 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -98.3 -39.99 8.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.99 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -144.25 89.17 7.1 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.856 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.47 98.08 0.83 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.523 2.149 . . . . 0.0 112.34 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.511 ' H ' HD12 ' A' ' 299' ' ' LEU . 1.7 mp -58.78 -22.88 59.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.094 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 110.04 -118.16 4.98 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.45 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.429 ' HB2' ' HB ' ' A' ' 320' ' ' THR . . . -81.22 163.26 23.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 111.038 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 109' ' ' ALA . 15.5 m -141.59 176.04 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.142 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -87.49 -30.32 20.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.16 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.452 HD23 ' HB2' ' A' ' 307' ' ' TYR . 5.4 tp -58.1 122.22 12.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.975 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -64.51 -41.45 96.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.947 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.5 m -60.01 -53.3 59.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.93 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.452 ' HB2' HD23 ' A' ' 304' ' ' LEU . 2.5 t80 -67.4 -23.2 65.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.162 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.03 -31.24 66.81 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 110.85 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -76.24 -58.04 3.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -50.11 -32.44 15.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.766 ' O ' HD12 ' A' ' 317' ' ' ILE . 32.9 mt -85.76 -26.63 25.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.704 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -74.89 -6.05 47.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.515 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.47 -31.76 4.51 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.986 0.422 . . . . 0.0 110.82 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.87 134.8 24.39 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.317 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.494 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 11.2 Cg_endo -55.15 -27.14 54.48 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.42 2.08 . . . . 0.0 112.373 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -49.82 -42.02 46.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.037 0.446 . . . . 0.0 110.294 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.766 HD12 ' O ' ' A' ' 311' ' ' LEU . 30.8 mt -85.63 -33.55 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.851 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.494 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -58.8 -30.71 67.81 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.129 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.59 -31.98 70.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.082 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.429 ' HB ' ' HB2' ' A' ' 301' ' ' ALA . 25.3 m -62.49 -51.15 68.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.911 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 5.6 tpt -61.5 -37.51 83.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -64.77 -31.87 73.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -67.01 -38.28 85.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -78.7 -35.35 45.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -67.07 -43.65 82.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.928 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.31 -31.35 26.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.84 -164.07 1.82 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.528 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' GLU . . . . . 0.488 ' C ' HG23 ' A' ' 259' ' ' VAL . 7.4 mm-40 -137.34 129.11 28.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.37 . . . . 0.0 110.892 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.661 HG23 ' CE1' ' A' ' 64' ' ' HIS . 31.2 mt -77.22 138.98 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.113 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 30.4 mtm -76.77 130.47 76.11 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.919 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.44 175.55 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.378 2.052 . . . . 0.0 112.271 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -114.17 32.1 6.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.819 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.482 HD12 ' HB2' ' A' ' 335' ' ' GLN . 42.3 pt -99.63 153.59 37.7 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.2 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.66 -25.2 34.44 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.583 2.188 . . . . 0.0 112.382 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.482 ' HB2' HD12 ' A' ' 333' ' ' ILE . 3.9 mp0 -58.62 -25.16 62.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.096 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 23.3 mmm -56.19 -32.47 64.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.052 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.3 m -59.52 -48.68 80.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.0 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -59.14 -31.55 69.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.06 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.743 ' CZ ' HG21 ' A' ' 343' ' ' VAL . 85.0 t80 -69.34 -32.25 71.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.489 ' CZ2' ' CZ ' ' A' ' 155' ' ' TYR . 68.9 m95 -66.38 -30.63 71.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.961 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -84.71 -51.73 6.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.178 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -55.23 -54.41 43.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.43 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.743 HG21 ' CZ ' ' A' ' 339' ' ' PHE . 28.8 t -59.03 -30.66 44.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.228 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.436 ' O ' HD12 ' A' ' 348' ' ' ILE . 0.2 OUTLIER -59.44 -57.48 12.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.975 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 345' ' ' THR . . . . . 0.44 HG22 ' CG ' ' A' ' 349' ' ' ASN . 3.6 m -68.66 -27.29 65.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.108 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -57.14 -61.74 2.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.397 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 23.3 t -61.8 -43.15 96.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.309 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.436 HD12 ' O ' ' A' ' 344' ' ' ARG . 27.7 mt -63.56 -44.98 98.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.109 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.44 ' CG ' HG22 ' A' ' 345' ' ' THR . 28.9 m-20 -59.79 -30.95 69.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -77.96 -51.06 10.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.108 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -60.17 -40.15 88.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.087 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 14.9 m -71.65 -22.42 61.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.122 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 86.5 27.52 29.74 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.453 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -89.59 -30.39 18.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.784 0.326 . . . . 0.0 110.9 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -145.37 145.07 31.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.888 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.7 p -62.37 169.51 2.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.795 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.612 HG23 HD22 ' A' ' 192' ' ' LEU . 1.5 p -62.51 -47.3 93.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.893 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 358' ' ' ASP . . . . . 0.5 ' HA ' HD12 ' A' ' 361' ' ' LEU . 3.2 m-20 -66.78 -31.42 72.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.987 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -72.19 -43.13 64.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.975 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -60.59 -40.6 92.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.162 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.947 ' CD2' HG12 ' A' ' 183' ' ' VAL . 0.5 OUTLIER -77.35 -31.82 54.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.806 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.6 -52.88 40.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -61.17 -47.28 86.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.408 ' O ' HD12 ' A' ' 368' ' ' ILE . . . -57.96 -37.73 74.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.072 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.834 ' O ' HG22 ' A' ' 369' ' ' THR . 0.8 OUTLIER -60.67 -42.15 96.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.794 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 31.6 m -71.68 -31.5 66.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.862 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 36.1 mtt180 -69.41 -42.02 75.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.72 HD13 HG11 ' A' ' 181' ' ' VAL . 4.8 mt -67.19 -51.96 47.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.834 HG22 ' O ' ' A' ' 365' ' ' GLN . 9.8 t -95.44 43.59 1.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.994 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 1.2 tttm . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.245 -0.884 . . . . 0.0 110.92 179.986 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.694 HG23 ' HA ' ' A' ' 57' ' ' PRO . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.773 0.321 . . . . 0.0 110.904 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -151.64 154.34 36.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -83.62 139.89 32.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.925 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.38 26.51 43.16 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.539 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.0 159.74 32.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.78 0.324 . . . . 0.0 110.915 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.42 HD11 ' HB3' ' A' ' 275' ' ' LEU . 7.4 mt -128.09 109.98 12.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.5 t -83.6 147.01 6.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.15 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.74 HD13 HD12 ' A' ' 20' ' ' LEU . 29.6 mt -127.42 107.5 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.949 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.468 ' CE3' HD12 ' A' ' 43' ' ' LEU . 3.6 m0 -97.98 106.76 19.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.798 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.648 HD11 ' HE3' ' A' ' 15' ' ' LYS . 15.7 tt -140.67 158.19 24.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.085 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -59.1 146.51 38.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.26 -26.13 74.16 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.598 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.24 46.45 1.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.914 0.388 . . . . 0.0 111.006 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.648 ' HE3' HD11 ' A' ' 11' ' ' ILE . 1.6 mtmt -141.34 -176.13 4.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.833 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.78 80.33 0.12 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.516 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 19.2 p90 -83.65 -35.61 24.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.868 0.366 . . . . 0.0 110.942 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.4 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 6.9 t-20 -60.31 -31.17 70.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.548 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -67.61 -58.1 8.17 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.476 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.74 HD12 HD13 ' A' ' 9' ' ' ILE . 4.0 mm? -60.79 -30.41 70.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.81 0.338 . . . . 0.0 110.885 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.51 -43.89 95.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.059 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -75.64 -51.96 11.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 19' ' ' GLY . 23.9 t -59.05 -31.21 45.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.055 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.42 -34.41 84.73 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.424 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.8 mmtm -72.46 -28.16 62.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.824 0.345 . . . . 0.0 110.957 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -46.1 89.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.989 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -62.48 -41.21 98.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.956 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -69.79 -30.89 68.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.941 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.8 mttp -82.66 -26.66 31.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.086 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -91.78 -24.98 19.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.726 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.6 p -125.4 -44.19 1.87 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.692 0.282 . . . . 0.0 111.59 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.3 -26.82 5.17 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.585 -0.816 . . . . 0.0 112.467 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.6 mm -59.96 124.33 14.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.826 0.346 . . . . 0.0 111.058 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.3 mtmt -72.23 153.7 41.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.948 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.5 t -140.54 110.58 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.106 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.4 m -105.53 130.25 53.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.933 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.596 HG22 HD12 ' A' ' 9' ' ' ILE . 21.7 t -97.94 110.52 25.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.051 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -103.35 141.18 36.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.974 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -136.57 70.17 59.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.813 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.655 ' HG2' HD22 ' A' ' 43' ' ' LEU . 73.7 Cg_endo -75.63 156.06 40.16 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.629 2.219 . . . . 0.0 112.503 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.69 140.69 37.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.506 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? 56.39 41.72 28.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.675 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.655 HD22 ' HG2' ' A' ' 40' ' ' PRO . 0.9 OUTLIER -89.1 16.87 6.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.554 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -60.99 -42.18 97.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.876 0.369 . . . . 0.0 110.694 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -85.45 -6.3 59.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.252 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.565 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -82.85 -20.07 36.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.376 -179.837 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.59 ' CE2' HD12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -78.86 -52.58 1.25 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.617 0.246 . . . . 0.0 111.224 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.424 ' HD3' ' CB ' ' A' ' 47' ' ' PHE . 35.2 Cg_exo -59.94 -40.07 65.56 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.47 2.113 . . . . 0.0 112.366 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.442 ' CG ' ' N ' ' A' ' 50' ' ' VAL . 7.9 pt20 -60.12 -49.08 79.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.01 0.433 . . . . 0.0 111.058 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.728 ' O ' HG22 ' A' ' 53' ' ' THR . 34.2 m -79.28 -23.92 12.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.212 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.14 -27.79 48.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.19 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.13 -34.85 75.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.197 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.728 HG22 ' O ' ' A' ' 50' ' ' VAL . 11.8 t -69.52 -26.8 64.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.972 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.34 32.52 4.87 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.602 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.32 -81.25 0.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.789 0.328 . . . . 0.0 110.933 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 54.3 -170.85 1.11 Allowed Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.605 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.694 ' HA ' HG23 ' A' ' 2' ' ' THR . 55.2 Cg_endo -69.59 -179.57 2.93 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.577 2.185 . . . . 0.0 112.253 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -110.2 -31.3 7.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.976 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.8 mt -143.75 137.41 24.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.235 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.59 HD12 ' CE2' ' A' ' 47' ' ' PHE . 2.6 tt -142.36 159.72 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.887 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.48 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 41.7 m-85 -130.46 135.83 48.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.065 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -176.04 161.79 2.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.863 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.92 148.97 28.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.201 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.805 ' CD2' ' HB1' ' A' ' 96' ' ' ALA . 45.4 p-80 -60.7 -36.03 77.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.867 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -60.34 -30.28 69.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -93.85 17.17 12.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.208 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -112.2 29.24 8.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.854 0.359 . . . . 0.0 110.87 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.83 25.35 6.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.535 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -120.53 -36.4 0.79 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.483 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -83.07 -27.59 30.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.745 0.307 . . . . 0.0 111.036 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.538 ' HB2' HD12 ' A' ' 76' ' ' LEU . . . -84.03 -36.88 22.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.165 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -59.19 -32.54 70.02 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.078 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 m -90.1 -23.14 21.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.141 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.96 57.87 0.76 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.45 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.2 mt -139.25 32.36 2.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.793 0.33 . . . . 0.0 110.916 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.538 HD12 ' HB2' ' A' ' 71' ' ' ALA . 13.0 mt -144.4 160.57 40.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.56 163.28 12.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.066 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.453 ' HA ' HG22 ' A' ' 104' ' ' ILE . 1.1 tp10 -93.56 -165.48 1.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.643 HD11 ' CB ' ' A' ' 103' ' ' LEU . 44.6 pt -157.49 172.87 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.957 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 48.1 p -156.54 77.48 4.24 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.802 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.42 134.29 26.27 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.641 2.227 . . . . 0.0 112.348 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.71 174.26 10.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.758 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -59.66 -37.05 77.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.825 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.72 -30.05 69.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.064 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -77.58 -47.72 18.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.895 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -65.64 -30.89 71.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.954 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.04 -27.07 64.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.053 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -95.94 39.83 1.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.03 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.464 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 8.3 mt -157.99 173.74 16.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.861 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.5 ' CZ ' ' HE2' ' A' ' 321' ' ' MET . 27.2 m-85 -89.34 150.78 45.38 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.057 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -67.79 -56.39 0.21 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.454 2.103 . . . . 0.0 112.441 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.83 ' CE1' HG23 ' A' ' 93' ' ' THR . 44.2 p90 -55.68 -41.01 73.09 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.4 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.83 HG23 ' CE1' ' A' ' 92' ' ' PHE . 13.8 p -56.89 -29.62 63.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.068 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.464 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 55.0 m95 -74.52 -30.85 61.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.914 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.85 -28.43 64.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.0 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.805 ' HB1' ' CD2' ' A' ' 64' ' ' HIS . . . -72.26 -29.57 64.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.226 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.0 m -100.46 50.82 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.259 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.707 ' HB3' HD23 ' A' ' 103' ' ' LEU . 7.0 ptm180 -156.08 142.27 18.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -93.69 -47.97 6.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.927 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -151.48 58.71 0.88 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.842 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.08 -27.88 14.96 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.611 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.22 152.47 21.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 110.891 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.707 HD23 ' HB3' ' A' ' 98' ' ' ARG . 13.7 mt -110.59 150.38 29.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.453 HG22 ' HA ' ' A' ' 78' ' ' GLU . 2.2 pp -146.68 30.37 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.221 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.597 ' HB1' ' HB2' ' A' ' 263' ' ' SER . . . -164.34 -176.87 4.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.168 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -142.02 89.35 8.85 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.922 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.717 ' HB3' HG21 ' A' ' 261' ' ' VAL . 51.4 Cg_exo -52.86 129.92 35.12 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.551 2.167 . . . . 0.0 112.214 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.496 ' CG2' HD21 ' A' ' 290' ' ' LEU . 30.4 mt -112.91 -61.34 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.226 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.44 ' CB ' HD13 ' A' ' 299' ' ' LEU . . . -127.34 150.6 49.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.175 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.658 HG13 ' O ' ' A' ' 260' ' ' GLY . 21.5 t -120.72 137.39 54.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.033 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -116.36 161.66 18.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.952 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -169.17 158.44 8.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.098 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.8 mt -67.71 -178.28 0.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.936 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 226' ' ' ILE . 0.3 OUTLIER -169.95 169.27 8.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.929 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.456 ' HB2' HD23 ' A' ' 247' ' ' LEU . 8.4 tp -101.24 142.8 32.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.89 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.7 mt -127.72 131.94 69.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.077 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -134.97 161.18 36.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -115.74 117.76 31.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.024 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -66.64 -28.46 68.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -56.82 -40.78 76.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.928 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.458 HD22 ' NZ ' ' A' ' 144' ' ' LYS . 81.7 mt -88.06 -80.15 0.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.83 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.802 HD22 ' HB1' ' A' ' 223' ' ' ALA . 1.0 OUTLIER -81.21 144.46 54.24 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.84 -43.06 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.477 2.118 . . . . 0.0 112.295 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -139.42 142.77 33.36 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.853 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.61 150.94 36.25 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.566 2.177 . . . . 0.0 112.337 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.28 120.02 6.32 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.56 2.173 . . . . 0.0 112.309 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -94.88 20.59 8.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.95 142.0 29.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.914 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.669 ' CE3' HD12 ' A' ' 132' ' ' ILE . 2.1 m95 -72.54 -25.95 61.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.017 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.1 -21.93 56.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.213 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.407 ' O ' HD12 ' A' ' 135' ' ' LEU . 14.1 mt-10 -77.5 -26.28 51.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.203 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.794 HD13 HD22 ' A' ' 147' ' ' LEU . 36.8 mt -62.26 -54.45 49.26 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.534 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.615 ' HB3' HD21 ' A' ' 198' ' ' LEU . 18.7 Cg_endo -60.23 -28.32 86.67 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.185 1.923 . . . . 0.0 112.131 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.59 -30.21 41.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 131' ' ' GLU . 0.2 OUTLIER -73.74 -35.78 65.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.814 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.37 -27.92 39.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -85.65 -28.21 24.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.072 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -84.45 -37.27 21.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.11 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.709 HD13 ' HA ' ' A' ' 146' ' ' ALA . 0.5 OUTLIER -75.4 -17.21 60.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.487 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.09 -29.54 57.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.876 0.369 . . . . 0.0 110.656 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.46 -37.12 82.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.928 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -78.46 -27.11 46.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.022 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 113.66 45.11 0.73 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.509 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.458 ' NZ ' HD22 ' A' ' 121' ' ' LEU . 11.8 mtmt -162.03 -178.24 6.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.814 0.34 . . . . 0.0 110.937 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.2 t -112.0 176.99 4.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.848 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.709 ' HA ' HD13 ' A' ' 139' ' ' LEU . . . -101.96 -68.42 0.82 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.199 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.794 HD22 HD13 ' A' ' 132' ' ' ILE . 6.3 tp -140.42 145.72 37.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.963 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.664 ' CG ' ' HB2' ' A' ' 213' ' ' ALA . 0.0 OUTLIER -141.21 -177.82 5.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.805 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.434 ' CZ ' ' CE ' ' A' ' 204' ' ' MET . 22.6 p90 -179.4 170.93 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.818 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.555 ' ND2' ' CG ' ' A' ' 156' ' ' PHE . 5.1 p30 -79.47 131.06 35.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.476 HD23 HG21 ' A' ' 157' ' ' THR . 11.2 mt -105.91 29.13 6.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.992 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -104.41 -30.48 10.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.944 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -119.78 120.69 30.3 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.935 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.05 -21.94 29.18 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.509 2.139 . . . . 0.0 112.434 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.5 ' CD1' ' CE2' ' A' ' 258' ' ' PHE . 2.5 m-85 -53.91 -30.02 44.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.129 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.555 ' CG ' ' ND2' ' A' ' 150' ' ' ASN . 4.3 m-85 -89.81 -30.24 18.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.902 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.479 ' O ' HD12 ' A' ' 161' ' ' ILE . 17.3 p -95.03 18.42 12.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.263 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.471 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 13.4 t-105 -87.44 -46.86 0.49 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.313 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.592 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 59.2 Cg_exo -51.72 -25.38 20.39 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.329 2.02 . . . . 0.0 112.438 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 49.6 tp -76.73 -61.95 1.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.001 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.479 HD12 ' O ' ' A' ' 157' ' ' THR . 4.3 mt -69.33 -46.42 76.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.224 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -57.65 -34.05 68.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.25 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -60.09 -41.33 92.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.681 ' OD2' ' HB3' ' A' ' 190' ' ' ALA . 16.5 t0 -68.21 -20.09 64.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.187 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 121.44 41.72 0.49 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.467 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.614 ' HA2' ' HB2' ' A' ' 188' ' ' ALA . . . -119.54 103.6 0.98 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.507 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.44 ' CD2' ' HA3' ' A' ' 182' ' ' GLY . 30.3 p90 -114.15 -177.4 3.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.796 0.332 . . . . 0.0 110.882 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.437 ' HB2' ' CE1' ' A' ' 339' ' ' PHE . . . -108.19 -35.09 6.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.087 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.415 ' CE2' HD11 ' A' ' 333' ' ' ILE . 34.6 m-85 -136.39 152.97 51.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.88 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.27 118.93 37.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.061 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.42 ' CE1' ' HA ' ' A' ' 175' ' ' LYS . 6.5 t80 -79.53 121.24 24.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.489 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -170.41 147.32 2.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.969 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 63.4 42.36 6.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.863 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.4 ' O ' ' CZ ' ' A' ' 171' ' ' TYR . . . 102.83 -63.16 0.44 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.694 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.42 ' HA ' ' CE1' ' A' ' 171' ' ' TYR . 35.9 pttt -128.7 -166.92 1.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.805 0.336 . . . . 0.0 110.994 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -94.09 174.0 7.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -131.31 158.61 40.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.975 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.539 HG21 ' HG2' ' A' ' 335' ' ' GLN . 44.9 pt -92.76 -6.44 10.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.601 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.33 25.89 4.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.755 0.312 . . . . 0.0 111.073 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -152.91 102.53 2.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.859 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.586 HG12 ' H ' ' A' ' 183' ' ' VAL . 24.2 t -93.96 145.95 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.104 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLY . . . . . 0.44 ' HA3' ' CD2' ' A' ' 167' ' ' TYR . . . -96.88 -20.46 23.88 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.734 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.65 ' CG1' HD22 ' A' ' 361' ' ' LEU . 21.4 t -55.17 -40.76 56.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.822 0.344 . . . . 0.0 111.346 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -84.29 57.19 4.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.974 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -118.82 168.56 10.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.834 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.59 -32.97 70.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.133 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -83.47 -38.41 10.87 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.534 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.614 ' HB2' ' HA2' ' A' ' 166' ' ' GLY . . . -59.16 -34.35 72.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.866 0.365 . . . . 0.0 111.168 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.526 ' HA ' HD11 ' A' ' 361' ' ' LEU . 9.5 ttmt -59.95 -54.54 44.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.681 ' HB3' ' OD2' ' A' ' 164' ' ' ASP . . . -60.89 -30.14 69.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.177 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -57.9 -54.23 39.04 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.557 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.815 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.1 OUTLIER -65.26 -44.86 86.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.1 m -53.5 -25.22 15.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.203 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -69.49 -60.59 2.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.801 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.503 ' HA ' HD12 ' A' ' 198' ' ' LEU . 2.1 tp -62.3 -33.2 74.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.662 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 192' ' ' LEU . 47.3 t -69.04 -34.57 64.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.975 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -74.06 -38.34 63.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.615 HD21 ' HB3' ' A' ' 133' ' ' PRO . 5.5 mt -57.94 -54.15 50.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.001 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 8.6 mt -68.38 -24.86 30.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.135 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -64.35 -40.89 96.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.022 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -95.81 22.07 7.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.232 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.03 79.22 0.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.844 0.354 . . . . 0.0 111.027 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -149.82 25.44 0.84 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.886 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' MET . . . . . 0.434 ' CE ' ' CZ ' ' A' ' 149' ' ' PHE . 23.1 mtp -160.77 -178.78 7.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.822 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -130.05 114.01 15.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.842 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -67.66 -32.58 73.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.89 46.75 1.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.976 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.492 HG23 HG21 ' A' ' 212' ' ' ILE . 57.2 m -98.41 138.17 36.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.923 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -106.15 176.05 5.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.828 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -75.77 -33.56 60.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.938 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.4 m -82.79 -28.18 30.47 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.092 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.492 HG21 HG23 ' A' ' 208' ' ' THR . 0.3 OUTLIER -45.66 -47.47 4.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.218 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.767 ' HB1' HG23 ' A' ' 225' ' ' THR . . . -71.73 -28.09 63.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.16 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.428 ' HA ' ' CE2' ' A' ' 217' ' ' PHE . 0.4 OUTLIER -61.86 -63.0 1.4 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.937 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.77 -21.45 66.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.365 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.444 ' HB1' ' HB2' ' A' ' 221' ' ' GLU . . . -54.09 -61.11 2.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.274 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.431 ' CD1' ' N ' ' A' ' 218' ' ' ASN . 11.2 p90 -68.8 -30.72 69.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.925 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ASN . . . . . 0.431 ' N ' ' CD1' ' A' ' 217' ' ' PHE . 5.5 t-20 -60.18 -30.68 69.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.28 28.76 7.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.921 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 58.57 95.92 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.53 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.444 ' HB2' ' HB1' ' A' ' 216' ' ' ALA . 40.2 mt-10 -150.46 -46.89 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.337 . . . . 0.0 110.88 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.3 t -124.71 171.97 9.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.802 ' HB1' HD22 ' A' ' 122' ' ' LEU . . . -93.12 -54.05 3.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.084 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.428 ' HE2' ' HB2' ' A' ' 147' ' ' LEU . 2.9 mpp? -111.08 163.53 13.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.767 HG23 ' HB1' ' A' ' 213' ' ' ALA . 78.4 m -163.99 152.62 13.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.434 HG23 ' O ' ' A' ' 114' ' ' SER . 4.8 mt -126.7 129.56 71.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.018 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.685 ' OD1' ' HB2' ' A' ' 231' ' ' ALA . 15.7 t-20 -145.43 159.31 43.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -75.86 -156.44 6.21 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.54 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.417 ' HD2' ' CZ3' ' A' ' 230' ' ' TRP . 43.3 Cg_endo -68.14 -24.22 38.71 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.554 2.169 . . . . 0.0 112.473 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' TRP . . . . . 0.417 ' CZ3' ' HD2' ' A' ' 229' ' ' PRO . 44.9 p90 -84.06 57.02 3.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.403 . . . . 0.0 110.92 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.685 ' HB2' ' OD1' ' A' ' 227' ' ' ASN . . . -143.0 -44.79 0.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.199 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' TRP . . . . . 0.522 ' HA ' HD12 ' A' ' 235' ' ' ILE . 20.3 m0 -52.98 -40.84 64.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.058 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 13.0 m -61.71 -30.85 71.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.864 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -64.78 -31.71 73.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.929 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.817 HG21 ' CD1' ' A' ' 242' ' ' TYR . 4.8 mt -84.23 57.77 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.056 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.67 -48.51 2.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.816 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 2.5 m -108.98 31.23 5.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.888 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 3.4 t -100.37 -29.73 12.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp 64.04 40.57 7.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.07 117.62 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.042 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -62.02 124.19 20.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.817 ' CD1' HG21 ' A' ' 235' ' ' ILE . 21.1 p90 -118.94 132.04 56.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.876 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -109.14 131.3 10.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.517 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.472 HG21 ' CZ2' ' A' ' 232' ' ' TRP . 21.3 t -99.21 117.42 44.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.809 0.338 . . . . 0.0 111.085 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.7 t -135.8 149.66 49.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 247' ' ' LEU . 0.7 OUTLIER -55.09 152.22 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.257 0.551 . . . . 0.0 111.311 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.456 HD23 ' HB2' ' A' ' 115' ' ' LEU . 40.7 mt -72.35 152.15 92.1 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.077 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.73 177.15 2.43 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.619 2.213 . . . . 0.0 112.258 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.429 HG22 ' HA ' ' A' ' 254' ' ' PRO . 57.5 p -115.57 152.76 32.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -100.37 116.48 32.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.76 25.97 15.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.038 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 93.64 -21.09 43.04 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.695 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -87.74 142.18 32.38 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.685 0.278 . . . . 0.0 110.901 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.429 ' HA ' HG22 ' A' ' 249' ' ' THR . 73.3 Cg_endo -75.8 163.26 33.87 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.578 2.185 . . . . 0.0 112.339 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.4 p -88.18 179.52 6.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.892 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.421 ' N ' ' HD3' ' A' ' 257' ' ' PRO . 5.5 mtmm -136.55 62.86 44.92 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.939 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 256' ' ' LYS . 32.3 Cg_exo -57.94 -173.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.537 2.158 . . . . 0.0 112.242 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' PHE . . . . . 0.5 ' CE2' ' CD1' ' A' ' 155' ' ' TYR . 43.4 m-85 -103.91 126.22 50.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.729 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.2 t -108.63 138.53 35.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.378 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.658 ' O ' HG13 ' A' ' 110' ' ' VAL . . . -119.78 156.3 15.89 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.258 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.717 HG21 ' HB3' ' A' ' 107' ' ' PRO . 10.9 p -139.65 152.2 22.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.819 0.342 . . . . 0.0 111.238 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 20.3 tp -105.25 110.28 22.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.597 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 0.9 OUTLIER -125.74 155.95 40.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.933 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -100.85 133.46 45.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.113 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -101.38 161.74 18.05 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.489 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 31.5 mt -135.14 152.0 31.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.822 0.344 . . . . 0.0 111.146 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -91.47 149.27 21.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.952 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.98 -28.38 68.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.189 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -55.82 -30.0 60.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.268 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 5.9 t 59.09 62.5 4.11 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.55 -32.84 14.6 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.583 2.188 . . . . 0.0 112.297 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.433 ' OD1' HD12 ' A' ' 275' ' ' LEU . 4.5 t-20 -162.33 46.86 0.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.891 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 34.0 mttt -59.62 -31.83 69.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -60.15 -54.97 39.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.897 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.433 HD12 ' OD1' ' A' ' 272' ' ' ASN . 77.8 mt -75.24 -31.06 60.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -59.87 -45.86 91.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.34 -51.26 70.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.906 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -61.81 -45.39 94.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -66.09 -37.85 86.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.972 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 55.3 mt -81.33 -21.01 39.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.376 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -93.52 -43.32 8.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.796 0.331 . . . . 0.0 111.334 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -92.08 -48.92 6.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.211 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.485 ' HB3' HG12 ' A' ' 23' ' ' VAL . 10.4 m-85 -96.96 38.56 1.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.166 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.567 HD21 HD11 ' A' ' 20' ' ' LEU . 0.2 OUTLIER 179.96 38.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.888 179.842 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -177.77 37.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.825 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 38.3 p -140.79 167.28 22.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.921 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -64.91 -30.43 71.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.969 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -76.24 -30.64 57.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.981 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -90.71 -50.76 2.83 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.588 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.496 HD21 ' CG2' ' A' ' 108' ' ' ILE . 3.5 mt -59.28 -41.1 88.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.991 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -62.37 -37.06 84.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.959 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.41 -47.57 83.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.043 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.514 HG22 ' HA3' ' A' ' 19' ' ' GLY . 25.3 t -72.94 -30.92 33.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.027 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -71.81 -31.25 66.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 9.9 mtmt -63.41 -34.84 78.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.99 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -99.53 -34.74 10.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.078 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.4 tptt -148.43 91.33 4.76 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.98 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.5 108.54 2.24 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.495 2.13 . . . . 0.0 112.296 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.44 HD13 ' CB ' ' A' ' 109' ' ' ALA . 4.9 mt -59.53 -28.4 67.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.013 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 107.37 -125.83 8.15 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.461 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.83 94.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.846 0.355 . . . . 0.0 111.039 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.788 HG21 ' HB3' ' A' ' 307' ' ' TYR . 30.1 m -67.65 158.08 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.184 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 108' ' ' ILE . . . -87.94 -26.45 22.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.141 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 10.0 tp -55.97 127.63 31.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.963 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -67.31 -29.49 69.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.048 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.26 -26.09 36.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.226 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.788 ' HB3' HG21 ' A' ' 302' ' ' VAL . 0.1 OUTLIER -96.54 -22.98 16.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.396 -179.674 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.38 -33.4 69.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.859 0.362 . . . . 0.0 110.948 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -75.48 -53.49 8.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.907 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -49.66 -34.13 17.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.767 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.722 ' HB3' HG21 ' A' ' 317' ' ' ILE . 12.4 mt -85.8 -26.46 25.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.641 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -71.56 -14.12 61.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.433 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -48.0 -34.1 8.85 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.965 0.412 . . . . 0.0 110.83 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.52 138.1 21.34 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.381 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.464 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 11.4 Cg_endo -55.3 -23.56 38.23 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.407 2.071 . . . . 0.0 112.432 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.05 -41.58 59.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.961 0.41 . . . . 0.0 110.34 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.722 HG21 ' HB3' ' A' ' 311' ' ' LEU . 33.8 mm -85.57 -33.65 7.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.952 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -68.67 -30.08 68.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.223 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -73.64 -51.71 15.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.178 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 8.8 t -58.94 -30.73 68.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.995 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.5 ' HE2' ' CZ ' ' A' ' 90' ' ' TYR . 4.9 ttt -85.47 -31.03 23.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.983 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -59.27 -46.96 87.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.912 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -66.05 -31.52 72.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -72.06 -49.21 38.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.088 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -59.97 -35.64 75.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.919 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -96.27 21.07 9.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.085 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -133.3 -179.11 16.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.514 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.09 137.2 42.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.819 0.343 . . . . 0.0 110.929 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.585 HG22 ' HE2' ' A' ' 64' ' ' HIS . 12.2 mt -80.29 144.28 10.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.055 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 15.1 ttm -57.21 113.32 5.95 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.941 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.83 -172.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.459 2.106 . . . . 0.0 112.315 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -152.76 38.6 0.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.923 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.637 HD12 ' HB2' ' A' ' 335' ' ' GLN . 10.2 pt -107.2 155.75 38.8 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.129 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.34 -27.75 47.42 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.535 2.157 . . . . 0.0 112.336 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.637 ' HB2' HD12 ' A' ' 333' ' ' ILE . 6.4 mp0 -59.44 -22.59 61.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.091 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 9.5 mtp -54.63 -28.3 45.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.127 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.1 m -56.91 -53.96 52.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.014 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -59.66 -30.29 68.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.041 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.72 ' CZ ' HG21 ' A' ' 343' ' ' VAL . 51.6 t80 -58.95 -34.11 71.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.885 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.497 ' CH2' ' CE1' ' A' ' 155' ' ' TYR . 97.3 m95 -76.24 -21.86 55.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.175 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -84.83 -34.74 22.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.419 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -87.05 -57.95 2.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.85 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.849 ' O ' HG23 ' A' ' 347' ' ' VAL . 47.3 t -48.98 -56.55 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.804 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -52.89 -29.98 31.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.394 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 10.7 m -84.1 -55.71 4.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.113 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.889 ' HB1' ' HB1' ' A' ' 360' ' ' ALA . . . -51.44 -26.47 8.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.615 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 343' ' ' VAL . 31.3 t -82.75 -55.32 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.234 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 59.4 mt -64.94 -41.85 93.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.335 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -57.59 -39.29 76.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.001 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -86.32 -30.55 22.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.108 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -76.18 -29.03 57.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.233 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 72.7 m -95.6 20.74 9.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.175 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 56.04 25.39 46.12 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.644 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.82 -31.55 20.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.87 0.366 . . . . 0.0 110.869 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -144.71 -168.82 3.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.859 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 19.3 p -121.52 160.4 24.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 30.2 t -58.06 -56.31 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.063 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.49 -29.71 1.88 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.185 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -84.25 -42.75 15.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.889 ' HB1' ' HB1' ' A' ' 346' ' ' ALA . . . -60.3 -59.72 4.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.736 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.65 HD22 ' CG1' ' A' ' 183' ' ' VAL . 3.3 mt -58.39 -26.77 63.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.03 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 30.9 tttt -80.89 -59.18 2.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.782 0.325 . . . . 0.0 110.965 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -61.16 -44.76 96.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.83 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -52.49 -37.8 58.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.253 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.616 ' O ' HG23 ' A' ' 369' ' ' THR . 34.6 tt0 -59.42 -43.36 93.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.471 HG22 ' HD2' ' A' ' 370' ' ' LYS . 69.3 m -63.57 -39.92 95.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.984 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 31.9 mtt180 -67.06 -42.51 84.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.991 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 19.0 mt -75.45 -31.37 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.174 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 365' ' ' GLN . 63.6 p -81.91 -31.42 31.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.877 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.471 ' HD2' HG22 ' A' ' 366' ' ' THR . 3.5 mtpp . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.889 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.544 ' O ' HG23 ' A' ' 2' ' ' THR . 6.7 t . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.822 0.344 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -133.81 87.63 2.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.921 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -133.42 20.2 3.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.188 0.518 . . . . 0.0 111.207 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.466 ' O ' HG23 ' A' ' 33' ' ' ILE . . . 75.52 34.61 49.44 Favored Glycine 0 C--N 1.317 -0.503 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.509 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.78 -177.23 4.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.832 0.349 . . . . 0.0 110.931 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.3 mt -133.51 118.2 18.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.94 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.49 147.0 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.193 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.453 HD13 ' CD1' ' A' ' 20' ' ' LEU . 31.4 mt -132.59 107.44 12.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.947 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.425 ' CE3' ' HB3' ' A' ' 57' ' ' PRO . 19.7 m0 -92.95 106.65 18.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.873 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.8 tt -137.97 158.98 33.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.046 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -54.84 174.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.049 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.22 -23.99 49.53 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.68 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -137.6 81.42 1.86 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.849 0.357 . . . . 0.0 110.961 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.81 36.71 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.811 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.58 43.37 4.88 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.504 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -85.22 -31.33 23.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 0.0 110.904 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -32.58 70.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.923 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -80.83 -38.69 15.39 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.501 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.453 ' CD1' HD13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -61.48 -30.65 70.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.808 0.337 . . . . 0.0 110.896 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.36 -42.98 99.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -68.2 -44.18 76.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 19' ' ' GLY . 21.7 t -62.03 -33.46 58.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.213 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.11 -27.86 73.56 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.558 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -83.21 -27.74 29.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.759 0.314 . . . . 0.0 111.011 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -45.5 89.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.947 0.403 . . . . 0.0 110.956 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.434 ' CD2' ' HB ' ' A' ' 33' ' ' ILE . 10.4 t80 -61.51 -38.87 88.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.016 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.41 ' O ' ' HA2' ' A' ' 32' ' ' GLY . 28.3 mt-10 -60.75 -32.57 71.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.877 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.4 tttm -82.67 -24.36 33.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.918 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -90.8 -26.14 19.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.68 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.1 p -137.29 -44.28 0.56 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 28' ' ' GLU . . . 121.23 -17.82 9.01 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.687 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.466 HG23 ' O ' ' A' ' 5' ' ' GLY . 37.3 mm -59.94 105.43 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.872 0.368 . . . . 0.0 110.96 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -58.67 141.89 51.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.95 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.6 130.12 74.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.117 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.0 m -121.94 150.61 41.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.5 t -133.73 116.55 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.156 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -104.37 161.94 13.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.49 70.29 32.17 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.951 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.16 168.55 24.48 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.56 2.173 . . . . 0.0 112.215 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -89.94 140.13 29.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.935 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.477 ' O ' HD23 ' A' ' 43' ' ' LEU . 12.8 mmtt 74.91 -57.2 0.61 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.98 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.837 HD11 ' CZ3' ' A' ' 62' ' ' TRP . 0.4 OUTLIER 51.17 18.41 0.58 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.051 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.22 -57.03 3.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.796 0.331 . . . . 0.0 110.949 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -83.17 -6.84 59.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.45 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.54 -20.08 65.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.325 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.533 ' CZ ' HG21 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -87.21 -58.43 0.29 Allowed Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.189 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.508 ' HD3' ' CB ' ' A' ' 47' ' ' PHE . 52.0 Cg_exo -55.24 -30.71 73.05 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.33 2.02 . . . . 0.0 112.412 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.53 ' HG3' HG13 ' A' ' 50' ' ' VAL . 5.9 pt20 -60.08 -48.99 79.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.984 0.421 . . . . 0.0 111.084 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.53 HG13 ' HG3' ' A' ' 49' ' ' GLN . 5.5 m -93.18 17.63 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.762 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.656 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -91.06 -35.63 14.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.826 0.346 . . . . 0.0 111.164 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.21 -26.66 26.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.213 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.402 HG22 ' C ' ' A' ' 50' ' ' VAL . 10.1 t -59.96 -27.54 66.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.005 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.75 36.29 5.35 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.492 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.53 -78.2 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.894 0.378 . . . . 0.0 110.863 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.41 173.74 26.91 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.475 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.457 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 44.4 Cg_endo -68.49 -167.55 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.542 2.161 . . . . 0.0 112.242 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.75 -45.72 3.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.027 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.85 HD13 HD21 ' A' ' 280' ' ' LEU . 19.3 mt -149.39 159.06 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.29 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.533 HG21 ' CZ ' ' A' ' 47' ' ' PHE . 2.4 tt -159.02 159.47 2.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.866 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.511 ' HE2' HD21 ' A' ' 284' ' ' LEU . 4.1 m-85 -128.59 137.96 51.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.914 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.837 ' CZ3' HD11 ' A' ' 43' ' ' LEU . 2.9 t-105 -176.03 163.31 2.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.854 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.24 140.16 53.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.11 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.421 ' HE1' HG22 ' A' ' 329' ' ' ILE . 6.0 p80 -57.62 -30.9 65.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.963 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.67 -42.05 98.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.958 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.06 17.27 12.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.291 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.45 -26.02 13.03 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.735 0.302 . . . . 0.0 110.992 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.29 49.61 3.75 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.54 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -120.96 -34.08 0.93 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.583 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -93.38 -23.48 18.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.715 0.293 . . . . 0.0 111.096 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.529 ' HB2' HD12 ' A' ' 76' ' ' LEU . . . -75.59 -24.66 56.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.121 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -56.75 -38.18 72.05 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.033 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.4 t -90.52 -23.08 21.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.016 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.23 34.57 3.13 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.487 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.656 HD22 ' HB1' ' A' ' 51' ' ' ALA . 11.2 mt -85.57 -46.11 11.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 0.0 110.847 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.529 HD12 ' HB2' ' A' ' 71' ' ' ALA . 7.2 mt -74.1 170.64 15.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.834 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.623 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -100.7 155.03 18.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.032 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.12 -165.02 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.845 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.788 HD11 ' HB3' ' A' ' 103' ' ' LEU . 37.6 pt -157.02 166.82 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.044 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.0 p -156.53 77.45 4.25 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.779 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.39 154.53 60.85 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.641 2.228 . . . . 0.0 112.314 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.7 175.94 8.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.793 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 28.2 mttm -59.59 -45.34 92.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.85 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.08 -30.51 69.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.01 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -73.41 -35.15 65.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -81.6 -29.86 33.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.944 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.57 -40.2 70.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.012 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -59.22 -35.2 73.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.004 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.635 HD23 ' HB1' ' A' ' 303' ' ' ALA . 4.0 mt -90.6 148.84 22.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.865 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.437 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . 83.2 m-85 -78.42 144.61 66.32 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.966 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -49.35 -55.71 3.87 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.695 2.263 . . . . 0.0 112.844 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 93' ' ' THR . 21.7 p90 -49.33 -37.28 23.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.436 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.46 HG21 ' HB1' ' A' ' 303' ' ' ALA . 0.3 OUTLIER -59.71 -42.22 92.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.896 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.573 ' CZ2' HD13 ' A' ' 89' ' ' LEU . 61.4 m95 -69.65 -34.81 74.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.905 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.98 -25.82 67.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.007 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.45 ' HB2' HD13 ' A' ' 329' ' ' ILE . . . -74.67 -33.9 62.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.16 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.494 ' O ' HD23 ' A' ' 103' ' ' LEU . 5.6 m -103.52 64.2 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.198 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -156.01 123.64 5.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.32 -52.95 6.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.81 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -143.38 48.69 1.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.73 -25.34 25.42 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.597 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -91.24 135.12 34.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.366 . . . . 0.0 110.95 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.788 ' HB3' HD11 ' A' ' 79' ' ' ILE . 78.7 mt -88.71 150.46 22.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.83 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.584 ' O ' HD12 ' A' ' 104' ' ' ILE . 2.8 pp -157.14 34.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.193 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.693 ' HB1' ' HB2' ' A' ' 263' ' ' SER . . . -159.54 174.23 14.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.11 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.48 ' OH ' HG22 ' A' ' 79' ' ' ILE . 72.3 m-85 -133.42 82.24 52.85 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.807 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.65 119.39 4.64 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.625 2.216 . . . . 0.0 112.392 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.5 mt -101.69 -66.56 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.146 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.418 ' O ' HG12 ' A' ' 261' ' ' VAL . . . -108.58 148.94 29.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.096 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.77 125.26 66.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.141 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.67 148.9 24.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.908 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.509 ' HB1' ' HB3' ' A' ' 323' ' ' ASN . . . -169.94 153.77 4.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.049 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.2 mt -65.22 164.98 12.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.1 178.91 8.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.783 HD11 HD11 ' A' ' 147' ' ' LEU . 63.3 tp -137.62 114.22 10.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.939 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.929 HD12 ' HB2' ' A' ' 227' ' ' ASN . 5.1 mt -106.97 150.1 9.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.067 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.403 ' CE2' ' O ' ' A' ' 243' ' ' GLY . 45.1 p90 -148.55 165.45 31.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.955 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -91.58 121.26 33.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.59 -17.42 61.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.171 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.24 -50.84 68.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.76 0.314 . . . . 0.0 111.132 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.474 ' CD1' ' HB2' ' A' ' 223' ' ' ALA . 0.6 OUTLIER -110.89 -31.06 7.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.086 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.539 ' HB2' ' HB1' ' A' ' 223' ' ' ALA . 7.5 tp -104.39 89.35 2.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.964 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.13 -46.94 1.93 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.563 2.175 . . . . 0.0 112.295 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -119.24 128.92 25.67 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.826 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.914 ' CB ' HG21 ' A' ' 245' ' ' THR . 72.4 Cg_endo -76.58 147.76 28.62 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.424 2.083 . . . . 0.0 112.38 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.33 120.47 5.98 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.546 2.164 . . . . 0.0 112.335 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.96 20.57 8.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.1 p -136.5 141.96 43.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.93 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.644 ' CH2' HD13 ' A' ' 160' ' ' LEU . 12.6 m95 -81.68 -29.27 33.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -74.87 -15.84 60.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.378 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.79 -14.84 33.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.531 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.501 HD12 ' CE3' ' A' ' 129' ' ' TRP . 25.4 mt -65.88 -46.3 65.14 Favored Pre-proline 0 C--N 1.331 -0.214 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.484 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 50.9 Cg_exo -53.95 -49.98 15.27 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.293 1.995 . . . . 0.0 112.304 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.0 -35.28 76.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.134 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 135' ' ' LEU . 6.3 mt -63.97 -46.05 86.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.96 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.446 ' N ' ' HB2' ' A' ' 146' ' ' ALA . 11.8 t70 -52.08 -29.56 22.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.983 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -85.53 -27.76 25.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.044 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -85.05 -31.64 23.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.087 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.432 HD13 ' O ' ' A' ' 145' ' ' SER . 2.0 mt -83.87 -17.25 41.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.375 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -76.66 -29.11 56.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.808 0.337 . . . . 0.0 110.607 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.4 -37.35 85.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.892 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -80.57 -27.02 37.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.973 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 117.48 33.92 1.26 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.579 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.71 172.56 13.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.826 0.346 . . . . 0.0 110.882 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.432 ' O ' HD13 ' A' ' 139' ' ' LEU . 13.3 t -107.37 172.68 6.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.926 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.446 ' HB2' ' N ' ' A' ' 136' ' ' ASP . . . -73.19 -78.18 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.111 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.783 HD11 HD11 ' A' ' 115' ' ' LEU . 5.2 tp -137.86 115.98 11.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.922 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.669 ' SD ' HG23 ' A' ' 208' ' ' THR . 0.0 OUTLIER -84.55 158.2 21.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.229 0.538 . . . . 0.0 111.539 -179.726 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.445 ' H ' HG21 ' A' ' 208' ' ' THR . 38.1 p90 178.35 144.06 0.12 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.876 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -59.38 121.2 10.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.065 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.619 HD22 HD21 ' A' ' 195' ' ' LEU . 11.2 mt -107.32 32.94 4.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.891 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -95.61 -69.82 0.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.97 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -77.27 149.36 79.03 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.002 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.451 ' CB ' HG12 ' A' ' 343' ' ' VAL . 63.5 Cg_endo -73.16 -9.0 22.91 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.652 2.235 . . . . 0.0 112.618 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 258' ' ' PHE . 5.2 t80 -59.67 -26.51 65.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.746 0.308 . . . . 0.0 111.117 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -91.17 -36.1 14.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.056 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 43.9 p -81.48 -22.22 38.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.226 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.564 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 64.9 t-105 -53.03 -54.36 45.09 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.642 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 12.7 Cg_endo -56.29 -21.02 34.46 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.233 1.955 . . . . 0.0 112.431 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.644 HD13 ' CH2' ' A' ' 129' ' ' TRP . 1.9 tp -87.67 -42.57 12.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.853 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.856 HD13 HD12 ' A' ' 192' ' ' LEU . 20.0 mt -77.9 -46.21 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.147 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -59.98 -27.85 67.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.237 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.598 ' HB2' ' HA ' ' A' ' 255' ' ' SER . . . -56.65 -39.12 73.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.236 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.83 -20.14 55.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.162 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 136.02 -28.31 2.95 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.49 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.684 ' HA3' ' HB2' ' A' ' 188' ' ' ALA . . . -59.61 151.07 37.36 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.43 ' CG ' ' HA3' ' A' ' 182' ' ' GLY . 41.6 p90 -141.58 -176.16 4.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 110.916 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.405 ' HB2' ' CZ ' ' A' ' 339' ' ' PHE . . . -97.75 -49.0 4.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.053 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.466 ' CE2' HD11 ' A' ' 333' ' ' ILE . 92.1 m-85 -133.22 154.77 50.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.914 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.13 134.13 40.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -101.14 110.88 22.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.657 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -162.79 146.19 11.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.867 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 61.46 30.38 18.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 64.84 13.7 57.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.009 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.96 160.08 38.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.848 0.356 . . . . 0.0 111.01 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -101.5 102.11 12.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.816 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -59.01 136.63 58.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.986 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.0 pt -93.59 -29.05 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.186 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -69.44 -16.44 63.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.296 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -102.43 150.32 23.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.783 0.325 . . . . 0.0 111.01 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 183' ' ' VAL . 21.4 t -131.81 146.05 33.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.048 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLY . . . . . 0.43 ' HA3' ' CG ' ' A' ' 167' ' ' TYR . . . -103.06 -18.3 15.59 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.783 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.669 HG12 HD22 ' A' ' 361' ' ' LEU . 21.3 t -56.65 -44.38 81.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.81 0.338 . . . . 0.0 111.25 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -84.16 57.38 4.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.906 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -120.25 -177.3 3.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.868 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -76.21 -29.61 57.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.191 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -82.26 -47.19 6.2 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.556 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.684 ' HB2' ' HA3' ' A' ' 166' ' ' GLY . . . -57.31 -29.97 64.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.82 0.343 . . . . 0.0 111.197 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -67.92 -49.28 62.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.906 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -74.22 -30.15 62.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.163 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -58.85 -53.91 42.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.557 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.856 HD12 HD13 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -59.43 -43.96 92.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.86 0.362 . . . . 0.0 110.997 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 61.0 m -57.39 -21.79 38.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.257 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.617 ' CZ ' HD11 ' A' ' 198' ' ' LEU . 14.2 t80 -68.21 -60.53 2.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.824 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.619 HD21 HD22 ' A' ' 151' ' ' LEU . 4.2 tp -63.11 -35.59 80.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.626 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 192' ' ' LEU . 43.8 t -66.19 -56.81 12.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.983 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -67.63 -26.83 66.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.999 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.617 HD11 ' CZ ' ' A' ' 194' ' ' PHE . 4.9 mt -61.26 -58.42 8.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.003 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 195' ' ' LEU . 5.6 mt -57.65 -21.24 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.439 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -84.86 -35.71 22.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.407 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -113.08 19.43 17.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.703 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.34 -17.21 3.81 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 14.1 m80 64.22 43.8 4.72 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.884 0.373 . . . . 0.0 110.671 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.89 146.68 28.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.85 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -81.99 116.77 21.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.96 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.16 -10.15 59.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.413 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.6 56.93 4.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.875 0.369 . . . . 0.0 111.008 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.669 HG23 ' SD ' ' A' ' 148' ' ' MET . 0.6 OUTLIER -117.0 133.08 56.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.802 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.858 ' OD2' HD11 ' A' ' 212' ' ' ILE . 55.0 m-20 -154.11 176.1 12.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.029 0.442 . . . . 0.0 111.106 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.401 ' CD2' ' OE2' ' A' ' 214' ' ' GLU . 1.1 t80 -41.87 -61.64 1.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.81 -59.21 3.24 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.858 HD11 ' OD2' ' A' ' 209' ' ' ASP . 0.2 OUTLIER -53.81 -34.03 24.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.507 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.456 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -81.78 -24.14 36.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.712 0.291 . . . . 0.0 110.915 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.401 ' OE2' ' CD2' ' A' ' 210' ' ' TYR . 4.0 mt-10 -82.29 -46.08 14.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.939 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.13 -31.22 66.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.131 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.33 -35.74 78.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.023 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.421 ' CD1' HG22 ' A' ' 225' ' ' THR . 42.1 t80 -82.24 -36.53 27.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -59.11 -46.77 87.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.973 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -76.41 -27.98 56.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.958 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.35 31.2 6.58 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.521 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -77.94 -71.33 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.808 0.337 . . . . 0.0 110.86 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.4 t -68.0 129.0 38.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.539 ' HB1' ' HB2' ' A' ' 122' ' ' LEU . . . -59.18 -36.81 75.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.14 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.518 ' C ' HD12 ' A' ' 147' ' ' LEU . 9.7 ptt? -141.37 153.89 45.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.553 ' O ' HD12 ' A' ' 115' ' ' LEU . 9.0 t -151.42 157.89 42.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.43 HD12 ' CB ' ' A' ' 149' ' ' PHE . 30.2 mt -94.97 121.82 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.109 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.929 ' HB2' HD12 ' A' ' 116' ' ' ILE . 0.8 OUTLIER -137.84 165.44 26.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.822 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -124.39 -162.31 11.37 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.617 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.81 -10.28 26.14 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.846 2.364 . . . . 0.0 112.71 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -92.56 28.28 2.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.651 0.262 . . . . 0.0 111.386 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.05 19.18 1.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.371 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 9.6 m95 -81.2 -55.84 4.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.851 0.358 . . . . 0.0 110.919 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.7 m -57.3 -26.5 60.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.177 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -54.66 -29.27 52.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.092 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.803 HG21 ' CD1' ' A' ' 242' ' ' TYR . 3.2 mt -86.71 98.53 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.046 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -169.98 -49.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.1 t -73.35 -33.51 65.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' SER . . . . . 0.517 ' HB3' HG23 ' A' ' 240' ' ' VAL . 71.1 m -90.88 -30.26 17.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt 62.13 31.4 17.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.517 HG23 ' HB3' ' A' ' 238' ' ' SER . 21.6 t -74.43 124.2 31.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.083 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -61.93 94.24 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.827 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.803 ' CD1' HG21 ' A' ' 235' ' ' ILE . 50.3 p90 -89.99 123.02 33.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.924 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.403 ' O ' ' CE2' ' A' ' 117' ' ' TYR . . . -108.99 95.32 0.9 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.469 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 27.0 t -68.95 127.96 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.815 0.34 . . . . 0.0 111.088 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.914 HG21 ' CB ' ' A' ' 125' ' ' PRO . 9.9 t -134.0 159.33 41.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.7 t -66.65 152.02 9.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.97 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.2 mp -67.63 151.19 97.39 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.944 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.426 ' HG3' HD11 ' A' ' 132' ' ' ILE . 39.5 Cg_endo -67.14 162.98 35.92 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.543 2.162 . . . . 0.0 112.211 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 36.9 p -102.14 144.99 30.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.968 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.49 ' CE1' ' CZ ' ' A' ' 194' ' ' PHE . 26.9 t80 -129.31 132.06 47.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.06 18.44 8.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.282 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 91.21 -21.27 35.48 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.942 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -103.66 145.74 31.19 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.701 0.286 . . . . 0.0 110.926 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.66 164.04 34.58 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.589 2.192 . . . . 0.0 112.299 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.598 ' HA ' ' HB2' ' A' ' 163' ' ' ALA . 0.3 OUTLIER -62.15 -176.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 15.7 mttp -137.0 66.61 54.91 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.7 176.19 9.21 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.561 2.174 . . . . 0.0 112.324 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' PHE . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 155' ' ' TYR . 95.1 m-85 -95.26 166.12 12.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.99 136.4 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.293 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -131.15 121.68 3.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.349 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -113.67 133.64 58.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 111.233 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 12.9 tp -92.07 90.17 7.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.568 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.693 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 0.9 OUTLIER -84.87 167.01 16.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.08 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -98.97 114.99 27.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.997 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -81.92 149.8 28.59 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.529 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 31.3 mt -142.41 152.0 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 0.0 111.098 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -98.93 149.93 22.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.962 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.623 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -68.6 -36.68 79.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.065 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -97.35 36.54 1.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.14 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.3 m -69.27 146.5 96.77 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.888 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.51 -49.32 17.76 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.524 2.149 . . . . 0.0 112.264 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -141.76 83.4 1.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.82 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? -63.08 -34.33 77.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.82 -53.94 52.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.876 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 68.7 mt -59.78 -32.52 70.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.9 -40.69 96.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -52.3 25.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.9 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -60.34 -42.35 95.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.415 ' CE2' ' HB2' ' A' ' 27' ' ' PHE . 11.9 t80 -60.26 -64.28 1.01 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.123 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.978 HD22 HD22 ' A' ' 284' ' ' LEU . 26.2 mt -57.25 -21.65 35.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.411 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -90.48 -32.93 16.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.704 0.288 . . . . 0.0 111.375 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.402 ' O ' ' CD1' ' A' ' 283' ' ' TYR . 35.2 m-80 -104.34 20.39 18.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.285 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.558 ' O ' HG22 ' A' ' 286' ' ' THR . 96.1 m-85 -157.75 -66.25 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.825 0.345 . . . . 0.0 111.042 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.978 HD22 HD22 ' A' ' 280' ' ' LEU . 17.6 tp -60.84 -30.14 69.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.935 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 99.6 mt -121.89 82.28 1.93 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.964 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.56 HG23 ' HA3' ' A' ' 289' ' ' GLY . 0.6 OUTLIER -160.96 170.01 21.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.835 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.2 -57.07 8.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -69.26 -42.77 75.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.049 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.56 ' HA3' HG23 ' A' ' 286' ' ' THR . . . -57.77 -57.2 21.03 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.615 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.488 HD22 HG11 ' A' ' 302' ' ' VAL . 30.4 mt -58.59 -29.85 66.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.802 0.334 . . . . 0.0 110.976 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -60.05 -43.82 95.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.001 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -59.53 -53.67 55.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.142 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.1 t -59.65 -32.17 48.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.22 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -71.68 -31.21 66.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.944 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 49.1 mttm -65.69 -34.66 78.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.955 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.62 -35.04 11.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.5 90.71 4.55 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.889 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.91 112.61 2.75 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.548 2.165 . . . . 0.0 112.238 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 1.2 mt -97.4 25.82 5.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.003 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' GLY . . . . . 0.589 ' O ' HD13 ' A' ' 311' ' ' LEU . . . 58.29 -125.5 39.66 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.553 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.572 ' HB2' ' CG ' ' A' ' 321' ' ' MET . . . -64.97 156.05 32.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.78 0.324 . . . . 0.0 111.099 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.488 HG11 HD22 ' A' ' 290' ' ' LEU . 9.6 m -128.36 24.89 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.234 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.635 ' HB1' HD23 ' A' ' 89' ' ' LEU . . . 52.92 27.37 5.45 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.343 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.479 ' HB2' HG23 ' A' ' 302' ' ' VAL . 0.5 OUTLIER -116.0 125.24 52.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.862 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -67.01 -31.78 72.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.01 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.8 m -81.2 -29.8 34.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.164 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.422 ' CE2' ' HB2' ' A' ' 290' ' ' LEU . 1.9 t80 -87.91 -28.24 21.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.202 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 0.0 OUTLIER -54.09 -29.63 45.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.814 0.34 . . . . 0.0 111.062 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -67.79 -61.51 1.85 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -50.86 -33.7 24.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.77 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.78 ' HB3' HG21 ' A' ' 317' ' ' ILE . 46.9 mt -85.76 -25.83 26.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.781 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 308' ' ' GLU . . . -73.39 -7.44 51.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.558 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -47.21 -30.59 3.06 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.95 0.405 . . . . 0.0 110.895 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.33 133.81 24.31 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.283 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.512 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 10.8 Cg_endo -54.55 -29.04 58.27 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.421 2.081 . . . . 0.0 112.422 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -49.35 -41.76 39.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.095 0.474 . . . . 0.0 110.296 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.78 HG21 ' HB3' ' A' ' 311' ' ' LEU . 27.8 mt -85.6 -33.26 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.939 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.512 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -62.66 -30.83 71.67 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.11 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -79.31 -31.38 43.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.118 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.37 -35.47 80.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.572 ' CG ' ' HB2' ' A' ' 301' ' ' ALA . 45.8 mtp -81.88 -32.79 30.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.933 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.24 -31.34 70.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.943 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.509 ' HB3' ' HB1' ' A' ' 112' ' ' ALA . 6.3 m-80 -67.99 -38.77 83.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -71.17 -39.89 71.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.132 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -59.85 -35.03 73.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.957 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 6.7 mmtm -117.81 21.11 13.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.033 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -114.03 142.27 17.42 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.501 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -75.61 135.57 40.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.791 0.329 . . . . 0.0 110.884 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.45 HD13 ' HB2' ' A' ' 96' ' ' ALA . 30.8 mt -79.19 148.96 5.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.14 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 6.6 mtp -76.51 113.49 29.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.37 152.5 15.43 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.489 2.126 . . . . 0.0 112.312 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -106.01 39.15 1.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.854 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.466 HD11 ' CE2' ' A' ' 169' ' ' PHE . 22.7 pt -108.15 148.87 38.37 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.177 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.95 -27.71 30.08 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.559 2.172 . . . . 0.0 112.339 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 17.0 mp0 -59.33 -24.14 63.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.055 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 1.7 tpt -54.53 -26.8 34.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.188 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 38.3 m -58.23 -55.26 37.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.015 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -60.43 -29.61 69.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.166 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.711 ' O ' HG23 ' A' ' 343' ' ' VAL . 68.7 t80 -58.98 -51.71 68.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.026 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 40.3 m95 -56.47 -23.52 39.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.356 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -79.38 -61.38 2.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.125 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -59.63 -48.32 82.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.404 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 339' ' ' PHE . 31.7 t -58.18 -32.52 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.292 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 -68.11 -57.46 6.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.914 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 30.9 m -65.83 -28.32 68.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.137 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.581 ' HB1' ' HB1' ' A' ' 360' ' ' ALA . . . -60.09 -51.39 69.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.342 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 32.8 t -70.83 -47.31 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.272 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 57.8 mt -59.31 -43.29 89.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.054 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -60.36 -30.61 69.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.012 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -79.31 -52.51 8.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.34 -38.72 90.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.03 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 16.8 m -70.98 -22.35 62.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.139 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 87.5 26.79 29.18 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.589 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 30.4 mtt180 -91.27 -30.74 16.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.854 0.359 . . . . 0.0 110.915 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -146.45 -176.51 5.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.846 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 19.8 p -116.28 170.74 8.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.525 HG22 ' CD2' ' A' ' 192' ' ' LEU . 47.9 t -59.5 -55.29 24.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.005 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -47.42 -29.83 2.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.157 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -84.29 -41.97 16.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.965 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.581 ' HB1' ' HB1' ' A' ' 346' ' ' ALA . . . -60.08 -60.46 3.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.931 0.395 . . . . 0.0 110.765 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.669 HD22 HG12 ' A' ' 183' ' ' VAL . 3.1 mt -58.29 -27.02 63.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.978 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.94 -53.46 6.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.831 0.348 . . . . 0.0 111.007 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -59.36 -48.55 81.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.857 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.466 ' O ' HD12 ' A' ' 368' ' ' ILE . . . -58.57 -36.42 73.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.994 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.611 ' O ' HG23 ' A' ' 369' ' ' THR . 0.1 OUTLIER -59.78 -45.24 92.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.831 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -52.32 66.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.002 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -59.05 -48.38 81.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.998 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.466 HD12 ' O ' ' A' ' 364' ' ' ALA . 10.6 mt -65.88 -28.96 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.188 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.611 HG23 ' O ' ' A' ' 365' ' ' GLN . 32.6 p -83.37 -31.3 26.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.922 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.884 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.512 HG23 ' HG2' ' A' ' 271' ' ' PRO . 2.7 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.821 0.343 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -98.75 31.76 2.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.42 ' HB3' ' CD ' ' A' ' 6' ' ' LYS . 2.2 tt0 -92.83 -163.87 1.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.794 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -134.15 52.47 0.81 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.771 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.42 ' CD ' ' HB3' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -146.25 -174.93 4.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.793 0.33 . . . . 0.0 110.94 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 21.6 mt -130.56 123.62 29.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.5 t -91.27 142.04 13.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.156 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.848 HG21 ' CD2' ' A' ' 20' ' ' LEU . 29.5 mm -119.66 107.53 21.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.952 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.41 ' CD2' ' HG3' ' A' ' 57' ' ' PRO . 5.2 m0 -104.07 106.74 17.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.6 tt -150.84 150.52 13.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.11 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -64.36 158.91 22.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.916 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.87 57.74 3.68 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.522 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -125.86 -44.51 1.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.862 0.363 . . . . 0.0 110.912 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.75 -179.29 6.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.874 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.18 83.83 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.486 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -71.91 -35.5 69.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.809 0.338 . . . . 0.0 110.902 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -72.31 -31.18 65.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.85 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.25 -41.49 96.75 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.495 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.848 ' CD2' HG21 ' A' ' 9' ' ' ILE . 8.4 tp -67.23 -29.52 69.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.0 110.952 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.74 -42.29 79.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.101 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.67 -26.14 68.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.019 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.65 HG12 ' CZ ' ' A' ' 279' ' ' PHE . 17.5 t -76.71 -25.94 16.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -81.39 -42.54 9.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.599 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -27.69 69.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.767 0.318 . . . . 0.0 110.988 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -73.9 -41.52 62.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -60.43 -57.15 14.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.931 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.32 -21.19 48.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.295 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.42 -25.81 33.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.334 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -102.48 -33.74 9.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.583 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.68 -44.15 3.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.766 0.317 . . . . 0.0 111.402 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.31 -26.4 7.04 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.528 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.577 HG21 HD13 ' A' ' 275' ' ' LEU . 35.7 mm -62.25 122.65 13.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.338 . . . . 0.0 111.108 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -70.71 166.77 20.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.967 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.2 t -147.45 102.57 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.087 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.8 m -98.29 144.67 27.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.5 t -114.53 110.18 31.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.113 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -97.56 176.46 5.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.789 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -159.32 70.24 3.36 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.018 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.29 144.41 46.0 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.549 2.166 . . . . 0.0 112.171 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.21 139.13 48.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.966 0.412 . . . . 0.0 111.04 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.538 ' C ' HD23 ' A' ' 43' ' ' LEU . 4.4 mtmt 73.48 -58.39 0.6 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.873 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.538 HD23 ' C ' ' A' ' 42' ' ' LYS . 0.5 OUTLIER 49.18 18.69 0.25 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.114 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -83.29 -57.02 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -91.57 -7.4 50.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.354 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.546 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.5 tptt -67.75 -25.1 65.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.264 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.477 ' CB ' ' HD3' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -85.16 -57.68 0.36 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.179 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.477 ' HD3' ' CB ' ' A' ' 47' ' ' PHE . 54.0 Cg_exo -52.07 -35.8 63.2 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.416 2.077 . . . . 0.0 112.531 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.612 ' HG3' HG13 ' A' ' 50' ' ' VAL . 11.5 pt20 -60.09 -49.64 76.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.01 0.433 . . . . 0.0 111.053 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.612 HG13 ' HG3' ' A' ' 49' ' ' GLN . 6.2 m -96.68 27.0 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.418 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 1.037 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -88.55 -42.15 12.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.107 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.33 -33.65 76.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.098 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 55' ' ' ASP . 11.5 t -88.12 -31.31 19.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.52 39.61 68.38 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.518 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.417 ' H ' HG23 ' A' ' 53' ' ' THR . 8.8 t0 -97.73 -29.58 13.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.98 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.52 -160.5 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.551 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.442 ' HG2' ' CZ ' ' A' ' 47' ' ' PHE . 41.4 Cg_endo -67.54 -167.79 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.549 2.166 . . . . 0.0 112.263 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -124.12 -42.48 2.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.006 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 60' ' ' ILE . 16.7 mt -102.1 158.29 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.242 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.563 HG22 ' O ' ' A' ' 265' ' ' GLY . 2.4 tt -166.86 159.48 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.811 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.477 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 73.6 m-85 -119.85 140.58 50.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.987 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.505 ' HZ3' HD11 ' A' ' 43' ' ' LEU . 4.9 t-105 -174.07 151.11 1.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.64 134.54 57.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.091 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -53.26 -28.37 27.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.195 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -64.55 -35.06 79.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.005 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.438 ' HB3' ' CD1' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -94.41 17.18 13.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.296 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -106.84 30.62 5.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.827 0.346 . . . . 0.0 110.907 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -122.29 35.91 3.34 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.544 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -128.43 -41.7 0.27 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.51 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -80.62 -9.03 59.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.608 0.242 . . . . 0.0 111.364 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.22 -25.98 47.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.728 0.299 . . . . 0.0 111.144 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -60.72 -51.05 71.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.948 0.404 . . . . 0.0 110.661 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.7 m -72.04 -23.1 61.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.047 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.4 31.63 9.43 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.526 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.037 HD22 ' HB1' ' A' ' 51' ' ' ALA . 35.7 mt -72.5 -37.97 68.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.785 0.326 . . . . 0.0 110.952 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.674 HD13 HD13 ' A' ' 104' ' ' ILE . 6.7 mt -77.35 146.28 36.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.986 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.797 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -93.08 116.39 28.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.078 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -60.79 155.83 18.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.833 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.475 ' O ' HG23 ' A' ' 80' ' ' THR . 42.6 pt -124.68 179.19 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.131 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 79' ' ' ILE . 0.9 OUTLIER -159.82 77.81 2.79 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.893 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.31 163.45 34.42 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.613 2.209 . . . . 0.0 112.207 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -94.8 -179.43 4.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -59.18 -48.92 79.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.883 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.51 -31.16 72.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.104 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -74.59 -35.73 62.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.917 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.427 ' HA ' ' CZ2' ' A' ' 94' ' ' TRP . 15.5 mt-30 -79.87 -30.13 40.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.947 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -74.05 -39.26 63.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.985 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.83 -36.21 76.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.978 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.515 HD13 ' CZ2' ' A' ' 94' ' ' TRP . 0.4 OUTLIER -84.48 178.07 7.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.834 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.42 ' HB3' ' CE1' ' A' ' 92' ' ' PHE . 24.4 m-85 -86.79 142.38 34.4 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.039 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 63.7 Cg_exo -54.27 -55.85 3.03 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.581 2.188 . . . . 0.0 112.657 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.541 ' CE2' HG23 ' A' ' 93' ' ' THR . 50.0 p90 -60.32 -46.63 89.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.429 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.541 HG23 ' CE2' ' A' ' 92' ' ' PHE . 70.9 p -53.21 -27.6 22.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.797 0.332 . . . . 0.0 111.233 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.515 ' CZ2' HD13 ' A' ' 89' ' ' LEU . 22.8 m95 -74.68 -36.44 62.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.822 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -74.56 -7.7 53.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.342 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.76 -27.9 22.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.822 0.344 . . . . 0.0 111.183 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.516 ' CG1' ' HB3' ' A' ' 105' ' ' ALA . 27.5 m -93.0 47.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.288 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.9 124.31 13.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -108.94 -65.2 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.844 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -98.59 30.66 3.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.808 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.92 -25.96 21.1 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.558 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -92.17 170.55 9.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.333 . . . . 0.0 110.99 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.514 ' O ' HG23 ' A' ' 104' ' ' ILE . 5.9 mt -96.17 141.11 29.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.79 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.685 ' O ' HD12 ' A' ' 104' ' ' ILE . 1.8 pp -158.08 58.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.239 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.805 ' HB1' ' HB3' ' A' ' 263' ' ' SER . . . -177.33 172.25 1.89 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.229 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.732 ' CE1' HD12 ' A' ' 266' ' ' ILE . 26.0 m-85 -138.53 94.01 10.82 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.821 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.52 116.96 3.65 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.648 2.232 . . . . 0.0 112.381 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.0 mt -119.06 -64.39 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.118 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.588 ' CB ' HD22 ' A' ' 299' ' ' LEU . . . -113.7 142.84 45.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.147 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.676 HG22 HG13 ' A' ' 261' ' ' VAL . 21.5 t -106.86 151.88 8.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.116 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -130.94 149.14 52.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -171.72 146.36 2.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.2 mt -66.53 114.87 5.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.915 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.681 ' HB3' HG13 ' A' ' 244' ' ' VAL . 1.3 m -93.72 163.23 13.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.925 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 50.1 tp -100.72 101.54 12.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.766 HG22 ' CZ ' ' A' ' 217' ' ' PHE . 28.7 mt -86.16 119.91 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.119 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -137.84 148.9 45.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.943 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -81.42 156.75 25.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.6 mtmm -110.88 -30.25 7.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.978 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -61.17 -31.61 71.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.035 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.669 HD11 ' HA ' ' A' ' 223' ' ' ALA . 3.8 pp -111.6 -33.71 6.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.974 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.561 ' HB2' HD12 ' A' ' 121' ' ' LEU . 8.3 tp -119.25 88.98 38.83 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.995 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.26 -28.42 33.65 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.535 2.157 . . . . 0.0 112.283 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -140.26 112.58 7.31 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.836 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -78.82 167.59 22.05 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.586 2.191 . . . . 0.0 112.422 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.408 ' HD2' ' HE3' ' A' ' 224' ' ' MET . 56.2 Cg_endo -70.34 111.81 3.02 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.603 2.202 . . . . 0.0 112.322 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.45 -27.1 65.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.963 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 29.5 p -120.34 158.53 26.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.964 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.425 ' CE3' HD12 ' A' ' 132' ' ' ILE . 34.5 m95 -72.44 -30.06 64.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.967 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -72.2 -16.05 61.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.405 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.733 ' O ' HD12 ' A' ' 135' ' ' LEU . 2.6 mt-10 -89.76 0.05 57.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.581 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.48 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 12.2 mt -85.44 -46.5 0.62 Allowed Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 73.2 Cg_exo -49.25 -28.35 14.76 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.378 2.052 . . . . 0.0 112.44 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.27 -34.61 28.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.197 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.733 HD12 ' O ' ' A' ' 131' ' ' GLU . 0.2 OUTLIER -62.23 -42.55 99.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.092 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.406 ' OD2' ' HA ' ' A' ' 133' ' ' PRO . 7.5 p30 -57.09 -22.24 38.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.216 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -85.62 -33.71 21.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.079 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -85.1 -61.74 1.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.296 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.421 HD13 ' HB2' ' A' ' 223' ' ' ALA . 6.6 mt -53.79 -24.85 16.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.545 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -76.87 -24.77 52.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.742 0.306 . . . . 0.0 110.959 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.12 -33.75 69.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.903 0.383 . . . . 0.0 110.97 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.08 -27.12 39.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.029 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.44 42.16 0.77 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.491 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -144.99 -177.3 5.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 0.0 110.861 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.57 147.82 40.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.868 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -68.33 -68.82 0.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.201 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.698 HD13 ' HB2' ' A' ' 224' ' ' MET . 18.8 tp -148.79 132.92 17.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.043 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.777 ' HB2' HG21 ' A' ' 208' ' ' THR . 0.0 OUTLIER -126.17 179.61 5.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.712 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.428 ' HB2' ' CD2' ' A' ' 156' ' ' PHE . 50.6 p90 -178.28 -176.04 0.49 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.018 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -79.37 118.8 21.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.905 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.4 mt -98.93 29.2 3.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -112.09 -33.34 6.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.842 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -101.04 135.27 19.99 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.419 ' CB ' HG12 ' A' ' 343' ' ' VAL . 72.0 Cg_endo -76.56 -13.36 18.3 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.532 2.155 . . . . 0.0 112.612 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.495 ' CZ ' ' CH2' ' A' ' 340' ' ' TRP . 3.0 m-85 -57.37 -32.62 66.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.12 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.428 ' CD2' ' HB2' ' A' ' 149' ' ' PHE . 1.8 m-85 -77.44 -36.72 52.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.896 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.652 HG21 HG11 ' A' ' 347' ' ' VAL . 40.1 p -81.55 -23.07 37.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.045 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.545 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 64.5 t-105 -50.9 -54.15 40.03 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.572 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.611 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 14.9 Cg_endo -57.24 -22.02 46.61 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.196 1.931 . . . . 0.0 112.3 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.4 tp -80.44 -54.48 5.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.813 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.991 HG21 HD12 ' A' ' 192' ' ' LEU . 12.3 pt -71.16 -34.03 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.434 ' HB1' ' HG3' ' A' ' 256' ' ' LYS . . . -75.08 -28.9 60.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.175 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -56.5 -28.87 60.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.233 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -76.16 -20.04 57.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.222 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 139.55 -26.37 2.67 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.658 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.488 ' HA3' ' HB2' ' A' ' 188' ' ' ALA . . . -57.0 145.32 37.64 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.565 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -134.81 -176.35 4.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.801 0.334 . . . . 0.0 110.986 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.45 ' HB2' ' CZ2' ' A' ' 158' ' ' TRP . . . -107.58 -49.64 3.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.12 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.911 ' CE2' HD11 ' A' ' 333' ' ' ILE . 24.9 m-85 -127.83 158.73 36.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -99.44 118.58 36.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.017 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.404 ' CE1' ' O ' ' A' ' 174' ' ' GLY . 7.7 t80 -85.59 111.15 19.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.487 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.04 146.33 23.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.153 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 63.11 29.45 16.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.095 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 171' ' ' TYR . . . 90.55 -37.0 3.44 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.021 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.91 -177.24 3.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 0.0 111.067 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -98.92 -177.48 3.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.954 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -133.46 134.76 43.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.8 pt -87.12 -29.68 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.119 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -74.54 -16.33 60.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.219 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -104.96 117.35 33.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.807 0.337 . . . . 0.0 110.976 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.725 HG12 HG23 ' A' ' 183' ' ' VAL . 16.9 t -124.51 146.05 30.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.006 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -117.04 61.37 0.42 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.782 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.725 HG23 HG12 ' A' ' 181' ' ' VAL . 2.3 t -96.55 -61.58 2.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.846 0.355 . . . . 0.0 110.973 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -84.4 57.23 4.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.922 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -95.74 167.84 11.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.849 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -58.64 -31.14 67.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.178 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -85.98 -49.13 4.38 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.55 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.488 ' HB2' ' HA3' ' A' ' 166' ' ' GLY . . . -59.0 -31.59 68.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 0.0 111.182 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -60.02 -45.81 91.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.834 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -86.95 -28.2 22.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.154 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -57.81 -53.61 43.96 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.608 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.991 HD12 HG21 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -61.22 -32.65 72.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.339 . . . . 0.0 110.981 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.3 m -53.67 -25.15 16.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.091 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -65.89 -59.08 4.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.786 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.493 ' HA ' HD12 ' A' ' 198' ' ' LEU . 8.0 tt -64.78 -29.78 70.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.735 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.87 HG23 ' O ' ' A' ' 192' ' ' LEU . 41.2 t -69.49 -59.84 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.062 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -58.48 -29.55 66.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.051 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 195' ' ' LEU . 12.5 mt -60.06 -47.88 84.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 22.4 mt -76.53 -28.41 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.167 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.789 ' HD2' HG12 ' A' ' 196' ' ' VAL . 18.2 mtpt -62.06 -30.48 71.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.966 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -91.07 13.58 16.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.423 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt 56.13 44.04 25.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.956 0.407 . . . . 0.0 111.028 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.83 -28.1 12.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.904 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 87.7 mtp -113.69 176.74 4.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.932 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 19.8 m-20 -124.22 133.57 53.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -79.77 -38.99 31.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.094 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -59.25 -27.39 65.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.982 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.777 HG21 ' HB2' ' A' ' 148' ' ' MET . 1.6 m -49.45 146.74 3.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.227 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -154.23 176.08 12.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.858 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -61.08 -29.02 69.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.257 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.13 -59.36 2.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.84 0.352 . . . . 0.0 110.986 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -28.65 44.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.309 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.582 ' O ' HG21 ' A' ' 225' ' ' THR . . . -77.74 -21.75 51.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.769 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.16 -50.2 11.36 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.835 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.76 -30.61 68.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.127 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.3 -32.98 70.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.144 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.766 ' CZ ' HG22 ' A' ' 116' ' ' ILE . 19.4 t80 -79.42 -41.1 28.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.961 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -67.12 -36.11 81.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.5 mttm -83.73 -34.0 24.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.863 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.12 59.33 0.94 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.491 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -109.27 -72.69 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.803 0.335 . . . . 0.0 110.825 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.592 HG21 ' SD ' ' A' ' 148' ' ' MET . 10.6 t -74.36 169.12 18.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.924 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.669 ' HA ' HD11 ' A' ' 121' ' ' LEU . . . -81.53 -54.66 5.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.171 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.698 ' HB2' HD13 ' A' ' 147' ' ' LEU . 0.5 OUTLIER -125.78 163.59 22.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.004 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.582 HG21 ' O ' ' A' ' 213' ' ' ALA . 66.3 m -159.83 137.75 10.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 29.3 mt -112.98 135.22 53.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.163 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.523 ' HB3' ' HB2' ' A' ' 231' ' ' ALA . 33.5 t30 -150.47 155.78 40.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -62.47 -162.25 0.27 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.551 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.427 ' HD2' ' CZ3' ' A' ' 230' ' ' TRP . 34.5 Cg_endo -64.56 -23.09 64.48 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.649 2.233 . . . . 0.0 112.499 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' TRP . . . . . 0.427 ' CZ3' ' HD2' ' A' ' 229' ' ' PRO . 46.6 p90 -84.5 57.31 4.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.958 0.409 . . . . 0.0 110.875 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.523 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . . . -141.76 -44.94 0.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.18 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' TRP . . . . . 0.551 ' HA ' HD12 ' A' ' 235' ' ' ILE . 20.8 m0 -54.26 -30.59 51.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.086 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.5 m -62.71 -36.58 83.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.944 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -60.39 -34.39 73.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.919 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.551 HD12 ' HA ' ' A' ' 232' ' ' TRP . 10.6 mt -74.96 70.4 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.03 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -153.28 -46.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.871 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 62.4 m -61.29 -44.1 97.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.84 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 2.7 t -101.58 -34.13 9.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.93 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.97 104.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.6 t -135.01 142.32 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.122 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.05 95.66 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.627 ' HB2' HG23 ' A' ' 116' ' ' ILE . 55.0 p90 -100.54 135.6 41.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -100.53 148.16 18.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.466 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.681 HG13 ' HB3' ' A' ' 114' ' ' SER . 21.3 t -128.55 123.27 59.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.838 0.351 . . . . 0.0 111.119 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 10.0 t -143.45 153.78 43.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.864 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.502 HG11 ' CD ' ' A' ' 322' ' ' GLU . 0.8 OUTLIER -54.85 152.35 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.245 0.545 . . . . 0.0 111.381 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.412 ' N ' ' CG2' ' A' ' 246' ' ' VAL . 89.9 mt -67.68 136.24 92.68 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.855 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.422 ' HB2' ' CD1' ' A' ' 129' ' ' TRP . 52.3 Cg_exo -54.58 -170.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.412 2.075 . . . . 0.0 112.279 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.511 HG22 ' HA ' ' A' ' 254' ' ' PRO . 1.3 p -127.89 163.04 25.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -111.05 108.24 17.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.93 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 17.1 mttt 59.44 30.72 20.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.958 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 83.1 27.03 42.06 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.541 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.431 ' O ' HG22 ' A' ' 249' ' ' THR . 2.9 mm-40 -122.22 141.27 34.14 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.59 0.233 . . . . 0.0 110.852 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.511 ' HA ' HG22 ' A' ' 249' ' ' THR . 72.6 Cg_endo -76.37 145.34 26.82 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.544 2.163 . . . . 0.0 112.42 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.22 -172.64 1.77 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.769 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.434 ' HG3' ' HB1' ' A' ' 162' ' ' ALA . 12.3 mmmt -132.88 58.69 37.45 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.128 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.433 ' HD3' ' N ' ' A' ' 256' ' ' LYS . 62.3 Cg_exo -50.9 -179.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.406 2.071 . . . . 0.0 112.291 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' PHE . . . . . 0.494 ' CE2' ' CD2' ' A' ' 155' ' ' TYR . 10.9 m-85 -110.53 134.9 51.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.826 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 328' ' ' GLU . 23.8 t -97.17 132.13 42.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.203 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -145.57 106.13 0.37 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.307 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.676 HG13 HG22 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -106.21 149.53 9.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.881 0.372 . . . . 0.0 111.323 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 262' ' ' LEU . 11.9 tp -85.75 80.88 8.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.975 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.805 ' HB3' ' HB1' ' A' ' 105' ' ' ALA . 2.1 m -75.81 137.44 40.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.033 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.713 ' HB3' ' HB2' ' A' ' 106' ' ' TYR . . . -82.04 114.98 20.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.053 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.563 ' O ' HG22 ' A' ' 60' ' ' ILE . . . -83.38 117.82 4.51 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.565 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.732 HD12 ' CE1' ' A' ' 106' ' ' TYR . 29.2 mt -119.48 121.94 67.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.818 0.342 . . . . 0.0 110.998 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -79.59 148.64 31.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.953 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.797 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -67.51 -27.13 66.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.176 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -90.98 48.81 1.56 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.152 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 58.5 p -116.45 108.11 45.93 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.794 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.512 ' HG2' HG23 ' A' ' 2' ' ' THR . 38.3 Cg_endo -66.73 -24.37 47.54 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.418 2.079 . . . . 0.0 112.312 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -97.64 37.21 1.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.841 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -66.36 -41.09 89.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -59.58 -56.15 25.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.961 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.577 HD13 HG21 ' A' ' 33' ' ' ILE . 19.1 mt -60.32 -35.04 74.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.81 -50.72 40.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.075 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -44.62 95.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.873 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -63.07 -61.97 2.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.65 ' CZ ' HG12 ' A' ' 23' ' ' VAL . 72.8 t80 -55.09 -27.18 43.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.143 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.64 HD23 HD22 ' A' ' 284' ' ' LEU . 24.8 mt -76.95 -37.83 54.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.109 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.465 ' HG3' HD12 ' A' ' 285' ' ' LEU . 1.1 mp0 -93.62 -7.32 44.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.643 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -103.29 -35.8 8.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.653 0.263 . . . . 0.0 111.367 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -116.96 -35.77 4.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.406 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.64 HD22 HD23 ' A' ' 280' ' ' LEU . 1.5 tp -95.21 41.1 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.799 0.333 . . . . 0.0 111.134 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.465 HD12 ' HG3' ' A' ' 281' ' ' GLU . 2.7 mt -177.18 37.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.878 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.2 p -142.91 164.49 29.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -72.28 -30.21 64.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -79.45 -30.49 42.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.004 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -89.63 -50.92 3.01 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.589 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 87.2 mt -59.68 -31.0 69.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.363 . . . . 0.0 111.021 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -69.64 -31.21 69.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.46 -30.73 67.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.164 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.12 -30.02 9.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.39 -30.71 71.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.959 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -68.99 -33.62 73.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.027 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.55 -36.69 12.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.015 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -169.2 100.3 0.49 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.922 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.28 115.12 3.69 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.428 2.085 . . . . 0.0 112.32 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.588 HD22 ' CB ' ' A' ' 109' ' ' ALA . 0.8 OUTLIER -56.9 -24.63 53.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.026 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 109.76 -32.66 6.58 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.573 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -157.36 176.83 12.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 0.0 111.126 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.629 HG21 ' CD2' ' A' ' 307' ' ' TYR . 5.8 m -152.92 156.08 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.089 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.458 ' HB1' HD23 ' A' ' 89' ' ' LEU . . . -84.42 -30.32 25.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.135 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 304' ' ' LEU . 14.0 tp -59.67 123.97 18.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.908 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -72.66 -24.14 60.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.12 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.6 m -81.27 -24.13 37.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.179 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.629 ' CD2' HG21 ' A' ' 302' ' ' VAL . 26.3 t80 -95.33 -31.97 13.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.306 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -57.23 -29.72 63.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.343 . . . . 0.0 110.948 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -64.27 -59.87 3.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -50.89 -33.26 23.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.827 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.799 ' HB3' HG21 ' A' ' 317' ' ' ILE . 7.8 mt -85.76 -24.99 26.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.798 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -67.13 -13.82 62.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.494 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -47.48 -32.16 4.91 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.972 0.415 . . . . 0.0 110.941 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -112.69 140.65 24.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.37 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.483 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 11.6 Cg_endo -55.76 -26.99 59.59 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.425 2.083 . . . . 0.0 112.341 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -50.51 -41.24 53.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.079 0.466 . . . . 0.0 110.313 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.799 HG21 ' HB3' ' A' ' 311' ' ' LEU . 32.2 mm -85.58 -32.0 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.957 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.483 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -69.39 -30.69 68.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.171 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -74.42 -46.18 41.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.204 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 63.4 m -59.7 -31.35 69.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.925 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.91 -41.82 25.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.946 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.502 ' CD ' HG11 ' A' ' 246' ' ' VAL . 18.1 tt0 -60.0 -47.06 87.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.958 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -60.14 -54.27 47.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.966 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.79 -50.55 73.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.148 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -59.71 -33.29 71.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -96.59 21.15 9.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.123 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -128.18 161.88 21.97 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.521 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' GLU . . . . . 0.408 ' O ' HG23 ' A' ' 259' ' ' VAL . 0.4 OUTLIER -79.58 156.24 27.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.804 0.335 . . . . 0.0 110.873 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 25.3 mt -88.02 138.39 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.141 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.441 ' HG2' ' CD1' ' A' ' 258' ' ' PHE . 12.8 mtm -60.35 140.27 91.74 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.43 ' HG2' ' HE3' ' A' ' 336' ' ' MET . 72.6 Cg_endo -76.41 138.79 20.1 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.549 2.166 . . . . 0.0 112.333 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -101.87 30.98 4.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.911 HD11 ' CE2' ' A' ' 169' ' ' PHE . 9.4 pt -107.2 148.52 37.23 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.108 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.56 -24.47 18.77 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.584 2.19 . . . . 0.0 112.446 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.15 -26.34 38.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.184 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 336' ' ' MET . . . . . 0.43 ' HE3' ' HG2' ' A' ' 331' ' ' PRO . 17.3 ptm -57.31 -22.27 40.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.215 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 67.1 m -50.24 -48.8 54.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.175 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.52 -28.02 60.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.15 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.73 ' CZ ' HG21 ' A' ' 343' ' ' VAL . 78.0 t80 -58.25 -29.1 65.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.009 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.495 ' CH2' ' CZ ' ' A' ' 155' ' ' TYR . 94.2 m95 -60.28 -61.06 2.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.034 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.86 -30.72 71.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.091 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -62.04 -56.28 20.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.339 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.73 HG21 ' CZ ' ' A' ' 339' ' ' PHE . 21.4 t -78.62 -33.76 17.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.417 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -57.16 -57.45 12.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.15 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 345' ' ' THR . . . . . 0.637 HG22 ' OD1' ' A' ' 349' ' ' ASN . 21.0 m -66.71 -29.53 69.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.01 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -59.78 -56.84 16.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.24 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.652 HG11 HG21 ' A' ' 157' ' ' THR . 21.2 t -59.05 -40.57 81.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.284 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 26.2 mt -68.22 -41.6 84.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.064 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.637 ' OD1' HG22 ' A' ' 345' ' ' THR . 2.0 m120 -59.58 -30.2 68.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.967 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -91.1 -34.84 14.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.236 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -76.52 -33.33 58.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.228 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 5.6 t -66.27 -22.42 66.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.118 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 80.0 61.7 2.22 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.539 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 18.9 mtt-85 -140.29 -79.33 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.83 0.348 . . . . 0.0 110.836 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -77.55 177.55 7.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.758 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 65.8 p -106.57 145.13 32.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.776 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.41 HG12 ' HG ' ' A' ' 361' ' ' LEU . 40.3 t -51.44 -40.14 23.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.108 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -50.73 -38.51 47.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.62 -30.65 29.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -65.96 -58.17 6.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.062 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.673 HD22 HG12 ' A' ' 183' ' ' VAL . 12.1 mt -60.04 -25.29 65.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.037 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -72.83 -51.07 20.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.834 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -57.76 -48.46 79.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.85 -39.19 80.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.073 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.602 ' O ' HG23 ' A' ' 369' ' ' THR . 7.1 tm0? -58.86 -33.99 71.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.963 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 90.0 m -87.11 -40.36 14.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.925 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -59.07 -44.87 91.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.718 HD12 HG11 ' A' ' 181' ' ' VAL . 17.1 mt -69.45 -30.4 45.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.175 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.602 HG23 ' O ' ' A' ' 365' ' ' GLN . 76.2 p -82.97 -29.64 28.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.942 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 26.3 tttm . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.918 179.998 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.813 0.34 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -105.21 99.45 9.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 58.87 162.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.967 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.59 -58.4 0.53 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.506 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -142.14 174.6 10.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.815 0.34 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 33.7 mt -128.69 133.8 48.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.7 t -109.6 147.05 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.115 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.592 HG21 ' CD2' ' A' ' 20' ' ' LEU . 28.7 mm -120.49 107.51 20.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.968 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.419 ' CG ' ' HG3' ' A' ' 57' ' ' PRO . 0.5 OUTLIER -93.41 106.77 18.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.833 HD11 ' HD3' ' A' ' 15' ' ' LYS . 17.3 tt -163.15 123.02 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.006 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -142.53 162.68 34.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.928 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 109.57 58.81 0.52 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.984 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.6 t70 59.48 28.9 18.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.96 0.409 . . . . 0.0 110.556 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.833 ' HD3' HD11 ' A' ' 11' ' ' ILE . 3.3 mmpt? -83.16 173.56 11.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.8 54.67 4.62 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.527 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -72.62 -31.05 64.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.827 0.346 . . . . 0.0 110.909 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -74.53 -32.3 62.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.39 -37.85 8.67 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.512 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.592 ' CD2' HG21 ' A' ' 9' ' ' ILE . 6.2 tp -65.77 -31.22 72.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.783 0.325 . . . . 0.0 110.92 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.92 -31.02 70.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.128 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -66.59 -36.65 83.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.563 HG12 ' HB3' ' A' ' 283' ' ' TYR . 25.4 t -65.38 -31.39 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.074 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.97 -27.63 73.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.512 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.3 mmtt -59.24 -30.55 68.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.776 0.322 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.3 -40.48 58.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.881 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.632 ' CE1' HG21 ' A' ' 31' ' ' THR . 38.5 t80 -57.98 -52.89 63.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.017 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -68.94 -23.91 64.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.174 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -78.84 -25.83 44.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.22 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -103.89 -36.98 7.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.41 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.632 HG21 ' CE1' ' A' ' 27' ' ' PHE . 8.9 p -99.98 -44.11 6.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.225 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.06 -27.09 8.38 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.45 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.424 ' HB ' ' CE2' ' A' ' 27' ' ' PHE . 35.8 mm -64.32 118.83 7.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.779 0.323 . . . . 0.0 111.091 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -59.71 152.37 22.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.914 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.29 108.78 12.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.045 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.5 m -115.36 144.67 43.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.409 HG13 ' HB ' ' A' ' 9' ' ' ILE . 29.6 t -118.98 119.07 59.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.052 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -100.85 151.4 21.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -117.21 73.41 7.1 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.973 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.95 -179.99 5.51 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.646 2.231 . . . . 0.0 112.359 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -60.3 -158.88 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.416 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.466 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -47.13 -27.39 1.4 Allowed 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.598 0.237 . . . . 0.0 111.485 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 42' ' ' LYS . 0.3 OUTLIER 52.45 17.95 0.86 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.979 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -83.19 -57.04 3.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 0.0 110.972 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -92.77 -5.62 50.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.44 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.1 -18.94 29.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.557 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.679 ' CE2' HG21 ' A' ' 60' ' ' ILE . 13.3 t80 -83.37 -47.92 0.77 Allowed Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 116.762 -0.199 . . . . 0.0 111.49 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.545 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 41.9 Cg_exo -57.11 -38.23 96.14 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.336 2.024 . . . . 0.0 112.327 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.441 ' CG ' ' N ' ' A' ' 50' ' ' VAL . 4.6 pt20 -60.9 -47.31 86.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.044 0.45 . . . . 0.0 110.923 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.441 ' N ' ' CG ' ' A' ' 49' ' ' GLN . 20.3 m -76.99 -27.95 16.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.229 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 75' ' ' LEU . . . -56.7 -26.78 57.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.39 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.76 -35.73 71.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.237 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.0 t -110.8 -29.65 7.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.031 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.39 35.53 6.56 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.536 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.27 -27.45 20.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.785 0.326 . . . . 0.0 111.029 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.73 -156.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.544 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.419 ' HG3' ' CG ' ' A' ' 10' ' ' TRP . 46.0 Cg_endo -68.06 -167.84 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.623 2.215 . . . . 0.0 112.301 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -109.45 -31.27 7.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.894 HD13 HD21 ' A' ' 280' ' ' LEU . 22.2 mt -136.81 129.03 44.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.135 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.679 HG21 ' CE2' ' A' ' 47' ' ' PHE . 2.3 tt -114.88 159.07 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.093 0.473 . . . . 0.0 111.018 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.47 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 6.2 m-85 -130.56 113.14 13.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.784 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.3 t-105 -152.71 173.73 14.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.959 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.45 139.27 58.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.495 ' HB3' HG23 ' A' ' 261' ' ' VAL . 1.5 p80 -58.0 -33.69 69.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.038 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -59.67 -39.39 84.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.981 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -94.14 17.18 13.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.273 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.43 -4.71 37.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.416 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -94.82 26.4 18.74 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.56 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -124.5 4.42 8.74 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.84 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.521 ' O ' HD12 ' A' ' 75' ' ' LEU . 4.7 m-85 -112.59 -32.32 6.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.845 0.355 . . . . 0.0 110.998 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.51 -26.07 50.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.09 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -32.82 70.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.963 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.57 24.95 6.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.079 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 54.84 40.48 72.3 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.756 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.528 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 4.0 mt -100.32 -48.19 4.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.808 0.337 . . . . 0.0 110.934 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 20.5 mt -73.35 142.0 47.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.987 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.754 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -92.6 169.77 10.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.095 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.35 -164.9 1.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.942 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.748 HD11 ' CB ' ' A' ' 103' ' ' LEU . 35.8 pt -157.02 168.82 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.089 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 48.9 p -156.65 77.49 4.17 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.831 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.77 154.59 63.67 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.603 2.202 . . . . 0.0 112.315 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -78.08 164.77 24.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.813 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -59.74 -38.48 81.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.815 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.94 -44.39 85.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.005 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.674 ' CZ ' HD22 ' A' ' 285' ' ' LEU . 31.4 t80 -66.44 -37.37 85.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -69.07 -30.48 68.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.51 -28.32 62.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.969 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.66 43.19 1.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.024 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.455 HD13 ' CZ2' ' A' ' 94' ' ' TRP . 8.1 mt -151.93 139.04 19.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.876 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.438 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . 12.9 m-85 -73.31 129.77 85.39 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -49.06 -55.54 4.05 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.657 2.238 . . . . 0.0 112.996 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.699 ' HB2' HD11 ' A' ' 329' ' ' ILE . 10.7 p90 -49.78 -25.13 2.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.077 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.613 HG22 ' CE1' ' A' ' 92' ' ' PHE . 10.4 p -74.73 -30.57 61.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.819 0.342 . . . . 0.0 110.804 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.498 ' CZ3' HD13 ' A' ' 103' ' ' LEU . 12.2 m95 -73.1 -39.48 65.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.922 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -62.09 -27.34 68.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.999 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.53 ' HB2' HG21 ' A' ' 329' ' ' ILE . . . -64.98 -25.67 67.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.332 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 97' ' ' VAL . 27.6 m -121.09 72.81 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.911 0.386 . . . . 0.0 111.266 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -156.06 144.2 19.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.874 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -106.09 -64.53 1.15 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -123.8 41.76 3.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.824 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.84 25.58 29.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.522 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.99 145.35 49.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.765 0.317 . . . . 0.0 110.896 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.748 ' CB ' HD11 ' A' ' 79' ' ' ILE . 13.4 mt -87.93 140.41 29.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.939 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.0 pt -144.86 29.87 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.227 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -166.68 -177.11 3.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.153 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.431 ' OH ' HG22 ' A' ' 79' ' ' ILE . 5.9 m-85 -135.31 85.97 31.47 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.89 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.32 97.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.584 2.19 . . . . 0.0 112.321 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.7 mm -75.31 -66.16 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.204 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.748 ' HB2' HD12 ' A' ' 299' ' ' LEU . . . -112.74 164.41 13.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.181 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.451 HG22 ' CG1' ' A' ' 261' ' ' VAL . 21.3 t -130.51 106.96 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.07 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -91.44 163.55 14.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.933 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.465 ' HB2' ' HB2' ' A' ' 324' ' ' ALA . . . -163.02 144.3 9.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.061 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.437 HD12 ' H ' ' A' ' 258' ' ' PHE . 3.8 mt -62.05 145.22 53.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.1 p -140.35 -177.19 4.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.942 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.451 HD23 HG23 ' A' ' 245' ' ' THR . 35.2 tp -122.48 129.38 51.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.871 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.1 mp -110.51 125.83 67.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.064 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.433 ' CG ' ' HB3' ' A' ' 125' ' ' PRO . 28.2 p90 -125.72 160.42 29.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -92.38 -176.36 4.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.886 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.9 mttm -125.13 -45.31 1.86 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.869 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.16 -31.65 72.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 70.6 mt -98.98 -31.06 12.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.957 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.638 HD22 ' SD ' ' A' ' 224' ' ' MET . 9.9 tp -132.53 108.0 13.23 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.853 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.63 -45.84 3.1 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.377 2.051 . . . . 0.0 112.263 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -128.17 128.95 23.68 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.83 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.593 ' HA ' HD21 ' A' ' 122' ' ' LEU . 66.8 Cg_endo -74.11 144.18 33.36 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.448 2.099 . . . . 0.0 112.416 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.54 123.07 7.33 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.52 2.147 . . . . 0.0 112.315 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.0 mmtp -93.42 17.87 10.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.105 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.41 149.93 51.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.846 0.355 . . . . 0.0 110.795 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.603 ' CE3' HD12 ' A' ' 132' ' ' ILE . 3.7 m95 -78.52 -22.47 47.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.111 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.26 -18.4 36.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.362 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.54 -30.68 52.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.8 0.334 . . . . 0.0 111.113 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.742 HD13 HD22 ' A' ' 147' ' ' LEU . 24.5 mt -63.68 -54.79 39.41 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.673 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 12.2 Cg_endo -55.98 -30.63 78.8 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.205 1.937 . . . . 0.0 112.084 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.2 -29.16 57.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.808 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 135' ' ' LEU . 6.9 mt -72.74 -33.14 66.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.762 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.69 -22.9 38.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.202 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -85.35 -32.31 22.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.026 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -85.09 -48.44 9.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.138 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.854 HD13 ' HA ' ' A' ' 146' ' ' ALA . 1.2 mt -63.33 -17.45 62.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.403 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.42 -29.9 42.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.845 0.355 . . . . 0.0 110.814 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.34 -34.39 78.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.91 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -75.9 -27.09 57.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.97 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 113.11 40.21 1.08 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.48 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.66 -175.97 5.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.787 0.327 . . . . 0.0 110.862 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.9 t -115.34 159.12 21.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.854 ' HA ' HD13 ' A' ' 139' ' ' LEU . . . -84.57 -66.08 0.94 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.128 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.742 HD22 HD13 ' A' ' 132' ' ' ILE . 6.0 tp -154.02 141.62 19.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.939 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.854 ' HB2' HG21 ' A' ' 208' ' ' THR . 0.0 OUTLIER -135.46 -177.86 4.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.594 ' CZ ' HD11 ' A' ' 195' ' ' LEU . 8.2 p90 -177.22 175.0 1.57 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.867 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -69.0 111.17 4.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.851 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.654 HD13 ' HA ' ' A' ' 206' ' ' ALA . 6.6 mt -98.0 27.02 4.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.057 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -119.83 -40.0 2.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.822 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -99.37 146.42 31.73 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.813 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.502 ' HB3' HG12 ' A' ' 343' ' ' VAL . 87.7 Cg_endo -82.08 9.45 3.96 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.722 2.281 . . . . 0.0 113.028 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -75.41 -32.3 60.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.739 0.304 . . . . 0.0 111.13 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -94.98 -16.58 22.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.437 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 30.8 p -92.42 -24.41 18.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.69 0.281 . . . . 0.0 111.28 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.773 ' CE2' ' HB2' ' A' ' 162' ' ' ALA . 27.3 t-105 -53.4 -45.78 98.33 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.526 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.544 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 52.6 Cg_exo -52.67 -25.61 26.85 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.334 2.022 . . . . 0.0 112.28 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.493 HD11 ' CE1' ' A' ' 250' ' ' PHE . 4.8 tp -92.56 -42.96 9.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.933 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 21.0 mt -72.79 -54.66 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.773 ' HB2' ' CE2' ' A' ' 158' ' ' TRP . . . -60.2 -33.21 71.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.176 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -62.07 -33.48 74.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.142 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.28 -20.14 57.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.153 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 141.09 -26.9 2.45 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.561 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.7 158.01 53.35 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.537 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -146.8 171.26 15.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.327 . . . . 0.0 110.85 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -90.96 -67.55 0.85 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.078 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -120.83 121.14 37.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.788 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -63.69 123.99 20.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.931 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -86.36 115.28 23.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.483 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -165.04 148.38 8.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.106 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 64.73 29.22 12.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.162 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.7 -37.25 3.37 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.087 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.73 -173.35 2.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.886 0.374 . . . . 0.0 111.063 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -105.25 173.98 6.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.85 127.85 49.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.1 pt -79.34 -22.55 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.349 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.34 26.02 4.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.132 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -145.06 94.2 2.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.836 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.7 HG12 ' H ' ' A' ' 183' ' ' VAL . 21.6 t -114.27 131.75 65.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.163 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -87.88 -9.04 71.82 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.853 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.7 ' H ' HG12 ' A' ' 181' ' ' VAL . 0.3 OUTLIER -48.47 -41.8 11.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.892 0.377 . . . . 0.0 111.332 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.416 ' N ' ' CG1' ' A' ' 183' ' ' VAL . 25.8 t0 -84.61 57.17 4.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.915 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -118.26 -173.75 2.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.944 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.07 -34.77 57.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.113 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.57 -43.74 84.9 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.569 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.43 -30.62 67.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.833 0.349 . . . . 0.0 111.189 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.86 -38.68 82.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.869 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -86.96 -28.51 22.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.199 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -57.47 -54.62 35.79 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.607 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.871 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.7 OUTLIER -60.63 -53.11 61.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.829 0.347 . . . . 0.0 110.932 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.417 ' OG1' HG21 ' A' ' 357' ' ' VAL . 62.1 m -54.1 -24.93 19.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.121 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -70.86 -59.99 2.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.815 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.594 HD11 ' CZ ' ' A' ' 149' ' ' PHE . 2.6 tp -58.73 -33.07 69.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.669 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 192' ' ' LEU . 49.5 t -63.43 -54.52 31.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.902 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -66.06 -32.69 74.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.735 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.5 HD22 ' HB3' ' A' ' 133' ' ' PRO . 14.5 mt -57.11 -19.27 18.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.224 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 196' ' ' VAL . 4.7 mt -88.99 -60.11 2.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.803 0.335 . . . . 0.0 111.565 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -85.19 -47.27 10.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.008 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -71.0 -10.0 58.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.014 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -114.71 -82.98 0.61 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.808 0.337 . . . . 0.0 111.189 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 171.01 16.27 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.374 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' MET . . . . . 0.486 ' O ' HG23 ' A' ' 199' ' ' ILE . 0.2 OUTLIER -82.96 146.12 28.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.784 0.326 . . . . 0.0 110.77 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -102.04 137.42 40.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.031 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.654 ' HA ' HD13 ' A' ' 151' ' ' LEU . . . -79.99 -25.28 40.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.259 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -55.09 -31.1 60.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.132 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.854 HG21 ' HB2' ' A' ' 148' ' ' MET . 3.8 m -49.89 147.23 3.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.174 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.503 ' OD2' HD11 ' A' ' 212' ' ' ILE . 69.8 m-20 -154.15 176.22 12.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.015 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -41.59 -61.66 1.03 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.77 -59.26 3.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.833 0.349 . . . . 0.0 111.921 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.622 HD12 ' HA ' ' A' ' 208' ' ' THR . 0.2 OUTLIER -53.88 -30.67 19.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.342 -179.357 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.562 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -81.89 -25.76 34.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.801 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -82.31 -53.0 6.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.71 -25.75 63.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.323 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 221' ' ' GLU . . . -56.86 -32.27 65.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.239 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.515 ' CG ' HG21 ' A' ' 225' ' ' THR . 58.2 t80 -82.15 -34.0 29.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -75.46 -40.39 57.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -77.64 -31.92 53.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.928 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 103.01 72.13 0.91 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.546 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.412 ' HB2' ' HB1' ' A' ' 216' ' ' ALA . 6.7 mt-10 -128.39 -62.92 1.01 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.835 0.35 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.438 HG21 ' SD ' ' A' ' 148' ' ' MET . 8.9 t -93.5 135.88 34.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.939 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.92 -31.25 70.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.06 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.638 ' SD ' HD22 ' A' ' 122' ' ' LEU . 3.3 mpp? -120.8 151.21 39.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.942 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.515 HG21 ' CG ' ' A' ' 217' ' ' PHE . 9.0 t -157.67 159.58 37.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 24.8 mt -120.46 130.35 74.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.174 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.444 ' HB3' ' HB2' ' A' ' 231' ' ' ALA . 72.7 m-20 -160.95 165.34 30.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -105.99 -153.16 20.6 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.566 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.98 -26.19 24.38 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.629 2.22 . . . . 0.0 112.364 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 41.1 p90 -84.87 57.51 4.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.839 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.444 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . . . -156.45 -44.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.166 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -54.88 -48.01 73.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.021 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.3 m -66.77 -31.7 72.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.01 -32.2 73.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 4.8 mt -94.13 113.66 29.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.031 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -165.46 -49.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 7.0 m -65.87 -39.98 91.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.923 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' SER . . . . . 0.646 ' HB3' HG23 ' A' ' 240' ' ' VAL . 1.9 t -69.25 -29.5 67.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.921 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt 61.82 36.55 16.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.918 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.646 HG23 ' HB3' ' A' ' 238' ' ' SER . 26.8 t -79.01 108.29 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.043 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.42 92.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.924 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -97.58 160.05 14.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.23 137.86 9.43 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.445 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.28 124.15 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.784 0.326 . . . . 0.0 111.155 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.451 HG23 HD23 ' A' ' 115' ' ' LEU . 9.1 t -130.52 159.3 37.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.5 t -73.61 151.92 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.001 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.2 mt -74.22 149.82 87.22 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.884 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.441 ' HG2' ' CE2' ' A' ' 129' ' ' TRP . 50.9 Cg_endo -69.14 165.97 28.44 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.554 2.169 . . . . 0.0 112.341 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 4.0 p -92.33 163.64 13.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.963 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.493 ' CE1' HD11 ' A' ' 160' ' ' LEU . 8.3 t80 -128.89 111.12 12.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 8.8 mttt 60.28 28.23 17.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.023 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 93.79 -21.16 42.99 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.731 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -94.3 148.99 36.01 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.704 0.288 . . . . 0.0 110.945 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.2 154.36 66.06 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.594 2.196 . . . . 0.0 112.334 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.16 -174.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.837 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 2.0 mmtt -135.04 63.83 59.02 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.973 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -56.19 -177.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.532 2.154 . . . . 0.0 112.251 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' PHE . . . . . 0.437 ' H ' HD12 ' A' ' 113' ' ' LEU . 32.2 m-85 -118.83 116.59 26.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.766 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.2 t -85.8 123.4 39.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.288 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -121.92 117.64 3.45 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.271 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.614 HG12 ' O ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -109.48 127.47 66.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.37 . . . . 0.0 111.318 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 29.3 tp -91.11 85.38 5.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.297 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 1.4 m -86.33 175.19 8.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.134 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.449 ' HB1' ' CG2' ' A' ' 59' ' ' ILE . . . -107.06 114.99 29.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.006 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -85.9 128.8 8.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.553 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.435 HD11 HD13 ' A' ' 280' ' ' LEU . 28.0 mt -115.63 135.18 56.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.361 . . . . 0.0 111.08 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -85.49 140.62 30.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.754 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -70.39 -41.57 72.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.081 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -61.85 -28.95 69.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.149 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 3.7 m -58.17 109.48 1.85 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.979 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.57 -18.2 43.06 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.467 2.112 . . . . 0.0 112.499 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -92.88 46.27 1.22 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.03 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 16.3 mtmt -84.05 -31.96 25.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -62.11 -57.44 11.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 50.1 mt -62.51 -31.53 72.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.722 ' HB1' HD11 ' A' ' 59' ' ' ILE . . . -69.85 -46.62 65.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' LYS . . . . . 0.468 ' HA ' HD12 ' A' ' 280' ' ' LEU . 1.0 OUTLIER -57.68 -29.12 64.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.012 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -73.7 -52.96 11.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.043 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.416 ' CD1' ' HB2' ' A' ' 283' ' ' TYR . 79.1 t80 -59.93 -28.21 67.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.325 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.894 HD21 HD13 ' A' ' 59' ' ' ILE . 5.1 mt -80.31 -30.7 38.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.182 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.44 ' HG2' ' CE1' ' A' ' 85' ' ' PHE . 7.3 tt0 -93.65 -24.46 17.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.449 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -97.51 -50.16 4.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.445 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.563 ' HB3' HG12 ' A' ' 23' ' ' VAL . 4.4 m-85 -117.47 71.41 0.81 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.37 . . . . 0.0 111.296 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.824 ' CD2' HD23 ' A' ' 280' ' ' LEU . 5.6 tp -178.54 -39.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.91 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.674 HD22 ' CZ ' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -115.26 38.35 3.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.869 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.19 -176.38 2.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -80.87 -38.7 27.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -82.68 -36.28 26.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -65.67 -44.19 92.96 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.519 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 9.2 mt -70.14 -31.08 68.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 0.0 110.915 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -70.33 -36.96 74.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.994 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -59.27 -38.22 79.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.131 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.56 -29.45 20.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.111 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -74.06 -30.92 62.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.983 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 33.1 mttt -65.87 -35.41 80.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.959 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -99.0 -30.96 12.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.969 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.411 ' HA ' ' HD2' ' A' ' 298' ' ' PRO . 3.7 mmtt -152.97 95.18 3.02 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.931 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 298' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 297' ' ' LYS . 26.2 Cg_endo -62.29 119.52 6.66 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.513 2.142 . . . . 0.0 112.248 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.748 HD12 ' HB2' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -96.72 22.01 8.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.963 179.862 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 300' ' ' GLY . . . . . 0.662 ' O ' HD13 ' A' ' 311' ' ' LEU . . . 58.37 -133.96 52.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.664 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -58.71 174.68 0.31 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.816 0.341 . . . . 0.0 111.223 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.746 HG21 ' HB3' ' A' ' 307' ' ' TYR . 14.2 m -143.18 -179.7 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.07 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -93.86 -29.55 15.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.146 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.5 tp -58.89 152.27 19.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.916 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -77.01 -61.19 2.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.019 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 7.2 p -57.17 -49.79 74.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.079 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.746 ' HB3' HG21 ' A' ' 302' ' ' VAL . 0.1 OUTLIER -57.81 -25.04 60.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.027 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.46 -31.78 71.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.736 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -83.83 -42.1 16.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.865 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -52.44 -33.22 43.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.774 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.691 ' O ' HD12 ' A' ' 317' ' ' ILE . 83.7 mt -85.74 -21.37 28.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.919 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -76.47 -2.65 33.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.711 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 22.1 mmtt -47.26 -31.83 4.09 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 121.043 0.449 . . . . 0.0 110.856 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -117.41 140.22 27.08 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.309 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.565 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 14.4 Cg_endo -57.46 -32.4 94.01 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.349 2.033 . . . . 0.0 112.416 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 11.2 mtm-85 -48.58 -42.57 34.14 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.116 0.484 . . . . 0.0 110.243 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.691 HD12 ' O ' ' A' ' 311' ' ' LEU . 34.4 mt -85.56 -30.78 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.791 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.565 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -64.66 -33.92 77.07 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.125 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -74.97 -31.46 61.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.152 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 7.1 m -64.05 -48.48 76.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 10.8 tpt -60.96 -31.62 71.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -61.11 -43.77 98.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -62.35 -41.91 98.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' ALA . . . . . 0.465 ' HB2' ' HB2' ' A' ' 112' ' ' ALA . . . -60.03 -55.0 39.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.082 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -60.1 -30.03 68.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.931 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -95.84 21.08 8.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.145 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -131.38 -179.6 16.28 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.486 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.1 133.77 52.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.825 0.345 . . . . 0.0 110.906 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.699 HD11 ' HB2' ' A' ' 92' ' ' PHE . 22.9 mt -81.53 133.53 29.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.107 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 10.7 mtm -62.41 137.42 96.15 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.92 -172.38 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.522 2.148 . . . . 0.0 112.326 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -110.05 -26.07 9.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.027 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.701 HD12 ' HB2' ' A' ' 335' ' ' GLN . 33.5 pt -56.25 147.99 44.31 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.319 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.26 -8.91 22.65 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.636 2.224 . . . . 0.0 112.645 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.701 ' HB2' HD12 ' A' ' 333' ' ' ILE . 3.3 mp0 -54.53 -26.18 30.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.741 0.305 . . . . 0.0 111.103 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 336' ' ' MET . . . . . 0.404 ' O ' ' CD1' ' A' ' 340' ' ' TRP . 0.7 OUTLIER -56.8 -30.91 64.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.934 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.5 m -60.75 -57.31 13.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.971 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.97 -30.35 71.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.133 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.757 ' O ' HG23 ' A' ' 343' ' ' VAL . 39.0 t80 -59.73 -36.76 77.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.977 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.404 ' CD1' ' O ' ' A' ' 336' ' ' MET . 25.8 m95 -66.28 -51.01 61.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.945 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.89 -47.84 84.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.074 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -57.22 -44.63 83.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.301 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.844 ' O ' HG23 ' A' ' 347' ' ' VAL . 23.9 t -77.39 -28.55 16.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.27 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -57.43 13.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.945 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 3.7 m -60.57 -41.37 94.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.586 ' HB1' ' HB1' ' A' ' 360' ' ' ALA . . . -57.29 -34.92 69.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.23 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 343' ' ' VAL . 28.7 t -82.69 -45.91 19.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.188 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 9.4 mt -61.26 -57.59 11.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.162 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -58.77 -43.66 90.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.971 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.39 -29.87 70.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.082 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -78.51 -29.45 46.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.174 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 10.6 m -95.75 20.74 9.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.18 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 56.32 27.02 52.24 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.617 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 6.8 mtt-85 -89.86 -29.69 18.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.79 0.329 . . . . 0.0 110.963 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -143.86 162.27 36.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.899 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 30.6 p -97.96 156.85 16.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.844 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.543 HG22 HD23 ' A' ' 192' ' ' LEU . 25.6 t -56.88 -28.66 28.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.159 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -70.26 -56.5 6.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -61.88 -46.08 90.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.021 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.586 ' HB1' ' HB1' ' A' ' 346' ' ' ALA . . . -60.02 -50.37 73.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.139 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.424 ' CD1' HG12 ' A' ' 357' ' ' VAL . 28.0 mt -62.04 -30.18 70.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.47 -45.44 25.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.961 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -69.13 -45.59 69.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.99 -46.03 89.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -59.8 -43.25 94.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 10.0 m -64.66 -31.53 72.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.92 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 13.6 mtp85 -68.57 -35.71 77.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.943 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.699 HD13 ' CE2' ' A' ' 339' ' ' PHE . 19.3 mt -73.26 -28.86 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.177 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 2.2 p -82.62 -31.47 28.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.899 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.901 179.969 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 55' ' ' ASP . 10.0 t . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.809 0.337 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.2 165.24 12.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -82.59 154.85 24.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.568 ' O ' HG23 ' A' ' 33' ' ' ILE . . . 113.26 -35.9 4.33 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.455 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -113.76 169.86 8.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 0.0 110.871 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' A' ' 275' ' ' LEU . 44.7 mt -124.24 118.78 27.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.9 147.05 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.208 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.826 HG21 HD21 ' A' ' 20' ' ' LEU . 31.8 mt -137.32 107.34 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.927 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -96.81 109.36 22.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.84 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.458 HD11 ' CD ' ' A' ' 15' ' ' LYS . 14.9 tt -123.52 158.14 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.029 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -60.56 166.58 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.19 43.36 2.39 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.498 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -161.18 31.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.458 ' CD ' HD11 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -130.46 177.67 7.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.94 73.49 0.27 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.52 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -86.02 -33.06 21.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 0.0 110.947 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -60.43 -33.17 72.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.739 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -75.96 -28.46 60.61 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.531 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.826 HD21 HG21 ' A' ' 9' ' ' ILE . 3.7 tp -72.66 -30.99 64.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.811 0.338 . . . . 0.0 110.932 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.52 -37.94 83.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.103 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -70.39 -32.23 69.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 19' ' ' GLY . 26.8 t -72.2 -30.72 36.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.104 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.32 -38.6 33.4 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.538 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -59.88 -29.51 68.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.817 0.341 . . . . 0.0 110.94 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -74.78 -41.19 60.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.937 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.484 ' CD2' ' CE1' ' A' ' 283' ' ' TYR . 1.5 t80 -59.75 -52.62 64.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.907 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -58.53 -43.13 89.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.902 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -71.83 -25.39 61.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.83 -32.85 40.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.371 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.53 -44.23 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.473 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.16 -23.27 2.58 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.762 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.568 HG23 ' O ' ' A' ' 5' ' ' GLY . 33.1 mm -59.92 110.16 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.828 0.347 . . . . 0.0 111.037 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.6 mtmt -78.63 156.75 28.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.955 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.4 t -134.82 117.96 24.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.091 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.0 m -99.5 143.86 29.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.4 t -137.84 110.71 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.139 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -110.28 176.21 5.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.86 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -133.11 74.31 73.44 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.86 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.18 -179.13 4.07 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.64 2.227 . . . . 0.0 112.415 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -60.05 -159.43 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.53 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.476 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -46.46 -27.45 1.1 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.604 0.24 . . . . 0.0 111.53 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.567 HD12 ' CD1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 52.44 19.68 1.23 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.852 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.73 -57.12 4.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.829 0.347 . . . . 0.0 110.655 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -95.49 -7.72 37.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.002 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.87 -19.24 57.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.256 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.567 ' CD1' HD12 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -85.58 -55.94 0.39 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.045 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.444 ' HD3' ' CB ' ' A' ' 47' ' ' PHE . 72.6 Cg_exo -50.54 -35.63 46.79 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.589 2.193 . . . . 0.0 112.61 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.581 ' HG3' HG13 ' A' ' 50' ' ' VAL . 11.2 pt20 -59.49 -49.68 76.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.947 0.403 . . . . 0.0 111.004 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.581 HG13 ' HG3' ' A' ' 49' ' ' GLN . 6.6 m -95.29 18.05 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.552 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.09 -38.01 13.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.825 0.345 . . . . 0.0 111.216 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.51 -33.77 68.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.164 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.449 HG23 ' H ' ' A' ' 55' ' ' ASP . 3.3 t -96.43 -29.53 13.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.934 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.53 28.1 72.71 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.431 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.691 ' O ' HG22 ' A' ' 2' ' ' THR . 5.3 t0 -94.5 -28.26 15.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.74 0.305 . . . . 0.0 111.01 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.97 -105.11 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.597 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.444 ' CG ' ' CE2' ' A' ' 47' ' ' PHE . 61.4 Cg_endo -73.18 -169.12 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.49 2.127 . . . . 0.0 112.407 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -150.55 -46.86 0.12 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.813 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.2 mt -127.19 133.37 68.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.058 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.477 ' CG1' ' N ' ' A' ' 61' ' ' PHE . 1.9 tt -139.49 159.69 28.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.111 0.481 . . . . 0.0 110.942 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.6 ' CE2' HD21 ' A' ' 284' ' ' LEU . 65.2 m-85 -138.1 122.35 18.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.873 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -158.26 169.26 24.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.882 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.13 143.87 47.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -60.49 -31.52 70.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -59.74 -36.04 75.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.902 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.3 mmt-85 -94.69 17.18 13.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.231 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -105.71 -31.14 9.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.849 0.357 . . . . 0.0 110.858 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.5 -28.14 64.53 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.555 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.34 -28.83 74.01 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.559 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -91.89 -27.91 17.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.73 0.3 . . . . 0.0 110.982 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.589 ' HB2' HD12 ' A' ' 76' ' ' LEU . . . -79.53 -28.03 41.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.244 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.36 -31.71 69.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.063 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.6 m -88.09 -23.17 23.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.09 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.4 27.98 10.17 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.442 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.9 mt -81.25 -34.25 32.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.77 0.319 . . . . 0.0 110.868 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.589 HD12 ' HB2' ' A' ' 71' ' ' ALA . 25.5 mt -81.86 146.55 29.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.71 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -87.29 135.27 33.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.068 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.696 ' HA ' HG22 ' A' ' 104' ' ' ILE . 17.5 tp10 -69.57 159.72 32.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.09 0.472 . . . . 0.0 110.739 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.59 HG21 ' CE1' ' A' ' 106' ' ' TYR . 35.4 pt -135.29 -178.57 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.176 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 t -163.22 78.0 1.75 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.804 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.08 123.4 11.83 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.643 2.229 . . . . 0.0 112.282 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.5 -177.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.852 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -60.09 -40.56 90.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.913 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.79 -50.5 73.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.094 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -66.28 -35.31 80.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.46 -31.14 63.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.794 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -75.64 -36.51 60.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 57.19 4.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.885 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.514 HD13 ' CZ2' ' A' ' 94' ' ' TRP . 0.1 OUTLIER -173.61 162.02 4.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.774 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.48 ' CD1' ' CZ ' ' A' ' 92' ' ' PHE . 22.0 m-85 -78.51 136.22 60.09 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.077 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 53.3 Cg_exo -55.24 -55.72 2.91 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.526 2.15 . . . . 0.0 112.662 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.908 ' CE1' HG23 ' A' ' 93' ' ' THR . 25.0 p90 -54.87 -44.83 74.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.549 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.908 HG23 ' CE1' ' A' ' 92' ' ' PHE . 40.2 p -61.31 -27.6 68.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.189 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.514 ' CZ2' HD13 ' A' ' 89' ' ' LEU . 8.4 m95 -69.52 -29.29 66.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.941 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.401 ' HA ' ' CG ' ' A' ' 98' ' ' ARG . 1.3 m-20 -93.66 17.32 11.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.362 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -101.89 -29.69 11.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.76 0.314 . . . . 0.0 111.214 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.687 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 12.0 m -90.63 -35.73 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.446 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.401 ' CG ' ' HA ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -65.95 132.37 48.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.012 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.407 ' CE1' ' OD1' ' A' ' 332' ' ' ASN . 0.4 OUTLIER -82.0 -49.59 10.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.865 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -148.6 54.67 1.01 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.929 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.12 -27.27 20.01 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.645 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.51 158.9 20.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.782 0.325 . . . . 0.0 110.965 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 54.9 mt -117.5 131.03 56.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.884 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.696 HG22 ' HA ' ' A' ' 78' ' ' GLU . 2.8 pp -142.65 27.21 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.342 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.89 ' HB1' ' HB2' ' A' ' 263' ' ' SER . . . -158.25 179.33 9.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.869 0.366 . . . . 0.0 111.173 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.59 ' CE1' HG21 ' A' ' 79' ' ' ILE . 39.2 m-85 -140.87 89.49 9.96 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.833 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.462 ' HG3' HG13 ' A' ' 97' ' ' VAL . 52.6 Cg_exo -53.09 99.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.57 2.18 . . . . 0.0 112.269 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.62 ' HA ' HD21 ' A' ' 285' ' ' LEU . 25.2 mm -74.01 -66.23 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.161 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.423 ' O ' HG12 ' A' ' 261' ' ' VAL . . . -120.8 166.36 13.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.066 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 301' ' ' ALA . 10.9 p -123.22 139.07 51.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.092 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -116.74 147.93 41.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -161.85 149.62 14.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.141 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 113' ' ' LEU . 28.9 mt -68.27 126.02 28.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.9 m -124.9 147.29 48.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.503 HD12 HG12 ' A' ' 226' ' ' ILE . 5.2 tp -82.94 136.0 34.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.898 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.535 HG23 ' O ' ' A' ' 243' ' ' GLY . 4.3 mt -116.4 131.38 69.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.049 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -122.24 154.95 36.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.32 144.31 31.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.36 29.77 3.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.959 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.731 ' HB3' HD23 ' A' ' 121' ' ' LEU . 1.8 t70 -97.39 -61.17 1.44 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.895 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.731 HD23 ' HB3' ' A' ' 120' ' ' ASP . 0.2 OUTLIER -110.33 -32.83 6.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.849 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.517 HD21 ' HD3' ' A' ' 126' ' ' PRO . 14.1 tp -93.39 104.16 11.62 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.821 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.83 -47.21 2.0 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.405 2.07 . . . . 0.0 112.275 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -123.38 135.44 26.04 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.822 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.09 139.11 21.21 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.529 2.152 . . . . 0.0 112.32 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.517 ' HD3' HD21 ' A' ' 122' ' ' LEU . 74.5 Cg_endo -75.2 116.77 4.65 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.447 2.098 . . . . 0.0 112.394 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.01 23.41 6.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.03 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.5 p -134.77 141.95 46.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.865 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.804 ' CE3' HD12 ' A' ' 132' ' ' ILE . 2.4 m95 -79.94 -22.56 42.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.103 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.52 -24.72 53.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.181 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -81.18 -26.56 35.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.143 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.804 HD12 ' CE3' ' A' ' 129' ' ' TRP . 31.7 mt -57.28 -54.56 53.49 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.625 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 15.6 Cg_endo -57.47 -27.32 75.75 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.239 1.959 . . . . 0.0 112.089 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.0 -29.31 35.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.5 mt -73.92 -39.68 63.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.859 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.12 -26.35 11.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.058 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -85.58 -27.86 25.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.122 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.98 -48.62 9.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.153 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.808 HD13 ' HA ' ' A' ' 146' ' ' ALA . 0.2 OUTLIER -62.89 -17.32 61.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.411 -179.76 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -28.11 55.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.845 0.355 . . . . 0.0 110.847 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.88 -41.64 87.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.02 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 46.7 mttt -77.22 -27.01 53.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.02 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 116.07 31.48 1.88 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.488 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.72 -178.31 5.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 0.0 110.868 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.2 t -115.65 171.76 7.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.861 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.808 ' HA ' HD13 ' A' ' 139' ' ' LEU . . . -87.28 -57.59 2.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.155 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.479 ' HB2' ' HE2' ' A' ' 224' ' ' MET . 6.2 tp -161.21 143.83 12.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.987 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.455 ' SD ' HG21 ' A' ' 222' ' ' THR . 0.0 OUTLIER -132.29 -178.99 5.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -179.29 151.73 0.5 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -62.52 121.33 13.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.857 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.4 mt -98.26 28.6 3.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.938 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -112.63 -33.59 6.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.24 107.51 60.54 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.887 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -51.32 -24.13 15.14 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.485 2.123 . . . . 0.0 112.398 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.483 ' CE1' ' CD2' ' A' ' 258' ' ' PHE . 54.0 t80 -52.33 -27.79 16.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.199 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -87.11 -35.1 18.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.9 p -94.86 18.3 12.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.2 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.552 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 27.4 t-105 -73.76 -50.51 5.65 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.531 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 43.2 Cg_endo -68.2 -24.79 37.67 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.116 1.878 . . . . 0.0 112.508 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.673 ' CD2' HD13 ' A' ' 195' ' ' LEU . 52.1 tp -59.23 -37.47 77.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.841 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 4.8 mp -105.06 -33.28 2.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.991 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.52 -29.15 70.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.241 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.403 ' HB2' ' HA ' ' A' ' 255' ' ' SER . . . -56.64 -46.77 80.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.144 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -61.06 -20.07 62.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.124 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 125.63 53.55 0.17 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.489 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -134.53 123.64 3.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.512 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.433 ' CD2' ' HA3' ' A' ' 182' ' ' GLY . 20.7 p90 -117.99 -178.25 3.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.848 0.356 . . . . 0.0 110.871 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -100.07 -44.48 5.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.083 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -131.87 141.95 49.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.7 tptp -68.38 137.24 54.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.976 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.429 ' CE1' ' HA2' ' A' ' 174' ' ' GLY . 19.8 t80 -128.11 110.7 12.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.74 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.407 ' CG ' ' N ' ' A' ' 173' ' ' ASN . 9.7 pt-20 -139.01 -47.24 0.48 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.308 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.407 ' N ' ' CG ' ' A' ' 172' ' ' GLU . 15.0 m120 -95.72 41.85 1.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.073 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.429 ' HA2' ' CE1' ' A' ' 171' ' ' TYR . . . 57.78 20.55 40.54 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.706 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.406 ' O ' ' CD2' ' A' ' 171' ' ' TYR . 11.3 mttt -133.3 -171.37 2.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.337 . . . . 0.0 110.866 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -126.44 86.81 2.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.59 127.67 33.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.911 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.9 pt -81.46 -12.3 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.472 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -96.01 26.0 4.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.719 0.295 . . . . 0.0 111.149 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -148.4 116.16 6.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.935 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.715 HG12 ' H ' ' A' ' 183' ' ' VAL . 21.3 t -104.53 146.08 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.042 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLY . . . . . 0.433 ' HA3' ' CD2' ' A' ' 167' ' ' TYR . . . -96.97 -12.64 49.08 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.029 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.898 HG12 HD22 ' A' ' 361' ' ' LEU . 6.1 t -62.89 -43.5 98.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.815 0.34 . . . . 0.0 111.18 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -83.85 57.23 4.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.07 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -110.74 -172.78 2.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.12 -44.78 29.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.171 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.16 -34.78 28.84 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.583 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.62 -30.16 68.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.337 . . . . 0.0 111.179 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -60.51 -56.62 19.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.32 -26.53 55.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.225 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -56.14 -40.7 84.29 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.706 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.832 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.4 OUTLIER -76.77 -30.13 56.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.752 0.311 . . . . 0.0 110.94 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 66.2 m -56.35 -23.27 36.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.943 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -65.58 -60.53 2.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.791 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.673 HD13 ' CD2' ' A' ' 160' ' ' LEU . 5.2 tp -60.31 -30.96 69.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.703 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 192' ' ' LEU . 40.0 t -66.07 -48.41 81.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.007 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -82.43 -23.12 34.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.095 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.605 HD23 ' HG3' ' A' ' 202' ' ' LYS . 6.3 mt -64.25 -24.38 67.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.228 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 204' ' ' MET . 13.5 mt -88.96 -42.22 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.646 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 23.4 mtpt -85.02 -29.35 25.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.829 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -91.65 -10.18 41.28 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.605 ' HG3' HD23 ' A' ' 198' ' ' LEU . 13.4 mmtt -133.96 9.71 3.86 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.191 -0.204 . . . . 0.0 111.516 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' HIS . . . . . 0.424 ' CG ' ' O ' ' A' ' 202' ' ' LYS . 56.2 p-80 43.89 53.15 6.38 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.942 0.401 . . . . 0.0 111.376 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' MET . . . . . 0.432 ' O ' HG23 ' A' ' 199' ' ' ILE . 0.0 OUTLIER -82.84 128.42 34.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.844 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -59.94 119.89 8.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.991 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -80.04 -28.06 39.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.077 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -56.47 -24.36 45.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.182 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.653 ' HA ' HD12 ' A' ' 212' ' ' ILE . 7.6 m -36.29 145.91 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.94 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.476 ' OD2' HD11 ' A' ' 212' ' ' ILE . 59.4 m-20 -153.55 176.21 12.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.75 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -34.84 79.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.032 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.99 -59.13 2.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 0.0 111.226 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' A' ' 208' ' ' THR . 0.3 OUTLIER -58.88 -29.59 41.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.848 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -81.75 -21.23 37.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.995 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -75.47 -56.9 4.25 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.837 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.37 -29.53 68.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.136 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.524 ' HB1' ' HB2' ' A' ' 221' ' ' GLU . . . -58.94 -41.91 88.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.141 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.679 ' CG ' HG21 ' A' ' 225' ' ' THR . 19.1 t80 -75.65 -33.16 60.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -74.9 -38.39 61.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.956 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.35 -31.55 33.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.894 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.66 63.8 0.72 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.48 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.524 ' HB2' ' HB1' ' A' ' 216' ' ' ALA . 39.9 mm-40 -111.07 -32.99 6.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.342 . . . . 0.0 110.949 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.455 HG21 ' SD ' ' A' ' 148' ' ' MET . 9.6 t -121.05 162.26 20.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -84.08 -39.86 19.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.102 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.479 ' HE2' ' HB2' ' A' ' 147' ' ' LEU . 1.3 mpp? -126.71 165.81 18.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.897 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.679 HG21 ' CG ' ' A' ' 217' ' ' PHE . 9.8 t -166.65 139.52 3.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.503 HG12 HD12 ' A' ' 115' ' ' LEU . 22.9 mt -101.08 128.27 53.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.466 ' ND2' ' HB3' ' A' ' 231' ' ' ALA . 1.7 p-10 -165.3 144.74 6.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -63.84 -175.05 3.5 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.508 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.52 -20.91 35.34 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.662 2.241 . . . . 0.0 112.457 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' TRP . . . . . 0.428 ' CD1' ' N ' ' A' ' 231' ' ' ALA . 5.4 p90 -56.3 -30.7 62.86 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.001 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.466 ' HB3' ' ND2' ' A' ' 227' ' ' ASN . . . -72.92 -32.78 65.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.102 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' TRP . . . . . 0.881 ' HA ' HD12 ' A' ' 235' ' ' ILE . 50.6 m0 -57.29 -27.42 62.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.074 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.3 m -59.59 -55.42 34.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.024 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -62.59 -30.63 71.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.011 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.881 HD12 ' HA ' ' A' ' 232' ' ' TRP . 23.2 mt -70.78 96.69 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.085 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -160.48 -53.2 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.77 -33.92 74.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.917 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' SER . . . . . 0.458 ' HB2' HG23 ' A' ' 240' ' ' VAL . 99.1 p -60.19 -32.84 71.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.906 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm 60.69 33.34 20.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.458 HG23 ' HB2' ' A' ' 238' ' ' SER . 21.5 t -91.44 131.18 39.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.12 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.97 93.52 3.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.589 ' CE1' HG21 ' A' ' 235' ' ' ILE . 52.7 p90 -103.43 135.13 45.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.967 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.535 ' O ' HG23 ' A' ' 116' ' ' ILE . . . -101.97 -164.55 26.84 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.5 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.4 t -148.19 133.99 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 111.128 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 63.3 m -143.5 159.3 42.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.86 151.88 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.971 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.447 HD12 ' OD1' ' A' ' 323' ' ' ASN . 9.9 mt -59.64 141.05 88.94 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.874 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.43 ' HB2' ' CD1' ' A' ' 129' ' ' TRP . 50.3 Cg_exo -53.67 146.1 45.78 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.506 2.137 . . . . 0.0 112.242 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 67.6 p -81.19 -177.3 6.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -156.8 109.95 2.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 24.1 mtpt 59.57 31.04 20.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 83.84 27.12 39.1 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.549 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -138.16 142.2 34.69 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.667 0.27 . . . . 0.0 110.915 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.09 163.88 34.29 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.572 2.181 . . . . 0.0 112.342 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.403 ' HA ' ' HB2' ' A' ' 163' ' ' ALA . 8.5 m -74.25 153.05 39.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.845 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.35 72.62 0.93 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.868 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.8 -168.26 0.31 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.597 2.198 . . . . 0.0 112.335 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' PHE . . . . . 0.496 ' CE2' ' CD1' ' A' ' 158' ' ' TRP . 13.9 m-85 -101.99 165.6 11.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.924 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 328' ' ' GLU . 26.5 t -127.98 126.4 66.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.103 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -126.92 116.9 2.59 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.386 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -112.6 130.56 66.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.824 0.345 . . . . 0.0 111.078 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 7.3 tp -90.58 84.01 5.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.791 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.89 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 0.3 OUTLIER -83.53 166.27 18.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.966 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.581 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . . . -99.51 131.38 45.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.068 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -95.53 103.04 2.92 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.507 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.507 HD11 ' CD1' ' A' ' 280' ' ' LEU . 32.8 mt -100.5 103.05 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.797 0.332 . . . . 0.0 111.098 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -62.07 165.49 5.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.997 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.71 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -84.02 -24.97 30.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.279 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -96.4 30.25 2.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.301 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.44 125.05 90.59 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.83 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.23 -27.71 39.25 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.385 2.057 . . . . 0.0 112.339 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -145.9 85.51 1.69 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.883 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -64.85 -36.32 83.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.855 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.25 -57.69 9.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.459 ' HB3' HD11 ' A' ' 7' ' ' LEU . 10.1 mt -60.01 -31.53 70.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.957 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.92 -60.4 3.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.099 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' LYS . . . . . 0.515 ' HA ' HD12 ' A' ' 280' ' ' LEU . 0.3 OUTLIER -61.86 -29.16 70.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.964 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -59.47 -60.91 3.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.021 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.458 ' HE1' HD13 ' A' ' 284' ' ' LEU . 52.6 t80 -54.12 -24.27 17.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.403 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.913 HD23 HD22 ' A' ' 284' ' ' LEU . 95.1 mt -76.74 -40.72 47.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.265 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -93.56 -16.38 24.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.601 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.444 ' HB3' ' CD1' ' A' ' 283' ' ' TYR . 4.3 m120 -91.91 -58.06 2.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.639 0.257 . . . . 0.0 111.362 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.484 ' CE1' ' CD2' ' A' ' 27' ' ' PHE . 7.0 m-85 -126.83 75.86 1.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.37 . . . . 0.0 111.227 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.913 HD22 HD23 ' A' ' 280' ' ' LEU . 5.1 tp -177.99 -57.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.924 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.62 HD21 ' HA ' ' A' ' 108' ' ' ILE . 13.7 mt -94.41 47.29 1.18 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.891 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 18.0 p -128.53 176.98 7.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.891 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.425 ' HA ' ' CD1' ' A' ' 307' ' ' TYR . 9.2 p-10 -81.0 -34.98 32.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.933 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -82.69 -31.21 28.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.929 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.79 -56.64 5.8 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.583 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.444 HD21 HG22 ' A' ' 108' ' ' ILE . 0.9 OUTLIER -59.83 -30.7 69.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.76 0.314 . . . . 0.0 110.97 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -59.76 -41.06 90.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.036 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.72 -54.44 47.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.143 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.3 t -58.4 -28.31 35.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.282 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -71.08 -27.16 63.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.046 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 18.5 mttm -60.28 -34.19 73.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.189 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -110.73 -34.68 6.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.207 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 2.8 tppt? -133.41 83.71 48.73 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.062 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.42 119.32 6.26 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.579 2.186 . . . . 0.0 112.284 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 4.6 mp -95.71 20.95 9.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.07 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 57.09 -106.56 0.74 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.603 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.525 ' HB3' HG13 ' A' ' 110' ' ' VAL . . . -71.59 175.29 5.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 111.12 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 15.4 m -143.14 160.12 17.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.165 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 108' ' ' ILE . . . -79.96 -34.51 38.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.072 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.46 HD23 ' HB2' ' A' ' 307' ' ' TYR . 2.7 tp -71.37 110.65 6.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.891 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -60.59 -31.54 70.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.861 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.4 m -70.21 -33.23 71.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.561 ' CE2' HD11 ' A' ' 311' ' ' LEU . 12.5 t80 -83.78 -27.14 29.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.024 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -58.75 -30.62 67.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.878 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -63.19 -55.32 26.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.809 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.94 -35.25 45.31 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.749 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.678 ' CB ' HG21 ' A' ' 317' ' ' ILE . 15.8 mt -85.73 -23.97 27.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.756 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.46 -14.74 61.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.457 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -46.66 -31.37 2.85 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 120.921 0.391 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -116.64 137.89 24.05 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.302 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.77 -28.48 67.09 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.432 2.088 . . . . 0.0 112.459 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -51.72 -36.31 46.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.001 0.429 . . . . 0.0 110.37 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.678 HG21 ' CB ' ' A' ' 311' ' ' LEU . 35.7 mm -85.43 -35.45 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.85 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -69.83 -29.69 67.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.189 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -70.66 -56.01 7.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.148 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 8.7 m -60.1 -37.23 79.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.954 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.486 ' SD ' ' HB1' ' A' ' 301' ' ' ALA . 7.0 tpt -63.98 -31.34 72.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.951 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -69.45 -53.65 18.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.992 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.447 ' OD1' HD12 ' A' ' 247' ' ' LEU . 0.3 OUTLIER -60.2 -31.34 70.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.887 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.68 -31.33 72.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.14 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -75.43 -55.02 6.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.94 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -68.55 -30.29 69.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -58.43 142.56 45.05 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.529 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' GLU . . . . . 0.754 ' O ' HG23 ' A' ' 259' ' ' VAL . 26.8 tt0 -74.53 154.12 38.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.869 0.366 . . . . 0.0 110.872 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.532 HD11 ' HB2' ' A' ' 92' ' ' PHE . 23.3 mt -101.69 132.52 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.064 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.428 ' HG3' ' CD1' ' A' ' 258' ' ' PHE . 29.5 mtm -69.58 135.87 88.3 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.49 168.55 24.26 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.501 2.134 . . . . 0.0 112.347 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 332' ' ' ASN . . . . . 0.407 ' OD1' ' CE1' ' A' ' 99' ' ' TYR . 9.3 p30 -113.03 36.81 3.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.839 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.855 HD12 ' HB2' ' A' ' 335' ' ' GLN . 2.1 pt -105.98 154.29 39.59 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.158 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.26 -28.1 28.08 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.564 2.176 . . . . 0.0 112.308 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.855 ' HB2' HD12 ' A' ' 333' ' ' ILE . 15.0 mp0 -58.86 -26.26 64.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.047 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 336' ' ' MET . . . . . 0.4 ' O ' ' CD1' ' A' ' 340' ' ' TRP . 0.0 OUTLIER -56.08 -29.9 61.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.04 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.8 m -66.66 -41.65 87.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.936 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.85 -26.09 60.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.233 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.845 ' O ' HG23 ' A' ' 343' ' ' VAL . 87.5 t80 -57.95 -30.43 65.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.07 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.4 ' CD1' ' O ' ' A' ' 336' ' ' MET . 89.0 m95 -67.43 -53.28 30.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.004 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.89 -24.75 59.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.172 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -84.77 -29.13 25.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.397 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.853 ' O ' HG23 ' A' ' 347' ' ' VAL . 25.4 t -91.97 -50.27 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.259 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.404 ' O ' HD12 ' A' ' 348' ' ' ILE . 0.0 OUTLIER -52.66 -28.5 21.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.281 -179.773 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 19.5 m -85.72 -48.67 8.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.077 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.784 ' HB1' ' HB1' ' A' ' 360' ' ' ALA . . . -58.78 -29.12 66.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.388 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 343' ' ' VAL . 24.8 t -77.13 -52.26 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.293 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 344' ' ' ARG . 40.4 mt -61.38 -50.92 78.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.127 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -58.57 -30.18 66.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.925 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -82.68 -29.42 29.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.207 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -76.44 -27.08 56.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.272 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 3.3 m -95.83 20.77 9.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.224 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 55.75 24.7 41.65 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.703 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.87 -29.72 18.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.832 0.349 . . . . 0.0 110.887 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -138.69 153.26 48.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.817 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.14 165.08 20.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.805 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 358' ' ' ASP . 1.6 p -63.97 -45.4 96.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.154 0.502 . . . . 0.0 110.774 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 358' ' ' ASP . . . . . 0.468 ' N ' ' CG1' ' A' ' 357' ' ' VAL . 66.4 m-20 -60.02 -53.87 52.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.172 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -57.18 -31.24 65.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.177 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.784 ' HB1' ' HB1' ' A' ' 346' ' ' ALA . . . -61.07 -60.41 3.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.973 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.898 HD22 HG12 ' A' ' 183' ' ' VAL . 0.3 OUTLIER -63.31 -32.93 74.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.606 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.65 -59.05 3.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -59.17 -46.37 88.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.795 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -57.13 -37.16 71.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.076 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.411 ' HA ' HG21 ' A' ' 181' ' ' VAL . 5.4 tt0 -60.59 -45.4 94.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 6.5 m -61.03 -40.61 94.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.956 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 44.4 mtm180 -62.95 -43.52 98.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.937 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 15.8 mt -72.47 -32.19 40.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.047 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.491 HG23 ' O ' ' A' ' 369' ' ' THR . 4.8 t -160.76 91.83 0.92 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.912 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.461 HG21 ' OD2' ' A' ' 58' ' ' ASP . 1.5 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.802 0.334 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -72.73 149.96 43.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.911 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -69.46 137.23 52.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 107.76 29.4 4.4 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.474 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.443 ' HA ' HG22 ' A' ' 33' ' ' ILE . 2.3 ptpt -157.14 -177.94 6.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.817 0.341 . . . . 0.0 110.91 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 mt -150.09 112.49 4.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.8 t -100.58 131.07 48.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.162 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.638 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.3 mp -113.2 107.36 22.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.817 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.445 ' CD2' ' HG2' ' A' ' 57' ' ' PRO . 0.3 OUTLIER -95.22 106.7 18.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.842 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.9 tt -137.12 157.22 35.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.104 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -69.45 -179.59 1.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.51 61.02 0.31 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.558 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.41 31.11 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.815 0.34 . . . . 0.0 110.917 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -150.37 -176.73 5.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.854 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.75 64.79 1.84 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.536 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -78.92 -31.56 45.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.824 0.345 . . . . 0.0 110.921 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -63.1 -32.04 73.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.844 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.85 -30.82 57.14 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.46 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.516 HD21 HG21 ' A' ' 9' ' ' ILE . 14.1 tp -60.98 -30.68 70.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 110.887 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.89 -48.62 80.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.131 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -59.03 -30.66 68.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.966 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 36.5 t -69.04 -34.89 66.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.029 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.3 -35.71 83.1 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.465 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -59.63 -27.82 66.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.81 0.338 . . . . 0.0 111.014 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.42 -41.58 76.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.894 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.84 -51.26 67.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.0 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -64.66 -23.1 67.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.158 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -82.64 -25.45 33.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.309 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -101.22 -32.58 10.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.629 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.8 p -119.0 -44.18 2.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.781 0.325 . . . . 0.0 111.446 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.93 27.23 6.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.526 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.443 HG22 ' HA ' ' A' ' 6' ' ' LYS . 27.9 mm -94.19 130.49 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.761 0.315 . . . . 0.0 111.104 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -59.64 152.16 23.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.942 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.33 104.64 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.115 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.0 m -103.41 147.87 26.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -141.16 110.63 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -115.61 161.11 19.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.928 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -132.51 70.3 79.6 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.865 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.562 ' HG2' HD22 ' A' ' 43' ' ' LEU . 40.9 Cg_endo -68.13 161.14 45.71 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.59 2.193 . . . . 0.0 112.362 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -103.36 141.01 36.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.651 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.09 37.57 24.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.817 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.562 HD22 ' HG2' ' A' ' 40' ' ' PRO . 2.4 pp -79.07 5.57 11.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.747 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.4 -46.69 66.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.795 0.331 . . . . 0.0 111.173 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -90.03 -9.84 47.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.478 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.607 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -89.03 -18.91 26.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.649 0.261 . . . . 0.0 111.338 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.441 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -78.18 -50.86 1.71 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.682 0.277 . . . . 0.0 111.317 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 52.7 Cg_exo -55.31 -20.43 25.31 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.632 2.221 . . . . 0.0 112.944 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.429 ' CG ' ' N ' ' A' ' 50' ' ' VAL . 0.9 OUTLIER -85.71 -47.95 9.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.896 0.379 . . . . 0.0 111.327 -179.61 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 46' ' ' LYS . 11.2 m -79.57 -28.6 13.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.304 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.28 -41.69 89.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.88 -32.21 73.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.148 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.2 p -83.52 -30.83 26.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.937 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.443 ' HA3' ' HB1' ' A' ' 269' ' ' ALA . . . 75.5 25.85 66.97 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.559 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.26 -31.07 10.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.864 0.364 . . . . 0.0 110.892 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.38 -147.72 2.29 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.523 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.445 ' HG2' ' CD2' ' A' ' 10' ' ' TRP . 52.9 Cg_exo -52.57 -175.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.56 2.173 . . . . 0.0 112.314 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.461 ' OD2' HG21 ' A' ' 2' ' ' THR . 63.8 m-20 -135.25 -46.77 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.957 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.67 HG21 HD11 ' A' ' 280' ' ' LEU . 6.7 pt -117.24 130.65 71.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.25 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.758 HD11 ' CE3' ' A' ' 62' ' ' TRP . 2.8 tt -127.4 159.84 37.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.83 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.482 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 6.2 m-85 -119.65 140.52 50.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.139 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.758 ' CE3' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -176.07 153.76 1.34 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.724 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.89 158.44 6.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.09 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -55.99 -36.23 67.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.127 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -65.03 -29.68 70.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.066 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.7 17.25 12.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.365 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.867 ' CD2' ' HB2' ' A' ' 105' ' ' ALA . 2.6 m-85 -110.99 -31.8 7.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.8 0.333 . . . . 0.0 110.909 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.33 -28.3 61.68 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.519 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.06 -25.9 63.24 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.61 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -85.42 -19.32 31.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.627 0.251 . . . . 0.0 111.279 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.53 -39.47 16.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.759 0.314 . . . . 0.0 111.166 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -30.63 71.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.012 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.1 m -73.64 -23.09 59.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.08 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.81 26.79 30.96 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.561 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 mt -94.59 -30.12 14.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.84 0.353 . . . . 0.0 110.976 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 80.5 mt -83.09 160.86 21.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.032 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.482 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -109.17 -172.69 2.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.04 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.408 ' O ' ' CG2' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -88.57 -168.16 2.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.002 0.429 . . . . 0.0 110.958 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.778 HD11 ' CB ' ' A' ' 103' ' ' LEU . 7.6 pt -158.53 179.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.851 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 61.7 p -157.46 78.74 3.59 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.138 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.631 ' HD3' HD12 ' A' ' 79' ' ' ILE . 28.6 Cg_endo -62.22 113.2 1.8 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.575 2.183 . . . . 0.0 112.128 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.54 176.98 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.965 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -50.05 75.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.863 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 88' ' ' LYS . . . -56.66 -22.06 31.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.405 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.706 ' CZ ' HD22 ' A' ' 285' ' ' LEU . 0.3 OUTLIER -83.75 -54.52 4.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.898 0.38 . . . . 0.0 111.006 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.475 ' HG2' ' CZ2' ' A' ' 94' ' ' TRP . 17.3 mt-30 -69.79 -21.18 63.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.539 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -91.62 -9.07 45.39 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.449 ' HG2' HD12 ' A' ' 304' ' ' LEU . 0.0 OUTLIER -117.07 -23.01 8.13 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.497 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 85' ' ' PHE . 0.4 OUTLIER -82.72 135.13 35.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.868 0.366 . . . . 0.0 110.988 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.45 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . 33.1 m-85 -63.25 131.97 94.95 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.073 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.13 -55.57 3.74 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.682 2.255 . . . . 0.0 112.867 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.657 ' HD1' HD11 ' A' ' 329' ' ' ILE . 10.5 p90 -46.35 -28.02 1.21 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.908 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.477 HG22 ' CE1' ' A' ' 92' ' ' PHE . 11.7 p -72.95 -31.28 64.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.83 0.348 . . . . 0.0 110.858 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.736 ' CZ3' HD11 ' A' ' 103' ' ' LEU . 6.6 m95 -63.57 -31.42 72.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.817 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.26 -18.21 64.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.359 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.665 ' HB2' HG21 ' A' ' 329' ' ' ILE . . . -88.77 -18.11 28.44 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.574 HG23 ' CD2' ' A' ' 103' ' ' LEU . 4.8 m -103.82 -36.0 3.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.653 0.263 . . . . 0.0 111.541 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.9 116.92 7.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.885 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -99.85 -33.33 10.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.809 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -155.23 40.68 0.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.767 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.73 -22.37 40.78 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.658 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.7 pttp -104.21 179.77 4.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 111.018 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.778 ' CB ' HD11 ' A' ' 79' ' ' ILE . 17.6 mt -124.96 169.36 12.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.022 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.501 HD12 ' HD2' ' A' ' 67' ' ' PHE . 1.2 pp -156.61 -41.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.393 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.867 ' HB2' ' CD2' ' A' ' 67' ' ' PHE . . . -89.8 162.84 15.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 111.301 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.468 ' OH ' HG22 ' A' ' 79' ' ' ILE . 58.9 m-85 -120.14 79.93 27.0 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.551 ' O ' HD21 ' A' ' 285' ' ' LEU . 50.5 Cg_exo -54.19 137.47 70.51 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.607 2.205 . . . . 0.0 112.352 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.664 HD12 ' O ' ' A' ' 262' ' ' LEU . 3.1 mp -118.51 -60.15 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.126 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.61 ' HB2' HD13 ' A' ' 299' ' ' LEU . . . -125.37 150.42 47.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.141 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.518 HG23 ' HB2' ' A' ' 303' ' ' ALA . 21.4 t -122.02 101.15 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.33 174.69 9.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.974 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -169.97 124.59 0.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.07 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.467 HD23 ' HA2' ' A' ' 228' ' ' GLY . 2.9 mt -64.35 96.59 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.962 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.2 t -100.3 154.17 18.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.3 tt -83.24 128.57 34.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.907 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.681 HD12 ' HB2' ' A' ' 227' ' ' ASN . 4.1 mt -114.53 130.52 68.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.096 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -109.79 165.55 11.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -106.68 154.05 21.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.94 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -98.92 31.07 3.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -94.06 -45.78 7.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.89 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -144.04 38.96 1.32 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 20.1 tp -172.5 89.35 0.41 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.07 -44.79 2.31 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.527 2.151 . . . . 0.0 112.29 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -108.91 120.45 45.96 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.834 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.92 151.1 44.83 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.408 2.072 . . . . 0.0 112.389 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.63 119.03 5.71 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.587 2.192 . . . . 0.0 112.344 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.24 21.69 7.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.036 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.38 141.94 25.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.838 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.678 ' CE3' HD12 ' A' ' 132' ' ' ILE . 45.9 m95 -68.29 -27.99 66.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.001 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -73.47 -15.75 61.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.402 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.772 ' O ' HD12 ' A' ' 135' ' ' LEU . 0.5 OUTLIER -87.12 -3.91 59.1 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.708 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.678 HD12 ' CE3' ' A' ' 129' ' ' TRP . 11.3 mt -85.47 -48.13 0.59 Allowed Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.599 ' HG3' HD21 ' A' ' 198' ' ' LEU . 71.5 Cg_exo -48.51 -49.83 13.7 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.383 2.055 . . . . 0.0 112.411 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.45 -42.83 98.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.088 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.772 HD12 ' O ' ' A' ' 131' ' ' GLU . 0.2 OUTLIER -58.19 -48.61 79.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.595 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 1.4 t70 -53.4 -27.8 26.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -85.71 -28.91 24.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -84.96 -52.01 6.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.331 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.53 HD13 ' HA ' ' A' ' 146' ' ' ALA . 2.1 mt -58.88 -19.75 44.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.493 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.19 -29.56 48.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.823 0.344 . . . . 0.0 110.803 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.74 -36.72 77.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.66 -27.04 40.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.878 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.45 31.26 2.03 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.508 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -140.27 173.57 11.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.751 0.31 . . . . 0.0 110.924 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.493 ' O ' HD13 ' A' ' 139' ' ' LEU . 10.1 t -101.21 171.99 7.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.595 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -101.33 -68.4 0.82 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.267 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.674 HD22 HD13 ' A' ' 132' ' ' ILE . 4.0 tp -148.42 143.25 26.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.034 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.78 -177.81 5.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.808 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.572 ' O ' HG22 ' A' ' 208' ' ' THR . 32.1 p90 -178.54 -178.52 0.6 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -84.92 111.9 20.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.972 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.443 HD23 HG21 ' A' ' 157' ' ' THR . 9.9 mt -99.91 41.67 1.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.779 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -104.25 -32.5 9.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.06 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -134.59 143.92 48.64 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.018 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -57.55 -19.47 37.01 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.577 2.185 . . . . 0.0 112.491 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -48.13 -28.24 2.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.428 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -100.57 -29.95 12.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.081 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.443 HG21 HD23 ' A' ' 151' ' ' LEU . 16.2 p -96.83 17.66 16.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.354 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.543 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 11.8 t-105 -73.63 -50.37 5.9 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.538 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.588 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 47.2 Cg_endo -68.79 -15.82 41.05 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.153 1.902 . . . . 0.0 112.535 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 23.0 tp -77.27 -35.2 55.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 0.0 110.809 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.918 HD13 HD12 ' A' ' 192' ' ' LEU . 10.2 mt -105.1 -47.27 9.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.144 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -57.94 -28.68 64.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.312 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -56.51 -28.85 60.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.27 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.46 ' OD2' ' HB3' ' A' ' 190' ' ' ALA . 1.5 t0 -74.58 -20.1 60.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.212 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 139.01 -24.42 2.85 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.694 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.428 ' HA3' ' HB2' ' A' ' 188' ' ' ALA . . . -56.52 144.65 36.94 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.663 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.438 ' CD2' ' HA3' ' A' ' 182' ' ' GLY . 25.7 p90 -140.96 -177.01 4.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.337 . . . . 0.0 110.84 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -101.26 -34.49 9.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.14 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.778 ' CD2' HD11 ' A' ' 333' ' ' ILE . 90.0 m-85 -144.37 153.67 42.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.933 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.5 140.01 39.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.976 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.439 ' CZ ' ' HA2' ' A' ' 174' ' ' GLY . 57.7 t80 -143.99 110.81 5.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.685 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -135.03 -47.54 0.72 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.385 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -103.21 50.24 0.81 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 0.0 111.123 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.439 ' HA2' ' CZ ' ' A' ' 171' ' ' TYR . . . 57.71 19.77 36.91 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.735 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -125.22 170.79 10.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.793 0.33 . . . . 0.0 110.969 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -128.17 95.87 4.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.871 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.03 129.45 42.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.942 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.434 HG22 ' HG3' ' A' ' 335' ' ' GLN . 3.1 pt -82.75 -26.34 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.254 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.8 25.97 4.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.144 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -130.52 108.04 9.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.916 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.841 ' CG1' HG23 ' A' ' 183' ' ' VAL . 21.4 t -97.88 146.06 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.089 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLY . . . . . 0.438 ' HA3' ' CD2' ' A' ' 167' ' ' TYR . . . -117.17 33.2 5.13 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.738 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.841 HG23 ' CG1' ' A' ' 181' ' ' VAL . 3.4 t -92.5 -50.52 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.345 . . . . 0.0 110.92 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -83.98 57.06 3.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.963 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -102.98 -178.92 3.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.766 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -74.06 -32.1 63.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.019 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -85.96 -42.61 6.67 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.571 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 183' ' ' VAL . . . -58.33 -39.88 80.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.817 0.342 . . . . 0.0 111.227 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -59.25 -31.25 68.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.864 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.46 ' HB3' ' OD2' ' A' ' 164' ' ' ASP . . . -87.48 -30.25 20.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.096 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.4 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -64.73 -49.01 66.17 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.544 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.918 HD12 HD13 ' A' ' 161' ' ' ILE . 0.4 OUTLIER -60.43 -43.57 96.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.834 0.35 . . . . 0.0 110.848 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 17.0 m -58.13 -27.43 63.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.928 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.539 ' CE2' HD11 ' A' ' 198' ' ' LEU . 19.4 t80 -60.27 -60.58 3.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.766 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.421 ' O ' HD12 ' A' ' 199' ' ' ILE . 4.8 tp -60.56 -31.65 70.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.541 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.863 HG23 ' O ' ' A' ' 192' ' ' LEU . 45.6 t -65.03 -61.64 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.936 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.61 -28.28 69.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.778 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.599 HD21 ' HG3' ' A' ' 133' ' ' PRO . 3.3 mt -58.57 -55.59 33.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.953 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.421 HD12 ' O ' ' A' ' 195' ' ' LEU . 4.7 mt -55.26 -30.01 24.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.072 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -82.16 -34.09 29.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.937 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -106.49 29.98 6.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -144.92 -36.06 0.31 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.275 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 10.4 m80 76.28 41.64 0.21 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.925 0.393 . . . . 0.0 110.811 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.97 -175.38 5.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.759 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -108.16 126.76 53.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.963 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -79.44 -30.22 42.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.012 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.96 -15.98 62.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.22 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.701 ' HA ' HD12 ' A' ' 212' ' ' ILE . 30.0 m -36.81 148.43 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.974 0.416 . . . . 0.0 111.878 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.4 ' OD2' HD11 ' A' ' 212' ' ' ILE . 63.7 m-20 -154.05 176.19 12.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.808 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -64.79 -28.73 69.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.47 -59.17 2.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.812 0.339 . . . . 0.0 111.12 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 208' ' ' THR . 0.2 OUTLIER -59.18 -27.48 36.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.833 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -80.1 -20.43 45.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.838 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.59 -49.99 13.47 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.885 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.89 -32.44 69.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.104 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.68 -30.19 68.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.077 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -75.24 -47.73 26.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -59.54 -44.9 93.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -61.65 -29.0 69.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.826 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.59 37.67 5.49 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.473 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -94.52 -76.43 0.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 110.923 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 10.5 t -70.07 123.39 21.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.46 -31.71 68.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.047 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.446 ' HE1' ' HB2' ' A' ' 147' ' ' LEU . 1.5 mpp? -119.87 151.16 39.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 6.6 t -166.69 147.56 6.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 24.0 mt -95.66 116.81 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.085 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.681 ' HB2' HD12 ' A' ' 116' ' ' ILE . 9.9 m120 -119.26 165.43 14.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.852 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.467 ' HA2' HD23 ' A' ' 113' ' ' LEU . . . -119.64 -175.14 15.79 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.548 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.1 -20.29 30.22 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.648 2.232 . . . . 0.0 112.533 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 36.5 p90 -94.31 26.02 3.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.284 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.408 ' HB3' ' HB3' ' A' ' 227' ' ' ASN . . . -124.62 -1.66 7.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.685 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -81.02 -21.73 39.95 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.763 0.316 . . . . 0.0 111.226 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.6 m -72.97 -28.86 62.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.113 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ASN . . . . . 0.736 ' OD1' HG23 ' A' ' 235' ' ' ILE . 23.9 p30 -78.98 -32.88 45.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.075 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.736 HG23 ' OD1' ' A' ' 234' ' ' ASN . 2.1 pt -88.91 87.32 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.125 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -171.23 -46.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.862 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 63.3 p -93.54 -30.97 14.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.91 -26.3 64.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.023 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 62.68 67.21 0.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.87 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.97 128.6 56.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.013 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -62.01 104.88 0.51 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -106.49 148.73 27.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -137.85 113.71 1.01 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.499 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 26.9 t -78.68 120.49 29.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.791 0.329 . . . . 0.0 111.119 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 5.6 t -131.18 159.29 38.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.65 151.91 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.019 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 11.4 mt -72.21 152.75 92.46 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.881 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.44 164.34 31.2 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.508 2.139 . . . . 0.0 112.274 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.538 HG22 ' HA ' ' A' ' 254' ' ' PRO . 18.8 p -106.52 152.07 24.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.963 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -102.55 111.74 24.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt 60.42 28.1 17.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.971 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 93.83 -21.04 43.73 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.671 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -83.67 149.12 56.47 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.689 0.281 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.538 ' HA ' HG22 ' A' ' 249' ' ' THR . 56.5 Cg_endo -70.6 154.92 64.11 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.544 2.162 . . . . 0.0 112.304 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 91.1 p -65.29 166.33 10.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.417 ' N ' ' CD ' ' A' ' 257' ' ' PRO . 0.1 OUTLIER -133.59 52.8 8.95 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.951 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 256' ' ' LYS . 73.2 Cg_endo -76.28 -172.98 1.52 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.583 2.189 . . . . 0.0 112.385 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 258' ' ' PHE . . . . . 0.435 ' CD1' ' HG2' ' A' ' 330' ' ' MET . 13.5 m-85 -92.22 158.44 16.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.81 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 20.4 t -144.01 119.28 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.227 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -99.16 155.53 19.95 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.297 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.532 ' O ' HG13 ' A' ' 261' ' ' VAL . 14.9 p -144.0 116.74 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.815 0.34 . . . . 0.0 111.286 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.664 ' O ' HD12 ' A' ' 108' ' ' ILE . 52.0 tp -68.42 127.03 31.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.794 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.706 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 79.6 p -140.93 154.56 46.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.056 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -102.07 138.65 38.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.958 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -109.59 130.2 9.83 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.598 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 23.4 mt -109.58 119.01 58.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.754 0.312 . . . . 0.0 111.02 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -76.91 150.45 35.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.965 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.482 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -60.28 -31.65 70.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.027 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.443 ' HB1' ' HA3' ' A' ' 54' ' ' GLY . . . -92.55 48.02 1.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.083 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.0 t -108.89 97.39 24.19 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.869 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.57 -30.2 21.0 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.537 2.158 . . . . 0.0 112.38 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -101.19 56.87 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.82 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 9.2 tptp -70.55 -55.08 9.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -62.25 -34.36 76.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.939 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 275' ' ' LEU . 20.6 mt -73.66 -31.75 63.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.02 -48.42 81.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.102 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -60.54 -56.33 22.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.814 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 18.6 tt0 -57.19 -22.12 38.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.136 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -86.63 -60.65 1.93 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.165 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.67 HD11 HG21 ' A' ' 59' ' ' ILE . 2.3 mt -81.46 -56.39 4.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.433 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.28 -18.2 47.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.917 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 6.5 m-20 -120.11 -58.2 1.88 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.668 0.271 . . . . 0.0 111.609 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -86.97 57.54 4.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.954 0.406 . . . . 0.0 111.143 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 7.1 tp -172.51 -41.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.964 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.706 HD22 ' CZ ' ' A' ' 85' ' ' PHE . 1.9 mp -97.62 38.21 1.3 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.926 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.8 p -117.83 165.42 13.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.853 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -62.38 -30.4 71.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.934 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -82.46 -49.62 9.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -59.34 -49.56 77.16 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.572 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.435 HD21 HG22 ' A' ' 108' ' ' ILE . 2.8 mt -60.1 -30.89 69.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.815 0.34 . . . . 0.0 110.916 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -64.09 -41.89 97.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.951 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.08 -58.15 9.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.147 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.39 -29.45 42.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.204 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -70.51 -31.88 69.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.899 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -65.66 -34.63 78.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.954 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.61 -31.39 12.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.951 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.9 95.56 1.98 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.935 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.53 108.98 1.95 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.455 2.104 . . . . 0.0 112.291 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.61 HD13 ' HB2' ' A' ' 109' ' ' ALA . 5.0 mt -58.96 -28.26 66.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.003 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 99.64 -109.37 3.73 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.56 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.575 ' HB2' ' HB ' ' A' ' 320' ' ' THR . . . -75.23 93.73 2.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.82 0.343 . . . . 0.0 111.072 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.2 134.0 30.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.518 ' HB2' HG23 ' A' ' 110' ' ' VAL . . . -65.6 -27.4 68.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.023 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.488 HD23 ' HB2' ' A' ' 307' ' ' TYR . 24.6 tp -59.25 111.16 1.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.432 ' CG ' ' CE2' ' A' ' 90' ' ' TYR . 3.9 mttm -64.98 -45.07 87.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.974 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 17.2 m -54.74 -27.12 38.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.102 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.62 ' CE2' HD11 ' A' ' 311' ' ' LEU . 4.9 t80 -99.95 -25.31 14.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.12 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 0.2 OUTLIER -58.11 -34.4 70.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.86 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.41 -62.8 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.863 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -52.18 -31.8 33.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.789 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.801 ' HB3' HG21 ' A' ' 317' ' ' ILE . 12.3 mt -85.7 -25.05 26.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.793 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' A' ' 308' ' ' GLU . . . -67.25 -13.47 62.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.526 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 4.3 mtmm -46.51 -32.91 3.65 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.906 0.384 . . . . 0.0 110.925 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.64 140.16 24.95 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.354 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.435 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 12.0 Cg_endo -56.02 -25.59 54.71 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.393 2.062 . . . . 0.0 112.352 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -50.87 -40.21 55.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.038 0.447 . . . . 0.0 110.316 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.801 HG21 ' HB3' ' A' ' 311' ' ' LEU . 32.1 mm -85.5 -33.79 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.014 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -69.29 -29.72 67.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.241 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -72.08 -48.97 40.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.205 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.575 ' HB ' ' HB2' ' A' ' 301' ' ' ALA . 1.7 m -59.98 -38.62 83.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 5.3 tpt -72.58 -43.09 63.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.948 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -60.77 -31.87 71.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -69.5 -31.84 70.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.932 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -73.16 -50.18 24.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.143 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -61.39 -51.47 68.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 29.5 mtpt -59.97 -30.72 69.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.993 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -97.19 164.34 22.38 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.493 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -97.56 150.59 20.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.775 0.321 . . . . 0.0 110.897 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.665 HG21 ' HB2' ' A' ' 96' ' ' ALA . 32.1 mt -84.37 142.77 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.435 ' HG2' ' CD1' ' A' ' 258' ' ' PHE . 32.4 mtm -58.85 131.81 86.47 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.894 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.65 -174.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.367 2.045 . . . . 0.0 112.305 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -132.65 30.76 4.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.878 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.778 HD11 ' CD2' ' A' ' 169' ' ' PHE . 27.2 pt -106.11 147.31 34.6 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.35 -25.56 21.56 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.56 2.174 . . . . 0.0 112.437 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.434 ' HG3' HG22 ' A' ' 178' ' ' ILE . 75.1 mm-40 -55.15 -29.5 57.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.071 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 13.9 ttt -58.75 -24.49 61.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.055 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 337' ' ' SER . . . . . 0.402 ' O ' ' CE2' ' A' ' 341' ' ' TYR . 8.0 m -56.66 -38.93 72.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.047 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -86.16 -33.3 20.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.1 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.721 ' CZ ' HG21 ' A' ' 343' ' ' VAL . 48.6 t80 -59.76 -26.29 65.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.115 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 20.8 m95 -56.36 -52.45 64.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.17 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 341' ' ' TYR . . . . . 0.402 ' CE2' ' O ' ' A' ' 337' ' ' SER . 0.2 OUTLIER -84.89 -31.79 23.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.666 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 339' ' ' PHE . . . -50.49 -40.16 50.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.478 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.721 HG21 ' CZ ' ' A' ' 339' ' ' PHE . 17.5 t -95.93 -26.19 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.259 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -52.37 -56.35 15.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.162 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 12.4 m -64.3 -29.63 70.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.011 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -67.14 -55.32 14.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.248 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 343' ' ' VAL . 21.9 t -57.24 -43.2 81.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.278 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 22.7 mt -67.04 -53.74 31.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.089 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -59.95 -30.69 69.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -82.91 -38.38 22.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.131 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -67.84 -30.57 69.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.094 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 17.4 t -71.18 -22.38 62.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.111 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 96.24 -21.6 44.43 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.66 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -57.76 -31.34 66.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.856 0.36 . . . . 0.0 110.928 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -122.46 151.57 41.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 30.2 p -85.44 169.36 13.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.772 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.465 HG13 HD22 ' A' ' 192' ' ' LEU . 29.2 t -72.55 -51.68 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.969 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -47.1 -32.53 4.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.353 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.22 -44.69 14.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.996 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -56.45 -60.46 3.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.061 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.659 HD22 HG12 ' A' ' 183' ' ' VAL . 7.9 mt -56.98 -26.13 59.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.813 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.6 -35.92 33.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.85 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -57.85 -49.4 76.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.948 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -59.3 -39.11 81.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.082 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.832 ' HA ' HG21 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -59.08 -41.9 89.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.96 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 28.3 m -63.38 -49.59 73.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -43.44 94.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.998 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 13.9 mt -73.81 -40.4 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.082 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 365' ' ' GLN . 13.1 p -98.26 30.72 3.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.952 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.88 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.808 0.337 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -136.12 32.32 2.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -151.09 166.33 31.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.8 -16.49 76.29 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.718 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.418 ' HA ' HG22 ' A' ' 33' ' ' ILE . 1.2 pptp? -69.87 153.45 43.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.807 0.337 . . . . 0.0 110.935 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 mt -102.28 138.8 38.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.953 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 t -106.94 147.03 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.168 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.776 HD12 HG22 ' A' ' 37' ' ' VAL . 25.8 mt -125.43 107.51 18.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.967 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.413 ' CG ' ' HB3' ' A' ' 57' ' ' PRO . 0.9 OUTLIER -92.27 109.67 21.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.83 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.3 tt -153.89 148.02 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.05 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -60.4 170.29 1.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.927 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.16 29.56 9.9 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.566 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -90.88 -52.97 4.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.361 . . . . 0.0 110.943 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -79.9 -175.61 5.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -59.06 87.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.516 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 36.9 p90 -83.57 -44.24 14.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.343 . . . . 0.0 110.867 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.428 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 12.9 t30 -70.62 -31.72 68.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.1 -32.77 51.73 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.525 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.607 HD12 HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -60.18 -41.86 93.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.861 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.81 -30.22 68.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.089 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -59.5 -33.99 72.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.985 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.459 HG22 ' HB3' ' A' ' 292' ' ' ALA . 30.1 t -62.22 -31.26 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.11 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.57 -29.56 72.91 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.517 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 mmtt -59.85 -33.35 71.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.331 . . . . 0.0 110.944 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -42.04 72.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.854 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.642 ' CE1' HG21 ' A' ' 31' ' ' THR . 12.7 t80 -59.37 -59.22 5.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.939 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -57.8 -21.92 44.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.35 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -69.5 -26.31 64.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.512 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -117.74 -39.01 3.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.78 0.324 . . . . 0.0 111.49 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.642 HG21 ' CE1' ' A' ' 27' ' ' PHE . 15.1 p -90.68 -32.99 15.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.183 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.67 -22.39 35.98 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.663 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.446 HD13 HD13 ' A' ' 275' ' ' LEU . 38.8 mt -66.17 139.34 21.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.821 0.343 . . . . 0.0 111.046 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.0 170.01 17.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.982 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.6 t -146.99 111.06 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.042 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.1 m -101.85 150.63 22.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.948 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.776 HG22 HD12 ' A' ' 9' ' ' ILE . 21.9 t -130.14 110.19 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.117 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.408 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 60.2 mm-40 -96.52 165.7 12.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.562 ' CE1' HG12 ' A' ' 37' ' ' VAL . 50.9 m-70 -149.6 72.31 9.79 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.843 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.62 -179.75 3.54 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.601 2.201 . . . . 0.0 112.347 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -118.58 143.77 46.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.74 28.95 18.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.604 ' H ' HD23 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -59.27 -26.92 65.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.099 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.447 ' CG ' ' CH2' ' A' ' 62' ' ' TRP . 26.1 mt-10 -56.99 -30.59 64.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.013 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -95.89 -19.02 19.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.203 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.904 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.4 mtmp? -88.68 -29.6 19.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.803 0.335 . . . . 0.0 111.16 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.453 ' CZ ' HG21 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -52.83 -50.63 80.27 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.344 -179.803 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 38.4 Cg_exo -61.1 -23.64 77.73 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.573 2.182 . . . . 0.0 112.741 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -91.28 -40.38 11.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.835 0.35 . . . . 0.0 111.278 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.904 HG22 ' O ' ' A' ' 46' ' ' LYS . 9.9 m -80.45 -28.02 11.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.133 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.31 -22.53 59.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.303 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.3 -28.35 41.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.406 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.586 HG23 ' HB2' ' A' ' 55' ' ' ASP . 7.2 t -135.29 24.01 3.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.175 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 53.31 24.54 22.99 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.729 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.586 ' HB2' HG23 ' A' ' 53' ' ' THR . 9.4 t0 -74.67 -30.14 61.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.885 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.67 -150.47 0.64 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.543 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.413 ' HB3' ' CG ' ' A' ' 10' ' ' TRP . 59.2 Cg_endo -71.97 177.69 6.78 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.597 2.198 . . . . 0.0 112.36 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.58 -31.57 7.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.804 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.684 HG21 HD21 ' A' ' 280' ' ' LEU . 30.3 mt -128.32 139.83 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.048 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.715 HD11 ' HE3' ' A' ' 62' ' ' TRP . 2.5 tt -140.34 160.14 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.062 0.458 . . . . 0.0 110.962 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.482 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 9.0 m-85 -132.58 136.02 46.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.078 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.715 ' HE3' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -176.08 152.01 1.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.756 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.61 157.76 3.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.231 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.56 ' CD2' ' N ' ' A' ' 65' ' ' ASP . 5.2 p-80 -54.89 -29.65 56.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.085 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.56 ' N ' ' CD2' ' A' ' 64' ' ' HIS . 5.7 t0 -58.86 -34.33 71.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.099 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.81 17.14 12.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.345 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.457 ' HB3' HD11 ' A' ' 104' ' ' ILE . 2.0 m-85 -113.29 -24.23 9.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.655 0.264 . . . . 0.0 111.28 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -83.05 55.49 5.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.466 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -153.15 -42.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.574 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -82.86 -14.4 54.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.628 0.251 . . . . 0.0 111.258 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.47 -35.35 24.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.78 0.324 . . . . 0.0 111.205 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -62.28 -30.02 70.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.9 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.4 t -83.61 -23.12 32.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.057 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.5 28.26 13.21 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.479 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.0 mt -88.81 -34.3 17.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.801 0.334 . . . . 0.0 110.955 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 27.6 mt -79.11 167.01 21.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.417 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -106.7 126.23 52.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.083 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.457 ' CG ' ' N ' ' A' ' 79' ' ' ILE . 19.2 tt0 -65.42 164.05 14.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.795 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.542 HG21 ' CE1' ' A' ' 106' ' ' TYR . 40.6 pt -139.8 -179.65 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.208 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.447 HG23 ' O ' ' A' ' 79' ' ' ILE . 0.9 OUTLIER -158.89 77.86 3.11 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.45 ' HD2' HD12 ' A' ' 103' ' ' LEU . 37.2 Cg_endo -65.61 119.17 6.15 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.593 2.196 . . . . 0.0 112.27 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.35 177.92 0.33 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.824 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 11.2 mtmm -60.21 -45.45 93.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.52 -31.56 69.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.001 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -72.26 -52.21 17.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.871 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -64.37 -25.88 68.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.951 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.8 -28.36 67.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.157 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.522 ' O ' HD12 ' A' ' 304' ' ' LEU . 0.0 OUTLIER -97.86 34.26 1.93 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.118 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.517 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 94.2 mt -153.37 174.22 14.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.91 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.438 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . 44.7 m-85 -99.83 142.25 24.27 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.989 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -56.17 -55.88 2.53 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.617 2.211 . . . . 0.0 112.932 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.544 ' CE1' HG22 ' A' ' 93' ' ' THR . 38.2 p90 -52.98 -37.86 61.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.892 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.544 HG22 ' CE1' ' A' ' 92' ' ' PHE . 30.0 p -64.25 -27.88 69.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.722 0.296 . . . . 0.0 111.115 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.517 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 11.2 m95 -73.26 -24.52 60.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.218 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.42 11.31 19.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.466 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -101.83 -31.39 10.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.812 0.339 . . . . 0.0 111.257 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.669 ' CG1' ' HB3' ' A' ' 105' ' ' ALA . 9.0 m -87.92 -35.5 8.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.312 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.93 117.98 9.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.926 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -97.93 -67.24 0.86 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -99.62 30.74 3.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.922 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.02 -24.63 27.75 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.564 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.4 133.04 42.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 0.0 110.944 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.45 HD12 ' HD2' ' A' ' 81' ' ' PRO . 88.8 mt -66.35 150.0 49.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.868 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.664 ' O ' HD12 ' A' ' 104' ' ' ILE . 2.5 pp -155.02 36.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.145 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.702 ' HB1' ' HB2' ' A' ' 263' ' ' SER . . . -172.73 157.43 3.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.131 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.542 ' CE1' HG21 ' A' ' 79' ' ' ILE . 72.8 m-85 -118.01 80.85 15.3 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.455 ' HB3' HG21 ' A' ' 261' ' ' VAL . 48.4 Cg_exo -55.98 138.79 83.46 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.564 2.176 . . . . 0.0 112.233 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.703 HD13 ' O ' ' A' ' 284' ' ' LEU . 24.7 mt -134.46 -51.73 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.121 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.685 ' CB ' HD22 ' A' ' 299' ' ' LEU . . . -108.67 171.56 7.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.123 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.5 t -141.5 129.05 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.126 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.448 ' O ' HG13 ' A' ' 259' ' ' VAL . 0.1 OUTLIER -115.97 144.59 43.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -162.79 151.78 14.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.576 HD22 HG22 ' A' ' 226' ' ' ILE . 13.8 mt -61.22 124.56 20.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.1 m -115.66 165.28 13.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.0 tp -105.47 101.26 10.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.858 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 32.8 mt -91.45 119.77 39.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.109 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.525 ' CD1' HG22 ' A' ' 245' ' ' THR . 43.0 p90 -118.79 148.1 43.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.931 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -73.68 165.23 25.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.881 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.32 -31.13 6.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.02 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -74.8 -39.4 61.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.023 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.7 mt -109.53 28.61 8.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.076 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.8 tp -176.96 89.44 0.25 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.97 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -69.03 -30.51 25.56 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.516 2.144 . . . . 0.0 112.248 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -133.99 120.98 15.49 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.22 153.84 41.05 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.47 2.113 . . . . 0.0 112.379 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.05 122.11 8.15 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.587 2.191 . . . . 0.0 112.289 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 128' ' ' THR . 2.1 mmmp? -93.75 18.13 10.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 127' ' ' LYS . 5.4 p -156.99 141.96 17.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.8 0.334 . . . . 0.0 110.81 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.684 ' CE3' HD12 ' A' ' 132' ' ' ILE . 27.9 m95 -61.77 -31.78 72.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -68.89 -15.88 63.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.336 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.98 0.52 57.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.551 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.684 HD12 ' CE3' ' A' ' 129' ' ' TRP . 16.6 mt -85.37 -46.24 0.63 Allowed Pre-proline 0 C--N 1.332 -0.184 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 72.0 Cg_exo -48.74 -57.49 2.33 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.369 2.046 . . . . 0.0 112.447 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.28 -36.97 83.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.995 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.2 mt -58.39 -52.29 66.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.997 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.437 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 4.9 t0 -46.08 -31.75 2.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.436 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -85.61 -27.02 25.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.232 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -57.93 -64.18 1.0 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.289 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.646 ' H ' HD13 ' A' ' 139' ' ' LEU . 0.0 OUTLIER -68.49 -16.32 63.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.567 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.407 ' H ' HD22 ' A' ' 139' ' ' LEU . 2.6 ttmt -63.4 -21.57 66.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.884 0.373 . . . . 0.0 110.461 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.51 -41.74 81.39 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.672 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.404 ' HD2' ' HA ' ' A' ' 139' ' ' LEU . 0.0 OUTLIER -81.85 -26.28 34.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.784 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 119.52 21.48 3.63 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.615 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -116.0 -174.98 2.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.775 0.322 . . . . 0.0 110.943 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.2 p -130.17 158.38 39.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.913 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.483 ' HB2' HD11 ' A' ' 139' ' ' LEU . . . -76.76 -62.72 1.54 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.179 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.831 HD11 HG13 ' A' ' 226' ' ' ILE . 4.0 tp -148.66 143.44 26.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.015 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.48 ' SD ' HG21 ' A' ' 222' ' ' THR . 0.0 OUTLIER -129.26 -177.83 4.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.778 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.9 p90 179.63 145.99 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.9 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.536 HD22 ' HD2' ' A' ' 156' ' ' PHE . 0.5 OUTLIER -62.9 126.97 29.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.952 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.7 mt -98.48 31.62 2.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.848 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -101.51 -31.33 10.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -119.71 146.5 41.76 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.905 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.1 -3.41 13.71 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.553 2.168 . . . . 0.0 112.677 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.5 ' CZ ' ' CH2' ' A' ' 340' ' ' TRP . 0.4 OUTLIER -57.8 -32.12 67.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.826 0.346 . . . . 0.0 110.954 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.536 ' HD2' HD22 ' A' ' 150' ' ' ASN . 26.8 m-85 -94.69 4.04 54.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.544 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.532 HG21 HG11 ' A' ' 347' ' ' VAL . 55.8 p -106.77 -28.12 10.35 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.796 0.332 . . . . 0.0 111.049 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.483 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 11.7 t-105 -55.94 -46.66 99.73 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.308 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.76 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 77.2 Cg_exo -50.35 -25.51 13.95 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.377 2.051 . . . . 0.0 112.479 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.701 HD21 ' HB3' ' A' ' 194' ' ' PHE . 3.6 tp -94.06 -38.84 10.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.018 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.646 HG12 HD12 ' A' ' 192' ' ' LEU . 21.4 mt -76.04 -55.45 11.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.179 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.09 -25.97 68.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.243 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.76 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -57.17 -56.09 26.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.239 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -96.05 -20.1 18.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.231 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -77.06 -104.65 0.15 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.525 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -150.49 -86.98 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.531 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -172.83 -179.6 2.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.837 0.351 . . . . 0.0 110.897 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.02 -48.8 6.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.066 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -141.86 140.61 32.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.965 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -77.5 136.83 38.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.848 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.487 ' CE2' ' CE2' ' A' ' 176' ' ' TYR . 0.3 OUTLIER -101.69 110.64 22.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.779 179.834 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -133.96 145.02 49.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.126 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 48.69 32.09 3.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.249 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 68.0 26.61 73.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.424 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.23 -171.32 2.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.359 . . . . 0.0 110.839 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.487 ' CE2' ' CE2' ' A' ' 171' ' ' TYR . 1.1 m-85 -130.54 131.7 45.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.848 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.73 139.4 32.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.633 HG21 ' OE1' ' A' ' 335' ' ' GLN . 19.9 pt -95.03 -18.4 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.334 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.91 26.01 4.37 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.113 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -140.52 78.58 1.66 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.882 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.669 HG12 ' H ' ' A' ' 183' ' ' VAL . 21.7 t -94.24 137.71 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.162 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.29 0.3 40.6 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.857 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.669 ' H ' HG12 ' A' ' 181' ' ' VAL . 0.3 OUTLIER -54.05 -42.67 55.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.921 0.391 . . . . 0.0 111.31 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.418 ' N ' ' CG1' ' A' ' 183' ' ' VAL . 22.9 t0 -96.09 61.51 2.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.971 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -91.57 165.47 13.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.84 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -59.87 -38.71 82.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.14 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -85.92 -25.11 38.93 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.565 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.15 -30.56 66.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 0.0 111.163 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -61.03 -38.2 85.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -87.56 -30.06 20.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -59.31 -51.05 61.44 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.555 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.852 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.3 OUTLIER -60.24 -41.01 92.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.805 0.336 . . . . 0.0 110.904 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.8 m -54.07 -25.5 22.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.161 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.701 ' HB3' HD21 ' A' ' 160' ' ' LEU . 1.3 t80 -65.28 -60.57 2.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.784 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.762 ' HA ' HD12 ' A' ' 198' ' ' LEU . 3.9 tp -63.86 -33.47 75.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.68 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.852 HG23 ' O ' ' A' ' 192' ' ' LEU . 46.2 t -65.9 -44.68 92.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.941 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.5 -28.11 60.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.938 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.762 HD12 ' HA ' ' A' ' 195' ' ' LEU . 16.6 mt -57.82 -53.72 55.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.005 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 14.9 mt -68.81 -29.86 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.003 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.685 ' HD2' HG12 ' A' ' 196' ' ' VAL . 24.1 mtpt -75.8 -29.86 58.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.968 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -95.32 22.76 6.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.177 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.49 75.27 0.33 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.931 0.396 . . . . 0.0 111.156 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.4 -41.97 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.74 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' MET . . . . . 0.7 ' CE ' HD13 ' A' ' 198' ' ' LEU . 0.1 OUTLIER -103.01 145.56 29.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.846 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -90.03 113.96 25.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.867 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.19 -26.72 66.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.154 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -92.98 46.49 1.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.931 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 51.9 m -113.36 138.75 49.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.784 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.519 ' HB2' HD11 ' A' ' 212' ' ' ILE . 1.8 m-20 -151.35 176.3 11.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.945 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -42.67 -62.98 0.86 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.38 -59.25 4.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.004 0.43 . . . . 0.0 111.591 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 209' ' ' ASP . 0.0 OUTLIER -52.96 -31.9 17.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.183 -179.53 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -81.98 -28.3 32.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.763 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -82.36 -56.15 4.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.026 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.08 -31.26 61.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.334 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.46 -36.0 73.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.122 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.72 ' CG ' HG21 ' A' ' 225' ' ' THR . 29.0 t80 -82.24 -31.75 30.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.994 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -63.97 -46.94 82.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.99 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.09 -36.76 58.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.95 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 110.33 56.92 0.51 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.506 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -108.66 -29.71 8.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.801 0.334 . . . . 0.0 110.949 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.48 HG21 ' SD ' ' A' ' 148' ' ' MET . 9.8 t -117.38 140.1 50.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.937 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.06 -31.14 68.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.095 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 9.8 mtp -134.43 163.29 30.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.72 HG21 ' CG ' ' A' ' 217' ' ' PHE . 4.7 t -166.62 132.49 2.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.831 HG13 HD11 ' A' ' 147' ' ' LEU . 25.6 mt -96.62 116.81 39.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.087 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -156.29 165.3 36.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.428 ' HA3' ' CZ3' ' A' ' 230' ' ' TRP . . . -82.53 170.77 50.77 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.478 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.81 -25.59 27.64 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.661 2.241 . . . . 0.0 112.325 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' TRP . . . . . 0.428 ' CZ3' ' HA3' ' A' ' 228' ' ' GLY . 28.5 p90 -59.29 -30.97 68.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.965 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -59.46 -29.95 68.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.152 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 27.9 m0 -59.61 -28.91 67.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.049 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.9 m -57.81 -31.07 66.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.003 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -72.16 -59.61 2.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 4.5 mt -78.49 116.66 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.082 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -168.66 -47.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.934 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 22.2 p -76.48 -38.71 54.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 11.8 t -66.16 -29.41 69.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.957 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 62.16 81.72 0.19 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.35 143.8 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.104 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -85.25 87.47 7.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.932 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -104.64 167.61 9.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.06 174.28 21.99 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.523 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 20.9 t -140.01 127.52 24.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.793 0.33 . . . . 0.0 111.076 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.525 HG22 ' CD1' ' A' ' 117' ' ' TYR . 8.7 t -143.53 151.34 40.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.967 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.417 ' CG2' ' N ' ' A' ' 247' ' ' LEU . 0.7 OUTLIER -54.51 152.3 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.292 0.568 . . . . 0.0 111.295 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.417 ' N ' ' CG2' ' A' ' 246' ' ' VAL . 9.2 mt -71.45 146.6 91.87 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.977 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.419 ' HG2' ' CD1' ' A' ' 129' ' ' TRP . 50.8 Cg_endo -69.18 177.17 5.44 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.541 2.16 . . . . 0.0 112.265 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 44.6 p -121.12 175.47 6.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -142.85 121.94 12.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 20.7 mttm 60.1 31.67 20.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 74.35 27.03 66.62 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.52 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -136.48 128.99 17.43 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.554 0.216 . . . . 0.0 110.821 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.07 163.09 35.86 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.505 2.137 . . . . 0.0 112.354 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.82 -172.95 3.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.786 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -134.72 63.87 60.77 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.952 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -56.88 127.78 27.25 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.554 2.169 . . . . 0.0 112.182 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' PHE . . . . . 0.425 ' CD2' ' CD1' ' A' ' 155' ' ' TYR . 98.5 m-85 -60.65 139.96 57.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.739 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 111' ' ' GLU . 25.5 t -120.32 146.25 25.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.294 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -134.65 86.57 0.26 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.294 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' A' ' 107' ' ' PRO . 7.5 p -60.52 128.85 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.843 0.354 . . . . 0.0 111.326 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.3 tp -89.9 106.9 18.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.702 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 0.5 OUTLIER -117.56 174.32 6.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.961 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . . . -109.44 154.51 22.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.03 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.0 129.77 8.11 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.515 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.438 HD12 ' CE1' ' A' ' 106' ' ' TYR . 4.4 mt -125.74 100.53 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.803 0.335 . . . . 0.0 110.998 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.19 162.63 4.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.956 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.417 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -70.78 -28.36 64.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -90.51 49.94 1.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.132 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.5 m -109.1 102.76 50.17 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.782 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.81 -23.91 47.51 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.419 2.079 . . . . 0.0 112.366 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -98.37 31.11 2.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.934 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.99 -38.35 90.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.886 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -61.7 -49.52 76.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.96 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.446 HD13 HD13 ' A' ' 33' ' ' ILE . 78.2 mt -77.7 -31.02 52.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.942 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.67 -55.4 20.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.178 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -44.82 74.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.045 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.415 ' HG3' ' ND2' ' A' ' 282' ' ' ASN . 14.5 tt0 -63.89 -43.38 96.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -66.83 -37.11 83.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.766 HD23 ' CD2' ' A' ' 284' ' ' LEU . 2.8 mt -78.71 -22.24 46.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.445 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.55 -29.94 15.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.505 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.415 ' ND2' ' HG3' ' A' ' 278' ' ' GLU . 22.9 m-80 -94.67 -58.09 2.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.728 0.299 . . . . 0.0 111.494 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -106.49 58.12 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.94 0.4 . . . . 0.0 111.319 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.766 ' CD2' HD23 ' A' ' 280' ' ' LEU . 2.0 tp 177.64 38.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.942 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.78 HD23 HD13 ' A' ' 304' ' ' LEU . 0.4 OUTLIER 179.3 38.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.872 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 44.7 p -153.48 172.37 17.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.947 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -63.15 -29.28 70.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.018 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -78.22 -30.15 48.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.019 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -92.2 -51.8 2.33 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.624 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.603 HD21 HG22 ' A' ' 108' ' ' ILE . 1.5 mt -59.03 -30.59 68.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.764 0.316 . . . . 0.0 110.999 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -72.81 -31.45 64.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.937 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.459 ' HB3' HG22 ' A' ' 23' ' ' VAL . . . -59.25 -40.49 86.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.138 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.2 t -83.53 -30.81 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.138 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -63.31 -29.72 70.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.977 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -58.77 -33.66 70.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.96 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -102.61 -35.82 8.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.0 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 4.2 mmtm -146.61 90.36 5.57 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.932 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.2 104.79 1.44 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.53 2.154 . . . . 0.0 112.265 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.685 HD22 ' CB ' ' A' ' 109' ' ' ALA . 2.2 mp -58.42 -26.75 63.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.994 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 90.13 -94.72 2.01 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.523 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -79.05 122.01 25.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.784 0.326 . . . . 0.0 111.073 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.528 HG11 ' CD2' ' A' ' 307' ' ' TYR . 21.3 m -111.59 165.98 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.18 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -92.13 -29.24 16.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.167 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.78 HD13 HD23 ' A' ' 285' ' ' LEU . 5.0 tp -58.16 120.91 9.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.936 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -65.22 -31.63 72.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.9 -31.75 51.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.617 ' CE2' HD11 ' A' ' 311' ' ' LEU . 5.4 t80 -84.68 -28.26 26.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.021 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -59.4 -31.79 69.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.84 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -73.08 -58.91 2.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.853 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -51.53 -32.21 27.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.771 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.785 ' HB3' HG21 ' A' ' 317' ' ' ILE . 13.3 mt -85.78 -26.14 25.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.667 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.7 -16.48 62.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.343 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -47.82 -32.62 6.29 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.931 0.396 . . . . 0.0 110.832 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -108.67 138.53 20.3 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.345 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 11.8 Cg_endo -55.89 -30.67 78.26 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.418 2.078 . . . . 0.0 112.374 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -49.68 -39.32 36.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.001 0.429 . . . . 0.0 110.299 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.785 HG21 ' HB3' ' A' ' 311' ' ' LEU . 18.5 mm -85.57 -33.58 7.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.964 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -69.2 -57.48 5.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.205 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.19 -49.58 75.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.258 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 73.8 m -58.73 -31.02 67.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.987 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 9.1 tpt -79.98 -32.13 39.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -61.43 -56.13 23.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.94 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -65.12 -30.44 71.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.942 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.09 -56.54 20.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.134 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -64.09 -37.52 87.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.875 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 12.0 tttp -67.52 -31.92 72.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -76.97 -162.02 14.3 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.501 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -129.27 160.46 32.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.762 0.315 . . . . 0.0 110.949 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.492 HG22 ' N ' ' A' ' 330' ' ' MET . 29.8 mt -86.78 158.81 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.127 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.492 ' N ' HG22 ' A' ' 329' ' ' ILE . 6.1 mtp -80.13 131.07 63.83 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.899 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -57.3 158.36 18.82 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.392 2.061 . . . . 0.0 112.181 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -110.23 -26.53 9.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.087 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 34.9 pt -55.59 150.44 25.49 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.248 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.71 -25.42 24.22 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.594 2.196 . . . . 0.0 112.417 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.633 ' OE1' HG21 ' A' ' 178' ' ' ILE . 0.9 OUTLIER -56.57 -28.36 60.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.062 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -27.86 66.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.061 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 4.9 m -55.87 -56.2 23.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.01 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.59 -30.8 71.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.09 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.778 ' O ' HG23 ' A' ' 343' ' ' VAL . 47.1 t80 -59.7 -40.49 88.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.946 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.5 ' CH2' ' CZ ' ' A' ' 155' ' ' TYR . 96.7 m95 -63.6 -55.75 21.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.024 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -58.8 -44.3 90.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.082 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -59.17 -58.73 7.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.19 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 339' ' ' PHE . 24.4 t -59.21 -28.43 39.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.228 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.71 -53.89 49.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.073 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.67 -30.61 68.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.959 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -59.26 -52.83 63.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.212 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 343' ' ' VAL . 21.2 t -59.19 -36.74 64.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.198 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 29.3 mt -76.37 -37.15 30.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.158 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -58.93 -30.95 68.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.95 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -87.6 -46.68 9.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.053 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.13 -40.53 96.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.123 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 8.1 m -67.92 -22.43 65.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.104 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 85.12 27.6 33.3 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.564 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.19 -30.28 21.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.852 0.358 . . . . 0.0 110.918 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -146.09 -173.92 4.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 4.4 p -104.48 156.12 18.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.951 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.529 HG13 HD22 ' A' ' 192' ' ' LEU . 43.1 t -59.12 -29.93 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.977 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.12 -49.29 70.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.23 -34.88 71.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.995 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -65.98 -52.85 45.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.98 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.591 HD22 ' O ' ' A' ' 183' ' ' VAL . 89.9 mt -61.75 -28.72 69.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -81.19 -41.16 22.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.871 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -73.72 -46.98 42.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.14 -43.65 87.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.145 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -62.95 -36.17 82.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.933 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.573 HG22 ' HG2' ' A' ' 370' ' ' LYS . 21.3 m -60.34 -42.99 96.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -59.71 -29.82 68.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.924 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.563 HD12 ' CD2' ' A' ' 339' ' ' PHE . 26.2 mm -71.02 -35.66 60.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.076 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 1.4 t -152.77 78.64 1.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.573 ' HG2' HG22 ' A' ' 366' ' ' THR . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.92 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.55 HG21 ' HD2' ' A' ' 271' ' ' PRO . 7.5 t . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.798 0.332 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.26 173.54 10.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.883 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 58.24 174.63 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.983 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -84.98 55.92 4.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.494 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -125.15 173.29 8.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.861 0.362 . . . . 0.0 110.887 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.455 HD11 ' HB3' ' A' ' 275' ' ' LEU . 6.1 mt -141.9 115.82 9.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.2 t -89.61 146.99 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.212 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.902 HG21 HD21 ' A' ' 20' ' ' LEU . 5.4 mt -128.16 107.47 16.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.925 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.449 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 8.6 m0 -93.78 106.7 18.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.854 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.3 tt -123.29 145.81 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.081 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -60.13 170.56 1.22 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.79 47.91 2.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.52 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -157.23 31.4 0.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.856 0.36 . . . . 0.0 110.907 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.33 -172.3 3.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.92 93.84 1.53 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.501 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -85.97 -37.5 18.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.816 0.341 . . . . 0.0 110.923 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -75.73 -32.72 60.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.976 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.9 -28.21 59.22 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.507 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.902 HD21 HG21 ' A' ' 9' ' ' ILE . 18.5 tp -80.05 -32.4 39.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.76 0.314 . . . . 0.0 110.931 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.77 -31.81 71.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.175 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -60.23 -31.05 69.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.965 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.8 t -64.62 -41.14 91.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.088 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.99 -34.96 88.64 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.499 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.0 mttp -60.03 -28.59 67.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.826 0.346 . . . . 0.0 110.934 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -83.0 -38.5 22.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.849 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -55.82 -45.69 78.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.096 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -60.36 -38.35 83.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.937 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.39 -28.81 66.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.901 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -83.76 -32.66 25.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.311 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.462 HG23 HG12 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -139.06 -44.15 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.391 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.98 20.9 5.5 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.721 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.613 HG21 HD13 ' A' ' 275' ' ' LEU . 29.4 mm -80.67 114.9 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.814 0.34 . . . . 0.0 110.985 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -57.65 145.48 33.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.003 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.4 t -138.96 109.31 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.111 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.2 m -104.14 128.54 51.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.911 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.572 HG22 HD12 ' A' ' 9' ' ' ILE . 21.5 t -114.74 113.86 44.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.149 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -114.78 156.8 24.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.9 p-80 -122.47 71.49 37.22 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.855 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.573 ' HG2' HD22 ' A' ' 43' ' ' LEU . 57.1 Cg_endo -70.77 165.84 30.82 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.603 2.202 . . . . 0.0 112.377 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -126.0 141.21 52.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.815 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.5 mmtm 59.68 36.96 22.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.839 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.573 HD22 ' HG2' ' A' ' 40' ' ' PRO . 0.6 OUTLIER -78.19 -3.51 42.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.48 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -58.29 -36.91 74.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.84 0.352 . . . . 0.0 110.964 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.47 -19.75 23.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.172 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.777 ' O ' HG22 ' A' ' 50' ' ' VAL . 2.5 mtpp -87.41 -19.0 28.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.344 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.451 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 7.0 t80 -70.91 -48.52 14.41 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.361 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 2.9 Cg_exo -76.04 -31.32 5.02 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.791 2.327 . . . . 0.0 112.688 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.602 ' HG3' HG13 ' A' ' 50' ' ' VAL . 7.8 pt20 -60.28 -50.69 72.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.834 0.35 . . . . 0.0 111.239 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 46' ' ' LYS . 7.4 m -97.17 27.09 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.434 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.19 -29.98 31.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.184 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.55 -32.49 25.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.207 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.483 HG22 ' HA ' ' A' ' 50' ' ' VAL . 2.2 t -82.75 -29.65 29.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.944 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.71 26.96 23.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.517 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.42 -26.02 24.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.829 0.347 . . . . 0.0 111.009 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.4 -178.52 0.4 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.554 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.449 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 60.9 Cg_endo -72.59 -168.23 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.609 2.206 . . . . 0.0 112.364 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.29 -46.22 3.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.814 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.9 mt -117.88 138.88 47.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.596 HD11 ' CE3' ' A' ' 62' ' ' TRP . 2.6 tt -139.02 159.69 29.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.12 0.486 . . . . 0.0 110.952 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.481 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 28.1 m-85 -127.62 136.17 51.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.942 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.596 ' CE3' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -172.01 157.69 4.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.913 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.36 156.1 30.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.094 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.584 ' CD2' ' HB1' ' A' ' 96' ' ' ALA . 18.3 p-80 -56.48 -41.93 77.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.085 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -59.26 -31.35 69.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.08 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.418 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 8.6 mmm180 -94.25 17.19 13.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.334 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.402 ' CE2' ' O ' ' A' ' 62' ' ' TRP . 0.8 OUTLIER -109.65 -13.33 14.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.285 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -92.5 21.89 35.93 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.739 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.42 -23.83 4.65 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.559 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.46 ' O ' HD12 ' A' ' 75' ' ' LEU . 29.3 m-85 -100.47 -28.08 13.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.737 0.303 . . . . 0.0 110.972 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.0 -25.78 53.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.11 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -59.29 -29.3 67.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.155 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 m -96.65 24.99 5.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.13 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.49 29.46 39.31 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.791 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.46 HD12 ' O ' ' A' ' 70' ' ' TYR . 7.3 mt -87.81 -40.61 13.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 0.0 110.944 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.4 mt -83.33 148.52 27.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.931 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.546 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -82.31 165.33 20.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.128 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.475 ' OE1' HG22 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -88.03 -165.63 1.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.935 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.665 HD11 ' HB3' ' A' ' 103' ' ' LEU . 33.8 pt -157.33 164.62 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.968 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 47.0 p -156.31 77.43 4.36 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.837 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.64 161.16 46.15 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.646 2.231 . . . . 0.0 112.269 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.38 165.07 16.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.809 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.35 -38.28 76.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.884 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.37 -29.31 61.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.063 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.428 ' CZ ' HD13 ' A' ' 285' ' ' LEU . 7.4 t80 -78.54 -32.01 47.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.434 ' HG2' ' CE2' ' A' ' 94' ' ' TRP . 0.0 OUTLIER -82.21 -29.62 31.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.994 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -73.74 -36.42 65.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.048 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.466 ' HG3' HD12 ' A' ' 89' ' ' LEU . 2.6 pttt -59.87 -30.28 68.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.012 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.532 HD11 HD11 ' A' ' 285' ' ' LEU . 1.1 mp -88.45 162.54 16.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.849 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.424 ' HB3' ' CE1' ' A' ' 92' ' ' PHE . 15.2 m-85 -75.09 141.09 74.07 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.064 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -54.31 -55.88 3.0 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.658 2.239 . . . . 0.0 113.022 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.476 ' CE2' HG23 ' A' ' 93' ' ' THR . 42.4 p90 -56.16 -42.21 76.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.734 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.476 HG23 ' CE2' ' A' ' 92' ' ' PHE . 30.6 p -59.46 -28.06 66.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.754 0.312 . . . . 0.0 111.103 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.434 ' CE2' ' HG2' ' A' ' 86' ' ' GLN . 7.2 m95 -75.01 -25.82 59.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.113 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.405 ' HA ' ' CG ' ' A' ' 98' ' ' ARG . 5.9 m-20 -90.55 12.42 18.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.398 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.584 ' HB1' ' CD2' ' A' ' 64' ' ' HIS . . . -101.9 -48.26 4.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.779 0.324 . . . . 0.0 111.289 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.879 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 7.2 m -78.98 -33.14 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.387 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 0.9 OUTLIER -66.09 121.17 14.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.99 -179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -122.96 142.68 50.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.727 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 69.59 25.31 5.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.071 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.57 7.27 88.13 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.109 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.04 141.64 47.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.846 0.355 . . . . 0.0 111.006 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.665 ' HB3' HD11 ' A' ' 79' ' ' ILE . 1.2 mp -75.85 149.82 37.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.953 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.475 HG22 ' OE1' ' A' ' 78' ' ' GLU . 2.5 pp -157.14 26.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.387 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.879 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -161.59 179.09 8.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.073 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -137.66 89.97 14.99 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.939 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.695 ' HB3' HG21 ' A' ' 261' ' ' VAL . 44.2 Cg_exo -56.23 131.47 46.06 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.524 2.149 . . . . 0.0 112.228 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.672 ' CG2' HD21 ' A' ' 290' ' ' LEU . 4.0 mt -127.24 -48.06 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 262' ' ' LEU . . . -113.34 138.44 50.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.089 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.34 128.92 67.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.1 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -109.2 148.17 31.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.958 ' HB3' HG23 ' A' ' 320' ' ' THR . . . -157.93 137.05 11.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.405 HD11 ' HE1' ' A' ' 155' ' ' TYR . 8.6 mt -66.85 109.08 2.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.864 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.85 161.14 14.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.931 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.726 HD22 ' HD3' ' A' ' 248' ' ' PRO . 6.8 tp -96.78 111.79 23.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.8 mt -97.98 132.09 43.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.1 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.436 ' CD1' ' HB3' ' A' ' 125' ' ' PRO . 34.7 p90 -129.74 159.33 36.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.001 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.557 ' HB3' HD12 ' A' ' 121' ' ' LEU . 5.3 m120 -86.39 120.93 28.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.0 mtpp -77.93 -27.97 49.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.037 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -65.46 -30.48 71.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.1 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.557 HD12 ' HB3' ' A' ' 118' ' ' ASN . 1.9 mp -110.42 -35.7 5.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.114 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 16.2 tp -110.43 101.92 49.98 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.97 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.82 -27.79 37.08 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.37 2.047 . . . . 0.0 112.303 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -137.98 130.34 16.33 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.436 ' HB3' ' CD1' ' A' ' 117' ' ' TYR . 71.7 Cg_endo -76.99 151.55 30.94 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.538 2.159 . . . . 0.0 112.326 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.438 ' HB2' HD11 ' A' ' 132' ' ' ILE . 72.4 Cg_endo -76.26 103.03 1.68 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.54 2.16 . . . . 0.0 112.328 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -24.28 59.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.092 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.39 143.69 35.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.902 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.441 ' CE3' HG13 ' A' ' 132' ' ' ILE . 18.4 m95 -78.1 -30.82 49.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -67.64 -15.82 63.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.314 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.81 -11.11 43.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.609 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.476 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 25.6 mm -70.96 -46.56 15.15 Favored Pre-proline 0 CA--C 1.53 0.197 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.476 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 75.3 Cg_exo -48.12 -57.94 2.04 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.396 2.064 . . . . 0.0 112.489 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.32 -35.18 79.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.061 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.2 mt -58.44 -51.02 71.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.052 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.545 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 4.8 t70 -46.74 -28.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.508 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -85.58 -27.97 25.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.312 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.56 -63.71 1.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.302 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.666 ' H ' HD13 ' A' ' 139' ' ' LEU . 0.0 OUTLIER -68.96 -16.4 63.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.646 -179.597 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.418 ' N ' HD22 ' A' ' 139' ' ' LEU . 0.0 OUTLIER -64.54 -21.58 66.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.804 0.335 . . . . 0.0 110.495 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.44 -41.61 80.82 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.126 0.489 . . . . 0.0 110.581 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.4 ' HD2' ' HA ' ' A' ' 139' ' ' LEU . 0.0 OUTLIER -83.01 -26.75 30.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.784 179.711 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.34 18.6 3.36 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.76 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -111.4 -174.96 2.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.826 0.345 . . . . 0.0 110.893 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.6 t -132.12 163.9 27.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.878 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.545 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -79.26 -64.47 1.18 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.303 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.5 ' CD1' HD11 ' A' ' 115' ' ' LEU . 1.0 OUTLIER -153.28 148.44 26.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.102 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.474 ' SD ' HG21 ' A' ' 222' ' ' THR . 0.0 OUTLIER -137.05 -177.87 4.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.754 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -179.26 152.74 0.55 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.954 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.405 ' OD1' ' CD2' ' A' ' 156' ' ' PHE . 12.9 p-10 -67.95 113.11 5.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.679 ' CD2' HD21 ' A' ' 195' ' ' LEU . 8.8 mt -94.1 45.26 1.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.854 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -110.44 -30.29 7.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.008 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -125.14 125.86 25.24 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.885 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.84 -22.32 29.32 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.446 2.098 . . . . 0.0 112.341 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.405 ' HE1' HD11 ' A' ' 113' ' ' LEU . 44.4 t80 -54.19 -31.1 51.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.091 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.405 ' CD2' ' OD1' ' A' ' 150' ' ' ASN . 0.2 OUTLIER -89.16 -31.25 18.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.4 HG21 HD22 ' A' ' 195' ' ' LEU . 0.1 OUTLIER -94.93 12.43 28.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.241 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.55 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 29.7 t-105 -68.23 -54.85 14.04 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.433 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 17.4 Cg_endo -57.82 -20.26 42.88 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.238 1.959 . . . . 0.0 112.413 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.678 HD23 HD13 ' A' ' 195' ' ' LEU . 21.3 tp -78.8 -27.41 44.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.945 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 18.3 mt -101.67 -47.72 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.127 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -60.07 -36.48 77.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.214 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.42 84.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.232 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.05 -20.16 56.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.252 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 130.9 71.74 0.11 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.509 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 188' ' ' ALA . . . -171.77 172.67 44.78 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.489 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -162.39 173.57 13.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.82 0.343 . . . . 0.0 110.946 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.71 -53.34 4.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.052 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -127.72 146.22 50.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.784 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.85 108.12 17.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.049 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -73.51 110.95 8.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.577 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -159.38 145.6 16.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.935 0.398 . . . . 0.0 111.099 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 62.11 29.19 17.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.18 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.41 -37.27 3.36 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.14 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 5.1 pttm -102.04 179.61 4.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 111.139 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 176' ' ' TYR . 1.3 m-85 -110.19 115.21 29.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.801 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -58.45 134.83 57.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.899 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.8 pt -95.05 -16.63 7.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.415 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.04 25.96 4.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.024 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -150.13 110.05 4.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.817 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.775 HG12 ' H ' ' A' ' 183' ' ' VAL . 22.0 t -124.49 139.67 50.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.173 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -96.5 -5.58 58.93 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.831 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.775 ' H ' HG12 ' A' ' 181' ' ' VAL . 0.3 OUTLIER -51.85 -42.6 33.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.927 0.394 . . . . 0.0 111.36 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.417 ' N ' ' CG1' ' A' ' 183' ' ' VAL . 37.2 t0 -105.2 65.55 0.73 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.91 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.421 ' H ' ' HB3' ' A' ' 188' ' ' ALA . 0.5 OUTLIER -118.11 -168.84 1.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -74.81 -39.22 61.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.142 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -85.89 -37.85 9.05 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.468 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.442 ' HB2' ' HA3' ' A' ' 166' ' ' GLY . . . -60.21 -30.61 69.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.809 0.337 . . . . 0.0 111.163 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.44 -49.82 76.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.919 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.23 -27.88 66.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.201 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -58.18 -56.59 24.36 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.545 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.868 ' O ' HG23 ' A' ' 196' ' ' VAL . 6.9 tp -59.57 -50.44 73.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.77 0.319 . . . . 0.0 110.893 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.39 -24.72 57.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.07 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -66.84 -60.5 2.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.824 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.679 HD21 ' CD2' ' A' ' 151' ' ' LEU . 4.8 tp -57.55 -31.85 66.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.657 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 192' ' ' LEU . 48.8 t -61.73 -61.58 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.983 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.62 -27.73 68.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.848 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mt -60.28 -46.6 89.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.99 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.527 HG23 ' O ' ' A' ' 204' ' ' MET . 5.1 mt -64.35 -30.02 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.171 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.87 -30.33 26.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.367 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -98.65 -6.44 29.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.8 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -117.58 -9.82 10.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.588 0.232 . . . . 0.0 111.546 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 24.9 m80 62.96 41.48 8.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.873 0.368 . . . . 0.0 110.61 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' MET . . . . . 0.527 ' O ' HG23 ' A' ' 199' ' ' ILE . 0.0 OUTLIER -82.96 134.73 35.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.88 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -74.47 122.73 23.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -73.09 -13.84 61.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.449 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -83.93 3.96 31.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.537 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.457 ' HA ' HD12 ' A' ' 212' ' ' ILE . 56.5 m -52.53 144.6 13.2 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.769 0.319 . . . . 0.0 111.12 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.514 ' HB2' HD11 ' A' ' 212' ' ' ILE . 1.5 m-20 -153.65 176.39 12.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.048 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.409 ' OH ' ' CZ2' ' A' ' 230' ' ' TRP . 0.8 OUTLIER -46.0 -62.95 1.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.406 -179.506 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.23 -59.04 6.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.599 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.514 HD11 ' HB2' ' A' ' 209' ' ' ASP . 0.0 OUTLIER -55.81 -33.46 34.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.21 -179.428 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -81.91 -25.54 34.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.779 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.34 -47.2 12.62 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.975 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.23 -32.16 62.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.253 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.47 -25.18 50.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.217 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.59 ' CD2' HG21 ' A' ' 225' ' ' THR . 1.1 t80 -69.3 -62.66 1.29 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.991 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -68.94 -45.57 70.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.03 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.41 -29.4 66.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.959 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.57 41.28 10.04 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.514 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -89.19 -31.31 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.794 0.33 . . . . 0.0 110.893 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.474 HG21 ' SD ' ' A' ' 148' ' ' MET . 11.0 t -124.64 163.17 22.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.934 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -90.26 -35.24 15.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.032 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -130.5 163.22 27.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.818 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.59 HG21 ' CD2' ' A' ' 217' ' ' PHE . 1.8 t -166.72 162.67 16.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.97 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.9 mt -111.61 118.8 58.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.021 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -144.27 165.42 27.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.924 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -98.59 -174.76 32.46 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.536 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.12 -24.67 27.77 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.562 2.175 . . . . 0.0 112.415 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' TRP . . . . . 0.409 ' CZ2' ' OH ' ' A' ' 210' ' ' TYR . 24.7 p90 -59.03 -30.83 68.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.91 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -71.33 -26.68 62.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.191 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 27.6 m0 -55.83 -39.62 71.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.981 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.6 m -69.47 -31.7 70.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -69.67 -35.85 75.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.924 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 22.7 mt -75.83 116.52 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.079 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -173.31 -42.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.933 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.41 -55.51 13.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 20.9 t -63.67 -28.68 70.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.941 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt 60.84 76.01 0.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.902 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 22.6 t -121.08 112.21 34.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.045 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.04 108.87 1.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.942 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -117.3 145.13 44.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.844 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -117.63 179.15 17.22 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.513 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.56 128.84 74.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 0.0 111.13 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.9 t -143.03 159.28 42.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.956 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.62 152.06 7.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.01 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.85 145.25 91.68 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.833 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.726 ' HD3' HD22 ' A' ' 115' ' ' LEU . 51.0 Cg_exo -53.7 137.29 66.91 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.477 2.118 . . . . 0.0 112.267 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 1.3 p -77.08 160.6 28.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -145.37 126.62 14.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt 62.26 18.01 9.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.287 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.24 38.66 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.888 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -103.84 149.29 37.01 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.731 0.3 . . . . 0.0 110.873 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.66 162.07 42.62 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.509 2.139 . . . . 0.0 112.229 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 39.7 p -71.14 179.59 2.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.832 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -128.84 58.07 33.91 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.84 136.47 32.88 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.548 2.165 . . . . 0.0 112.316 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' PHE . . . . . 0.497 ' CZ ' ' CD1' ' A' ' 158' ' ' TRP . 85.9 m-85 -59.51 140.1 56.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.978 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.68 145.76 12.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -134.81 108.42 0.71 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.469 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.695 HG21 ' HB3' ' A' ' 107' ' ' PRO . 7.4 p -88.74 160.84 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 0.0 111.152 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.462 ' N ' HG22 ' A' ' 261' ' ' VAL . 9.6 tp -121.62 131.43 54.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.77 169.43 19.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.964 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -105.4 127.36 52.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.058 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -90.44 148.21 19.5 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.537 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.648 HD11 HD12 ' A' ' 280' ' ' LEU . 31.3 mt -127.3 115.76 41.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.861 0.362 . . . . 0.0 111.125 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -77.05 135.88 38.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.912 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.546 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -64.77 -30.43 71.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.132 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -58.98 -30.98 68.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.7 111.18 8.12 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.87 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.55 ' HD2' HG21 ' A' ' 2' ' ' THR . 46.8 Cg_endo -68.27 -14.05 39.39 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.402 2.068 . . . . 0.0 112.583 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -84.47 57.22 4.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.939 0.4 . . . . 0.0 110.942 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.6 tppm? -82.77 -36.75 25.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -59.95 -49.18 78.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.613 HD13 HG21 ' A' ' 33' ' ' ILE . 37.4 mt -71.08 -33.33 70.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.968 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.34 93.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.044 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -63.14 -54.17 41.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -62.9 -33.28 74.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -69.64 -46.74 65.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.047 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.773 HD22 HD22 ' A' ' 284' ' ' LEU . 79.9 mt -81.42 -21.67 38.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.383 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -93.66 -48.21 6.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.765 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -103.77 18.05 22.77 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.605 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -163.47 52.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.879 0.371 . . . . 0.0 111.213 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.773 HD22 HD22 ' A' ' 280' ' ' LEU . 7.1 tp -174.83 -65.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.897 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.809 ' CD2' HD13 ' A' ' 304' ' ' LEU . 1.0 OUTLIER -84.95 58.41 5.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.947 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.23 -179.09 5.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.881 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.75 -36.97 31.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -75.76 -31.05 59.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.907 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -79.42 -52.1 4.95 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.532 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.672 HD21 ' CG2' ' A' ' 108' ' ' ILE . 10.1 mt -60.04 -35.35 74.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.819 0.342 . . . . 0.0 110.958 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -59.96 -44.02 94.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.29 -53.68 51.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.12 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.8 t -59.64 -47.14 92.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.128 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -66.44 -31.6 72.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.914 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 2.4 mtmm -63.1 -33.9 76.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.942 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -98.82 -32.43 11.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.024 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.4 ' HA ' ' HD2' ' A' ' 298' ' ' PRO . 4.1 mmtt -154.49 95.12 2.72 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.915 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 298' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 297' ' ' LYS . 36.6 Cg_endo -65.81 123.65 11.63 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.488 2.125 . . . . 0.0 112.314 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.455 ' H ' HD12 ' A' ' 299' ' ' LEU . 1.0 OUTLIER -93.38 17.44 11.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.133 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 81.78 -142.8 22.87 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.59 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -58.41 174.94 0.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 111.192 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.594 HG21 ' HB3' ' A' ' 307' ' ' TYR . 13.4 m -140.47 133.14 32.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.111 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -59.46 -33.79 71.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.208 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.829 HD23 ' HB2' ' A' ' 307' ' ' TYR . 14.0 tp -60.16 114.86 3.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -60.14 -30.67 69.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.951 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 32.6 m -70.36 -39.39 74.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.935 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.829 ' HB2' HD23 ' A' ' 304' ' ' LEU . 1.0 OUTLIER -86.22 -26.76 24.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.014 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -59.89 -31.7 70.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.807 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -69.76 -54.51 13.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.862 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.73 -34.74 19.82 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.788 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.578 ' HB3' HG21 ' A' ' 317' ' ' ILE . 88.3 mt -85.72 -26.63 25.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.697 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -70.53 -12.3 61.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.439 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -47.76 -31.77 5.21 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.925 0.393 . . . . 0.0 110.81 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -116.11 140.26 26.13 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.35 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.475 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 12.6 Cg_endo -56.52 -24.82 55.25 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.384 2.056 . . . . 0.0 112.414 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -50.96 -41.48 59.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.008 0.433 . . . . 0.0 110.302 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.578 HG21 ' HB3' ' A' ' 311' ' ' LEU . 30.1 mm -85.55 -32.72 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.882 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.475 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -69.11 -29.63 67.74 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.233 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.33 -30.65 66.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.151 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.958 HG23 ' HB3' ' A' ' 112' ' ' ALA . 56.6 m -84.61 -36.35 22.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 6.8 tpt -64.41 -40.21 95.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -59.92 -43.73 94.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.931 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -79.26 -29.13 42.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.023 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.6 -39.96 94.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.19 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -71.65 -55.01 8.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.994 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.13 -47.33 74.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.836 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -58.99 147.71 40.9 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.482 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -86.22 149.85 24.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.337 . . . . 0.0 110.911 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.4 HD11 ' HB2' ' A' ' 92' ' ' PHE . 28.4 mt -87.98 141.96 13.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.085 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 71.6 mtm -63.84 124.16 84.06 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.944 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -56.38 -164.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.38 2.053 . . . . 0.0 112.261 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -150.61 30.82 0.66 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 31.5 pt -117.86 153.73 51.01 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.108 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.51 -20.36 70.38 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.606 2.204 . . . . 0.0 112.445 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -60.39 -27.46 67.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.099 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 1.4 tpt -74.78 -30.21 61.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.074 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.84 -44.98 86.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.001 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -63.52 -29.93 71.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.108 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.856 ' CE1' HG21 ' A' ' 343' ' ' VAL . 11.9 t80 -59.45 -48.6 81.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.973 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 24.2 m95 -59.01 -30.27 67.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.044 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -81.31 -44.17 18.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.046 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.698 ' HB1' ' HA ' ' A' ' 364' ' ' ALA . . . -61.83 -61.66 2.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.269 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.856 HG21 ' CE1' ' A' ' 339' ' ' PHE . 21.9 t -58.39 -23.73 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.427 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.84 -57.41 12.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.093 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 345' ' ' THR . . . . . 0.587 HG22 ' ND2' ' A' ' 349' ' ' ASN . 26.4 m -72.18 -30.27 64.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.107 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.27 -50.79 66.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.289 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 343' ' ' VAL . 33.3 t -62.91 -45.27 99.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.249 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 27.6 mt -67.85 -42.59 86.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.113 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.587 ' ND2' HG22 ' A' ' 345' ' ' THR . 55.7 m-20 -58.13 -45.71 86.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.985 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -74.57 -28.71 61.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.197 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.19 -35.98 76.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.268 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.09 20.76 9.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.185 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 55.82 26.0 46.11 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.602 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -82.03 -30.44 31.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.866 0.365 . . . . 0.0 110.941 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -145.42 174.75 10.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 41.0 p -100.47 151.64 21.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.566 HG22 HD23 ' A' ' 192' ' ' LEU . 40.5 t -55.91 -27.41 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.053 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -73.81 -47.71 36.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.82 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -35.4 62.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.051 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.0 -56.7 13.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.971 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 92.1 mt -61.63 -29.81 70.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.818 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -56.14 25.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.887 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -63.78 -47.62 80.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.932 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.698 ' HA ' ' HB1' ' A' ' 342' ' ' ALA . . . -61.61 -52.84 62.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.151 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.85 ' HA ' HD12 ' A' ' 368' ' ' ILE . 15.6 tm0? -57.36 -30.49 64.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.005 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 60.5 m -82.62 -33.41 27.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.952 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -66.99 -33.81 76.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.936 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.85 HD12 ' HA ' ' A' ' 365' ' ' GLN . 5.2 mt -65.92 -30.13 49.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.04 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.7 p -80.14 -29.94 38.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 34.3 mttp . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.895 180.0 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.482 HG21 ' HB3' ' A' ' 58' ' ' ASP . 8.5 t . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.832 0.348 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -170.68 35.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.914 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -143.9 -166.37 2.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.785 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -84.91 56.02 5.0 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.463 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.51 ' HE2' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -142.08 -178.38 5.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.754 0.312 . . . . 0.0 110.938 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.403 HD21 ' HB3' ' A' ' 275' ' ' LEU . 15.2 mt -145.83 118.38 8.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.51 HG22 ' HE2' ' A' ' 6' ' ' LYS . 30.1 t -92.2 132.46 36.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.118 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.622 HG21 ' CD2' ' A' ' 20' ' ' LEU . 34.3 mt -121.56 107.2 19.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.46 ' CG ' ' HG2' ' A' ' 57' ' ' PRO . 0.9 OUTLIER -94.89 112.98 24.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.871 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.455 HD11 ' HD2' ' A' ' 15' ' ' LYS . 2.8 tt -144.93 146.16 20.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.105 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -66.26 161.57 21.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.858 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.13 55.99 4.97 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.512 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -153.34 36.03 0.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.795 0.331 . . . . 0.0 110.897 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.455 ' HD2' HD11 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -148.44 179.94 7.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.92 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.2 66.92 3.11 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.505 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 12.2 p90 -79.47 -31.4 42.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.821 0.344 . . . . 0.0 110.911 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.445 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 51.7 t-20 -60.49 -32.92 71.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.944 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.65 -28.59 51.06 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.493 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.622 ' CD2' HG21 ' A' ' 9' ' ' ILE . 14.0 tp -69.27 -33.46 73.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.865 0.364 . . . . 0.0 110.906 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.23 -40.83 91.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.119 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.4 -33.1 70.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.035 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.1 t -70.91 -32.74 49.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.11 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.63 -33.07 63.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.489 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -66.86 -29.44 69.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.845 0.355 . . . . 0.0 110.937 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.14 -40.13 46.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -58.3 -54.67 44.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.959 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -37.56 77.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.941 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -72.01 -26.3 62.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.975 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -82.95 -31.79 27.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.523 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 17.3 p -138.14 -44.22 0.51 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.611 0.243 . . . . 0.0 111.594 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.53 -20.2 2.95 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.689 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.3 mm -59.94 114.68 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.807 0.337 . . . . 0.0 111.047 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.3 mttp -82.69 170.13 15.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.988 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.28 125.51 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.104 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 m -116.6 125.1 51.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -105.15 127.95 59.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -115.49 153.68 30.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.861 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -117.83 70.27 7.19 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.425 ' HG3' ' CD2' ' A' ' 10' ' ' TRP . 88.0 Cg_endo -77.07 174.53 12.68 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.685 2.256 . . . . 0.0 112.475 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -60.94 -156.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.474 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.474 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -46.95 -26.49 1.01 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.516 0.198 . . . . 0.0 111.457 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.474 HD23 ' O ' ' A' ' 42' ' ' LYS . 0.3 OUTLIER 54.77 18.11 2.0 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.879 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -79.17 -55.78 4.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.834 0.349 . . . . 0.0 110.782 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -93.67 -7.8 42.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.363 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.478 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -80.71 -19.17 45.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.385 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.425 ' CB ' ' HD3' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -84.46 -53.36 0.51 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.197 -179.762 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.425 ' HD3' ' CB ' ' A' ' 47' ' ' PHE . 32.6 Cg_exo -57.84 -32.44 94.97 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.485 2.123 . . . . 0.0 112.37 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.488 ' HG3' HG13 ' A' ' 50' ' ' VAL . 11.4 pt20 -61.31 -47.07 87.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.058 0.456 . . . . 0.0 111.016 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.488 HG13 ' HG3' ' A' ' 49' ' ' GLN . 4.1 m -95.1 27.05 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.484 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.16 -32.18 30.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.348 . . . . 0.0 111.2 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.52 -32.82 19.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.171 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 51.6 p -72.73 -31.4 64.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.93 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.89 26.08 46.79 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.563 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -96.24 -28.66 14.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.808 0.337 . . . . 0.0 110.895 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.97 166.14 3.98 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.665 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.46 ' HG2' ' CG ' ' A' ' 10' ' ' TRP . 50.0 Cg_exo -53.38 -172.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.681 2.254 . . . . 0.0 112.38 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.482 ' HB3' HG21 ' A' ' 2' ' ' THR . 8.2 p30 -109.48 -29.02 8.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.953 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.484 HG21 HD21 ' A' ' 280' ' ' LEU . 30.9 mt -132.13 157.08 43.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.205 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.481 ' CG1' ' N ' ' A' ' 61' ' ' PHE . 2.0 tt -163.35 159.36 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.133 0.492 . . . . 0.0 110.897 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.481 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 3.9 m-85 -132.73 124.95 29.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.835 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.6 t-105 -159.41 171.43 19.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.851 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.7 134.04 55.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.163 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.434 ' CD2' HG23 ' A' ' 261' ' ' VAL . 13.2 p80 -58.56 -31.0 67.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.97 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -59.89 -29.97 68.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.988 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -88.48 -30.27 19.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.923 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -58.36 -30.12 66.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.968 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.81 -27.47 61.83 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.578 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.33 -28.45 71.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.488 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -87.22 -30.16 21.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.815 0.34 . . . . 0.0 110.947 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.18 -29.08 42.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.123 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -57.91 -29.55 65.19 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.063 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.55 -23.15 17.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.085 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.02 28.4 9.36 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.515 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.5 mt -81.81 -32.63 31.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.852 0.358 . . . . 0.0 110.913 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 76' ' ' LEU . 38.5 mt -76.0 160.68 29.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.502 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -101.77 133.0 47.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.453 ' CG ' ' N ' ' A' ' 79' ' ' ILE . 19.3 tt0 -61.36 164.01 6.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.722 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.498 ' O ' HG23 ' A' ' 80' ' ' THR . 43.1 pt -141.22 177.6 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.145 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 79' ' ' ILE . 0.7 OUTLIER -162.03 77.9 2.08 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.802 179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.51 135.92 41.02 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.555 2.17 . . . . 0.0 112.318 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.39 173.42 0.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -62.39 -48.47 79.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.64 -31.3 69.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.121 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -71.08 -44.26 66.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.89 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -64.08 -44.76 91.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.904 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -65.8 -29.75 70.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.94 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -59.62 -45.35 92.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.945 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.837 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 46.3 mt -88.23 173.64 8.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.879 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.435 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . 10.6 m-85 -81.57 149.55 64.83 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.063 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.33 -55.93 2.45 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.637 2.225 . . . . 0.0 112.706 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.454 ' CE1' ' CG2' ' A' ' 93' ' ' THR . 50.8 p90 -56.55 -44.12 80.58 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.771 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.454 ' CG2' ' CE1' ' A' ' 92' ' ' PHE . 39.3 p -54.49 -28.07 42.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.74 0.305 . . . . 0.0 111.116 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.837 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 49.6 m95 -76.83 -46.09 26.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.821 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.73 -26.53 67.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.069 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.401 ' HB2' HD13 ' A' ' 329' ' ' ILE . . . -71.71 -28.74 63.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.279 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 11.2 m -107.42 64.58 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.22 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -156.06 120.07 4.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.98 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -118.93 136.48 54.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.781 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 62.64 17.94 10.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.18 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.79 21.9 56.75 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.947 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.05 156.43 48.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.832 0.349 . . . . 0.0 110.994 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.547 ' O ' HG23 ' A' ' 104' ' ' ILE . 5.8 mt -93.8 142.67 27.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.547 HG23 ' O ' ' A' ' 103' ' ' LEU . 2.6 pp -159.0 36.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.206 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.589 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -160.79 176.91 10.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.186 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.425 ' CE1' HG21 ' A' ' 79' ' ' ILE . 39.3 m-85 -139.34 87.4 13.63 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.81 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.553 ' CG ' HG21 ' A' ' 97' ' ' VAL . 61.3 Cg_exo -51.77 102.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.571 2.18 . . . . 0.0 112.327 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.742 HD12 HD23 ' A' ' 284' ' ' LEU . 20.7 mm -76.67 -64.27 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.095 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.581 ' O ' HG12 ' A' ' 261' ' ' VAL . . . -131.88 171.63 13.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.078 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.28 148.11 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.055 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.77 159.8 37.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.961 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -169.07 145.25 3.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.107 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.2 mt -62.56 108.39 1.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.1 m -92.56 161.83 14.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.0 tp -109.3 102.12 11.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.907 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.7 mp -91.94 131.46 38.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.131 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.45 ' CD1' ' HG2' ' A' ' 125' ' ' PRO . 46.1 p90 -113.51 165.51 12.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.949 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.414 ' ND2' ' OE2' ' A' ' 221' ' ' GLU . 2.7 m120 -109.84 106.16 15.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.821 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -58.58 -22.86 57.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.612 ' HB3' HD23 ' A' ' 121' ' ' LEU . 2.5 t0 -55.04 -32.81 62.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.113 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.612 HD23 ' HB3' ' A' ' 120' ' ' ASP . 0.1 OUTLIER -128.86 -42.03 1.43 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.201 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 122' ' ' LEU . 14.4 tp -104.85 90.67 3.68 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.009 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.84 -43.83 2.37 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.532 2.155 . . . . 0.0 112.283 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -126.51 91.37 47.69 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.45 ' HG2' ' CD1' ' A' ' 117' ' ' TYR . 75.6 Cg_exo -50.58 151.83 9.9 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.586 2.191 . . . . 0.0 112.357 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.76 119.5 5.46 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.566 2.178 . . . . 0.0 112.366 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.05 -21.22 62.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.036 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 12.0 p -100.86 146.1 27.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.903 0.382 . . . . 0.0 111.058 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.88 ' CE3' HD12 ' A' ' 132' ' ' ILE . 4.4 m95 -77.36 -28.44 52.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.958 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.96 -15.74 60.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.526 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -89.19 -21.94 23.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.528 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.88 HD12 ' CE3' ' A' ' 129' ' ' TRP . 41.4 mt -59.76 -46.99 98.44 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.592 ' HG3' HD21 ' A' ' 198' ' ' LEU . 75.7 Cg_exo -49.5 -45.17 32.06 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.412 2.075 . . . . 0.0 112.416 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.26 -38.71 92.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.05 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.499 HD23 ' CD1' ' A' ' 139' ' ' LEU . 0.2 OUTLIER -65.34 -33.59 76.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.865 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.528 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 41.9 t0 -63.77 -24.4 67.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.1 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -85.53 -31.67 22.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.115 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -85.01 -47.11 10.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.208 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.779 HD22 ' HB2' ' A' ' 223' ' ' ALA . 0.3 OUTLIER -62.14 -17.87 59.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.394 -179.742 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.32 -27.92 53.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.736 0.303 . . . . 0.0 110.879 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.6 -41.69 90.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.05 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.7 mtpt -72.59 -27.11 61.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.017 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 114.51 29.4 2.71 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.504 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt -141.75 166.99 23.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.844 0.354 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.0 t -97.71 159.13 15.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.871 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.618 ' HA ' HD13 ' A' ' 139' ' ' LEU . . . -85.45 -32.07 22.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.17 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.824 HD12 ' CB ' ' A' ' 224' ' ' MET . 1.0 OUTLIER -169.98 124.1 0.75 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.018 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.413 ' HB2' HG21 ' A' ' 208' ' ' THR . 0.4 OUTLIER -129.43 166.65 19.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.59 179.697 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.8 p90 179.01 -170.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.803 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -89.14 109.64 20.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.905 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.674 HD21 HD11 ' A' ' 195' ' ' LEU . 13.7 mt -88.97 -29.13 19.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.952 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -59.17 -31.46 69.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.885 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.38 111.28 59.45 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.6 -23.48 19.8 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.428 2.085 . . . . 0.0 112.318 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.496 ' CE1' ' CD1' ' A' ' 258' ' ' PHE . 0.3 OUTLIER -50.6 -27.41 6.78 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.232 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -96.81 -22.47 16.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.219 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.839 ' O ' HD12 ' A' ' 161' ' ' ILE . 17.2 p -92.35 11.75 24.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.398 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.467 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 22.8 t-105 -87.58 -47.45 0.48 Allowed Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.309 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 53.7 Cg_exo -52.52 -23.32 18.95 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.374 2.049 . . . . 0.0 112.574 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.679 HD11 ' CD2' ' A' ' 194' ' ' PHE . 5.6 tp -86.02 -67.38 0.81 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.103 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.839 HD12 ' O ' ' A' ' 157' ' ' THR . 5.4 mt -57.73 -41.69 80.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.237 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.499 ' HB1' ' HB2' ' A' ' 256' ' ' LYS . . . -59.8 -38.27 81.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.197 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.673 ' HB2' ' HA ' ' A' ' 255' ' ' SER . . . -57.79 -36.17 71.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.229 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.94 -20.18 56.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.169 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 130.04 -22.0 4.86 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.636 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.562 ' HA3' ' HB2' ' A' ' 188' ' ' ALA . . . -69.32 154.65 53.25 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.496 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.442 ' CD1' ' HA3' ' A' ' 182' ' ' GLY . 25.6 p90 -148.85 -175.13 4.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 0.0 110.926 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.474 ' HB1' ' CE1' ' A' ' 339' ' ' PHE . . . -111.31 -48.9 3.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.024 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -130.28 127.53 39.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.828 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 167' ' ' TYR . 11.1 tttm -94.65 112.79 24.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.092 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.403 ' HB2' ' CE1' ' A' ' 176' ' ' TYR . 62.5 t80 -68.93 110.89 4.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.544 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -172.48 156.06 3.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.961 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 62.73 46.23 5.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.007 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 104.09 -62.27 0.4 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.723 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -151.09 -171.47 3.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 111.009 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.403 ' CE1' ' HB2' ' A' ' 171' ' ' TYR . 88.2 m-85 -59.49 125.9 25.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.9 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -82.19 127.51 33.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.876 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.2 pt -73.18 -27.6 24.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.202 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -97.25 26.04 5.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.052 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -125.44 96.35 4.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.921 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.796 HG21 ' HA ' ' A' ' 365' ' ' GLN . 23.5 t -96.29 146.01 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.111 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLY . . . . . 0.442 ' HA3' ' CD1' ' A' ' 167' ' ' TYR . . . -114.71 -7.04 18.57 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.995 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.662 HG12 HD22 ' A' ' 361' ' ' LEU . 11.1 t -56.51 -43.31 77.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.866 0.333 . . . . 0.0 111.181 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.06 57.26 4.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.919 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -104.61 -178.87 3.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.75 -52.15 22.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.108 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -76.82 -29.59 57.2 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.561 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.562 ' HB2' ' HA3' ' A' ' 166' ' ' GLY . . . -58.29 -33.93 69.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.829 0.347 . . . . 0.0 111.122 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.59 -31.2 72.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -87.47 -36.86 17.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.137 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -60.29 -46.85 93.52 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.461 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.939 HD12 HG22 ' A' ' 357' ' ' VAL . 3.1 tm? -60.33 -45.93 91.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.831 0.348 . . . . 0.0 110.854 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.554 ' OG1' HG21 ' A' ' 357' ' ' VAL . 91.7 m -67.02 -24.28 66.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.977 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.679 ' CD2' HD11 ' A' ' 160' ' ' LEU . 24.7 t80 -59.27 -60.67 3.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.812 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.674 HD11 HD21 ' A' ' 151' ' ' LEU . 3.7 tp -61.18 -30.29 70.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.554 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 192' ' ' LEU . 49.1 t -69.86 -43.28 79.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.005 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.34 -24.32 34.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.133 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.592 HD21 ' HG3' ' A' ' 133' ' ' PRO . 0.7 OUTLIER -63.87 -35.21 79.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.033 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.517 HG23 ' O ' ' A' ' 204' ' ' MET . 12.4 mt -77.75 -33.74 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.3 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 4.0 mtpp -85.07 -28.99 25.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.146 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -91.39 -10.18 42.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.558 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.569 ' HG3' HD23 ' A' ' 198' ' ' LEU . 13.1 mmtm -130.83 9.02 4.9 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.5 0.191 . . . . 0.0 111.49 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' HIS . . . . . 0.424 ' CG ' ' O ' ' A' ' 202' ' ' LYS . 40.1 p-80 43.67 52.96 6.16 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.888 0.375 . . . . 0.0 111.426 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' MET . . . . . 0.517 ' O ' HG23 ' A' ' 199' ' ' ILE . 48.0 mtp -82.76 133.51 35.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -59.37 119.75 8.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.073 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -80.07 -29.77 39.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.059 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.74 -20.85 52.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.222 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.413 HG21 ' HB2' ' A' ' 148' ' ' MET . 7.2 m -45.16 149.31 0.5 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.916 0.388 . . . . 0.0 111.398 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.527 ' OD2' HD11 ' A' ' 212' ' ' ILE . 11.2 m-20 -154.07 176.28 12.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.661 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 211' ' ' SER . 0.3 OUTLIER -62.96 -30.48 71.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.93 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.454 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 0.7 OUTLIER -68.78 -59.21 3.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.953 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.527 HD11 ' OD2' ' A' ' 209' ' ' ASP . 0.0 OUTLIER -58.83 -28.85 38.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.358 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -74.07 -33.61 63.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.781 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.75 -28.63 30.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.53 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.37 -36.42 83.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.474 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.433 ' HA ' ' HA3' ' A' ' 220' ' ' GLY . . . -52.46 -25.22 9.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.307 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -66.92 -53.9 27.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.979 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -90.06 -13.96 34.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.03 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -176.84 101.85 0.05 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.979 0.419 . . . . 0.0 111.275 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 216' ' ' ALA . . . 149.73 -46.85 0.64 Allowed Glycine 0 N--CA 1.453 -0.229 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.049 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.414 ' OE2' ' ND2' ' A' ' 118' ' ' ASN . 0.3 OUTLIER 63.97 101.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.944 0.402 . . . . 0.0 111.561 179.469 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.564 HG21 ' HB ' ' A' ' 225' ' ' THR . 13.3 t -116.05 124.89 51.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.374 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.779 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -45.92 -32.64 2.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.604 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.824 ' CB ' HD12 ' A' ' 147' ' ' LEU . 26.3 mtm -156.89 142.54 17.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.914 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.564 ' HB ' HG21 ' A' ' 222' ' ' THR . 4.1 t -164.3 126.24 2.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.444 HG12 HD21 ' A' ' 247' ' ' LEU . 4.0 mt -95.71 126.99 48.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.096 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -141.28 165.49 27.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -82.48 -170.94 46.06 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.496 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.406 ' HD2' ' CE3' ' A' ' 230' ' ' TRP . 74.1 Cg_endo -74.99 -2.89 13.13 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.638 2.225 . . . . 0.0 112.751 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' TRP . . . . . 0.406 ' CE3' ' HD2' ' A' ' 229' ' ' PRO . 39.0 p90 -95.97 34.08 1.6 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.694 0.283 . . . . 0.0 111.104 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -136.86 11.29 3.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.557 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 8.7 m0 -81.19 -39.43 25.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.808 0.337 . . . . 0.0 110.965 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.45 -29.92 68.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.024 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.71 -30.45 65.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.993 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.548 HG21 ' CE1' ' A' ' 242' ' ' TYR . 4.4 mt -88.63 84.67 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.071 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ASP . . . . . 0.603 ' O ' HG23 ' A' ' 237' ' ' THR . 33.9 p-10 -160.76 37.19 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.915 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' THR . . . . . 0.603 HG23 ' O ' ' A' ' 236' ' ' ASP . 0.8 OUTLIER -165.71 -43.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.957 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 82.8 p -63.08 -30.68 71.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.964 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 7.4 mmtm 61.09 36.05 18.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 20.8 t -95.41 121.73 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.105 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -61.98 111.97 2.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.868 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.548 ' CE1' HG21 ' A' ' 235' ' ' ILE . 50.8 p90 -109.26 146.96 33.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.91 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -126.14 147.19 16.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.492 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 20.8 t -110.18 127.05 67.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.814 0.34 . . . . 0.0 111.126 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.3 t -143.61 146.81 33.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.419 ' CG2' ' N ' ' A' ' 247' ' ' LEU . 0.7 OUTLIER -55.17 152.31 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.217 0.532 . . . . 0.0 111.32 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.444 HD21 HG12 ' A' ' 226' ' ' ILE . 13.5 mt -72.08 147.62 91.04 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.946 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.561 ' HG3' HD11 ' A' ' 132' ' ' ILE . 36.1 Cg_endo -65.43 166.45 19.47 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.535 2.157 . . . . 0.0 112.282 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 254' ' ' PRO . 4.5 p -110.32 162.2 14.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.943 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -117.24 110.58 18.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.913 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 9.1 mttm 59.84 25.3 14.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.042 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 92.93 -21.07 41.61 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.714 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -80.48 126.59 78.26 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.539 0.209 . . . . 0.0 110.832 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.462 ' HA ' HG22 ' A' ' 249' ' ' THR . 71.4 Cg_endo -74.76 143.88 30.5 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.433 2.089 . . . . 0.0 112.34 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.673 ' HA ' ' HB2' ' A' ' 163' ' ' ALA . 89.7 p -60.64 -178.29 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.777 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.499 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . 11.6 mttp -136.99 62.25 38.82 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.014 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.414 ' HD3' ' N ' ' A' ' 256' ' ' LYS . 35.7 Cg_exo -57.43 -161.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.497 2.131 . . . . 0.0 112.207 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 258' ' ' PHE . . . . . 0.496 ' CD1' ' CE1' ' A' ' 155' ' ' TYR . 63.1 m-85 -122.3 136.89 54.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.821 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 25.8 t -97.15 117.82 42.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.178 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -114.61 114.23 3.2 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.405 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -112.84 142.34 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.849 0.357 . . . . 0.0 111.151 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 14.8 tp -101.76 81.44 2.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.724 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.545 ' OG ' ' HB1' ' A' ' 105' ' ' ALA . 14.9 p -85.32 166.2 16.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.971 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -99.72 148.37 24.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.055 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -125.26 131.4 7.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.521 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 3.9 mp -124.13 102.4 10.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.789 0.328 . . . . 0.0 111.064 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -59.59 148.33 33.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.993 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.502 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -60.74 -30.55 70.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.092 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.83 57.1 4.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.014 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 8.0 m -145.56 93.29 5.35 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.84 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -48.64 -26.72 9.67 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.585 2.19 . . . . 0.0 112.464 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -86.21 56.24 3.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.835 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.27 -49.64 9.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.905 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -60.04 -43.72 95.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.864 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.403 ' HB3' HD21 ' A' ' 7' ' ' LEU . 46.6 mt -66.06 -32.18 73.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.8 -44.27 86.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.074 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.11 -49.39 74.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -63.05 -32.31 73.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.89 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.402 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 84.1 t80 -69.57 -47.59 63.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.97 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.507 HD23 HD22 ' A' ' 284' ' ' LEU . 1.6 mt -81.49 -21.17 38.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.383 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -93.61 -48.25 6.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.793 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -102.99 17.72 23.39 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.519 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.402 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 21.4 m-85 -163.81 44.59 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.884 0.373 . . . . 0.0 111.193 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.742 HD23 HD12 ' A' ' 108' ' ' ILE . 3.1 tp -177.95 -55.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 3.0 mt -89.99 52.56 2.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.7 p -138.31 -178.17 5.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -71.54 -43.27 66.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.888 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -82.72 -33.62 27.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -60.55 -61.88 6.59 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.563 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.566 HD13 ' CD2' ' A' ' 307' ' ' TYR . 2.8 mt -60.96 -34.27 74.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.333 . . . . 0.0 110.917 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.94 -41.99 93.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.94 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -59.5 -36.4 75.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.14 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.6 t -85.4 -30.67 6.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -59.77 -36.0 75.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -66.88 -32.72 74.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -89.46 -32.75 17.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.961 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -162.65 91.53 1.27 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.983 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.66 123.68 10.72 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.499 2.133 . . . . 0.0 112.315 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.468 ' H ' HD12 ' A' ' 299' ' ' LEU . 3.1 mp -93.33 16.87 12.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.11 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 59.09 -116.93 9.51 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.542 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -59.58 155.71 14.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.861 0.362 . . . . 0.0 111.093 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.544 HG11 ' CD2' ' A' ' 307' ' ' TYR . 16.7 m -141.1 156.16 21.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.162 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.49 ' HB3' HD22 ' A' ' 89' ' ' LEU . . . -69.87 -36.2 75.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.098 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.638 HD23 ' HB2' ' A' ' 307' ' ' TYR . 9.2 tp -61.35 122.32 14.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -70.05 -27.28 64.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.009 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 69.0 m -81.25 -27.61 35.11 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.149 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.638 ' HB2' HD23 ' A' ' 304' ' ' LEU . 8.3 t80 -83.06 -31.24 27.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.24 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -30.71 69.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.881 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -69.8 -50.23 45.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.891 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -51.22 -39.46 56.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.75 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.765 ' HB3' HG21 ' A' ' 317' ' ' ILE . 72.4 mt -85.68 -23.05 27.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.866 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.99 -14.95 61.66 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.491 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -46.41 -30.61 2.22 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.891 0.377 . . . . 0.0 110.912 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.89 142.04 27.79 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.339 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.42 -33.52 96.43 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.476 2.117 . . . . 0.0 112.521 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -49.18 -37.15 21.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.007 0.432 . . . . 0.0 110.364 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.765 HG21 ' HB3' ' A' ' 311' ' ' LEU . 33.1 mm -85.56 -34.33 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.876 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.3 -31.81 72.84 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.154 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.09 -45.75 83.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.175 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 60.3 m -61.34 -35.24 76.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 2.9 tpt -66.38 -46.62 76.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -62.76 -33.68 75.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -75.33 -32.19 60.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.45 -45.38 72.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.045 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -59.67 -31.54 69.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.854 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -96.59 21.12 9.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.145 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -117.15 135.95 12.29 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.524 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -79.27 143.03 35.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.781 0.324 . . . . 0.0 110.886 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.401 HD13 ' HB2' ' A' ' 96' ' ' ALA . 26.0 mt -75.76 133.88 30.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.142 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 27.4 mtm -60.29 125.63 82.16 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.778 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.77 172.06 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.352 2.035 . . . . 0.0 112.245 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -132.35 41.03 3.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 31.7 pt -117.56 143.98 33.29 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.108 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.49 -23.84 49.91 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.595 2.196 . . . . 0.0 112.426 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.13 -22.46 40.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.203 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 37.8 mtp -54.66 -24.2 20.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.288 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 44.7 m -57.14 -36.89 71.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.085 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -82.41 -28.19 31.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.189 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.778 ' CZ ' HG21 ' A' ' 343' ' ' VAL . 79.7 t80 -57.4 -31.22 65.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.979 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -62.74 -61.0 2.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.018 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -63.2 -27.96 69.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.131 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -73.44 -38.24 65.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.351 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.831 ' O ' HG23 ' A' ' 347' ' ' VAL . 25.9 t -88.58 -46.35 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.299 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.563 ' HG2' HD11 ' A' ' 348' ' ' ILE . 7.1 ttt180 -55.75 -57.36 12.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.129 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 29.8 m -61.97 -27.25 68.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.115 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 350' ' ' ALA . . . -76.3 -32.66 58.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.322 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 343' ' ' VAL . 33.0 t -82.71 -42.68 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.282 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.563 HD11 ' HG2' ' A' ' 344' ' ' ARG . 17.4 mt -62.31 -59.05 4.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.125 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -59.6 -30.36 68.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.935 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 346' ' ' ALA . . . -73.56 -52.06 14.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.112 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.26 -32.2 72.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.137 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.25 -22.4 64.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.092 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 103.45 -27.21 20.85 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.573 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -58.97 -77.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.882 0.372 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -65.55 140.89 58.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.844 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 78.2 p -87.92 178.02 6.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.787 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.939 HG22 HD12 ' A' ' 192' ' ' LEU . 23.3 t -77.62 -55.11 11.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.945 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -47.69 -33.0 6.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.319 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -82.08 -45.79 14.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.143 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -57.43 -60.46 3.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.052 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.662 HD22 HG12 ' A' ' 183' ' ' VAL . 7.3 mt -58.7 -27.29 64.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.074 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -81.2 -37.06 29.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.955 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -70.36 -45.53 65.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.863 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.404 ' O ' HD12 ' A' ' 368' ' ' ILE . . . -58.2 -30.78 66.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.11 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.796 ' HA ' HG21 ' A' ' 181' ' ' VAL . 3.5 tt0 -69.39 -30.46 68.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 7.0 m -85.05 -30.14 24.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.051 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -74.19 -41.99 60.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.0 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 364' ' ' ALA . 12.4 mt -73.48 -28.92 26.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.218 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 365' ' ' GLN . 79.6 p -90.98 -46.09 8.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.867 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.932 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 40.4 tttt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.796 0.331 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.7 t -80.45 166.42 21.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -120.97 178.24 4.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.917 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -93.04 168.73 10.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.79 36.43 87.12 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.481 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.8 170.32 21.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.848 0.356 . . . . 0.0 110.949 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.6 mt -140.38 124.51 17.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.88 106.97 21.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.059 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.706 HG21 HD21 ' A' ' 20' ' ' LEU . 4.0 mp -99.26 121.23 49.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.578 ' CE3' HD13 ' A' ' 43' ' ' LEU . 1.4 m0 -91.23 133.7 35.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.984 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.535 HG23 ' HB3' ' A' ' 39' ' ' HIS . 9.4 tp -125.01 159.56 31.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.962 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.404 ' N ' HG13 ' A' ' 11' ' ' ILE . 26.6 m-20 -93.49 31.71 1.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.159 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.45 ' H ' HG23 ' A' ' 11' ' ' ILE . . . 47.46 37.77 12.97 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.06 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -178.64 53.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.846 0.355 . . . . 0.0 111.004 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.401 ' CB ' HD11 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -179.75 78.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.865 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.47 49.8 73.17 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.534 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 36.3 p90 -78.99 -38.83 35.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.813 0.339 . . . . 0.0 110.919 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.438 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 2.6 t30 -86.92 -31.68 20.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.949 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.57 -37.44 68.41 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.531 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.706 HD21 HG21 ' A' ' 9' ' ' ILE . 4.9 tp -63.75 -32.23 73.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.856 0.36 . . . . 0.0 110.949 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.67 -31.23 72.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.081 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -63.51 -43.64 96.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.912 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.87 -35.44 60.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.109 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.412 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . -65.96 -43.73 93.05 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.445 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -59.73 -25.62 64.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.772 0.32 . . . . 0.0 111.002 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -82.58 -38.95 22.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.991 0.424 . . . . 0.0 110.882 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.34 -50.13 73.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.029 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -38.39 81.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.93 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.06 -25.12 64.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.095 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -88.38 -32.49 18.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.372 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.0 p -136.65 -44.14 0.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.375 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.67 20.61 4.94 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.657 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.56 HG21 HD13 ' A' ' 275' ' ' LEU . 32.9 mm -85.78 126.72 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.852 0.358 . . . . 0.0 111.043 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -65.45 148.68 51.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.412 HG21 ' HA2' ' A' ' 24' ' ' GLY . 21.5 t -143.38 104.36 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.09 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.6 m -109.54 150.6 27.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.999 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 9' ' ' ILE . 21.6 t -133.15 127.83 55.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.064 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -126.26 155.56 41.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.91 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.535 ' HB3' HG23 ' A' ' 11' ' ' ILE . 7.6 p80 -135.96 70.22 63.92 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.851 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.523 ' HG2' HD22 ' A' ' 43' ' ' LEU . 44.4 Cg_endo -68.77 170.27 15.73 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.584 2.189 . . . . 0.0 112.468 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -108.34 141.42 40.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.717 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.98 32.94 19.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.663 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.623 HD11 ' HZ3' ' A' ' 62' ' ' TRP . 2.3 pp -77.34 -0.78 26.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.699 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -56.98 -57.09 14.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.784 0.326 . . . . 0.0 111.16 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -88.41 -25.64 22.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.185 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.532 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -74.0 -18.97 60.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.295 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.462 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 78.4 t80 -74.07 -56.33 2.72 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.504 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 40.6 Cg_endo -67.0 -23.91 46.05 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.298 1.998 . . . . 0.0 112.883 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -65.12 -46.03 82.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.873 0.368 . . . . 0.0 111.155 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.532 HG22 ' O ' ' A' ' 46' ' ' LYS . 5.8 m -87.06 -28.99 5.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.314 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.463 ' HB1' ' OD1' ' A' ' 267' ' ' ASN . . . -56.9 -29.61 63.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.261 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.59 -33.37 71.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.13 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.2 p -93.87 -30.78 14.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.949 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.73 25.61 24.77 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.59 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -94.44 -32.97 13.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.869 0.366 . . . . 0.0 110.867 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.27 -143.94 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.534 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.422 ' HG3' ' CD2' ' A' ' 10' ' ' TRP . 43.6 Cg_endo -68.09 -167.78 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.538 2.159 . . . . 0.0 112.329 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -123.75 -51.9 1.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.0 mt -109.77 138.46 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.092 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.469 ' CG1' ' N ' ' A' ' 61' ' ' PHE . 3.0 tt -125.82 159.72 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.069 0.461 . . . . 0.0 111.029 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.469 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 46.4 m-85 -135.08 125.63 26.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.932 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.623 ' HZ3' HD11 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -160.27 175.95 12.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.52 157.01 37.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.142 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.661 ' CE1' HG23 ' A' ' 329' ' ' ILE . 15.8 p-80 -57.98 -34.11 69.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.994 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.419 ' N ' ' CD2' ' A' ' 64' ' ' HIS . 16.0 t70 -60.59 -48.82 80.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.08 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.416 ' HG3' ' CD1' ' A' ' 62' ' ' TRP . 30.5 mmm180 -74.87 -27.85 60.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.021 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.402 ' CE2' ' HB2' ' A' ' 263' ' ' SER . 1.0 OUTLIER -57.65 -22.37 45.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.147 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -94.6 33.7 5.18 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.576 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -118.4 -32.49 1.35 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.51 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -88.41 -27.52 21.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.775 0.322 . . . . 0.0 110.98 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.33 -30.72 38.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.053 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.422 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 3.5 pt20 -61.05 -36.4 79.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.962 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 m -89.75 -23.06 21.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.126 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.74 59.2 0.87 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.452 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.0 mt -138.31 31.69 2.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.362 . . . . 0.0 110.961 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' A' ' 268' ' ' ALA . 14.1 mt -138.88 161.45 37.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.792 ' HB2' ' O ' ' A' ' 267' ' ' ASN . . . -97.8 151.21 20.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.058 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.469 ' CD ' HG22 ' A' ' 104' ' ' ILE . 1.0 OUTLIER -77.06 -165.37 0.55 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.93 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.441 HD13 ' N ' ' A' ' 105' ' ' ALA . 33.4 pt -157.64 171.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.085 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 79' ' ' ILE . 41.8 p -158.1 77.42 3.52 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.741 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.48 160.16 47.39 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.631 2.221 . . . . 0.0 112.347 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.35 -176.94 3.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.753 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.3 mttp -59.89 -38.94 83.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.81 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.18 -28.04 61.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.075 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -79.19 -37.69 37.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.935 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -82.14 -25.95 33.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.085 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -79.19 -40.83 29.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.163 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.452 ' NZ ' HD13 ' A' ' 285' ' ' LEU . 32.5 pttt -58.37 -39.45 79.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.083 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.707 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 24.9 mt -83.01 162.1 21.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.872 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.499 ' HB2' HG23 ' A' ' 93' ' ' THR . 26.1 m-85 -88.26 147.63 40.72 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.03 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -54.21 -55.71 3.18 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.567 2.178 . . . . 0.0 112.736 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.547 ' CE1' HG22 ' A' ' 93' ' ' THR . 40.2 p90 -54.09 -39.62 66.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.808 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.547 HG22 ' CE1' ' A' ' 92' ' ' PHE . 27.8 p -61.42 -32.98 72.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.745 0.307 . . . . 0.0 110.826 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.707 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 45.3 m95 -67.75 -32.0 72.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.793 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -60.35 -26.98 67.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.055 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.622 ' HB1' ' CB ' ' A' ' 64' ' ' HIS . . . -73.12 -28.67 62.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.258 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.612 ' CG1' ' HB3' ' A' ' 105' ' ' ALA . 3.8 m -104.05 56.24 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.936 0.398 . . . . 0.0 111.245 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -156.08 130.45 8.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.422 ' CE2' ' HB3' ' A' ' 72' ' ' GLN . 1.8 t80 -96.23 -64.74 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.838 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -127.69 45.78 2.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.795 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.16 -26.8 19.4 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.526 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.2 141.8 33.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.841 0.353 . . . . 0.0 110.88 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 32.1 mt -97.01 132.05 43.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.843 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.547 ' O ' HD12 ' A' ' 104' ' ' ILE . 2.6 pp -138.31 30.47 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.196 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.612 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . . . -173.8 178.73 2.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.152 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.806 ' OH ' HD11 ' A' ' 266' ' ' ILE . 1.1 p90 -155.74 96.09 2.4 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.807 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.63 ' HB3' HG21 ' A' ' 261' ' ' VAL . 54.0 Cg_exo -52.54 144.99 39.39 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.504 2.136 . . . . 0.0 112.424 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.612 HG23 ' CD2' ' A' ' 285' ' ' LEU . 5.4 mt -128.31 -59.3 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.047 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.526 ' HA ' HG12 ' A' ' 302' ' ' VAL . . . -105.86 145.75 30.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.096 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.478 HG22 HG23 ' A' ' 261' ' ' VAL . 32.7 t -121.18 138.36 51.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.136 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -139.47 160.08 40.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.863 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -172.31 152.74 2.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.083 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.512 HD23 ' HA2' ' A' ' 228' ' ' GLY . 5.3 mt -71.02 101.94 2.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.44 -176.52 3.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.6 tp -96.81 114.61 26.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.919 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.7 mt -108.9 114.01 45.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.004 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -124.88 165.53 17.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.906 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.39 144.51 34.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.926 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.5 mtmm -98.5 33.39 2.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.961 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -93.13 -48.12 6.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.949 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.96 -35.26 5.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.008 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.464 HD21 ' O ' ' A' ' 124' ' ' ASN . 1.6 tt -108.53 95.32 15.95 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.979 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.48 -45.24 1.26 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.484 2.123 . . . . 0.0 112.353 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.464 ' O ' HD21 ' A' ' 122' ' ' LEU . 6.3 m120 -100.34 114.71 65.81 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.51 153.01 39.11 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.416 2.077 . . . . 0.0 112.364 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.52 116.24 4.64 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.576 2.184 . . . . 0.0 112.289 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.93 -23.73 38.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.027 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 73.2 p -118.01 149.7 40.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.895 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.895 ' CE3' HD12 ' A' ' 132' ' ' ILE . 26.5 m95 -69.63 -31.27 69.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.854 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -68.8 -15.65 63.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.427 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -85.5 -16.95 37.87 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.895 HD12 ' CE3' ' A' ' 129' ' ' TRP . 24.0 mt -71.78 -49.42 10.78 Favored Pre-proline 0 C--N 1.331 -0.204 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.53 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 83.3 Cg_exo -44.99 -46.58 12.96 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.499 2.132 . . . . 0.0 112.509 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.07 -40.07 92.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.997 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.926 HD23 HD12 ' A' ' 139' ' ' LEU . 0.2 OUTLIER -64.73 -36.84 85.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.797 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.706 ' OD1' ' HB3' ' A' ' 146' ' ' ALA . 1.6 m-20 -57.76 -27.51 63.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.067 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.433 ' HE2' ' CE1' ' A' ' 203' ' ' HIS . 50.1 mttm -85.6 -31.6 22.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.069 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -85.1 -56.46 3.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.171 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.926 HD12 HD23 ' A' ' 135' ' ' LEU . 0.2 OUTLIER -55.42 -26.77 43.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.272 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -77.67 -28.26 51.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.804 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.42 -38.28 83.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.951 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 41.3 mttt -73.64 -27.12 61.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.073 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.2 32.4 1.83 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.599 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.2 mtmt -149.82 159.7 44.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 0.0 110.874 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.608 ' O ' HD22 ' A' ' 139' ' ' LEU . 84.7 p -82.33 170.11 15.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.975 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.72 ' HA ' HD13 ' A' ' 139' ' ' LEU . . . -102.67 -56.69 2.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.169 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.666 HD22 HD13 ' A' ' 132' ' ' ILE . 4.0 tp -153.54 136.32 15.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.92 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.588 ' SD ' HG21 ' A' ' 222' ' ' THR . 0.0 OUTLIER -133.87 -177.91 4.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.82 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.518 ' HZ ' HD11 ' A' ' 195' ' ' LEU . 51.1 p90 -177.25 -172.78 0.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.875 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.424 ' HB3' ' CD1' ' A' ' 156' ' ' PHE . 60.2 t-20 -83.59 114.21 21.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.941 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.4 mt -98.57 30.8 3.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.911 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -127.54 30.33 5.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -168.49 111.42 0.55 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.627 ' CB ' HG12 ' A' ' 343' ' ' VAL . 78.0 Cg_exo -50.26 -25.74 14.07 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.453 2.102 . . . . 0.0 112.353 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.494 ' CD2' ' CD2' ' A' ' 258' ' ' PHE . 0.8 OUTLIER -58.4 -31.5 67.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.424 ' CD1' ' HB3' ' A' ' 150' ' ' ASN . 13.6 m-85 -74.43 -30.53 61.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.44 ' O ' HD12 ' A' ' 161' ' ' ILE . 21.1 p -102.56 30.34 4.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.067 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.468 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 1.4 t-105 -83.59 -48.45 0.73 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.093 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.512 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 32.4 Cg_exo -58.13 -18.83 38.49 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.417 2.078 . . . . 0.0 112.497 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 15.6 tp -92.66 -32.13 14.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.155 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.661 HD13 HD12 ' A' ' 192' ' ' LEU . 15.6 mt -95.79 -58.02 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.222 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.463 ' HB1' ' HE3' ' A' ' 256' ' ' LYS . . . -56.15 -31.1 63.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.252 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -59.08 -44.82 91.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.135 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -63.73 -20.08 65.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.185 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 131.71 71.26 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.56 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -158.2 142.9 8.84 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.493 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -147.48 179.47 7.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.332 . . . . 0.0 110.999 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.635 ' HB2' ' CZ ' ' A' ' 339' ' ' PHE . . . -103.55 -33.01 9.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.983 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -141.25 155.31 46.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.793 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 9.1 tttm -103.35 111.32 23.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.057 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.437 ' CD1' ' CZ ' ' A' ' 176' ' ' TYR . 57.4 t80 -73.81 110.91 8.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.412 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -158.76 150.92 21.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.08 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 61.51 29.93 18.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.059 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 90.78 -38.54 3.2 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.014 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -108.05 -177.11 3.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.918 0.389 . . . . 0.0 111.079 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.437 ' CZ ' ' CD1' ' A' ' 171' ' ' TYR . 4.9 m-85 -108.1 121.14 44.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.921 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -58.75 132.5 54.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.7 pt -91.02 -23.63 5.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.385 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.39 26.05 4.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.15 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -141.53 90.12 2.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.919 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.72 HG11 HD13 ' A' ' 368' ' ' ILE . 16.2 t -100.75 146.01 10.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.079 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -111.0 66.55 0.23 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.652 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.947 HG12 ' CD2' ' A' ' 361' ' ' LEU . 1.5 t -103.13 -60.52 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.91 0.386 . . . . 0.0 111.064 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.498 ' HA ' HD13 ' A' ' 361' ' ' LEU . 35.1 p-10 -83.46 56.7 3.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.11 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -95.77 168.43 10.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.814 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -59.83 -34.17 72.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.113 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -85.93 -45.51 5.67 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.611 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 183' ' ' VAL . . . -58.9 -38.69 79.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.785 0.326 . . . . 0.0 111.17 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -60.07 -34.7 73.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -87.55 -30.99 20.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.168 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -58.45 -50.5 66.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.57 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.888 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.2 OUTLIER -60.77 -43.08 98.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.806 0.336 . . . . 0.0 110.931 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 9.9 m -50.19 -27.37 5.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.252 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -67.93 -58.67 4.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.811 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.518 HD11 ' HZ ' ' A' ' 149' ' ' PHE . 4.1 tp -64.76 -30.1 71.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 192' ' ' LEU . 47.6 t -66.18 -56.92 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.062 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.84 -28.41 61.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.146 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 195' ' ' LEU . 26.2 mt -59.69 -58.22 9.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.012 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 9.0 mt -61.39 -28.8 44.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.057 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.33 -35.4 66.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -90.2 16.46 8.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.44 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.84 39.12 27.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.821 0.343 . . . . 0.0 111.216 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' HIS . . . . . 0.433 ' CE1' ' HE2' ' A' ' 137' ' ' LYS . 2.8 m-70 -90.2 -23.86 21.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.888 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 13.9 mtt -132.91 -177.51 4.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.777 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -115.59 147.86 40.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.918 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -78.8 -30.52 45.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.041 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.37 60.04 4.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.783 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.587 ' HA ' HD12 ' A' ' 212' ' ' ILE . 0.2 OUTLIER -117.43 138.55 51.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.928 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.444 ' OD2' HD11 ' A' ' 212' ' ' ILE . 57.3 m-20 -154.19 176.16 12.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.732 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -64.68 -39.84 94.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.231 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.03 -59.08 3.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.876 0.369 . . . . 0.0 110.988 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.587 HD12 ' HA ' ' A' ' 208' ' ' THR . 0.3 OUTLIER -57.63 -29.11 33.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.656 179.805 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.405 ' CB ' ' HG3' ' A' ' 148' ' ' MET . . . -80.61 -22.63 40.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.961 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -77.88 -36.62 49.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.866 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -72.47 -38.2 68.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.037 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.66 -30.8 67.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.121 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -81.71 -36.88 28.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.93 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -68.28 -46.85 69.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.52 -30.1 71.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.13 43.79 1.99 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.49 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -100.3 -74.49 0.6 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.882 0.373 . . . . 0.0 110.903 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.588 HG21 ' SD ' ' A' ' 148' ' ' MET . 11.3 t -74.34 142.81 45.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.72 -30.98 46.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.049 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.422 ' SD ' HD13 ' A' ' 122' ' ' LEU . 2.1 mpp? -128.34 156.24 43.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.929 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 9.4 t -166.64 147.36 6.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.47 HD12 ' HB3' ' A' ' 149' ' ' PHE . 4.5 mt -109.85 126.51 67.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.029 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -144.92 165.43 28.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.512 ' HA2' HD23 ' A' ' 113' ' ' LEU . . . -80.96 -169.44 41.46 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.533 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.419 ' HD2' ' CZ3' ' A' ' 230' ' ' TRP . 55.1 Cg_endo -69.81 -8.98 24.99 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.562 2.175 . . . . 0.0 112.699 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' TRP . . . . . 0.427 ' CZ3' ' HA3' ' A' ' 228' ' ' GLY . 41.0 p90 -94.36 39.25 1.09 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.758 0.314 . . . . 0.0 111.09 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -113.47 -33.19 5.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.129 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 22.4 m0 -63.14 -31.42 72.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.862 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 49.6 m -60.8 -33.69 73.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.96 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.35 -50.89 72.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 18.1 pt -75.58 134.81 28.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.123 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -176.26 -40.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.69 -36.05 9.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.35 -32.69 58.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.923 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt 60.06 74.65 0.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.27 122.0 56.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.063 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -63.18 107.3 1.02 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -98.13 157.65 16.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.3 120.68 2.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.463 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.5 t -94.39 123.04 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 111.1 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 58.9 m -143.52 136.18 27.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.409 ' CG2' ' N ' ' A' ' 247' ' ' LEU . 0.7 OUTLIER -54.62 152.34 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.241 0.543 . . . . 0.0 111.328 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.409 ' N ' ' CG2' ' A' ' 246' ' ' VAL . 4.7 mt -59.62 139.47 89.5 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.884 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.423 ' HB2' ' CD1' ' A' ' 129' ' ' TRP . 51.2 Cg_exo -54.0 -172.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.504 2.136 . . . . 0.0 112.276 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 2.7 p -122.65 165.48 16.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.883 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.416 ' CD2' ' HG3' ' A' ' 251' ' ' LYS . 14.6 t80 -129.0 117.54 21.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.416 ' HG3' ' CD2' ' A' ' 250' ' ' PHE . 6.2 mtpp 59.96 31.99 20.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 73.8 27.02 67.81 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.564 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -118.85 147.81 43.16 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.7 0.286 . . . . 0.0 110.859 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.7 149.89 55.53 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.538 2.159 . . . . 0.0 112.286 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 66.9 p -73.81 159.19 33.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.463 ' HE3' ' HB1' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -121.39 54.59 4.56 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.876 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.19 155.27 64.92 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.575 2.183 . . . . 0.0 112.281 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.494 ' CD2' ' CD2' ' A' ' 155' ' ' TYR . 67.0 m-85 -74.17 166.21 23.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.894 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.488 HG23 ' C ' ' A' ' 328' ' ' GLU . 22.0 t -116.7 134.95 58.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.24 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -128.93 96.24 0.4 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.388 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.63 HG21 ' HB3' ' A' ' 107' ' ' PRO . 10.2 p -98.8 159.96 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.819 0.342 . . . . 0.0 111.216 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.464 ' N ' HG22 ' A' ' 261' ' ' VAL . 12.2 tp -122.21 104.67 9.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.903 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.402 ' HB2' ' CE2' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -109.07 170.3 8.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.924 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.555 ' HB3' ' CE1' ' A' ' 106' ' ' TYR . . . -101.95 143.6 31.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.058 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -116.05 152.43 17.97 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.56 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.806 HD11 ' OH ' ' A' ' 106' ' ' TYR . 30.2 mt -135.15 144.37 34.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.833 0.349 . . . . 0.0 110.983 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.792 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -82.49 153.69 25.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 76' ' ' LEU . . . -84.08 -22.8 31.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.355 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -53.66 -82.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.226 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' SER . . . . . 0.418 ' N ' ' HD3' ' A' ' 271' ' ' PRO . 0.3 OUTLIER 179.58 65.56 0.13 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.94 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' A' ' 270' ' ' SER . 4.9 Cg_exo -76.67 -71.44 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.812 2.341 . . . . 0.0 112.088 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.635 ' ND2' HD12 ' A' ' 275' ' ' LEU . 0.6 OUTLIER 174.88 68.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.625 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.26 -28.13 69.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.086 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -77.07 -49.35 15.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.146 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.635 HD12 ' ND2' ' A' ' 272' ' ' ASN . 99.3 mt -76.04 -44.44 39.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.096 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -58.46 -53.38 59.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.155 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 24.6 tttp -59.97 -30.67 69.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.959 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -81.04 -38.51 27.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.943 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.431 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 49.8 t80 -72.55 -34.93 67.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.951 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.987 HD23 HD22 ' A' ' 284' ' ' LEU . 7.8 mt -81.46 -20.77 39.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.396 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -91.08 -48.7 6.81 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.434 ' O ' ' CG ' ' A' ' 283' ' ' TYR . 0.0 OUTLIER -114.16 28.37 8.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.073 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.434 ' CG ' ' O ' ' A' ' 282' ' ' ASN . 32.3 m-85 -164.39 32.75 0.07 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.856 0.36 . . . . 0.0 111.005 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.987 HD22 HD23 ' A' ' 280' ' ' LEU . 10.6 tp -168.66 -42.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.898 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.612 ' CD2' HG23 ' A' ' 108' ' ' ILE . 1.9 mt -98.16 30.38 3.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.897 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 65.8 p -138.95 164.52 29.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.853 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.27 -27.81 62.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.077 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -67.03 -41.88 85.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.022 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.4 ' O ' HG23 ' A' ' 293' ' ' VAL . . . -92.41 -46.47 3.5 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.678 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.505 ' CD2' HG11 ' A' ' 302' ' ' VAL . 0.6 OUTLIER -57.67 -53.61 56.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.801 0.334 . . . . 0.0 111.09 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -58.83 -32.49 69.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.965 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -66.6 -42.51 86.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.141 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 289' ' ' GLY . 21.8 t -81.84 -30.3 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.175 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -69.83 -30.78 68.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 7.9 mtpp -63.58 -33.6 75.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.952 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -98.3 -39.99 8.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.99 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -144.25 89.17 7.1 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.856 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.47 98.08 0.83 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.523 2.149 . . . . 0.0 112.34 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.511 ' H ' HD12 ' A' ' 299' ' ' LEU . 1.7 mp -58.78 -22.88 59.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.094 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 110.04 -118.16 4.98 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.45 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.429 ' HB2' ' HB ' ' A' ' 320' ' ' THR . . . -81.22 163.26 23.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 111.038 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 109' ' ' ALA . 15.5 m -141.59 176.04 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.142 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -87.49 -30.32 20.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.16 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.452 HD23 ' HB2' ' A' ' 307' ' ' TYR . 5.4 tp -58.1 122.22 12.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.975 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -64.51 -41.45 96.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.947 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.5 m -60.01 -53.3 59.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.93 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.452 ' HB2' HD23 ' A' ' 304' ' ' LEU . 2.5 t80 -67.4 -23.2 65.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.162 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.03 -31.24 66.81 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 110.85 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -76.24 -58.04 3.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -50.11 -32.44 15.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.766 ' O ' HD12 ' A' ' 317' ' ' ILE . 32.9 mt -85.76 -26.63 25.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.704 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -74.89 -6.05 47.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.515 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.47 -31.76 4.51 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.986 0.422 . . . . 0.0 110.82 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.87 134.8 24.39 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.317 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.494 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 11.2 Cg_endo -55.15 -27.14 54.48 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.42 2.08 . . . . 0.0 112.373 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -49.82 -42.02 46.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.037 0.446 . . . . 0.0 110.294 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.766 HD12 ' O ' ' A' ' 311' ' ' LEU . 30.8 mt -85.63 -33.55 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.851 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.494 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -58.8 -30.71 67.81 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.129 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.59 -31.98 70.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.082 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.429 ' HB ' ' HB2' ' A' ' 301' ' ' ALA . 25.3 m -62.49 -51.15 68.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.911 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 5.6 tpt -61.5 -37.51 83.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -64.77 -31.87 73.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -67.01 -38.28 85.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -78.7 -35.35 45.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -67.07 -43.65 82.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.928 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.31 -31.35 26.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.84 -164.07 1.82 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.528 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' GLU . . . . . 0.488 ' C ' HG23 ' A' ' 259' ' ' VAL . 7.4 mm-40 -137.34 129.11 28.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.37 . . . . 0.0 110.892 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.661 HG23 ' CE1' ' A' ' 64' ' ' HIS . 31.2 mt -77.22 138.98 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.113 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 30.4 mtm -76.77 130.47 76.11 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.919 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.44 175.55 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.378 2.052 . . . . 0.0 112.271 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -114.17 32.1 6.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.819 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.482 HD12 ' HB2' ' A' ' 335' ' ' GLN . 42.3 pt -99.63 153.59 37.7 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.2 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.66 -25.2 34.44 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.583 2.188 . . . . 0.0 112.382 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.482 ' HB2' HD12 ' A' ' 333' ' ' ILE . 3.9 mp0 -58.62 -25.16 62.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.096 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 23.3 mmm -56.19 -32.47 64.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.052 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.3 m -59.52 -48.68 80.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.0 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -59.14 -31.55 69.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.06 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.743 ' CZ ' HG21 ' A' ' 343' ' ' VAL . 85.0 t80 -69.34 -32.25 71.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.489 ' CZ2' ' CZ ' ' A' ' 155' ' ' TYR . 68.9 m95 -66.38 -30.63 71.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.961 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -84.71 -51.73 6.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.178 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -55.23 -54.41 43.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.43 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.743 HG21 ' CZ ' ' A' ' 339' ' ' PHE . 28.8 t -59.03 -30.66 44.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.228 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.436 ' O ' HD12 ' A' ' 348' ' ' ILE . 0.2 OUTLIER -59.44 -57.48 12.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.975 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 345' ' ' THR . . . . . 0.44 HG22 ' CG ' ' A' ' 349' ' ' ASN . 3.6 m -68.66 -27.29 65.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.108 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -57.14 -61.74 2.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.397 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 23.3 t -61.8 -43.15 96.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.309 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.436 HD12 ' O ' ' A' ' 344' ' ' ARG . 27.7 mt -63.56 -44.98 98.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.109 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.44 ' CG ' HG22 ' A' ' 345' ' ' THR . 28.9 m-20 -59.79 -30.95 69.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -77.96 -51.06 10.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.108 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -60.17 -40.15 88.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.087 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 14.9 m -71.65 -22.42 61.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.122 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 86.5 27.52 29.74 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.453 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -89.59 -30.39 18.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.784 0.326 . . . . 0.0 110.9 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -145.37 145.07 31.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.888 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.7 p -62.37 169.51 2.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.795 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.612 HG23 HD22 ' A' ' 192' ' ' LEU . 1.5 p -62.51 -47.3 93.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.893 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ASP . . . . . 0.5 ' HA ' HD12 ' A' ' 361' ' ' LEU . 3.2 m-20 -66.78 -31.42 72.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.987 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -72.19 -43.13 64.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.975 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -60.59 -40.6 92.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.162 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.947 ' CD2' HG12 ' A' ' 183' ' ' VAL . 0.5 OUTLIER -77.35 -31.82 54.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.806 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.6 -52.88 40.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -61.17 -47.28 86.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.408 ' O ' HD12 ' A' ' 368' ' ' ILE . . . -57.96 -37.73 74.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.072 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.834 ' O ' HG22 ' A' ' 369' ' ' THR . 0.8 OUTLIER -60.67 -42.15 96.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.794 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 31.6 m -71.68 -31.5 66.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.862 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 36.1 mtt180 -69.41 -42.02 75.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.72 HD13 HG11 ' A' ' 181' ' ' VAL . 4.8 mt -67.19 -51.96 47.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.834 HG22 ' O ' ' A' ' 365' ' ' GLN . 9.8 t -95.44 43.59 1.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.994 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 1.2 tttm . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.245 -0.884 . . . . 0.0 110.92 179.986 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 47.3 mttt . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.838 0.351 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.694 HG23 ' HA ' ' A' ' 57' ' ' PRO . 0.6 OUTLIER -89.47 -175.75 4.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -151.64 154.34 36.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -83.62 139.89 32.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.925 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.38 26.51 43.16 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.539 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.0 159.74 32.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.78 0.324 . . . . 0.0 110.915 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.42 HD11 ' HB3' ' A' ' 275' ' ' LEU . 7.4 mt -128.09 109.98 12.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.5 t -83.6 147.01 6.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.15 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.74 HD13 HD12 ' A' ' 20' ' ' LEU . 29.6 mt -127.42 107.5 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.949 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.468 ' CE3' HD12 ' A' ' 43' ' ' LEU . 3.6 m0 -97.98 106.76 19.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.798 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.648 HD11 ' HE3' ' A' ' 15' ' ' LYS . 15.7 tt -140.67 158.19 24.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.085 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -59.1 146.51 38.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.26 -26.13 74.16 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.598 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.24 46.45 1.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.914 0.388 . . . . 0.0 111.006 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.648 ' HE3' HD11 ' A' ' 11' ' ' ILE . 1.6 mtmt -141.34 -176.13 4.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.833 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.78 80.33 0.12 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.516 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 19.2 p90 -83.65 -35.61 24.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.868 0.366 . . . . 0.0 110.942 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.4 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 6.9 t-20 -60.31 -31.17 70.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.548 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -67.61 -58.1 8.17 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.476 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.74 HD12 HD13 ' A' ' 9' ' ' ILE . 4.0 mm? -60.79 -30.41 70.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.81 0.338 . . . . 0.0 110.885 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.51 -43.89 95.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.059 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -75.64 -51.96 11.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 19' ' ' GLY . 23.9 t -59.05 -31.21 45.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.055 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.42 -34.41 84.73 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.424 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.8 mmtm -72.46 -28.16 62.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.824 0.345 . . . . 0.0 110.957 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -46.1 89.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.989 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -62.48 -41.21 98.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.956 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -69.79 -30.89 68.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.941 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.8 mttp -82.66 -26.66 31.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.086 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -91.78 -24.98 19.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.726 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.6 p -125.4 -44.19 1.87 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.692 0.282 . . . . 0.0 111.59 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.3 -26.82 5.17 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.585 -0.816 . . . . 0.0 112.467 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.6 mm -59.96 124.33 14.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.826 0.346 . . . . 0.0 111.058 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.3 mtmt -72.23 153.7 41.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.948 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.5 t -140.54 110.58 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.106 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.4 m -105.53 130.25 53.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.933 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.596 HG22 HD12 ' A' ' 9' ' ' ILE . 21.7 t -97.94 110.52 25.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.051 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -103.35 141.18 36.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.974 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -136.57 70.17 59.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.813 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.655 ' HG2' HD22 ' A' ' 43' ' ' LEU . 73.7 Cg_endo -75.63 156.06 40.16 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.629 2.219 . . . . 0.0 112.503 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.69 140.69 37.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.506 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? 56.39 41.72 28.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.675 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.655 HD22 ' HG2' ' A' ' 40' ' ' PRO . 0.9 OUTLIER -89.1 16.87 6.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.554 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -60.99 -42.18 97.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.876 0.369 . . . . 0.0 110.694 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -85.45 -6.3 59.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.252 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.565 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -82.85 -20.07 36.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.376 -179.837 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.59 ' CE2' HD12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -78.86 -52.58 1.25 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.617 0.246 . . . . 0.0 111.224 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.424 ' HD3' ' CB ' ' A' ' 47' ' ' PHE . 35.2 Cg_exo -59.94 -40.07 65.56 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.47 2.113 . . . . 0.0 112.366 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.442 ' CG ' ' N ' ' A' ' 50' ' ' VAL . 7.9 pt20 -60.12 -49.08 79.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.01 0.433 . . . . 0.0 111.058 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.728 ' O ' HG22 ' A' ' 53' ' ' THR . 34.2 m -79.28 -23.92 12.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.212 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.14 -27.79 48.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.19 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.13 -34.85 75.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.197 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.728 HG22 ' O ' ' A' ' 50' ' ' VAL . 11.8 t -69.52 -26.8 64.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.972 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.34 32.52 4.87 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.602 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.32 -81.25 0.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.789 0.328 . . . . 0.0 110.933 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 54.3 -170.85 1.11 Allowed Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.605 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.694 ' HA ' HG23 ' A' ' 2' ' ' THR . 55.2 Cg_endo -69.59 -179.57 2.93 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.577 2.185 . . . . 0.0 112.253 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -110.2 -31.3 7.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.976 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.8 mt -143.75 137.41 24.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.235 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.59 HD12 ' CE2' ' A' ' 47' ' ' PHE . 2.6 tt -142.36 159.72 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.887 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.48 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 41.7 m-85 -130.46 135.83 48.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.065 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -176.04 161.79 2.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.863 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.92 148.97 28.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.201 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.805 ' CD2' ' HB1' ' A' ' 96' ' ' ALA . 45.4 p-80 -60.7 -36.03 77.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.867 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -60.34 -30.28 69.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -93.85 17.17 12.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.208 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -112.2 29.24 8.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.854 0.359 . . . . 0.0 110.87 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.83 25.35 6.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.535 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -120.53 -36.4 0.79 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.483 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -83.07 -27.59 30.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.745 0.307 . . . . 0.0 111.036 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.538 ' HB2' HD12 ' A' ' 76' ' ' LEU . . . -84.03 -36.88 22.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.165 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -59.19 -32.54 70.02 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.078 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 m -90.1 -23.14 21.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.141 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.96 57.87 0.76 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.45 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.2 mt -139.25 32.36 2.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.793 0.33 . . . . 0.0 110.916 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.538 HD12 ' HB2' ' A' ' 71' ' ' ALA . 13.0 mt -144.4 160.57 40.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.56 163.28 12.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.066 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.453 ' HA ' HG22 ' A' ' 104' ' ' ILE . 1.1 tp10 -93.56 -165.48 1.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.643 HD11 ' CB ' ' A' ' 103' ' ' LEU . 44.6 pt -157.49 172.87 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.957 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 48.1 p -156.54 77.48 4.24 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.802 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.42 134.29 26.27 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.641 2.227 . . . . 0.0 112.348 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.71 174.26 10.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.758 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -59.66 -37.05 77.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.825 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.72 -30.05 69.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.064 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -77.58 -47.72 18.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.895 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -65.64 -30.89 71.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.954 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.04 -27.07 64.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.053 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -95.94 39.83 1.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.03 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.464 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 8.3 mt -157.99 173.74 16.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.861 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.5 ' CZ ' ' HE2' ' A' ' 321' ' ' MET . 27.2 m-85 -89.34 150.78 45.38 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.057 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -67.79 -56.39 0.21 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.454 2.103 . . . . 0.0 112.441 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.83 ' CE1' HG23 ' A' ' 93' ' ' THR . 44.2 p90 -55.68 -41.01 73.09 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.4 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.83 HG23 ' CE1' ' A' ' 92' ' ' PHE . 13.8 p -56.89 -29.62 63.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.068 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.464 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 55.0 m95 -74.52 -30.85 61.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.914 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.85 -28.43 64.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.0 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.805 ' HB1' ' CD2' ' A' ' 64' ' ' HIS . . . -72.26 -29.57 64.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.226 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.0 m -100.46 50.82 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.259 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.707 ' HB3' HD23 ' A' ' 103' ' ' LEU . 7.0 ptm180 -156.08 142.27 18.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -93.69 -47.97 6.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.927 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -151.48 58.71 0.88 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.842 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.08 -27.88 14.96 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.611 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.22 152.47 21.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 110.891 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.707 HD23 ' HB3' ' A' ' 98' ' ' ARG . 13.7 mt -110.59 150.38 29.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.453 HG22 ' HA ' ' A' ' 78' ' ' GLU . 2.2 pp -146.68 30.37 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.221 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.597 ' HB1' ' HB2' ' A' ' 263' ' ' SER . . . -164.34 -176.87 4.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.168 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -142.02 89.35 8.85 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.922 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.717 ' HB3' HG21 ' A' ' 261' ' ' VAL . 51.4 Cg_exo -52.86 129.92 35.12 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.551 2.167 . . . . 0.0 112.214 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.496 ' CG2' HD21 ' A' ' 290' ' ' LEU . 30.4 mt -112.91 -61.34 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.226 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.44 ' CB ' HD13 ' A' ' 299' ' ' LEU . . . -127.34 150.6 49.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.175 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.658 HG13 ' O ' ' A' ' 260' ' ' GLY . 21.5 t -120.72 137.39 54.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.033 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -116.36 161.66 18.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.952 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -169.17 158.44 8.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.098 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.8 mt -67.71 -178.28 0.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.936 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 226' ' ' ILE . 0.3 OUTLIER -169.95 169.27 8.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.929 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.456 ' HB2' HD23 ' A' ' 247' ' ' LEU . 8.4 tp -101.24 142.8 32.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.89 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.7 mt -127.72 131.94 69.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.077 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -134.97 161.18 36.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -115.74 117.76 31.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.024 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -66.64 -28.46 68.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -56.82 -40.78 76.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.928 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.458 HD22 ' NZ ' ' A' ' 144' ' ' LYS . 81.7 mt -88.06 -80.15 0.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.83 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.802 HD22 ' HB1' ' A' ' 223' ' ' ALA . 1.0 OUTLIER -81.21 144.46 54.24 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.84 -43.06 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.477 2.118 . . . . 0.0 112.295 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -139.42 142.77 33.36 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.853 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.61 150.94 36.25 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.566 2.177 . . . . 0.0 112.337 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.28 120.02 6.32 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.56 2.173 . . . . 0.0 112.309 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -94.88 20.59 8.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.95 142.0 29.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.914 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.669 ' CE3' HD12 ' A' ' 132' ' ' ILE . 2.1 m95 -72.54 -25.95 61.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.017 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.1 -21.93 56.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.213 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.407 ' O ' HD12 ' A' ' 135' ' ' LEU . 14.1 mt-10 -77.5 -26.28 51.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.203 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.794 HD13 HD22 ' A' ' 147' ' ' LEU . 36.8 mt -62.26 -54.45 49.26 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.534 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.615 ' HB3' HD21 ' A' ' 198' ' ' LEU . 18.7 Cg_endo -60.23 -28.32 86.67 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.185 1.923 . . . . 0.0 112.131 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.59 -30.21 41.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 131' ' ' GLU . 0.2 OUTLIER -73.74 -35.78 65.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.814 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.37 -27.92 39.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -85.65 -28.21 24.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.072 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -84.45 -37.27 21.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.11 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.709 HD13 ' HA ' ' A' ' 146' ' ' ALA . 0.5 OUTLIER -75.4 -17.21 60.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.487 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.09 -29.54 57.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.876 0.369 . . . . 0.0 110.656 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.46 -37.12 82.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.928 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -78.46 -27.11 46.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.022 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 113.66 45.11 0.73 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.509 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.458 ' NZ ' HD22 ' A' ' 121' ' ' LEU . 11.8 mtmt -162.03 -178.24 6.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.814 0.34 . . . . 0.0 110.937 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.2 t -112.0 176.99 4.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.848 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.709 ' HA ' HD13 ' A' ' 139' ' ' LEU . . . -101.96 -68.42 0.82 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.199 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.794 HD22 HD13 ' A' ' 132' ' ' ILE . 6.3 tp -140.42 145.72 37.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.963 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.664 ' CG ' ' HB2' ' A' ' 213' ' ' ALA . 0.0 OUTLIER -141.21 -177.82 5.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.805 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.434 ' CZ ' ' CE ' ' A' ' 204' ' ' MET . 22.6 p90 -179.4 170.93 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.818 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.555 ' ND2' ' CG ' ' A' ' 156' ' ' PHE . 5.1 p30 -79.47 131.06 35.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.476 HD23 HG21 ' A' ' 157' ' ' THR . 11.2 mt -105.91 29.13 6.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.992 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -104.41 -30.48 10.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.944 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -119.78 120.69 30.3 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.935 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.05 -21.94 29.18 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.509 2.139 . . . . 0.0 112.434 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.5 ' CD1' ' CE2' ' A' ' 258' ' ' PHE . 2.5 m-85 -53.91 -30.02 44.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.129 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.555 ' CG ' ' ND2' ' A' ' 150' ' ' ASN . 4.3 m-85 -89.81 -30.24 18.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.902 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.479 ' O ' HD12 ' A' ' 161' ' ' ILE . 17.3 p -95.03 18.42 12.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.263 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.471 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 13.4 t-105 -87.44 -46.86 0.49 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.313 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.592 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 59.2 Cg_exo -51.72 -25.38 20.39 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.329 2.02 . . . . 0.0 112.438 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 49.6 tp -76.73 -61.95 1.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.001 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.479 HD12 ' O ' ' A' ' 157' ' ' THR . 4.3 mt -69.33 -46.42 76.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.224 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -57.65 -34.05 68.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.25 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -60.09 -41.33 92.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.681 ' OD2' ' HB3' ' A' ' 190' ' ' ALA . 16.5 t0 -68.21 -20.09 64.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.187 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 121.44 41.72 0.49 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.467 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.614 ' HA2' ' HB2' ' A' ' 188' ' ' ALA . . . -119.54 103.6 0.98 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.507 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.44 ' CD2' ' HA3' ' A' ' 182' ' ' GLY . 30.3 p90 -114.15 -177.4 3.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.796 0.332 . . . . 0.0 110.882 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.437 ' HB2' ' CE1' ' A' ' 339' ' ' PHE . . . -108.19 -35.09 6.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.087 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.415 ' CE2' HD11 ' A' ' 333' ' ' ILE . 34.6 m-85 -136.39 152.97 51.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.88 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.27 118.93 37.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.061 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.42 ' CE1' ' HA ' ' A' ' 175' ' ' LYS . 6.5 t80 -79.53 121.24 24.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.489 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -170.41 147.32 2.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.969 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 63.4 42.36 6.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.863 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.4 ' O ' ' CZ ' ' A' ' 171' ' ' TYR . . . 102.83 -63.16 0.44 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.694 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.42 ' HA ' ' CE1' ' A' ' 171' ' ' TYR . 35.9 pttt -128.7 -166.92 1.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.805 0.336 . . . . 0.0 110.994 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -94.09 174.0 7.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -131.31 158.61 40.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.975 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.539 HG21 ' HG2' ' A' ' 335' ' ' GLN . 44.9 pt -92.76 -6.44 10.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.601 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.33 25.89 4.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.755 0.312 . . . . 0.0 111.073 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -152.91 102.53 2.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.859 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.586 HG12 ' H ' ' A' ' 183' ' ' VAL . 24.2 t -93.96 145.95 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.104 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 0.44 ' HA3' ' CD2' ' A' ' 167' ' ' TYR . . . -96.88 -20.46 23.88 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.734 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.65 ' CG1' HD22 ' A' ' 361' ' ' LEU . 21.4 t -55.17 -40.76 56.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.822 0.344 . . . . 0.0 111.346 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -84.29 57.19 4.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.974 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -118.82 168.56 10.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.834 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.59 -32.97 70.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.133 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -83.47 -38.41 10.87 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.534 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.614 ' HB2' ' HA2' ' A' ' 166' ' ' GLY . . . -59.16 -34.35 72.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.866 0.365 . . . . 0.0 111.168 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.526 ' HA ' HD11 ' A' ' 361' ' ' LEU . 9.5 ttmt -59.95 -54.54 44.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.681 ' HB3' ' OD2' ' A' ' 164' ' ' ASP . . . -60.89 -30.14 69.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.177 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -57.9 -54.23 39.04 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.557 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.815 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.1 OUTLIER -65.26 -44.86 86.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.1 m -53.5 -25.22 15.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.203 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -69.49 -60.59 2.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.801 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.503 ' HA ' HD12 ' A' ' 198' ' ' LEU . 2.1 tp -62.3 -33.2 74.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.662 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 192' ' ' LEU . 47.3 t -69.04 -34.57 64.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.975 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -74.06 -38.34 63.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.615 HD21 ' HB3' ' A' ' 133' ' ' PRO . 5.5 mt -57.94 -54.15 50.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.001 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 8.6 mt -68.38 -24.86 30.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.135 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -64.35 -40.89 96.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.022 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -95.81 22.07 7.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.232 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.03 79.22 0.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.844 0.354 . . . . 0.0 111.027 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -149.82 25.44 0.84 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.886 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' MET . . . . . 0.434 ' CE ' ' CZ ' ' A' ' 149' ' ' PHE . 23.1 mtp -160.77 -178.78 7.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.822 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -130.05 114.01 15.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.842 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -67.66 -32.58 73.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.89 46.75 1.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.976 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.492 HG23 HG21 ' A' ' 212' ' ' ILE . 57.2 m -98.41 138.17 36.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.923 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -106.15 176.05 5.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.828 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -75.77 -33.56 60.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.938 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.4 m -82.79 -28.18 30.47 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.092 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.492 HG21 HG23 ' A' ' 208' ' ' THR . 0.3 OUTLIER -45.66 -47.47 4.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.218 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.767 ' HB1' HG23 ' A' ' 225' ' ' THR . . . -71.73 -28.09 63.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.16 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.428 ' HA ' ' CE2' ' A' ' 217' ' ' PHE . 0.4 OUTLIER -61.86 -63.0 1.4 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.937 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.77 -21.45 66.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.365 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.444 ' HB1' ' HB2' ' A' ' 221' ' ' GLU . . . -54.09 -61.11 2.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.274 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.431 ' CD1' ' N ' ' A' ' 218' ' ' ASN . 11.2 p90 -68.8 -30.72 69.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.925 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.431 ' N ' ' CD1' ' A' ' 217' ' ' PHE . 5.5 t-20 -60.18 -30.68 69.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.28 28.76 7.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.921 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 58.57 95.92 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.53 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.444 ' HB2' ' HB1' ' A' ' 216' ' ' ALA . 40.2 mt-10 -150.46 -46.89 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.337 . . . . 0.0 110.88 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.3 t -124.71 171.97 9.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.802 ' HB1' HD22 ' A' ' 122' ' ' LEU . . . -93.12 -54.05 3.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.084 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.428 ' HE2' ' HB2' ' A' ' 147' ' ' LEU . 2.9 mpp? -111.08 163.53 13.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.767 HG23 ' HB1' ' A' ' 213' ' ' ALA . 78.4 m -163.99 152.62 13.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.434 HG23 ' O ' ' A' ' 114' ' ' SER . 4.8 mt -126.7 129.56 71.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.018 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.685 ' OD1' ' HB2' ' A' ' 231' ' ' ALA . 15.7 t-20 -145.43 159.31 43.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -75.86 -156.44 6.21 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.54 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.417 ' HD2' ' CZ3' ' A' ' 230' ' ' TRP . 43.3 Cg_endo -68.14 -24.22 38.71 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.554 2.169 . . . . 0.0 112.473 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' TRP . . . . . 0.417 ' CZ3' ' HD2' ' A' ' 229' ' ' PRO . 44.9 p90 -84.06 57.02 3.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.403 . . . . 0.0 110.92 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.685 ' HB2' ' OD1' ' A' ' 227' ' ' ASN . . . -143.0 -44.79 0.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.199 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' TRP . . . . . 0.522 ' HA ' HD12 ' A' ' 235' ' ' ILE . 20.3 m0 -52.98 -40.84 64.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.058 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 13.0 m -61.71 -30.85 71.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.864 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -64.78 -31.71 73.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.929 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.817 HG21 ' CD1' ' A' ' 242' ' ' TYR . 4.8 mt -84.23 57.77 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.056 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.67 -48.51 2.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.816 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 2.5 m -108.98 31.23 5.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.888 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 3.4 t -100.37 -29.73 12.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp 64.04 40.57 7.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.07 117.62 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.042 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -62.02 124.19 20.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.817 ' CD1' HG21 ' A' ' 235' ' ' ILE . 21.1 p90 -118.94 132.04 56.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.876 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -109.14 131.3 10.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.517 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.472 HG21 ' CZ2' ' A' ' 232' ' ' TRP . 21.3 t -99.21 117.42 44.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.809 0.338 . . . . 0.0 111.085 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.7 t -135.8 149.66 49.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 247' ' ' LEU . 0.7 OUTLIER -55.09 152.22 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.257 0.551 . . . . 0.0 111.311 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.456 HD23 ' HB2' ' A' ' 115' ' ' LEU . 40.7 mt -72.35 152.15 92.1 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.077 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.73 177.15 2.43 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.619 2.213 . . . . 0.0 112.258 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.429 HG22 ' HA ' ' A' ' 254' ' ' PRO . 57.5 p -115.57 152.76 32.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -100.37 116.48 32.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.76 25.97 15.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.038 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 93.64 -21.09 43.04 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.695 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -87.74 142.18 32.38 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.685 0.278 . . . . 0.0 110.901 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.429 ' HA ' HG22 ' A' ' 249' ' ' THR . 73.3 Cg_endo -75.8 163.26 33.87 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.578 2.185 . . . . 0.0 112.339 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.4 p -88.18 179.52 6.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.892 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.421 ' N ' ' HD3' ' A' ' 257' ' ' PRO . 5.5 mtmm -136.55 62.86 44.92 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.939 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 256' ' ' LYS . 32.3 Cg_exo -57.94 -173.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.537 2.158 . . . . 0.0 112.242 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.5 ' CE2' ' CD1' ' A' ' 155' ' ' TYR . 43.4 m-85 -103.91 126.22 50.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.729 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.2 t -108.63 138.53 35.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.378 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.658 ' O ' HG13 ' A' ' 110' ' ' VAL . . . -119.78 156.3 15.89 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.258 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.717 HG21 ' HB3' ' A' ' 107' ' ' PRO . 10.9 p -139.65 152.2 22.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.819 0.342 . . . . 0.0 111.238 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 20.3 tp -105.25 110.28 22.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.597 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 0.9 OUTLIER -125.74 155.95 40.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.933 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -100.85 133.46 45.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.113 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -101.38 161.74 18.05 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.489 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 31.5 mt -135.14 152.0 31.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.822 0.344 . . . . 0.0 111.146 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -91.47 149.27 21.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.952 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.98 -28.38 68.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.189 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -55.82 -30.0 60.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.268 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 5.9 t 59.09 62.5 4.11 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.55 -32.84 14.6 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.583 2.188 . . . . 0.0 112.297 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.433 ' OD1' HD12 ' A' ' 275' ' ' LEU . 4.5 t-20 -162.33 46.86 0.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.891 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 34.0 mttt -59.62 -31.83 69.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -60.15 -54.97 39.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.897 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.433 HD12 ' OD1' ' A' ' 272' ' ' ASN . 77.8 mt -75.24 -31.06 60.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -59.87 -45.86 91.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.34 -51.26 70.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.906 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -61.81 -45.39 94.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -66.09 -37.85 86.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.972 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 55.3 mt -81.33 -21.01 39.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.376 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -93.52 -43.32 8.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.796 0.331 . . . . 0.0 111.334 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -92.08 -48.92 6.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.211 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.485 ' HB3' HG12 ' A' ' 23' ' ' VAL . 10.4 m-85 -96.96 38.56 1.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.166 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.567 HD21 HD11 ' A' ' 20' ' ' LEU . 0.2 OUTLIER 179.96 38.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.888 179.842 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -177.77 37.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.825 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 38.3 p -140.79 167.28 22.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.921 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -64.91 -30.43 71.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.969 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -76.24 -30.64 57.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.981 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -90.71 -50.76 2.83 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.588 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.496 HD21 ' CG2' ' A' ' 108' ' ' ILE . 3.5 mt -59.28 -41.1 88.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.991 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -62.37 -37.06 84.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.959 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.41 -47.57 83.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.043 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.514 HG22 ' HA3' ' A' ' 19' ' ' GLY . 25.3 t -72.94 -30.92 33.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.027 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -71.81 -31.25 66.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 9.9 mtmt -63.41 -34.84 78.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.99 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -99.53 -34.74 10.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.078 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.4 tptt -148.43 91.33 4.76 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.98 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.5 108.54 2.24 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.495 2.13 . . . . 0.0 112.296 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.44 HD13 ' CB ' ' A' ' 109' ' ' ALA . 4.9 mt -59.53 -28.4 67.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.013 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 107.37 -125.83 8.15 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.461 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.83 94.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.846 0.355 . . . . 0.0 111.039 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.788 HG21 ' HB3' ' A' ' 307' ' ' TYR . 30.1 m -67.65 158.08 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.184 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 108' ' ' ILE . . . -87.94 -26.45 22.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.141 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 10.0 tp -55.97 127.63 31.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.963 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -67.31 -29.49 69.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.048 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.26 -26.09 36.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.226 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.788 ' HB3' HG21 ' A' ' 302' ' ' VAL . 0.1 OUTLIER -96.54 -22.98 16.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.396 -179.674 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.38 -33.4 69.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.859 0.362 . . . . 0.0 110.948 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -75.48 -53.49 8.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.907 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -49.66 -34.13 17.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.767 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.722 ' HB3' HG21 ' A' ' 317' ' ' ILE . 12.4 mt -85.8 -26.46 25.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.641 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -71.56 -14.12 61.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.433 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -48.0 -34.1 8.85 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.965 0.412 . . . . 0.0 110.83 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.52 138.1 21.34 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.381 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.464 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 11.4 Cg_endo -55.3 -23.56 38.23 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.407 2.071 . . . . 0.0 112.432 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.05 -41.58 59.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.961 0.41 . . . . 0.0 110.34 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.722 HG21 ' HB3' ' A' ' 311' ' ' LEU . 33.8 mm -85.57 -33.65 7.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.952 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -68.67 -30.08 68.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.223 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -73.64 -51.71 15.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.178 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 8.8 t -58.94 -30.73 68.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.995 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.5 ' HE2' ' CZ ' ' A' ' 90' ' ' TYR . 4.9 ttt -85.47 -31.03 23.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.983 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -59.27 -46.96 87.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.912 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -66.05 -31.52 72.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -72.06 -49.21 38.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.088 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -59.97 -35.64 75.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.919 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -96.27 21.07 9.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.085 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -133.3 -179.11 16.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.514 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.09 137.2 42.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.819 0.343 . . . . 0.0 110.929 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.585 HG22 ' HE2' ' A' ' 64' ' ' HIS . 12.2 mt -80.29 144.28 10.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.055 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 15.1 ttm -57.21 113.32 5.95 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.941 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.83 -172.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.459 2.106 . . . . 0.0 112.315 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -152.76 38.6 0.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.923 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.637 HD12 ' HB2' ' A' ' 335' ' ' GLN . 10.2 pt -107.2 155.75 38.8 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.129 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.34 -27.75 47.42 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.535 2.157 . . . . 0.0 112.336 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.637 ' HB2' HD12 ' A' ' 333' ' ' ILE . 6.4 mp0 -59.44 -22.59 61.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.091 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 9.5 mtp -54.63 -28.3 45.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.127 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.1 m -56.91 -53.96 52.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.014 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -59.66 -30.29 68.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.041 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.72 ' CZ ' HG21 ' A' ' 343' ' ' VAL . 51.6 t80 -58.95 -34.11 71.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.885 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.497 ' CH2' ' CE1' ' A' ' 155' ' ' TYR . 97.3 m95 -76.24 -21.86 55.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.175 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -84.83 -34.74 22.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.419 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -87.05 -57.95 2.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.85 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.849 ' O ' HG23 ' A' ' 347' ' ' VAL . 47.3 t -48.98 -56.55 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.804 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -52.89 -29.98 31.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.394 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 10.7 m -84.1 -55.71 4.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.113 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.889 ' HB1' ' HB1' ' A' ' 360' ' ' ALA . . . -51.44 -26.47 8.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.615 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 343' ' ' VAL . 31.3 t -82.75 -55.32 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.234 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 59.4 mt -64.94 -41.85 93.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.335 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -57.59 -39.29 76.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.001 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -86.32 -30.55 22.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.108 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -76.18 -29.03 57.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.233 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 72.7 m -95.6 20.74 9.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.175 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 56.04 25.39 46.12 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.644 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.82 -31.55 20.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.87 0.366 . . . . 0.0 110.869 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -144.71 -168.82 3.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.859 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 19.3 p -121.52 160.4 24.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 30.2 t -58.06 -56.31 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.063 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.49 -29.71 1.88 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.185 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -84.25 -42.75 15.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.889 ' HB1' ' HB1' ' A' ' 346' ' ' ALA . . . -60.3 -59.72 4.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.736 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.65 HD22 ' CG1' ' A' ' 183' ' ' VAL . 3.3 mt -58.39 -26.77 63.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.03 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 30.9 tttt -80.89 -59.18 2.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.782 0.325 . . . . 0.0 110.965 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -61.16 -44.76 96.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.83 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -52.49 -37.8 58.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.253 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.616 ' O ' HG23 ' A' ' 369' ' ' THR . 34.6 tt0 -59.42 -43.36 93.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.471 HG22 ' HD2' ' A' ' 370' ' ' LYS . 69.3 m -63.57 -39.92 95.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.984 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 31.9 mtt180 -67.06 -42.51 84.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.991 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 19.0 mt -75.45 -31.37 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.174 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 365' ' ' GLN . 63.6 p -81.91 -31.42 31.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.877 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.471 ' HD2' HG22 ' A' ' 366' ' ' THR . 3.5 mtpp . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.889 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.821 0.343 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.544 ' O ' HG23 ' A' ' 2' ' ' THR . 6.7 t -150.52 91.23 1.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -133.81 87.63 2.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.921 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -133.42 20.2 3.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.188 0.518 . . . . 0.0 111.207 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.466 ' O ' HG23 ' A' ' 33' ' ' ILE . . . 75.52 34.61 49.44 Favored Glycine 0 C--N 1.317 -0.503 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.509 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.78 -177.23 4.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.832 0.349 . . . . 0.0 110.931 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.3 mt -133.51 118.2 18.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.94 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.49 147.0 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.193 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.453 HD13 ' CD1' ' A' ' 20' ' ' LEU . 31.4 mt -132.59 107.44 12.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.947 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.425 ' CE3' ' HB3' ' A' ' 57' ' ' PRO . 19.7 m0 -92.95 106.65 18.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.873 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.8 tt -137.97 158.98 33.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.046 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -54.84 174.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.049 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.22 -23.99 49.53 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.68 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -137.6 81.42 1.86 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.849 0.357 . . . . 0.0 110.961 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.81 36.71 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.811 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.58 43.37 4.88 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.504 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -85.22 -31.33 23.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 0.0 110.904 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -32.58 70.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.923 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -80.83 -38.69 15.39 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.501 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.453 ' CD1' HD13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -61.48 -30.65 70.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.808 0.337 . . . . 0.0 110.896 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.36 -42.98 99.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -68.2 -44.18 76.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 19' ' ' GLY . 21.7 t -62.03 -33.46 58.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.213 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.11 -27.86 73.56 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.558 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -83.21 -27.74 29.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.759 0.314 . . . . 0.0 111.011 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -45.5 89.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.947 0.403 . . . . 0.0 110.956 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.434 ' CD2' ' HB ' ' A' ' 33' ' ' ILE . 10.4 t80 -61.51 -38.87 88.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.016 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.41 ' O ' ' HA2' ' A' ' 32' ' ' GLY . 28.3 mt-10 -60.75 -32.57 71.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.877 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.4 tttm -82.67 -24.36 33.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.918 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -90.8 -26.14 19.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.68 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.1 p -137.29 -44.28 0.56 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 28' ' ' GLU . . . 121.23 -17.82 9.01 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.687 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.466 HG23 ' O ' ' A' ' 5' ' ' GLY . 37.3 mm -59.94 105.43 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.872 0.368 . . . . 0.0 110.96 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -58.67 141.89 51.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.95 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.6 130.12 74.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.117 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.0 m -121.94 150.61 41.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.5 t -133.73 116.55 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.156 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -104.37 161.94 13.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.49 70.29 32.17 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.951 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.16 168.55 24.48 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.56 2.173 . . . . 0.0 112.215 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -89.94 140.13 29.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.935 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.477 ' O ' HD23 ' A' ' 43' ' ' LEU . 12.8 mmtt 74.91 -57.2 0.61 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.98 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.837 HD11 ' CZ3' ' A' ' 62' ' ' TRP . 0.4 OUTLIER 51.17 18.41 0.58 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.051 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.22 -57.03 3.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.796 0.331 . . . . 0.0 110.949 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -83.17 -6.84 59.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.45 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.54 -20.08 65.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.325 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.533 ' CZ ' HG21 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -87.21 -58.43 0.29 Allowed Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.189 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.508 ' HD3' ' CB ' ' A' ' 47' ' ' PHE . 52.0 Cg_exo -55.24 -30.71 73.05 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.33 2.02 . . . . 0.0 112.412 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.53 ' HG3' HG13 ' A' ' 50' ' ' VAL . 5.9 pt20 -60.08 -48.99 79.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.984 0.421 . . . . 0.0 111.084 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.53 HG13 ' HG3' ' A' ' 49' ' ' GLN . 5.5 m -93.18 17.63 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.762 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.656 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -91.06 -35.63 14.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.826 0.346 . . . . 0.0 111.164 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.21 -26.66 26.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.213 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.402 HG22 ' C ' ' A' ' 50' ' ' VAL . 10.1 t -59.96 -27.54 66.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.005 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.75 36.29 5.35 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.492 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.53 -78.2 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.894 0.378 . . . . 0.0 110.863 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.41 173.74 26.91 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.475 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.457 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 44.4 Cg_endo -68.49 -167.55 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.542 2.161 . . . . 0.0 112.242 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.75 -45.72 3.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.027 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.85 HD13 HD21 ' A' ' 280' ' ' LEU . 19.3 mt -149.39 159.06 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.29 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.533 HG21 ' CZ ' ' A' ' 47' ' ' PHE . 2.4 tt -159.02 159.47 2.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.866 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.511 ' HE2' HD21 ' A' ' 284' ' ' LEU . 4.1 m-85 -128.59 137.96 51.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.914 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.837 ' CZ3' HD11 ' A' ' 43' ' ' LEU . 2.9 t-105 -176.03 163.31 2.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.854 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.24 140.16 53.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.11 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.421 ' HE1' HG22 ' A' ' 329' ' ' ILE . 6.0 p80 -57.62 -30.9 65.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.963 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.67 -42.05 98.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.958 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.06 17.27 12.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.291 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.45 -26.02 13.03 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.735 0.302 . . . . 0.0 110.992 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.29 49.61 3.75 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.54 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -120.96 -34.08 0.93 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.583 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -93.38 -23.48 18.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.715 0.293 . . . . 0.0 111.096 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.529 ' HB2' HD12 ' A' ' 76' ' ' LEU . . . -75.59 -24.66 56.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.121 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -56.75 -38.18 72.05 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.033 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.4 t -90.52 -23.08 21.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.016 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.23 34.57 3.13 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.487 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.656 HD22 ' HB1' ' A' ' 51' ' ' ALA . 11.2 mt -85.57 -46.11 11.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 0.0 110.847 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.529 HD12 ' HB2' ' A' ' 71' ' ' ALA . 7.2 mt -74.1 170.64 15.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.834 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.623 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -100.7 155.03 18.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.032 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.12 -165.02 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.845 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.788 HD11 ' HB3' ' A' ' 103' ' ' LEU . 37.6 pt -157.02 166.82 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.044 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.0 p -156.53 77.45 4.25 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.779 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.39 154.53 60.85 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.641 2.228 . . . . 0.0 112.314 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.7 175.94 8.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.793 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 28.2 mttm -59.59 -45.34 92.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.85 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.08 -30.51 69.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.01 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -73.41 -35.15 65.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -81.6 -29.86 33.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.944 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.57 -40.2 70.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.012 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -59.22 -35.2 73.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.004 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.635 HD23 ' HB1' ' A' ' 303' ' ' ALA . 4.0 mt -90.6 148.84 22.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.865 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.437 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . 83.2 m-85 -78.42 144.61 66.32 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.966 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -49.35 -55.71 3.87 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.695 2.263 . . . . 0.0 112.844 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 93' ' ' THR . 21.7 p90 -49.33 -37.28 23.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.436 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.46 HG21 ' HB1' ' A' ' 303' ' ' ALA . 0.3 OUTLIER -59.71 -42.22 92.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.896 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.573 ' CZ2' HD13 ' A' ' 89' ' ' LEU . 61.4 m95 -69.65 -34.81 74.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.905 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.98 -25.82 67.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.007 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.45 ' HB2' HD13 ' A' ' 329' ' ' ILE . . . -74.67 -33.9 62.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.16 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.494 ' O ' HD23 ' A' ' 103' ' ' LEU . 5.6 m -103.52 64.2 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.198 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -156.01 123.64 5.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.32 -52.95 6.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.81 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -143.38 48.69 1.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.73 -25.34 25.42 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.597 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -91.24 135.12 34.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.366 . . . . 0.0 110.95 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.788 ' HB3' HD11 ' A' ' 79' ' ' ILE . 78.7 mt -88.71 150.46 22.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.83 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.584 ' O ' HD12 ' A' ' 104' ' ' ILE . 2.8 pp -157.14 34.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.193 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.693 ' HB1' ' HB2' ' A' ' 263' ' ' SER . . . -159.54 174.23 14.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.11 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.48 ' OH ' HG22 ' A' ' 79' ' ' ILE . 72.3 m-85 -133.42 82.24 52.85 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.807 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.65 119.39 4.64 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.625 2.216 . . . . 0.0 112.392 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.5 mt -101.69 -66.56 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.146 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.418 ' O ' HG12 ' A' ' 261' ' ' VAL . . . -108.58 148.94 29.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.096 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.77 125.26 66.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.141 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.67 148.9 24.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.908 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.509 ' HB1' ' HB3' ' A' ' 323' ' ' ASN . . . -169.94 153.77 4.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.049 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.2 mt -65.22 164.98 12.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.1 178.91 8.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.783 HD11 HD11 ' A' ' 147' ' ' LEU . 63.3 tp -137.62 114.22 10.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.939 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.929 HD12 ' HB2' ' A' ' 227' ' ' ASN . 5.1 mt -106.97 150.1 9.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.067 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.403 ' CE2' ' O ' ' A' ' 243' ' ' GLY . 45.1 p90 -148.55 165.45 31.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.955 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -91.58 121.26 33.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.59 -17.42 61.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.171 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.24 -50.84 68.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.76 0.314 . . . . 0.0 111.132 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.474 ' CD1' ' HB2' ' A' ' 223' ' ' ALA . 0.6 OUTLIER -110.89 -31.06 7.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.086 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.539 ' HB2' ' HB1' ' A' ' 223' ' ' ALA . 7.5 tp -104.39 89.35 2.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.964 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.13 -46.94 1.93 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.563 2.175 . . . . 0.0 112.295 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -119.24 128.92 25.67 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.826 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.914 ' CB ' HG21 ' A' ' 245' ' ' THR . 72.4 Cg_endo -76.58 147.76 28.62 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.424 2.083 . . . . 0.0 112.38 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.33 120.47 5.98 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.546 2.164 . . . . 0.0 112.335 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.96 20.57 8.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.1 p -136.5 141.96 43.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.93 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.644 ' CH2' HD13 ' A' ' 160' ' ' LEU . 12.6 m95 -81.68 -29.27 33.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -74.87 -15.84 60.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.378 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.79 -14.84 33.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.531 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.501 HD12 ' CE3' ' A' ' 129' ' ' TRP . 25.4 mt -65.88 -46.3 65.14 Favored Pre-proline 0 C--N 1.331 -0.214 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.484 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 50.9 Cg_exo -53.95 -49.98 15.27 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.293 1.995 . . . . 0.0 112.304 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.0 -35.28 76.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.134 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 135' ' ' LEU . 6.3 mt -63.97 -46.05 86.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.96 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.446 ' N ' ' HB2' ' A' ' 146' ' ' ALA . 11.8 t70 -52.08 -29.56 22.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.983 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -85.53 -27.76 25.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.044 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -85.05 -31.64 23.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.087 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.432 HD13 ' O ' ' A' ' 145' ' ' SER . 2.0 mt -83.87 -17.25 41.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.375 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -76.66 -29.11 56.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.808 0.337 . . . . 0.0 110.607 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.4 -37.35 85.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.892 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -80.57 -27.02 37.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.973 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 117.48 33.92 1.26 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.579 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.71 172.56 13.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.826 0.346 . . . . 0.0 110.882 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.432 ' O ' HD13 ' A' ' 139' ' ' LEU . 13.3 t -107.37 172.68 6.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.926 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.446 ' HB2' ' N ' ' A' ' 136' ' ' ASP . . . -73.19 -78.18 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.111 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.783 HD11 HD11 ' A' ' 115' ' ' LEU . 5.2 tp -137.86 115.98 11.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.922 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.669 ' SD ' HG23 ' A' ' 208' ' ' THR . 0.0 OUTLIER -84.55 158.2 21.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.229 0.538 . . . . 0.0 111.539 -179.726 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.445 ' H ' HG21 ' A' ' 208' ' ' THR . 38.1 p90 178.35 144.06 0.12 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.876 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -59.38 121.2 10.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.065 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.619 HD22 HD21 ' A' ' 195' ' ' LEU . 11.2 mt -107.32 32.94 4.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.891 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -95.61 -69.82 0.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.97 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -77.27 149.36 79.03 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.002 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.451 ' CB ' HG12 ' A' ' 343' ' ' VAL . 63.5 Cg_endo -73.16 -9.0 22.91 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.652 2.235 . . . . 0.0 112.618 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 258' ' ' PHE . 5.2 t80 -59.67 -26.51 65.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.746 0.308 . . . . 0.0 111.117 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -91.17 -36.1 14.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.056 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 43.9 p -81.48 -22.22 38.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.226 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.564 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 64.9 t-105 -53.03 -54.36 45.09 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.642 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 12.7 Cg_endo -56.29 -21.02 34.46 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.233 1.955 . . . . 0.0 112.431 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.644 HD13 ' CH2' ' A' ' 129' ' ' TRP . 1.9 tp -87.67 -42.57 12.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.853 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.856 HD13 HD12 ' A' ' 192' ' ' LEU . 20.0 mt -77.9 -46.21 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.147 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -59.98 -27.85 67.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.237 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.598 ' HB2' ' HA ' ' A' ' 255' ' ' SER . . . -56.65 -39.12 73.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.236 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.83 -20.14 55.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.162 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 136.02 -28.31 2.95 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.49 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.684 ' HA3' ' HB2' ' A' ' 188' ' ' ALA . . . -59.61 151.07 37.36 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.43 ' CG ' ' HA3' ' A' ' 182' ' ' GLY . 41.6 p90 -141.58 -176.16 4.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 110.916 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.405 ' HB2' ' CZ ' ' A' ' 339' ' ' PHE . . . -97.75 -49.0 4.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.053 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.466 ' CE2' HD11 ' A' ' 333' ' ' ILE . 92.1 m-85 -133.22 154.77 50.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.914 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.13 134.13 40.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -101.14 110.88 22.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.657 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -162.79 146.19 11.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.867 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 61.46 30.38 18.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 64.84 13.7 57.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.009 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.96 160.08 38.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.848 0.356 . . . . 0.0 111.01 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -101.5 102.11 12.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.816 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -59.01 136.63 58.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.986 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.0 pt -93.59 -29.05 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.186 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -69.44 -16.44 63.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.296 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -102.43 150.32 23.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.783 0.325 . . . . 0.0 111.01 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 183' ' ' VAL . 21.4 t -131.81 146.05 33.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.048 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 0.43 ' HA3' ' CG ' ' A' ' 167' ' ' TYR . . . -103.06 -18.3 15.59 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.783 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.669 HG12 HD22 ' A' ' 361' ' ' LEU . 21.3 t -56.65 -44.38 81.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.81 0.338 . . . . 0.0 111.25 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -84.16 57.38 4.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.906 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -120.25 -177.3 3.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.868 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -76.21 -29.61 57.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.191 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -82.26 -47.19 6.2 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.556 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.684 ' HB2' ' HA3' ' A' ' 166' ' ' GLY . . . -57.31 -29.97 64.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.82 0.343 . . . . 0.0 111.197 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -67.92 -49.28 62.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.906 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -74.22 -30.15 62.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.163 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -58.85 -53.91 42.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.557 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.856 HD12 HD13 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -59.43 -43.96 92.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.86 0.362 . . . . 0.0 110.997 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 61.0 m -57.39 -21.79 38.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.257 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.617 ' CZ ' HD11 ' A' ' 198' ' ' LEU . 14.2 t80 -68.21 -60.53 2.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.824 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.619 HD21 HD22 ' A' ' 151' ' ' LEU . 4.2 tp -63.11 -35.59 80.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.626 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 192' ' ' LEU . 43.8 t -66.19 -56.81 12.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.983 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -67.63 -26.83 66.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.999 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.617 HD11 ' CZ ' ' A' ' 194' ' ' PHE . 4.9 mt -61.26 -58.42 8.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.003 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 195' ' ' LEU . 5.6 mt -57.65 -21.24 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.439 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -84.86 -35.71 22.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.407 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -113.08 19.43 17.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.703 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.34 -17.21 3.81 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 14.1 m80 64.22 43.8 4.72 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.884 0.373 . . . . 0.0 110.671 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.89 146.68 28.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.85 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -81.99 116.77 21.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.96 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.16 -10.15 59.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.413 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.6 56.93 4.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.875 0.369 . . . . 0.0 111.008 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.669 HG23 ' SD ' ' A' ' 148' ' ' MET . 0.6 OUTLIER -117.0 133.08 56.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.802 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.858 ' OD2' HD11 ' A' ' 212' ' ' ILE . 55.0 m-20 -154.11 176.1 12.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.029 0.442 . . . . 0.0 111.106 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.401 ' CD2' ' OE2' ' A' ' 214' ' ' GLU . 1.1 t80 -41.87 -61.64 1.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.81 -59.21 3.24 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.858 HD11 ' OD2' ' A' ' 209' ' ' ASP . 0.2 OUTLIER -53.81 -34.03 24.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.507 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.456 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -81.78 -24.14 36.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.712 0.291 . . . . 0.0 110.915 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.401 ' OE2' ' CD2' ' A' ' 210' ' ' TYR . 4.0 mt-10 -82.29 -46.08 14.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.939 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.13 -31.22 66.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.131 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.33 -35.74 78.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.023 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.421 ' CD1' HG22 ' A' ' 225' ' ' THR . 42.1 t80 -82.24 -36.53 27.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -59.11 -46.77 87.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.973 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -76.41 -27.98 56.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.958 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.35 31.2 6.58 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.521 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -77.94 -71.33 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.808 0.337 . . . . 0.0 110.86 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.4 t -68.0 129.0 38.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.539 ' HB1' ' HB2' ' A' ' 122' ' ' LEU . . . -59.18 -36.81 75.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.14 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.518 ' C ' HD12 ' A' ' 147' ' ' LEU . 9.7 ptt? -141.37 153.89 45.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.553 ' O ' HD12 ' A' ' 115' ' ' LEU . 9.0 t -151.42 157.89 42.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.43 HD12 ' CB ' ' A' ' 149' ' ' PHE . 30.2 mt -94.97 121.82 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.109 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.929 ' HB2' HD12 ' A' ' 116' ' ' ILE . 0.8 OUTLIER -137.84 165.44 26.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.822 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -124.39 -162.31 11.37 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.617 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.81 -10.28 26.14 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.846 2.364 . . . . 0.0 112.71 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -92.56 28.28 2.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.651 0.262 . . . . 0.0 111.386 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.05 19.18 1.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.371 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 9.6 m95 -81.2 -55.84 4.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.851 0.358 . . . . 0.0 110.919 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.7 m -57.3 -26.5 60.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.177 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -54.66 -29.27 52.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.092 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.803 HG21 ' CD1' ' A' ' 242' ' ' TYR . 3.2 mt -86.71 98.53 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.046 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -169.98 -49.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.1 t -73.35 -33.51 65.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' SER . . . . . 0.517 ' HB3' HG23 ' A' ' 240' ' ' VAL . 71.1 m -90.88 -30.26 17.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt 62.13 31.4 17.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.517 HG23 ' HB3' ' A' ' 238' ' ' SER . 21.6 t -74.43 124.2 31.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.083 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -61.93 94.24 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.827 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.803 ' CD1' HG21 ' A' ' 235' ' ' ILE . 50.3 p90 -89.99 123.02 33.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.924 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.403 ' O ' ' CE2' ' A' ' 117' ' ' TYR . . . -108.99 95.32 0.9 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.469 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 27.0 t -68.95 127.96 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.815 0.34 . . . . 0.0 111.088 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.914 HG21 ' CB ' ' A' ' 125' ' ' PRO . 9.9 t -134.0 159.33 41.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.7 t -66.65 152.02 9.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.97 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.2 mp -67.63 151.19 97.39 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.944 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.426 ' HG3' HD11 ' A' ' 132' ' ' ILE . 39.5 Cg_endo -67.14 162.98 35.92 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.543 2.162 . . . . 0.0 112.211 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 36.9 p -102.14 144.99 30.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.968 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.49 ' CE1' ' CZ ' ' A' ' 194' ' ' PHE . 26.9 t80 -129.31 132.06 47.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.06 18.44 8.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.282 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 91.21 -21.27 35.48 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.942 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -103.66 145.74 31.19 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.701 0.286 . . . . 0.0 110.926 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.66 164.04 34.58 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.589 2.192 . . . . 0.0 112.299 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.598 ' HA ' ' HB2' ' A' ' 163' ' ' ALA . 0.3 OUTLIER -62.15 -176.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 15.7 mttp -137.0 66.61 54.91 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.7 176.19 9.21 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.561 2.174 . . . . 0.0 112.324 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 155' ' ' TYR . 95.1 m-85 -95.26 166.12 12.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.99 136.4 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.293 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -131.15 121.68 3.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.349 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -113.67 133.64 58.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 111.233 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 12.9 tp -92.07 90.17 7.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.568 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.693 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 0.9 OUTLIER -84.87 167.01 16.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.08 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -98.97 114.99 27.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.997 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -81.92 149.8 28.59 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.529 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 31.3 mt -142.41 152.0 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 0.0 111.098 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -98.93 149.93 22.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.962 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.623 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -68.6 -36.68 79.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.065 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -97.35 36.54 1.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.14 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.3 m -69.27 146.5 96.77 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.888 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.51 -49.32 17.76 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.524 2.149 . . . . 0.0 112.264 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -141.76 83.4 1.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.82 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? -63.08 -34.33 77.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.82 -53.94 52.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.876 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 68.7 mt -59.78 -32.52 70.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.9 -40.69 96.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -52.3 25.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.9 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -60.34 -42.35 95.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.415 ' CE2' ' HB2' ' A' ' 27' ' ' PHE . 11.9 t80 -60.26 -64.28 1.01 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.123 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.978 HD22 HD22 ' A' ' 284' ' ' LEU . 26.2 mt -57.25 -21.65 35.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.411 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -90.48 -32.93 16.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.704 0.288 . . . . 0.0 111.375 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.402 ' O ' ' CD1' ' A' ' 283' ' ' TYR . 35.2 m-80 -104.34 20.39 18.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.285 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.558 ' O ' HG22 ' A' ' 286' ' ' THR . 96.1 m-85 -157.75 -66.25 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.825 0.345 . . . . 0.0 111.042 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.978 HD22 HD22 ' A' ' 280' ' ' LEU . 17.6 tp -60.84 -30.14 69.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.935 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 99.6 mt -121.89 82.28 1.93 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.964 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.56 HG23 ' HA3' ' A' ' 289' ' ' GLY . 0.6 OUTLIER -160.96 170.01 21.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.835 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.2 -57.07 8.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -69.26 -42.77 75.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.049 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.56 ' HA3' HG23 ' A' ' 286' ' ' THR . . . -57.77 -57.2 21.03 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.615 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.488 HD22 HG11 ' A' ' 302' ' ' VAL . 30.4 mt -58.59 -29.85 66.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.802 0.334 . . . . 0.0 110.976 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -60.05 -43.82 95.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.001 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -59.53 -53.67 55.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.142 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.1 t -59.65 -32.17 48.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.22 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -71.68 -31.21 66.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.944 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 49.1 mttm -65.69 -34.66 78.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.955 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.62 -35.04 11.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.5 90.71 4.55 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.889 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.91 112.61 2.75 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.548 2.165 . . . . 0.0 112.238 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 1.2 mt -97.4 25.82 5.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.003 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' GLY . . . . . 0.589 ' O ' HD13 ' A' ' 311' ' ' LEU . . . 58.29 -125.5 39.66 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.553 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.572 ' HB2' ' CG ' ' A' ' 321' ' ' MET . . . -64.97 156.05 32.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.78 0.324 . . . . 0.0 111.099 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.488 HG11 HD22 ' A' ' 290' ' ' LEU . 9.6 m -128.36 24.89 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.234 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.635 ' HB1' HD23 ' A' ' 89' ' ' LEU . . . 52.92 27.37 5.45 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.343 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.479 ' HB2' HG23 ' A' ' 302' ' ' VAL . 0.5 OUTLIER -116.0 125.24 52.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.862 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -67.01 -31.78 72.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.01 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.8 m -81.2 -29.8 34.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.164 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.422 ' CE2' ' HB2' ' A' ' 290' ' ' LEU . 1.9 t80 -87.91 -28.24 21.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.202 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 0.0 OUTLIER -54.09 -29.63 45.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.814 0.34 . . . . 0.0 111.062 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -67.79 -61.51 1.85 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -50.86 -33.7 24.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.77 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.78 ' HB3' HG21 ' A' ' 317' ' ' ILE . 46.9 mt -85.76 -25.83 26.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.781 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 308' ' ' GLU . . . -73.39 -7.44 51.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.558 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -47.21 -30.59 3.06 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.95 0.405 . . . . 0.0 110.895 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.33 133.81 24.31 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.283 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.512 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 10.8 Cg_endo -54.55 -29.04 58.27 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.421 2.081 . . . . 0.0 112.422 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -49.35 -41.76 39.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.095 0.474 . . . . 0.0 110.296 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.78 HG21 ' HB3' ' A' ' 311' ' ' LEU . 27.8 mt -85.6 -33.26 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.939 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.512 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -62.66 -30.83 71.67 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.11 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -79.31 -31.38 43.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.118 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.37 -35.47 80.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.572 ' CG ' ' HB2' ' A' ' 301' ' ' ALA . 45.8 mtp -81.88 -32.79 30.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.933 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.24 -31.34 70.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.943 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.509 ' HB3' ' HB1' ' A' ' 112' ' ' ALA . 6.3 m-80 -67.99 -38.77 83.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -71.17 -39.89 71.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.132 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -59.85 -35.03 73.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.957 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 6.7 mmtm -117.81 21.11 13.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.033 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -114.03 142.27 17.42 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.501 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -75.61 135.57 40.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.791 0.329 . . . . 0.0 110.884 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.45 HD13 ' HB2' ' A' ' 96' ' ' ALA . 30.8 mt -79.19 148.96 5.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.14 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 6.6 mtp -76.51 113.49 29.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.37 152.5 15.43 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.489 2.126 . . . . 0.0 112.312 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -106.01 39.15 1.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.854 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.466 HD11 ' CE2' ' A' ' 169' ' ' PHE . 22.7 pt -108.15 148.87 38.37 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.177 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.95 -27.71 30.08 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.559 2.172 . . . . 0.0 112.339 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 17.0 mp0 -59.33 -24.14 63.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.055 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 1.7 tpt -54.53 -26.8 34.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.188 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 38.3 m -58.23 -55.26 37.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.015 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -60.43 -29.61 69.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.166 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.711 ' O ' HG23 ' A' ' 343' ' ' VAL . 68.7 t80 -58.98 -51.71 68.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.026 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 40.3 m95 -56.47 -23.52 39.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.356 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -79.38 -61.38 2.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.125 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -59.63 -48.32 82.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.404 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 339' ' ' PHE . 31.7 t -58.18 -32.52 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.292 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 -68.11 -57.46 6.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.914 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 30.9 m -65.83 -28.32 68.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.137 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.581 ' HB1' ' HB1' ' A' ' 360' ' ' ALA . . . -60.09 -51.39 69.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.342 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 32.8 t -70.83 -47.31 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.272 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 57.8 mt -59.31 -43.29 89.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.054 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -60.36 -30.61 69.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.012 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -79.31 -52.51 8.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.34 -38.72 90.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.03 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 16.8 m -70.98 -22.35 62.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.139 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 87.5 26.79 29.18 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.589 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 30.4 mtt180 -91.27 -30.74 16.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.854 0.359 . . . . 0.0 110.915 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -146.45 -176.51 5.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.846 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 19.8 p -116.28 170.74 8.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.525 HG22 ' CD2' ' A' ' 192' ' ' LEU . 47.9 t -59.5 -55.29 24.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.005 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -47.42 -29.83 2.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.157 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -84.29 -41.97 16.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.965 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.581 ' HB1' ' HB1' ' A' ' 346' ' ' ALA . . . -60.08 -60.46 3.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.931 0.395 . . . . 0.0 110.765 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.669 HD22 HG12 ' A' ' 183' ' ' VAL . 3.1 mt -58.29 -27.02 63.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.978 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.94 -53.46 6.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.831 0.348 . . . . 0.0 111.007 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -59.36 -48.55 81.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.857 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.466 ' O ' HD12 ' A' ' 368' ' ' ILE . . . -58.57 -36.42 73.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.994 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.611 ' O ' HG23 ' A' ' 369' ' ' THR . 0.1 OUTLIER -59.78 -45.24 92.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.831 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -52.32 66.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.002 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -59.05 -48.38 81.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.998 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.466 HD12 ' O ' ' A' ' 364' ' ' ALA . 10.6 mt -65.88 -28.96 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.188 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.611 HG23 ' O ' ' A' ' 365' ' ' GLN . 32.6 p -83.37 -31.3 26.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.922 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.884 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 32.2 mttt . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.788 0.327 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.512 HG23 ' HG2' ' A' ' 271' ' ' PRO . 2.7 t -80.12 98.07 7.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.91 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -98.75 31.76 2.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.42 ' HB3' ' CD ' ' A' ' 6' ' ' LYS . 2.2 tt0 -92.83 -163.87 1.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.794 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -134.15 52.47 0.81 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.771 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.42 ' CD ' ' HB3' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -146.25 -174.93 4.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.793 0.33 . . . . 0.0 110.94 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 21.6 mt -130.56 123.62 29.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.5 t -91.27 142.04 13.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.156 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.848 HG21 ' CD2' ' A' ' 20' ' ' LEU . 29.5 mm -119.66 107.53 21.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.952 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.41 ' CD2' ' HG3' ' A' ' 57' ' ' PRO . 5.2 m0 -104.07 106.74 17.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.6 tt -150.84 150.52 13.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.11 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -64.36 158.91 22.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.916 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.87 57.74 3.68 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.522 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -125.86 -44.51 1.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.862 0.363 . . . . 0.0 110.912 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.75 -179.29 6.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.874 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.18 83.83 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.486 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -71.91 -35.5 69.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.809 0.338 . . . . 0.0 110.902 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -72.31 -31.18 65.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.85 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.25 -41.49 96.75 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.495 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.848 ' CD2' HG21 ' A' ' 9' ' ' ILE . 8.4 tp -67.23 -29.52 69.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.0 110.952 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.74 -42.29 79.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.101 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.67 -26.14 68.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.019 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.65 HG12 ' CZ ' ' A' ' 279' ' ' PHE . 17.5 t -76.71 -25.94 16.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -81.39 -42.54 9.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.599 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -27.69 69.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.767 0.318 . . . . 0.0 110.988 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -73.9 -41.52 62.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -60.43 -57.15 14.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.931 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.32 -21.19 48.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.295 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.42 -25.81 33.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.334 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -102.48 -33.74 9.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.583 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.68 -44.15 3.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.766 0.317 . . . . 0.0 111.402 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.31 -26.4 7.04 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.528 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.577 HG21 HD13 ' A' ' 275' ' ' LEU . 35.7 mm -62.25 122.65 13.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.338 . . . . 0.0 111.108 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -70.71 166.77 20.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.967 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.2 t -147.45 102.57 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.087 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.8 m -98.29 144.67 27.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.5 t -114.53 110.18 31.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.113 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -97.56 176.46 5.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.789 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -159.32 70.24 3.36 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.018 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.29 144.41 46.0 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.549 2.166 . . . . 0.0 112.171 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.21 139.13 48.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.966 0.412 . . . . 0.0 111.04 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.538 ' C ' HD23 ' A' ' 43' ' ' LEU . 4.4 mtmt 73.48 -58.39 0.6 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.873 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.538 HD23 ' C ' ' A' ' 42' ' ' LYS . 0.5 OUTLIER 49.18 18.69 0.25 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.114 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -83.29 -57.02 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -91.57 -7.4 50.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.354 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.546 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.5 tptt -67.75 -25.1 65.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.264 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.477 ' CB ' ' HD3' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -85.16 -57.68 0.36 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.179 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.477 ' HD3' ' CB ' ' A' ' 47' ' ' PHE . 54.0 Cg_exo -52.07 -35.8 63.2 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.416 2.077 . . . . 0.0 112.531 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.612 ' HG3' HG13 ' A' ' 50' ' ' VAL . 11.5 pt20 -60.09 -49.64 76.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.01 0.433 . . . . 0.0 111.053 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.612 HG13 ' HG3' ' A' ' 49' ' ' GLN . 6.2 m -96.68 27.0 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.418 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 1.037 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -88.55 -42.15 12.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.107 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.33 -33.65 76.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.098 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 55' ' ' ASP . 11.5 t -88.12 -31.31 19.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.52 39.61 68.38 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.518 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.417 ' H ' HG23 ' A' ' 53' ' ' THR . 8.8 t0 -97.73 -29.58 13.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.98 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.52 -160.5 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.551 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.442 ' HG2' ' CZ ' ' A' ' 47' ' ' PHE . 41.4 Cg_endo -67.54 -167.79 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.549 2.166 . . . . 0.0 112.263 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -124.12 -42.48 2.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.006 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 60' ' ' ILE . 16.7 mt -102.1 158.29 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.242 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.563 HG22 ' O ' ' A' ' 265' ' ' GLY . 2.4 tt -166.86 159.48 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.811 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.477 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 73.6 m-85 -119.85 140.58 50.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.987 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.505 ' HZ3' HD11 ' A' ' 43' ' ' LEU . 4.9 t-105 -174.07 151.11 1.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.64 134.54 57.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.091 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -53.26 -28.37 27.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.195 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -64.55 -35.06 79.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.005 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.438 ' HB3' ' CD1' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -94.41 17.18 13.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.296 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -106.84 30.62 5.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.827 0.346 . . . . 0.0 110.907 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -122.29 35.91 3.34 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.544 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -128.43 -41.7 0.27 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.51 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -80.62 -9.03 59.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.608 0.242 . . . . 0.0 111.364 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.22 -25.98 47.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.728 0.299 . . . . 0.0 111.144 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -60.72 -51.05 71.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.948 0.404 . . . . 0.0 110.661 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.7 m -72.04 -23.1 61.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.047 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.4 31.63 9.43 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.526 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.037 HD22 ' HB1' ' A' ' 51' ' ' ALA . 35.7 mt -72.5 -37.97 68.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.785 0.326 . . . . 0.0 110.952 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.674 HD13 HD13 ' A' ' 104' ' ' ILE . 6.7 mt -77.35 146.28 36.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.986 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.797 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -93.08 116.39 28.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.078 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -60.79 155.83 18.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.833 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.475 ' O ' HG23 ' A' ' 80' ' ' THR . 42.6 pt -124.68 179.19 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.131 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 79' ' ' ILE . 0.9 OUTLIER -159.82 77.81 2.79 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.893 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.31 163.45 34.42 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.613 2.209 . . . . 0.0 112.207 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -94.8 -179.43 4.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -59.18 -48.92 79.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.883 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.51 -31.16 72.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.104 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -74.59 -35.73 62.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.917 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.427 ' HA ' ' CZ2' ' A' ' 94' ' ' TRP . 15.5 mt-30 -79.87 -30.13 40.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.947 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -74.05 -39.26 63.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.985 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.83 -36.21 76.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.978 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.515 HD13 ' CZ2' ' A' ' 94' ' ' TRP . 0.4 OUTLIER -84.48 178.07 7.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.834 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.42 ' HB3' ' CE1' ' A' ' 92' ' ' PHE . 24.4 m-85 -86.79 142.38 34.4 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.039 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 63.7 Cg_exo -54.27 -55.85 3.03 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.581 2.188 . . . . 0.0 112.657 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.541 ' CE2' HG23 ' A' ' 93' ' ' THR . 50.0 p90 -60.32 -46.63 89.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.429 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.541 HG23 ' CE2' ' A' ' 92' ' ' PHE . 70.9 p -53.21 -27.6 22.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.797 0.332 . . . . 0.0 111.233 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.515 ' CZ2' HD13 ' A' ' 89' ' ' LEU . 22.8 m95 -74.68 -36.44 62.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.822 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -74.56 -7.7 53.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.342 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.76 -27.9 22.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.822 0.344 . . . . 0.0 111.183 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.516 ' CG1' ' HB3' ' A' ' 105' ' ' ALA . 27.5 m -93.0 47.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.288 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.9 124.31 13.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -108.94 -65.2 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.844 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -98.59 30.66 3.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.808 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.92 -25.96 21.1 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.558 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -92.17 170.55 9.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.333 . . . . 0.0 110.99 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.514 ' O ' HG23 ' A' ' 104' ' ' ILE . 5.9 mt -96.17 141.11 29.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.79 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.685 ' O ' HD12 ' A' ' 104' ' ' ILE . 1.8 pp -158.08 58.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.239 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.805 ' HB1' ' HB3' ' A' ' 263' ' ' SER . . . -177.33 172.25 1.89 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.229 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.732 ' CE1' HD12 ' A' ' 266' ' ' ILE . 26.0 m-85 -138.53 94.01 10.82 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.821 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.52 116.96 3.65 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.648 2.232 . . . . 0.0 112.381 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.0 mt -119.06 -64.39 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.118 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.588 ' CB ' HD22 ' A' ' 299' ' ' LEU . . . -113.7 142.84 45.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.147 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.676 HG22 HG13 ' A' ' 261' ' ' VAL . 21.5 t -106.86 151.88 8.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.116 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -130.94 149.14 52.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -171.72 146.36 2.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.2 mt -66.53 114.87 5.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.915 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.681 ' HB3' HG13 ' A' ' 244' ' ' VAL . 1.3 m -93.72 163.23 13.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.925 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 50.1 tp -100.72 101.54 12.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.766 HG22 ' CZ ' ' A' ' 217' ' ' PHE . 28.7 mt -86.16 119.91 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.119 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -137.84 148.9 45.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.943 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -81.42 156.75 25.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.6 mtmm -110.88 -30.25 7.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.978 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -61.17 -31.61 71.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.035 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.669 HD11 ' HA ' ' A' ' 223' ' ' ALA . 3.8 pp -111.6 -33.71 6.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.974 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.561 ' HB2' HD12 ' A' ' 121' ' ' LEU . 8.3 tp -119.25 88.98 38.83 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.995 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.26 -28.42 33.65 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.535 2.157 . . . . 0.0 112.283 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -140.26 112.58 7.31 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.836 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -78.82 167.59 22.05 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.586 2.191 . . . . 0.0 112.422 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.408 ' HD2' ' HE3' ' A' ' 224' ' ' MET . 56.2 Cg_endo -70.34 111.81 3.02 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.603 2.202 . . . . 0.0 112.322 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.45 -27.1 65.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.963 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 29.5 p -120.34 158.53 26.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.964 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.425 ' CE3' HD12 ' A' ' 132' ' ' ILE . 34.5 m95 -72.44 -30.06 64.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.967 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -72.2 -16.05 61.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.405 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.733 ' O ' HD12 ' A' ' 135' ' ' LEU . 2.6 mt-10 -89.76 0.05 57.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.581 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.48 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 12.2 mt -85.44 -46.5 0.62 Allowed Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 73.2 Cg_exo -49.25 -28.35 14.76 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.378 2.052 . . . . 0.0 112.44 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.27 -34.61 28.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.197 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.733 HD12 ' O ' ' A' ' 131' ' ' GLU . 0.2 OUTLIER -62.23 -42.55 99.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.092 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.406 ' OD2' ' HA ' ' A' ' 133' ' ' PRO . 7.5 p30 -57.09 -22.24 38.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.216 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -85.62 -33.71 21.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.079 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -85.1 -61.74 1.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.296 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.421 HD13 ' HB2' ' A' ' 223' ' ' ALA . 6.6 mt -53.79 -24.85 16.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.545 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -76.87 -24.77 52.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.742 0.306 . . . . 0.0 110.959 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.12 -33.75 69.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.903 0.383 . . . . 0.0 110.97 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.08 -27.12 39.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.029 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.44 42.16 0.77 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.491 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -144.99 -177.3 5.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 0.0 110.861 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.57 147.82 40.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.868 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -68.33 -68.82 0.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.201 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.698 HD13 ' HB2' ' A' ' 224' ' ' MET . 18.8 tp -148.79 132.92 17.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.043 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.777 ' HB2' HG21 ' A' ' 208' ' ' THR . 0.0 OUTLIER -126.17 179.61 5.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.712 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.428 ' HB2' ' CD2' ' A' ' 156' ' ' PHE . 50.6 p90 -178.28 -176.04 0.49 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.018 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -79.37 118.8 21.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.905 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.4 mt -98.93 29.2 3.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -112.09 -33.34 6.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.842 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -101.04 135.27 19.99 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.419 ' CB ' HG12 ' A' ' 343' ' ' VAL . 72.0 Cg_endo -76.56 -13.36 18.3 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.532 2.155 . . . . 0.0 112.612 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.495 ' CZ ' ' CH2' ' A' ' 340' ' ' TRP . 3.0 m-85 -57.37 -32.62 66.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.12 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.428 ' CD2' ' HB2' ' A' ' 149' ' ' PHE . 1.8 m-85 -77.44 -36.72 52.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.896 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.652 HG21 HG11 ' A' ' 347' ' ' VAL . 40.1 p -81.55 -23.07 37.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.045 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.545 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 64.5 t-105 -50.9 -54.15 40.03 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.572 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.611 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 14.9 Cg_endo -57.24 -22.02 46.61 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.196 1.931 . . . . 0.0 112.3 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.4 tp -80.44 -54.48 5.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.813 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.991 HG21 HD12 ' A' ' 192' ' ' LEU . 12.3 pt -71.16 -34.03 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.434 ' HB1' ' HG3' ' A' ' 256' ' ' LYS . . . -75.08 -28.9 60.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.175 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -56.5 -28.87 60.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.233 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -76.16 -20.04 57.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.222 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 139.55 -26.37 2.67 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.658 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.488 ' HA3' ' HB2' ' A' ' 188' ' ' ALA . . . -57.0 145.32 37.64 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.565 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -134.81 -176.35 4.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.801 0.334 . . . . 0.0 110.986 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.45 ' HB2' ' CZ2' ' A' ' 158' ' ' TRP . . . -107.58 -49.64 3.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.12 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.911 ' CE2' HD11 ' A' ' 333' ' ' ILE . 24.9 m-85 -127.83 158.73 36.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -99.44 118.58 36.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.017 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.404 ' CE1' ' O ' ' A' ' 174' ' ' GLY . 7.7 t80 -85.59 111.15 19.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.487 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.04 146.33 23.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.153 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 63.11 29.45 16.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.095 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 171' ' ' TYR . . . 90.55 -37.0 3.44 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.021 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.91 -177.24 3.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 0.0 111.067 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -98.92 -177.48 3.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.954 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -133.46 134.76 43.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.8 pt -87.12 -29.68 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.119 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -74.54 -16.33 60.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.219 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -104.96 117.35 33.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.807 0.337 . . . . 0.0 110.976 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.725 HG12 HG23 ' A' ' 183' ' ' VAL . 16.9 t -124.51 146.05 30.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.006 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -117.04 61.37 0.42 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.782 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.725 HG23 HG12 ' A' ' 181' ' ' VAL . 2.3 t -96.55 -61.58 2.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.846 0.355 . . . . 0.0 110.973 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -84.4 57.23 4.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.922 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -95.74 167.84 11.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.849 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -58.64 -31.14 67.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.178 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -85.98 -49.13 4.38 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.55 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.488 ' HB2' ' HA3' ' A' ' 166' ' ' GLY . . . -59.0 -31.59 68.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 0.0 111.182 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -60.02 -45.81 91.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.834 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -86.95 -28.2 22.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.154 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -57.81 -53.61 43.96 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.608 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.991 HD12 HG21 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -61.22 -32.65 72.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.339 . . . . 0.0 110.981 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.3 m -53.67 -25.15 16.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.091 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -65.89 -59.08 4.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.786 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.493 ' HA ' HD12 ' A' ' 198' ' ' LEU . 8.0 tt -64.78 -29.78 70.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.735 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.87 HG23 ' O ' ' A' ' 192' ' ' LEU . 41.2 t -69.49 -59.84 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.062 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -58.48 -29.55 66.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.051 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 195' ' ' LEU . 12.5 mt -60.06 -47.88 84.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 22.4 mt -76.53 -28.41 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.167 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.789 ' HD2' HG12 ' A' ' 196' ' ' VAL . 18.2 mtpt -62.06 -30.48 71.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.966 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -91.07 13.58 16.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.423 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt 56.13 44.04 25.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.956 0.407 . . . . 0.0 111.028 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.83 -28.1 12.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.904 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 87.7 mtp -113.69 176.74 4.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.932 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 19.8 m-20 -124.22 133.57 53.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -79.77 -38.99 31.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.094 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -59.25 -27.39 65.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.982 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.777 HG21 ' HB2' ' A' ' 148' ' ' MET . 1.6 m -49.45 146.74 3.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.227 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -154.23 176.08 12.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.858 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -61.08 -29.02 69.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.257 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.13 -59.36 2.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.84 0.352 . . . . 0.0 110.986 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -28.65 44.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.309 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.582 ' O ' HG21 ' A' ' 225' ' ' THR . . . -77.74 -21.75 51.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.769 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.16 -50.2 11.36 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.835 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.76 -30.61 68.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.127 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.3 -32.98 70.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.144 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.766 ' CZ ' HG22 ' A' ' 116' ' ' ILE . 19.4 t80 -79.42 -41.1 28.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.961 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -67.12 -36.11 81.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.5 mttm -83.73 -34.0 24.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.863 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.12 59.33 0.94 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.491 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -109.27 -72.69 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.803 0.335 . . . . 0.0 110.825 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.592 HG21 ' SD ' ' A' ' 148' ' ' MET . 10.6 t -74.36 169.12 18.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.924 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.669 ' HA ' HD11 ' A' ' 121' ' ' LEU . . . -81.53 -54.66 5.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.171 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.698 ' HB2' HD13 ' A' ' 147' ' ' LEU . 0.5 OUTLIER -125.78 163.59 22.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.004 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.582 HG21 ' O ' ' A' ' 213' ' ' ALA . 66.3 m -159.83 137.75 10.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 29.3 mt -112.98 135.22 53.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.163 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.523 ' HB3' ' HB2' ' A' ' 231' ' ' ALA . 33.5 t30 -150.47 155.78 40.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -62.47 -162.25 0.27 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.551 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.427 ' HD2' ' CZ3' ' A' ' 230' ' ' TRP . 34.5 Cg_endo -64.56 -23.09 64.48 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.649 2.233 . . . . 0.0 112.499 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' TRP . . . . . 0.427 ' CZ3' ' HD2' ' A' ' 229' ' ' PRO . 46.6 p90 -84.5 57.31 4.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.958 0.409 . . . . 0.0 110.875 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.523 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . . . -141.76 -44.94 0.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.18 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' TRP . . . . . 0.551 ' HA ' HD12 ' A' ' 235' ' ' ILE . 20.8 m0 -54.26 -30.59 51.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.086 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.5 m -62.71 -36.58 83.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.944 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -60.39 -34.39 73.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.919 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.551 HD12 ' HA ' ' A' ' 232' ' ' TRP . 10.6 mt -74.96 70.4 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.03 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -153.28 -46.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.871 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 62.4 m -61.29 -44.1 97.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.84 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 2.7 t -101.58 -34.13 9.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.93 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.97 104.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.6 t -135.01 142.32 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.122 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.05 95.66 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.627 ' HB2' HG23 ' A' ' 116' ' ' ILE . 55.0 p90 -100.54 135.6 41.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -100.53 148.16 18.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.466 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.681 HG13 ' HB3' ' A' ' 114' ' ' SER . 21.3 t -128.55 123.27 59.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.838 0.351 . . . . 0.0 111.119 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 10.0 t -143.45 153.78 43.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.864 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.502 HG11 ' CD ' ' A' ' 322' ' ' GLU . 0.8 OUTLIER -54.85 152.35 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.245 0.545 . . . . 0.0 111.381 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.412 ' N ' ' CG2' ' A' ' 246' ' ' VAL . 89.9 mt -67.68 136.24 92.68 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.855 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.422 ' HB2' ' CD1' ' A' ' 129' ' ' TRP . 52.3 Cg_exo -54.58 -170.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.412 2.075 . . . . 0.0 112.279 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.511 HG22 ' HA ' ' A' ' 254' ' ' PRO . 1.3 p -127.89 163.04 25.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -111.05 108.24 17.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.93 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 17.1 mttt 59.44 30.72 20.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.958 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 83.1 27.03 42.06 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.541 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.431 ' O ' HG22 ' A' ' 249' ' ' THR . 2.9 mm-40 -122.22 141.27 34.14 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.59 0.233 . . . . 0.0 110.852 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.511 ' HA ' HG22 ' A' ' 249' ' ' THR . 72.6 Cg_endo -76.37 145.34 26.82 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.544 2.163 . . . . 0.0 112.42 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.22 -172.64 1.77 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.769 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.434 ' HG3' ' HB1' ' A' ' 162' ' ' ALA . 12.3 mmmt -132.88 58.69 37.45 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.128 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.433 ' HD3' ' N ' ' A' ' 256' ' ' LYS . 62.3 Cg_exo -50.9 -179.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.406 2.071 . . . . 0.0 112.291 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.494 ' CE2' ' CD2' ' A' ' 155' ' ' TYR . 10.9 m-85 -110.53 134.9 51.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.826 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 328' ' ' GLU . 23.8 t -97.17 132.13 42.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.203 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -145.57 106.13 0.37 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.307 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.676 HG13 HG22 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -106.21 149.53 9.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.881 0.372 . . . . 0.0 111.323 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 262' ' ' LEU . 11.9 tp -85.75 80.88 8.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.975 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.805 ' HB3' ' HB1' ' A' ' 105' ' ' ALA . 2.1 m -75.81 137.44 40.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.033 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.713 ' HB3' ' HB2' ' A' ' 106' ' ' TYR . . . -82.04 114.98 20.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.053 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.563 ' O ' HG22 ' A' ' 60' ' ' ILE . . . -83.38 117.82 4.51 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.565 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.732 HD12 ' CE1' ' A' ' 106' ' ' TYR . 29.2 mt -119.48 121.94 67.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.818 0.342 . . . . 0.0 110.998 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -79.59 148.64 31.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.953 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.797 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -67.51 -27.13 66.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.176 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -90.98 48.81 1.56 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.152 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 58.5 p -116.45 108.11 45.93 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.794 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.512 ' HG2' HG23 ' A' ' 2' ' ' THR . 38.3 Cg_endo -66.73 -24.37 47.54 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.418 2.079 . . . . 0.0 112.312 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -97.64 37.21 1.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.841 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -66.36 -41.09 89.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -59.58 -56.15 25.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.961 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.577 HD13 HG21 ' A' ' 33' ' ' ILE . 19.1 mt -60.32 -35.04 74.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.81 -50.72 40.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.075 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -44.62 95.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.873 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -63.07 -61.97 2.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.65 ' CZ ' HG12 ' A' ' 23' ' ' VAL . 72.8 t80 -55.09 -27.18 43.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.143 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.64 HD23 HD22 ' A' ' 284' ' ' LEU . 24.8 mt -76.95 -37.83 54.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.109 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.465 ' HG3' HD12 ' A' ' 285' ' ' LEU . 1.1 mp0 -93.62 -7.32 44.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.643 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -103.29 -35.8 8.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.653 0.263 . . . . 0.0 111.367 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -116.96 -35.77 4.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.406 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.64 HD22 HD23 ' A' ' 280' ' ' LEU . 1.5 tp -95.21 41.1 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.799 0.333 . . . . 0.0 111.134 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.465 HD12 ' HG3' ' A' ' 281' ' ' GLU . 2.7 mt -177.18 37.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.878 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.2 p -142.91 164.49 29.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -72.28 -30.21 64.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -79.45 -30.49 42.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.004 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -89.63 -50.92 3.01 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.589 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 87.2 mt -59.68 -31.0 69.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.363 . . . . 0.0 111.021 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -69.64 -31.21 69.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.46 -30.73 67.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.164 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.12 -30.02 9.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.39 -30.71 71.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.959 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -68.99 -33.62 73.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.027 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.55 -36.69 12.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.015 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -169.2 100.3 0.49 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.922 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.28 115.12 3.69 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.428 2.085 . . . . 0.0 112.32 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.588 HD22 ' CB ' ' A' ' 109' ' ' ALA . 0.8 OUTLIER -56.9 -24.63 53.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.026 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 109.76 -32.66 6.58 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.573 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -157.36 176.83 12.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 0.0 111.126 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.629 HG21 ' CD2' ' A' ' 307' ' ' TYR . 5.8 m -152.92 156.08 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.089 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.458 ' HB1' HD23 ' A' ' 89' ' ' LEU . . . -84.42 -30.32 25.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.135 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 304' ' ' LEU . 14.0 tp -59.67 123.97 18.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.908 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -72.66 -24.14 60.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.12 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.6 m -81.27 -24.13 37.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.179 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.629 ' CD2' HG21 ' A' ' 302' ' ' VAL . 26.3 t80 -95.33 -31.97 13.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.306 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -57.23 -29.72 63.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.343 . . . . 0.0 110.948 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -64.27 -59.87 3.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -50.89 -33.26 23.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.827 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.799 ' HB3' HG21 ' A' ' 317' ' ' ILE . 7.8 mt -85.76 -24.99 26.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.798 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -67.13 -13.82 62.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.494 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -47.48 -32.16 4.91 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.972 0.415 . . . . 0.0 110.941 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -112.69 140.65 24.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.37 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.483 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 11.6 Cg_endo -55.76 -26.99 59.59 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.425 2.083 . . . . 0.0 112.341 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -50.51 -41.24 53.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.079 0.466 . . . . 0.0 110.313 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.799 HG21 ' HB3' ' A' ' 311' ' ' LEU . 32.2 mm -85.58 -32.0 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.957 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.483 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -69.39 -30.69 68.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.171 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -74.42 -46.18 41.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.204 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 63.4 m -59.7 -31.35 69.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.925 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.91 -41.82 25.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.946 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.502 ' CD ' HG11 ' A' ' 246' ' ' VAL . 18.1 tt0 -60.0 -47.06 87.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.958 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -60.14 -54.27 47.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.966 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.79 -50.55 73.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.148 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -59.71 -33.29 71.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -96.59 21.15 9.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.123 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -128.18 161.88 21.97 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.521 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' GLU . . . . . 0.408 ' O ' HG23 ' A' ' 259' ' ' VAL . 0.4 OUTLIER -79.58 156.24 27.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.804 0.335 . . . . 0.0 110.873 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 25.3 mt -88.02 138.39 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.141 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.441 ' HG2' ' CD1' ' A' ' 258' ' ' PHE . 12.8 mtm -60.35 140.27 91.74 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.43 ' HG2' ' HE3' ' A' ' 336' ' ' MET . 72.6 Cg_endo -76.41 138.79 20.1 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.549 2.166 . . . . 0.0 112.333 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -101.87 30.98 4.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.911 HD11 ' CE2' ' A' ' 169' ' ' PHE . 9.4 pt -107.2 148.52 37.23 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.108 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.56 -24.47 18.77 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.584 2.19 . . . . 0.0 112.446 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.15 -26.34 38.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.184 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.43 ' HE3' ' HG2' ' A' ' 331' ' ' PRO . 17.3 ptm -57.31 -22.27 40.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.215 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 67.1 m -50.24 -48.8 54.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.175 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.52 -28.02 60.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.15 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.73 ' CZ ' HG21 ' A' ' 343' ' ' VAL . 78.0 t80 -58.25 -29.1 65.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.009 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.495 ' CH2' ' CZ ' ' A' ' 155' ' ' TYR . 94.2 m95 -60.28 -61.06 2.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.034 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.86 -30.72 71.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.091 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -62.04 -56.28 20.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.339 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.73 HG21 ' CZ ' ' A' ' 339' ' ' PHE . 21.4 t -78.62 -33.76 17.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.417 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -57.16 -57.45 12.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.15 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' THR . . . . . 0.637 HG22 ' OD1' ' A' ' 349' ' ' ASN . 21.0 m -66.71 -29.53 69.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.01 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -59.78 -56.84 16.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.24 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.652 HG11 HG21 ' A' ' 157' ' ' THR . 21.2 t -59.05 -40.57 81.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.284 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 26.2 mt -68.22 -41.6 84.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.064 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.637 ' OD1' HG22 ' A' ' 345' ' ' THR . 2.0 m120 -59.58 -30.2 68.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.967 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -91.1 -34.84 14.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.236 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -76.52 -33.33 58.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.228 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 5.6 t -66.27 -22.42 66.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.118 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 80.0 61.7 2.22 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.539 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 18.9 mtt-85 -140.29 -79.33 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.83 0.348 . . . . 0.0 110.836 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -77.55 177.55 7.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.758 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 65.8 p -106.57 145.13 32.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.776 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.41 HG12 ' HG ' ' A' ' 361' ' ' LEU . 40.3 t -51.44 -40.14 23.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.108 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -50.73 -38.51 47.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.62 -30.65 29.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -65.96 -58.17 6.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.062 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.673 HD22 HG12 ' A' ' 183' ' ' VAL . 12.1 mt -60.04 -25.29 65.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.037 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -72.83 -51.07 20.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.834 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -57.76 -48.46 79.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.85 -39.19 80.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.073 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.602 ' O ' HG23 ' A' ' 369' ' ' THR . 7.1 tm0? -58.86 -33.99 71.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.963 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 90.0 m -87.11 -40.36 14.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.925 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -59.07 -44.87 91.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.718 HD12 HG11 ' A' ' 181' ' ' VAL . 17.1 mt -69.45 -30.4 45.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.175 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.602 HG23 ' O ' ' A' ' 365' ' ' GLN . 76.2 p -82.97 -29.64 28.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.942 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 26.3 tttm . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.918 179.998 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 22.2 tttt . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.826 0.346 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.3 t -102.17 125.78 48.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.894 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -105.21 99.45 9.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 58.87 162.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.967 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.59 -58.4 0.53 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.506 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -142.14 174.6 10.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.815 0.34 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 33.7 mt -128.69 133.8 48.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.7 t -109.6 147.05 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.115 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.592 HG21 ' CD2' ' A' ' 20' ' ' LEU . 28.7 mm -120.49 107.51 20.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.968 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.419 ' CG ' ' HG3' ' A' ' 57' ' ' PRO . 0.5 OUTLIER -93.41 106.77 18.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.833 HD11 ' HD3' ' A' ' 15' ' ' LYS . 17.3 tt -163.15 123.02 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.006 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -142.53 162.68 34.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.928 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 109.57 58.81 0.52 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.984 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.6 t70 59.48 28.9 18.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.96 0.409 . . . . 0.0 110.556 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.833 ' HD3' HD11 ' A' ' 11' ' ' ILE . 3.3 mmpt? -83.16 173.56 11.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.8 54.67 4.62 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.527 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -72.62 -31.05 64.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.827 0.346 . . . . 0.0 110.909 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -74.53 -32.3 62.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.39 -37.85 8.67 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.512 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.592 ' CD2' HG21 ' A' ' 9' ' ' ILE . 6.2 tp -65.77 -31.22 72.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.783 0.325 . . . . 0.0 110.92 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.92 -31.02 70.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.128 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -66.59 -36.65 83.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.563 HG12 ' HB3' ' A' ' 283' ' ' TYR . 25.4 t -65.38 -31.39 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.074 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.97 -27.63 73.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.512 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.3 mmtt -59.24 -30.55 68.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.776 0.322 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.3 -40.48 58.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.881 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.632 ' CE1' HG21 ' A' ' 31' ' ' THR . 38.5 t80 -57.98 -52.89 63.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.017 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -68.94 -23.91 64.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.174 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -78.84 -25.83 44.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.22 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -103.89 -36.98 7.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.41 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.632 HG21 ' CE1' ' A' ' 27' ' ' PHE . 8.9 p -99.98 -44.11 6.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.225 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.06 -27.09 8.38 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.45 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.424 ' HB ' ' CE2' ' A' ' 27' ' ' PHE . 35.8 mm -64.32 118.83 7.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.779 0.323 . . . . 0.0 111.091 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -59.71 152.37 22.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.914 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.29 108.78 12.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.045 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.5 m -115.36 144.67 43.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.409 HG13 ' HB ' ' A' ' 9' ' ' ILE . 29.6 t -118.98 119.07 59.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.052 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -100.85 151.4 21.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -117.21 73.41 7.1 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.973 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.95 -179.99 5.51 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.646 2.231 . . . . 0.0 112.359 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -60.3 -158.88 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.416 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.466 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -47.13 -27.39 1.4 Allowed 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.598 0.237 . . . . 0.0 111.485 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 42' ' ' LYS . 0.3 OUTLIER 52.45 17.95 0.86 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.979 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -83.19 -57.04 3.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 0.0 110.972 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -92.77 -5.62 50.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.44 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.1 -18.94 29.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.557 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.679 ' CE2' HG21 ' A' ' 60' ' ' ILE . 13.3 t80 -83.37 -47.92 0.77 Allowed Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 116.762 -0.199 . . . . 0.0 111.49 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.545 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 41.9 Cg_exo -57.11 -38.23 96.14 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.336 2.024 . . . . 0.0 112.327 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.441 ' CG ' ' N ' ' A' ' 50' ' ' VAL . 4.6 pt20 -60.9 -47.31 86.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.044 0.45 . . . . 0.0 110.923 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.441 ' N ' ' CG ' ' A' ' 49' ' ' GLN . 20.3 m -76.99 -27.95 16.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.229 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 75' ' ' LEU . . . -56.7 -26.78 57.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.39 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.76 -35.73 71.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.237 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.0 t -110.8 -29.65 7.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.031 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.39 35.53 6.56 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.536 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.27 -27.45 20.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.785 0.326 . . . . 0.0 111.029 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.73 -156.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.544 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.419 ' HG3' ' CG ' ' A' ' 10' ' ' TRP . 46.0 Cg_endo -68.06 -167.84 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.623 2.215 . . . . 0.0 112.301 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -109.45 -31.27 7.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.894 HD13 HD21 ' A' ' 280' ' ' LEU . 22.2 mt -136.81 129.03 44.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.135 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.679 HG21 ' CE2' ' A' ' 47' ' ' PHE . 2.3 tt -114.88 159.07 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.093 0.473 . . . . 0.0 111.018 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.47 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 6.2 m-85 -130.56 113.14 13.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.784 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.3 t-105 -152.71 173.73 14.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.959 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.45 139.27 58.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.495 ' HB3' HG23 ' A' ' 261' ' ' VAL . 1.5 p80 -58.0 -33.69 69.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.038 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -59.67 -39.39 84.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.981 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -94.14 17.18 13.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.273 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.43 -4.71 37.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.416 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -94.82 26.4 18.74 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.56 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -124.5 4.42 8.74 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.84 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.521 ' O ' HD12 ' A' ' 75' ' ' LEU . 4.7 m-85 -112.59 -32.32 6.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.845 0.355 . . . . 0.0 110.998 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.51 -26.07 50.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.09 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -32.82 70.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.963 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.57 24.95 6.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.079 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 54.84 40.48 72.3 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.756 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.528 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 4.0 mt -100.32 -48.19 4.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.808 0.337 . . . . 0.0 110.934 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 20.5 mt -73.35 142.0 47.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.987 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.754 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -92.6 169.77 10.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.095 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.35 -164.9 1.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.942 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.748 HD11 ' CB ' ' A' ' 103' ' ' LEU . 35.8 pt -157.02 168.82 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.089 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 48.9 p -156.65 77.49 4.17 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.831 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.77 154.59 63.67 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.603 2.202 . . . . 0.0 112.315 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -78.08 164.77 24.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.813 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -59.74 -38.48 81.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.815 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.94 -44.39 85.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.005 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.674 ' CZ ' HD22 ' A' ' 285' ' ' LEU . 31.4 t80 -66.44 -37.37 85.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -69.07 -30.48 68.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.51 -28.32 62.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.969 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.66 43.19 1.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.024 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.455 HD13 ' CZ2' ' A' ' 94' ' ' TRP . 8.1 mt -151.93 139.04 19.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.876 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.438 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . 12.9 m-85 -73.31 129.77 85.39 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -49.06 -55.54 4.05 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.657 2.238 . . . . 0.0 112.996 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.699 ' HB2' HD11 ' A' ' 329' ' ' ILE . 10.7 p90 -49.78 -25.13 2.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.077 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.613 HG22 ' CE1' ' A' ' 92' ' ' PHE . 10.4 p -74.73 -30.57 61.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.819 0.342 . . . . 0.0 110.804 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.498 ' CZ3' HD13 ' A' ' 103' ' ' LEU . 12.2 m95 -73.1 -39.48 65.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.922 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -62.09 -27.34 68.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.999 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.53 ' HB2' HG21 ' A' ' 329' ' ' ILE . . . -64.98 -25.67 67.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.332 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 97' ' ' VAL . 27.6 m -121.09 72.81 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.911 0.386 . . . . 0.0 111.266 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -156.06 144.2 19.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.874 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -106.09 -64.53 1.15 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -123.8 41.76 3.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.824 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.84 25.58 29.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.522 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.99 145.35 49.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.765 0.317 . . . . 0.0 110.896 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.748 ' CB ' HD11 ' A' ' 79' ' ' ILE . 13.4 mt -87.93 140.41 29.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.939 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.0 pt -144.86 29.87 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.227 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -166.68 -177.11 3.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.153 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.431 ' OH ' HG22 ' A' ' 79' ' ' ILE . 5.9 m-85 -135.31 85.97 31.47 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.89 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.32 97.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.584 2.19 . . . . 0.0 112.321 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.7 mm -75.31 -66.16 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.204 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.748 ' HB2' HD12 ' A' ' 299' ' ' LEU . . . -112.74 164.41 13.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.181 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.451 HG22 ' CG1' ' A' ' 261' ' ' VAL . 21.3 t -130.51 106.96 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.07 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -91.44 163.55 14.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.933 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.465 ' HB2' ' HB2' ' A' ' 324' ' ' ALA . . . -163.02 144.3 9.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.061 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.437 HD12 ' H ' ' A' ' 258' ' ' PHE . 3.8 mt -62.05 145.22 53.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.1 p -140.35 -177.19 4.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.942 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.451 HD23 HG23 ' A' ' 245' ' ' THR . 35.2 tp -122.48 129.38 51.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.871 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.1 mp -110.51 125.83 67.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.064 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.433 ' CG ' ' HB3' ' A' ' 125' ' ' PRO . 28.2 p90 -125.72 160.42 29.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -92.38 -176.36 4.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.886 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.9 mttm -125.13 -45.31 1.86 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.869 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.16 -31.65 72.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 70.6 mt -98.98 -31.06 12.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.957 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.638 HD22 ' SD ' ' A' ' 224' ' ' MET . 9.9 tp -132.53 108.0 13.23 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.853 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.63 -45.84 3.1 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.377 2.051 . . . . 0.0 112.263 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -128.17 128.95 23.68 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.83 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.593 ' HA ' HD21 ' A' ' 122' ' ' LEU . 66.8 Cg_endo -74.11 144.18 33.36 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.448 2.099 . . . . 0.0 112.416 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.54 123.07 7.33 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.52 2.147 . . . . 0.0 112.315 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.0 mmtp -93.42 17.87 10.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.105 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.41 149.93 51.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.846 0.355 . . . . 0.0 110.795 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.603 ' CE3' HD12 ' A' ' 132' ' ' ILE . 3.7 m95 -78.52 -22.47 47.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.111 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.26 -18.4 36.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.362 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.54 -30.68 52.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.8 0.334 . . . . 0.0 111.113 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.742 HD13 HD22 ' A' ' 147' ' ' LEU . 24.5 mt -63.68 -54.79 39.41 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.673 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 12.2 Cg_endo -55.98 -30.63 78.8 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.205 1.937 . . . . 0.0 112.084 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.2 -29.16 57.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.808 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 135' ' ' LEU . 6.9 mt -72.74 -33.14 66.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.762 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.69 -22.9 38.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.202 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -85.35 -32.31 22.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.026 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -85.09 -48.44 9.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.138 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.854 HD13 ' HA ' ' A' ' 146' ' ' ALA . 1.2 mt -63.33 -17.45 62.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.403 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.42 -29.9 42.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.845 0.355 . . . . 0.0 110.814 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.34 -34.39 78.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.91 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -75.9 -27.09 57.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.97 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 113.11 40.21 1.08 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.48 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.66 -175.97 5.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.787 0.327 . . . . 0.0 110.862 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.9 t -115.34 159.12 21.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.854 ' HA ' HD13 ' A' ' 139' ' ' LEU . . . -84.57 -66.08 0.94 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.128 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.742 HD22 HD13 ' A' ' 132' ' ' ILE . 6.0 tp -154.02 141.62 19.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.939 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.854 ' HB2' HG21 ' A' ' 208' ' ' THR . 0.0 OUTLIER -135.46 -177.86 4.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.594 ' CZ ' HD11 ' A' ' 195' ' ' LEU . 8.2 p90 -177.22 175.0 1.57 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.867 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -69.0 111.17 4.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.851 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.654 HD13 ' HA ' ' A' ' 206' ' ' ALA . 6.6 mt -98.0 27.02 4.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.057 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -119.83 -40.0 2.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.822 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -99.37 146.42 31.73 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.813 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.502 ' HB3' HG12 ' A' ' 343' ' ' VAL . 87.7 Cg_endo -82.08 9.45 3.96 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.722 2.281 . . . . 0.0 113.028 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -75.41 -32.3 60.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.739 0.304 . . . . 0.0 111.13 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -94.98 -16.58 22.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.437 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 30.8 p -92.42 -24.41 18.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.69 0.281 . . . . 0.0 111.28 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.773 ' CE2' ' HB2' ' A' ' 162' ' ' ALA . 27.3 t-105 -53.4 -45.78 98.33 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.526 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.544 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 52.6 Cg_exo -52.67 -25.61 26.85 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.334 2.022 . . . . 0.0 112.28 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.493 HD11 ' CE1' ' A' ' 250' ' ' PHE . 4.8 tp -92.56 -42.96 9.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.933 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 21.0 mt -72.79 -54.66 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.773 ' HB2' ' CE2' ' A' ' 158' ' ' TRP . . . -60.2 -33.21 71.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.176 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -62.07 -33.48 74.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.142 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.28 -20.14 57.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.153 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 141.09 -26.9 2.45 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.561 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.7 158.01 53.35 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.537 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -146.8 171.26 15.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.327 . . . . 0.0 110.85 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -90.96 -67.55 0.85 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.078 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -120.83 121.14 37.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.788 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -63.69 123.99 20.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.931 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -86.36 115.28 23.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.483 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -165.04 148.38 8.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.106 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 64.73 29.22 12.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.162 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.7 -37.25 3.37 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.087 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.73 -173.35 2.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.886 0.374 . . . . 0.0 111.063 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -105.25 173.98 6.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.85 127.85 49.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.1 pt -79.34 -22.55 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.349 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.34 26.02 4.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.132 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -145.06 94.2 2.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.836 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.7 HG12 ' H ' ' A' ' 183' ' ' VAL . 21.6 t -114.27 131.75 65.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.163 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -87.88 -9.04 71.82 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.853 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.7 ' H ' HG12 ' A' ' 181' ' ' VAL . 0.3 OUTLIER -48.47 -41.8 11.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.892 0.377 . . . . 0.0 111.332 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.416 ' N ' ' CG1' ' A' ' 183' ' ' VAL . 25.8 t0 -84.61 57.17 4.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.915 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -118.26 -173.75 2.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.944 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.07 -34.77 57.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.113 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.57 -43.74 84.9 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.569 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.43 -30.62 67.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.833 0.349 . . . . 0.0 111.189 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.86 -38.68 82.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.869 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -86.96 -28.51 22.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.199 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -57.47 -54.62 35.79 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.607 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.871 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.7 OUTLIER -60.63 -53.11 61.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.829 0.347 . . . . 0.0 110.932 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.417 ' OG1' HG21 ' A' ' 357' ' ' VAL . 62.1 m -54.1 -24.93 19.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.121 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -70.86 -59.99 2.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.815 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.594 HD11 ' CZ ' ' A' ' 149' ' ' PHE . 2.6 tp -58.73 -33.07 69.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.669 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 192' ' ' LEU . 49.5 t -63.43 -54.52 31.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.902 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -66.06 -32.69 74.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.735 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.5 HD22 ' HB3' ' A' ' 133' ' ' PRO . 14.5 mt -57.11 -19.27 18.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.224 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 196' ' ' VAL . 4.7 mt -88.99 -60.11 2.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.803 0.335 . . . . 0.0 111.565 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -85.19 -47.27 10.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.008 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -71.0 -10.0 58.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.014 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -114.71 -82.98 0.61 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.808 0.337 . . . . 0.0 111.189 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 171.01 16.27 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.374 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' MET . . . . . 0.486 ' O ' HG23 ' A' ' 199' ' ' ILE . 0.2 OUTLIER -82.96 146.12 28.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.784 0.326 . . . . 0.0 110.77 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -102.04 137.42 40.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.031 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.654 ' HA ' HD13 ' A' ' 151' ' ' LEU . . . -79.99 -25.28 40.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.259 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -55.09 -31.1 60.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.132 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.854 HG21 ' HB2' ' A' ' 148' ' ' MET . 3.8 m -49.89 147.23 3.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.174 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.503 ' OD2' HD11 ' A' ' 212' ' ' ILE . 69.8 m-20 -154.15 176.22 12.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.015 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -41.59 -61.66 1.03 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.77 -59.26 3.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.833 0.349 . . . . 0.0 111.921 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.622 HD12 ' HA ' ' A' ' 208' ' ' THR . 0.2 OUTLIER -53.88 -30.67 19.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.342 -179.357 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.562 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -81.89 -25.76 34.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.801 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -82.31 -53.0 6.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.71 -25.75 63.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.323 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 221' ' ' GLU . . . -56.86 -32.27 65.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.239 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.515 ' CG ' HG21 ' A' ' 225' ' ' THR . 58.2 t80 -82.15 -34.0 29.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -75.46 -40.39 57.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -77.64 -31.92 53.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.928 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 103.01 72.13 0.91 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.546 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.412 ' HB2' ' HB1' ' A' ' 216' ' ' ALA . 6.7 mt-10 -128.39 -62.92 1.01 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.835 0.35 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.438 HG21 ' SD ' ' A' ' 148' ' ' MET . 8.9 t -93.5 135.88 34.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.939 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.92 -31.25 70.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.06 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.638 ' SD ' HD22 ' A' ' 122' ' ' LEU . 3.3 mpp? -120.8 151.21 39.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.942 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.515 HG21 ' CG ' ' A' ' 217' ' ' PHE . 9.0 t -157.67 159.58 37.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 24.8 mt -120.46 130.35 74.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.174 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.444 ' HB3' ' HB2' ' A' ' 231' ' ' ALA . 72.7 m-20 -160.95 165.34 30.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -105.99 -153.16 20.6 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.566 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.98 -26.19 24.38 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.629 2.22 . . . . 0.0 112.364 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 41.1 p90 -84.87 57.51 4.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.839 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.444 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . . . -156.45 -44.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.166 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -54.88 -48.01 73.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.021 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.3 m -66.77 -31.7 72.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.01 -32.2 73.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 4.8 mt -94.13 113.66 29.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.031 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -165.46 -49.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 7.0 m -65.87 -39.98 91.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.923 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' SER . . . . . 0.646 ' HB3' HG23 ' A' ' 240' ' ' VAL . 1.9 t -69.25 -29.5 67.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.921 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt 61.82 36.55 16.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.918 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.646 HG23 ' HB3' ' A' ' 238' ' ' SER . 26.8 t -79.01 108.29 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.043 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.42 92.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.924 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -97.58 160.05 14.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.23 137.86 9.43 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.445 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.28 124.15 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.784 0.326 . . . . 0.0 111.155 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.451 HG23 HD23 ' A' ' 115' ' ' LEU . 9.1 t -130.52 159.3 37.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.5 t -73.61 151.92 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.001 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.2 mt -74.22 149.82 87.22 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.884 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.441 ' HG2' ' CE2' ' A' ' 129' ' ' TRP . 50.9 Cg_endo -69.14 165.97 28.44 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.554 2.169 . . . . 0.0 112.341 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 4.0 p -92.33 163.64 13.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.963 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.493 ' CE1' HD11 ' A' ' 160' ' ' LEU . 8.3 t80 -128.89 111.12 12.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 8.8 mttt 60.28 28.23 17.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.023 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 93.79 -21.16 42.99 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.731 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -94.3 148.99 36.01 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.704 0.288 . . . . 0.0 110.945 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.2 154.36 66.06 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.594 2.196 . . . . 0.0 112.334 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.16 -174.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.837 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 2.0 mmtt -135.04 63.83 59.02 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.973 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -56.19 -177.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.532 2.154 . . . . 0.0 112.251 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.437 ' H ' HD12 ' A' ' 113' ' ' LEU . 32.2 m-85 -118.83 116.59 26.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.766 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.2 t -85.8 123.4 39.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.288 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -121.92 117.64 3.45 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.271 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.614 HG12 ' O ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -109.48 127.47 66.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.37 . . . . 0.0 111.318 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 29.3 tp -91.11 85.38 5.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.297 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 1.4 m -86.33 175.19 8.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.134 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.449 ' HB1' ' CG2' ' A' ' 59' ' ' ILE . . . -107.06 114.99 29.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.006 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -85.9 128.8 8.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.553 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.435 HD11 HD13 ' A' ' 280' ' ' LEU . 28.0 mt -115.63 135.18 56.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.361 . . . . 0.0 111.08 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -85.49 140.62 30.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.754 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -70.39 -41.57 72.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.081 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -61.85 -28.95 69.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.149 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 3.7 m -58.17 109.48 1.85 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.979 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.57 -18.2 43.06 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.467 2.112 . . . . 0.0 112.499 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -92.88 46.27 1.22 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.03 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 16.3 mtmt -84.05 -31.96 25.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -62.11 -57.44 11.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 50.1 mt -62.51 -31.53 72.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.722 ' HB1' HD11 ' A' ' 59' ' ' ILE . . . -69.85 -46.62 65.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' LYS . . . . . 0.468 ' HA ' HD12 ' A' ' 280' ' ' LEU . 1.0 OUTLIER -57.68 -29.12 64.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.012 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -73.7 -52.96 11.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.043 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.416 ' CD1' ' HB2' ' A' ' 283' ' ' TYR . 79.1 t80 -59.93 -28.21 67.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.325 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.894 HD21 HD13 ' A' ' 59' ' ' ILE . 5.1 mt -80.31 -30.7 38.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.182 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.44 ' HG2' ' CE1' ' A' ' 85' ' ' PHE . 7.3 tt0 -93.65 -24.46 17.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.449 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -97.51 -50.16 4.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.445 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.563 ' HB3' HG12 ' A' ' 23' ' ' VAL . 4.4 m-85 -117.47 71.41 0.81 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.37 . . . . 0.0 111.296 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.824 ' CD2' HD23 ' A' ' 280' ' ' LEU . 5.6 tp -178.54 -39.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.91 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.674 HD22 ' CZ ' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -115.26 38.35 3.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.869 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.19 -176.38 2.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -80.87 -38.7 27.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -82.68 -36.28 26.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -65.67 -44.19 92.96 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.519 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 9.2 mt -70.14 -31.08 68.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 0.0 110.915 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -70.33 -36.96 74.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.994 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -59.27 -38.22 79.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.131 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.56 -29.45 20.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.111 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -74.06 -30.92 62.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.983 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 33.1 mttt -65.87 -35.41 80.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.959 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -99.0 -30.96 12.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.969 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.411 ' HA ' ' HD2' ' A' ' 298' ' ' PRO . 3.7 mmtt -152.97 95.18 3.02 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.931 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 297' ' ' LYS . 26.2 Cg_endo -62.29 119.52 6.66 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.513 2.142 . . . . 0.0 112.248 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.748 HD12 ' HB2' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -96.72 22.01 8.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.963 179.862 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 300' ' ' GLY . . . . . 0.662 ' O ' HD13 ' A' ' 311' ' ' LEU . . . 58.37 -133.96 52.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.664 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -58.71 174.68 0.31 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.816 0.341 . . . . 0.0 111.223 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.746 HG21 ' HB3' ' A' ' 307' ' ' TYR . 14.2 m -143.18 -179.7 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.07 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -93.86 -29.55 15.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.146 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.5 tp -58.89 152.27 19.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.916 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -77.01 -61.19 2.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.019 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 7.2 p -57.17 -49.79 74.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.079 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.746 ' HB3' HG21 ' A' ' 302' ' ' VAL . 0.1 OUTLIER -57.81 -25.04 60.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.027 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.46 -31.78 71.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.736 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -83.83 -42.1 16.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.865 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -52.44 -33.22 43.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.774 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.691 ' O ' HD12 ' A' ' 317' ' ' ILE . 83.7 mt -85.74 -21.37 28.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.919 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -76.47 -2.65 33.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.711 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 22.1 mmtt -47.26 -31.83 4.09 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 121.043 0.449 . . . . 0.0 110.856 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -117.41 140.22 27.08 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.309 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.565 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 14.4 Cg_endo -57.46 -32.4 94.01 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.349 2.033 . . . . 0.0 112.416 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 11.2 mtm-85 -48.58 -42.57 34.14 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.116 0.484 . . . . 0.0 110.243 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.691 HD12 ' O ' ' A' ' 311' ' ' LEU . 34.4 mt -85.56 -30.78 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.791 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.565 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -64.66 -33.92 77.07 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.125 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -74.97 -31.46 61.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.152 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 7.1 m -64.05 -48.48 76.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 10.8 tpt -60.96 -31.62 71.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -61.11 -43.77 98.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -62.35 -41.91 98.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' ALA . . . . . 0.465 ' HB2' ' HB2' ' A' ' 112' ' ' ALA . . . -60.03 -55.0 39.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.082 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -60.1 -30.03 68.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.931 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -95.84 21.08 8.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.145 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -131.38 -179.6 16.28 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.486 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.1 133.77 52.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.825 0.345 . . . . 0.0 110.906 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.699 HD11 ' HB2' ' A' ' 92' ' ' PHE . 22.9 mt -81.53 133.53 29.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.107 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 10.7 mtm -62.41 137.42 96.15 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.92 -172.38 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.522 2.148 . . . . 0.0 112.326 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -110.05 -26.07 9.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.027 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.701 HD12 ' HB2' ' A' ' 335' ' ' GLN . 33.5 pt -56.25 147.99 44.31 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.319 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.26 -8.91 22.65 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.636 2.224 . . . . 0.0 112.645 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.701 ' HB2' HD12 ' A' ' 333' ' ' ILE . 3.3 mp0 -54.53 -26.18 30.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.741 0.305 . . . . 0.0 111.103 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.404 ' O ' ' CD1' ' A' ' 340' ' ' TRP . 0.7 OUTLIER -56.8 -30.91 64.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.934 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.5 m -60.75 -57.31 13.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.971 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.97 -30.35 71.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.133 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.757 ' O ' HG23 ' A' ' 343' ' ' VAL . 39.0 t80 -59.73 -36.76 77.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.977 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.404 ' CD1' ' O ' ' A' ' 336' ' ' MET . 25.8 m95 -66.28 -51.01 61.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.945 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.89 -47.84 84.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.074 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -57.22 -44.63 83.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.301 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.844 ' O ' HG23 ' A' ' 347' ' ' VAL . 23.9 t -77.39 -28.55 16.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.27 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -57.43 13.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.945 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 3.7 m -60.57 -41.37 94.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.586 ' HB1' ' HB1' ' A' ' 360' ' ' ALA . . . -57.29 -34.92 69.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.23 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 343' ' ' VAL . 28.7 t -82.69 -45.91 19.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.188 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 9.4 mt -61.26 -57.59 11.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.162 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -58.77 -43.66 90.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.971 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.39 -29.87 70.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.082 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -78.51 -29.45 46.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.174 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 10.6 m -95.75 20.74 9.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.18 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 56.32 27.02 52.24 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.617 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 6.8 mtt-85 -89.86 -29.69 18.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.79 0.329 . . . . 0.0 110.963 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -143.86 162.27 36.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.899 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 30.6 p -97.96 156.85 16.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.844 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.543 HG22 HD23 ' A' ' 192' ' ' LEU . 25.6 t -56.88 -28.66 28.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.159 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -70.26 -56.5 6.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -61.88 -46.08 90.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.021 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.586 ' HB1' ' HB1' ' A' ' 346' ' ' ALA . . . -60.02 -50.37 73.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.139 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.424 ' CD1' HG12 ' A' ' 357' ' ' VAL . 28.0 mt -62.04 -30.18 70.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.47 -45.44 25.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.961 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -69.13 -45.59 69.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.99 -46.03 89.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -59.8 -43.25 94.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 10.0 m -64.66 -31.53 72.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.92 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 13.6 mtp85 -68.57 -35.71 77.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.943 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.699 HD13 ' CE2' ' A' ' 339' ' ' PHE . 19.3 mt -73.26 -28.86 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.177 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 2.2 p -82.62 -31.47 28.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.899 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.901 179.969 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.804 0.335 . . . . 0.0 111.254 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 55' ' ' ASP . 10.0 t -154.27 146.66 23.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.2 165.24 12.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -82.59 154.85 24.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.568 ' O ' HG23 ' A' ' 33' ' ' ILE . . . 113.26 -35.9 4.33 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.455 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -113.76 169.86 8.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 0.0 110.871 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' A' ' 275' ' ' LEU . 44.7 mt -124.24 118.78 27.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.9 147.05 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.208 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.826 HG21 HD21 ' A' ' 20' ' ' LEU . 31.8 mt -137.32 107.34 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.927 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -96.81 109.36 22.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.84 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.458 HD11 ' CD ' ' A' ' 15' ' ' LYS . 14.9 tt -123.52 158.14 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.029 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -60.56 166.58 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.19 43.36 2.39 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.498 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -161.18 31.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.458 ' CD ' HD11 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -130.46 177.67 7.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.94 73.49 0.27 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.52 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -86.02 -33.06 21.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 0.0 110.947 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -60.43 -33.17 72.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.739 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -75.96 -28.46 60.61 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.531 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.826 HD21 HG21 ' A' ' 9' ' ' ILE . 3.7 tp -72.66 -30.99 64.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.811 0.338 . . . . 0.0 110.932 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.52 -37.94 83.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.103 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -70.39 -32.23 69.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 19' ' ' GLY . 26.8 t -72.2 -30.72 36.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.104 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.32 -38.6 33.4 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.538 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -59.88 -29.51 68.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.817 0.341 . . . . 0.0 110.94 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -74.78 -41.19 60.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.937 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.484 ' CD2' ' CE1' ' A' ' 283' ' ' TYR . 1.5 t80 -59.75 -52.62 64.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.907 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -58.53 -43.13 89.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.902 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -71.83 -25.39 61.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.83 -32.85 40.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.371 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.53 -44.23 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.473 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.16 -23.27 2.58 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.762 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.568 HG23 ' O ' ' A' ' 5' ' ' GLY . 33.1 mm -59.92 110.16 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.828 0.347 . . . . 0.0 111.037 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.6 mtmt -78.63 156.75 28.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.955 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.4 t -134.82 117.96 24.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.091 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.0 m -99.5 143.86 29.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.4 t -137.84 110.71 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.139 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -110.28 176.21 5.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.86 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -133.11 74.31 73.44 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.86 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.18 -179.13 4.07 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.64 2.227 . . . . 0.0 112.415 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -60.05 -159.43 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.53 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.476 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -46.46 -27.45 1.1 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.604 0.24 . . . . 0.0 111.53 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.567 HD12 ' CD1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 52.44 19.68 1.23 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.852 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.73 -57.12 4.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.829 0.347 . . . . 0.0 110.655 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -95.49 -7.72 37.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.002 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.87 -19.24 57.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.256 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.567 ' CD1' HD12 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -85.58 -55.94 0.39 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.045 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.444 ' HD3' ' CB ' ' A' ' 47' ' ' PHE . 72.6 Cg_exo -50.54 -35.63 46.79 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.589 2.193 . . . . 0.0 112.61 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.581 ' HG3' HG13 ' A' ' 50' ' ' VAL . 11.2 pt20 -59.49 -49.68 76.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.947 0.403 . . . . 0.0 111.004 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.581 HG13 ' HG3' ' A' ' 49' ' ' GLN . 6.6 m -95.29 18.05 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.552 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.09 -38.01 13.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.825 0.345 . . . . 0.0 111.216 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.51 -33.77 68.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.164 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.449 HG23 ' H ' ' A' ' 55' ' ' ASP . 3.3 t -96.43 -29.53 13.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.934 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.53 28.1 72.71 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.431 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.691 ' O ' HG22 ' A' ' 2' ' ' THR . 5.3 t0 -94.5 -28.26 15.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.74 0.305 . . . . 0.0 111.01 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.97 -105.11 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.597 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.444 ' CG ' ' CE2' ' A' ' 47' ' ' PHE . 61.4 Cg_endo -73.18 -169.12 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.49 2.127 . . . . 0.0 112.407 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -150.55 -46.86 0.12 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.813 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.2 mt -127.19 133.37 68.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.058 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.477 ' CG1' ' N ' ' A' ' 61' ' ' PHE . 1.9 tt -139.49 159.69 28.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.111 0.481 . . . . 0.0 110.942 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.6 ' CE2' HD21 ' A' ' 284' ' ' LEU . 65.2 m-85 -138.1 122.35 18.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.873 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -158.26 169.26 24.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.882 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.13 143.87 47.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -60.49 -31.52 70.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -59.74 -36.04 75.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.902 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.3 mmt-85 -94.69 17.18 13.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.231 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -105.71 -31.14 9.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.849 0.357 . . . . 0.0 110.858 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.5 -28.14 64.53 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.555 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.34 -28.83 74.01 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.559 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -91.89 -27.91 17.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.73 0.3 . . . . 0.0 110.982 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.589 ' HB2' HD12 ' A' ' 76' ' ' LEU . . . -79.53 -28.03 41.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.244 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.36 -31.71 69.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.063 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.6 m -88.09 -23.17 23.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.09 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.4 27.98 10.17 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.442 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.9 mt -81.25 -34.25 32.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.77 0.319 . . . . 0.0 110.868 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.589 HD12 ' HB2' ' A' ' 71' ' ' ALA . 25.5 mt -81.86 146.55 29.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.71 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -87.29 135.27 33.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.068 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.696 ' HA ' HG22 ' A' ' 104' ' ' ILE . 17.5 tp10 -69.57 159.72 32.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.09 0.472 . . . . 0.0 110.739 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.59 HG21 ' CE1' ' A' ' 106' ' ' TYR . 35.4 pt -135.29 -178.57 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.176 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 t -163.22 78.0 1.75 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.804 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.08 123.4 11.83 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.643 2.229 . . . . 0.0 112.282 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.5 -177.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.852 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -60.09 -40.56 90.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.913 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.79 -50.5 73.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.094 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -66.28 -35.31 80.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.46 -31.14 63.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.794 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -75.64 -36.51 60.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 57.19 4.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.885 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.514 HD13 ' CZ2' ' A' ' 94' ' ' TRP . 0.1 OUTLIER -173.61 162.02 4.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.774 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.48 ' CD1' ' CZ ' ' A' ' 92' ' ' PHE . 22.0 m-85 -78.51 136.22 60.09 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.077 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 53.3 Cg_exo -55.24 -55.72 2.91 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.526 2.15 . . . . 0.0 112.662 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.908 ' CE1' HG23 ' A' ' 93' ' ' THR . 25.0 p90 -54.87 -44.83 74.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.549 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.908 HG23 ' CE1' ' A' ' 92' ' ' PHE . 40.2 p -61.31 -27.6 68.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.189 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.514 ' CZ2' HD13 ' A' ' 89' ' ' LEU . 8.4 m95 -69.52 -29.29 66.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.941 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.401 ' HA ' ' CG ' ' A' ' 98' ' ' ARG . 1.3 m-20 -93.66 17.32 11.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.362 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -101.89 -29.69 11.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.76 0.314 . . . . 0.0 111.214 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.687 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 12.0 m -90.63 -35.73 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.446 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.401 ' CG ' ' HA ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -65.95 132.37 48.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.012 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.407 ' CE1' ' OD1' ' A' ' 332' ' ' ASN . 0.4 OUTLIER -82.0 -49.59 10.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.865 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -148.6 54.67 1.01 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.929 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.12 -27.27 20.01 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.645 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.51 158.9 20.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.782 0.325 . . . . 0.0 110.965 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 54.9 mt -117.5 131.03 56.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.884 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.696 HG22 ' HA ' ' A' ' 78' ' ' GLU . 2.8 pp -142.65 27.21 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.342 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.89 ' HB1' ' HB2' ' A' ' 263' ' ' SER . . . -158.25 179.33 9.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.869 0.366 . . . . 0.0 111.173 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.59 ' CE1' HG21 ' A' ' 79' ' ' ILE . 39.2 m-85 -140.87 89.49 9.96 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.833 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.462 ' HG3' HG13 ' A' ' 97' ' ' VAL . 52.6 Cg_exo -53.09 99.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.57 2.18 . . . . 0.0 112.269 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.62 ' HA ' HD21 ' A' ' 285' ' ' LEU . 25.2 mm -74.01 -66.23 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.161 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.423 ' O ' HG12 ' A' ' 261' ' ' VAL . . . -120.8 166.36 13.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.066 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 301' ' ' ALA . 10.9 p -123.22 139.07 51.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.092 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -116.74 147.93 41.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -161.85 149.62 14.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.141 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 113' ' ' LEU . 28.9 mt -68.27 126.02 28.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.9 m -124.9 147.29 48.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.503 HD12 HG12 ' A' ' 226' ' ' ILE . 5.2 tp -82.94 136.0 34.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.898 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.535 HG23 ' O ' ' A' ' 243' ' ' GLY . 4.3 mt -116.4 131.38 69.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.049 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -122.24 154.95 36.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.32 144.31 31.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.36 29.77 3.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.959 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.731 ' HB3' HD23 ' A' ' 121' ' ' LEU . 1.8 t70 -97.39 -61.17 1.44 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.895 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.731 HD23 ' HB3' ' A' ' 120' ' ' ASP . 0.2 OUTLIER -110.33 -32.83 6.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.849 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.517 HD21 ' HD3' ' A' ' 126' ' ' PRO . 14.1 tp -93.39 104.16 11.62 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.821 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.83 -47.21 2.0 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.405 2.07 . . . . 0.0 112.275 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -123.38 135.44 26.04 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.822 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.09 139.11 21.21 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.529 2.152 . . . . 0.0 112.32 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.517 ' HD3' HD21 ' A' ' 122' ' ' LEU . 74.5 Cg_endo -75.2 116.77 4.65 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.447 2.098 . . . . 0.0 112.394 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.01 23.41 6.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.03 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.5 p -134.77 141.95 46.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.865 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.804 ' CE3' HD12 ' A' ' 132' ' ' ILE . 2.4 m95 -79.94 -22.56 42.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.103 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.52 -24.72 53.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.181 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -81.18 -26.56 35.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.143 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.804 HD12 ' CE3' ' A' ' 129' ' ' TRP . 31.7 mt -57.28 -54.56 53.49 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.625 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 15.6 Cg_endo -57.47 -27.32 75.75 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.239 1.959 . . . . 0.0 112.089 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.0 -29.31 35.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.5 mt -73.92 -39.68 63.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.859 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.12 -26.35 11.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.058 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -85.58 -27.86 25.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.122 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.98 -48.62 9.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.153 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.808 HD13 ' HA ' ' A' ' 146' ' ' ALA . 0.2 OUTLIER -62.89 -17.32 61.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.411 -179.76 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -28.11 55.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.845 0.355 . . . . 0.0 110.847 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.88 -41.64 87.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.02 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 46.7 mttt -77.22 -27.01 53.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.02 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 116.07 31.48 1.88 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.488 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.72 -178.31 5.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 0.0 110.868 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.2 t -115.65 171.76 7.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.861 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.808 ' HA ' HD13 ' A' ' 139' ' ' LEU . . . -87.28 -57.59 2.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.155 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.479 ' HB2' ' HE2' ' A' ' 224' ' ' MET . 6.2 tp -161.21 143.83 12.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.987 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.455 ' SD ' HG21 ' A' ' 222' ' ' THR . 0.0 OUTLIER -132.29 -178.99 5.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -179.29 151.73 0.5 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -62.52 121.33 13.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.857 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.4 mt -98.26 28.6 3.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.938 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -112.63 -33.59 6.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.24 107.51 60.54 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.887 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -51.32 -24.13 15.14 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.485 2.123 . . . . 0.0 112.398 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.483 ' CE1' ' CD2' ' A' ' 258' ' ' PHE . 54.0 t80 -52.33 -27.79 16.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.199 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -87.11 -35.1 18.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.9 p -94.86 18.3 12.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.2 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.552 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 27.4 t-105 -73.76 -50.51 5.65 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.531 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 43.2 Cg_endo -68.2 -24.79 37.67 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.116 1.878 . . . . 0.0 112.508 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.673 ' CD2' HD13 ' A' ' 195' ' ' LEU . 52.1 tp -59.23 -37.47 77.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.841 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 4.8 mp -105.06 -33.28 2.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.991 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.52 -29.15 70.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.241 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.403 ' HB2' ' HA ' ' A' ' 255' ' ' SER . . . -56.64 -46.77 80.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.144 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -61.06 -20.07 62.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.124 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 125.63 53.55 0.17 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.489 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -134.53 123.64 3.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.512 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.433 ' CD2' ' HA3' ' A' ' 182' ' ' GLY . 20.7 p90 -117.99 -178.25 3.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.848 0.356 . . . . 0.0 110.871 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -100.07 -44.48 5.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.083 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -131.87 141.95 49.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.7 tptp -68.38 137.24 54.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.976 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.429 ' CE1' ' HA2' ' A' ' 174' ' ' GLY . 19.8 t80 -128.11 110.7 12.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.74 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.407 ' CG ' ' N ' ' A' ' 173' ' ' ASN . 9.7 pt-20 -139.01 -47.24 0.48 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.308 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.407 ' N ' ' CG ' ' A' ' 172' ' ' GLU . 15.0 m120 -95.72 41.85 1.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.073 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.429 ' HA2' ' CE1' ' A' ' 171' ' ' TYR . . . 57.78 20.55 40.54 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.706 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.406 ' O ' ' CD2' ' A' ' 171' ' ' TYR . 11.3 mttt -133.3 -171.37 2.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.337 . . . . 0.0 110.866 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -126.44 86.81 2.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.59 127.67 33.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.911 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.9 pt -81.46 -12.3 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.472 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -96.01 26.0 4.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.719 0.295 . . . . 0.0 111.149 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -148.4 116.16 6.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.935 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.715 HG12 ' H ' ' A' ' 183' ' ' VAL . 21.3 t -104.53 146.08 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.042 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 0.433 ' HA3' ' CD2' ' A' ' 167' ' ' TYR . . . -96.97 -12.64 49.08 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.029 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.898 HG12 HD22 ' A' ' 361' ' ' LEU . 6.1 t -62.89 -43.5 98.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.815 0.34 . . . . 0.0 111.18 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -83.85 57.23 4.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.07 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -110.74 -172.78 2.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.12 -44.78 29.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.171 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.16 -34.78 28.84 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.583 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.62 -30.16 68.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.337 . . . . 0.0 111.179 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -60.51 -56.62 19.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.32 -26.53 55.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.225 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -56.14 -40.7 84.29 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.706 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.832 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.4 OUTLIER -76.77 -30.13 56.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.752 0.311 . . . . 0.0 110.94 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 66.2 m -56.35 -23.27 36.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.943 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -65.58 -60.53 2.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.791 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.673 HD13 ' CD2' ' A' ' 160' ' ' LEU . 5.2 tp -60.31 -30.96 69.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.703 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 192' ' ' LEU . 40.0 t -66.07 -48.41 81.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.007 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -82.43 -23.12 34.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.095 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.605 HD23 ' HG3' ' A' ' 202' ' ' LYS . 6.3 mt -64.25 -24.38 67.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.228 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 204' ' ' MET . 13.5 mt -88.96 -42.22 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.646 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 23.4 mtpt -85.02 -29.35 25.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.829 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -91.65 -10.18 41.28 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.605 ' HG3' HD23 ' A' ' 198' ' ' LEU . 13.4 mmtt -133.96 9.71 3.86 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.191 -0.204 . . . . 0.0 111.516 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' HIS . . . . . 0.424 ' CG ' ' O ' ' A' ' 202' ' ' LYS . 56.2 p-80 43.89 53.15 6.38 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.942 0.401 . . . . 0.0 111.376 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' MET . . . . . 0.432 ' O ' HG23 ' A' ' 199' ' ' ILE . 0.0 OUTLIER -82.84 128.42 34.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.844 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -59.94 119.89 8.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.991 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -80.04 -28.06 39.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.077 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -56.47 -24.36 45.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.182 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.653 ' HA ' HD12 ' A' ' 212' ' ' ILE . 7.6 m -36.29 145.91 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.94 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.476 ' OD2' HD11 ' A' ' 212' ' ' ILE . 59.4 m-20 -153.55 176.21 12.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.75 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -34.84 79.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.032 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.99 -59.13 2.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 0.0 111.226 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' A' ' 208' ' ' THR . 0.3 OUTLIER -58.88 -29.59 41.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.848 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -81.75 -21.23 37.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.995 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -75.47 -56.9 4.25 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.837 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.37 -29.53 68.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.136 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.524 ' HB1' ' HB2' ' A' ' 221' ' ' GLU . . . -58.94 -41.91 88.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.141 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.679 ' CG ' HG21 ' A' ' 225' ' ' THR . 19.1 t80 -75.65 -33.16 60.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -74.9 -38.39 61.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.956 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.35 -31.55 33.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.894 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.66 63.8 0.72 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.48 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.524 ' HB2' ' HB1' ' A' ' 216' ' ' ALA . 39.9 mm-40 -111.07 -32.99 6.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.342 . . . . 0.0 110.949 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.455 HG21 ' SD ' ' A' ' 148' ' ' MET . 9.6 t -121.05 162.26 20.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -84.08 -39.86 19.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.102 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.479 ' HE2' ' HB2' ' A' ' 147' ' ' LEU . 1.3 mpp? -126.71 165.81 18.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.897 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.679 HG21 ' CG ' ' A' ' 217' ' ' PHE . 9.8 t -166.65 139.52 3.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.503 HG12 HD12 ' A' ' 115' ' ' LEU . 22.9 mt -101.08 128.27 53.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.466 ' ND2' ' HB3' ' A' ' 231' ' ' ALA . 1.7 p-10 -165.3 144.74 6.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -63.84 -175.05 3.5 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.508 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.52 -20.91 35.34 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.662 2.241 . . . . 0.0 112.457 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' TRP . . . . . 0.428 ' CD1' ' N ' ' A' ' 231' ' ' ALA . 5.4 p90 -56.3 -30.7 62.86 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.001 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.466 ' HB3' ' ND2' ' A' ' 227' ' ' ASN . . . -72.92 -32.78 65.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.102 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' TRP . . . . . 0.881 ' HA ' HD12 ' A' ' 235' ' ' ILE . 50.6 m0 -57.29 -27.42 62.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.074 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.3 m -59.59 -55.42 34.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.024 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -62.59 -30.63 71.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.011 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.881 HD12 ' HA ' ' A' ' 232' ' ' TRP . 23.2 mt -70.78 96.69 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.085 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -160.48 -53.2 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.77 -33.92 74.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.917 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' SER . . . . . 0.458 ' HB2' HG23 ' A' ' 240' ' ' VAL . 99.1 p -60.19 -32.84 71.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.906 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm 60.69 33.34 20.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.458 HG23 ' HB2' ' A' ' 238' ' ' SER . 21.5 t -91.44 131.18 39.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.12 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.97 93.52 3.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.589 ' CE1' HG21 ' A' ' 235' ' ' ILE . 52.7 p90 -103.43 135.13 45.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.967 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.535 ' O ' HG23 ' A' ' 116' ' ' ILE . . . -101.97 -164.55 26.84 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.5 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.4 t -148.19 133.99 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 111.128 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 63.3 m -143.5 159.3 42.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.86 151.88 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.971 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.447 HD12 ' OD1' ' A' ' 323' ' ' ASN . 9.9 mt -59.64 141.05 88.94 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.874 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.43 ' HB2' ' CD1' ' A' ' 129' ' ' TRP . 50.3 Cg_exo -53.67 146.1 45.78 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.506 2.137 . . . . 0.0 112.242 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 67.6 p -81.19 -177.3 6.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -156.8 109.95 2.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 24.1 mtpt 59.57 31.04 20.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 83.84 27.12 39.1 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.549 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -138.16 142.2 34.69 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.667 0.27 . . . . 0.0 110.915 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.09 163.88 34.29 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.572 2.181 . . . . 0.0 112.342 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.403 ' HA ' ' HB2' ' A' ' 163' ' ' ALA . 8.5 m -74.25 153.05 39.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.845 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.35 72.62 0.93 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.868 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.8 -168.26 0.31 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.597 2.198 . . . . 0.0 112.335 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.496 ' CE2' ' CD1' ' A' ' 158' ' ' TRP . 13.9 m-85 -101.99 165.6 11.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.924 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 328' ' ' GLU . 26.5 t -127.98 126.4 66.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.103 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -126.92 116.9 2.59 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.386 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -112.6 130.56 66.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.824 0.345 . . . . 0.0 111.078 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 7.3 tp -90.58 84.01 5.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.791 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.89 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 0.3 OUTLIER -83.53 166.27 18.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.966 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.581 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . . . -99.51 131.38 45.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.068 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -95.53 103.04 2.92 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.507 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.507 HD11 ' CD1' ' A' ' 280' ' ' LEU . 32.8 mt -100.5 103.05 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.797 0.332 . . . . 0.0 111.098 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -62.07 165.49 5.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.997 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.71 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -84.02 -24.97 30.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.279 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -96.4 30.25 2.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.301 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.44 125.05 90.59 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.83 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.23 -27.71 39.25 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.385 2.057 . . . . 0.0 112.339 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -145.9 85.51 1.69 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.883 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -64.85 -36.32 83.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.855 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.25 -57.69 9.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.459 ' HB3' HD11 ' A' ' 7' ' ' LEU . 10.1 mt -60.01 -31.53 70.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.957 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.92 -60.4 3.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.099 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' LYS . . . . . 0.515 ' HA ' HD12 ' A' ' 280' ' ' LEU . 0.3 OUTLIER -61.86 -29.16 70.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.964 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -59.47 -60.91 3.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.021 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.458 ' HE1' HD13 ' A' ' 284' ' ' LEU . 52.6 t80 -54.12 -24.27 17.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.403 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.913 HD23 HD22 ' A' ' 284' ' ' LEU . 95.1 mt -76.74 -40.72 47.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.265 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -93.56 -16.38 24.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.601 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.444 ' HB3' ' CD1' ' A' ' 283' ' ' TYR . 4.3 m120 -91.91 -58.06 2.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.639 0.257 . . . . 0.0 111.362 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.484 ' CE1' ' CD2' ' A' ' 27' ' ' PHE . 7.0 m-85 -126.83 75.86 1.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.37 . . . . 0.0 111.227 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.913 HD22 HD23 ' A' ' 280' ' ' LEU . 5.1 tp -177.99 -57.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.924 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.62 HD21 ' HA ' ' A' ' 108' ' ' ILE . 13.7 mt -94.41 47.29 1.18 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.891 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 18.0 p -128.53 176.98 7.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.891 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.425 ' HA ' ' CD1' ' A' ' 307' ' ' TYR . 9.2 p-10 -81.0 -34.98 32.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.933 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -82.69 -31.21 28.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.929 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.79 -56.64 5.8 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.583 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.444 HD21 HG22 ' A' ' 108' ' ' ILE . 0.9 OUTLIER -59.83 -30.7 69.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.76 0.314 . . . . 0.0 110.97 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -59.76 -41.06 90.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.036 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.72 -54.44 47.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.143 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.3 t -58.4 -28.31 35.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.282 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -71.08 -27.16 63.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.046 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 18.5 mttm -60.28 -34.19 73.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.189 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -110.73 -34.68 6.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.207 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 2.8 tppt? -133.41 83.71 48.73 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.062 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.42 119.32 6.26 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.579 2.186 . . . . 0.0 112.284 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 4.6 mp -95.71 20.95 9.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.07 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 57.09 -106.56 0.74 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.603 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.525 ' HB3' HG13 ' A' ' 110' ' ' VAL . . . -71.59 175.29 5.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 111.12 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 15.4 m -143.14 160.12 17.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.165 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 108' ' ' ILE . . . -79.96 -34.51 38.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.072 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.46 HD23 ' HB2' ' A' ' 307' ' ' TYR . 2.7 tp -71.37 110.65 6.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.891 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -60.59 -31.54 70.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.861 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.4 m -70.21 -33.23 71.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.561 ' CE2' HD11 ' A' ' 311' ' ' LEU . 12.5 t80 -83.78 -27.14 29.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.024 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -58.75 -30.62 67.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.878 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -63.19 -55.32 26.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.809 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.94 -35.25 45.31 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.749 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.678 ' CB ' HG21 ' A' ' 317' ' ' ILE . 15.8 mt -85.73 -23.97 27.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.756 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.46 -14.74 61.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.457 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -46.66 -31.37 2.85 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 120.921 0.391 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -116.64 137.89 24.05 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.302 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.77 -28.48 67.09 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.432 2.088 . . . . 0.0 112.459 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -51.72 -36.31 46.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.001 0.429 . . . . 0.0 110.37 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.678 HG21 ' CB ' ' A' ' 311' ' ' LEU . 35.7 mm -85.43 -35.45 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.85 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -69.83 -29.69 67.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.189 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -70.66 -56.01 7.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.148 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 8.7 m -60.1 -37.23 79.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.954 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.486 ' SD ' ' HB1' ' A' ' 301' ' ' ALA . 7.0 tpt -63.98 -31.34 72.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.951 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -69.45 -53.65 18.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.992 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.447 ' OD1' HD12 ' A' ' 247' ' ' LEU . 0.3 OUTLIER -60.2 -31.34 70.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.887 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.68 -31.33 72.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.14 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -75.43 -55.02 6.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.94 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -68.55 -30.29 69.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -58.43 142.56 45.05 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.529 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' GLU . . . . . 0.754 ' O ' HG23 ' A' ' 259' ' ' VAL . 26.8 tt0 -74.53 154.12 38.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.869 0.366 . . . . 0.0 110.872 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.532 HD11 ' HB2' ' A' ' 92' ' ' PHE . 23.3 mt -101.69 132.52 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.064 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.428 ' HG3' ' CD1' ' A' ' 258' ' ' PHE . 29.5 mtm -69.58 135.87 88.3 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.49 168.55 24.26 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.501 2.134 . . . . 0.0 112.347 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.407 ' OD1' ' CE1' ' A' ' 99' ' ' TYR . 9.3 p30 -113.03 36.81 3.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.839 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.855 HD12 ' HB2' ' A' ' 335' ' ' GLN . 2.1 pt -105.98 154.29 39.59 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.158 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.26 -28.1 28.08 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.564 2.176 . . . . 0.0 112.308 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.855 ' HB2' HD12 ' A' ' 333' ' ' ILE . 15.0 mp0 -58.86 -26.26 64.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.047 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.4 ' O ' ' CD1' ' A' ' 340' ' ' TRP . 0.0 OUTLIER -56.08 -29.9 61.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.04 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.8 m -66.66 -41.65 87.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.936 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.85 -26.09 60.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.233 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.845 ' O ' HG23 ' A' ' 343' ' ' VAL . 87.5 t80 -57.95 -30.43 65.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.07 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.4 ' CD1' ' O ' ' A' ' 336' ' ' MET . 89.0 m95 -67.43 -53.28 30.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.004 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.89 -24.75 59.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.172 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -84.77 -29.13 25.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.397 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.853 ' O ' HG23 ' A' ' 347' ' ' VAL . 25.4 t -91.97 -50.27 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.259 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.404 ' O ' HD12 ' A' ' 348' ' ' ILE . 0.0 OUTLIER -52.66 -28.5 21.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.281 -179.773 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 19.5 m -85.72 -48.67 8.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.077 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.784 ' HB1' ' HB1' ' A' ' 360' ' ' ALA . . . -58.78 -29.12 66.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.388 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 343' ' ' VAL . 24.8 t -77.13 -52.26 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.293 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 344' ' ' ARG . 40.4 mt -61.38 -50.92 78.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.127 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -58.57 -30.18 66.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.925 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -82.68 -29.42 29.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.207 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -76.44 -27.08 56.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.272 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 3.3 m -95.83 20.77 9.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.224 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 55.75 24.7 41.65 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.703 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.87 -29.72 18.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.832 0.349 . . . . 0.0 110.887 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -138.69 153.26 48.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.817 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.14 165.08 20.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.805 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 358' ' ' ASP . 1.6 p -63.97 -45.4 96.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.154 0.502 . . . . 0.0 110.774 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 358' ' ' ASP . . . . . 0.468 ' N ' ' CG1' ' A' ' 357' ' ' VAL . 66.4 m-20 -60.02 -53.87 52.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.172 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -57.18 -31.24 65.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.177 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.784 ' HB1' ' HB1' ' A' ' 346' ' ' ALA . . . -61.07 -60.41 3.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.973 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.898 HD22 HG12 ' A' ' 183' ' ' VAL . 0.3 OUTLIER -63.31 -32.93 74.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.606 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.65 -59.05 3.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -59.17 -46.37 88.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.795 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -57.13 -37.16 71.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.076 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.411 ' HA ' HG21 ' A' ' 181' ' ' VAL . 5.4 tt0 -60.59 -45.4 94.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 6.5 m -61.03 -40.61 94.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.956 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 44.4 mtm180 -62.95 -43.52 98.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.937 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 15.8 mt -72.47 -32.19 40.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.047 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.491 HG23 ' O ' ' A' ' 369' ' ' THR . 4.8 t -160.76 91.83 0.92 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.912 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.827 0.346 . . . . 0.0 111.172 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.461 HG21 ' OD2' ' A' ' 58' ' ' ASP . 1.5 m -79.11 104.81 9.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -72.73 149.96 43.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.911 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -69.46 137.23 52.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 107.76 29.4 4.4 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.474 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.443 ' HA ' HG22 ' A' ' 33' ' ' ILE . 2.3 ptpt -157.14 -177.94 6.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.817 0.341 . . . . 0.0 110.91 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 mt -150.09 112.49 4.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.8 t -100.58 131.07 48.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.162 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.638 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.3 mp -113.2 107.36 22.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.817 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.445 ' CD2' ' HG2' ' A' ' 57' ' ' PRO . 0.3 OUTLIER -95.22 106.7 18.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.842 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.9 tt -137.12 157.22 35.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.104 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -69.45 -179.59 1.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.51 61.02 0.31 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.558 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.41 31.11 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.815 0.34 . . . . 0.0 110.917 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -150.37 -176.73 5.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.854 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.75 64.79 1.84 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.536 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -78.92 -31.56 45.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.824 0.345 . . . . 0.0 110.921 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -63.1 -32.04 73.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.844 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.85 -30.82 57.14 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.46 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.516 HD21 HG21 ' A' ' 9' ' ' ILE . 14.1 tp -60.98 -30.68 70.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 110.887 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.89 -48.62 80.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.131 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -59.03 -30.66 68.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.966 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 36.5 t -69.04 -34.89 66.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.029 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.3 -35.71 83.1 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.465 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -59.63 -27.82 66.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.81 0.338 . . . . 0.0 111.014 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.42 -41.58 76.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.894 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.84 -51.26 67.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.0 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -64.66 -23.1 67.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.158 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -82.64 -25.45 33.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.309 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -101.22 -32.58 10.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.629 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.8 p -119.0 -44.18 2.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.781 0.325 . . . . 0.0 111.446 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.93 27.23 6.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.526 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.443 HG22 ' HA ' ' A' ' 6' ' ' LYS . 27.9 mm -94.19 130.49 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.761 0.315 . . . . 0.0 111.104 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -59.64 152.16 23.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.942 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.33 104.64 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.115 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.0 m -103.41 147.87 26.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -141.16 110.63 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -115.61 161.11 19.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.928 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -132.51 70.3 79.6 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.865 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.562 ' HG2' HD22 ' A' ' 43' ' ' LEU . 40.9 Cg_endo -68.13 161.14 45.71 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.59 2.193 . . . . 0.0 112.362 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -103.36 141.01 36.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.651 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.09 37.57 24.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.817 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.562 HD22 ' HG2' ' A' ' 40' ' ' PRO . 2.4 pp -79.07 5.57 11.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.747 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.4 -46.69 66.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.795 0.331 . . . . 0.0 111.173 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -90.03 -9.84 47.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.478 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.607 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -89.03 -18.91 26.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.649 0.261 . . . . 0.0 111.338 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.441 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -78.18 -50.86 1.71 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.682 0.277 . . . . 0.0 111.317 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 52.7 Cg_exo -55.31 -20.43 25.31 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.632 2.221 . . . . 0.0 112.944 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.429 ' CG ' ' N ' ' A' ' 50' ' ' VAL . 0.9 OUTLIER -85.71 -47.95 9.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.896 0.379 . . . . 0.0 111.327 -179.61 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 46' ' ' LYS . 11.2 m -79.57 -28.6 13.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.304 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.28 -41.69 89.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.88 -32.21 73.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.148 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.2 p -83.52 -30.83 26.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.937 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.443 ' HA3' ' HB1' ' A' ' 269' ' ' ALA . . . 75.5 25.85 66.97 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.559 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.26 -31.07 10.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.864 0.364 . . . . 0.0 110.892 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.38 -147.72 2.29 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.523 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.445 ' HG2' ' CD2' ' A' ' 10' ' ' TRP . 52.9 Cg_exo -52.57 -175.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.56 2.173 . . . . 0.0 112.314 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.461 ' OD2' HG21 ' A' ' 2' ' ' THR . 63.8 m-20 -135.25 -46.77 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.957 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.67 HG21 HD11 ' A' ' 280' ' ' LEU . 6.7 pt -117.24 130.65 71.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.25 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.758 HD11 ' CE3' ' A' ' 62' ' ' TRP . 2.8 tt -127.4 159.84 37.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.83 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.482 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 6.2 m-85 -119.65 140.52 50.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.139 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.758 ' CE3' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -176.07 153.76 1.34 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.724 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.89 158.44 6.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.09 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -55.99 -36.23 67.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.127 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -65.03 -29.68 70.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.066 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.7 17.25 12.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.365 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.867 ' CD2' ' HB2' ' A' ' 105' ' ' ALA . 2.6 m-85 -110.99 -31.8 7.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.8 0.333 . . . . 0.0 110.909 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.33 -28.3 61.68 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.519 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.06 -25.9 63.24 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.61 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -85.42 -19.32 31.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.627 0.251 . . . . 0.0 111.279 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.53 -39.47 16.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.759 0.314 . . . . 0.0 111.166 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -30.63 71.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.012 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.1 m -73.64 -23.09 59.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.08 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.81 26.79 30.96 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.561 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 mt -94.59 -30.12 14.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.84 0.353 . . . . 0.0 110.976 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 80.5 mt -83.09 160.86 21.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.032 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.482 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -109.17 -172.69 2.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.04 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.408 ' O ' ' CG2' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -88.57 -168.16 2.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.002 0.429 . . . . 0.0 110.958 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.778 HD11 ' CB ' ' A' ' 103' ' ' LEU . 7.6 pt -158.53 179.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.851 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 61.7 p -157.46 78.74 3.59 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.138 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.631 ' HD3' HD12 ' A' ' 79' ' ' ILE . 28.6 Cg_endo -62.22 113.2 1.8 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.575 2.183 . . . . 0.0 112.128 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.54 176.98 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.965 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -50.05 75.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.863 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 88' ' ' LYS . . . -56.66 -22.06 31.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.405 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.706 ' CZ ' HD22 ' A' ' 285' ' ' LEU . 0.3 OUTLIER -83.75 -54.52 4.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.898 0.38 . . . . 0.0 111.006 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.475 ' HG2' ' CZ2' ' A' ' 94' ' ' TRP . 17.3 mt-30 -69.79 -21.18 63.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.539 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -91.62 -9.07 45.39 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.449 ' HG2' HD12 ' A' ' 304' ' ' LEU . 0.0 OUTLIER -117.07 -23.01 8.13 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.497 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 85' ' ' PHE . 0.4 OUTLIER -82.72 135.13 35.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.868 0.366 . . . . 0.0 110.988 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.45 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . 33.1 m-85 -63.25 131.97 94.95 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.073 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.13 -55.57 3.74 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.682 2.255 . . . . 0.0 112.867 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.657 ' HD1' HD11 ' A' ' 329' ' ' ILE . 10.5 p90 -46.35 -28.02 1.21 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.908 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.477 HG22 ' CE1' ' A' ' 92' ' ' PHE . 11.7 p -72.95 -31.28 64.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.83 0.348 . . . . 0.0 110.858 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.736 ' CZ3' HD11 ' A' ' 103' ' ' LEU . 6.6 m95 -63.57 -31.42 72.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.817 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.26 -18.21 64.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.359 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.665 ' HB2' HG21 ' A' ' 329' ' ' ILE . . . -88.77 -18.11 28.44 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.574 HG23 ' CD2' ' A' ' 103' ' ' LEU . 4.8 m -103.82 -36.0 3.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.653 0.263 . . . . 0.0 111.541 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.9 116.92 7.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.885 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -99.85 -33.33 10.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.809 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -155.23 40.68 0.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.767 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.73 -22.37 40.78 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.658 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.7 pttp -104.21 179.77 4.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 111.018 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.778 ' CB ' HD11 ' A' ' 79' ' ' ILE . 17.6 mt -124.96 169.36 12.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.022 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.501 HD12 ' HD2' ' A' ' 67' ' ' PHE . 1.2 pp -156.61 -41.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.393 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.867 ' HB2' ' CD2' ' A' ' 67' ' ' PHE . . . -89.8 162.84 15.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 111.301 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.468 ' OH ' HG22 ' A' ' 79' ' ' ILE . 58.9 m-85 -120.14 79.93 27.0 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.551 ' O ' HD21 ' A' ' 285' ' ' LEU . 50.5 Cg_exo -54.19 137.47 70.51 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.607 2.205 . . . . 0.0 112.352 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.664 HD12 ' O ' ' A' ' 262' ' ' LEU . 3.1 mp -118.51 -60.15 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.126 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.61 ' HB2' HD13 ' A' ' 299' ' ' LEU . . . -125.37 150.42 47.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.141 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.518 HG23 ' HB2' ' A' ' 303' ' ' ALA . 21.4 t -122.02 101.15 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.33 174.69 9.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.974 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -169.97 124.59 0.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.07 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.467 HD23 ' HA2' ' A' ' 228' ' ' GLY . 2.9 mt -64.35 96.59 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.962 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.2 t -100.3 154.17 18.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.3 tt -83.24 128.57 34.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.907 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.681 HD12 ' HB2' ' A' ' 227' ' ' ASN . 4.1 mt -114.53 130.52 68.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.096 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -109.79 165.55 11.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -106.68 154.05 21.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.94 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -98.92 31.07 3.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -94.06 -45.78 7.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.89 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -144.04 38.96 1.32 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 20.1 tp -172.5 89.35 0.41 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.07 -44.79 2.31 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.527 2.151 . . . . 0.0 112.29 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -108.91 120.45 45.96 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.834 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.92 151.1 44.83 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.408 2.072 . . . . 0.0 112.389 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.63 119.03 5.71 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.587 2.192 . . . . 0.0 112.344 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.24 21.69 7.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.036 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.38 141.94 25.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.838 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.678 ' CE3' HD12 ' A' ' 132' ' ' ILE . 45.9 m95 -68.29 -27.99 66.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.001 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -73.47 -15.75 61.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.402 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.772 ' O ' HD12 ' A' ' 135' ' ' LEU . 0.5 OUTLIER -87.12 -3.91 59.1 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.708 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.678 HD12 ' CE3' ' A' ' 129' ' ' TRP . 11.3 mt -85.47 -48.13 0.59 Allowed Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.599 ' HG3' HD21 ' A' ' 198' ' ' LEU . 71.5 Cg_exo -48.51 -49.83 13.7 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.383 2.055 . . . . 0.0 112.411 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.45 -42.83 98.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.088 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.772 HD12 ' O ' ' A' ' 131' ' ' GLU . 0.2 OUTLIER -58.19 -48.61 79.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.595 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 1.4 t70 -53.4 -27.8 26.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -85.71 -28.91 24.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -84.96 -52.01 6.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.331 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.53 HD13 ' HA ' ' A' ' 146' ' ' ALA . 2.1 mt -58.88 -19.75 44.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.493 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.19 -29.56 48.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.823 0.344 . . . . 0.0 110.803 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.74 -36.72 77.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.66 -27.04 40.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.878 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.45 31.26 2.03 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.508 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -140.27 173.57 11.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.751 0.31 . . . . 0.0 110.924 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.493 ' O ' HD13 ' A' ' 139' ' ' LEU . 10.1 t -101.21 171.99 7.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.595 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -101.33 -68.4 0.82 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.267 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.674 HD22 HD13 ' A' ' 132' ' ' ILE . 4.0 tp -148.42 143.25 26.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.034 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.78 -177.81 5.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.808 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.572 ' O ' HG22 ' A' ' 208' ' ' THR . 32.1 p90 -178.54 -178.52 0.6 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -84.92 111.9 20.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.972 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.443 HD23 HG21 ' A' ' 157' ' ' THR . 9.9 mt -99.91 41.67 1.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.779 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -104.25 -32.5 9.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.06 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -134.59 143.92 48.64 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.018 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -57.55 -19.47 37.01 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.577 2.185 . . . . 0.0 112.491 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -48.13 -28.24 2.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.428 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -100.57 -29.95 12.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.081 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.443 HG21 HD23 ' A' ' 151' ' ' LEU . 16.2 p -96.83 17.66 16.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.354 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.543 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 11.8 t-105 -73.63 -50.37 5.9 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.538 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.588 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 47.2 Cg_endo -68.79 -15.82 41.05 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.153 1.902 . . . . 0.0 112.535 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 23.0 tp -77.27 -35.2 55.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 0.0 110.809 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.918 HD13 HD12 ' A' ' 192' ' ' LEU . 10.2 mt -105.1 -47.27 9.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.144 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -57.94 -28.68 64.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.312 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -56.51 -28.85 60.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.27 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.46 ' OD2' ' HB3' ' A' ' 190' ' ' ALA . 1.5 t0 -74.58 -20.1 60.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.212 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 139.01 -24.42 2.85 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.694 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.428 ' HA3' ' HB2' ' A' ' 188' ' ' ALA . . . -56.52 144.65 36.94 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.663 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.438 ' CD2' ' HA3' ' A' ' 182' ' ' GLY . 25.7 p90 -140.96 -177.01 4.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.337 . . . . 0.0 110.84 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -101.26 -34.49 9.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.14 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.778 ' CD2' HD11 ' A' ' 333' ' ' ILE . 90.0 m-85 -144.37 153.67 42.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.933 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.5 140.01 39.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.976 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.439 ' CZ ' ' HA2' ' A' ' 174' ' ' GLY . 57.7 t80 -143.99 110.81 5.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.685 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -135.03 -47.54 0.72 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.385 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -103.21 50.24 0.81 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 0.0 111.123 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.439 ' HA2' ' CZ ' ' A' ' 171' ' ' TYR . . . 57.71 19.77 36.91 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.735 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -125.22 170.79 10.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.793 0.33 . . . . 0.0 110.969 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -128.17 95.87 4.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.871 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.03 129.45 42.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.942 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.434 HG22 ' HG3' ' A' ' 335' ' ' GLN . 3.1 pt -82.75 -26.34 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.254 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.8 25.97 4.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.144 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -130.52 108.04 9.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.916 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.841 ' CG1' HG23 ' A' ' 183' ' ' VAL . 21.4 t -97.88 146.06 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.089 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 0.438 ' HA3' ' CD2' ' A' ' 167' ' ' TYR . . . -117.17 33.2 5.13 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.738 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.841 HG23 ' CG1' ' A' ' 181' ' ' VAL . 3.4 t -92.5 -50.52 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.345 . . . . 0.0 110.92 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -83.98 57.06 3.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.963 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -102.98 -178.92 3.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.766 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -74.06 -32.1 63.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.019 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -85.96 -42.61 6.67 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.571 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 183' ' ' VAL . . . -58.33 -39.88 80.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.817 0.342 . . . . 0.0 111.227 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -59.25 -31.25 68.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.864 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.46 ' HB3' ' OD2' ' A' ' 164' ' ' ASP . . . -87.48 -30.25 20.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.096 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.4 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -64.73 -49.01 66.17 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.544 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.918 HD12 HD13 ' A' ' 161' ' ' ILE . 0.4 OUTLIER -60.43 -43.57 96.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.834 0.35 . . . . 0.0 110.848 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 17.0 m -58.13 -27.43 63.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.928 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.539 ' CE2' HD11 ' A' ' 198' ' ' LEU . 19.4 t80 -60.27 -60.58 3.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.766 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.421 ' O ' HD12 ' A' ' 199' ' ' ILE . 4.8 tp -60.56 -31.65 70.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.541 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.863 HG23 ' O ' ' A' ' 192' ' ' LEU . 45.6 t -65.03 -61.64 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.936 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.61 -28.28 69.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.778 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.599 HD21 ' HG3' ' A' ' 133' ' ' PRO . 3.3 mt -58.57 -55.59 33.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.953 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.421 HD12 ' O ' ' A' ' 195' ' ' LEU . 4.7 mt -55.26 -30.01 24.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.072 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -82.16 -34.09 29.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.937 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -106.49 29.98 6.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -144.92 -36.06 0.31 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.275 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 10.4 m80 76.28 41.64 0.21 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.925 0.393 . . . . 0.0 110.811 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.97 -175.38 5.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.759 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -108.16 126.76 53.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.963 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -79.44 -30.22 42.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.012 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.96 -15.98 62.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.22 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.701 ' HA ' HD12 ' A' ' 212' ' ' ILE . 30.0 m -36.81 148.43 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.974 0.416 . . . . 0.0 111.878 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.4 ' OD2' HD11 ' A' ' 212' ' ' ILE . 63.7 m-20 -154.05 176.19 12.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.808 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -64.79 -28.73 69.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.47 -59.17 2.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.812 0.339 . . . . 0.0 111.12 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 208' ' ' THR . 0.2 OUTLIER -59.18 -27.48 36.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.833 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -80.1 -20.43 45.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.838 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.59 -49.99 13.47 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.885 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.89 -32.44 69.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.104 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.68 -30.19 68.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.077 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -75.24 -47.73 26.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -59.54 -44.9 93.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -61.65 -29.0 69.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.826 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.59 37.67 5.49 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.473 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -94.52 -76.43 0.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 110.923 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 10.5 t -70.07 123.39 21.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.46 -31.71 68.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.047 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.446 ' HE1' ' HB2' ' A' ' 147' ' ' LEU . 1.5 mpp? -119.87 151.16 39.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 6.6 t -166.69 147.56 6.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 24.0 mt -95.66 116.81 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.085 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.681 ' HB2' HD12 ' A' ' 116' ' ' ILE . 9.9 m120 -119.26 165.43 14.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.852 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.467 ' HA2' HD23 ' A' ' 113' ' ' LEU . . . -119.64 -175.14 15.79 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.548 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.1 -20.29 30.22 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.648 2.232 . . . . 0.0 112.533 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 36.5 p90 -94.31 26.02 3.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.284 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.408 ' HB3' ' HB3' ' A' ' 227' ' ' ASN . . . -124.62 -1.66 7.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.685 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -81.02 -21.73 39.95 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.763 0.316 . . . . 0.0 111.226 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.6 m -72.97 -28.86 62.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.113 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ASN . . . . . 0.736 ' OD1' HG23 ' A' ' 235' ' ' ILE . 23.9 p30 -78.98 -32.88 45.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.075 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.736 HG23 ' OD1' ' A' ' 234' ' ' ASN . 2.1 pt -88.91 87.32 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.125 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -171.23 -46.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.862 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 63.3 p -93.54 -30.97 14.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.91 -26.3 64.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.023 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 62.68 67.21 0.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.87 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.97 128.6 56.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.013 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -62.01 104.88 0.51 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -106.49 148.73 27.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -137.85 113.71 1.01 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.499 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 26.9 t -78.68 120.49 29.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.791 0.329 . . . . 0.0 111.119 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 5.6 t -131.18 159.29 38.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.65 151.91 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.019 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 11.4 mt -72.21 152.75 92.46 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.881 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.44 164.34 31.2 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.508 2.139 . . . . 0.0 112.274 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.538 HG22 ' HA ' ' A' ' 254' ' ' PRO . 18.8 p -106.52 152.07 24.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.963 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -102.55 111.74 24.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt 60.42 28.1 17.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.971 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 93.83 -21.04 43.73 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.671 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -83.67 149.12 56.47 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.689 0.281 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.538 ' HA ' HG22 ' A' ' 249' ' ' THR . 56.5 Cg_endo -70.6 154.92 64.11 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.544 2.162 . . . . 0.0 112.304 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 91.1 p -65.29 166.33 10.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.417 ' N ' ' CD ' ' A' ' 257' ' ' PRO . 0.1 OUTLIER -133.59 52.8 8.95 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.951 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 256' ' ' LYS . 73.2 Cg_endo -76.28 -172.98 1.52 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.583 2.189 . . . . 0.0 112.385 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.435 ' CD1' ' HG2' ' A' ' 330' ' ' MET . 13.5 m-85 -92.22 158.44 16.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.81 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 20.4 t -144.01 119.28 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.227 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -99.16 155.53 19.95 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.297 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.532 ' O ' HG13 ' A' ' 261' ' ' VAL . 14.9 p -144.0 116.74 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.815 0.34 . . . . 0.0 111.286 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.664 ' O ' HD12 ' A' ' 108' ' ' ILE . 52.0 tp -68.42 127.03 31.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.794 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.706 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 79.6 p -140.93 154.56 46.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.056 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -102.07 138.65 38.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.958 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -109.59 130.2 9.83 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.598 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 23.4 mt -109.58 119.01 58.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.754 0.312 . . . . 0.0 111.02 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -76.91 150.45 35.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.965 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.482 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -60.28 -31.65 70.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.027 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.443 ' HB1' ' HA3' ' A' ' 54' ' ' GLY . . . -92.55 48.02 1.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.083 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.0 t -108.89 97.39 24.19 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.869 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.57 -30.2 21.0 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.537 2.158 . . . . 0.0 112.38 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -101.19 56.87 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.82 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 9.2 tptp -70.55 -55.08 9.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -62.25 -34.36 76.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.939 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 275' ' ' LEU . 20.6 mt -73.66 -31.75 63.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.02 -48.42 81.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.102 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -60.54 -56.33 22.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.814 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 18.6 tt0 -57.19 -22.12 38.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.136 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -86.63 -60.65 1.93 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.165 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.67 HD11 HG21 ' A' ' 59' ' ' ILE . 2.3 mt -81.46 -56.39 4.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.433 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.28 -18.2 47.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.917 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 6.5 m-20 -120.11 -58.2 1.88 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.668 0.271 . . . . 0.0 111.609 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -86.97 57.54 4.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.954 0.406 . . . . 0.0 111.143 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 7.1 tp -172.51 -41.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.964 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.706 HD22 ' CZ ' ' A' ' 85' ' ' PHE . 1.9 mp -97.62 38.21 1.3 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.926 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.8 p -117.83 165.42 13.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.853 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -62.38 -30.4 71.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.934 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -82.46 -49.62 9.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -59.34 -49.56 77.16 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.572 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.435 HD21 HG22 ' A' ' 108' ' ' ILE . 2.8 mt -60.1 -30.89 69.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.815 0.34 . . . . 0.0 110.916 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -64.09 -41.89 97.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.951 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.08 -58.15 9.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.147 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.39 -29.45 42.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.204 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -70.51 -31.88 69.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.899 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -65.66 -34.63 78.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.954 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.61 -31.39 12.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.951 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.9 95.56 1.98 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.935 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.53 108.98 1.95 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.455 2.104 . . . . 0.0 112.291 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.61 HD13 ' HB2' ' A' ' 109' ' ' ALA . 5.0 mt -58.96 -28.26 66.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.003 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 99.64 -109.37 3.73 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.56 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.575 ' HB2' ' HB ' ' A' ' 320' ' ' THR . . . -75.23 93.73 2.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.82 0.343 . . . . 0.0 111.072 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.2 134.0 30.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.518 ' HB2' HG23 ' A' ' 110' ' ' VAL . . . -65.6 -27.4 68.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.023 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.488 HD23 ' HB2' ' A' ' 307' ' ' TYR . 24.6 tp -59.25 111.16 1.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.432 ' CG ' ' CE2' ' A' ' 90' ' ' TYR . 3.9 mttm -64.98 -45.07 87.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.974 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 17.2 m -54.74 -27.12 38.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.102 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.62 ' CE2' HD11 ' A' ' 311' ' ' LEU . 4.9 t80 -99.95 -25.31 14.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.12 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 0.2 OUTLIER -58.11 -34.4 70.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.86 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.41 -62.8 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.863 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -52.18 -31.8 33.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.789 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.801 ' HB3' HG21 ' A' ' 317' ' ' ILE . 12.3 mt -85.7 -25.05 26.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.793 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' A' ' 308' ' ' GLU . . . -67.25 -13.47 62.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.526 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 4.3 mtmm -46.51 -32.91 3.65 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.906 0.384 . . . . 0.0 110.925 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.64 140.16 24.95 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.354 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.435 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 12.0 Cg_endo -56.02 -25.59 54.71 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.393 2.062 . . . . 0.0 112.352 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -50.87 -40.21 55.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.038 0.447 . . . . 0.0 110.316 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.801 HG21 ' HB3' ' A' ' 311' ' ' LEU . 32.1 mm -85.5 -33.79 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.014 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -69.29 -29.72 67.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.241 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -72.08 -48.97 40.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.205 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.575 ' HB ' ' HB2' ' A' ' 301' ' ' ALA . 1.7 m -59.98 -38.62 83.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 5.3 tpt -72.58 -43.09 63.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.948 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -60.77 -31.87 71.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -69.5 -31.84 70.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.932 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -73.16 -50.18 24.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.143 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -61.39 -51.47 68.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 29.5 mtpt -59.97 -30.72 69.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.993 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -97.19 164.34 22.38 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.493 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -97.56 150.59 20.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.775 0.321 . . . . 0.0 110.897 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.665 HG21 ' HB2' ' A' ' 96' ' ' ALA . 32.1 mt -84.37 142.77 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.435 ' HG2' ' CD1' ' A' ' 258' ' ' PHE . 32.4 mtm -58.85 131.81 86.47 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.894 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.65 -174.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.367 2.045 . . . . 0.0 112.305 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -132.65 30.76 4.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.878 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.778 HD11 ' CD2' ' A' ' 169' ' ' PHE . 27.2 pt -106.11 147.31 34.6 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.35 -25.56 21.56 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.56 2.174 . . . . 0.0 112.437 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.434 ' HG3' HG22 ' A' ' 178' ' ' ILE . 75.1 mm-40 -55.15 -29.5 57.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.071 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 13.9 ttt -58.75 -24.49 61.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.055 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' SER . . . . . 0.402 ' O ' ' CE2' ' A' ' 341' ' ' TYR . 8.0 m -56.66 -38.93 72.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.047 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -86.16 -33.3 20.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.1 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.721 ' CZ ' HG21 ' A' ' 343' ' ' VAL . 48.6 t80 -59.76 -26.29 65.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.115 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 20.8 m95 -56.36 -52.45 64.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.17 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' TYR . . . . . 0.402 ' CE2' ' O ' ' A' ' 337' ' ' SER . 0.2 OUTLIER -84.89 -31.79 23.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.666 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 339' ' ' PHE . . . -50.49 -40.16 50.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.478 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.721 HG21 ' CZ ' ' A' ' 339' ' ' PHE . 17.5 t -95.93 -26.19 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.259 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -52.37 -56.35 15.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.162 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 12.4 m -64.3 -29.63 70.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.011 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -67.14 -55.32 14.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.248 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 343' ' ' VAL . 21.9 t -57.24 -43.2 81.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.278 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 22.7 mt -67.04 -53.74 31.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.089 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -59.95 -30.69 69.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -82.91 -38.38 22.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.131 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -67.84 -30.57 69.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.094 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 17.4 t -71.18 -22.38 62.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.111 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 96.24 -21.6 44.43 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.66 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -57.76 -31.34 66.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.856 0.36 . . . . 0.0 110.928 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -122.46 151.57 41.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 30.2 p -85.44 169.36 13.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.772 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.465 HG13 HD22 ' A' ' 192' ' ' LEU . 29.2 t -72.55 -51.68 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.969 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -47.1 -32.53 4.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.353 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.22 -44.69 14.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.996 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -56.45 -60.46 3.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.061 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.659 HD22 HG12 ' A' ' 183' ' ' VAL . 7.9 mt -56.98 -26.13 59.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.813 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.6 -35.92 33.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.85 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -57.85 -49.4 76.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.948 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -59.3 -39.11 81.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.082 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.832 ' HA ' HG21 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -59.08 -41.9 89.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.96 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 28.3 m -63.38 -49.59 73.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -43.44 94.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.998 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 13.9 mt -73.81 -40.4 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.082 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 365' ' ' GLN . 13.1 p -98.26 30.72 3.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.952 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.88 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.827 0.346 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.72 125.3 25.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.917 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -136.12 32.32 2.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -151.09 166.33 31.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.8 -16.49 76.29 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.718 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.418 ' HA ' HG22 ' A' ' 33' ' ' ILE . 1.2 pptp? -69.87 153.45 43.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.807 0.337 . . . . 0.0 110.935 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 mt -102.28 138.8 38.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.953 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 t -106.94 147.03 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.168 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.776 HD12 HG22 ' A' ' 37' ' ' VAL . 25.8 mt -125.43 107.51 18.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.967 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.413 ' CG ' ' HB3' ' A' ' 57' ' ' PRO . 0.9 OUTLIER -92.27 109.67 21.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.83 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.3 tt -153.89 148.02 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.05 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -60.4 170.29 1.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.927 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.16 29.56 9.9 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.566 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -90.88 -52.97 4.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.361 . . . . 0.0 110.943 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -79.9 -175.61 5.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -59.06 87.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.516 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 36.9 p90 -83.57 -44.24 14.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.343 . . . . 0.0 110.867 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.428 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 12.9 t30 -70.62 -31.72 68.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.1 -32.77 51.73 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.525 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.607 HD12 HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -60.18 -41.86 93.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.861 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.81 -30.22 68.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.089 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -59.5 -33.99 72.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.985 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.459 HG22 ' HB3' ' A' ' 292' ' ' ALA . 30.1 t -62.22 -31.26 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.11 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.57 -29.56 72.91 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.517 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 mmtt -59.85 -33.35 71.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.331 . . . . 0.0 110.944 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -42.04 72.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.854 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.642 ' CE1' HG21 ' A' ' 31' ' ' THR . 12.7 t80 -59.37 -59.22 5.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.939 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -57.8 -21.92 44.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.35 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -69.5 -26.31 64.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.512 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -117.74 -39.01 3.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.78 0.324 . . . . 0.0 111.49 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.642 HG21 ' CE1' ' A' ' 27' ' ' PHE . 15.1 p -90.68 -32.99 15.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.183 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.67 -22.39 35.98 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.663 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.446 HD13 HD13 ' A' ' 275' ' ' LEU . 38.8 mt -66.17 139.34 21.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.821 0.343 . . . . 0.0 111.046 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.0 170.01 17.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.982 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.6 t -146.99 111.06 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.042 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.1 m -101.85 150.63 22.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.948 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.776 HG22 HD12 ' A' ' 9' ' ' ILE . 21.9 t -130.14 110.19 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.117 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.408 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 60.2 mm-40 -96.52 165.7 12.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.562 ' CE1' HG12 ' A' ' 37' ' ' VAL . 50.9 m-70 -149.6 72.31 9.79 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.843 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.62 -179.75 3.54 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.601 2.201 . . . . 0.0 112.347 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -118.58 143.77 46.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.74 28.95 18.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.604 ' H ' HD23 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -59.27 -26.92 65.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.099 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.447 ' CG ' ' CH2' ' A' ' 62' ' ' TRP . 26.1 mt-10 -56.99 -30.59 64.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.013 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -95.89 -19.02 19.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.203 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.904 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.4 mtmp? -88.68 -29.6 19.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.803 0.335 . . . . 0.0 111.16 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.453 ' CZ ' HG21 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -52.83 -50.63 80.27 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.344 -179.803 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 38.4 Cg_exo -61.1 -23.64 77.73 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.573 2.182 . . . . 0.0 112.741 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -91.28 -40.38 11.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.835 0.35 . . . . 0.0 111.278 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.904 HG22 ' O ' ' A' ' 46' ' ' LYS . 9.9 m -80.45 -28.02 11.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.133 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.31 -22.53 59.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.303 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.3 -28.35 41.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.406 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.586 HG23 ' HB2' ' A' ' 55' ' ' ASP . 7.2 t -135.29 24.01 3.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.175 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 53.31 24.54 22.99 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.729 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.586 ' HB2' HG23 ' A' ' 53' ' ' THR . 9.4 t0 -74.67 -30.14 61.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.885 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.67 -150.47 0.64 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.543 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.413 ' HB3' ' CG ' ' A' ' 10' ' ' TRP . 59.2 Cg_endo -71.97 177.69 6.78 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.597 2.198 . . . . 0.0 112.36 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.58 -31.57 7.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.804 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.684 HG21 HD21 ' A' ' 280' ' ' LEU . 30.3 mt -128.32 139.83 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.048 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.715 HD11 ' HE3' ' A' ' 62' ' ' TRP . 2.5 tt -140.34 160.14 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.062 0.458 . . . . 0.0 110.962 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.482 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 9.0 m-85 -132.58 136.02 46.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.078 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.715 ' HE3' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -176.08 152.01 1.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.756 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.61 157.76 3.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.231 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.56 ' CD2' ' N ' ' A' ' 65' ' ' ASP . 5.2 p-80 -54.89 -29.65 56.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.085 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.56 ' N ' ' CD2' ' A' ' 64' ' ' HIS . 5.7 t0 -58.86 -34.33 71.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.099 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.81 17.14 12.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.345 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.457 ' HB3' HD11 ' A' ' 104' ' ' ILE . 2.0 m-85 -113.29 -24.23 9.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.655 0.264 . . . . 0.0 111.28 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -83.05 55.49 5.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.466 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -153.15 -42.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.574 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -82.86 -14.4 54.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.628 0.251 . . . . 0.0 111.258 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.47 -35.35 24.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.78 0.324 . . . . 0.0 111.205 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -62.28 -30.02 70.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.9 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.4 t -83.61 -23.12 32.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.057 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.5 28.26 13.21 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.479 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.0 mt -88.81 -34.3 17.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.801 0.334 . . . . 0.0 110.955 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 27.6 mt -79.11 167.01 21.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.417 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -106.7 126.23 52.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.083 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.457 ' CG ' ' N ' ' A' ' 79' ' ' ILE . 19.2 tt0 -65.42 164.05 14.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.795 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.542 HG21 ' CE1' ' A' ' 106' ' ' TYR . 40.6 pt -139.8 -179.65 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.208 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.447 HG23 ' O ' ' A' ' 79' ' ' ILE . 0.9 OUTLIER -158.89 77.86 3.11 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.45 ' HD2' HD12 ' A' ' 103' ' ' LEU . 37.2 Cg_endo -65.61 119.17 6.15 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.593 2.196 . . . . 0.0 112.27 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.35 177.92 0.33 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.824 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 11.2 mtmm -60.21 -45.45 93.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.52 -31.56 69.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.001 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -72.26 -52.21 17.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.871 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -64.37 -25.88 68.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.951 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.8 -28.36 67.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.157 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.522 ' O ' HD12 ' A' ' 304' ' ' LEU . 0.0 OUTLIER -97.86 34.26 1.93 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.118 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.517 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 94.2 mt -153.37 174.22 14.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.91 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.438 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . 44.7 m-85 -99.83 142.25 24.27 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.989 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -56.17 -55.88 2.53 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.617 2.211 . . . . 0.0 112.932 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.544 ' CE1' HG22 ' A' ' 93' ' ' THR . 38.2 p90 -52.98 -37.86 61.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.892 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.544 HG22 ' CE1' ' A' ' 92' ' ' PHE . 30.0 p -64.25 -27.88 69.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.722 0.296 . . . . 0.0 111.115 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.517 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 11.2 m95 -73.26 -24.52 60.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.218 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.42 11.31 19.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.466 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -101.83 -31.39 10.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.812 0.339 . . . . 0.0 111.257 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.669 ' CG1' ' HB3' ' A' ' 105' ' ' ALA . 9.0 m -87.92 -35.5 8.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.312 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.93 117.98 9.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.926 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -97.93 -67.24 0.86 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -99.62 30.74 3.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.922 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.02 -24.63 27.75 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.564 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.4 133.04 42.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 0.0 110.944 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.45 HD12 ' HD2' ' A' ' 81' ' ' PRO . 88.8 mt -66.35 150.0 49.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.868 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.664 ' O ' HD12 ' A' ' 104' ' ' ILE . 2.5 pp -155.02 36.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.145 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.702 ' HB1' ' HB2' ' A' ' 263' ' ' SER . . . -172.73 157.43 3.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.131 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.542 ' CE1' HG21 ' A' ' 79' ' ' ILE . 72.8 m-85 -118.01 80.85 15.3 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.455 ' HB3' HG21 ' A' ' 261' ' ' VAL . 48.4 Cg_exo -55.98 138.79 83.46 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.564 2.176 . . . . 0.0 112.233 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.703 HD13 ' O ' ' A' ' 284' ' ' LEU . 24.7 mt -134.46 -51.73 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.121 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.685 ' CB ' HD22 ' A' ' 299' ' ' LEU . . . -108.67 171.56 7.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.123 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.5 t -141.5 129.05 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.126 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.448 ' O ' HG13 ' A' ' 259' ' ' VAL . 0.1 OUTLIER -115.97 144.59 43.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -162.79 151.78 14.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.576 HD22 HG22 ' A' ' 226' ' ' ILE . 13.8 mt -61.22 124.56 20.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.1 m -115.66 165.28 13.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.0 tp -105.47 101.26 10.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.858 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 32.8 mt -91.45 119.77 39.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.109 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.525 ' CD1' HG22 ' A' ' 245' ' ' THR . 43.0 p90 -118.79 148.1 43.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.931 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -73.68 165.23 25.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.881 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.32 -31.13 6.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.02 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -74.8 -39.4 61.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.023 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.7 mt -109.53 28.61 8.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.076 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.8 tp -176.96 89.44 0.25 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.97 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -69.03 -30.51 25.56 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.516 2.144 . . . . 0.0 112.248 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -133.99 120.98 15.49 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.22 153.84 41.05 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.47 2.113 . . . . 0.0 112.379 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.05 122.11 8.15 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.587 2.191 . . . . 0.0 112.289 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 128' ' ' THR . 2.1 mmmp? -93.75 18.13 10.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 127' ' ' LYS . 5.4 p -156.99 141.96 17.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.8 0.334 . . . . 0.0 110.81 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.684 ' CE3' HD12 ' A' ' 132' ' ' ILE . 27.9 m95 -61.77 -31.78 72.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -68.89 -15.88 63.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.336 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.98 0.52 57.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.551 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.684 HD12 ' CE3' ' A' ' 129' ' ' TRP . 16.6 mt -85.37 -46.24 0.63 Allowed Pre-proline 0 C--N 1.332 -0.184 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 72.0 Cg_exo -48.74 -57.49 2.33 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.369 2.046 . . . . 0.0 112.447 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.28 -36.97 83.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.995 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.2 mt -58.39 -52.29 66.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.997 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.437 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 4.9 t0 -46.08 -31.75 2.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.436 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -85.61 -27.02 25.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.232 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -57.93 -64.18 1.0 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.289 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.646 ' H ' HD13 ' A' ' 139' ' ' LEU . 0.0 OUTLIER -68.49 -16.32 63.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.567 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.407 ' H ' HD22 ' A' ' 139' ' ' LEU . 2.6 ttmt -63.4 -21.57 66.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.884 0.373 . . . . 0.0 110.461 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.51 -41.74 81.39 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.672 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.404 ' HD2' ' HA ' ' A' ' 139' ' ' LEU . 0.0 OUTLIER -81.85 -26.28 34.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.784 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 119.52 21.48 3.63 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.615 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -116.0 -174.98 2.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.775 0.322 . . . . 0.0 110.943 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.2 p -130.17 158.38 39.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.913 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.483 ' HB2' HD11 ' A' ' 139' ' ' LEU . . . -76.76 -62.72 1.54 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.179 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.831 HD11 HG13 ' A' ' 226' ' ' ILE . 4.0 tp -148.66 143.44 26.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.015 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.48 ' SD ' HG21 ' A' ' 222' ' ' THR . 0.0 OUTLIER -129.26 -177.83 4.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.778 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.9 p90 179.63 145.99 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.9 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.536 HD22 ' HD2' ' A' ' 156' ' ' PHE . 0.5 OUTLIER -62.9 126.97 29.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.952 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.7 mt -98.48 31.62 2.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.848 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -101.51 -31.33 10.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -119.71 146.5 41.76 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.905 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.1 -3.41 13.71 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.553 2.168 . . . . 0.0 112.677 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.5 ' CZ ' ' CH2' ' A' ' 340' ' ' TRP . 0.4 OUTLIER -57.8 -32.12 67.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.826 0.346 . . . . 0.0 110.954 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.536 ' HD2' HD22 ' A' ' 150' ' ' ASN . 26.8 m-85 -94.69 4.04 54.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.544 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.532 HG21 HG11 ' A' ' 347' ' ' VAL . 55.8 p -106.77 -28.12 10.35 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.796 0.332 . . . . 0.0 111.049 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.483 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 11.7 t-105 -55.94 -46.66 99.73 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.308 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.76 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 77.2 Cg_exo -50.35 -25.51 13.95 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.377 2.051 . . . . 0.0 112.479 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.701 HD21 ' HB3' ' A' ' 194' ' ' PHE . 3.6 tp -94.06 -38.84 10.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.018 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.646 HG12 HD12 ' A' ' 192' ' ' LEU . 21.4 mt -76.04 -55.45 11.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.179 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.09 -25.97 68.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.243 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.76 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -57.17 -56.09 26.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.239 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -96.05 -20.1 18.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.231 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -77.06 -104.65 0.15 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.525 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -150.49 -86.98 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.531 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -172.83 -179.6 2.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.837 0.351 . . . . 0.0 110.897 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.02 -48.8 6.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.066 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -141.86 140.61 32.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.965 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -77.5 136.83 38.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.848 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.487 ' CE2' ' CE2' ' A' ' 176' ' ' TYR . 0.3 OUTLIER -101.69 110.64 22.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.779 179.834 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -133.96 145.02 49.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.126 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 48.69 32.09 3.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.249 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 68.0 26.61 73.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.424 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.23 -171.32 2.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.359 . . . . 0.0 110.839 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.487 ' CE2' ' CE2' ' A' ' 171' ' ' TYR . 1.1 m-85 -130.54 131.7 45.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.848 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.73 139.4 32.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.633 HG21 ' OE1' ' A' ' 335' ' ' GLN . 19.9 pt -95.03 -18.4 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.334 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.91 26.01 4.37 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.113 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -140.52 78.58 1.66 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.882 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.669 HG12 ' H ' ' A' ' 183' ' ' VAL . 21.7 t -94.24 137.71 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.162 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.29 0.3 40.6 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.857 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.669 ' H ' HG12 ' A' ' 181' ' ' VAL . 0.3 OUTLIER -54.05 -42.67 55.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.921 0.391 . . . . 0.0 111.31 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.418 ' N ' ' CG1' ' A' ' 183' ' ' VAL . 22.9 t0 -96.09 61.51 2.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.971 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -91.57 165.47 13.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.84 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -59.87 -38.71 82.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.14 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -85.92 -25.11 38.93 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.565 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.15 -30.56 66.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 0.0 111.163 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -61.03 -38.2 85.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -87.56 -30.06 20.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -59.31 -51.05 61.44 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.555 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.852 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.3 OUTLIER -60.24 -41.01 92.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.805 0.336 . . . . 0.0 110.904 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.8 m -54.07 -25.5 22.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.161 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.701 ' HB3' HD21 ' A' ' 160' ' ' LEU . 1.3 t80 -65.28 -60.57 2.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.784 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.762 ' HA ' HD12 ' A' ' 198' ' ' LEU . 3.9 tp -63.86 -33.47 75.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.68 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.852 HG23 ' O ' ' A' ' 192' ' ' LEU . 46.2 t -65.9 -44.68 92.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.941 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.5 -28.11 60.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.938 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.762 HD12 ' HA ' ' A' ' 195' ' ' LEU . 16.6 mt -57.82 -53.72 55.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.005 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 14.9 mt -68.81 -29.86 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.003 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.685 ' HD2' HG12 ' A' ' 196' ' ' VAL . 24.1 mtpt -75.8 -29.86 58.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.968 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -95.32 22.76 6.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.177 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.49 75.27 0.33 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.931 0.396 . . . . 0.0 111.156 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.4 -41.97 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.74 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' MET . . . . . 0.7 ' CE ' HD13 ' A' ' 198' ' ' LEU . 0.1 OUTLIER -103.01 145.56 29.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.846 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -90.03 113.96 25.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.867 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.19 -26.72 66.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.154 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -92.98 46.49 1.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.931 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 51.9 m -113.36 138.75 49.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.784 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.519 ' HB2' HD11 ' A' ' 212' ' ' ILE . 1.8 m-20 -151.35 176.3 11.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.945 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -42.67 -62.98 0.86 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.38 -59.25 4.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.004 0.43 . . . . 0.0 111.591 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 209' ' ' ASP . 0.0 OUTLIER -52.96 -31.9 17.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.183 -179.53 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -81.98 -28.3 32.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.763 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -82.36 -56.15 4.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.026 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.08 -31.26 61.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.334 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.46 -36.0 73.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.122 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.72 ' CG ' HG21 ' A' ' 225' ' ' THR . 29.0 t80 -82.24 -31.75 30.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.994 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -63.97 -46.94 82.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.99 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.09 -36.76 58.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.95 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 110.33 56.92 0.51 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.506 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -108.66 -29.71 8.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.801 0.334 . . . . 0.0 110.949 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.48 HG21 ' SD ' ' A' ' 148' ' ' MET . 9.8 t -117.38 140.1 50.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.937 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.06 -31.14 68.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.095 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 9.8 mtp -134.43 163.29 30.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.72 HG21 ' CG ' ' A' ' 217' ' ' PHE . 4.7 t -166.62 132.49 2.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.831 HG13 HD11 ' A' ' 147' ' ' LEU . 25.6 mt -96.62 116.81 39.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.087 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -156.29 165.3 36.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.428 ' HA3' ' CZ3' ' A' ' 230' ' ' TRP . . . -82.53 170.77 50.77 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.478 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.81 -25.59 27.64 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.661 2.241 . . . . 0.0 112.325 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' TRP . . . . . 0.428 ' CZ3' ' HA3' ' A' ' 228' ' ' GLY . 28.5 p90 -59.29 -30.97 68.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.965 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -59.46 -29.95 68.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.152 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 27.9 m0 -59.61 -28.91 67.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.049 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.9 m -57.81 -31.07 66.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.003 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -72.16 -59.61 2.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 4.5 mt -78.49 116.66 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.082 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -168.66 -47.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.934 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 22.2 p -76.48 -38.71 54.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 11.8 t -66.16 -29.41 69.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.957 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 62.16 81.72 0.19 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.35 143.8 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.104 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -85.25 87.47 7.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.932 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -104.64 167.61 9.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.06 174.28 21.99 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.523 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 20.9 t -140.01 127.52 24.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.793 0.33 . . . . 0.0 111.076 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.525 HG22 ' CD1' ' A' ' 117' ' ' TYR . 8.7 t -143.53 151.34 40.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.967 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.417 ' CG2' ' N ' ' A' ' 247' ' ' LEU . 0.7 OUTLIER -54.51 152.3 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.292 0.568 . . . . 0.0 111.295 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.417 ' N ' ' CG2' ' A' ' 246' ' ' VAL . 9.2 mt -71.45 146.6 91.87 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.977 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.419 ' HG2' ' CD1' ' A' ' 129' ' ' TRP . 50.8 Cg_endo -69.18 177.17 5.44 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.541 2.16 . . . . 0.0 112.265 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 44.6 p -121.12 175.47 6.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -142.85 121.94 12.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 20.7 mttm 60.1 31.67 20.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 74.35 27.03 66.62 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.52 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -136.48 128.99 17.43 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.554 0.216 . . . . 0.0 110.821 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.07 163.09 35.86 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.505 2.137 . . . . 0.0 112.354 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.82 -172.95 3.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.786 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -134.72 63.87 60.77 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.952 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -56.88 127.78 27.25 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.554 2.169 . . . . 0.0 112.182 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.425 ' CD2' ' CD1' ' A' ' 155' ' ' TYR . 98.5 m-85 -60.65 139.96 57.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.739 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 111' ' ' GLU . 25.5 t -120.32 146.25 25.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.294 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -134.65 86.57 0.26 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.294 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' A' ' 107' ' ' PRO . 7.5 p -60.52 128.85 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.843 0.354 . . . . 0.0 111.326 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.3 tp -89.9 106.9 18.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.702 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 0.5 OUTLIER -117.56 174.32 6.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.961 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . . . -109.44 154.51 22.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.03 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.0 129.77 8.11 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.515 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.438 HD12 ' CE1' ' A' ' 106' ' ' TYR . 4.4 mt -125.74 100.53 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.803 0.335 . . . . 0.0 110.998 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.19 162.63 4.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.956 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.417 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -70.78 -28.36 64.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -90.51 49.94 1.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.132 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.5 m -109.1 102.76 50.17 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.782 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.81 -23.91 47.51 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.419 2.079 . . . . 0.0 112.366 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -98.37 31.11 2.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.934 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.99 -38.35 90.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.886 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -61.7 -49.52 76.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.96 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.446 HD13 HD13 ' A' ' 33' ' ' ILE . 78.2 mt -77.7 -31.02 52.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.942 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.67 -55.4 20.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.178 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -44.82 74.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.045 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.415 ' HG3' ' ND2' ' A' ' 282' ' ' ASN . 14.5 tt0 -63.89 -43.38 96.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -66.83 -37.11 83.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.766 HD23 ' CD2' ' A' ' 284' ' ' LEU . 2.8 mt -78.71 -22.24 46.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.445 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.55 -29.94 15.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.505 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.415 ' ND2' ' HG3' ' A' ' 278' ' ' GLU . 22.9 m-80 -94.67 -58.09 2.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.728 0.299 . . . . 0.0 111.494 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -106.49 58.12 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.94 0.4 . . . . 0.0 111.319 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.766 ' CD2' HD23 ' A' ' 280' ' ' LEU . 2.0 tp 177.64 38.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.942 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.78 HD23 HD13 ' A' ' 304' ' ' LEU . 0.4 OUTLIER 179.3 38.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.872 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 44.7 p -153.48 172.37 17.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.947 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -63.15 -29.28 70.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.018 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -78.22 -30.15 48.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.019 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -92.2 -51.8 2.33 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.624 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.603 HD21 HG22 ' A' ' 108' ' ' ILE . 1.5 mt -59.03 -30.59 68.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.764 0.316 . . . . 0.0 110.999 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -72.81 -31.45 64.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.937 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.459 ' HB3' HG22 ' A' ' 23' ' ' VAL . . . -59.25 -40.49 86.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.138 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.2 t -83.53 -30.81 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.138 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -63.31 -29.72 70.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.977 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -58.77 -33.66 70.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.96 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -102.61 -35.82 8.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.0 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 4.2 mmtm -146.61 90.36 5.57 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.932 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.2 104.79 1.44 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.53 2.154 . . . . 0.0 112.265 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.685 HD22 ' CB ' ' A' ' 109' ' ' ALA . 2.2 mp -58.42 -26.75 63.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.994 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 90.13 -94.72 2.01 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.523 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -79.05 122.01 25.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.784 0.326 . . . . 0.0 111.073 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.528 HG11 ' CD2' ' A' ' 307' ' ' TYR . 21.3 m -111.59 165.98 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.18 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -92.13 -29.24 16.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.167 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.78 HD13 HD23 ' A' ' 285' ' ' LEU . 5.0 tp -58.16 120.91 9.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.936 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -65.22 -31.63 72.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.9 -31.75 51.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.617 ' CE2' HD11 ' A' ' 311' ' ' LEU . 5.4 t80 -84.68 -28.26 26.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.021 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -59.4 -31.79 69.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.84 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -73.08 -58.91 2.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.853 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -51.53 -32.21 27.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.771 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.785 ' HB3' HG21 ' A' ' 317' ' ' ILE . 13.3 mt -85.78 -26.14 25.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.667 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.7 -16.48 62.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.343 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -47.82 -32.62 6.29 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.931 0.396 . . . . 0.0 110.832 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -108.67 138.53 20.3 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.345 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 11.8 Cg_endo -55.89 -30.67 78.26 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.418 2.078 . . . . 0.0 112.374 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -49.68 -39.32 36.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.001 0.429 . . . . 0.0 110.299 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.785 HG21 ' HB3' ' A' ' 311' ' ' LEU . 18.5 mm -85.57 -33.58 7.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.964 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -69.2 -57.48 5.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.205 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.19 -49.58 75.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.258 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 73.8 m -58.73 -31.02 67.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.987 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 9.1 tpt -79.98 -32.13 39.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -61.43 -56.13 23.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.94 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -65.12 -30.44 71.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.942 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.09 -56.54 20.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.134 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -64.09 -37.52 87.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.875 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 12.0 tttp -67.52 -31.92 72.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -76.97 -162.02 14.3 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.501 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -129.27 160.46 32.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.762 0.315 . . . . 0.0 110.949 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.492 HG22 ' N ' ' A' ' 330' ' ' MET . 29.8 mt -86.78 158.81 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.127 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.492 ' N ' HG22 ' A' ' 329' ' ' ILE . 6.1 mtp -80.13 131.07 63.83 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.899 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -57.3 158.36 18.82 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.392 2.061 . . . . 0.0 112.181 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -110.23 -26.53 9.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.087 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 34.9 pt -55.59 150.44 25.49 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.248 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.71 -25.42 24.22 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.594 2.196 . . . . 0.0 112.417 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.633 ' OE1' HG21 ' A' ' 178' ' ' ILE . 0.9 OUTLIER -56.57 -28.36 60.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.062 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -27.86 66.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.061 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 4.9 m -55.87 -56.2 23.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.01 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.59 -30.8 71.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.09 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.778 ' O ' HG23 ' A' ' 343' ' ' VAL . 47.1 t80 -59.7 -40.49 88.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.946 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.5 ' CH2' ' CZ ' ' A' ' 155' ' ' TYR . 96.7 m95 -63.6 -55.75 21.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.024 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -58.8 -44.3 90.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.082 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -59.17 -58.73 7.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.19 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 339' ' ' PHE . 24.4 t -59.21 -28.43 39.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.228 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.71 -53.89 49.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.073 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.67 -30.61 68.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.959 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -59.26 -52.83 63.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.212 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 343' ' ' VAL . 21.2 t -59.19 -36.74 64.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.198 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 29.3 mt -76.37 -37.15 30.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.158 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -58.93 -30.95 68.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.95 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -87.6 -46.68 9.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.053 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.13 -40.53 96.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.123 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 8.1 m -67.92 -22.43 65.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.104 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 85.12 27.6 33.3 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.564 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.19 -30.28 21.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.852 0.358 . . . . 0.0 110.918 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -146.09 -173.92 4.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 4.4 p -104.48 156.12 18.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.951 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.529 HG13 HD22 ' A' ' 192' ' ' LEU . 43.1 t -59.12 -29.93 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.977 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.12 -49.29 70.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.23 -34.88 71.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.995 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -65.98 -52.85 45.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.98 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.591 HD22 ' O ' ' A' ' 183' ' ' VAL . 89.9 mt -61.75 -28.72 69.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -81.19 -41.16 22.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.871 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -73.72 -46.98 42.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.14 -43.65 87.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.145 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -62.95 -36.17 82.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.933 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.573 HG22 ' HG2' ' A' ' 370' ' ' LYS . 21.3 m -60.34 -42.99 96.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -59.71 -29.82 68.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.924 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.563 HD12 ' CD2' ' A' ' 339' ' ' PHE . 26.2 mm -71.02 -35.66 60.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.076 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 1.4 t -152.77 78.64 1.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.573 ' HG2' HG22 ' A' ' 366' ' ' THR . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.92 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.799 0.333 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.55 HG21 ' HD2' ' A' ' 271' ' ' PRO . 7.5 t -58.93 99.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.94 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.26 173.54 10.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.883 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 58.24 174.63 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.983 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -84.98 55.92 4.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.494 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -125.15 173.29 8.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.861 0.362 . . . . 0.0 110.887 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.455 HD11 ' HB3' ' A' ' 275' ' ' LEU . 6.1 mt -141.9 115.82 9.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.2 t -89.61 146.99 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.212 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.902 HG21 HD21 ' A' ' 20' ' ' LEU . 5.4 mt -128.16 107.47 16.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.925 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.449 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 8.6 m0 -93.78 106.7 18.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.854 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.3 tt -123.29 145.81 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.081 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -60.13 170.56 1.22 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.79 47.91 2.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.52 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -157.23 31.4 0.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.856 0.36 . . . . 0.0 110.907 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.33 -172.3 3.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.92 93.84 1.53 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.501 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -85.97 -37.5 18.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.816 0.341 . . . . 0.0 110.923 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -75.73 -32.72 60.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.976 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.9 -28.21 59.22 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.507 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.902 HD21 HG21 ' A' ' 9' ' ' ILE . 18.5 tp -80.05 -32.4 39.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.76 0.314 . . . . 0.0 110.931 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.77 -31.81 71.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.175 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -60.23 -31.05 69.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.965 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.8 t -64.62 -41.14 91.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.088 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.99 -34.96 88.64 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.499 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.0 mttp -60.03 -28.59 67.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.826 0.346 . . . . 0.0 110.934 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -83.0 -38.5 22.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.849 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -55.82 -45.69 78.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.096 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -60.36 -38.35 83.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.937 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.39 -28.81 66.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.901 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -83.76 -32.66 25.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.311 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.462 HG23 HG12 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -139.06 -44.15 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.391 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.98 20.9 5.5 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.721 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.613 HG21 HD13 ' A' ' 275' ' ' LEU . 29.4 mm -80.67 114.9 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.814 0.34 . . . . 0.0 110.985 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -57.65 145.48 33.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.003 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.4 t -138.96 109.31 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.111 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.2 m -104.14 128.54 51.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.911 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.572 HG22 HD12 ' A' ' 9' ' ' ILE . 21.5 t -114.74 113.86 44.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.149 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -114.78 156.8 24.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.9 p-80 -122.47 71.49 37.22 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.855 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.573 ' HG2' HD22 ' A' ' 43' ' ' LEU . 57.1 Cg_endo -70.77 165.84 30.82 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.603 2.202 . . . . 0.0 112.377 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -126.0 141.21 52.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.815 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.5 mmtm 59.68 36.96 22.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.839 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.573 HD22 ' HG2' ' A' ' 40' ' ' PRO . 0.6 OUTLIER -78.19 -3.51 42.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.48 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -58.29 -36.91 74.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.84 0.352 . . . . 0.0 110.964 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.47 -19.75 23.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.172 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.777 ' O ' HG22 ' A' ' 50' ' ' VAL . 2.5 mtpp -87.41 -19.0 28.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.344 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.451 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 7.0 t80 -70.91 -48.52 14.41 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.361 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 2.9 Cg_exo -76.04 -31.32 5.02 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.791 2.327 . . . . 0.0 112.688 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.602 ' HG3' HG13 ' A' ' 50' ' ' VAL . 7.8 pt20 -60.28 -50.69 72.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.834 0.35 . . . . 0.0 111.239 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 46' ' ' LYS . 7.4 m -97.17 27.09 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.434 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.19 -29.98 31.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.184 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.55 -32.49 25.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.207 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.483 HG22 ' HA ' ' A' ' 50' ' ' VAL . 2.2 t -82.75 -29.65 29.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.944 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.71 26.96 23.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.517 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.42 -26.02 24.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.829 0.347 . . . . 0.0 111.009 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.4 -178.52 0.4 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.554 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.449 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 60.9 Cg_endo -72.59 -168.23 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.609 2.206 . . . . 0.0 112.364 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.29 -46.22 3.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.814 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.9 mt -117.88 138.88 47.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.596 HD11 ' CE3' ' A' ' 62' ' ' TRP . 2.6 tt -139.02 159.69 29.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.12 0.486 . . . . 0.0 110.952 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.481 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 28.1 m-85 -127.62 136.17 51.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.942 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.596 ' CE3' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -172.01 157.69 4.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.913 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.36 156.1 30.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.094 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.584 ' CD2' ' HB1' ' A' ' 96' ' ' ALA . 18.3 p-80 -56.48 -41.93 77.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.085 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -59.26 -31.35 69.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.08 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.418 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 8.6 mmm180 -94.25 17.19 13.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.334 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.402 ' CE2' ' O ' ' A' ' 62' ' ' TRP . 0.8 OUTLIER -109.65 -13.33 14.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.285 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -92.5 21.89 35.93 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.739 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.42 -23.83 4.65 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.559 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.46 ' O ' HD12 ' A' ' 75' ' ' LEU . 29.3 m-85 -100.47 -28.08 13.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.737 0.303 . . . . 0.0 110.972 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.0 -25.78 53.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.11 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -59.29 -29.3 67.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.155 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 m -96.65 24.99 5.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.13 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.49 29.46 39.31 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.791 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.46 HD12 ' O ' ' A' ' 70' ' ' TYR . 7.3 mt -87.81 -40.61 13.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 0.0 110.944 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.4 mt -83.33 148.52 27.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.931 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.546 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -82.31 165.33 20.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.128 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.475 ' OE1' HG22 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -88.03 -165.63 1.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.935 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.665 HD11 ' HB3' ' A' ' 103' ' ' LEU . 33.8 pt -157.33 164.62 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.968 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 47.0 p -156.31 77.43 4.36 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.837 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.64 161.16 46.15 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.646 2.231 . . . . 0.0 112.269 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.38 165.07 16.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.809 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.35 -38.28 76.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.884 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.37 -29.31 61.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.063 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.428 ' CZ ' HD13 ' A' ' 285' ' ' LEU . 7.4 t80 -78.54 -32.01 47.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.434 ' HG2' ' CE2' ' A' ' 94' ' ' TRP . 0.0 OUTLIER -82.21 -29.62 31.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.994 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -73.74 -36.42 65.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.048 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.466 ' HG3' HD12 ' A' ' 89' ' ' LEU . 2.6 pttt -59.87 -30.28 68.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.012 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.532 HD11 HD11 ' A' ' 285' ' ' LEU . 1.1 mp -88.45 162.54 16.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.849 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.424 ' HB3' ' CE1' ' A' ' 92' ' ' PHE . 15.2 m-85 -75.09 141.09 74.07 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.064 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -54.31 -55.88 3.0 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.658 2.239 . . . . 0.0 113.022 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.476 ' CE2' HG23 ' A' ' 93' ' ' THR . 42.4 p90 -56.16 -42.21 76.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.734 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.476 HG23 ' CE2' ' A' ' 92' ' ' PHE . 30.6 p -59.46 -28.06 66.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.754 0.312 . . . . 0.0 111.103 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.434 ' CE2' ' HG2' ' A' ' 86' ' ' GLN . 7.2 m95 -75.01 -25.82 59.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.113 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.405 ' HA ' ' CG ' ' A' ' 98' ' ' ARG . 5.9 m-20 -90.55 12.42 18.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.398 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.584 ' HB1' ' CD2' ' A' ' 64' ' ' HIS . . . -101.9 -48.26 4.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.779 0.324 . . . . 0.0 111.289 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.879 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 7.2 m -78.98 -33.14 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.387 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 0.9 OUTLIER -66.09 121.17 14.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.99 -179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -122.96 142.68 50.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.727 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 69.59 25.31 5.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.071 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.57 7.27 88.13 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.109 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.04 141.64 47.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.846 0.355 . . . . 0.0 111.006 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.665 ' HB3' HD11 ' A' ' 79' ' ' ILE . 1.2 mp -75.85 149.82 37.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.953 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.475 HG22 ' OE1' ' A' ' 78' ' ' GLU . 2.5 pp -157.14 26.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.387 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.879 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -161.59 179.09 8.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.073 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -137.66 89.97 14.99 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.939 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.695 ' HB3' HG21 ' A' ' 261' ' ' VAL . 44.2 Cg_exo -56.23 131.47 46.06 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.524 2.149 . . . . 0.0 112.228 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.672 ' CG2' HD21 ' A' ' 290' ' ' LEU . 4.0 mt -127.24 -48.06 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 262' ' ' LEU . . . -113.34 138.44 50.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.089 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.34 128.92 67.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.1 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -109.2 148.17 31.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.958 ' HB3' HG23 ' A' ' 320' ' ' THR . . . -157.93 137.05 11.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.405 HD11 ' HE1' ' A' ' 155' ' ' TYR . 8.6 mt -66.85 109.08 2.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.864 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.85 161.14 14.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.931 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.726 HD22 ' HD3' ' A' ' 248' ' ' PRO . 6.8 tp -96.78 111.79 23.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.8 mt -97.98 132.09 43.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.1 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.436 ' CD1' ' HB3' ' A' ' 125' ' ' PRO . 34.7 p90 -129.74 159.33 36.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.001 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.557 ' HB3' HD12 ' A' ' 121' ' ' LEU . 5.3 m120 -86.39 120.93 28.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.0 mtpp -77.93 -27.97 49.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.037 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -65.46 -30.48 71.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.1 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.557 HD12 ' HB3' ' A' ' 118' ' ' ASN . 1.9 mp -110.42 -35.7 5.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.114 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 16.2 tp -110.43 101.92 49.98 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.97 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.82 -27.79 37.08 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.37 2.047 . . . . 0.0 112.303 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -137.98 130.34 16.33 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.436 ' HB3' ' CD1' ' A' ' 117' ' ' TYR . 71.7 Cg_endo -76.99 151.55 30.94 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.538 2.159 . . . . 0.0 112.326 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.438 ' HB2' HD11 ' A' ' 132' ' ' ILE . 72.4 Cg_endo -76.26 103.03 1.68 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.54 2.16 . . . . 0.0 112.328 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -24.28 59.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.092 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.39 143.69 35.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.902 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.441 ' CE3' HG13 ' A' ' 132' ' ' ILE . 18.4 m95 -78.1 -30.82 49.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -67.64 -15.82 63.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.314 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.81 -11.11 43.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.609 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.476 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 25.6 mm -70.96 -46.56 15.15 Favored Pre-proline 0 CA--C 1.53 0.197 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.476 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 75.3 Cg_exo -48.12 -57.94 2.04 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.396 2.064 . . . . 0.0 112.489 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.32 -35.18 79.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.061 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.2 mt -58.44 -51.02 71.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.052 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.545 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 4.8 t70 -46.74 -28.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.508 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -85.58 -27.97 25.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.312 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.56 -63.71 1.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.302 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.666 ' H ' HD13 ' A' ' 139' ' ' LEU . 0.0 OUTLIER -68.96 -16.4 63.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.646 -179.597 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.418 ' N ' HD22 ' A' ' 139' ' ' LEU . 0.0 OUTLIER -64.54 -21.58 66.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.804 0.335 . . . . 0.0 110.495 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.44 -41.61 80.82 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.126 0.489 . . . . 0.0 110.581 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.4 ' HD2' ' HA ' ' A' ' 139' ' ' LEU . 0.0 OUTLIER -83.01 -26.75 30.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.784 179.711 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.34 18.6 3.36 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.76 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -111.4 -174.96 2.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.826 0.345 . . . . 0.0 110.893 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.6 t -132.12 163.9 27.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.878 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.545 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -79.26 -64.47 1.18 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.303 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.5 ' CD1' HD11 ' A' ' 115' ' ' LEU . 1.0 OUTLIER -153.28 148.44 26.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.102 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.474 ' SD ' HG21 ' A' ' 222' ' ' THR . 0.0 OUTLIER -137.05 -177.87 4.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.754 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -179.26 152.74 0.55 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.954 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.405 ' OD1' ' CD2' ' A' ' 156' ' ' PHE . 12.9 p-10 -67.95 113.11 5.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.679 ' CD2' HD21 ' A' ' 195' ' ' LEU . 8.8 mt -94.1 45.26 1.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.854 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -110.44 -30.29 7.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.008 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -125.14 125.86 25.24 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.885 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.84 -22.32 29.32 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.446 2.098 . . . . 0.0 112.341 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.405 ' HE1' HD11 ' A' ' 113' ' ' LEU . 44.4 t80 -54.19 -31.1 51.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.091 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.405 ' CD2' ' OD1' ' A' ' 150' ' ' ASN . 0.2 OUTLIER -89.16 -31.25 18.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.4 HG21 HD22 ' A' ' 195' ' ' LEU . 0.1 OUTLIER -94.93 12.43 28.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.241 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.55 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 29.7 t-105 -68.23 -54.85 14.04 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.433 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 17.4 Cg_endo -57.82 -20.26 42.88 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.238 1.959 . . . . 0.0 112.413 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.678 HD23 HD13 ' A' ' 195' ' ' LEU . 21.3 tp -78.8 -27.41 44.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.945 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 18.3 mt -101.67 -47.72 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.127 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -60.07 -36.48 77.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.214 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.42 84.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.232 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.05 -20.16 56.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.252 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 130.9 71.74 0.11 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.509 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 188' ' ' ALA . . . -171.77 172.67 44.78 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.489 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -162.39 173.57 13.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.82 0.343 . . . . 0.0 110.946 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.71 -53.34 4.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.052 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -127.72 146.22 50.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.784 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.85 108.12 17.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.049 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -73.51 110.95 8.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.577 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -159.38 145.6 16.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.935 0.398 . . . . 0.0 111.099 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 62.11 29.19 17.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.18 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.41 -37.27 3.36 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.14 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 5.1 pttm -102.04 179.61 4.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 111.139 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 176' ' ' TYR . 1.3 m-85 -110.19 115.21 29.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.801 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -58.45 134.83 57.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.899 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.8 pt -95.05 -16.63 7.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.415 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.04 25.96 4.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.024 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -150.13 110.05 4.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.817 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.775 HG12 ' H ' ' A' ' 183' ' ' VAL . 22.0 t -124.49 139.67 50.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.173 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -96.5 -5.58 58.93 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.831 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.775 ' H ' HG12 ' A' ' 181' ' ' VAL . 0.3 OUTLIER -51.85 -42.6 33.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.927 0.394 . . . . 0.0 111.36 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.417 ' N ' ' CG1' ' A' ' 183' ' ' VAL . 37.2 t0 -105.2 65.55 0.73 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.91 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.421 ' H ' ' HB3' ' A' ' 188' ' ' ALA . 0.5 OUTLIER -118.11 -168.84 1.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -74.81 -39.22 61.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.142 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -85.89 -37.85 9.05 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.468 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.442 ' HB2' ' HA3' ' A' ' 166' ' ' GLY . . . -60.21 -30.61 69.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.809 0.337 . . . . 0.0 111.163 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.44 -49.82 76.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.919 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.23 -27.88 66.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.201 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -58.18 -56.59 24.36 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.545 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.868 ' O ' HG23 ' A' ' 196' ' ' VAL . 6.9 tp -59.57 -50.44 73.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.77 0.319 . . . . 0.0 110.893 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.39 -24.72 57.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.07 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -66.84 -60.5 2.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.824 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.679 HD21 ' CD2' ' A' ' 151' ' ' LEU . 4.8 tp -57.55 -31.85 66.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.657 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 192' ' ' LEU . 48.8 t -61.73 -61.58 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.983 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.62 -27.73 68.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.848 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mt -60.28 -46.6 89.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.99 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.527 HG23 ' O ' ' A' ' 204' ' ' MET . 5.1 mt -64.35 -30.02 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.171 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.87 -30.33 26.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.367 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -98.65 -6.44 29.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.8 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -117.58 -9.82 10.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.588 0.232 . . . . 0.0 111.546 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 24.9 m80 62.96 41.48 8.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.873 0.368 . . . . 0.0 110.61 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' MET . . . . . 0.527 ' O ' HG23 ' A' ' 199' ' ' ILE . 0.0 OUTLIER -82.96 134.73 35.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.88 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -74.47 122.73 23.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -73.09 -13.84 61.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.449 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -83.93 3.96 31.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.537 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.457 ' HA ' HD12 ' A' ' 212' ' ' ILE . 56.5 m -52.53 144.6 13.2 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.769 0.319 . . . . 0.0 111.12 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.514 ' HB2' HD11 ' A' ' 212' ' ' ILE . 1.5 m-20 -153.65 176.39 12.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.048 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.409 ' OH ' ' CZ2' ' A' ' 230' ' ' TRP . 0.8 OUTLIER -46.0 -62.95 1.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.406 -179.506 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.23 -59.04 6.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.599 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.514 HD11 ' HB2' ' A' ' 209' ' ' ASP . 0.0 OUTLIER -55.81 -33.46 34.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.21 -179.428 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -81.91 -25.54 34.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.779 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.34 -47.2 12.62 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.975 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.23 -32.16 62.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.253 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.47 -25.18 50.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.217 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.59 ' CD2' HG21 ' A' ' 225' ' ' THR . 1.1 t80 -69.3 -62.66 1.29 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.991 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -68.94 -45.57 70.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.03 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.41 -29.4 66.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.959 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.57 41.28 10.04 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.514 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -89.19 -31.31 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.794 0.33 . . . . 0.0 110.893 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.474 HG21 ' SD ' ' A' ' 148' ' ' MET . 11.0 t -124.64 163.17 22.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.934 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -90.26 -35.24 15.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.032 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -130.5 163.22 27.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.818 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.59 HG21 ' CD2' ' A' ' 217' ' ' PHE . 1.8 t -166.72 162.67 16.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.97 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.9 mt -111.61 118.8 58.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.021 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -144.27 165.42 27.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.924 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -98.59 -174.76 32.46 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.536 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.12 -24.67 27.77 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.562 2.175 . . . . 0.0 112.415 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' TRP . . . . . 0.409 ' CZ2' ' OH ' ' A' ' 210' ' ' TYR . 24.7 p90 -59.03 -30.83 68.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.91 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -71.33 -26.68 62.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.191 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 27.6 m0 -55.83 -39.62 71.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.981 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.6 m -69.47 -31.7 70.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -69.67 -35.85 75.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.924 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 22.7 mt -75.83 116.52 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.079 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -173.31 -42.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.933 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.41 -55.51 13.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 20.9 t -63.67 -28.68 70.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.941 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt 60.84 76.01 0.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.902 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 22.6 t -121.08 112.21 34.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.045 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.04 108.87 1.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.942 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -117.3 145.13 44.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.844 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -117.63 179.15 17.22 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.513 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.56 128.84 74.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 0.0 111.13 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.9 t -143.03 159.28 42.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.956 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.62 152.06 7.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.01 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.85 145.25 91.68 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.833 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.726 ' HD3' HD22 ' A' ' 115' ' ' LEU . 51.0 Cg_exo -53.7 137.29 66.91 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.477 2.118 . . . . 0.0 112.267 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 1.3 p -77.08 160.6 28.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -145.37 126.62 14.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt 62.26 18.01 9.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.287 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.24 38.66 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.888 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -103.84 149.29 37.01 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.731 0.3 . . . . 0.0 110.873 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.66 162.07 42.62 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.509 2.139 . . . . 0.0 112.229 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 39.7 p -71.14 179.59 2.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.832 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -128.84 58.07 33.91 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.84 136.47 32.88 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.548 2.165 . . . . 0.0 112.316 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.497 ' CZ ' ' CD1' ' A' ' 158' ' ' TRP . 85.9 m-85 -59.51 140.1 56.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.978 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.68 145.76 12.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -134.81 108.42 0.71 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.469 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.695 HG21 ' HB3' ' A' ' 107' ' ' PRO . 7.4 p -88.74 160.84 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 0.0 111.152 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.462 ' N ' HG22 ' A' ' 261' ' ' VAL . 9.6 tp -121.62 131.43 54.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.77 169.43 19.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.964 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -105.4 127.36 52.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.058 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -90.44 148.21 19.5 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.537 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.648 HD11 HD12 ' A' ' 280' ' ' LEU . 31.3 mt -127.3 115.76 41.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.861 0.362 . . . . 0.0 111.125 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -77.05 135.88 38.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.912 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.546 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -64.77 -30.43 71.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.132 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -58.98 -30.98 68.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.7 111.18 8.12 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.87 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.55 ' HD2' HG21 ' A' ' 2' ' ' THR . 46.8 Cg_endo -68.27 -14.05 39.39 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.402 2.068 . . . . 0.0 112.583 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -84.47 57.22 4.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.939 0.4 . . . . 0.0 110.942 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.6 tppm? -82.77 -36.75 25.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -59.95 -49.18 78.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.613 HD13 HG21 ' A' ' 33' ' ' ILE . 37.4 mt -71.08 -33.33 70.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.968 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.34 93.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.044 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -63.14 -54.17 41.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -62.9 -33.28 74.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -69.64 -46.74 65.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.047 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.773 HD22 HD22 ' A' ' 284' ' ' LEU . 79.9 mt -81.42 -21.67 38.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.383 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -93.66 -48.21 6.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.765 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -103.77 18.05 22.77 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.605 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -163.47 52.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.879 0.371 . . . . 0.0 111.213 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.773 HD22 HD22 ' A' ' 280' ' ' LEU . 7.1 tp -174.83 -65.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.897 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.809 ' CD2' HD13 ' A' ' 304' ' ' LEU . 1.0 OUTLIER -84.95 58.41 5.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.947 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.23 -179.09 5.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.881 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.75 -36.97 31.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -75.76 -31.05 59.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.907 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -79.42 -52.1 4.95 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.532 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.672 HD21 ' CG2' ' A' ' 108' ' ' ILE . 10.1 mt -60.04 -35.35 74.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.819 0.342 . . . . 0.0 110.958 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -59.96 -44.02 94.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.29 -53.68 51.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.12 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.8 t -59.64 -47.14 92.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.128 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -66.44 -31.6 72.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.914 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 2.4 mtmm -63.1 -33.9 76.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.942 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -98.82 -32.43 11.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.024 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.4 ' HA ' ' HD2' ' A' ' 298' ' ' PRO . 4.1 mmtt -154.49 95.12 2.72 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.915 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 298' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 297' ' ' LYS . 36.6 Cg_endo -65.81 123.65 11.63 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.488 2.125 . . . . 0.0 112.314 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.455 ' H ' HD12 ' A' ' 299' ' ' LEU . 1.0 OUTLIER -93.38 17.44 11.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.133 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 81.78 -142.8 22.87 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.59 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -58.41 174.94 0.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 111.192 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.594 HG21 ' HB3' ' A' ' 307' ' ' TYR . 13.4 m -140.47 133.14 32.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.111 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -59.46 -33.79 71.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.208 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.829 HD23 ' HB2' ' A' ' 307' ' ' TYR . 14.0 tp -60.16 114.86 3.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -60.14 -30.67 69.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.951 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 32.6 m -70.36 -39.39 74.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.935 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.829 ' HB2' HD23 ' A' ' 304' ' ' LEU . 1.0 OUTLIER -86.22 -26.76 24.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.014 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -59.89 -31.7 70.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.807 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -69.76 -54.51 13.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.862 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.73 -34.74 19.82 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.788 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.578 ' HB3' HG21 ' A' ' 317' ' ' ILE . 88.3 mt -85.72 -26.63 25.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.697 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -70.53 -12.3 61.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.439 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -47.76 -31.77 5.21 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.925 0.393 . . . . 0.0 110.81 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -116.11 140.26 26.13 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.35 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.475 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 12.6 Cg_endo -56.52 -24.82 55.25 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.384 2.056 . . . . 0.0 112.414 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -50.96 -41.48 59.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.008 0.433 . . . . 0.0 110.302 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.578 HG21 ' HB3' ' A' ' 311' ' ' LEU . 30.1 mm -85.55 -32.72 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.882 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.475 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -69.11 -29.63 67.74 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.233 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.33 -30.65 66.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.151 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.958 HG23 ' HB3' ' A' ' 112' ' ' ALA . 56.6 m -84.61 -36.35 22.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 6.8 tpt -64.41 -40.21 95.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -59.92 -43.73 94.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.931 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -79.26 -29.13 42.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.023 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.6 -39.96 94.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.19 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -71.65 -55.01 8.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.994 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.13 -47.33 74.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.836 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -58.99 147.71 40.9 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.482 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -86.22 149.85 24.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.337 . . . . 0.0 110.911 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.4 HD11 ' HB2' ' A' ' 92' ' ' PHE . 28.4 mt -87.98 141.96 13.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.085 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 71.6 mtm -63.84 124.16 84.06 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.944 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -56.38 -164.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.38 2.053 . . . . 0.0 112.261 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -150.61 30.82 0.66 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 31.5 pt -117.86 153.73 51.01 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.108 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.51 -20.36 70.38 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.606 2.204 . . . . 0.0 112.445 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -60.39 -27.46 67.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.099 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 1.4 tpt -74.78 -30.21 61.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.074 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.84 -44.98 86.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.001 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -63.52 -29.93 71.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.108 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.856 ' CE1' HG21 ' A' ' 343' ' ' VAL . 11.9 t80 -59.45 -48.6 81.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.973 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 24.2 m95 -59.01 -30.27 67.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.044 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -81.31 -44.17 18.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.046 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.698 ' HB1' ' HA ' ' A' ' 364' ' ' ALA . . . -61.83 -61.66 2.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.269 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.856 HG21 ' CE1' ' A' ' 339' ' ' PHE . 21.9 t -58.39 -23.73 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.427 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.84 -57.41 12.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.093 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 345' ' ' THR . . . . . 0.587 HG22 ' ND2' ' A' ' 349' ' ' ASN . 26.4 m -72.18 -30.27 64.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.107 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.27 -50.79 66.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.289 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 343' ' ' VAL . 33.3 t -62.91 -45.27 99.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.249 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 27.6 mt -67.85 -42.59 86.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.113 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.587 ' ND2' HG22 ' A' ' 345' ' ' THR . 55.7 m-20 -58.13 -45.71 86.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.985 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -74.57 -28.71 61.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.197 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.19 -35.98 76.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.268 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.09 20.76 9.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.185 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 55.82 26.0 46.11 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.602 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -82.03 -30.44 31.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.866 0.365 . . . . 0.0 110.941 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -145.42 174.75 10.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 41.0 p -100.47 151.64 21.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.566 HG22 HD23 ' A' ' 192' ' ' LEU . 40.5 t -55.91 -27.41 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.053 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -73.81 -47.71 36.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.82 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -35.4 62.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.051 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.0 -56.7 13.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.971 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 92.1 mt -61.63 -29.81 70.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.818 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -56.14 25.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.887 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -63.78 -47.62 80.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.932 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.698 ' HA ' ' HB1' ' A' ' 342' ' ' ALA . . . -61.61 -52.84 62.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.151 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.85 ' HA ' HD12 ' A' ' 368' ' ' ILE . 15.6 tm0? -57.36 -30.49 64.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.005 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 60.5 m -82.62 -33.41 27.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.952 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -66.99 -33.81 76.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.936 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.85 HD12 ' HA ' ' A' ' 365' ' ' GLN . 5.2 mt -65.92 -30.13 49.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.04 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.7 p -80.14 -29.94 38.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 34.3 mttp . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.895 180.0 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.86 0.362 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.482 HG21 ' HB3' ' A' ' 58' ' ' ASP . 8.5 t -118.24 133.31 56.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.94 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -170.68 35.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.914 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -143.9 -166.37 2.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.785 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -84.91 56.02 5.0 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.463 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.51 ' HE2' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -142.08 -178.38 5.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.754 0.312 . . . . 0.0 110.938 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.403 HD21 ' HB3' ' A' ' 275' ' ' LEU . 15.2 mt -145.83 118.38 8.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.51 HG22 ' HE2' ' A' ' 6' ' ' LYS . 30.1 t -92.2 132.46 36.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.118 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.622 HG21 ' CD2' ' A' ' 20' ' ' LEU . 34.3 mt -121.56 107.2 19.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.46 ' CG ' ' HG2' ' A' ' 57' ' ' PRO . 0.9 OUTLIER -94.89 112.98 24.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.871 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.455 HD11 ' HD2' ' A' ' 15' ' ' LYS . 2.8 tt -144.93 146.16 20.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.105 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -66.26 161.57 21.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.858 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.13 55.99 4.97 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.512 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -153.34 36.03 0.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.795 0.331 . . . . 0.0 110.897 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.455 ' HD2' HD11 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -148.44 179.94 7.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.92 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.2 66.92 3.11 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.505 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 12.2 p90 -79.47 -31.4 42.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.821 0.344 . . . . 0.0 110.911 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.445 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 51.7 t-20 -60.49 -32.92 71.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.944 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.65 -28.59 51.06 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.493 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.622 ' CD2' HG21 ' A' ' 9' ' ' ILE . 14.0 tp -69.27 -33.46 73.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.865 0.364 . . . . 0.0 110.906 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.23 -40.83 91.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.119 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.4 -33.1 70.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.035 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.1 t -70.91 -32.74 49.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.11 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.63 -33.07 63.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.489 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -66.86 -29.44 69.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.845 0.355 . . . . 0.0 110.937 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.14 -40.13 46.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -58.3 -54.67 44.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.959 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -37.56 77.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.941 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -72.01 -26.3 62.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.975 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -82.95 -31.79 27.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.523 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 17.3 p -138.14 -44.22 0.51 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.611 0.243 . . . . 0.0 111.594 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.53 -20.2 2.95 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.689 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.3 mm -59.94 114.68 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.807 0.337 . . . . 0.0 111.047 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.3 mttp -82.69 170.13 15.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.988 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.28 125.51 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.104 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 m -116.6 125.1 51.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -105.15 127.95 59.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -115.49 153.68 30.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.861 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -117.83 70.27 7.19 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.425 ' HG3' ' CD2' ' A' ' 10' ' ' TRP . 88.0 Cg_endo -77.07 174.53 12.68 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.685 2.256 . . . . 0.0 112.475 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -60.94 -156.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.474 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.474 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -46.95 -26.49 1.01 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.516 0.198 . . . . 0.0 111.457 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.474 HD23 ' O ' ' A' ' 42' ' ' LYS . 0.3 OUTLIER 54.77 18.11 2.0 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.879 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -79.17 -55.78 4.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.834 0.349 . . . . 0.0 110.782 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -93.67 -7.8 42.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.363 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.478 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -80.71 -19.17 45.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.385 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.425 ' CB ' ' HD3' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -84.46 -53.36 0.51 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.197 -179.762 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.425 ' HD3' ' CB ' ' A' ' 47' ' ' PHE . 32.6 Cg_exo -57.84 -32.44 94.97 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.485 2.123 . . . . 0.0 112.37 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.488 ' HG3' HG13 ' A' ' 50' ' ' VAL . 11.4 pt20 -61.31 -47.07 87.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.058 0.456 . . . . 0.0 111.016 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.488 HG13 ' HG3' ' A' ' 49' ' ' GLN . 4.1 m -95.1 27.05 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.484 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.16 -32.18 30.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.348 . . . . 0.0 111.2 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.52 -32.82 19.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.171 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 51.6 p -72.73 -31.4 64.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.93 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.89 26.08 46.79 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.563 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -96.24 -28.66 14.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.808 0.337 . . . . 0.0 110.895 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.97 166.14 3.98 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.665 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.46 ' HG2' ' CG ' ' A' ' 10' ' ' TRP . 50.0 Cg_exo -53.38 -172.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.681 2.254 . . . . 0.0 112.38 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.482 ' HB3' HG21 ' A' ' 2' ' ' THR . 8.2 p30 -109.48 -29.02 8.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.953 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.484 HG21 HD21 ' A' ' 280' ' ' LEU . 30.9 mt -132.13 157.08 43.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.205 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.481 ' CG1' ' N ' ' A' ' 61' ' ' PHE . 2.0 tt -163.35 159.36 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.133 0.492 . . . . 0.0 110.897 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.481 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 3.9 m-85 -132.73 124.95 29.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.835 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.6 t-105 -159.41 171.43 19.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.851 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.7 134.04 55.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.163 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.434 ' CD2' HG23 ' A' ' 261' ' ' VAL . 13.2 p80 -58.56 -31.0 67.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.97 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -59.89 -29.97 68.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.988 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -88.48 -30.27 19.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.923 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -58.36 -30.12 66.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.968 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.81 -27.47 61.83 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.578 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.33 -28.45 71.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.488 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -87.22 -30.16 21.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.815 0.34 . . . . 0.0 110.947 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.18 -29.08 42.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.123 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -57.91 -29.55 65.19 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.063 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.55 -23.15 17.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.085 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.02 28.4 9.36 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.515 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.5 mt -81.81 -32.63 31.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.852 0.358 . . . . 0.0 110.913 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 76' ' ' LEU . 38.5 mt -76.0 160.68 29.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.502 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -101.77 133.0 47.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.453 ' CG ' ' N ' ' A' ' 79' ' ' ILE . 19.3 tt0 -61.36 164.01 6.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.722 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.498 ' O ' HG23 ' A' ' 80' ' ' THR . 43.1 pt -141.22 177.6 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.145 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 79' ' ' ILE . 0.7 OUTLIER -162.03 77.9 2.08 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.802 179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.51 135.92 41.02 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.555 2.17 . . . . 0.0 112.318 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.39 173.42 0.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -62.39 -48.47 79.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.64 -31.3 69.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.121 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -71.08 -44.26 66.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.89 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -64.08 -44.76 91.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.904 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -65.8 -29.75 70.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.94 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -59.62 -45.35 92.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.945 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.837 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 46.3 mt -88.23 173.64 8.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.879 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.435 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . 10.6 m-85 -81.57 149.55 64.83 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.063 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.33 -55.93 2.45 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.637 2.225 . . . . 0.0 112.706 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.454 ' CE1' ' CG2' ' A' ' 93' ' ' THR . 50.8 p90 -56.55 -44.12 80.58 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.771 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.454 ' CG2' ' CE1' ' A' ' 92' ' ' PHE . 39.3 p -54.49 -28.07 42.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.74 0.305 . . . . 0.0 111.116 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.837 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 49.6 m95 -76.83 -46.09 26.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.821 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.73 -26.53 67.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.069 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.401 ' HB2' HD13 ' A' ' 329' ' ' ILE . . . -71.71 -28.74 63.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.279 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 11.2 m -107.42 64.58 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.22 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -156.06 120.07 4.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.98 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -118.93 136.48 54.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.781 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 62.64 17.94 10.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.18 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.79 21.9 56.75 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.947 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.05 156.43 48.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.832 0.349 . . . . 0.0 110.994 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.547 ' O ' HG23 ' A' ' 104' ' ' ILE . 5.8 mt -93.8 142.67 27.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.547 HG23 ' O ' ' A' ' 103' ' ' LEU . 2.6 pp -159.0 36.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.206 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.589 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -160.79 176.91 10.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.186 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.425 ' CE1' HG21 ' A' ' 79' ' ' ILE . 39.3 m-85 -139.34 87.4 13.63 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.81 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.553 ' CG ' HG21 ' A' ' 97' ' ' VAL . 61.3 Cg_exo -51.77 102.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.571 2.18 . . . . 0.0 112.327 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.742 HD12 HD23 ' A' ' 284' ' ' LEU . 20.7 mm -76.67 -64.27 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.095 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.581 ' O ' HG12 ' A' ' 261' ' ' VAL . . . -131.88 171.63 13.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.078 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.28 148.11 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.055 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.77 159.8 37.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.961 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -169.07 145.25 3.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.107 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.2 mt -62.56 108.39 1.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.1 m -92.56 161.83 14.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.0 tp -109.3 102.12 11.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.907 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.7 mp -91.94 131.46 38.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.131 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.45 ' CD1' ' HG2' ' A' ' 125' ' ' PRO . 46.1 p90 -113.51 165.51 12.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.949 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.414 ' ND2' ' OE2' ' A' ' 221' ' ' GLU . 2.7 m120 -109.84 106.16 15.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.821 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -58.58 -22.86 57.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.612 ' HB3' HD23 ' A' ' 121' ' ' LEU . 2.5 t0 -55.04 -32.81 62.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.113 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.612 HD23 ' HB3' ' A' ' 120' ' ' ASP . 0.1 OUTLIER -128.86 -42.03 1.43 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.201 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 122' ' ' LEU . 14.4 tp -104.85 90.67 3.68 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.009 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.84 -43.83 2.37 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.532 2.155 . . . . 0.0 112.283 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -126.51 91.37 47.69 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.45 ' HG2' ' CD1' ' A' ' 117' ' ' TYR . 75.6 Cg_exo -50.58 151.83 9.9 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.586 2.191 . . . . 0.0 112.357 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.76 119.5 5.46 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.566 2.178 . . . . 0.0 112.366 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.05 -21.22 62.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.036 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 12.0 p -100.86 146.1 27.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.903 0.382 . . . . 0.0 111.058 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.88 ' CE3' HD12 ' A' ' 132' ' ' ILE . 4.4 m95 -77.36 -28.44 52.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.958 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.96 -15.74 60.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.526 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -89.19 -21.94 23.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.528 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.88 HD12 ' CE3' ' A' ' 129' ' ' TRP . 41.4 mt -59.76 -46.99 98.44 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.592 ' HG3' HD21 ' A' ' 198' ' ' LEU . 75.7 Cg_exo -49.5 -45.17 32.06 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.412 2.075 . . . . 0.0 112.416 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.26 -38.71 92.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.05 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.499 HD23 ' CD1' ' A' ' 139' ' ' LEU . 0.2 OUTLIER -65.34 -33.59 76.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.865 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.528 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 41.9 t0 -63.77 -24.4 67.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.1 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -85.53 -31.67 22.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.115 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -85.01 -47.11 10.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.208 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.779 HD22 ' HB2' ' A' ' 223' ' ' ALA . 0.3 OUTLIER -62.14 -17.87 59.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.394 -179.742 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.32 -27.92 53.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.736 0.303 . . . . 0.0 110.879 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.6 -41.69 90.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.05 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.7 mtpt -72.59 -27.11 61.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.017 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 114.51 29.4 2.71 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.504 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt -141.75 166.99 23.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.844 0.354 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.0 t -97.71 159.13 15.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.871 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.618 ' HA ' HD13 ' A' ' 139' ' ' LEU . . . -85.45 -32.07 22.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.17 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.824 HD12 ' CB ' ' A' ' 224' ' ' MET . 1.0 OUTLIER -169.98 124.1 0.75 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.018 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.413 ' HB2' HG21 ' A' ' 208' ' ' THR . 0.4 OUTLIER -129.43 166.65 19.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.59 179.697 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.8 p90 179.01 -170.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.803 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -89.14 109.64 20.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.905 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.674 HD21 HD11 ' A' ' 195' ' ' LEU . 13.7 mt -88.97 -29.13 19.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.952 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -59.17 -31.46 69.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.885 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.38 111.28 59.45 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.6 -23.48 19.8 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.428 2.085 . . . . 0.0 112.318 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.496 ' CE1' ' CD1' ' A' ' 258' ' ' PHE . 0.3 OUTLIER -50.6 -27.41 6.78 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.232 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -96.81 -22.47 16.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.219 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.839 ' O ' HD12 ' A' ' 161' ' ' ILE . 17.2 p -92.35 11.75 24.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.398 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.467 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 22.8 t-105 -87.58 -47.45 0.48 Allowed Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.309 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 53.7 Cg_exo -52.52 -23.32 18.95 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.374 2.049 . . . . 0.0 112.574 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.679 HD11 ' CD2' ' A' ' 194' ' ' PHE . 5.6 tp -86.02 -67.38 0.81 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.103 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.839 HD12 ' O ' ' A' ' 157' ' ' THR . 5.4 mt -57.73 -41.69 80.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.237 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.499 ' HB1' ' HB2' ' A' ' 256' ' ' LYS . . . -59.8 -38.27 81.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.197 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.673 ' HB2' ' HA ' ' A' ' 255' ' ' SER . . . -57.79 -36.17 71.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.229 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.94 -20.18 56.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.169 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 130.04 -22.0 4.86 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.636 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.562 ' HA3' ' HB2' ' A' ' 188' ' ' ALA . . . -69.32 154.65 53.25 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.496 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.442 ' CD1' ' HA3' ' A' ' 182' ' ' GLY . 25.6 p90 -148.85 -175.13 4.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 0.0 110.926 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.474 ' HB1' ' CE1' ' A' ' 339' ' ' PHE . . . -111.31 -48.9 3.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.024 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -130.28 127.53 39.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.828 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 167' ' ' TYR . 11.1 tttm -94.65 112.79 24.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.092 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.403 ' HB2' ' CE1' ' A' ' 176' ' ' TYR . 62.5 t80 -68.93 110.89 4.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.544 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -172.48 156.06 3.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.961 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 62.73 46.23 5.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.007 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 104.09 -62.27 0.4 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.723 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -151.09 -171.47 3.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 111.009 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.403 ' CE1' ' HB2' ' A' ' 171' ' ' TYR . 88.2 m-85 -59.49 125.9 25.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.9 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -82.19 127.51 33.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.876 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.2 pt -73.18 -27.6 24.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.202 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -97.25 26.04 5.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.052 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -125.44 96.35 4.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.921 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.796 HG21 ' HA ' ' A' ' 365' ' ' GLN . 23.5 t -96.29 146.01 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.111 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 0.442 ' HA3' ' CD1' ' A' ' 167' ' ' TYR . . . -114.71 -7.04 18.57 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.995 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.662 HG12 HD22 ' A' ' 361' ' ' LEU . 11.1 t -56.51 -43.31 77.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.866 0.333 . . . . 0.0 111.181 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.06 57.26 4.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.919 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -104.61 -178.87 3.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.75 -52.15 22.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.108 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -76.82 -29.59 57.2 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.561 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.562 ' HB2' ' HA3' ' A' ' 166' ' ' GLY . . . -58.29 -33.93 69.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.829 0.347 . . . . 0.0 111.122 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.59 -31.2 72.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -87.47 -36.86 17.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.137 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -60.29 -46.85 93.52 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.461 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.939 HD12 HG22 ' A' ' 357' ' ' VAL . 3.1 tm? -60.33 -45.93 91.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.831 0.348 . . . . 0.0 110.854 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.554 ' OG1' HG21 ' A' ' 357' ' ' VAL . 91.7 m -67.02 -24.28 66.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.977 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.679 ' CD2' HD11 ' A' ' 160' ' ' LEU . 24.7 t80 -59.27 -60.67 3.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.812 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.674 HD11 HD21 ' A' ' 151' ' ' LEU . 3.7 tp -61.18 -30.29 70.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.554 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 192' ' ' LEU . 49.1 t -69.86 -43.28 79.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.005 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.34 -24.32 34.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.133 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.592 HD21 ' HG3' ' A' ' 133' ' ' PRO . 0.7 OUTLIER -63.87 -35.21 79.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.033 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.517 HG23 ' O ' ' A' ' 204' ' ' MET . 12.4 mt -77.75 -33.74 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.3 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 4.0 mtpp -85.07 -28.99 25.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.146 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -91.39 -10.18 42.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.558 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.569 ' HG3' HD23 ' A' ' 198' ' ' LEU . 13.1 mmtm -130.83 9.02 4.9 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.5 0.191 . . . . 0.0 111.49 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' HIS . . . . . 0.424 ' CG ' ' O ' ' A' ' 202' ' ' LYS . 40.1 p-80 43.67 52.96 6.16 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.888 0.375 . . . . 0.0 111.426 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' MET . . . . . 0.517 ' O ' HG23 ' A' ' 199' ' ' ILE . 48.0 mtp -82.76 133.51 35.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -59.37 119.75 8.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.073 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -80.07 -29.77 39.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.059 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.74 -20.85 52.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.222 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.413 HG21 ' HB2' ' A' ' 148' ' ' MET . 7.2 m -45.16 149.31 0.5 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.916 0.388 . . . . 0.0 111.398 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.527 ' OD2' HD11 ' A' ' 212' ' ' ILE . 11.2 m-20 -154.07 176.28 12.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.661 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 211' ' ' SER . 0.3 OUTLIER -62.96 -30.48 71.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.93 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.454 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 0.7 OUTLIER -68.78 -59.21 3.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.953 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.527 HD11 ' OD2' ' A' ' 209' ' ' ASP . 0.0 OUTLIER -58.83 -28.85 38.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.358 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -74.07 -33.61 63.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.781 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.75 -28.63 30.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.53 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.37 -36.42 83.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.474 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.433 ' HA ' ' HA3' ' A' ' 220' ' ' GLY . . . -52.46 -25.22 9.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.307 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -66.92 -53.9 27.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.979 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -90.06 -13.96 34.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.03 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -176.84 101.85 0.05 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.979 0.419 . . . . 0.0 111.275 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 216' ' ' ALA . . . 149.73 -46.85 0.64 Allowed Glycine 0 N--CA 1.453 -0.229 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.049 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.414 ' OE2' ' ND2' ' A' ' 118' ' ' ASN . 0.3 OUTLIER 63.97 101.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.944 0.402 . . . . 0.0 111.561 179.469 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.564 HG21 ' HB ' ' A' ' 225' ' ' THR . 13.3 t -116.05 124.89 51.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.374 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.779 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -45.92 -32.64 2.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.604 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.824 ' CB ' HD12 ' A' ' 147' ' ' LEU . 26.3 mtm -156.89 142.54 17.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.914 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.564 ' HB ' HG21 ' A' ' 222' ' ' THR . 4.1 t -164.3 126.24 2.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.444 HG12 HD21 ' A' ' 247' ' ' LEU . 4.0 mt -95.71 126.99 48.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.096 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -141.28 165.49 27.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -82.48 -170.94 46.06 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.496 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.406 ' HD2' ' CE3' ' A' ' 230' ' ' TRP . 74.1 Cg_endo -74.99 -2.89 13.13 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.638 2.225 . . . . 0.0 112.751 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' TRP . . . . . 0.406 ' CE3' ' HD2' ' A' ' 229' ' ' PRO . 39.0 p90 -95.97 34.08 1.6 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.694 0.283 . . . . 0.0 111.104 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -136.86 11.29 3.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.557 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 8.7 m0 -81.19 -39.43 25.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.808 0.337 . . . . 0.0 110.965 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.45 -29.92 68.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.024 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.71 -30.45 65.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.993 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.548 HG21 ' CE1' ' A' ' 242' ' ' TYR . 4.4 mt -88.63 84.67 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.071 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.603 ' O ' HG23 ' A' ' 237' ' ' THR . 33.9 p-10 -160.76 37.19 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.915 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.603 HG23 ' O ' ' A' ' 236' ' ' ASP . 0.8 OUTLIER -165.71 -43.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.957 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 82.8 p -63.08 -30.68 71.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.964 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 7.4 mmtm 61.09 36.05 18.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 20.8 t -95.41 121.73 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.105 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -61.98 111.97 2.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.868 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.548 ' CE1' HG21 ' A' ' 235' ' ' ILE . 50.8 p90 -109.26 146.96 33.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.91 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -126.14 147.19 16.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.492 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 20.8 t -110.18 127.05 67.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.814 0.34 . . . . 0.0 111.126 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.3 t -143.61 146.81 33.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.419 ' CG2' ' N ' ' A' ' 247' ' ' LEU . 0.7 OUTLIER -55.17 152.31 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.217 0.532 . . . . 0.0 111.32 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.444 HD21 HG12 ' A' ' 226' ' ' ILE . 13.5 mt -72.08 147.62 91.04 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.946 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.561 ' HG3' HD11 ' A' ' 132' ' ' ILE . 36.1 Cg_endo -65.43 166.45 19.47 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.535 2.157 . . . . 0.0 112.282 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 254' ' ' PRO . 4.5 p -110.32 162.2 14.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.943 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -117.24 110.58 18.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.913 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 9.1 mttm 59.84 25.3 14.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.042 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 92.93 -21.07 41.61 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.714 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -80.48 126.59 78.26 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.539 0.209 . . . . 0.0 110.832 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.462 ' HA ' HG22 ' A' ' 249' ' ' THR . 71.4 Cg_endo -74.76 143.88 30.5 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.433 2.089 . . . . 0.0 112.34 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.673 ' HA ' ' HB2' ' A' ' 163' ' ' ALA . 89.7 p -60.64 -178.29 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.777 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.499 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . 11.6 mttp -136.99 62.25 38.82 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.014 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.414 ' HD3' ' N ' ' A' ' 256' ' ' LYS . 35.7 Cg_exo -57.43 -161.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.497 2.131 . . . . 0.0 112.207 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.496 ' CD1' ' CE1' ' A' ' 155' ' ' TYR . 63.1 m-85 -122.3 136.89 54.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.821 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 25.8 t -97.15 117.82 42.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.178 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -114.61 114.23 3.2 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.405 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -112.84 142.34 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.849 0.357 . . . . 0.0 111.151 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 14.8 tp -101.76 81.44 2.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.724 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.545 ' OG ' ' HB1' ' A' ' 105' ' ' ALA . 14.9 p -85.32 166.2 16.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.971 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -99.72 148.37 24.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.055 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -125.26 131.4 7.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.521 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 3.9 mp -124.13 102.4 10.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.789 0.328 . . . . 0.0 111.064 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -59.59 148.33 33.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.993 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.502 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -60.74 -30.55 70.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.092 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.83 57.1 4.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.014 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 8.0 m -145.56 93.29 5.35 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.84 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -48.64 -26.72 9.67 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.585 2.19 . . . . 0.0 112.464 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -86.21 56.24 3.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.835 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.27 -49.64 9.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.905 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -60.04 -43.72 95.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.864 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.403 ' HB3' HD21 ' A' ' 7' ' ' LEU . 46.6 mt -66.06 -32.18 73.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.8 -44.27 86.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.074 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.11 -49.39 74.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -63.05 -32.31 73.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.89 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.402 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 84.1 t80 -69.57 -47.59 63.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.97 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.507 HD23 HD22 ' A' ' 284' ' ' LEU . 1.6 mt -81.49 -21.17 38.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.383 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -93.61 -48.25 6.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.793 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -102.99 17.72 23.39 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.519 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.402 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 21.4 m-85 -163.81 44.59 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.884 0.373 . . . . 0.0 111.193 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.742 HD23 HD12 ' A' ' 108' ' ' ILE . 3.1 tp -177.95 -55.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 3.0 mt -89.99 52.56 2.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.7 p -138.31 -178.17 5.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -71.54 -43.27 66.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.888 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -82.72 -33.62 27.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -60.55 -61.88 6.59 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.563 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.566 HD13 ' CD2' ' A' ' 307' ' ' TYR . 2.8 mt -60.96 -34.27 74.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.333 . . . . 0.0 110.917 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.94 -41.99 93.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.94 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -59.5 -36.4 75.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.14 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.6 t -85.4 -30.67 6.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -59.77 -36.0 75.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -66.88 -32.72 74.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -89.46 -32.75 17.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.961 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -162.65 91.53 1.27 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.983 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.66 123.68 10.72 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.499 2.133 . . . . 0.0 112.315 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.468 ' H ' HD12 ' A' ' 299' ' ' LEU . 3.1 mp -93.33 16.87 12.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.11 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 59.09 -116.93 9.51 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.542 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -59.58 155.71 14.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.861 0.362 . . . . 0.0 111.093 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.544 HG11 ' CD2' ' A' ' 307' ' ' TYR . 16.7 m -141.1 156.16 21.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.162 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.49 ' HB3' HD22 ' A' ' 89' ' ' LEU . . . -69.87 -36.2 75.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.098 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.638 HD23 ' HB2' ' A' ' 307' ' ' TYR . 9.2 tp -61.35 122.32 14.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -70.05 -27.28 64.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.009 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 69.0 m -81.25 -27.61 35.11 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.149 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.638 ' HB2' HD23 ' A' ' 304' ' ' LEU . 8.3 t80 -83.06 -31.24 27.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.24 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -30.71 69.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.881 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -69.8 -50.23 45.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.891 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -51.22 -39.46 56.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.75 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.765 ' HB3' HG21 ' A' ' 317' ' ' ILE . 72.4 mt -85.68 -23.05 27.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.866 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.99 -14.95 61.66 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.491 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -46.41 -30.61 2.22 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.891 0.377 . . . . 0.0 110.912 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.89 142.04 27.79 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.339 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.42 -33.52 96.43 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.476 2.117 . . . . 0.0 112.521 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -49.18 -37.15 21.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.007 0.432 . . . . 0.0 110.364 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.765 HG21 ' HB3' ' A' ' 311' ' ' LEU . 33.1 mm -85.56 -34.33 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.876 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.3 -31.81 72.84 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.154 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.09 -45.75 83.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.175 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 60.3 m -61.34 -35.24 76.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 2.9 tpt -66.38 -46.62 76.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -62.76 -33.68 75.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -75.33 -32.19 60.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.45 -45.38 72.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.045 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -59.67 -31.54 69.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.854 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -96.59 21.12 9.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.145 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -117.15 135.95 12.29 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.524 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -79.27 143.03 35.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.781 0.324 . . . . 0.0 110.886 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.401 HD13 ' HB2' ' A' ' 96' ' ' ALA . 26.0 mt -75.76 133.88 30.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.142 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 27.4 mtm -60.29 125.63 82.16 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.778 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.77 172.06 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.352 2.035 . . . . 0.0 112.245 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -132.35 41.03 3.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 31.7 pt -117.56 143.98 33.29 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.108 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.49 -23.84 49.91 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.595 2.196 . . . . 0.0 112.426 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.13 -22.46 40.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.203 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 37.8 mtp -54.66 -24.2 20.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.288 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 44.7 m -57.14 -36.89 71.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.085 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -82.41 -28.19 31.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.189 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.778 ' CZ ' HG21 ' A' ' 343' ' ' VAL . 79.7 t80 -57.4 -31.22 65.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.979 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -62.74 -61.0 2.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.018 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -63.2 -27.96 69.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.131 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -73.44 -38.24 65.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.351 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.831 ' O ' HG23 ' A' ' 347' ' ' VAL . 25.9 t -88.58 -46.35 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.299 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.563 ' HG2' HD11 ' A' ' 348' ' ' ILE . 7.1 ttt180 -55.75 -57.36 12.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.129 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 29.8 m -61.97 -27.25 68.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.115 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 350' ' ' ALA . . . -76.3 -32.66 58.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.322 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 343' ' ' VAL . 33.0 t -82.71 -42.68 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.282 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.563 HD11 ' HG2' ' A' ' 344' ' ' ARG . 17.4 mt -62.31 -59.05 4.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.125 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -59.6 -30.36 68.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.935 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 346' ' ' ALA . . . -73.56 -52.06 14.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.112 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.26 -32.2 72.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.137 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.25 -22.4 64.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.092 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 103.45 -27.21 20.85 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.573 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -58.97 -77.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.882 0.372 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -65.55 140.89 58.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.844 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 78.2 p -87.92 178.02 6.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.787 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.939 HG22 HD12 ' A' ' 192' ' ' LEU . 23.3 t -77.62 -55.11 11.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.945 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -47.69 -33.0 6.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.319 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -82.08 -45.79 14.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.143 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -57.43 -60.46 3.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.052 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.662 HD22 HG12 ' A' ' 183' ' ' VAL . 7.3 mt -58.7 -27.29 64.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.074 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -81.2 -37.06 29.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.955 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -70.36 -45.53 65.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.863 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.404 ' O ' HD12 ' A' ' 368' ' ' ILE . . . -58.2 -30.78 66.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.11 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.796 ' HA ' HG21 ' A' ' 181' ' ' VAL . 3.5 tt0 -69.39 -30.46 68.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 7.0 m -85.05 -30.14 24.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.051 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -74.19 -41.99 60.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.0 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 364' ' ' ALA . 12.4 mt -73.48 -28.92 26.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.218 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 365' ' ' GLN . 79.6 p -90.98 -46.09 8.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.867 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.932 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.81 0.338 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -120.97 178.24 4.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.917 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -93.04 168.73 10.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.79 36.43 87.12 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.481 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.8 170.32 21.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.848 0.356 . . . . 0.0 110.949 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.6 mt -140.38 124.51 17.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.88 106.97 21.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.059 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.706 HG21 HD21 ' A' ' 20' ' ' LEU . 4.0 mp -99.26 121.23 49.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.578 ' CE3' HD13 ' A' ' 43' ' ' LEU . 1.4 m0 -91.23 133.7 35.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.984 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.535 HG23 ' HB3' ' A' ' 39' ' ' HIS . 9.4 tp -125.01 159.56 31.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.962 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.404 ' N ' HG13 ' A' ' 11' ' ' ILE . 26.6 m-20 -93.49 31.71 1.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.159 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.45 ' H ' HG23 ' A' ' 11' ' ' ILE . . . 47.46 37.77 12.97 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.06 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -178.64 53.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.846 0.355 . . . . 0.0 111.004 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.401 ' CB ' HD11 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -179.75 78.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.865 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.47 49.8 73.17 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.534 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 36.3 p90 -78.99 -38.83 35.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.813 0.339 . . . . 0.0 110.919 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.438 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 2.6 t30 -86.92 -31.68 20.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.949 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.57 -37.44 68.41 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.531 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.706 HD21 HG21 ' A' ' 9' ' ' ILE . 4.9 tp -63.75 -32.23 73.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.856 0.36 . . . . 0.0 110.949 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.67 -31.23 72.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.081 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -63.51 -43.64 96.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.912 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.87 -35.44 60.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.109 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.412 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . -65.96 -43.73 93.05 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.445 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -59.73 -25.62 64.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.772 0.32 . . . . 0.0 111.002 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -82.58 -38.95 22.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.991 0.424 . . . . 0.0 110.882 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.34 -50.13 73.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.029 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -38.39 81.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.93 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.06 -25.12 64.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.095 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -88.38 -32.49 18.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.372 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.0 p -136.65 -44.14 0.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.375 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.67 20.61 4.94 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.657 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.56 HG21 HD13 ' A' ' 275' ' ' LEU . 32.9 mm -85.78 126.72 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.852 0.358 . . . . 0.0 111.043 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -65.45 148.68 51.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.412 HG21 ' HA2' ' A' ' 24' ' ' GLY . 21.5 t -143.38 104.36 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.09 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.6 m -109.54 150.6 27.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.999 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 9' ' ' ILE . 21.6 t -133.15 127.83 55.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.064 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -126.26 155.56 41.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.91 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.535 ' HB3' HG23 ' A' ' 11' ' ' ILE . 7.6 p80 -135.96 70.22 63.92 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.851 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.523 ' HG2' HD22 ' A' ' 43' ' ' LEU . 44.4 Cg_endo -68.77 170.27 15.73 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.584 2.189 . . . . 0.0 112.468 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -108.34 141.42 40.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.717 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.98 32.94 19.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.663 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.623 HD11 ' HZ3' ' A' ' 62' ' ' TRP . 2.3 pp -77.34 -0.78 26.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.699 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -56.98 -57.09 14.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.784 0.326 . . . . 0.0 111.16 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -88.41 -25.64 22.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.185 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.532 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -74.0 -18.97 60.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.295 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.462 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 78.4 t80 -74.07 -56.33 2.72 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.504 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 40.6 Cg_endo -67.0 -23.91 46.05 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.298 1.998 . . . . 0.0 112.883 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -65.12 -46.03 82.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.873 0.368 . . . . 0.0 111.155 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.532 HG22 ' O ' ' A' ' 46' ' ' LYS . 5.8 m -87.06 -28.99 5.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.314 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.463 ' HB1' ' OD1' ' A' ' 267' ' ' ASN . . . -56.9 -29.61 63.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.261 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.59 -33.37 71.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.13 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.2 p -93.87 -30.78 14.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.949 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.73 25.61 24.77 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.59 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -94.44 -32.97 13.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.869 0.366 . . . . 0.0 110.867 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.27 -143.94 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.534 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.422 ' HG3' ' CD2' ' A' ' 10' ' ' TRP . 43.6 Cg_endo -68.09 -167.78 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.538 2.159 . . . . 0.0 112.329 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -123.75 -51.9 1.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.0 mt -109.77 138.46 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.092 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.469 ' CG1' ' N ' ' A' ' 61' ' ' PHE . 3.0 tt -125.82 159.72 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.069 0.461 . . . . 0.0 111.029 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.469 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 46.4 m-85 -135.08 125.63 26.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.932 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.623 ' HZ3' HD11 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -160.27 175.95 12.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.52 157.01 37.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.142 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.755 ' HD2' HG12 ' A' ' 261' ' ' VAL . 32.2 p80 -57.98 -34.11 69.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.994 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -60.59 -48.82 80.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.08 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.416 ' HG3' ' CD1' ' A' ' 62' ' ' TRP . 30.5 mmm180 -74.87 -27.85 60.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.021 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.402 ' CE2' ' HB2' ' A' ' 263' ' ' SER . 1.0 OUTLIER -57.65 -22.37 45.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.147 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -94.6 33.7 5.18 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.576 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -118.4 -32.49 1.35 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.51 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -88.41 -27.52 21.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.775 0.322 . . . . 0.0 110.98 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.33 -30.72 38.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.053 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.422 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 3.5 pt20 -61.05 -36.4 79.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.962 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 m -89.75 -23.06 21.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.126 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.74 59.2 0.87 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.452 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.0 mt -138.31 31.69 2.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.362 . . . . 0.0 110.961 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' A' ' 268' ' ' ALA . 14.1 mt -138.88 161.45 37.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.792 ' HB2' ' O ' ' A' ' 267' ' ' ASN . . . -97.8 151.21 20.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.058 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.469 ' CD ' HG22 ' A' ' 104' ' ' ILE . 1.0 OUTLIER -77.06 -165.37 0.55 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.93 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.441 HD13 ' N ' ' A' ' 105' ' ' ALA . 33.4 pt -157.64 171.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.085 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 79' ' ' ILE . 41.8 p -158.1 77.42 3.52 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.741 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.48 160.16 47.39 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.631 2.221 . . . . 0.0 112.347 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.35 -176.94 3.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.753 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.3 mttp -59.89 -38.94 83.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.81 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.18 -28.04 61.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.075 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -79.19 -37.69 37.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.935 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -82.14 -25.95 33.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.085 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -79.19 -40.83 29.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.163 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.452 ' NZ ' HD13 ' A' ' 285' ' ' LEU . 32.5 pttt -58.37 -39.45 79.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.083 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.707 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 24.9 mt -83.01 162.1 21.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.872 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.499 ' HB2' HG23 ' A' ' 93' ' ' THR . 26.1 m-85 -88.26 147.63 40.72 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.03 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -54.21 -55.71 3.18 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.567 2.178 . . . . 0.0 112.736 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.547 ' CE1' HG22 ' A' ' 93' ' ' THR . 40.2 p90 -54.09 -39.62 66.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.808 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.547 HG22 ' CE1' ' A' ' 92' ' ' PHE . 27.8 p -61.42 -32.98 72.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.745 0.307 . . . . 0.0 110.826 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.707 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 45.3 m95 -67.75 -32.0 72.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.793 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -60.35 -26.98 67.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.055 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.622 ' HB1' ' CB ' ' A' ' 64' ' ' HIS . . . -73.12 -28.67 62.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.258 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.612 ' CG1' ' HB3' ' A' ' 105' ' ' ALA . 3.8 m -104.05 56.24 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.936 0.398 . . . . 0.0 111.245 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -156.08 130.45 8.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.422 ' CE2' ' HB3' ' A' ' 72' ' ' GLN . 1.8 t80 -96.23 -64.74 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.838 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -127.69 45.78 2.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.795 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.16 -26.8 19.4 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.526 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.2 141.8 33.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.841 0.353 . . . . 0.0 110.88 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 32.1 mt -97.01 132.05 43.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.843 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.547 ' O ' HD12 ' A' ' 104' ' ' ILE . 2.6 pp -138.31 30.47 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.196 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.612 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . . . -173.8 178.73 2.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.152 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.806 ' OH ' HD11 ' A' ' 266' ' ' ILE . 1.1 p90 -155.74 96.09 2.4 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.807 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.63 ' HB3' HG21 ' A' ' 261' ' ' VAL . 54.0 Cg_exo -52.54 144.99 39.39 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.504 2.136 . . . . 0.0 112.424 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.612 HG23 ' CD2' ' A' ' 285' ' ' LEU . 5.4 mt -128.31 -59.3 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.047 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.526 ' HA ' HG12 ' A' ' 302' ' ' VAL . . . -105.86 145.75 30.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.096 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.478 HG22 HG23 ' A' ' 261' ' ' VAL . 32.7 t -121.18 138.36 51.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.136 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -139.47 160.08 40.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.863 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -172.31 152.74 2.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.083 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.512 HD23 ' HA2' ' A' ' 228' ' ' GLY . 5.3 mt -71.02 101.94 2.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.44 -176.52 3.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.6 tp -96.81 114.61 26.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.919 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.7 mt -108.9 114.01 45.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.004 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -124.88 165.53 17.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.906 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.39 144.51 34.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.926 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.5 mtmm -98.5 33.39 2.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.961 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -93.13 -48.12 6.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.949 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.96 -35.26 5.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.008 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.464 HD21 ' O ' ' A' ' 124' ' ' ASN . 1.6 tt -108.53 95.32 15.95 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.979 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.48 -45.24 1.26 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.484 2.123 . . . . 0.0 112.353 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.464 ' O ' HD21 ' A' ' 122' ' ' LEU . 6.3 m120 -100.34 114.71 65.81 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.51 153.01 39.11 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.416 2.077 . . . . 0.0 112.364 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.52 116.24 4.64 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.576 2.184 . . . . 0.0 112.289 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.93 -23.73 38.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.027 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 73.2 p -118.01 149.7 40.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.895 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.895 ' CE3' HD12 ' A' ' 132' ' ' ILE . 26.5 m95 -69.63 -31.27 69.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.854 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -68.8 -15.65 63.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.427 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -85.5 -16.95 37.87 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.895 HD12 ' CE3' ' A' ' 129' ' ' TRP . 24.0 mt -71.78 -49.42 10.78 Favored Pre-proline 0 C--N 1.331 -0.204 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.53 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 83.3 Cg_exo -44.99 -46.58 12.96 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.499 2.132 . . . . 0.0 112.509 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.07 -40.07 92.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.997 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.926 HD23 HD12 ' A' ' 139' ' ' LEU . 0.2 OUTLIER -64.73 -36.84 85.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.797 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.706 ' OD1' ' HB3' ' A' ' 146' ' ' ALA . 1.6 m-20 -57.76 -27.51 63.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.067 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.433 ' HE2' ' CE1' ' A' ' 203' ' ' HIS . 50.1 mttm -85.6 -31.6 22.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.069 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -85.1 -56.46 3.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.171 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.926 HD12 HD23 ' A' ' 135' ' ' LEU . 0.2 OUTLIER -55.42 -26.77 43.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.272 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -77.67 -28.26 51.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.804 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.42 -38.28 83.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.951 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 41.3 mttt -73.64 -27.12 61.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.073 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.2 32.4 1.83 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.599 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.2 mtmt -149.82 159.7 44.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 0.0 110.874 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.608 ' O ' HD22 ' A' ' 139' ' ' LEU . 84.7 p -82.33 170.11 15.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.975 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.72 ' HA ' HD13 ' A' ' 139' ' ' LEU . . . -102.67 -56.69 2.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.169 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.666 HD22 HD13 ' A' ' 132' ' ' ILE . 4.0 tp -153.54 136.32 15.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.92 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.588 ' SD ' HG21 ' A' ' 222' ' ' THR . 0.0 OUTLIER -133.87 -177.91 4.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.82 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.518 ' HZ ' HD11 ' A' ' 195' ' ' LEU . 51.1 p90 -177.25 -172.78 0.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.875 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.424 ' HB3' ' CD1' ' A' ' 156' ' ' PHE . 60.2 t-20 -83.59 114.21 21.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.941 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.4 mt -98.57 30.8 3.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.911 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -127.54 30.33 5.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -168.49 111.42 0.55 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.627 ' CB ' HG12 ' A' ' 343' ' ' VAL . 78.0 Cg_exo -50.26 -25.74 14.07 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.453 2.102 . . . . 0.0 112.353 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.494 ' CD2' ' CD2' ' A' ' 258' ' ' PHE . 0.8 OUTLIER -58.4 -31.5 67.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.424 ' CD1' ' HB3' ' A' ' 150' ' ' ASN . 13.6 m-85 -74.43 -30.53 61.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.44 ' O ' HD12 ' A' ' 161' ' ' ILE . 21.1 p -102.56 30.34 4.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.067 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.468 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 1.4 t-105 -83.59 -48.45 0.73 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.093 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.512 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 32.4 Cg_exo -58.13 -18.83 38.49 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.417 2.078 . . . . 0.0 112.497 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 15.6 tp -92.66 -32.13 14.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.155 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.661 HD13 HD12 ' A' ' 192' ' ' LEU . 15.6 mt -95.79 -58.02 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.222 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.463 ' HB1' ' HE3' ' A' ' 256' ' ' LYS . . . -56.15 -31.1 63.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.252 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -59.08 -44.82 91.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.135 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -63.73 -20.08 65.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.185 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 131.71 71.26 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.56 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -158.2 142.9 8.84 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.493 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -147.48 179.47 7.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.332 . . . . 0.0 110.999 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.635 ' HB2' ' CZ ' ' A' ' 339' ' ' PHE . . . -103.55 -33.01 9.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.983 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -141.25 155.31 46.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.793 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 9.1 tttm -103.35 111.32 23.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.057 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.437 ' CD1' ' CZ ' ' A' ' 176' ' ' TYR . 57.4 t80 -73.81 110.91 8.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.412 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -158.76 150.92 21.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.08 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 61.51 29.93 18.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.059 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 90.78 -38.54 3.2 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.014 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -108.05 -177.11 3.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.918 0.389 . . . . 0.0 111.079 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.437 ' CZ ' ' CD1' ' A' ' 171' ' ' TYR . 4.9 m-85 -108.1 121.14 44.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.921 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -58.75 132.5 54.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.7 pt -91.02 -23.63 5.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.385 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.39 26.05 4.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.15 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -141.53 90.12 2.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.919 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.72 HG11 HD13 ' A' ' 368' ' ' ILE . 16.2 t -100.75 146.01 10.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.079 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -111.0 66.55 0.23 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.652 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.947 HG12 ' CD2' ' A' ' 361' ' ' LEU . 1.5 t -103.13 -60.52 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.91 0.386 . . . . 0.0 111.064 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.498 ' HA ' HD13 ' A' ' 361' ' ' LEU . 35.1 p-10 -83.46 56.7 3.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.11 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -95.77 168.43 10.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.814 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -59.83 -34.17 72.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.113 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -85.93 -45.51 5.67 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.611 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 183' ' ' VAL . . . -58.9 -38.69 79.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.785 0.326 . . . . 0.0 111.17 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -60.07 -34.7 73.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -87.55 -30.99 20.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.168 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -58.45 -50.5 66.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.57 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.888 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.2 OUTLIER -60.77 -43.08 98.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.806 0.336 . . . . 0.0 110.931 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 9.9 m -50.19 -27.37 5.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.252 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -67.93 -58.67 4.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.811 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.518 HD11 ' HZ ' ' A' ' 149' ' ' PHE . 4.1 tp -64.76 -30.1 71.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 192' ' ' LEU . 47.6 t -66.18 -56.92 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.062 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.84 -28.41 61.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.146 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 195' ' ' LEU . 26.2 mt -59.69 -58.22 9.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.012 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 9.0 mt -61.39 -28.8 44.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.057 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.33 -35.4 66.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -90.2 16.46 8.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.44 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.84 39.12 27.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.821 0.343 . . . . 0.0 111.216 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . 0.433 ' CE1' ' HE2' ' A' ' 137' ' ' LYS . 2.8 m-70 -90.2 -23.86 21.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.888 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 13.9 mtt -132.91 -177.51 4.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.777 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -115.59 147.86 40.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.918 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -78.8 -30.52 45.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.041 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.37 60.04 4.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.783 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.587 ' HA ' HD12 ' A' ' 212' ' ' ILE . 0.2 OUTLIER -117.43 138.55 51.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.928 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.444 ' OD2' HD11 ' A' ' 212' ' ' ILE . 57.3 m-20 -154.19 176.16 12.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.732 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -64.68 -39.84 94.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.231 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.03 -59.08 3.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.876 0.369 . . . . 0.0 110.988 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.587 HD12 ' HA ' ' A' ' 208' ' ' THR . 0.3 OUTLIER -57.63 -29.11 33.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.656 179.805 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.405 ' CB ' ' HG3' ' A' ' 148' ' ' MET . . . -80.61 -22.63 40.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.961 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -77.88 -36.62 49.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.866 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -72.47 -38.2 68.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.037 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.66 -30.8 67.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.121 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -81.71 -36.88 28.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.93 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -68.28 -46.85 69.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.52 -30.1 71.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.13 43.79 1.99 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.49 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -100.3 -74.49 0.6 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.882 0.373 . . . . 0.0 110.903 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.588 HG21 ' SD ' ' A' ' 148' ' ' MET . 11.3 t -74.34 142.81 45.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.72 -30.98 46.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.049 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.422 ' SD ' HD13 ' A' ' 122' ' ' LEU . 2.1 mpp? -128.34 156.24 43.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.929 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 9.4 t -166.64 147.36 6.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.47 HD12 ' HB3' ' A' ' 149' ' ' PHE . 4.5 mt -109.85 126.51 67.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.029 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -144.92 165.43 28.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.512 ' HA2' HD23 ' A' ' 113' ' ' LEU . . . -80.96 -169.44 41.46 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.533 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.419 ' HD2' ' CZ3' ' A' ' 230' ' ' TRP . 55.1 Cg_endo -69.81 -8.98 24.99 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.562 2.175 . . . . 0.0 112.699 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . 0.427 ' CZ3' ' HA3' ' A' ' 228' ' ' GLY . 41.0 p90 -94.36 39.25 1.09 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.758 0.314 . . . . 0.0 111.09 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -113.47 -33.19 5.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.129 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 22.4 m0 -63.14 -31.42 72.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.862 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 49.6 m -60.8 -33.69 73.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.96 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.35 -50.89 72.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 18.1 pt -75.58 134.81 28.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.123 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -176.26 -40.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.69 -36.05 9.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.35 -32.69 58.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.923 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt 60.06 74.65 0.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.27 122.0 56.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.063 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -63.18 107.3 1.02 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -98.13 157.65 16.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.3 120.68 2.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.463 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.5 t -94.39 123.04 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 111.1 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 58.9 m -143.52 136.18 27.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.409 ' CG2' ' N ' ' A' ' 247' ' ' LEU . 0.7 OUTLIER -54.62 152.34 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.241 0.543 . . . . 0.0 111.328 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.409 ' N ' ' CG2' ' A' ' 246' ' ' VAL . 4.7 mt -59.62 139.47 89.5 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.884 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.423 ' HB2' ' CD1' ' A' ' 129' ' ' TRP . 51.2 Cg_exo -54.0 -172.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.504 2.136 . . . . 0.0 112.276 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 2.7 p -122.65 165.48 16.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.883 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.416 ' CD2' ' HG3' ' A' ' 251' ' ' LYS . 14.6 t80 -129.0 117.54 21.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.416 ' HG3' ' CD2' ' A' ' 250' ' ' PHE . 6.2 mtpp 59.96 31.99 20.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 73.8 27.02 67.81 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.564 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -118.85 147.81 43.16 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.7 0.286 . . . . 0.0 110.859 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.7 149.89 55.53 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.538 2.159 . . . . 0.0 112.286 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 66.9 p -73.81 159.19 33.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.463 ' HE3' ' HB1' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -121.39 54.59 4.56 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.876 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.19 155.27 64.92 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.575 2.183 . . . . 0.0 112.281 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . 0.494 ' CD2' ' CD2' ' A' ' 155' ' ' TYR . 67.0 m-85 -74.17 166.21 23.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.894 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.488 HG23 ' C ' ' A' ' 328' ' ' GLU . 22.0 t -116.7 134.95 58.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.24 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -128.93 96.24 0.4 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.388 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.755 HG12 ' HD2' ' A' ' 64' ' ' HIS . 10.2 p -98.8 159.96 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.819 0.342 . . . . 0.0 111.216 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.464 ' N ' HG22 ' A' ' 261' ' ' VAL . 12.2 tp -122.21 104.67 9.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.903 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.402 ' HB2' ' CE2' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -109.07 170.3 8.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.924 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.555 ' HB3' ' CE1' ' A' ' 106' ' ' TYR . . . -101.95 143.6 31.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.058 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -116.05 152.43 17.97 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.56 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.806 HD11 ' OH ' ' A' ' 106' ' ' TYR . 30.2 mt -135.15 144.37 34.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.833 0.349 . . . . 0.0 110.983 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.792 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -82.49 153.69 25.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 76' ' ' LEU . . . -84.08 -22.8 31.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.355 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -53.66 -82.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.226 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . 0.418 ' N ' ' HD3' ' A' ' 271' ' ' PRO . 0.3 OUTLIER 179.58 65.56 0.13 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.94 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' A' ' 270' ' ' SER . 4.9 Cg_exo -76.67 -71.44 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.812 2.341 . . . . 0.0 112.088 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.635 ' ND2' HD12 ' A' ' 275' ' ' LEU . 0.6 OUTLIER 174.88 68.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.625 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.26 -28.13 69.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.086 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -77.07 -49.35 15.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.146 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.635 HD12 ' ND2' ' A' ' 272' ' ' ASN . 99.3 mt -76.04 -44.44 39.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.096 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -58.46 -53.38 59.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.155 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 24.6 tttp -59.97 -30.67 69.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.959 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -81.04 -38.51 27.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.943 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.431 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 49.8 t80 -72.55 -34.93 67.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.951 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.987 HD23 HD22 ' A' ' 284' ' ' LEU . 7.8 mt -81.46 -20.77 39.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.396 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -91.08 -48.7 6.81 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.434 ' O ' ' CG ' ' A' ' 283' ' ' TYR . 0.0 OUTLIER -114.16 28.37 8.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.073 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.434 ' CG ' ' O ' ' A' ' 282' ' ' ASN . 32.3 m-85 -164.39 32.75 0.07 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.856 0.36 . . . . 0.0 111.005 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.987 HD22 HD23 ' A' ' 280' ' ' LEU . 10.6 tp -168.66 -42.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.898 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.612 ' CD2' HG23 ' A' ' 108' ' ' ILE . 1.9 mt -98.16 30.38 3.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.897 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 65.8 p -138.95 164.52 29.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.853 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.27 -27.81 62.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.077 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -67.03 -41.88 85.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.022 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.4 ' O ' HG23 ' A' ' 293' ' ' VAL . . . -92.41 -46.47 3.5 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.678 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.505 ' CD2' HG11 ' A' ' 302' ' ' VAL . 0.6 OUTLIER -57.67 -53.61 56.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.801 0.334 . . . . 0.0 111.09 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -58.83 -32.49 69.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.965 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -66.6 -42.51 86.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.141 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 289' ' ' GLY . 21.8 t -81.84 -30.3 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.175 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -69.83 -30.78 68.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 7.9 mtpp -63.58 -33.6 75.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.952 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -98.3 -39.99 8.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.99 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -144.25 89.17 7.1 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.856 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.47 98.08 0.83 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.523 2.149 . . . . 0.0 112.34 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.511 ' H ' HD12 ' A' ' 299' ' ' LEU . 1.7 mp -58.78 -22.88 59.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.094 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 110.04 -118.16 4.98 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.45 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.429 ' HB2' ' HB ' ' A' ' 320' ' ' THR . . . -81.22 163.26 23.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 111.038 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 109' ' ' ALA . 15.5 m -141.59 176.04 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.142 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -87.49 -30.32 20.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.16 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.452 HD23 ' HB2' ' A' ' 307' ' ' TYR . 5.4 tp -58.1 122.22 12.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.975 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -64.51 -41.45 96.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.947 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.5 m -60.01 -53.3 59.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.93 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.452 ' HB2' HD23 ' A' ' 304' ' ' LEU . 2.5 t80 -67.4 -23.2 65.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.162 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.03 -31.24 66.81 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 110.85 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -76.24 -58.04 3.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -50.11 -32.44 15.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.766 ' O ' HD12 ' A' ' 317' ' ' ILE . 32.9 mt -85.76 -26.63 25.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.704 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -74.89 -6.05 47.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.515 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.47 -31.76 4.51 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.986 0.422 . . . . 0.0 110.82 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.87 134.8 24.39 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.317 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.494 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 11.2 Cg_endo -55.15 -27.14 54.48 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.42 2.08 . . . . 0.0 112.373 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -49.82 -42.02 46.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.037 0.446 . . . . 0.0 110.294 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.766 HD12 ' O ' ' A' ' 311' ' ' LEU . 30.8 mt -85.63 -33.55 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.851 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.494 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -58.8 -30.71 67.81 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.129 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.59 -31.98 70.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.082 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.429 ' HB ' ' HB2' ' A' ' 301' ' ' ALA . 25.3 m -62.49 -51.15 68.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.911 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 5.6 tpt -61.5 -37.51 83.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -64.77 -31.87 73.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -67.01 -38.28 85.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -78.7 -35.35 45.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -67.07 -43.65 82.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.928 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.31 -31.35 26.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.84 -164.07 1.82 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.528 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . 0.488 ' C ' HG23 ' A' ' 259' ' ' VAL . 7.4 mm-40 -137.34 129.11 28.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.37 . . . . 0.0 110.892 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.461 HG23 ' NE2' ' A' ' 64' ' ' HIS . 31.2 mt -77.22 138.98 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.113 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 30.4 mtm -76.77 130.47 76.11 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.919 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.44 175.55 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.378 2.052 . . . . 0.0 112.271 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -114.17 32.1 6.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.819 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.482 HD12 ' HB2' ' A' ' 335' ' ' GLN . 42.3 pt -99.63 153.59 37.7 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.2 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.66 -25.2 34.44 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.583 2.188 . . . . 0.0 112.382 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.482 ' HB2' HD12 ' A' ' 333' ' ' ILE . 3.9 mp0 -58.62 -25.16 62.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.096 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 23.3 mmm -56.19 -32.47 64.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.052 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.3 m -59.52 -48.68 80.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.0 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -59.14 -31.55 69.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.06 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.743 ' CZ ' HG21 ' A' ' 343' ' ' VAL . 85.0 t80 -69.34 -32.25 71.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.489 ' CZ2' ' CZ ' ' A' ' 155' ' ' TYR . 68.9 m95 -66.38 -30.63 71.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.961 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -84.71 -51.73 6.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.178 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -55.23 -54.41 43.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.43 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.743 HG21 ' CZ ' ' A' ' 339' ' ' PHE . 28.8 t -59.03 -30.66 44.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.228 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.436 ' O ' HD12 ' A' ' 348' ' ' ILE . 0.2 OUTLIER -59.44 -57.48 12.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.975 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . 0.44 HG22 ' CG ' ' A' ' 349' ' ' ASN . 3.6 m -68.66 -27.29 65.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.108 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -57.14 -61.74 2.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.397 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 23.3 t -61.8 -43.15 96.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.309 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.436 HD12 ' O ' ' A' ' 344' ' ' ARG . 27.7 mt -63.56 -44.98 98.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.109 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.44 ' CG ' HG22 ' A' ' 345' ' ' THR . 28.9 m-20 -59.79 -30.95 69.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -77.96 -51.06 10.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.108 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -60.17 -40.15 88.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.087 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 14.9 m -71.65 -22.42 61.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.122 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 86.5 27.52 29.74 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.453 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -89.59 -30.39 18.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.784 0.326 . . . . 0.0 110.9 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -145.37 145.07 31.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.888 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.7 p -62.37 169.51 2.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.795 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.612 HG23 HD22 ' A' ' 192' ' ' LEU . 1.5 p -62.51 -47.3 93.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.893 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . 0.5 ' HA ' HD12 ' A' ' 361' ' ' LEU . 3.2 m-20 -66.78 -31.42 72.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.987 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -72.19 -43.13 64.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.975 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -60.59 -40.6 92.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.162 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.947 ' CD2' HG12 ' A' ' 183' ' ' VAL . 0.5 OUTLIER -77.35 -31.82 54.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.806 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.6 -52.88 40.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -61.17 -47.28 86.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.408 ' O ' HD12 ' A' ' 368' ' ' ILE . . . -57.96 -37.73 74.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.072 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.834 ' O ' HG22 ' A' ' 369' ' ' THR . 0.8 OUTLIER -60.67 -42.15 96.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.794 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 31.6 m -71.68 -31.5 66.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.862 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 36.1 mtt180 -69.41 -42.02 75.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.72 HD13 HG11 ' A' ' 181' ' ' VAL . 4.8 mt -67.19 -51.96 47.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.834 HG22 ' O ' ' A' ' 365' ' ' GLN . 9.8 t -95.44 43.59 1.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.994 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 1.2 tttm . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.245 -0.884 . . . . 0.0 110.92 179.986 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.694 HG23 ' HA ' ' A' ' 57' ' ' PRO . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.773 0.321 . . . . 0.0 110.904 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -151.64 154.34 36.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -83.62 139.89 32.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.925 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.38 26.51 43.16 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.539 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.0 159.74 32.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.78 0.324 . . . . 0.0 110.915 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.42 HD11 ' HB3' ' A' ' 275' ' ' LEU . 7.4 mt -128.09 109.98 12.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.5 t -83.6 147.01 6.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.15 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.74 HD13 HD12 ' A' ' 20' ' ' LEU . 29.6 mt -127.42 107.5 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.949 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.468 ' CE3' HD12 ' A' ' 43' ' ' LEU . 3.6 m0 -97.98 106.76 19.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.798 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.648 HD11 ' HE3' ' A' ' 15' ' ' LYS . 15.7 tt -140.67 158.19 24.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.085 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -59.1 146.51 38.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.26 -26.13 74.16 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.598 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.24 46.45 1.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.914 0.388 . . . . 0.0 111.006 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.648 ' HE3' HD11 ' A' ' 11' ' ' ILE . 1.6 mtmt -141.34 -176.13 4.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.833 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.78 80.33 0.12 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.516 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 19.2 p90 -83.65 -35.61 24.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.868 0.366 . . . . 0.0 110.942 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.4 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 6.9 t-20 -60.31 -31.17 70.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.548 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -67.61 -58.1 8.17 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.476 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.74 HD12 HD13 ' A' ' 9' ' ' ILE . 4.0 mm? -60.79 -30.41 70.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.81 0.338 . . . . 0.0 110.885 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.51 -43.89 95.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.059 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -75.64 -51.96 11.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 19' ' ' GLY . 23.9 t -59.05 -31.21 45.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.055 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.42 -34.41 84.73 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.424 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.8 mmtm -72.46 -28.16 62.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.824 0.345 . . . . 0.0 110.957 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -46.1 89.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.989 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -62.48 -41.21 98.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.956 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -69.79 -30.89 68.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.941 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.8 mttp -82.66 -26.66 31.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.086 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -91.78 -24.98 19.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.726 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.6 p -125.4 -44.19 1.87 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.692 0.282 . . . . 0.0 111.59 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.3 -26.82 5.17 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.585 -0.816 . . . . 0.0 112.467 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.6 mm -59.96 124.33 14.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.826 0.346 . . . . 0.0 111.058 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.3 mtmt -72.23 153.7 41.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.948 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.5 t -140.54 110.58 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.106 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.4 m -105.53 130.25 53.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.933 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.596 HG22 HD12 ' A' ' 9' ' ' ILE . 21.7 t -97.94 110.52 25.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.051 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -103.35 141.18 36.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.974 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -136.57 70.17 59.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.813 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.655 ' HG2' HD22 ' A' ' 43' ' ' LEU . 73.7 Cg_endo -75.63 156.06 40.16 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.629 2.219 . . . . 0.0 112.503 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.69 140.69 37.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.506 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? 56.39 41.72 28.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.675 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.655 HD22 ' HG2' ' A' ' 40' ' ' PRO . 0.9 OUTLIER -89.1 16.87 6.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.554 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -60.99 -42.18 97.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.876 0.369 . . . . 0.0 110.694 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -85.45 -6.3 59.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.252 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.565 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -82.85 -20.07 36.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.376 -179.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.59 ' CE2' HD12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -78.86 -52.58 1.25 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.617 0.246 . . . . 0.0 111.224 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.424 ' HD3' ' CB ' ' A' ' 47' ' ' PHE . 35.2 Cg_exo -59.94 -40.07 65.56 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.47 2.113 . . . . 0.0 112.366 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.442 ' CG ' ' N ' ' A' ' 50' ' ' VAL . 1.7 pt20 -60.12 -49.08 79.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.01 0.433 . . . . 0.0 111.058 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.728 ' O ' HG22 ' A' ' 53' ' ' THR . 34.2 m -79.28 -23.92 12.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.212 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.14 -27.79 48.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.19 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.13 -34.85 75.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.197 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.728 HG22 ' O ' ' A' ' 50' ' ' VAL . 11.8 t -69.52 -26.8 64.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.972 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.34 32.52 4.87 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.602 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.32 -81.25 0.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.789 0.328 . . . . 0.0 110.933 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 54.3 -170.85 1.11 Allowed Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.605 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.694 ' HA ' HG23 ' A' ' 2' ' ' THR . 55.2 Cg_endo -69.59 -179.57 2.93 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.577 2.185 . . . . 0.0 112.253 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -110.2 -31.3 7.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.976 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.8 mt -143.75 137.41 24.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.235 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.59 HD12 ' CE2' ' A' ' 47' ' ' PHE . 2.6 tt -142.36 159.72 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.887 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.48 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 41.7 m-85 -130.46 135.83 48.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.065 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -176.04 161.79 2.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.863 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.92 148.97 28.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.201 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.805 ' CD2' ' HB1' ' A' ' 96' ' ' ALA . 45.4 p-80 -60.7 -36.03 77.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.867 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -60.34 -30.28 69.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -93.85 17.17 12.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.208 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -112.2 29.24 8.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.854 0.359 . . . . 0.0 110.87 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.83 25.35 6.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.535 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -120.53 -36.4 0.79 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.483 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -83.07 -27.59 30.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.745 0.307 . . . . 0.0 111.036 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.538 ' HB2' HD12 ' A' ' 76' ' ' LEU . . . -84.03 -36.88 22.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.165 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -59.19 -32.54 70.02 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.078 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 m -90.1 -23.14 21.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.141 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.96 57.87 0.76 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.45 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.2 mt -139.25 32.36 2.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.793 0.33 . . . . 0.0 110.916 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.538 HD12 ' HB2' ' A' ' 71' ' ' ALA . 13.0 mt -144.4 160.57 40.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.56 163.28 12.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.066 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.453 ' HA ' HG22 ' A' ' 104' ' ' ILE . 1.1 tp10 -93.56 -165.48 1.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.643 HD11 ' CB ' ' A' ' 103' ' ' LEU . 44.6 pt -157.49 172.87 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.957 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 48.1 p -156.54 77.48 4.24 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.802 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.42 134.29 26.27 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.641 2.227 . . . . 0.0 112.348 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.71 174.26 10.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.758 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -59.66 -37.05 77.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.825 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.72 -30.05 69.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.064 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -77.58 -47.72 18.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.895 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -65.64 -30.89 71.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.954 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.04 -27.07 64.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.053 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -95.94 39.83 1.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.03 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.464 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 8.3 mt -157.99 173.74 16.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.861 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.5 ' CZ ' ' HE2' ' A' ' 321' ' ' MET . 27.2 m-85 -89.34 150.78 45.38 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.057 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -67.79 -56.39 0.21 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.454 2.103 . . . . 0.0 112.441 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.83 ' CE1' HG23 ' A' ' 93' ' ' THR . 44.2 p90 -55.68 -41.01 73.09 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.4 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.83 HG23 ' CE1' ' A' ' 92' ' ' PHE . 13.8 p -56.89 -29.62 63.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.068 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.464 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 55.0 m95 -74.52 -30.85 61.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.914 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.85 -28.43 64.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.0 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.805 ' HB1' ' CD2' ' A' ' 64' ' ' HIS . . . -72.26 -29.57 64.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.226 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.0 m -100.46 50.82 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.259 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.707 ' HB3' HD23 ' A' ' 103' ' ' LEU . 7.0 ptm180 -156.08 142.27 18.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -93.69 -47.97 6.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.927 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -151.48 58.71 0.88 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.842 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.08 -27.88 14.96 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.611 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.22 152.47 21.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 110.891 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.707 HD23 ' HB3' ' A' ' 98' ' ' ARG . 13.7 mt -110.59 150.38 29.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.453 HG22 ' HA ' ' A' ' 78' ' ' GLU . 2.2 pp -146.68 30.37 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.221 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.597 ' HB1' ' HB2' ' A' ' 263' ' ' SER . . . -164.34 -176.87 4.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.168 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -142.02 89.35 8.85 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.922 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.717 ' HB3' HG21 ' A' ' 261' ' ' VAL . 51.4 Cg_exo -52.86 129.92 35.12 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.551 2.167 . . . . 0.0 112.214 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.496 ' CG2' HD21 ' A' ' 290' ' ' LEU . 30.4 mt -112.91 -61.34 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.226 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.44 ' CB ' HD13 ' A' ' 299' ' ' LEU . . . -127.34 150.6 49.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.175 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.658 HG13 ' O ' ' A' ' 260' ' ' GLY . 21.5 t -120.72 137.39 54.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.033 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -116.36 161.66 18.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.952 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -169.17 158.44 8.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.098 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.8 mt -67.71 -178.28 0.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.936 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 226' ' ' ILE . 0.3 OUTLIER -169.95 169.27 8.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.929 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.456 ' HB2' HD23 ' A' ' 247' ' ' LEU . 8.4 tp -101.24 142.8 32.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.89 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.7 mt -127.72 131.94 69.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.077 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -134.97 161.18 36.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -115.74 117.76 31.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.024 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -66.64 -28.46 68.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -56.82 -40.78 76.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.928 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.458 HD22 ' NZ ' ' A' ' 144' ' ' LYS . 81.7 mt -88.06 -80.15 0.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.83 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.802 HD22 ' HB1' ' A' ' 223' ' ' ALA . 1.0 OUTLIER -81.21 144.46 54.24 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.84 -43.06 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.477 2.118 . . . . 0.0 112.295 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -139.42 142.77 33.36 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.853 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.61 150.94 36.25 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.566 2.177 . . . . 0.0 112.337 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.28 120.02 6.32 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.56 2.173 . . . . 0.0 112.309 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -94.88 20.59 8.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.95 142.0 29.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.914 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.669 ' CE3' HD12 ' A' ' 132' ' ' ILE . 2.1 m95 -72.54 -25.95 61.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.017 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.1 -21.93 56.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.213 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.407 ' O ' HD12 ' A' ' 135' ' ' LEU . 14.1 mt-10 -77.5 -26.28 51.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.203 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.794 HD13 HD22 ' A' ' 147' ' ' LEU . 36.8 mt -62.26 -54.45 49.26 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.534 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.615 ' HB3' HD21 ' A' ' 198' ' ' LEU . 18.7 Cg_endo -60.23 -28.32 86.67 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.185 1.923 . . . . 0.0 112.131 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.59 -30.21 41.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 131' ' ' GLU . 0.2 OUTLIER -73.74 -35.78 65.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.814 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.37 -27.92 39.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -85.65 -28.21 24.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.072 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -84.45 -37.27 21.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.11 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.709 HD13 ' HA ' ' A' ' 146' ' ' ALA . 0.5 OUTLIER -75.4 -17.21 60.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.487 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.09 -29.54 57.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.876 0.369 . . . . 0.0 110.656 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.46 -37.12 82.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.928 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -78.46 -27.11 46.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.022 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 113.66 45.11 0.73 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.509 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.458 ' NZ ' HD22 ' A' ' 121' ' ' LEU . 11.8 mtmt -162.03 -178.24 6.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.814 0.34 . . . . 0.0 110.937 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.2 t -112.0 176.99 4.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.848 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.709 ' HA ' HD13 ' A' ' 139' ' ' LEU . . . -101.96 -68.42 0.82 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.199 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.794 HD22 HD13 ' A' ' 132' ' ' ILE . 6.3 tp -140.42 145.72 37.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.963 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.664 ' CG ' ' HB2' ' A' ' 213' ' ' ALA . 0.0 OUTLIER -141.21 -177.82 5.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.805 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.434 ' CZ ' ' CE ' ' A' ' 204' ' ' MET . 22.6 p90 -179.4 170.93 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.818 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.405 ' OD1' ' CG ' ' A' ' 156' ' ' PHE . 4.4 p-10 -79.47 131.06 35.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.476 HD23 HG21 ' A' ' 157' ' ' THR . 11.2 mt -105.91 29.13 6.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.992 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -104.41 -30.48 10.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.944 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -119.78 120.69 30.3 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.935 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.05 -21.94 29.18 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.509 2.139 . . . . 0.0 112.434 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.5 ' CD1' ' CE2' ' A' ' 258' ' ' PHE . 2.5 m-85 -53.91 -30.02 44.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.129 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.405 ' CG ' ' OD1' ' A' ' 150' ' ' ASN . 4.3 m-85 -89.81 -30.24 18.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.902 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.479 ' O ' HD12 ' A' ' 161' ' ' ILE . 17.3 p -95.03 18.42 12.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.263 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.471 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 13.4 t-105 -87.44 -46.86 0.49 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.313 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.592 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 59.2 Cg_exo -51.72 -25.38 20.39 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.329 2.02 . . . . 0.0 112.438 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 49.6 tp -76.73 -61.95 1.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.001 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.479 HD12 ' O ' ' A' ' 157' ' ' THR . 4.3 mt -69.33 -46.42 76.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.224 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -57.65 -34.05 68.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.25 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -60.09 -41.33 92.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.681 ' OD2' ' HB3' ' A' ' 190' ' ' ALA . 16.5 t0 -68.21 -20.09 64.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.187 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 121.44 41.72 0.49 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.467 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.614 ' HA2' ' HB2' ' A' ' 188' ' ' ALA . . . -119.54 103.6 0.98 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.507 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.44 ' CD2' ' HA3' ' A' ' 182' ' ' GLY . 30.3 p90 -114.15 -177.4 3.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.796 0.332 . . . . 0.0 110.882 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.437 ' HB2' ' CE1' ' A' ' 339' ' ' PHE . . . -108.19 -35.09 6.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.087 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.415 ' CE2' HD11 ' A' ' 333' ' ' ILE . 34.6 m-85 -136.39 152.97 51.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.88 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.27 118.93 37.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.061 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.42 ' CE1' ' HA ' ' A' ' 175' ' ' LYS . 6.5 t80 -79.53 121.24 24.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.489 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -170.41 147.32 2.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.969 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 63.4 42.36 6.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.863 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.4 ' O ' ' CZ ' ' A' ' 171' ' ' TYR . . . 102.83 -63.16 0.44 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.694 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.42 ' HA ' ' CE1' ' A' ' 171' ' ' TYR . 35.9 pttt -128.7 -166.92 1.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.805 0.336 . . . . 0.0 110.994 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -94.09 174.0 7.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -131.31 158.61 40.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.975 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.539 HG21 ' HG2' ' A' ' 335' ' ' GLN . 44.9 pt -92.76 -6.44 10.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.601 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.33 25.89 4.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.755 0.312 . . . . 0.0 111.073 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -152.91 102.53 2.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.859 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.586 HG12 ' H ' ' A' ' 183' ' ' VAL . 24.2 t -93.96 145.95 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.104 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . 0.44 ' HA3' ' CD2' ' A' ' 167' ' ' TYR . . . -96.88 -20.46 23.88 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.734 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.65 ' CG1' HD22 ' A' ' 361' ' ' LEU . 21.4 t -55.17 -40.76 56.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.822 0.344 . . . . 0.0 111.346 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -84.29 57.19 4.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.974 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -118.82 168.56 10.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.834 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.59 -32.97 70.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.133 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -83.47 -38.41 10.87 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.534 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.614 ' HB2' ' HA2' ' A' ' 166' ' ' GLY . . . -59.16 -34.35 72.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.866 0.365 . . . . 0.0 111.168 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.526 ' HA ' HD11 ' A' ' 361' ' ' LEU . 9.5 ttmt -59.95 -54.54 44.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.681 ' HB3' ' OD2' ' A' ' 164' ' ' ASP . . . -60.89 -30.14 69.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.177 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -57.9 -54.23 39.04 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.557 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.815 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.1 OUTLIER -65.26 -44.86 86.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.1 m -53.5 -25.22 15.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.203 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -69.49 -60.59 2.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.801 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.503 ' HA ' HD12 ' A' ' 198' ' ' LEU . 2.1 tp -62.3 -33.2 74.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.662 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 192' ' ' LEU . 47.3 t -69.04 -34.57 64.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.975 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -74.06 -38.34 63.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.615 HD21 ' HB3' ' A' ' 133' ' ' PRO . 5.5 mt -57.94 -54.15 50.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.001 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 8.6 mt -68.38 -24.86 30.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.135 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -64.35 -40.89 96.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.022 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -95.81 22.07 7.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.232 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.03 79.22 0.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.844 0.354 . . . . 0.0 111.027 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -149.82 25.44 0.84 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.886 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . 0.434 ' CE ' ' CZ ' ' A' ' 149' ' ' PHE . 23.1 mtp -160.77 -178.78 7.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.822 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -130.05 114.01 15.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.842 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -67.66 -32.58 73.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.89 46.75 1.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.976 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.492 HG23 HG21 ' A' ' 212' ' ' ILE . 57.2 m -98.41 138.17 36.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.923 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -106.15 176.05 5.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.828 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -75.77 -33.56 60.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.938 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.4 m -82.79 -28.18 30.47 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.092 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.492 HG21 HG23 ' A' ' 208' ' ' THR . 0.3 OUTLIER -45.66 -47.47 4.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.218 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.767 ' HB1' HG23 ' A' ' 225' ' ' THR . . . -71.73 -28.09 63.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.16 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.428 ' HA ' ' CE2' ' A' ' 217' ' ' PHE . 0.4 OUTLIER -61.86 -63.0 1.4 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.937 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.77 -21.45 66.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.365 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.444 ' HB1' ' HB2' ' A' ' 221' ' ' GLU . . . -54.09 -61.11 2.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.274 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.431 ' CD1' ' N ' ' A' ' 218' ' ' ASN . 11.2 p90 -68.8 -30.72 69.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.925 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . 0.431 ' N ' ' CD1' ' A' ' 217' ' ' PHE . 5.5 t-20 -60.18 -30.68 69.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.28 28.76 7.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.921 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 58.57 95.92 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.53 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.444 ' HB2' ' HB1' ' A' ' 216' ' ' ALA . 40.2 mt-10 -150.46 -46.89 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.337 . . . . 0.0 110.88 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.3 t -124.71 171.97 9.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.802 ' HB1' HD22 ' A' ' 122' ' ' LEU . . . -93.12 -54.05 3.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.084 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.428 ' HE2' ' HB2' ' A' ' 147' ' ' LEU . 2.9 mpp? -111.08 163.53 13.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.767 HG23 ' HB1' ' A' ' 213' ' ' ALA . 78.4 m -163.99 152.62 13.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.434 HG23 ' O ' ' A' ' 114' ' ' SER . 4.8 mt -126.7 129.56 71.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.018 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.835 ' ND2' ' HB2' ' A' ' 231' ' ' ALA . 2.0 t30 -145.43 159.31 43.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -75.86 -156.44 6.21 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.54 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.417 ' HD2' ' CZ3' ' A' ' 230' ' ' TRP . 43.3 Cg_endo -68.14 -24.22 38.71 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.554 2.169 . . . . 0.0 112.473 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . 0.417 ' CZ3' ' HD2' ' A' ' 229' ' ' PRO . 44.9 p90 -84.06 57.02 3.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.403 . . . . 0.0 110.92 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.835 ' HB2' ' ND2' ' A' ' 227' ' ' ASN . . . -143.0 -44.79 0.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.199 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . 0.522 ' HA ' HD12 ' A' ' 235' ' ' ILE . 20.3 m0 -52.98 -40.84 64.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.058 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 13.0 m -61.71 -30.85 71.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.864 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -64.78 -31.71 73.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.929 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.817 HG21 ' CD1' ' A' ' 242' ' ' TYR . 4.8 mt -84.23 57.77 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.056 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.67 -48.51 2.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.816 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 2.5 m -108.98 31.23 5.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.888 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 3.4 t -100.37 -29.73 12.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp 64.04 40.57 7.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.07 117.62 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.042 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -62.02 124.19 20.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.817 ' CD1' HG21 ' A' ' 235' ' ' ILE . 21.1 p90 -118.94 132.04 56.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.876 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -109.14 131.3 10.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.517 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.472 HG21 ' CZ2' ' A' ' 232' ' ' TRP . 21.3 t -99.21 117.42 44.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.809 0.338 . . . . 0.0 111.085 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.7 t -135.8 149.66 49.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 247' ' ' LEU . 0.7 OUTLIER -55.09 152.22 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.257 0.551 . . . . 0.0 111.311 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.456 HD23 ' HB2' ' A' ' 115' ' ' LEU . 40.7 mt -72.35 152.15 92.1 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.077 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.73 177.15 2.43 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.619 2.213 . . . . 0.0 112.258 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.429 HG22 ' HA ' ' A' ' 254' ' ' PRO . 57.5 p -115.57 152.76 32.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -100.37 116.48 32.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.76 25.97 15.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.038 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 93.64 -21.09 43.04 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.695 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -87.74 142.18 32.38 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.685 0.278 . . . . 0.0 110.901 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.429 ' HA ' HG22 ' A' ' 249' ' ' THR . 73.3 Cg_endo -75.8 163.26 33.87 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.578 2.185 . . . . 0.0 112.339 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.4 p -88.18 179.52 6.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.892 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.421 ' N ' ' HD3' ' A' ' 257' ' ' PRO . 5.5 mtmm -136.55 62.86 44.92 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.939 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 256' ' ' LYS . 32.3 Cg_exo -57.94 -173.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.537 2.158 . . . . 0.0 112.242 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . 0.5 ' CE2' ' CD1' ' A' ' 155' ' ' TYR . 43.4 m-85 -103.91 126.22 50.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.729 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.2 t -108.63 138.53 35.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.378 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.658 ' O ' HG13 ' A' ' 110' ' ' VAL . . . -119.78 156.3 15.89 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.258 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.717 HG21 ' HB3' ' A' ' 107' ' ' PRO . 10.9 p -139.65 152.2 22.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.819 0.342 . . . . 0.0 111.238 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 20.3 tp -105.25 110.28 22.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.597 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 0.9 OUTLIER -125.74 155.95 40.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.933 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -100.85 133.46 45.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.113 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -101.38 161.74 18.05 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.489 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 31.5 mt -135.14 152.0 31.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.822 0.344 . . . . 0.0 111.146 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -91.47 149.27 21.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.952 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.98 -28.38 68.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.189 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -55.82 -30.0 60.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.268 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 5.9 t 59.09 62.5 4.11 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.55 -32.84 14.6 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.583 2.188 . . . . 0.0 112.297 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.433 ' OD1' HD12 ' A' ' 275' ' ' LEU . 4.5 t-20 -162.33 46.86 0.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.891 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 34.0 mttt -59.62 -31.83 69.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -60.15 -54.97 39.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.897 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.433 HD12 ' OD1' ' A' ' 272' ' ' ASN . 77.8 mt -75.24 -31.06 60.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -59.87 -45.86 91.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.34 -51.26 70.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.906 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -61.81 -45.39 94.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -66.09 -37.85 86.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.972 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 55.3 mt -81.33 -21.01 39.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.376 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -93.52 -43.32 8.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.796 0.331 . . . . 0.0 111.334 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -92.08 -48.92 6.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.211 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.485 ' HB3' HG12 ' A' ' 23' ' ' VAL . 10.4 m-85 -96.96 38.56 1.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.166 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.567 HD21 HD11 ' A' ' 20' ' ' LEU . 0.2 OUTLIER 179.96 38.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.888 179.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -177.77 37.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.825 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 38.3 p -140.79 167.28 22.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.921 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -64.91 -30.43 71.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.969 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -76.24 -30.64 57.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.981 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -90.71 -50.76 2.83 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.588 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.496 HD21 ' CG2' ' A' ' 108' ' ' ILE . 3.5 mt -59.28 -41.1 88.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.991 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -62.37 -37.06 84.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.959 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.41 -47.57 83.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.043 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.514 HG22 ' HA3' ' A' ' 19' ' ' GLY . 25.3 t -72.94 -30.92 33.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.027 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -71.81 -31.25 66.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 9.9 mtmt -63.41 -34.84 78.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.99 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -99.53 -34.74 10.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.078 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.4 tptt -148.43 91.33 4.76 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.98 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.5 108.54 2.24 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.495 2.13 . . . . 0.0 112.296 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.44 HD13 ' CB ' ' A' ' 109' ' ' ALA . 4.9 mt -59.53 -28.4 67.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.013 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 107.37 -125.83 8.15 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.461 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.83 94.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.846 0.355 . . . . 0.0 111.039 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.788 HG21 ' HB3' ' A' ' 307' ' ' TYR . 30.1 m -67.65 158.08 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.184 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 108' ' ' ILE . . . -87.94 -26.45 22.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.141 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 10.0 tp -55.97 127.63 31.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.963 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -67.31 -29.49 69.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.048 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.26 -26.09 36.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.226 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.788 ' HB3' HG21 ' A' ' 302' ' ' VAL . 0.1 OUTLIER -96.54 -22.98 16.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.396 -179.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.38 -33.4 69.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.859 0.362 . . . . 0.0 110.948 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -75.48 -53.49 8.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.907 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -49.66 -34.13 17.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.767 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.722 ' HB3' HG21 ' A' ' 317' ' ' ILE . 12.4 mt -85.8 -26.46 25.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.641 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -71.56 -14.12 61.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.433 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -48.0 -34.1 8.85 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.965 0.412 . . . . 0.0 110.83 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.52 138.1 21.34 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.381 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.464 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 11.4 Cg_endo -55.3 -23.56 38.23 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.407 2.071 . . . . 0.0 112.432 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.05 -41.58 59.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.961 0.41 . . . . 0.0 110.34 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.722 HG21 ' HB3' ' A' ' 311' ' ' LEU . 33.8 mm -85.57 -33.65 7.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.952 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -68.67 -30.08 68.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.223 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -73.64 -51.71 15.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.178 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 8.8 t -58.94 -30.73 68.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.995 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.5 ' HE2' ' CZ ' ' A' ' 90' ' ' TYR . 4.9 ttt -85.47 -31.03 23.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.983 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -59.27 -46.96 87.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.912 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -66.05 -31.52 72.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -72.06 -49.21 38.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.088 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -59.97 -35.64 75.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.919 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -96.27 21.07 9.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.085 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -133.3 -179.11 16.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.514 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.09 137.2 42.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.819 0.343 . . . . 0.0 110.929 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.585 HG22 ' HE2' ' A' ' 64' ' ' HIS . 12.2 mt -80.29 144.28 10.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.055 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 15.1 ttm -57.21 113.32 5.95 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.941 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.83 -172.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.459 2.106 . . . . 0.0 112.315 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -152.76 38.6 0.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.923 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.637 HD12 ' HB2' ' A' ' 335' ' ' GLN . 10.2 pt -107.2 155.75 38.8 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.129 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.34 -27.75 47.42 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.535 2.157 . . . . 0.0 112.336 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.637 ' HB2' HD12 ' A' ' 333' ' ' ILE . 1.4 mp0 -59.44 -22.59 61.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.091 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 9.5 mtp -54.63 -28.3 45.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.127 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.1 m -56.91 -53.96 52.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.014 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -59.66 -30.29 68.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.041 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.72 ' CZ ' HG21 ' A' ' 343' ' ' VAL . 51.6 t80 -58.95 -34.11 71.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.885 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.497 ' CH2' ' CE1' ' A' ' 155' ' ' TYR . 97.3 m95 -76.24 -21.86 55.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.175 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -84.83 -34.74 22.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.419 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -87.05 -57.95 2.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.85 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.849 ' O ' HG23 ' A' ' 347' ' ' VAL . 47.3 t -48.98 -56.55 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.804 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -52.89 -29.98 31.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.394 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 10.7 m -84.1 -55.71 4.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.113 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.889 ' HB1' ' HB1' ' A' ' 360' ' ' ALA . . . -51.44 -26.47 8.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.615 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 343' ' ' VAL . 31.3 t -82.75 -55.32 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.234 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 59.4 mt -64.94 -41.85 93.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.335 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -57.59 -39.29 76.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.001 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -86.32 -30.55 22.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.108 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -76.18 -29.03 57.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.233 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 72.7 m -95.6 20.74 9.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.175 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 56.04 25.39 46.12 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.644 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.82 -31.55 20.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.87 0.366 . . . . 0.0 110.869 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -144.71 -168.82 3.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.859 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 19.3 p -121.52 160.4 24.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 30.2 t -58.06 -56.31 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.063 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.49 -29.71 1.88 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.185 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -84.25 -42.75 15.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.889 ' HB1' ' HB1' ' A' ' 346' ' ' ALA . . . -60.3 -59.72 4.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.736 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.65 HD22 ' CG1' ' A' ' 183' ' ' VAL . 3.3 mt -58.39 -26.77 63.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.03 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 30.9 tttt -80.89 -59.18 2.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.782 0.325 . . . . 0.0 110.965 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -61.16 -44.76 96.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.83 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -52.49 -37.8 58.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.253 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.616 ' O ' HG23 ' A' ' 369' ' ' THR . 19.9 tt0 -59.42 -43.36 93.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.471 HG22 ' HD2' ' A' ' 370' ' ' LYS . 69.3 m -63.57 -39.92 95.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.984 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 31.9 mtt180 -67.06 -42.51 84.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.991 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 19.0 mt -75.45 -31.37 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.174 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 365' ' ' GLN . 63.6 p -81.91 -31.42 31.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.877 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.471 ' HD2' HG22 ' A' ' 366' ' ' THR . 3.5 mtpp . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.889 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.544 ' O ' HG23 ' A' ' 2' ' ' THR . 6.7 t . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.822 0.344 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -133.81 87.63 2.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.921 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -133.42 20.2 3.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.188 0.518 . . . . 0.0 111.207 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.466 ' O ' HG23 ' A' ' 33' ' ' ILE . . . 75.52 34.61 49.44 Favored Glycine 0 C--N 1.317 -0.503 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.509 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.78 -177.23 4.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.832 0.349 . . . . 0.0 110.931 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.3 mt -133.51 118.2 18.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.94 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.49 147.0 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.193 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.453 HD13 ' CD1' ' A' ' 20' ' ' LEU . 31.4 mt -132.59 107.44 12.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.947 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.425 ' CE3' ' HB3' ' A' ' 57' ' ' PRO . 19.7 m0 -92.95 106.65 18.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.873 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.8 tt -137.97 158.98 33.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.046 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -54.84 174.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.049 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.22 -23.99 49.53 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.68 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -137.6 81.42 1.86 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.849 0.357 . . . . 0.0 110.961 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.81 36.71 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.811 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.58 43.37 4.88 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.504 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -85.22 -31.33 23.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 0.0 110.904 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -32.58 70.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.923 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -80.83 -38.69 15.39 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.501 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.453 ' CD1' HD13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -61.48 -30.65 70.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.808 0.337 . . . . 0.0 110.896 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.36 -42.98 99.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -68.2 -44.18 76.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 19' ' ' GLY . 21.7 t -62.03 -33.46 58.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.213 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.11 -27.86 73.56 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.558 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -83.21 -27.74 29.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.759 0.314 . . . . 0.0 111.011 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -45.5 89.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.947 0.403 . . . . 0.0 110.956 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.434 ' CD2' ' HB ' ' A' ' 33' ' ' ILE . 10.4 t80 -61.51 -38.87 88.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.016 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.41 ' O ' ' HA2' ' A' ' 32' ' ' GLY . 28.3 mt-10 -60.75 -32.57 71.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.877 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.4 tttm -82.67 -24.36 33.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.918 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -90.8 -26.14 19.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.68 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.1 p -137.29 -44.28 0.56 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 28' ' ' GLU . . . 121.23 -17.82 9.01 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.687 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.466 HG23 ' O ' ' A' ' 5' ' ' GLY . 37.3 mm -59.94 105.43 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.872 0.368 . . . . 0.0 110.96 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -58.67 141.89 51.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.95 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.6 130.12 74.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.117 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.0 m -121.94 150.61 41.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.5 t -133.73 116.55 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.156 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -104.37 161.94 13.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.49 70.29 32.17 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.951 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.16 168.55 24.48 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.56 2.173 . . . . 0.0 112.215 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -89.94 140.13 29.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.935 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.477 ' O ' HD23 ' A' ' 43' ' ' LEU . 12.8 mmtt 74.91 -57.2 0.61 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.98 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.837 HD11 ' CZ3' ' A' ' 62' ' ' TRP . 0.4 OUTLIER 51.17 18.41 0.58 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.051 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.22 -57.03 3.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.796 0.331 . . . . 0.0 110.949 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -83.17 -6.84 59.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.45 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.54 -20.08 65.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.325 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.533 ' CZ ' HG21 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -87.21 -58.43 0.29 Allowed Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.189 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.508 ' HD3' ' CB ' ' A' ' 47' ' ' PHE . 52.0 Cg_exo -55.24 -30.71 73.05 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.33 2.02 . . . . 0.0 112.412 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.53 ' HG3' HG13 ' A' ' 50' ' ' VAL . 5.9 pt20 -60.08 -48.99 79.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.984 0.421 . . . . 0.0 111.084 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.53 HG13 ' HG3' ' A' ' 49' ' ' GLN . 5.5 m -93.18 17.63 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.762 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.656 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -91.06 -35.63 14.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.826 0.346 . . . . 0.0 111.164 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.21 -26.66 26.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.213 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.402 HG22 ' C ' ' A' ' 50' ' ' VAL . 10.1 t -59.96 -27.54 66.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.005 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.75 36.29 5.35 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.492 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.53 -78.2 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.894 0.378 . . . . 0.0 110.863 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.41 173.74 26.91 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.475 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.457 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 44.4 Cg_endo -68.49 -167.55 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.542 2.161 . . . . 0.0 112.242 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.75 -45.72 3.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.027 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.85 HD13 HD21 ' A' ' 280' ' ' LEU . 19.3 mt -149.39 159.06 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.29 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.533 HG21 ' CZ ' ' A' ' 47' ' ' PHE . 2.4 tt -159.02 159.47 2.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.866 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.511 ' HE2' HD21 ' A' ' 284' ' ' LEU . 4.1 m-85 -128.59 137.96 51.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.914 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.837 ' CZ3' HD11 ' A' ' 43' ' ' LEU . 2.9 t-105 -176.03 163.31 2.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.854 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.24 140.16 53.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.11 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.421 ' HE1' HG22 ' A' ' 329' ' ' ILE . 6.0 p80 -57.62 -30.9 65.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.963 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.67 -42.05 98.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.958 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.06 17.27 12.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.291 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.45 -26.02 13.03 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.735 0.302 . . . . 0.0 110.992 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.29 49.61 3.75 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.54 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -120.96 -34.08 0.93 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.583 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -93.38 -23.48 18.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.715 0.293 . . . . 0.0 111.096 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.529 ' HB2' HD12 ' A' ' 76' ' ' LEU . . . -75.59 -24.66 56.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.121 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -56.75 -38.18 72.05 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.033 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.4 t -90.52 -23.08 21.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.016 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.23 34.57 3.13 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.487 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.656 HD22 ' HB1' ' A' ' 51' ' ' ALA . 11.2 mt -85.57 -46.11 11.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 0.0 110.847 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.529 HD12 ' HB2' ' A' ' 71' ' ' ALA . 7.2 mt -74.1 170.64 15.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.834 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.623 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -100.7 155.03 18.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.032 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.12 -165.02 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.845 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.788 HD11 ' HB3' ' A' ' 103' ' ' LEU . 37.6 pt -157.02 166.82 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.044 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.0 p -156.53 77.45 4.25 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.779 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.39 154.53 60.85 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.641 2.228 . . . . 0.0 112.314 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.7 175.94 8.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.793 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 28.2 mttm -59.59 -45.34 92.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.85 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.08 -30.51 69.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.01 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -73.41 -35.15 65.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -81.6 -29.86 33.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.944 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.57 -40.2 70.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.012 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -59.22 -35.2 73.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.004 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.635 HD23 ' HB1' ' A' ' 303' ' ' ALA . 4.0 mt -90.6 148.84 22.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.865 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.437 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . 83.2 m-85 -78.42 144.61 66.32 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.966 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -49.35 -55.71 3.87 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.695 2.263 . . . . 0.0 112.844 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 93' ' ' THR . 21.7 p90 -49.33 -37.28 23.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.436 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.46 HG21 ' HB1' ' A' ' 303' ' ' ALA . 0.3 OUTLIER -59.71 -42.22 92.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.896 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.573 ' CZ2' HD13 ' A' ' 89' ' ' LEU . 61.4 m95 -69.65 -34.81 74.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.905 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.98 -25.82 67.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.007 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.45 ' HB2' HD13 ' A' ' 329' ' ' ILE . . . -74.67 -33.9 62.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.16 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.494 ' O ' HD23 ' A' ' 103' ' ' LEU . 5.6 m -103.52 64.2 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.198 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -156.01 123.64 5.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.32 -52.95 6.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.81 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -143.38 48.69 1.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.73 -25.34 25.42 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.597 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -91.24 135.12 34.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.366 . . . . 0.0 110.95 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.788 ' HB3' HD11 ' A' ' 79' ' ' ILE . 78.7 mt -88.71 150.46 22.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.83 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.584 ' O ' HD12 ' A' ' 104' ' ' ILE . 2.8 pp -157.14 34.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.193 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.693 ' HB1' ' HB2' ' A' ' 263' ' ' SER . . . -159.54 174.23 14.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.11 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.48 ' OH ' HG22 ' A' ' 79' ' ' ILE . 72.3 m-85 -133.42 82.24 52.85 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.807 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.65 119.39 4.64 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.625 2.216 . . . . 0.0 112.392 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.5 mt -101.69 -66.56 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.146 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.418 ' O ' HG12 ' A' ' 261' ' ' VAL . . . -108.58 148.94 29.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.096 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.77 125.26 66.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.141 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.67 148.9 24.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.908 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.509 ' HB1' ' HB3' ' A' ' 323' ' ' ASN . . . -169.94 153.77 4.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.049 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.2 mt -65.22 164.98 12.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.1 178.91 8.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.783 HD11 HD11 ' A' ' 147' ' ' LEU . 63.3 tp -137.62 114.22 10.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.939 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.929 HD12 ' HB2' ' A' ' 227' ' ' ASN . 5.1 mt -106.97 150.1 9.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.067 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.403 ' CE2' ' O ' ' A' ' 243' ' ' GLY . 45.1 p90 -148.55 165.45 31.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.955 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -91.58 121.26 33.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.59 -17.42 61.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.171 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.24 -50.84 68.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.76 0.314 . . . . 0.0 111.132 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.474 ' CD1' ' HB2' ' A' ' 223' ' ' ALA . 0.6 OUTLIER -110.89 -31.06 7.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.086 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.539 ' HB2' ' HB1' ' A' ' 223' ' ' ALA . 7.5 tp -104.39 89.35 2.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.964 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.13 -46.94 1.93 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.563 2.175 . . . . 0.0 112.295 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -119.24 128.92 25.67 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.826 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.914 ' CB ' HG21 ' A' ' 245' ' ' THR . 72.4 Cg_endo -76.58 147.76 28.62 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.424 2.083 . . . . 0.0 112.38 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.33 120.47 5.98 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.546 2.164 . . . . 0.0 112.335 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.96 20.57 8.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.1 p -136.5 141.96 43.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.93 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.644 ' CH2' HD13 ' A' ' 160' ' ' LEU . 12.6 m95 -81.68 -29.27 33.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -74.87 -15.84 60.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.378 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.79 -14.84 33.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.531 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.501 HD12 ' CE3' ' A' ' 129' ' ' TRP . 25.4 mt -65.88 -46.3 65.14 Favored Pre-proline 0 C--N 1.331 -0.214 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.484 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 50.9 Cg_exo -53.95 -49.98 15.27 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.293 1.995 . . . . 0.0 112.304 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.0 -35.28 76.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.134 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 135' ' ' LEU . 6.3 mt -63.97 -46.05 86.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.96 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.446 ' N ' ' HB2' ' A' ' 146' ' ' ALA . 11.8 t70 -52.08 -29.56 22.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.983 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -85.53 -27.76 25.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.044 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -85.05 -31.64 23.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.087 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.432 HD13 ' O ' ' A' ' 145' ' ' SER . 2.0 mt -83.87 -17.25 41.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.375 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -76.66 -29.11 56.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.808 0.337 . . . . 0.0 110.607 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.4 -37.35 85.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.892 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -80.57 -27.02 37.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.973 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 117.48 33.92 1.26 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.579 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.71 172.56 13.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.826 0.346 . . . . 0.0 110.882 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.432 ' O ' HD13 ' A' ' 139' ' ' LEU . 13.3 t -107.37 172.68 6.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.926 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.446 ' HB2' ' N ' ' A' ' 136' ' ' ASP . . . -73.19 -78.18 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.111 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.783 HD11 HD11 ' A' ' 115' ' ' LEU . 5.2 tp -137.86 115.98 11.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.922 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.669 ' SD ' HG23 ' A' ' 208' ' ' THR . 0.0 OUTLIER -84.55 158.2 21.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.229 0.538 . . . . 0.0 111.539 -179.726 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.445 ' H ' HG21 ' A' ' 208' ' ' THR . 38.1 p90 178.35 144.06 0.12 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.876 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -59.38 121.2 10.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.065 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.619 HD22 HD21 ' A' ' 195' ' ' LEU . 11.2 mt -107.32 32.94 4.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.891 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -95.61 -69.82 0.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.97 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -77.27 149.36 79.03 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.002 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.451 ' CB ' HG12 ' A' ' 343' ' ' VAL . 63.5 Cg_endo -73.16 -9.0 22.91 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.652 2.235 . . . . 0.0 112.618 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 258' ' ' PHE . 5.2 t80 -59.67 -26.51 65.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.746 0.308 . . . . 0.0 111.117 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -91.17 -36.1 14.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.056 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 43.9 p -81.48 -22.22 38.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.226 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.564 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 64.9 t-105 -53.03 -54.36 45.09 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.642 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 12.7 Cg_endo -56.29 -21.02 34.46 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.233 1.955 . . . . 0.0 112.431 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.644 HD13 ' CH2' ' A' ' 129' ' ' TRP . 1.9 tp -87.67 -42.57 12.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.853 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.856 HD13 HD12 ' A' ' 192' ' ' LEU . 20.0 mt -77.9 -46.21 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.147 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -59.98 -27.85 67.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.237 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.598 ' HB2' ' HA ' ' A' ' 255' ' ' SER . . . -56.65 -39.12 73.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.236 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.83 -20.14 55.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.162 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 136.02 -28.31 2.95 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.49 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.684 ' HA3' ' HB2' ' A' ' 188' ' ' ALA . . . -59.61 151.07 37.36 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.43 ' CG ' ' HA3' ' A' ' 182' ' ' GLY . 41.6 p90 -141.58 -176.16 4.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 110.916 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.405 ' HB2' ' CZ ' ' A' ' 339' ' ' PHE . . . -97.75 -49.0 4.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.053 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.466 ' CE2' HD11 ' A' ' 333' ' ' ILE . 92.1 m-85 -133.22 154.77 50.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.914 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.13 134.13 40.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -101.14 110.88 22.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.657 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -162.79 146.19 11.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.867 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 61.46 30.38 18.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 64.84 13.7 57.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.009 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.96 160.08 38.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.848 0.356 . . . . 0.0 111.01 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -101.5 102.11 12.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.816 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -59.01 136.63 58.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.986 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.521 HG21 ' NE2' ' A' ' 335' ' ' GLN . 3.0 pt -93.59 -29.05 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.186 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -69.44 -16.44 63.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.296 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -102.43 150.32 23.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.783 0.325 . . . . 0.0 111.01 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 183' ' ' VAL . 21.4 t -131.81 146.05 33.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.048 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . 0.43 ' HA3' ' CG ' ' A' ' 167' ' ' TYR . . . -103.06 -18.3 15.59 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.783 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.669 HG12 HD22 ' A' ' 361' ' ' LEU . 21.3 t -56.65 -44.38 81.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.81 0.338 . . . . 0.0 111.25 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -84.16 57.38 4.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.906 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -120.25 -177.3 3.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.868 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -76.21 -29.61 57.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.191 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -82.26 -47.19 6.2 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.556 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.684 ' HB2' ' HA3' ' A' ' 166' ' ' GLY . . . -57.31 -29.97 64.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.82 0.343 . . . . 0.0 111.197 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -67.92 -49.28 62.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.906 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -74.22 -30.15 62.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.163 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -58.85 -53.91 42.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.557 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.856 HD12 HD13 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -59.43 -43.96 92.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.86 0.362 . . . . 0.0 110.997 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 61.0 m -57.39 -21.79 38.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.257 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.617 ' CZ ' HD11 ' A' ' 198' ' ' LEU . 14.2 t80 -68.21 -60.53 2.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.824 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.619 HD21 HD22 ' A' ' 151' ' ' LEU . 4.2 tp -63.11 -35.59 80.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.626 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 192' ' ' LEU . 43.8 t -66.19 -56.81 12.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.983 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -67.63 -26.83 66.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.999 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.617 HD11 ' CZ ' ' A' ' 194' ' ' PHE . 4.9 mt -61.26 -58.42 8.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.003 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 195' ' ' LEU . 5.6 mt -57.65 -21.24 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.439 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -84.86 -35.71 22.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.407 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -113.08 19.43 17.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.703 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.34 -17.21 3.81 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 14.1 m80 64.22 43.8 4.72 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.884 0.373 . . . . 0.0 110.671 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.89 146.68 28.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.85 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -81.99 116.77 21.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.96 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.16 -10.15 59.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.413 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.6 56.93 4.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.875 0.369 . . . . 0.0 111.008 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.669 HG23 ' SD ' ' A' ' 148' ' ' MET . 0.6 OUTLIER -117.0 133.08 56.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.802 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.858 ' OD2' HD11 ' A' ' 212' ' ' ILE . 55.0 m-20 -154.11 176.1 12.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.029 0.442 . . . . 0.0 111.106 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.401 ' CD2' ' OE2' ' A' ' 214' ' ' GLU . 1.1 t80 -41.87 -61.64 1.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.81 -59.21 3.24 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.858 HD11 ' OD2' ' A' ' 209' ' ' ASP . 0.2 OUTLIER -53.81 -34.03 24.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.507 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.456 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -81.78 -24.14 36.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.712 0.291 . . . . 0.0 110.915 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.401 ' OE2' ' CD2' ' A' ' 210' ' ' TYR . 4.0 mt-10 -82.29 -46.08 14.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.939 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.13 -31.22 66.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.131 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.33 -35.74 78.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.023 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.421 ' CD1' HG22 ' A' ' 225' ' ' THR . 42.1 t80 -82.24 -36.53 27.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -59.11 -46.77 87.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.973 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -76.41 -27.98 56.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.958 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.35 31.2 6.58 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.521 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -77.94 -71.33 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.808 0.337 . . . . 0.0 110.86 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.4 t -68.0 129.0 38.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.539 ' HB1' ' HB2' ' A' ' 122' ' ' LEU . . . -59.18 -36.81 75.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.14 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.518 ' C ' HD12 ' A' ' 147' ' ' LEU . 9.7 ptt? -141.37 153.89 45.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.553 ' O ' HD12 ' A' ' 115' ' ' LEU . 9.0 t -151.42 157.89 42.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.43 HD12 ' CB ' ' A' ' 149' ' ' PHE . 30.2 mt -94.97 121.82 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.109 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.929 ' HB2' HD12 ' A' ' 116' ' ' ILE . 0.8 OUTLIER -137.84 165.44 26.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.822 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -124.39 -162.31 11.37 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.617 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.81 -10.28 26.14 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.846 2.364 . . . . 0.0 112.71 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -92.56 28.28 2.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.651 0.262 . . . . 0.0 111.386 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.05 19.18 1.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.371 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 9.6 m95 -81.2 -55.84 4.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.851 0.358 . . . . 0.0 110.919 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.7 m -57.3 -26.5 60.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.177 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -54.66 -29.27 52.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.092 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.803 HG21 ' CD1' ' A' ' 242' ' ' TYR . 3.2 mt -86.71 98.53 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.046 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -169.98 -49.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.1 t -73.35 -33.51 65.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . 0.517 ' HB3' HG23 ' A' ' 240' ' ' VAL . 71.1 m -90.88 -30.26 17.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt 62.13 31.4 17.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.517 HG23 ' HB3' ' A' ' 238' ' ' SER . 21.6 t -74.43 124.2 31.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.083 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -61.93 94.24 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.827 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.803 ' CD1' HG21 ' A' ' 235' ' ' ILE . 50.3 p90 -89.99 123.02 33.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.924 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.403 ' O ' ' CE2' ' A' ' 117' ' ' TYR . . . -108.99 95.32 0.9 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.469 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 27.0 t -68.95 127.96 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.815 0.34 . . . . 0.0 111.088 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.914 HG21 ' CB ' ' A' ' 125' ' ' PRO . 9.9 t -134.0 159.33 41.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.7 t -66.65 152.02 9.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.97 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.2 mp -67.63 151.19 97.39 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.944 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.426 ' HG3' HD11 ' A' ' 132' ' ' ILE . 39.5 Cg_endo -67.14 162.98 35.92 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.543 2.162 . . . . 0.0 112.211 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 36.9 p -102.14 144.99 30.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.968 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.49 ' CE1' ' CZ ' ' A' ' 194' ' ' PHE . 26.9 t80 -129.31 132.06 47.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.06 18.44 8.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.282 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 91.21 -21.27 35.48 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.942 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.66 145.74 31.19 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.701 0.286 . . . . 0.0 110.926 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.66 164.04 34.58 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.589 2.192 . . . . 0.0 112.299 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.598 ' HA ' ' HB2' ' A' ' 163' ' ' ALA . 0.3 OUTLIER -62.15 -176.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 15.7 mttp -137.0 66.61 54.91 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.7 176.19 9.21 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.561 2.174 . . . . 0.0 112.324 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 155' ' ' TYR . 95.1 m-85 -95.26 166.12 12.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.99 136.4 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.293 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -131.15 121.68 3.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.349 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -113.67 133.64 58.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 111.233 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 12.9 tp -92.07 90.17 7.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.568 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.693 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 0.9 OUTLIER -84.87 167.01 16.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.08 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -98.97 114.99 27.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.997 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -81.92 149.8 28.59 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.529 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 31.3 mt -142.41 152.0 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 0.0 111.098 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -98.93 149.93 22.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.962 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.623 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -68.6 -36.68 79.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.065 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -97.35 36.54 1.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.14 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.3 m -69.27 146.5 96.77 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.888 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.51 -49.32 17.76 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.524 2.149 . . . . 0.0 112.264 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -141.76 83.4 1.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.82 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? -63.08 -34.33 77.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.82 -53.94 52.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.876 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 68.7 mt -59.78 -32.52 70.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.9 -40.69 96.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -52.3 25.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.9 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -60.34 -42.35 95.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.415 ' CE2' ' HB2' ' A' ' 27' ' ' PHE . 11.9 t80 -60.26 -64.28 1.01 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.123 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.978 HD22 HD22 ' A' ' 284' ' ' LEU . 26.2 mt -57.25 -21.65 35.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.411 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -90.48 -32.93 16.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.704 0.288 . . . . 0.0 111.375 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.402 ' O ' ' CD1' ' A' ' 283' ' ' TYR . 35.2 m-80 -104.34 20.39 18.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.285 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.558 ' O ' HG22 ' A' ' 286' ' ' THR . 96.1 m-85 -157.75 -66.25 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.825 0.345 . . . . 0.0 111.042 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.978 HD22 HD22 ' A' ' 280' ' ' LEU . 17.6 tp -60.84 -30.14 69.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.935 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 99.6 mt -121.89 82.28 1.93 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.964 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.56 HG23 ' HA3' ' A' ' 289' ' ' GLY . 0.6 OUTLIER -160.96 170.01 21.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.835 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.2 -57.07 8.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -69.26 -42.77 75.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.049 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.56 ' HA3' HG23 ' A' ' 286' ' ' THR . . . -57.77 -57.2 21.03 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.615 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.488 HD22 HG11 ' A' ' 302' ' ' VAL . 30.4 mt -58.59 -29.85 66.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.802 0.334 . . . . 0.0 110.976 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -60.05 -43.82 95.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.001 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -59.53 -53.67 55.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.142 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.1 t -59.65 -32.17 48.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.22 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -71.68 -31.21 66.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.944 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 49.1 mttm -65.69 -34.66 78.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.955 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.62 -35.04 11.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.5 90.71 4.55 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.889 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.91 112.61 2.75 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.548 2.165 . . . . 0.0 112.238 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 1.2 mt -97.4 25.82 5.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.003 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . 0.589 ' O ' HD13 ' A' ' 311' ' ' LEU . . . 58.29 -125.5 39.66 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.553 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.572 ' HB2' ' CG ' ' A' ' 321' ' ' MET . . . -64.97 156.05 32.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.78 0.324 . . . . 0.0 111.099 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.488 HG11 HD22 ' A' ' 290' ' ' LEU . 9.6 m -128.36 24.89 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.234 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.635 ' HB1' HD23 ' A' ' 89' ' ' LEU . . . 52.92 27.37 5.45 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.343 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.479 ' HB2' HG23 ' A' ' 302' ' ' VAL . 0.5 OUTLIER -116.0 125.24 52.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.862 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -67.01 -31.78 72.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.01 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.8 m -81.2 -29.8 34.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.164 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.422 ' CE2' ' HB2' ' A' ' 290' ' ' LEU . 1.9 t80 -87.91 -28.24 21.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.202 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 0.0 OUTLIER -54.09 -29.63 45.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.814 0.34 . . . . 0.0 111.062 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -67.79 -61.51 1.85 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -50.86 -33.7 24.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.77 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.78 ' HB3' HG21 ' A' ' 317' ' ' ILE . 46.9 mt -85.76 -25.83 26.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.781 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 308' ' ' GLU . . . -73.39 -7.44 51.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.558 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -47.21 -30.59 3.06 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.95 0.405 . . . . 0.0 110.895 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.33 133.81 24.31 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.283 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.512 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 10.8 Cg_endo -54.55 -29.04 58.27 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.421 2.081 . . . . 0.0 112.422 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -49.35 -41.76 39.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.095 0.474 . . . . 0.0 110.296 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.78 HG21 ' HB3' ' A' ' 311' ' ' LEU . 27.8 mt -85.6 -33.26 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.939 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.512 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -62.66 -30.83 71.67 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.11 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -79.31 -31.38 43.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.118 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.37 -35.47 80.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.572 ' CG ' ' HB2' ' A' ' 301' ' ' ALA . 45.8 mtp -81.88 -32.79 30.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.933 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.24 -31.34 70.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.943 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.509 ' HB3' ' HB1' ' A' ' 112' ' ' ALA . 6.3 m-80 -67.99 -38.77 83.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -71.17 -39.89 71.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.132 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -59.85 -35.03 73.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.957 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 6.7 mmtm -117.81 21.11 13.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.033 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -114.03 142.27 17.42 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.501 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -75.61 135.57 40.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.791 0.329 . . . . 0.0 110.884 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.45 HD13 ' HB2' ' A' ' 96' ' ' ALA . 30.8 mt -79.19 148.96 5.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.14 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 6.6 mtp -76.51 113.49 29.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.37 152.5 15.43 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.489 2.126 . . . . 0.0 112.312 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -106.01 39.15 1.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.854 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.466 HD11 ' CE2' ' A' ' 169' ' ' PHE . 22.7 pt -108.15 148.87 38.37 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.177 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.95 -27.71 30.08 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.559 2.172 . . . . 0.0 112.339 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.521 ' NE2' HG21 ' A' ' 178' ' ' ILE . 3.6 mp0 -59.33 -24.14 63.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.055 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 1.7 tpt -54.53 -26.8 34.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.188 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 38.3 m -58.23 -55.26 37.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.015 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -60.43 -29.61 69.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.166 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.711 ' O ' HG23 ' A' ' 343' ' ' VAL . 68.7 t80 -58.98 -51.71 68.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.026 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 40.3 m95 -56.47 -23.52 39.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.356 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -79.38 -61.38 2.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.125 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -59.63 -48.32 82.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.404 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 339' ' ' PHE . 31.7 t -58.18 -32.52 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.292 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 -68.11 -57.46 6.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.914 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 30.9 m -65.83 -28.32 68.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.137 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.581 ' HB1' ' HB1' ' A' ' 360' ' ' ALA . . . -60.09 -51.39 69.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.342 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 32.8 t -70.83 -47.31 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.272 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 57.8 mt -59.31 -43.29 89.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.054 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -60.36 -30.61 69.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.012 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -79.31 -52.51 8.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.34 -38.72 90.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.03 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 16.8 m -70.98 -22.35 62.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.139 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 87.5 26.79 29.18 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.589 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 30.4 mtt180 -91.27 -30.74 16.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.854 0.359 . . . . 0.0 110.915 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -146.45 -176.51 5.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.846 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 19.8 p -116.28 170.74 8.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.525 HG22 ' CD2' ' A' ' 192' ' ' LEU . 47.9 t -59.5 -55.29 24.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.005 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -47.42 -29.83 2.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.157 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -84.29 -41.97 16.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.965 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.581 ' HB1' ' HB1' ' A' ' 346' ' ' ALA . . . -60.08 -60.46 3.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.931 0.395 . . . . 0.0 110.765 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.669 HD22 HG12 ' A' ' 183' ' ' VAL . 3.1 mt -58.29 -27.02 63.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.978 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.94 -53.46 6.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.831 0.348 . . . . 0.0 111.007 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -59.36 -48.55 81.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.857 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.466 ' O ' HD12 ' A' ' 368' ' ' ILE . . . -58.57 -36.42 73.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.994 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.611 ' O ' HG23 ' A' ' 369' ' ' THR . 0.1 OUTLIER -59.78 -45.24 92.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.831 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -52.32 66.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.002 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -59.05 -48.38 81.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.998 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.466 HD12 ' O ' ' A' ' 364' ' ' ALA . 10.6 mt -65.88 -28.96 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.188 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.611 HG23 ' O ' ' A' ' 365' ' ' GLN . 32.6 p -83.37 -31.3 26.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.922 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.884 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.512 HG23 ' HG2' ' A' ' 271' ' ' PRO . 2.7 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.821 0.343 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -98.75 31.76 2.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.42 ' HB3' ' CD ' ' A' ' 6' ' ' LYS . 2.2 tt0 -92.83 -163.87 1.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.794 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -134.15 52.47 0.81 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.771 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.42 ' CD ' ' HB3' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -146.25 -174.93 4.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.793 0.33 . . . . 0.0 110.94 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 21.6 mt -130.56 123.62 29.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.5 t -91.27 142.04 13.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.156 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.848 HG21 ' CD2' ' A' ' 20' ' ' LEU . 29.5 mm -119.66 107.53 21.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.952 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.41 ' CD2' ' HG3' ' A' ' 57' ' ' PRO . 5.2 m0 -104.07 106.74 17.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.6 tt -150.84 150.52 13.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.11 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -64.36 158.91 22.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.916 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.87 57.74 3.68 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.522 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -125.86 -44.51 1.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.862 0.363 . . . . 0.0 110.912 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.75 -179.29 6.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.874 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.18 83.83 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.486 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -71.91 -35.5 69.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.809 0.338 . . . . 0.0 110.902 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -72.31 -31.18 65.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.85 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.25 -41.49 96.75 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.495 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.848 ' CD2' HG21 ' A' ' 9' ' ' ILE . 8.4 tp -67.23 -29.52 69.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.0 110.952 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.74 -42.29 79.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.101 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.67 -26.14 68.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.019 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.65 HG12 ' CZ ' ' A' ' 279' ' ' PHE . 17.5 t -76.71 -25.94 16.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -81.39 -42.54 9.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.599 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -27.69 69.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.767 0.318 . . . . 0.0 110.988 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -73.9 -41.52 62.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -60.43 -57.15 14.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.931 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.32 -21.19 48.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.295 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.42 -25.81 33.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.334 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -102.48 -33.74 9.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.583 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.68 -44.15 3.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.766 0.317 . . . . 0.0 111.402 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.31 -26.4 7.04 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.528 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.577 HG21 HD13 ' A' ' 275' ' ' LEU . 35.7 mm -62.25 122.65 13.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.338 . . . . 0.0 111.108 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -70.71 166.77 20.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.967 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.2 t -147.45 102.57 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.087 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.8 m -98.29 144.67 27.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.5 t -114.53 110.18 31.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.113 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -97.56 176.46 5.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.789 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -159.32 70.24 3.36 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.018 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.29 144.41 46.0 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.549 2.166 . . . . 0.0 112.171 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.21 139.13 48.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.966 0.412 . . . . 0.0 111.04 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.538 ' C ' HD23 ' A' ' 43' ' ' LEU . 4.4 mtmt 73.48 -58.39 0.6 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.873 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.538 HD23 ' C ' ' A' ' 42' ' ' LYS . 0.5 OUTLIER 49.18 18.69 0.25 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.114 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -83.29 -57.02 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -91.57 -7.4 50.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.354 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.546 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.5 tptt -67.75 -25.1 65.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.264 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.477 ' CB ' ' HD3' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -85.16 -57.68 0.36 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.179 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.477 ' HD3' ' CB ' ' A' ' 47' ' ' PHE . 54.0 Cg_exo -52.07 -35.8 63.2 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.416 2.077 . . . . 0.0 112.531 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.612 ' HG3' HG13 ' A' ' 50' ' ' VAL . 11.5 pt20 -60.09 -49.64 76.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.01 0.433 . . . . 0.0 111.053 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.612 HG13 ' HG3' ' A' ' 49' ' ' GLN . 6.2 m -96.68 27.0 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.418 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 1.037 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -88.55 -42.15 12.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.107 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.33 -33.65 76.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.098 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 55' ' ' ASP . 11.5 t -88.12 -31.31 19.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.52 39.61 68.38 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.518 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.417 ' H ' HG23 ' A' ' 53' ' ' THR . 8.8 t0 -97.73 -29.58 13.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.98 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.52 -160.5 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.551 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.442 ' HG2' ' CZ ' ' A' ' 47' ' ' PHE . 41.4 Cg_endo -67.54 -167.79 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.549 2.166 . . . . 0.0 112.263 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -124.12 -42.48 2.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.006 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 60' ' ' ILE . 16.7 mt -102.1 158.29 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.242 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.563 HG22 ' O ' ' A' ' 265' ' ' GLY . 2.4 tt -166.86 159.48 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.811 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.477 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 73.6 m-85 -119.85 140.58 50.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.987 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.505 ' HZ3' HD11 ' A' ' 43' ' ' LEU . 4.9 t-105 -174.07 151.11 1.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.64 134.54 57.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.091 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -53.26 -28.37 27.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.195 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -64.55 -35.06 79.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.005 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.438 ' HB3' ' CD1' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -94.41 17.18 13.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.296 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -106.84 30.62 5.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.827 0.346 . . . . 0.0 110.907 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -122.29 35.91 3.34 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.544 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -128.43 -41.7 0.27 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.51 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -80.62 -9.03 59.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.608 0.242 . . . . 0.0 111.364 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.22 -25.98 47.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.728 0.299 . . . . 0.0 111.144 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -60.72 -51.05 71.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.948 0.404 . . . . 0.0 110.661 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.7 m -72.04 -23.1 61.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.047 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.4 31.63 9.43 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.526 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.037 HD22 ' HB1' ' A' ' 51' ' ' ALA . 35.7 mt -72.5 -37.97 68.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.785 0.326 . . . . 0.0 110.952 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.674 HD13 HD13 ' A' ' 104' ' ' ILE . 6.7 mt -77.35 146.28 36.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.986 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.797 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -93.08 116.39 28.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.078 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -60.79 155.83 18.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.833 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.475 ' O ' HG23 ' A' ' 80' ' ' THR . 42.6 pt -124.68 179.19 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.131 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 79' ' ' ILE . 0.9 OUTLIER -159.82 77.81 2.79 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.893 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.31 163.45 34.42 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.613 2.209 . . . . 0.0 112.207 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -94.8 -179.43 4.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -59.18 -48.92 79.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.883 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.51 -31.16 72.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.104 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -74.59 -35.73 62.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.917 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.427 ' HA ' ' CZ2' ' A' ' 94' ' ' TRP . 15.5 mt-30 -79.87 -30.13 40.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.947 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -74.05 -39.26 63.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.985 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.83 -36.21 76.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.978 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.515 HD13 ' CZ2' ' A' ' 94' ' ' TRP . 0.4 OUTLIER -84.48 178.07 7.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.834 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.42 ' HB3' ' CE1' ' A' ' 92' ' ' PHE . 24.4 m-85 -86.79 142.38 34.4 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.039 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 63.7 Cg_exo -54.27 -55.85 3.03 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.581 2.188 . . . . 0.0 112.657 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.541 ' CE2' HG23 ' A' ' 93' ' ' THR . 50.0 p90 -60.32 -46.63 89.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.429 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.541 HG23 ' CE2' ' A' ' 92' ' ' PHE . 70.9 p -53.21 -27.6 22.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.797 0.332 . . . . 0.0 111.233 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.515 ' CZ2' HD13 ' A' ' 89' ' ' LEU . 22.8 m95 -74.68 -36.44 62.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.822 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -74.56 -7.7 53.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.342 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.76 -27.9 22.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.822 0.344 . . . . 0.0 111.183 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.516 ' CG1' ' HB3' ' A' ' 105' ' ' ALA . 27.5 m -93.0 47.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.288 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.9 124.31 13.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -108.94 -65.2 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.844 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -98.59 30.66 3.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.808 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.92 -25.96 21.1 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.558 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -92.17 170.55 9.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.333 . . . . 0.0 110.99 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.514 ' O ' HG23 ' A' ' 104' ' ' ILE . 5.9 mt -96.17 141.11 29.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.79 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.685 ' O ' HD12 ' A' ' 104' ' ' ILE . 1.8 pp -158.08 58.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.239 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.805 ' HB1' ' HB3' ' A' ' 263' ' ' SER . . . -177.33 172.25 1.89 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.229 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.732 ' CE1' HD12 ' A' ' 266' ' ' ILE . 26.0 m-85 -138.53 94.01 10.82 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.821 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.52 116.96 3.65 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.648 2.232 . . . . 0.0 112.381 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.0 mt -119.06 -64.39 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.118 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.588 ' CB ' HD22 ' A' ' 299' ' ' LEU . . . -113.7 142.84 45.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.147 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.676 HG22 HG13 ' A' ' 261' ' ' VAL . 21.5 t -106.86 151.88 8.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.116 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -130.94 149.14 52.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -171.72 146.36 2.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.2 mt -66.53 114.87 5.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.915 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.681 ' HB3' HG13 ' A' ' 244' ' ' VAL . 1.3 m -93.72 163.23 13.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.925 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 50.1 tp -100.72 101.54 12.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.766 HG22 ' CZ ' ' A' ' 217' ' ' PHE . 28.7 mt -86.16 119.91 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.119 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -137.84 148.9 45.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.943 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -81.42 156.75 25.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.6 mtmm -110.88 -30.25 7.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.978 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -61.17 -31.61 71.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.035 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.669 HD11 ' HA ' ' A' ' 223' ' ' ALA . 3.8 pp -111.6 -33.71 6.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.974 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.561 ' HB2' HD12 ' A' ' 121' ' ' LEU . 8.3 tp -119.25 88.98 38.83 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.995 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.26 -28.42 33.65 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.535 2.157 . . . . 0.0 112.283 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -140.26 112.58 7.31 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.836 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -78.82 167.59 22.05 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.586 2.191 . . . . 0.0 112.422 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.408 ' HD2' ' HE3' ' A' ' 224' ' ' MET . 56.2 Cg_endo -70.34 111.81 3.02 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.603 2.202 . . . . 0.0 112.322 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.45 -27.1 65.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.963 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 29.5 p -120.34 158.53 26.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.964 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.425 ' CE3' HD12 ' A' ' 132' ' ' ILE . 34.5 m95 -72.44 -30.06 64.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.967 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -72.2 -16.05 61.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.405 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.733 ' O ' HD12 ' A' ' 135' ' ' LEU . 2.6 mt-10 -89.76 0.05 57.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.581 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.48 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 12.2 mt -85.44 -46.5 0.62 Allowed Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 73.2 Cg_exo -49.25 -28.35 14.76 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.378 2.052 . . . . 0.0 112.44 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.27 -34.61 28.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.197 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.733 HD12 ' O ' ' A' ' 131' ' ' GLU . 0.2 OUTLIER -62.23 -42.55 99.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.092 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.406 ' OD2' ' HA ' ' A' ' 133' ' ' PRO . 7.5 p30 -57.09 -22.24 38.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.216 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -85.62 -33.71 21.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.079 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -85.1 -61.74 1.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.296 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.421 HD13 ' HB2' ' A' ' 223' ' ' ALA . 6.6 mt -53.79 -24.85 16.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.545 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -76.87 -24.77 52.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.742 0.306 . . . . 0.0 110.959 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.12 -33.75 69.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.903 0.383 . . . . 0.0 110.97 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.08 -27.12 39.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.029 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.44 42.16 0.77 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.491 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -144.99 -177.3 5.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 0.0 110.861 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.57 147.82 40.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.868 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -68.33 -68.82 0.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.201 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.698 HD13 ' HB2' ' A' ' 224' ' ' MET . 18.8 tp -148.79 132.92 17.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.043 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.777 ' HB2' HG21 ' A' ' 208' ' ' THR . 0.0 OUTLIER -126.17 179.61 5.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.712 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.428 ' HB2' ' CD2' ' A' ' 156' ' ' PHE . 50.6 p90 -178.28 -176.04 0.49 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.018 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -79.37 118.8 21.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.905 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.4 mt -98.93 29.2 3.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -112.09 -33.34 6.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.842 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -101.04 135.27 19.99 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.419 ' CB ' HG12 ' A' ' 343' ' ' VAL . 72.0 Cg_endo -76.56 -13.36 18.3 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.532 2.155 . . . . 0.0 112.612 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.495 ' CZ ' ' CH2' ' A' ' 340' ' ' TRP . 3.0 m-85 -57.37 -32.62 66.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.12 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.428 ' CD2' ' HB2' ' A' ' 149' ' ' PHE . 1.8 m-85 -77.44 -36.72 52.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.896 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.652 HG21 HG11 ' A' ' 347' ' ' VAL . 40.1 p -81.55 -23.07 37.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.045 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.545 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 64.5 t-105 -50.9 -54.15 40.03 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.572 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.611 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 14.9 Cg_endo -57.24 -22.02 46.61 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.196 1.931 . . . . 0.0 112.3 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.4 tp -80.44 -54.48 5.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.813 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.991 HG21 HD12 ' A' ' 192' ' ' LEU . 12.3 pt -71.16 -34.03 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.434 ' HB1' ' HG3' ' A' ' 256' ' ' LYS . . . -75.08 -28.9 60.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.175 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -56.5 -28.87 60.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.233 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -76.16 -20.04 57.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.222 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 139.55 -26.37 2.67 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.658 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.488 ' HA3' ' HB2' ' A' ' 188' ' ' ALA . . . -57.0 145.32 37.64 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.565 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -134.81 -176.35 4.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.801 0.334 . . . . 0.0 110.986 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.45 ' HB2' ' CZ2' ' A' ' 158' ' ' TRP . . . -107.58 -49.64 3.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.12 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.911 ' CE2' HD11 ' A' ' 333' ' ' ILE . 24.9 m-85 -127.83 158.73 36.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -99.44 118.58 36.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.017 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.404 ' CE1' ' O ' ' A' ' 174' ' ' GLY . 7.7 t80 -85.59 111.15 19.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.487 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.04 146.33 23.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.153 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 63.11 29.45 16.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.095 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 171' ' ' TYR . . . 90.55 -37.0 3.44 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.021 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.91 -177.24 3.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 0.0 111.067 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -98.92 -177.48 3.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.954 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -133.46 134.76 43.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.8 pt -87.12 -29.68 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.119 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -74.54 -16.33 60.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.219 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -104.96 117.35 33.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.807 0.337 . . . . 0.0 110.976 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.725 HG12 HG23 ' A' ' 183' ' ' VAL . 16.9 t -124.51 146.05 30.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.006 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -117.04 61.37 0.42 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.782 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.725 HG23 HG12 ' A' ' 181' ' ' VAL . 2.3 t -96.55 -61.58 2.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.846 0.355 . . . . 0.0 110.973 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -84.4 57.23 4.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.922 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -95.74 167.84 11.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.849 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -58.64 -31.14 67.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.178 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -85.98 -49.13 4.38 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.55 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.488 ' HB2' ' HA3' ' A' ' 166' ' ' GLY . . . -59.0 -31.59 68.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 0.0 111.182 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -60.02 -45.81 91.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.834 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -86.95 -28.2 22.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.154 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -57.81 -53.61 43.96 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.608 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.991 HD12 HG21 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -61.22 -32.65 72.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.339 . . . . 0.0 110.981 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.3 m -53.67 -25.15 16.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.091 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -65.89 -59.08 4.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.786 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.493 ' HA ' HD12 ' A' ' 198' ' ' LEU . 8.0 tt -64.78 -29.78 70.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.735 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.87 HG23 ' O ' ' A' ' 192' ' ' LEU . 41.2 t -69.49 -59.84 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.062 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -58.48 -29.55 66.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.051 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 195' ' ' LEU . 12.5 mt -60.06 -47.88 84.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 22.4 mt -76.53 -28.41 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.167 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.789 ' HD2' HG12 ' A' ' 196' ' ' VAL . 18.2 mtpt -62.06 -30.48 71.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.966 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -91.07 13.58 16.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.423 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt 56.13 44.04 25.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.956 0.407 . . . . 0.0 111.028 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.83 -28.1 12.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.904 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 87.7 mtp -113.69 176.74 4.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.932 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 19.8 m-20 -124.22 133.57 53.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -79.77 -38.99 31.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.094 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -59.25 -27.39 65.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.982 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.777 HG21 ' HB2' ' A' ' 148' ' ' MET . 1.6 m -49.45 146.74 3.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.227 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -154.23 176.08 12.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.858 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -61.08 -29.02 69.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.257 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.13 -59.36 2.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.84 0.352 . . . . 0.0 110.986 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -28.65 44.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.309 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.582 ' O ' HG21 ' A' ' 225' ' ' THR . . . -77.74 -21.75 51.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.769 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.16 -50.2 11.36 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.835 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.76 -30.61 68.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.127 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.3 -32.98 70.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.144 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.766 ' CZ ' HG22 ' A' ' 116' ' ' ILE . 19.4 t80 -79.42 -41.1 28.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.961 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -67.12 -36.11 81.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.5 mttm -83.73 -34.0 24.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.863 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.12 59.33 0.94 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.491 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -109.27 -72.69 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.803 0.335 . . . . 0.0 110.825 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.592 HG21 ' SD ' ' A' ' 148' ' ' MET . 10.6 t -74.36 169.12 18.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.924 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.669 ' HA ' HD11 ' A' ' 121' ' ' LEU . . . -81.53 -54.66 5.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.171 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.698 ' HB2' HD13 ' A' ' 147' ' ' LEU . 0.5 OUTLIER -125.78 163.59 22.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.004 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.582 HG21 ' O ' ' A' ' 213' ' ' ALA . 66.3 m -159.83 137.75 10.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 29.3 mt -112.98 135.22 53.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.163 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.523 ' HB3' ' HB2' ' A' ' 231' ' ' ALA . 33.5 t30 -150.47 155.78 40.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -62.47 -162.25 0.27 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.551 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.427 ' HD2' ' CZ3' ' A' ' 230' ' ' TRP . 34.5 Cg_endo -64.56 -23.09 64.48 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.649 2.233 . . . . 0.0 112.499 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . 0.427 ' CZ3' ' HD2' ' A' ' 229' ' ' PRO . 46.6 p90 -84.5 57.31 4.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.958 0.409 . . . . 0.0 110.875 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.523 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . . . -141.76 -44.94 0.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.18 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . 0.551 ' HA ' HD12 ' A' ' 235' ' ' ILE . 20.8 m0 -54.26 -30.59 51.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.086 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.5 m -62.71 -36.58 83.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.944 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -60.39 -34.39 73.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.919 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.551 HD12 ' HA ' ' A' ' 232' ' ' TRP . 10.6 mt -74.96 70.4 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.03 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -153.28 -46.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.871 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 62.4 m -61.29 -44.1 97.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.84 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 2.7 t -101.58 -34.13 9.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.93 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.97 104.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.6 t -135.01 142.32 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.122 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.05 95.66 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.627 ' HB2' HG23 ' A' ' 116' ' ' ILE . 55.0 p90 -100.54 135.6 41.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -100.53 148.16 18.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.466 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.681 HG13 ' HB3' ' A' ' 114' ' ' SER . 21.3 t -128.55 123.27 59.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.838 0.351 . . . . 0.0 111.119 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 10.0 t -143.45 153.78 43.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.864 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.502 HG11 ' CD ' ' A' ' 322' ' ' GLU . 0.8 OUTLIER -54.85 152.35 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.245 0.545 . . . . 0.0 111.381 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.412 ' N ' ' CG2' ' A' ' 246' ' ' VAL . 89.9 mt -67.68 136.24 92.68 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.855 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.422 ' HB2' ' CD1' ' A' ' 129' ' ' TRP . 52.3 Cg_exo -54.58 -170.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.412 2.075 . . . . 0.0 112.279 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.511 HG22 ' HA ' ' A' ' 254' ' ' PRO . 1.3 p -127.89 163.04 25.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -111.05 108.24 17.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.93 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 17.1 mttt 59.44 30.72 20.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.958 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 83.1 27.03 42.06 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.541 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.431 ' O ' HG22 ' A' ' 249' ' ' THR . 2.9 mm-40 -122.22 141.27 34.14 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.59 0.233 . . . . 0.0 110.852 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.511 ' HA ' HG22 ' A' ' 249' ' ' THR . 72.6 Cg_endo -76.37 145.34 26.82 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.544 2.163 . . . . 0.0 112.42 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.22 -172.64 1.77 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.769 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.434 ' HG3' ' HB1' ' A' ' 162' ' ' ALA . 12.3 mmmt -132.88 58.69 37.45 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.128 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.433 ' HD3' ' N ' ' A' ' 256' ' ' LYS . 62.3 Cg_exo -50.9 -179.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.406 2.071 . . . . 0.0 112.291 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . 0.494 ' CE2' ' CD2' ' A' ' 155' ' ' TYR . 10.9 m-85 -110.53 134.9 51.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.826 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 328' ' ' GLU . 23.8 t -97.17 132.13 42.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.203 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -145.57 106.13 0.37 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.307 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.676 HG13 HG22 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -106.21 149.53 9.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.881 0.372 . . . . 0.0 111.323 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 262' ' ' LEU . 11.9 tp -85.75 80.88 8.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.975 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.805 ' HB3' ' HB1' ' A' ' 105' ' ' ALA . 2.1 m -75.81 137.44 40.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.033 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.713 ' HB3' ' HB2' ' A' ' 106' ' ' TYR . . . -82.04 114.98 20.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.053 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.563 ' O ' HG22 ' A' ' 60' ' ' ILE . . . -83.38 117.82 4.51 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.565 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.732 HD12 ' CE1' ' A' ' 106' ' ' TYR . 29.2 mt -119.48 121.94 67.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.818 0.342 . . . . 0.0 110.998 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -79.59 148.64 31.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.953 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.797 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -67.51 -27.13 66.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.176 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -90.98 48.81 1.56 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.152 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 58.5 p -116.45 108.11 45.93 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.794 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.512 ' HG2' HG23 ' A' ' 2' ' ' THR . 38.3 Cg_endo -66.73 -24.37 47.54 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.418 2.079 . . . . 0.0 112.312 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -97.64 37.21 1.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.841 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -66.36 -41.09 89.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -59.58 -56.15 25.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.961 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.577 HD13 HG21 ' A' ' 33' ' ' ILE . 19.1 mt -60.32 -35.04 74.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.81 -50.72 40.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.075 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -44.62 95.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.873 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -63.07 -61.97 2.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.65 ' CZ ' HG12 ' A' ' 23' ' ' VAL . 72.8 t80 -55.09 -27.18 43.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.143 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.64 HD23 HD22 ' A' ' 284' ' ' LEU . 24.8 mt -76.95 -37.83 54.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.109 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.465 ' HG3' HD12 ' A' ' 285' ' ' LEU . 1.1 mp0 -93.62 -7.32 44.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.643 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -103.29 -35.8 8.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.653 0.263 . . . . 0.0 111.367 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -116.96 -35.77 4.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.406 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.64 HD22 HD23 ' A' ' 280' ' ' LEU . 1.5 tp -95.21 41.1 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.799 0.333 . . . . 0.0 111.134 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.465 HD12 ' HG3' ' A' ' 281' ' ' GLU . 2.7 mt -177.18 37.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.878 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.2 p -142.91 164.49 29.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -72.28 -30.21 64.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -79.45 -30.49 42.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.004 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -89.63 -50.92 3.01 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.589 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 87.2 mt -59.68 -31.0 69.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.363 . . . . 0.0 111.021 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -69.64 -31.21 69.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.46 -30.73 67.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.164 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.12 -30.02 9.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.39 -30.71 71.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.959 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -68.99 -33.62 73.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.027 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.55 -36.69 12.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.015 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -169.2 100.3 0.49 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.922 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.28 115.12 3.69 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.428 2.085 . . . . 0.0 112.32 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.588 HD22 ' CB ' ' A' ' 109' ' ' ALA . 0.8 OUTLIER -56.9 -24.63 53.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.026 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 109.76 -32.66 6.58 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.573 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -157.36 176.83 12.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 0.0 111.126 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.629 HG21 ' CD2' ' A' ' 307' ' ' TYR . 5.8 m -152.92 156.08 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.089 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.458 ' HB1' HD23 ' A' ' 89' ' ' LEU . . . -84.42 -30.32 25.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.135 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 304' ' ' LEU . 14.0 tp -59.67 123.97 18.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.908 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -72.66 -24.14 60.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.12 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.6 m -81.27 -24.13 37.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.179 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.629 ' CD2' HG21 ' A' ' 302' ' ' VAL . 26.3 t80 -95.33 -31.97 13.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.306 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -57.23 -29.72 63.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.343 . . . . 0.0 110.948 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -64.27 -59.87 3.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -50.89 -33.26 23.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.827 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.799 ' HB3' HG21 ' A' ' 317' ' ' ILE . 7.8 mt -85.76 -24.99 26.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.798 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -67.13 -13.82 62.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.494 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -47.48 -32.16 4.91 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.972 0.415 . . . . 0.0 110.941 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -112.69 140.65 24.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.37 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.483 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 11.6 Cg_endo -55.76 -26.99 59.59 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.425 2.083 . . . . 0.0 112.341 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -50.51 -41.24 53.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.079 0.466 . . . . 0.0 110.313 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.799 HG21 ' HB3' ' A' ' 311' ' ' LEU . 32.2 mm -85.58 -32.0 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.957 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.483 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -69.39 -30.69 68.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.171 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -74.42 -46.18 41.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.204 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 63.4 m -59.7 -31.35 69.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.925 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.91 -41.82 25.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.946 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.502 ' CD ' HG11 ' A' ' 246' ' ' VAL . 18.1 tt0 -60.0 -47.06 87.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.958 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -60.14 -54.27 47.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.966 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.79 -50.55 73.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.148 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -59.71 -33.29 71.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -96.59 21.15 9.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.123 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -128.18 161.88 21.97 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.521 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . 0.408 ' O ' HG23 ' A' ' 259' ' ' VAL . 0.4 OUTLIER -79.58 156.24 27.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.804 0.335 . . . . 0.0 110.873 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 25.3 mt -88.02 138.39 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.141 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.441 ' HG2' ' CD1' ' A' ' 258' ' ' PHE . 12.8 mtm -60.35 140.27 91.74 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.43 ' HG2' ' HE3' ' A' ' 336' ' ' MET . 72.6 Cg_endo -76.41 138.79 20.1 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.549 2.166 . . . . 0.0 112.333 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -101.87 30.98 4.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.911 HD11 ' CE2' ' A' ' 169' ' ' PHE . 9.4 pt -107.2 148.52 37.23 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.108 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.56 -24.47 18.77 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.584 2.19 . . . . 0.0 112.446 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.15 -26.34 38.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.184 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 0.43 ' HE3' ' HG2' ' A' ' 331' ' ' PRO . 17.3 ptm -57.31 -22.27 40.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.215 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 67.1 m -50.24 -48.8 54.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.175 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.52 -28.02 60.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.15 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.73 ' CZ ' HG21 ' A' ' 343' ' ' VAL . 78.0 t80 -58.25 -29.1 65.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.009 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.495 ' CH2' ' CZ ' ' A' ' 155' ' ' TYR . 94.2 m95 -60.28 -61.06 2.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.034 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.86 -30.72 71.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.091 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -62.04 -56.28 20.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.339 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.73 HG21 ' CZ ' ' A' ' 339' ' ' PHE . 21.4 t -78.62 -33.76 17.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.417 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -57.16 -57.45 12.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.15 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . 0.637 HG22 ' OD1' ' A' ' 349' ' ' ASN . 21.0 m -66.71 -29.53 69.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.01 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -59.78 -56.84 16.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.24 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.652 HG11 HG21 ' A' ' 157' ' ' THR . 21.2 t -59.05 -40.57 81.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.284 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 26.2 mt -68.22 -41.6 84.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.064 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.637 ' OD1' HG22 ' A' ' 345' ' ' THR . 2.0 m120 -59.58 -30.2 68.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.967 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -91.1 -34.84 14.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.236 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -76.52 -33.33 58.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.228 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 5.6 t -66.27 -22.42 66.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.118 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 80.0 61.7 2.22 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.539 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 18.9 mtt-85 -140.29 -79.33 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.83 0.348 . . . . 0.0 110.836 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -77.55 177.55 7.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.758 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 65.8 p -106.57 145.13 32.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.776 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.41 HG12 ' HG ' ' A' ' 361' ' ' LEU . 40.3 t -51.44 -40.14 23.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.108 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -50.73 -38.51 47.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.62 -30.65 29.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -65.96 -58.17 6.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.062 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.673 HD22 HG12 ' A' ' 183' ' ' VAL . 12.1 mt -60.04 -25.29 65.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.037 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -72.83 -51.07 20.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.834 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -57.76 -48.46 79.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.85 -39.19 80.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.073 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.602 ' O ' HG23 ' A' ' 369' ' ' THR . 7.1 tm0? -58.86 -33.99 71.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.963 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 90.0 m -87.11 -40.36 14.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.925 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -59.07 -44.87 91.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.718 HD12 HG11 ' A' ' 181' ' ' VAL . 17.1 mt -69.45 -30.4 45.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.175 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.602 HG23 ' O ' ' A' ' 365' ' ' GLN . 76.2 p -82.97 -29.64 28.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.942 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 26.3 tttm . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.918 179.998 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.813 0.34 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -105.21 99.45 9.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 58.87 162.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.967 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.59 -58.4 0.53 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.506 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -142.14 174.6 10.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.815 0.34 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 33.7 mt -128.69 133.8 48.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.7 t -109.6 147.05 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.115 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.592 HG21 ' CD2' ' A' ' 20' ' ' LEU . 28.7 mm -120.49 107.51 20.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.968 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.419 ' CG ' ' HG3' ' A' ' 57' ' ' PRO . 0.5 OUTLIER -93.41 106.77 18.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.833 HD11 ' HD3' ' A' ' 15' ' ' LYS . 17.3 tt -163.15 123.02 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.006 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -142.53 162.68 34.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.928 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 109.57 58.81 0.52 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.984 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.6 t70 59.48 28.9 18.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.96 0.409 . . . . 0.0 110.556 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.833 ' HD3' HD11 ' A' ' 11' ' ' ILE . 3.3 mmpt? -83.16 173.56 11.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.8 54.67 4.62 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.527 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -72.62 -31.05 64.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.827 0.346 . . . . 0.0 110.909 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -74.53 -32.3 62.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.39 -37.85 8.67 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.512 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.592 ' CD2' HG21 ' A' ' 9' ' ' ILE . 6.2 tp -65.77 -31.22 72.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.783 0.325 . . . . 0.0 110.92 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.92 -31.02 70.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.128 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -66.59 -36.65 83.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.563 HG12 ' HB3' ' A' ' 283' ' ' TYR . 25.4 t -65.38 -31.39 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.074 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.97 -27.63 73.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.512 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.3 mmtt -59.24 -30.55 68.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.776 0.322 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.3 -40.48 58.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.881 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.632 ' CE1' HG21 ' A' ' 31' ' ' THR . 38.5 t80 -57.98 -52.89 63.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.017 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -68.94 -23.91 64.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.174 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -78.84 -25.83 44.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.22 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -103.89 -36.98 7.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.41 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.632 HG21 ' CE1' ' A' ' 27' ' ' PHE . 8.9 p -99.98 -44.11 6.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.225 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.06 -27.09 8.38 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.45 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.424 ' HB ' ' CE2' ' A' ' 27' ' ' PHE . 35.8 mm -64.32 118.83 7.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.779 0.323 . . . . 0.0 111.091 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -59.71 152.37 22.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.914 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.29 108.78 12.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.045 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.5 m -115.36 144.67 43.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.409 HG13 ' HB ' ' A' ' 9' ' ' ILE . 29.6 t -118.98 119.07 59.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.052 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -100.85 151.4 21.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -117.21 73.41 7.1 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.973 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.95 -179.99 5.51 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.646 2.231 . . . . 0.0 112.359 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -60.3 -158.88 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.416 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.466 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -47.13 -27.39 1.4 Allowed 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.598 0.237 . . . . 0.0 111.485 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 42' ' ' LYS . 0.3 OUTLIER 52.45 17.95 0.86 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.979 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -83.19 -57.04 3.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 0.0 110.972 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -92.77 -5.62 50.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.44 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.1 -18.94 29.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.557 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.679 ' CE2' HG21 ' A' ' 60' ' ' ILE . 13.3 t80 -83.37 -47.92 0.77 Allowed Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 116.762 -0.199 . . . . 0.0 111.49 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.545 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 41.9 Cg_exo -57.11 -38.23 96.14 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.336 2.024 . . . . 0.0 112.327 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.441 ' CG ' ' N ' ' A' ' 50' ' ' VAL . 4.6 pt20 -60.9 -47.31 86.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.044 0.45 . . . . 0.0 110.923 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.441 ' N ' ' CG ' ' A' ' 49' ' ' GLN . 20.3 m -76.99 -27.95 16.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.229 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 75' ' ' LEU . . . -56.7 -26.78 57.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.39 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.76 -35.73 71.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.237 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.0 t -110.8 -29.65 7.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.031 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.39 35.53 6.56 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.536 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.27 -27.45 20.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.785 0.326 . . . . 0.0 111.029 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.73 -156.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.544 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.419 ' HG3' ' CG ' ' A' ' 10' ' ' TRP . 46.0 Cg_endo -68.06 -167.84 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.623 2.215 . . . . 0.0 112.301 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -109.45 -31.27 7.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.894 HD13 HD21 ' A' ' 280' ' ' LEU . 22.2 mt -136.81 129.03 44.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.135 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.679 HG21 ' CE2' ' A' ' 47' ' ' PHE . 2.3 tt -114.88 159.07 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.093 0.473 . . . . 0.0 111.018 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.47 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 6.2 m-85 -130.56 113.14 13.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.784 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.3 t-105 -152.71 173.73 14.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.959 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.45 139.27 58.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.495 ' HB3' HG23 ' A' ' 261' ' ' VAL . 1.5 p80 -58.0 -33.69 69.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.038 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -59.67 -39.39 84.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.981 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -94.14 17.18 13.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.273 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.43 -4.71 37.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.416 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -94.82 26.4 18.74 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.56 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -124.5 4.42 8.74 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.84 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.521 ' O ' HD12 ' A' ' 75' ' ' LEU . 4.7 m-85 -112.59 -32.32 6.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.845 0.355 . . . . 0.0 110.998 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.51 -26.07 50.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.09 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -32.82 70.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.963 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.57 24.95 6.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.079 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 54.84 40.48 72.3 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.756 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.528 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 4.0 mt -100.32 -48.19 4.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.808 0.337 . . . . 0.0 110.934 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 20.5 mt -73.35 142.0 47.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.987 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.754 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -92.6 169.77 10.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.095 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.35 -164.9 1.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.942 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.748 HD11 ' CB ' ' A' ' 103' ' ' LEU . 35.8 pt -157.02 168.82 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.089 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 48.9 p -156.65 77.49 4.17 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.831 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.77 154.59 63.67 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.603 2.202 . . . . 0.0 112.315 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -78.08 164.77 24.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.813 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -59.74 -38.48 81.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.815 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.94 -44.39 85.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.005 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.674 ' CZ ' HD22 ' A' ' 285' ' ' LEU . 31.4 t80 -66.44 -37.37 85.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -69.07 -30.48 68.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.51 -28.32 62.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.969 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.66 43.19 1.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.024 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.455 HD13 ' CZ2' ' A' ' 94' ' ' TRP . 8.1 mt -151.93 139.04 19.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.876 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.438 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . 12.9 m-85 -73.31 129.77 85.39 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -49.06 -55.54 4.05 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.657 2.238 . . . . 0.0 112.996 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.699 ' HB2' HD11 ' A' ' 329' ' ' ILE . 10.7 p90 -49.78 -25.13 2.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.077 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.613 HG22 ' CE1' ' A' ' 92' ' ' PHE . 10.4 p -74.73 -30.57 61.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.819 0.342 . . . . 0.0 110.804 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.498 ' CZ3' HD13 ' A' ' 103' ' ' LEU . 12.2 m95 -73.1 -39.48 65.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.922 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -62.09 -27.34 68.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.999 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.53 ' HB2' HG21 ' A' ' 329' ' ' ILE . . . -64.98 -25.67 67.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.332 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 97' ' ' VAL . 27.6 m -121.09 72.81 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.911 0.386 . . . . 0.0 111.266 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -156.06 144.2 19.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.874 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -106.09 -64.53 1.15 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -123.8 41.76 3.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.824 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.84 25.58 29.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.522 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.99 145.35 49.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.765 0.317 . . . . 0.0 110.896 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.748 ' CB ' HD11 ' A' ' 79' ' ' ILE . 13.4 mt -87.93 140.41 29.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.939 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.0 pt -144.86 29.87 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.227 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -166.68 -177.11 3.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.153 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.431 ' OH ' HG22 ' A' ' 79' ' ' ILE . 5.9 m-85 -135.31 85.97 31.47 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.89 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.32 97.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.584 2.19 . . . . 0.0 112.321 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.7 mm -75.31 -66.16 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.204 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.748 ' HB2' HD12 ' A' ' 299' ' ' LEU . . . -112.74 164.41 13.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.181 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.451 HG22 ' CG1' ' A' ' 261' ' ' VAL . 21.3 t -130.51 106.96 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.07 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -91.44 163.55 14.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.933 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.465 ' HB2' ' HB2' ' A' ' 324' ' ' ALA . . . -163.02 144.3 9.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.061 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.437 HD12 ' H ' ' A' ' 258' ' ' PHE . 3.8 mt -62.05 145.22 53.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.1 p -140.35 -177.19 4.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.942 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.451 HD23 HG23 ' A' ' 245' ' ' THR . 35.2 tp -122.48 129.38 51.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.871 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.1 mp -110.51 125.83 67.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.064 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.433 ' CG ' ' HB3' ' A' ' 125' ' ' PRO . 28.2 p90 -125.72 160.42 29.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -92.38 -176.36 4.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.886 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.9 mttm -125.13 -45.31 1.86 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.869 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.16 -31.65 72.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 70.6 mt -98.98 -31.06 12.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.957 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.638 HD22 ' SD ' ' A' ' 224' ' ' MET . 9.9 tp -132.53 108.0 13.23 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.853 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.63 -45.84 3.1 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.377 2.051 . . . . 0.0 112.263 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -128.17 128.95 23.68 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.83 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.593 ' HA ' HD21 ' A' ' 122' ' ' LEU . 66.8 Cg_endo -74.11 144.18 33.36 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.448 2.099 . . . . 0.0 112.416 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.54 123.07 7.33 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.52 2.147 . . . . 0.0 112.315 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.0 mmtp -93.42 17.87 10.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.105 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.41 149.93 51.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.846 0.355 . . . . 0.0 110.795 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.603 ' CE3' HD12 ' A' ' 132' ' ' ILE . 3.7 m95 -78.52 -22.47 47.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.111 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.26 -18.4 36.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.362 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.54 -30.68 52.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.8 0.334 . . . . 0.0 111.113 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.742 HD13 HD22 ' A' ' 147' ' ' LEU . 24.5 mt -63.68 -54.79 39.41 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.673 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 12.2 Cg_endo -55.98 -30.63 78.8 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.205 1.937 . . . . 0.0 112.084 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.2 -29.16 57.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.808 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 135' ' ' LEU . 6.9 mt -72.74 -33.14 66.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.762 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.69 -22.9 38.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.202 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -85.35 -32.31 22.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.026 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -85.09 -48.44 9.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.138 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.854 HD13 ' HA ' ' A' ' 146' ' ' ALA . 1.2 mt -63.33 -17.45 62.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.403 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.42 -29.9 42.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.845 0.355 . . . . 0.0 110.814 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.34 -34.39 78.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.91 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -75.9 -27.09 57.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.97 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 113.11 40.21 1.08 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.48 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.66 -175.97 5.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.787 0.327 . . . . 0.0 110.862 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.9 t -115.34 159.12 21.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.854 ' HA ' HD13 ' A' ' 139' ' ' LEU . . . -84.57 -66.08 0.94 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.128 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.742 HD22 HD13 ' A' ' 132' ' ' ILE . 6.0 tp -154.02 141.62 19.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.939 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.854 ' HB2' HG21 ' A' ' 208' ' ' THR . 0.0 OUTLIER -135.46 -177.86 4.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.594 ' CZ ' HD11 ' A' ' 195' ' ' LEU . 8.2 p90 -177.22 175.0 1.57 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.867 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -69.0 111.17 4.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.851 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.654 HD13 ' HA ' ' A' ' 206' ' ' ALA . 6.6 mt -98.0 27.02 4.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.057 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -119.83 -40.0 2.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.822 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -99.37 146.42 31.73 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.813 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.502 ' HB3' HG12 ' A' ' 343' ' ' VAL . 87.7 Cg_endo -82.08 9.45 3.96 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.722 2.281 . . . . 0.0 113.028 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -75.41 -32.3 60.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.739 0.304 . . . . 0.0 111.13 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -94.98 -16.58 22.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.437 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 30.8 p -92.42 -24.41 18.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.69 0.281 . . . . 0.0 111.28 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.773 ' CE2' ' HB2' ' A' ' 162' ' ' ALA . 27.3 t-105 -53.4 -45.78 98.33 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.526 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.544 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 52.6 Cg_exo -52.67 -25.61 26.85 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.334 2.022 . . . . 0.0 112.28 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.493 HD11 ' CE1' ' A' ' 250' ' ' PHE . 4.8 tp -92.56 -42.96 9.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.933 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 21.0 mt -72.79 -54.66 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.773 ' HB2' ' CE2' ' A' ' 158' ' ' TRP . . . -60.2 -33.21 71.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.176 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -62.07 -33.48 74.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.142 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.28 -20.14 57.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.153 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 141.09 -26.9 2.45 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.561 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.7 158.01 53.35 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.537 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -146.8 171.26 15.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.327 . . . . 0.0 110.85 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -90.96 -67.55 0.85 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.078 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -120.83 121.14 37.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.788 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -63.69 123.99 20.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.931 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -86.36 115.28 23.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.483 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -165.04 148.38 8.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.106 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 64.73 29.22 12.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.162 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.7 -37.25 3.37 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.087 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.73 -173.35 2.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.886 0.374 . . . . 0.0 111.063 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -105.25 173.98 6.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.85 127.85 49.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.1 pt -79.34 -22.55 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.349 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.34 26.02 4.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.132 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -145.06 94.2 2.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.836 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.7 HG12 ' H ' ' A' ' 183' ' ' VAL . 21.6 t -114.27 131.75 65.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.163 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -87.88 -9.04 71.82 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.853 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.7 ' H ' HG12 ' A' ' 181' ' ' VAL . 0.3 OUTLIER -48.47 -41.8 11.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.892 0.377 . . . . 0.0 111.332 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.416 ' N ' ' CG1' ' A' ' 183' ' ' VAL . 25.8 t0 -84.61 57.17 4.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.915 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -118.26 -173.75 2.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.944 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.07 -34.77 57.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.113 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.57 -43.74 84.9 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.569 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.43 -30.62 67.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.833 0.349 . . . . 0.0 111.189 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.86 -38.68 82.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.869 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -86.96 -28.51 22.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.199 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -57.47 -54.62 35.79 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.607 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.871 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.7 OUTLIER -60.63 -53.11 61.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.829 0.347 . . . . 0.0 110.932 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.417 ' OG1' HG21 ' A' ' 357' ' ' VAL . 62.1 m -54.1 -24.93 19.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.121 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -70.86 -59.99 2.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.815 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.594 HD11 ' CZ ' ' A' ' 149' ' ' PHE . 2.6 tp -58.73 -33.07 69.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.669 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 192' ' ' LEU . 49.5 t -63.43 -54.52 31.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.902 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -66.06 -32.69 74.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.735 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.5 HD22 ' HB3' ' A' ' 133' ' ' PRO . 14.5 mt -57.11 -19.27 18.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.224 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 196' ' ' VAL . 4.7 mt -88.99 -60.11 2.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.803 0.335 . . . . 0.0 111.565 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -85.19 -47.27 10.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.008 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -71.0 -10.0 58.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.014 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -114.71 -82.98 0.61 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.808 0.337 . . . . 0.0 111.189 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 171.01 16.27 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.374 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . 0.486 ' O ' HG23 ' A' ' 199' ' ' ILE . 0.2 OUTLIER -82.96 146.12 28.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.784 0.326 . . . . 0.0 110.77 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -102.04 137.42 40.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.031 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.654 ' HA ' HD13 ' A' ' 151' ' ' LEU . . . -79.99 -25.28 40.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.259 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -55.09 -31.1 60.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.132 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.854 HG21 ' HB2' ' A' ' 148' ' ' MET . 3.8 m -49.89 147.23 3.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.174 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.503 ' OD2' HD11 ' A' ' 212' ' ' ILE . 69.8 m-20 -154.15 176.22 12.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.015 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -41.59 -61.66 1.03 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.77 -59.26 3.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.833 0.349 . . . . 0.0 111.921 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.622 HD12 ' HA ' ' A' ' 208' ' ' THR . 0.2 OUTLIER -53.88 -30.67 19.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.342 -179.357 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.562 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -81.89 -25.76 34.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.801 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -82.31 -53.0 6.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.71 -25.75 63.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.323 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 221' ' ' GLU . . . -56.86 -32.27 65.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.239 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.515 ' CG ' HG21 ' A' ' 225' ' ' THR . 58.2 t80 -82.15 -34.0 29.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -75.46 -40.39 57.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -77.64 -31.92 53.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.928 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 103.01 72.13 0.91 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.546 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.412 ' HB2' ' HB1' ' A' ' 216' ' ' ALA . 6.7 mt-10 -128.39 -62.92 1.01 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.835 0.35 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.438 HG21 ' SD ' ' A' ' 148' ' ' MET . 8.9 t -93.5 135.88 34.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.939 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.92 -31.25 70.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.06 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.638 ' SD ' HD22 ' A' ' 122' ' ' LEU . 3.3 mpp? -120.8 151.21 39.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.942 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.515 HG21 ' CG ' ' A' ' 217' ' ' PHE . 9.0 t -157.67 159.58 37.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 24.8 mt -120.46 130.35 74.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.174 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.444 ' HB3' ' HB2' ' A' ' 231' ' ' ALA . 72.7 m-20 -160.95 165.34 30.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -105.99 -153.16 20.6 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.566 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.98 -26.19 24.38 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.629 2.22 . . . . 0.0 112.364 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 41.1 p90 -84.87 57.51 4.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.839 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.444 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . . . -156.45 -44.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.166 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -54.88 -48.01 73.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.021 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.3 m -66.77 -31.7 72.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.01 -32.2 73.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 4.8 mt -94.13 113.66 29.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.031 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -165.46 -49.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 7.0 m -65.87 -39.98 91.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.923 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . 0.646 ' HB3' HG23 ' A' ' 240' ' ' VAL . 1.9 t -69.25 -29.5 67.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.921 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt 61.82 36.55 16.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.918 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.646 HG23 ' HB3' ' A' ' 238' ' ' SER . 26.8 t -79.01 108.29 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.043 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.42 92.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.924 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -97.58 160.05 14.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.23 137.86 9.43 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.445 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.28 124.15 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.784 0.326 . . . . 0.0 111.155 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.451 HG23 HD23 ' A' ' 115' ' ' LEU . 9.1 t -130.52 159.3 37.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.5 t -73.61 151.92 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.001 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.2 mt -74.22 149.82 87.22 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.884 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.441 ' HG2' ' CE2' ' A' ' 129' ' ' TRP . 50.9 Cg_endo -69.14 165.97 28.44 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.554 2.169 . . . . 0.0 112.341 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 4.0 p -92.33 163.64 13.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.963 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.493 ' CE1' HD11 ' A' ' 160' ' ' LEU . 8.3 t80 -128.89 111.12 12.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 8.8 mttt 60.28 28.23 17.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.023 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 93.79 -21.16 42.99 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.731 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -94.3 148.99 36.01 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.704 0.288 . . . . 0.0 110.945 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.2 154.36 66.06 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.594 2.196 . . . . 0.0 112.334 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.16 -174.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.837 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 2.0 mmtt -135.04 63.83 59.02 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.973 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -56.19 -177.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.532 2.154 . . . . 0.0 112.251 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . 0.437 ' H ' HD12 ' A' ' 113' ' ' LEU . 32.2 m-85 -118.83 116.59 26.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.766 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.2 t -85.8 123.4 39.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.288 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -121.92 117.64 3.45 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.271 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.614 HG12 ' O ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -109.48 127.47 66.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.37 . . . . 0.0 111.318 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 29.3 tp -91.11 85.38 5.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.297 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 1.4 m -86.33 175.19 8.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.134 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.449 ' HB1' ' CG2' ' A' ' 59' ' ' ILE . . . -107.06 114.99 29.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.006 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -85.9 128.8 8.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.553 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.435 HD11 HD13 ' A' ' 280' ' ' LEU . 28.0 mt -115.63 135.18 56.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.361 . . . . 0.0 111.08 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -85.49 140.62 30.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.754 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -70.39 -41.57 72.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.081 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -61.85 -28.95 69.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.149 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 3.7 m -58.17 109.48 1.85 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.979 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.57 -18.2 43.06 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.467 2.112 . . . . 0.0 112.499 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -92.88 46.27 1.22 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.03 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 16.3 mtmt -84.05 -31.96 25.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -62.11 -57.44 11.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 50.1 mt -62.51 -31.53 72.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.722 ' HB1' HD11 ' A' ' 59' ' ' ILE . . . -69.85 -46.62 65.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . 0.468 ' HA ' HD12 ' A' ' 280' ' ' LEU . 1.0 OUTLIER -57.68 -29.12 64.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.012 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -73.7 -52.96 11.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.043 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.416 ' CD1' ' HB2' ' A' ' 283' ' ' TYR . 79.1 t80 -59.93 -28.21 67.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.325 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.894 HD21 HD13 ' A' ' 59' ' ' ILE . 5.1 mt -80.31 -30.7 38.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.182 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.44 ' HG2' ' CE1' ' A' ' 85' ' ' PHE . 7.3 tt0 -93.65 -24.46 17.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.449 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -97.51 -50.16 4.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.445 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.563 ' HB3' HG12 ' A' ' 23' ' ' VAL . 4.4 m-85 -117.47 71.41 0.81 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.37 . . . . 0.0 111.296 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.824 ' CD2' HD23 ' A' ' 280' ' ' LEU . 5.6 tp -178.54 -39.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.91 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.674 HD22 ' CZ ' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -115.26 38.35 3.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.869 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.19 -176.38 2.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -80.87 -38.7 27.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -82.68 -36.28 26.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -65.67 -44.19 92.96 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.519 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 9.2 mt -70.14 -31.08 68.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 0.0 110.915 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -70.33 -36.96 74.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.994 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -59.27 -38.22 79.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.131 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.56 -29.45 20.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.111 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -74.06 -30.92 62.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.983 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 33.1 mttt -65.87 -35.41 80.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.959 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -99.0 -30.96 12.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.969 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.411 ' HA ' ' HD2' ' A' ' 298' ' ' PRO . 3.7 mmtt -152.97 95.18 3.02 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.931 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 297' ' ' LYS . 26.2 Cg_endo -62.29 119.52 6.66 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.513 2.142 . . . . 0.0 112.248 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.748 HD12 ' HB2' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -96.72 22.01 8.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.963 179.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . 0.662 ' O ' HD13 ' A' ' 311' ' ' LEU . . . 58.37 -133.96 52.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.664 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -58.71 174.68 0.31 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.816 0.341 . . . . 0.0 111.223 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.746 HG21 ' HB3' ' A' ' 307' ' ' TYR . 14.2 m -143.18 -179.7 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.07 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -93.86 -29.55 15.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.146 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.5 tp -58.89 152.27 19.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.916 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -77.01 -61.19 2.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.019 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 7.2 p -57.17 -49.79 74.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.079 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.746 ' HB3' HG21 ' A' ' 302' ' ' VAL . 0.1 OUTLIER -57.81 -25.04 60.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.027 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.46 -31.78 71.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.736 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -83.83 -42.1 16.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.865 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -52.44 -33.22 43.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.774 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.691 ' O ' HD12 ' A' ' 317' ' ' ILE . 83.7 mt -85.74 -21.37 28.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.919 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -76.47 -2.65 33.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.711 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 22.1 mmtt -47.26 -31.83 4.09 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 121.043 0.449 . . . . 0.0 110.856 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -117.41 140.22 27.08 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.309 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.565 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 14.4 Cg_endo -57.46 -32.4 94.01 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.349 2.033 . . . . 0.0 112.416 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 11.2 mtm-85 -48.58 -42.57 34.14 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.116 0.484 . . . . 0.0 110.243 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.691 HD12 ' O ' ' A' ' 311' ' ' LEU . 34.4 mt -85.56 -30.78 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.791 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.565 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -64.66 -33.92 77.07 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.125 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -74.97 -31.46 61.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.152 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 7.1 m -64.05 -48.48 76.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 10.8 tpt -60.96 -31.62 71.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -61.11 -43.77 98.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -62.35 -41.91 98.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . 0.465 ' HB2' ' HB2' ' A' ' 112' ' ' ALA . . . -60.03 -55.0 39.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.082 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -60.1 -30.03 68.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.931 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -95.84 21.08 8.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.145 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -131.38 -179.6 16.28 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.486 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.1 133.77 52.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.825 0.345 . . . . 0.0 110.906 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.699 HD11 ' HB2' ' A' ' 92' ' ' PHE . 22.9 mt -81.53 133.53 29.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.107 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 10.7 mtm -62.41 137.42 96.15 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.92 -172.38 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.522 2.148 . . . . 0.0 112.326 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -110.05 -26.07 9.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.027 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.701 HD12 ' HB2' ' A' ' 335' ' ' GLN . 33.5 pt -56.25 147.99 44.31 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.319 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.26 -8.91 22.65 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.636 2.224 . . . . 0.0 112.645 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.701 ' HB2' HD12 ' A' ' 333' ' ' ILE . 3.3 mp0 -54.53 -26.18 30.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.741 0.305 . . . . 0.0 111.103 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 0.404 ' O ' ' CD1' ' A' ' 340' ' ' TRP . 0.7 OUTLIER -56.8 -30.91 64.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.934 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.5 m -60.75 -57.31 13.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.971 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.97 -30.35 71.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.133 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.757 ' O ' HG23 ' A' ' 343' ' ' VAL . 39.0 t80 -59.73 -36.76 77.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.977 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.404 ' CD1' ' O ' ' A' ' 336' ' ' MET . 25.8 m95 -66.28 -51.01 61.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.945 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.89 -47.84 84.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.074 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -57.22 -44.63 83.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.301 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.844 ' O ' HG23 ' A' ' 347' ' ' VAL . 23.9 t -77.39 -28.55 16.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.27 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -57.43 13.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.945 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 3.7 m -60.57 -41.37 94.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.586 ' HB1' ' HB1' ' A' ' 360' ' ' ALA . . . -57.29 -34.92 69.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.23 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 343' ' ' VAL . 28.7 t -82.69 -45.91 19.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.188 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 9.4 mt -61.26 -57.59 11.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.162 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -58.77 -43.66 90.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.971 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.39 -29.87 70.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.082 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -78.51 -29.45 46.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.174 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 10.6 m -95.75 20.74 9.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.18 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 56.32 27.02 52.24 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.617 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 6.8 mtt-85 -89.86 -29.69 18.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.79 0.329 . . . . 0.0 110.963 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -143.86 162.27 36.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.899 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 30.6 p -97.96 156.85 16.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.844 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.543 HG22 HD23 ' A' ' 192' ' ' LEU . 25.6 t -56.88 -28.66 28.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.159 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -70.26 -56.5 6.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -61.88 -46.08 90.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.021 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.586 ' HB1' ' HB1' ' A' ' 346' ' ' ALA . . . -60.02 -50.37 73.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.139 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.424 ' CD1' HG12 ' A' ' 357' ' ' VAL . 28.0 mt -62.04 -30.18 70.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.47 -45.44 25.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.961 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -69.13 -45.59 69.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.99 -46.03 89.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -59.8 -43.25 94.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 10.0 m -64.66 -31.53 72.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.92 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 13.6 mtp85 -68.57 -35.71 77.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.943 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.699 HD13 ' CE2' ' A' ' 339' ' ' PHE . 19.3 mt -73.26 -28.86 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.177 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 2.2 p -82.62 -31.47 28.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.899 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.901 179.969 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 55' ' ' ASP . 10.0 t . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.809 0.337 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.2 165.24 12.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -82.59 154.85 24.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.568 ' O ' HG23 ' A' ' 33' ' ' ILE . . . 113.26 -35.9 4.33 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.455 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -113.76 169.86 8.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 0.0 110.871 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' A' ' 275' ' ' LEU . 44.7 mt -124.24 118.78 27.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.9 147.05 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.208 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.826 HG21 HD21 ' A' ' 20' ' ' LEU . 31.8 mt -137.32 107.34 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.927 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -96.81 109.36 22.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.84 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.458 HD11 ' CD ' ' A' ' 15' ' ' LYS . 14.9 tt -123.52 158.14 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.029 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -60.56 166.58 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.19 43.36 2.39 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.498 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -161.18 31.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.458 ' CD ' HD11 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -130.46 177.67 7.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.94 73.49 0.27 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.52 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -86.02 -33.06 21.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 0.0 110.947 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -60.43 -33.17 72.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.739 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -75.96 -28.46 60.61 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.531 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.826 HD21 HG21 ' A' ' 9' ' ' ILE . 3.7 tp -72.66 -30.99 64.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.811 0.338 . . . . 0.0 110.932 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.52 -37.94 83.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.103 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -70.39 -32.23 69.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 19' ' ' GLY . 26.8 t -72.2 -30.72 36.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.104 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.32 -38.6 33.4 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.538 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -59.88 -29.51 68.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.817 0.341 . . . . 0.0 110.94 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -74.78 -41.19 60.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.937 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.484 ' CD2' ' CE1' ' A' ' 283' ' ' TYR . 1.5 t80 -59.75 -52.62 64.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.907 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -58.53 -43.13 89.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.902 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -71.83 -25.39 61.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.83 -32.85 40.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.371 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.53 -44.23 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.473 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.16 -23.27 2.58 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.762 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.568 HG23 ' O ' ' A' ' 5' ' ' GLY . 33.1 mm -59.92 110.16 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.828 0.347 . . . . 0.0 111.037 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.6 mtmt -78.63 156.75 28.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.955 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.4 t -134.82 117.96 24.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.091 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.0 m -99.5 143.86 29.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.4 t -137.84 110.71 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.139 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -110.28 176.21 5.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.86 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -133.11 74.31 73.44 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.86 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.18 -179.13 4.07 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.64 2.227 . . . . 0.0 112.415 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -60.05 -159.43 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.53 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.476 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -46.46 -27.45 1.1 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.604 0.24 . . . . 0.0 111.53 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.567 HD12 ' CD1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 52.44 19.68 1.23 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.852 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.73 -57.12 4.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.829 0.347 . . . . 0.0 110.655 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -95.49 -7.72 37.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.002 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.87 -19.24 57.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.256 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.567 ' CD1' HD12 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -85.58 -55.94 0.39 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.045 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.444 ' HD3' ' CB ' ' A' ' 47' ' ' PHE . 72.6 Cg_exo -50.54 -35.63 46.79 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.589 2.193 . . . . 0.0 112.61 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.581 ' HG3' HG13 ' A' ' 50' ' ' VAL . 11.2 pt20 -59.49 -49.68 76.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.947 0.403 . . . . 0.0 111.004 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.581 HG13 ' HG3' ' A' ' 49' ' ' GLN . 6.6 m -95.29 18.05 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.552 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.09 -38.01 13.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.825 0.345 . . . . 0.0 111.216 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.51 -33.77 68.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.164 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.449 HG23 ' H ' ' A' ' 55' ' ' ASP . 3.3 t -96.43 -29.53 13.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.934 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.53 28.1 72.71 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.431 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.691 ' O ' HG22 ' A' ' 2' ' ' THR . 5.3 t0 -94.5 -28.26 15.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.74 0.305 . . . . 0.0 111.01 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.97 -105.11 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.597 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.444 ' CG ' ' CE2' ' A' ' 47' ' ' PHE . 61.4 Cg_endo -73.18 -169.12 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.49 2.127 . . . . 0.0 112.407 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -150.55 -46.86 0.12 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.813 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.2 mt -127.19 133.37 68.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.058 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.477 ' CG1' ' N ' ' A' ' 61' ' ' PHE . 1.9 tt -139.49 159.69 28.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.111 0.481 . . . . 0.0 110.942 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.6 ' CE2' HD21 ' A' ' 284' ' ' LEU . 65.2 m-85 -138.1 122.35 18.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.873 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -158.26 169.26 24.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.882 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.13 143.87 47.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -60.49 -31.52 70.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -59.74 -36.04 75.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.902 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.3 mmt-85 -94.69 17.18 13.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.231 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -105.71 -31.14 9.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.849 0.357 . . . . 0.0 110.858 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.5 -28.14 64.53 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.555 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.34 -28.83 74.01 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.559 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -91.89 -27.91 17.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.73 0.3 . . . . 0.0 110.982 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.589 ' HB2' HD12 ' A' ' 76' ' ' LEU . . . -79.53 -28.03 41.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.244 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.36 -31.71 69.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.063 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.6 m -88.09 -23.17 23.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.09 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.4 27.98 10.17 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.442 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.9 mt -81.25 -34.25 32.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.77 0.319 . . . . 0.0 110.868 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.589 HD12 ' HB2' ' A' ' 71' ' ' ALA . 25.5 mt -81.86 146.55 29.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.71 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -87.29 135.27 33.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.068 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.696 ' HA ' HG22 ' A' ' 104' ' ' ILE . 17.5 tp10 -69.57 159.72 32.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.09 0.472 . . . . 0.0 110.739 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.59 HG21 ' CE1' ' A' ' 106' ' ' TYR . 35.4 pt -135.29 -178.57 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.176 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 t -163.22 78.0 1.75 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.804 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.08 123.4 11.83 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.643 2.229 . . . . 0.0 112.282 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.5 -177.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.852 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -60.09 -40.56 90.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.913 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.79 -50.5 73.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.094 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -66.28 -35.31 80.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.46 -31.14 63.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.794 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -75.64 -36.51 60.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 57.19 4.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.885 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.514 HD13 ' CZ2' ' A' ' 94' ' ' TRP . 0.1 OUTLIER -173.61 162.02 4.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.774 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.48 ' CD1' ' CZ ' ' A' ' 92' ' ' PHE . 22.0 m-85 -78.51 136.22 60.09 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.077 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 53.3 Cg_exo -55.24 -55.72 2.91 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.526 2.15 . . . . 0.0 112.662 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.908 ' CE1' HG23 ' A' ' 93' ' ' THR . 25.0 p90 -54.87 -44.83 74.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.549 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.908 HG23 ' CE1' ' A' ' 92' ' ' PHE . 40.2 p -61.31 -27.6 68.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.189 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.514 ' CZ2' HD13 ' A' ' 89' ' ' LEU . 8.4 m95 -69.52 -29.29 66.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.941 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.401 ' HA ' ' CG ' ' A' ' 98' ' ' ARG . 1.3 m-20 -93.66 17.32 11.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.362 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -101.89 -29.69 11.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.76 0.314 . . . . 0.0 111.214 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.687 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 12.0 m -90.63 -35.73 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.446 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.401 ' CG ' ' HA ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -65.95 132.37 48.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.012 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.407 ' CE1' ' OD1' ' A' ' 332' ' ' ASN . 0.4 OUTLIER -82.0 -49.59 10.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.865 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -148.6 54.67 1.01 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.929 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.12 -27.27 20.01 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.645 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.51 158.9 20.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.782 0.325 . . . . 0.0 110.965 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 54.9 mt -117.5 131.03 56.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.884 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.696 HG22 ' HA ' ' A' ' 78' ' ' GLU . 2.8 pp -142.65 27.21 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.342 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.89 ' HB1' ' HB2' ' A' ' 263' ' ' SER . . . -158.25 179.33 9.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.869 0.366 . . . . 0.0 111.173 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.59 ' CE1' HG21 ' A' ' 79' ' ' ILE . 39.2 m-85 -140.87 89.49 9.96 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.833 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.462 ' HG3' HG13 ' A' ' 97' ' ' VAL . 52.6 Cg_exo -53.09 99.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.57 2.18 . . . . 0.0 112.269 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.62 ' HA ' HD21 ' A' ' 285' ' ' LEU . 25.2 mm -74.01 -66.23 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.161 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.423 ' O ' HG12 ' A' ' 261' ' ' VAL . . . -120.8 166.36 13.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.066 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 301' ' ' ALA . 10.9 p -123.22 139.07 51.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.092 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -116.74 147.93 41.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -161.85 149.62 14.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.141 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 113' ' ' LEU . 28.9 mt -68.27 126.02 28.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.9 m -124.9 147.29 48.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.503 HD12 HG12 ' A' ' 226' ' ' ILE . 5.2 tp -82.94 136.0 34.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.898 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.535 HG23 ' O ' ' A' ' 243' ' ' GLY . 4.3 mt -116.4 131.38 69.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.049 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -122.24 154.95 36.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.32 144.31 31.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.36 29.77 3.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.959 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.731 ' HB3' HD23 ' A' ' 121' ' ' LEU . 1.8 t70 -97.39 -61.17 1.44 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.895 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.731 HD23 ' HB3' ' A' ' 120' ' ' ASP . 0.2 OUTLIER -110.33 -32.83 6.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.849 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.517 HD21 ' HD3' ' A' ' 126' ' ' PRO . 14.1 tp -93.39 104.16 11.62 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.821 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.83 -47.21 2.0 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.405 2.07 . . . . 0.0 112.275 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -123.38 135.44 26.04 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.822 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.09 139.11 21.21 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.529 2.152 . . . . 0.0 112.32 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.517 ' HD3' HD21 ' A' ' 122' ' ' LEU . 74.5 Cg_endo -75.2 116.77 4.65 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.447 2.098 . . . . 0.0 112.394 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.01 23.41 6.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.03 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.5 p -134.77 141.95 46.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.865 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.804 ' CE3' HD12 ' A' ' 132' ' ' ILE . 2.4 m95 -79.94 -22.56 42.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.103 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.52 -24.72 53.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.181 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -81.18 -26.56 35.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.143 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.804 HD12 ' CE3' ' A' ' 129' ' ' TRP . 31.7 mt -57.28 -54.56 53.49 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.625 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 15.6 Cg_endo -57.47 -27.32 75.75 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.239 1.959 . . . . 0.0 112.089 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.0 -29.31 35.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.5 mt -73.92 -39.68 63.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.859 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.12 -26.35 11.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.058 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -85.58 -27.86 25.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.122 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.98 -48.62 9.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.153 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.808 HD13 ' HA ' ' A' ' 146' ' ' ALA . 0.2 OUTLIER -62.89 -17.32 61.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.411 -179.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -28.11 55.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.845 0.355 . . . . 0.0 110.847 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.88 -41.64 87.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.02 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 46.7 mttt -77.22 -27.01 53.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.02 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 116.07 31.48 1.88 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.488 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.72 -178.31 5.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 0.0 110.868 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.2 t -115.65 171.76 7.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.861 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.808 ' HA ' HD13 ' A' ' 139' ' ' LEU . . . -87.28 -57.59 2.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.155 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.479 ' HB2' ' HE2' ' A' ' 224' ' ' MET . 6.2 tp -161.21 143.83 12.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.987 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.455 ' SD ' HG21 ' A' ' 222' ' ' THR . 0.0 OUTLIER -132.29 -178.99 5.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -179.29 151.73 0.5 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -62.52 121.33 13.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.857 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.4 mt -98.26 28.6 3.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.938 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -112.63 -33.59 6.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.24 107.51 60.54 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.887 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -51.32 -24.13 15.14 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.485 2.123 . . . . 0.0 112.398 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.483 ' CE1' ' CD2' ' A' ' 258' ' ' PHE . 54.0 t80 -52.33 -27.79 16.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.199 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -87.11 -35.1 18.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.9 p -94.86 18.3 12.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.2 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.552 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 27.4 t-105 -73.76 -50.51 5.65 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.531 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 43.2 Cg_endo -68.2 -24.79 37.67 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.116 1.878 . . . . 0.0 112.508 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.673 ' CD2' HD13 ' A' ' 195' ' ' LEU . 52.1 tp -59.23 -37.47 77.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.841 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 4.8 mp -105.06 -33.28 2.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.991 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.52 -29.15 70.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.241 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.403 ' HB2' ' HA ' ' A' ' 255' ' ' SER . . . -56.64 -46.77 80.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.144 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -61.06 -20.07 62.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.124 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 125.63 53.55 0.17 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.489 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -134.53 123.64 3.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.512 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.433 ' CD2' ' HA3' ' A' ' 182' ' ' GLY . 20.7 p90 -117.99 -178.25 3.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.848 0.356 . . . . 0.0 110.871 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -100.07 -44.48 5.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.083 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -131.87 141.95 49.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.7 tptp -68.38 137.24 54.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.976 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.429 ' CE1' ' HA2' ' A' ' 174' ' ' GLY . 19.8 t80 -128.11 110.7 12.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.74 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.407 ' CG ' ' N ' ' A' ' 173' ' ' ASN . 9.7 pt-20 -139.01 -47.24 0.48 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.308 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.407 ' N ' ' CG ' ' A' ' 172' ' ' GLU . 49.4 m-80 -95.72 41.85 1.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.073 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.429 ' HA2' ' CE1' ' A' ' 171' ' ' TYR . . . 57.78 20.55 40.54 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.706 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.406 ' O ' ' CD2' ' A' ' 171' ' ' TYR . 11.3 mttt -133.3 -171.37 2.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.337 . . . . 0.0 110.866 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -126.44 86.81 2.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.59 127.67 33.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.911 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.9 pt -81.46 -12.3 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.472 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -96.01 26.0 4.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.719 0.295 . . . . 0.0 111.149 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -148.4 116.16 6.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.935 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.715 HG12 ' H ' ' A' ' 183' ' ' VAL . 21.3 t -104.53 146.08 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.042 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . 0.433 ' HA3' ' CD2' ' A' ' 167' ' ' TYR . . . -96.97 -12.64 49.08 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.029 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.898 HG12 HD22 ' A' ' 361' ' ' LEU . 6.1 t -62.89 -43.5 98.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.815 0.34 . . . . 0.0 111.18 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -83.85 57.23 4.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.07 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -110.74 -172.78 2.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.12 -44.78 29.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.171 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.16 -34.78 28.84 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.583 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.62 -30.16 68.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.337 . . . . 0.0 111.179 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -60.51 -56.62 19.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.32 -26.53 55.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.225 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -56.14 -40.7 84.29 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.706 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.832 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.4 OUTLIER -76.77 -30.13 56.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.752 0.311 . . . . 0.0 110.94 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 66.2 m -56.35 -23.27 36.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.943 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -65.58 -60.53 2.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.791 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.673 HD13 ' CD2' ' A' ' 160' ' ' LEU . 5.2 tp -60.31 -30.96 69.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.703 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 192' ' ' LEU . 40.0 t -66.07 -48.41 81.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.007 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -82.43 -23.12 34.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.095 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.605 HD23 ' HG3' ' A' ' 202' ' ' LYS . 6.3 mt -64.25 -24.38 67.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.228 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 204' ' ' MET . 13.5 mt -88.96 -42.22 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.646 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 23.4 mtpt -85.02 -29.35 25.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.829 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -91.65 -10.18 41.28 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.605 ' HG3' HD23 ' A' ' 198' ' ' LEU . 13.4 mmtt -133.96 9.71 3.86 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.191 -0.204 . . . . 0.0 111.516 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . 0.424 ' CG ' ' O ' ' A' ' 202' ' ' LYS . 56.2 p-80 43.89 53.15 6.38 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.942 0.401 . . . . 0.0 111.376 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . 0.432 ' O ' HG23 ' A' ' 199' ' ' ILE . 0.0 OUTLIER -82.84 128.42 34.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.844 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -59.94 119.89 8.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.991 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -80.04 -28.06 39.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.077 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -56.47 -24.36 45.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.182 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.653 ' HA ' HD12 ' A' ' 212' ' ' ILE . 7.6 m -36.29 145.91 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.94 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.476 ' OD2' HD11 ' A' ' 212' ' ' ILE . 59.4 m-20 -153.55 176.21 12.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.75 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -34.84 79.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.032 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.99 -59.13 2.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 0.0 111.226 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' A' ' 208' ' ' THR . 0.3 OUTLIER -58.88 -29.59 41.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.848 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -81.75 -21.23 37.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.995 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -75.47 -56.9 4.25 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.837 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.37 -29.53 68.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.136 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.524 ' HB1' ' HB2' ' A' ' 221' ' ' GLU . . . -58.94 -41.91 88.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.141 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.679 ' CG ' HG21 ' A' ' 225' ' ' THR . 19.1 t80 -75.65 -33.16 60.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -74.9 -38.39 61.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.956 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.35 -31.55 33.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.894 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.66 63.8 0.72 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.48 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.524 ' HB2' ' HB1' ' A' ' 216' ' ' ALA . 39.9 mm-40 -111.07 -32.99 6.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.342 . . . . 0.0 110.949 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.455 HG21 ' SD ' ' A' ' 148' ' ' MET . 9.6 t -121.05 162.26 20.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -84.08 -39.86 19.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.102 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.479 ' HE2' ' HB2' ' A' ' 147' ' ' LEU . 1.3 mpp? -126.71 165.81 18.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.897 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.679 HG21 ' CG ' ' A' ' 217' ' ' PHE . 9.8 t -166.65 139.52 3.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.503 HG12 HD12 ' A' ' 115' ' ' LEU . 22.9 mt -101.08 128.27 53.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.466 ' ND2' ' HB3' ' A' ' 231' ' ' ALA . 1.7 p-10 -165.3 144.74 6.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -63.84 -175.05 3.5 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.508 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.52 -20.91 35.34 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.662 2.241 . . . . 0.0 112.457 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . 0.428 ' CD1' ' N ' ' A' ' 231' ' ' ALA . 5.4 p90 -56.3 -30.7 62.86 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.001 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.466 ' HB3' ' ND2' ' A' ' 227' ' ' ASN . . . -72.92 -32.78 65.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.102 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . 0.881 ' HA ' HD12 ' A' ' 235' ' ' ILE . 50.6 m0 -57.29 -27.42 62.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.074 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.3 m -59.59 -55.42 34.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.024 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -62.59 -30.63 71.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.011 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.881 HD12 ' HA ' ' A' ' 232' ' ' TRP . 23.2 mt -70.78 96.69 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.085 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -160.48 -53.2 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.77 -33.92 74.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.917 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . 0.458 ' HB2' HG23 ' A' ' 240' ' ' VAL . 99.1 p -60.19 -32.84 71.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.906 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm 60.69 33.34 20.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.458 HG23 ' HB2' ' A' ' 238' ' ' SER . 21.5 t -91.44 131.18 39.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.12 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.97 93.52 3.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.589 ' CE1' HG21 ' A' ' 235' ' ' ILE . 52.7 p90 -103.43 135.13 45.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.967 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.535 ' O ' HG23 ' A' ' 116' ' ' ILE . . . -101.97 -164.55 26.84 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.5 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.4 t -148.19 133.99 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 111.128 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 63.3 m -143.5 159.3 42.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.86 151.88 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.971 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.447 HD12 ' OD1' ' A' ' 323' ' ' ASN . 9.9 mt -59.64 141.05 88.94 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.874 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.43 ' HB2' ' CD1' ' A' ' 129' ' ' TRP . 50.3 Cg_exo -53.67 146.1 45.78 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.506 2.137 . . . . 0.0 112.242 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 67.6 p -81.19 -177.3 6.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -156.8 109.95 2.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 24.1 mtpt 59.57 31.04 20.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 83.84 27.12 39.1 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.549 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -138.16 142.2 34.69 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.667 0.27 . . . . 0.0 110.915 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.09 163.88 34.29 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.572 2.181 . . . . 0.0 112.342 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.403 ' HA ' ' HB2' ' A' ' 163' ' ' ALA . 8.5 m -74.25 153.05 39.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.845 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.35 72.62 0.93 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.868 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.8 -168.26 0.31 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.597 2.198 . . . . 0.0 112.335 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . 0.496 ' CE2' ' CD1' ' A' ' 158' ' ' TRP . 13.9 m-85 -101.99 165.6 11.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.924 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 328' ' ' GLU . 26.5 t -127.98 126.4 66.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.103 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -126.92 116.9 2.59 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.386 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -112.6 130.56 66.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.824 0.345 . . . . 0.0 111.078 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 7.3 tp -90.58 84.01 5.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.791 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.89 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 0.3 OUTLIER -83.53 166.27 18.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.966 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.581 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . . . -99.51 131.38 45.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.068 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -95.53 103.04 2.92 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.507 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.507 HD11 ' CD1' ' A' ' 280' ' ' LEU . 32.8 mt -100.5 103.05 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.797 0.332 . . . . 0.0 111.098 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -62.07 165.49 5.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.997 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.71 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -84.02 -24.97 30.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.279 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -96.4 30.25 2.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.301 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.44 125.05 90.59 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.83 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.23 -27.71 39.25 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.385 2.057 . . . . 0.0 112.339 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -145.9 85.51 1.69 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.883 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -64.85 -36.32 83.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.855 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.25 -57.69 9.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.459 ' HB3' HD11 ' A' ' 7' ' ' LEU . 10.1 mt -60.01 -31.53 70.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.957 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.92 -60.4 3.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.099 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . 0.515 ' HA ' HD12 ' A' ' 280' ' ' LEU . 0.3 OUTLIER -61.86 -29.16 70.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.964 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -59.47 -60.91 3.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.021 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.458 ' HE1' HD13 ' A' ' 284' ' ' LEU . 52.6 t80 -54.12 -24.27 17.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.403 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.913 HD23 HD22 ' A' ' 284' ' ' LEU . 95.1 mt -76.74 -40.72 47.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.265 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -93.56 -16.38 24.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.601 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.444 ' HB3' ' CD1' ' A' ' 283' ' ' TYR . 2.8 m-80 -91.91 -58.06 2.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.639 0.257 . . . . 0.0 111.362 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.484 ' CE1' ' CD2' ' A' ' 27' ' ' PHE . 7.0 m-85 -126.83 75.86 1.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.37 . . . . 0.0 111.227 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.913 HD22 HD23 ' A' ' 280' ' ' LEU . 5.1 tp -177.99 -57.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.924 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.62 HD21 ' HA ' ' A' ' 108' ' ' ILE . 13.7 mt -94.41 47.29 1.18 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.891 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 18.0 p -128.53 176.98 7.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.891 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.425 ' HA ' ' CD1' ' A' ' 307' ' ' TYR . 9.2 p-10 -81.0 -34.98 32.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.933 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -82.69 -31.21 28.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.929 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.79 -56.64 5.8 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.583 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.444 HD21 HG22 ' A' ' 108' ' ' ILE . 0.9 OUTLIER -59.83 -30.7 69.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.76 0.314 . . . . 0.0 110.97 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -59.76 -41.06 90.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.036 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.72 -54.44 47.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.143 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.3 t -58.4 -28.31 35.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.282 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -71.08 -27.16 63.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.046 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 18.5 mttm -60.28 -34.19 73.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.189 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -110.73 -34.68 6.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.207 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 2.8 tppt? -133.41 83.71 48.73 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.062 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.42 119.32 6.26 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.579 2.186 . . . . 0.0 112.284 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 4.6 mp -95.71 20.95 9.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.07 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 57.09 -106.56 0.74 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.603 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.525 ' HB3' HG13 ' A' ' 110' ' ' VAL . . . -71.59 175.29 5.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 111.12 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 15.4 m -143.14 160.12 17.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.165 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 108' ' ' ILE . . . -79.96 -34.51 38.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.072 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.46 HD23 ' HB2' ' A' ' 307' ' ' TYR . 2.7 tp -71.37 110.65 6.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.891 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -60.59 -31.54 70.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.861 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.4 m -70.21 -33.23 71.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.561 ' CE2' HD11 ' A' ' 311' ' ' LEU . 12.5 t80 -83.78 -27.14 29.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.024 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -58.75 -30.62 67.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.878 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -63.19 -55.32 26.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.809 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.94 -35.25 45.31 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.749 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.678 ' CB ' HG21 ' A' ' 317' ' ' ILE . 15.8 mt -85.73 -23.97 27.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.756 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.46 -14.74 61.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.457 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -46.66 -31.37 2.85 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 120.921 0.391 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -116.64 137.89 24.05 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.302 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.77 -28.48 67.09 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.432 2.088 . . . . 0.0 112.459 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -51.72 -36.31 46.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.001 0.429 . . . . 0.0 110.37 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.678 HG21 ' CB ' ' A' ' 311' ' ' LEU . 35.7 mm -85.43 -35.45 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.85 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -69.83 -29.69 67.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.189 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -70.66 -56.01 7.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.148 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 8.7 m -60.1 -37.23 79.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.954 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.486 ' SD ' ' HB1' ' A' ' 301' ' ' ALA . 7.0 tpt -63.98 -31.34 72.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.951 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -69.45 -53.65 18.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.992 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.447 ' OD1' HD12 ' A' ' 247' ' ' LEU . 0.3 OUTLIER -60.2 -31.34 70.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.887 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.68 -31.33 72.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.14 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -75.43 -55.02 6.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.94 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -68.55 -30.29 69.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -58.43 142.56 45.05 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.529 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . 0.754 ' O ' HG23 ' A' ' 259' ' ' VAL . 26.8 tt0 -74.53 154.12 38.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.869 0.366 . . . . 0.0 110.872 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.532 HD11 ' HB2' ' A' ' 92' ' ' PHE . 23.3 mt -101.69 132.52 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.064 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.428 ' HG3' ' CD1' ' A' ' 258' ' ' PHE . 29.5 mtm -69.58 135.87 88.3 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.49 168.55 24.26 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.501 2.134 . . . . 0.0 112.347 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . 0.407 ' OD1' ' CE1' ' A' ' 99' ' ' TYR . 9.3 p30 -113.03 36.81 3.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.839 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.855 HD12 ' HB2' ' A' ' 335' ' ' GLN . 2.1 pt -105.98 154.29 39.59 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.158 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.26 -28.1 28.08 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.564 2.176 . . . . 0.0 112.308 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.855 ' HB2' HD12 ' A' ' 333' ' ' ILE . 3.0 mp0 -58.86 -26.26 64.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.047 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 0.4 ' O ' ' CD1' ' A' ' 340' ' ' TRP . 0.0 OUTLIER -56.08 -29.9 61.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.04 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.8 m -66.66 -41.65 87.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.936 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.85 -26.09 60.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.233 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.845 ' O ' HG23 ' A' ' 343' ' ' VAL . 87.5 t80 -57.95 -30.43 65.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.07 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.4 ' CD1' ' O ' ' A' ' 336' ' ' MET . 89.0 m95 -67.43 -53.28 30.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.004 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.89 -24.75 59.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.172 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -84.77 -29.13 25.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.397 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.853 ' O ' HG23 ' A' ' 347' ' ' VAL . 25.4 t -91.97 -50.27 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.259 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.404 ' O ' HD12 ' A' ' 348' ' ' ILE . 0.0 OUTLIER -52.66 -28.5 21.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.281 -179.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 19.5 m -85.72 -48.67 8.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.077 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.784 ' HB1' ' HB1' ' A' ' 360' ' ' ALA . . . -58.78 -29.12 66.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.388 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 343' ' ' VAL . 24.8 t -77.13 -52.26 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.293 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 344' ' ' ARG . 40.4 mt -61.38 -50.92 78.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.127 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -58.57 -30.18 66.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.925 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -82.68 -29.42 29.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.207 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -76.44 -27.08 56.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.272 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 3.3 m -95.83 20.77 9.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.224 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 55.75 24.7 41.65 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.703 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.87 -29.72 18.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.832 0.349 . . . . 0.0 110.887 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -138.69 153.26 48.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.817 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.14 165.08 20.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.805 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 358' ' ' ASP . 1.6 p -63.97 -45.4 96.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.154 0.502 . . . . 0.0 110.774 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . 0.468 ' N ' ' CG1' ' A' ' 357' ' ' VAL . 66.4 m-20 -60.02 -53.87 52.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.172 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -57.18 -31.24 65.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.177 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.784 ' HB1' ' HB1' ' A' ' 346' ' ' ALA . . . -61.07 -60.41 3.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.973 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.898 HD22 HG12 ' A' ' 183' ' ' VAL . 0.3 OUTLIER -63.31 -32.93 74.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.606 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.65 -59.05 3.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -59.17 -46.37 88.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.795 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -57.13 -37.16 71.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.076 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.411 ' HA ' HG21 ' A' ' 181' ' ' VAL . 5.4 tt0 -60.59 -45.4 94.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 6.5 m -61.03 -40.61 94.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.956 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 44.4 mtm180 -62.95 -43.52 98.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.937 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 15.8 mt -72.47 -32.19 40.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.047 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.491 HG23 ' O ' ' A' ' 369' ' ' THR . 4.8 t -160.76 91.83 0.92 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.912 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.461 HG21 ' OD2' ' A' ' 58' ' ' ASP . 1.5 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.802 0.334 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -72.73 149.96 43.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.911 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -69.46 137.23 52.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 107.76 29.4 4.4 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.474 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.443 ' HA ' HG22 ' A' ' 33' ' ' ILE . 2.3 ptpt -157.14 -177.94 6.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.817 0.341 . . . . 0.0 110.91 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 mt -150.09 112.49 4.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.8 t -100.58 131.07 48.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.162 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.638 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.3 mp -113.2 107.36 22.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.817 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.445 ' CD2' ' HG2' ' A' ' 57' ' ' PRO . 0.3 OUTLIER -95.22 106.7 18.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.842 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.9 tt -137.12 157.22 35.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.104 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -69.45 -179.59 1.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.51 61.02 0.31 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.558 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.41 31.11 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.815 0.34 . . . . 0.0 110.917 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -150.37 -176.73 5.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.854 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.75 64.79 1.84 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.536 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -78.92 -31.56 45.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.824 0.345 . . . . 0.0 110.921 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -63.1 -32.04 73.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.844 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.85 -30.82 57.14 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.46 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.516 HD21 HG21 ' A' ' 9' ' ' ILE . 14.1 tp -60.98 -30.68 70.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 110.887 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.89 -48.62 80.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.131 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -59.03 -30.66 68.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.966 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 36.5 t -69.04 -34.89 66.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.029 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.3 -35.71 83.1 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.465 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -59.63 -27.82 66.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.81 0.338 . . . . 0.0 111.014 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.42 -41.58 76.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.894 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.84 -51.26 67.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.0 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -64.66 -23.1 67.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.158 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -82.64 -25.45 33.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.309 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -101.22 -32.58 10.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.629 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.8 p -119.0 -44.18 2.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.781 0.325 . . . . 0.0 111.446 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.93 27.23 6.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.526 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.443 HG22 ' HA ' ' A' ' 6' ' ' LYS . 27.9 mm -94.19 130.49 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.761 0.315 . . . . 0.0 111.104 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -59.64 152.16 23.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.942 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.33 104.64 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.115 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.0 m -103.41 147.87 26.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -141.16 110.63 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -115.61 161.11 19.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.928 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -132.51 70.3 79.6 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.865 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.562 ' HG2' HD22 ' A' ' 43' ' ' LEU . 40.9 Cg_endo -68.13 161.14 45.71 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.59 2.193 . . . . 0.0 112.362 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -103.36 141.01 36.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.651 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.09 37.57 24.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.817 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.562 HD22 ' HG2' ' A' ' 40' ' ' PRO . 2.4 pp -79.07 5.57 11.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.747 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.4 -46.69 66.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.795 0.331 . . . . 0.0 111.173 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -90.03 -9.84 47.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.478 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.607 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -89.03 -18.91 26.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.649 0.261 . . . . 0.0 111.338 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.441 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -78.18 -50.86 1.71 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.682 0.277 . . . . 0.0 111.317 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 52.7 Cg_exo -55.31 -20.43 25.31 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.632 2.221 . . . . 0.0 112.944 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.429 ' CG ' ' N ' ' A' ' 50' ' ' VAL . 0.9 OUTLIER -85.71 -47.95 9.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.896 0.379 . . . . 0.0 111.327 -179.61 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 46' ' ' LYS . 11.2 m -79.57 -28.6 13.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.304 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.28 -41.69 89.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.88 -32.21 73.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.148 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.2 p -83.52 -30.83 26.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.937 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.443 ' HA3' ' HB1' ' A' ' 269' ' ' ALA . . . 75.5 25.85 66.97 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.559 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.26 -31.07 10.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.864 0.364 . . . . 0.0 110.892 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.38 -147.72 2.29 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.523 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.445 ' HG2' ' CD2' ' A' ' 10' ' ' TRP . 52.9 Cg_exo -52.57 -175.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.56 2.173 . . . . 0.0 112.314 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.461 ' OD2' HG21 ' A' ' 2' ' ' THR . 63.8 m-20 -135.25 -46.77 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.957 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.67 HG21 HD11 ' A' ' 280' ' ' LEU . 6.7 pt -117.24 130.65 71.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.25 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.758 HD11 ' CE3' ' A' ' 62' ' ' TRP . 2.8 tt -127.4 159.84 37.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.83 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.482 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 6.2 m-85 -119.65 140.52 50.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.139 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.758 ' CE3' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -176.07 153.76 1.34 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.724 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.89 158.44 6.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.09 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -55.99 -36.23 67.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.127 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -65.03 -29.68 70.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.066 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.7 17.25 12.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.365 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.867 ' CD2' ' HB2' ' A' ' 105' ' ' ALA . 2.6 m-85 -110.99 -31.8 7.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.8 0.333 . . . . 0.0 110.909 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.33 -28.3 61.68 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.519 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.06 -25.9 63.24 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.61 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -85.42 -19.32 31.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.627 0.251 . . . . 0.0 111.279 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.53 -39.47 16.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.759 0.314 . . . . 0.0 111.166 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -30.63 71.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.012 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.1 m -73.64 -23.09 59.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.08 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.81 26.79 30.96 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.561 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 mt -94.59 -30.12 14.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.84 0.353 . . . . 0.0 110.976 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 80.5 mt -83.09 160.86 21.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.032 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.482 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -109.17 -172.69 2.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.04 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.408 ' O ' ' CG2' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -88.57 -168.16 2.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.002 0.429 . . . . 0.0 110.958 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.778 HD11 ' CB ' ' A' ' 103' ' ' LEU . 7.6 pt -158.53 179.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.851 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 61.7 p -157.46 78.74 3.59 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.138 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.631 ' HD3' HD12 ' A' ' 79' ' ' ILE . 28.6 Cg_endo -62.22 113.2 1.8 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.575 2.183 . . . . 0.0 112.128 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.54 176.98 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.965 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -50.05 75.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.863 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 88' ' ' LYS . . . -56.66 -22.06 31.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.405 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.706 ' CZ ' HD22 ' A' ' 285' ' ' LEU . 0.3 OUTLIER -83.75 -54.52 4.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.898 0.38 . . . . 0.0 111.006 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.475 ' HG2' ' CZ2' ' A' ' 94' ' ' TRP . 17.3 mt-30 -69.79 -21.18 63.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.539 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -91.62 -9.07 45.39 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.449 ' HG2' HD12 ' A' ' 304' ' ' LEU . 0.0 OUTLIER -117.07 -23.01 8.13 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.497 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 85' ' ' PHE . 0.4 OUTLIER -82.72 135.13 35.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.868 0.366 . . . . 0.0 110.988 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.45 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . 33.1 m-85 -63.25 131.97 94.95 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.073 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.13 -55.57 3.74 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.682 2.255 . . . . 0.0 112.867 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.657 ' HD1' HD11 ' A' ' 329' ' ' ILE . 10.5 p90 -46.35 -28.02 1.21 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.908 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.477 HG22 ' CE1' ' A' ' 92' ' ' PHE . 11.7 p -72.95 -31.28 64.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.83 0.348 . . . . 0.0 110.858 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.736 ' CZ3' HD11 ' A' ' 103' ' ' LEU . 6.6 m95 -63.57 -31.42 72.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.817 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.26 -18.21 64.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.359 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.665 ' HB2' HG21 ' A' ' 329' ' ' ILE . . . -88.77 -18.11 28.44 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.574 HG23 ' CD2' ' A' ' 103' ' ' LEU . 4.8 m -103.82 -36.0 3.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.653 0.263 . . . . 0.0 111.541 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.9 116.92 7.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.885 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -99.85 -33.33 10.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.809 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -155.23 40.68 0.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.767 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.73 -22.37 40.78 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.658 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.7 pttp -104.21 179.77 4.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 111.018 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.778 ' CB ' HD11 ' A' ' 79' ' ' ILE . 17.6 mt -124.96 169.36 12.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.022 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.501 HD12 ' HD2' ' A' ' 67' ' ' PHE . 1.2 pp -156.61 -41.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.393 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.867 ' HB2' ' CD2' ' A' ' 67' ' ' PHE . . . -89.8 162.84 15.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 111.301 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.468 ' OH ' HG22 ' A' ' 79' ' ' ILE . 58.9 m-85 -120.14 79.93 27.0 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.551 ' O ' HD21 ' A' ' 285' ' ' LEU . 50.5 Cg_exo -54.19 137.47 70.51 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.607 2.205 . . . . 0.0 112.352 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.664 HD12 ' O ' ' A' ' 262' ' ' LEU . 3.1 mp -118.51 -60.15 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.126 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.61 ' HB2' HD13 ' A' ' 299' ' ' LEU . . . -125.37 150.42 47.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.141 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.518 HG23 ' HB2' ' A' ' 303' ' ' ALA . 21.4 t -122.02 101.15 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.33 174.69 9.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.974 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -169.97 124.59 0.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.07 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.467 HD23 ' HA2' ' A' ' 228' ' ' GLY . 2.9 mt -64.35 96.59 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.962 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.2 t -100.3 154.17 18.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.3 tt -83.24 128.57 34.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.907 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.681 HD12 ' HB2' ' A' ' 227' ' ' ASN . 4.1 mt -114.53 130.52 68.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.096 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -109.79 165.55 11.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -106.68 154.05 21.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.94 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -98.92 31.07 3.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -94.06 -45.78 7.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.89 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -144.04 38.96 1.32 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 20.1 tp -172.5 89.35 0.41 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.07 -44.79 2.31 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.527 2.151 . . . . 0.0 112.29 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -108.91 120.45 45.96 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.834 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.92 151.1 44.83 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.408 2.072 . . . . 0.0 112.389 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.63 119.03 5.71 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.587 2.192 . . . . 0.0 112.344 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.24 21.69 7.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.036 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.38 141.94 25.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.838 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.678 ' CE3' HD12 ' A' ' 132' ' ' ILE . 45.9 m95 -68.29 -27.99 66.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.001 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -73.47 -15.75 61.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.402 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.772 ' O ' HD12 ' A' ' 135' ' ' LEU . 0.5 OUTLIER -87.12 -3.91 59.1 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.678 HD12 ' CE3' ' A' ' 129' ' ' TRP . 11.3 mt -85.47 -48.13 0.59 Allowed Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.599 ' HG3' HD21 ' A' ' 198' ' ' LEU . 71.5 Cg_exo -48.51 -49.83 13.7 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.383 2.055 . . . . 0.0 112.411 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.45 -42.83 98.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.088 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.772 HD12 ' O ' ' A' ' 131' ' ' GLU . 0.2 OUTLIER -58.19 -48.61 79.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.595 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 1.4 t70 -53.4 -27.8 26.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -85.71 -28.91 24.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -84.96 -52.01 6.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.331 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.53 HD13 ' HA ' ' A' ' 146' ' ' ALA . 2.1 mt -58.88 -19.75 44.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.493 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.19 -29.56 48.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.823 0.344 . . . . 0.0 110.803 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.74 -36.72 77.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.66 -27.04 40.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.878 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.45 31.26 2.03 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.508 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -140.27 173.57 11.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.751 0.31 . . . . 0.0 110.924 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.493 ' O ' HD13 ' A' ' 139' ' ' LEU . 10.1 t -101.21 171.99 7.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.595 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -101.33 -68.4 0.82 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.267 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.674 HD22 HD13 ' A' ' 132' ' ' ILE . 4.0 tp -148.42 143.25 26.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.034 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.78 -177.81 5.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.808 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.572 ' O ' HG22 ' A' ' 208' ' ' THR . 32.1 p90 -178.54 -178.52 0.6 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -84.92 111.9 20.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.972 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.443 HD23 HG21 ' A' ' 157' ' ' THR . 9.9 mt -99.91 41.67 1.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.779 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -104.25 -32.5 9.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.06 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -134.59 143.92 48.64 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.018 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -57.55 -19.47 37.01 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.577 2.185 . . . . 0.0 112.491 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -48.13 -28.24 2.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.428 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -100.57 -29.95 12.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.081 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.443 HG21 HD23 ' A' ' 151' ' ' LEU . 16.2 p -96.83 17.66 16.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.354 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.543 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 11.8 t-105 -73.63 -50.37 5.9 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.538 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.588 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 47.2 Cg_endo -68.79 -15.82 41.05 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.153 1.902 . . . . 0.0 112.535 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 23.0 tp -77.27 -35.2 55.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 0.0 110.809 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.918 HD13 HD12 ' A' ' 192' ' ' LEU . 10.2 mt -105.1 -47.27 9.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.144 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -57.94 -28.68 64.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.312 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -56.51 -28.85 60.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.27 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.46 ' OD2' ' HB3' ' A' ' 190' ' ' ALA . 1.5 t0 -74.58 -20.1 60.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.212 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 139.01 -24.42 2.85 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.694 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.428 ' HA3' ' HB2' ' A' ' 188' ' ' ALA . . . -56.52 144.65 36.94 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.663 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.438 ' CD2' ' HA3' ' A' ' 182' ' ' GLY . 25.7 p90 -140.96 -177.01 4.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.337 . . . . 0.0 110.84 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -101.26 -34.49 9.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.14 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.778 ' CD2' HD11 ' A' ' 333' ' ' ILE . 90.0 m-85 -144.37 153.67 42.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.933 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.5 140.01 39.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.976 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.439 ' CZ ' ' HA2' ' A' ' 174' ' ' GLY . 57.7 t80 -143.99 110.81 5.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.685 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -135.03 -47.54 0.72 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.385 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -103.21 50.24 0.81 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 0.0 111.123 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.439 ' HA2' ' CZ ' ' A' ' 171' ' ' TYR . . . 57.71 19.77 36.91 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.735 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -125.22 170.79 10.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.793 0.33 . . . . 0.0 110.969 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -128.17 95.87 4.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.871 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.03 129.45 42.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.942 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.434 HG22 ' HG3' ' A' ' 335' ' ' GLN . 3.1 pt -82.75 -26.34 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.254 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.8 25.97 4.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.144 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -130.52 108.04 9.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.916 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.841 ' CG1' HG23 ' A' ' 183' ' ' VAL . 21.4 t -97.88 146.06 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.089 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . 0.438 ' HA3' ' CD2' ' A' ' 167' ' ' TYR . . . -117.17 33.2 5.13 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.738 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.841 HG23 ' CG1' ' A' ' 181' ' ' VAL . 3.4 t -92.5 -50.52 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.345 . . . . 0.0 110.92 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -83.98 57.06 3.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.963 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -102.98 -178.92 3.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.766 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -74.06 -32.1 63.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.019 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -85.96 -42.61 6.67 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.571 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 183' ' ' VAL . . . -58.33 -39.88 80.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.817 0.342 . . . . 0.0 111.227 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -59.25 -31.25 68.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.864 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.46 ' HB3' ' OD2' ' A' ' 164' ' ' ASP . . . -87.48 -30.25 20.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.096 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.4 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -64.73 -49.01 66.17 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.544 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.918 HD12 HD13 ' A' ' 161' ' ' ILE . 0.4 OUTLIER -60.43 -43.57 96.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.834 0.35 . . . . 0.0 110.848 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 17.0 m -58.13 -27.43 63.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.928 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.539 ' CE2' HD11 ' A' ' 198' ' ' LEU . 19.4 t80 -60.27 -60.58 3.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.766 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.421 ' O ' HD12 ' A' ' 199' ' ' ILE . 4.8 tp -60.56 -31.65 70.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.541 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.863 HG23 ' O ' ' A' ' 192' ' ' LEU . 45.6 t -65.03 -61.64 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.936 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.61 -28.28 69.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.778 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.599 HD21 ' HG3' ' A' ' 133' ' ' PRO . 3.3 mt -58.57 -55.59 33.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.953 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.421 HD12 ' O ' ' A' ' 195' ' ' LEU . 4.7 mt -55.26 -30.01 24.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.072 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -82.16 -34.09 29.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.937 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -106.49 29.98 6.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -144.92 -36.06 0.31 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.275 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 10.4 m80 76.28 41.64 0.21 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.925 0.393 . . . . 0.0 110.811 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.97 -175.38 5.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.759 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -108.16 126.76 53.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.963 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -79.44 -30.22 42.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.012 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.96 -15.98 62.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.22 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.701 ' HA ' HD12 ' A' ' 212' ' ' ILE . 30.0 m -36.81 148.43 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.974 0.416 . . . . 0.0 111.878 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.4 ' OD2' HD11 ' A' ' 212' ' ' ILE . 63.7 m-20 -154.05 176.19 12.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.808 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -64.79 -28.73 69.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.47 -59.17 2.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.812 0.339 . . . . 0.0 111.12 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 208' ' ' THR . 0.2 OUTLIER -59.18 -27.48 36.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.833 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -80.1 -20.43 45.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.838 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.59 -49.99 13.47 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.885 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.89 -32.44 69.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.104 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.68 -30.19 68.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.077 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -75.24 -47.73 26.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -59.54 -44.9 93.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -61.65 -29.0 69.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.826 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.59 37.67 5.49 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.473 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -94.52 -76.43 0.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 110.923 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 10.5 t -70.07 123.39 21.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.46 -31.71 68.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.047 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.446 ' HE1' ' HB2' ' A' ' 147' ' ' LEU . 1.5 mpp? -119.87 151.16 39.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 6.6 t -166.69 147.56 6.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 24.0 mt -95.66 116.81 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.085 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.681 ' HB2' HD12 ' A' ' 116' ' ' ILE . 9.9 m120 -119.26 165.43 14.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.852 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.467 ' HA2' HD23 ' A' ' 113' ' ' LEU . . . -119.64 -175.14 15.79 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.548 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.1 -20.29 30.22 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.648 2.232 . . . . 0.0 112.533 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 36.5 p90 -94.31 26.02 3.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.284 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.408 ' HB3' ' HB3' ' A' ' 227' ' ' ASN . . . -124.62 -1.66 7.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.685 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -81.02 -21.73 39.95 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.763 0.316 . . . . 0.0 111.226 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.6 m -72.97 -28.86 62.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.113 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . 0.736 ' OD1' HG23 ' A' ' 235' ' ' ILE . 23.9 p30 -78.98 -32.88 45.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.075 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.736 HG23 ' OD1' ' A' ' 234' ' ' ASN . 2.1 pt -88.91 87.32 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.125 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -171.23 -46.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.862 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 63.3 p -93.54 -30.97 14.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.91 -26.3 64.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.023 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 62.68 67.21 0.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.87 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.97 128.6 56.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.013 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -62.01 104.88 0.51 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -106.49 148.73 27.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -137.85 113.71 1.01 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.499 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 26.9 t -78.68 120.49 29.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.791 0.329 . . . . 0.0 111.119 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 5.6 t -131.18 159.29 38.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.65 151.91 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.019 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 11.4 mt -72.21 152.75 92.46 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.881 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.44 164.34 31.2 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.508 2.139 . . . . 0.0 112.274 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.538 HG22 ' HA ' ' A' ' 254' ' ' PRO . 18.8 p -106.52 152.07 24.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.963 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -102.55 111.74 24.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt 60.42 28.1 17.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.971 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 93.83 -21.04 43.73 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.671 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -83.67 149.12 56.47 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.689 0.281 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.538 ' HA ' HG22 ' A' ' 249' ' ' THR . 56.5 Cg_endo -70.6 154.92 64.11 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.544 2.162 . . . . 0.0 112.304 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 91.1 p -65.29 166.33 10.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.417 ' N ' ' CD ' ' A' ' 257' ' ' PRO . 0.1 OUTLIER -133.59 52.8 8.95 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.951 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 256' ' ' LYS . 73.2 Cg_endo -76.28 -172.98 1.52 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.583 2.189 . . . . 0.0 112.385 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . 0.435 ' CD1' ' HG2' ' A' ' 330' ' ' MET . 13.5 m-85 -92.22 158.44 16.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.81 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 20.4 t -144.01 119.28 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.227 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -99.16 155.53 19.95 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.297 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.532 ' O ' HG13 ' A' ' 261' ' ' VAL . 14.9 p -144.0 116.74 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.815 0.34 . . . . 0.0 111.286 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.664 ' O ' HD12 ' A' ' 108' ' ' ILE . 52.0 tp -68.42 127.03 31.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.794 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.706 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 79.6 p -140.93 154.56 46.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.056 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -102.07 138.65 38.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.958 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -109.59 130.2 9.83 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.598 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 23.4 mt -109.58 119.01 58.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.754 0.312 . . . . 0.0 111.02 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -76.91 150.45 35.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.965 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.482 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -60.28 -31.65 70.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.027 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.443 ' HB1' ' HA3' ' A' ' 54' ' ' GLY . . . -92.55 48.02 1.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.083 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.0 t -108.89 97.39 24.19 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.869 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.57 -30.2 21.0 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.537 2.158 . . . . 0.0 112.38 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -101.19 56.87 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.82 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 9.2 tptp -70.55 -55.08 9.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -62.25 -34.36 76.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.939 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 275' ' ' LEU . 20.6 mt -73.66 -31.75 63.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.02 -48.42 81.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.102 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -60.54 -56.33 22.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.814 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 18.6 tt0 -57.19 -22.12 38.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.136 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -86.63 -60.65 1.93 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.165 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.67 HD11 HG21 ' A' ' 59' ' ' ILE . 2.3 mt -81.46 -56.39 4.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.433 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.28 -18.2 47.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.917 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 6.5 m-20 -120.11 -58.2 1.88 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.668 0.271 . . . . 0.0 111.609 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -86.97 57.54 4.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.954 0.406 . . . . 0.0 111.143 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 7.1 tp -172.51 -41.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.964 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.706 HD22 ' CZ ' ' A' ' 85' ' ' PHE . 1.9 mp -97.62 38.21 1.3 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.926 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.8 p -117.83 165.42 13.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.853 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -62.38 -30.4 71.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.934 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -82.46 -49.62 9.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -59.34 -49.56 77.16 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.572 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.435 HD21 HG22 ' A' ' 108' ' ' ILE . 2.8 mt -60.1 -30.89 69.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.815 0.34 . . . . 0.0 110.916 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -64.09 -41.89 97.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.951 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.08 -58.15 9.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.147 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.39 -29.45 42.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.204 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -70.51 -31.88 69.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.899 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -65.66 -34.63 78.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.954 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.61 -31.39 12.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.951 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.9 95.56 1.98 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.935 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.53 108.98 1.95 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.455 2.104 . . . . 0.0 112.291 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.61 HD13 ' HB2' ' A' ' 109' ' ' ALA . 5.0 mt -58.96 -28.26 66.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.003 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 99.64 -109.37 3.73 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.56 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.575 ' HB2' ' HB ' ' A' ' 320' ' ' THR . . . -75.23 93.73 2.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.82 0.343 . . . . 0.0 111.072 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.2 134.0 30.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.518 ' HB2' HG23 ' A' ' 110' ' ' VAL . . . -65.6 -27.4 68.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.023 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.488 HD23 ' HB2' ' A' ' 307' ' ' TYR . 24.6 tp -59.25 111.16 1.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.432 ' CG ' ' CE2' ' A' ' 90' ' ' TYR . 3.9 mttm -64.98 -45.07 87.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.974 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 17.2 m -54.74 -27.12 38.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.102 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.62 ' CE2' HD11 ' A' ' 311' ' ' LEU . 4.9 t80 -99.95 -25.31 14.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.12 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 0.2 OUTLIER -58.11 -34.4 70.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.86 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.41 -62.8 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.863 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -52.18 -31.8 33.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.789 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.801 ' HB3' HG21 ' A' ' 317' ' ' ILE . 12.3 mt -85.7 -25.05 26.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.793 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' A' ' 308' ' ' GLU . . . -67.25 -13.47 62.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.526 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 4.3 mtmm -46.51 -32.91 3.65 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.906 0.384 . . . . 0.0 110.925 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.64 140.16 24.95 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.354 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.435 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 12.0 Cg_endo -56.02 -25.59 54.71 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.393 2.062 . . . . 0.0 112.352 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -50.87 -40.21 55.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.038 0.447 . . . . 0.0 110.316 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.801 HG21 ' HB3' ' A' ' 311' ' ' LEU . 32.1 mm -85.5 -33.79 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.014 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -69.29 -29.72 67.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.241 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -72.08 -48.97 40.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.205 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.575 ' HB ' ' HB2' ' A' ' 301' ' ' ALA . 1.7 m -59.98 -38.62 83.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 5.3 tpt -72.58 -43.09 63.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.948 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -60.77 -31.87 71.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -69.5 -31.84 70.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.932 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -73.16 -50.18 24.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.143 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -61.39 -51.47 68.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 29.5 mtpt -59.97 -30.72 69.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.993 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -97.19 164.34 22.38 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.493 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -97.56 150.59 20.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.775 0.321 . . . . 0.0 110.897 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.665 HG21 ' HB2' ' A' ' 96' ' ' ALA . 32.1 mt -84.37 142.77 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.435 ' HG2' ' CD1' ' A' ' 258' ' ' PHE . 32.4 mtm -58.85 131.81 86.47 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.894 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.65 -174.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.367 2.045 . . . . 0.0 112.305 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -132.65 30.76 4.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.878 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.778 HD11 ' CD2' ' A' ' 169' ' ' PHE . 27.2 pt -106.11 147.31 34.6 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.35 -25.56 21.56 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.56 2.174 . . . . 0.0 112.437 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.434 ' HG3' HG22 ' A' ' 178' ' ' ILE . 75.1 mm-40 -55.15 -29.5 57.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.071 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 13.9 ttt -58.75 -24.49 61.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.055 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . 0.402 ' O ' ' CE2' ' A' ' 341' ' ' TYR . 8.0 m -56.66 -38.93 72.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.047 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -86.16 -33.3 20.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.1 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.721 ' CZ ' HG21 ' A' ' 343' ' ' VAL . 48.6 t80 -59.76 -26.29 65.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.115 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 20.8 m95 -56.36 -52.45 64.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.17 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 0.402 ' CE2' ' O ' ' A' ' 337' ' ' SER . 0.2 OUTLIER -84.89 -31.79 23.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.666 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 339' ' ' PHE . . . -50.49 -40.16 50.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.478 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.721 HG21 ' CZ ' ' A' ' 339' ' ' PHE . 17.5 t -95.93 -26.19 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.259 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -52.37 -56.35 15.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.162 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 12.4 m -64.3 -29.63 70.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.011 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -67.14 -55.32 14.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.248 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 343' ' ' VAL . 21.9 t -57.24 -43.2 81.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.278 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 22.7 mt -67.04 -53.74 31.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.089 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -59.95 -30.69 69.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -82.91 -38.38 22.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.131 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -67.84 -30.57 69.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.094 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 17.4 t -71.18 -22.38 62.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.111 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 96.24 -21.6 44.43 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.66 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -57.76 -31.34 66.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.856 0.36 . . . . 0.0 110.928 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -122.46 151.57 41.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 30.2 p -85.44 169.36 13.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.772 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.465 HG13 HD22 ' A' ' 192' ' ' LEU . 29.2 t -72.55 -51.68 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.969 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -47.1 -32.53 4.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.353 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.22 -44.69 14.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.996 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -56.45 -60.46 3.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.061 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.659 HD22 HG12 ' A' ' 183' ' ' VAL . 7.9 mt -56.98 -26.13 59.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.813 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.6 -35.92 33.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.85 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -57.85 -49.4 76.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.948 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -59.3 -39.11 81.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.082 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.832 ' HA ' HG21 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -59.08 -41.9 89.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.96 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 28.3 m -63.38 -49.59 73.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -43.44 94.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.998 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 13.9 mt -73.81 -40.4 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.082 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 365' ' ' GLN . 13.1 p -98.26 30.72 3.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.952 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.88 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.808 0.337 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -136.12 32.32 2.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -151.09 166.33 31.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.8 -16.49 76.29 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.718 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.418 ' HA ' HG22 ' A' ' 33' ' ' ILE . 1.2 pptp? -69.87 153.45 43.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.807 0.337 . . . . 0.0 110.935 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 mt -102.28 138.8 38.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.953 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 t -106.94 147.03 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.168 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.776 HD12 HG22 ' A' ' 37' ' ' VAL . 25.8 mt -125.43 107.51 18.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.967 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.413 ' CG ' ' HB3' ' A' ' 57' ' ' PRO . 0.9 OUTLIER -92.27 109.67 21.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.83 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.3 tt -153.89 148.02 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.05 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -60.4 170.29 1.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.927 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.16 29.56 9.9 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.566 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -90.88 -52.97 4.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.361 . . . . 0.0 110.943 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -79.9 -175.61 5.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -59.06 87.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.516 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 36.9 p90 -83.57 -44.24 14.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.343 . . . . 0.0 110.867 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.428 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 12.9 t30 -70.62 -31.72 68.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.1 -32.77 51.73 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.525 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.607 HD12 HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -60.18 -41.86 93.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.861 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.81 -30.22 68.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.089 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -59.5 -33.99 72.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.985 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.459 HG22 ' HB3' ' A' ' 292' ' ' ALA . 30.1 t -62.22 -31.26 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.11 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.57 -29.56 72.91 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.517 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 mmtt -59.85 -33.35 71.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.331 . . . . 0.0 110.944 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -42.04 72.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.854 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.642 ' CE1' HG21 ' A' ' 31' ' ' THR . 12.7 t80 -59.37 -59.22 5.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.939 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -57.8 -21.92 44.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.35 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -69.5 -26.31 64.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.512 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -117.74 -39.01 3.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.78 0.324 . . . . 0.0 111.49 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.642 HG21 ' CE1' ' A' ' 27' ' ' PHE . 15.1 p -90.68 -32.99 15.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.183 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.67 -22.39 35.98 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.663 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.446 HD13 HD13 ' A' ' 275' ' ' LEU . 38.8 mt -66.17 139.34 21.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.821 0.343 . . . . 0.0 111.046 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.0 170.01 17.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.982 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.6 t -146.99 111.06 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.042 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.1 m -101.85 150.63 22.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.948 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.776 HG22 HD12 ' A' ' 9' ' ' ILE . 21.9 t -130.14 110.19 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.117 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.408 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 60.2 mm-40 -96.52 165.7 12.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.562 ' CE1' HG12 ' A' ' 37' ' ' VAL . 50.9 m-70 -149.6 72.31 9.79 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.843 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.62 -179.75 3.54 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.601 2.201 . . . . 0.0 112.347 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -118.58 143.77 46.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.74 28.95 18.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.604 ' H ' HD23 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -59.27 -26.92 65.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.099 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.447 ' CG ' ' CH2' ' A' ' 62' ' ' TRP . 26.1 mt-10 -56.99 -30.59 64.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.013 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -95.89 -19.02 19.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.203 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.904 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.4 mtmp? -88.68 -29.6 19.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.803 0.335 . . . . 0.0 111.16 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.453 ' CZ ' HG21 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -52.83 -50.63 80.27 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.344 -179.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 38.4 Cg_exo -61.1 -23.64 77.73 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.573 2.182 . . . . 0.0 112.741 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.28 -40.38 11.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.835 0.35 . . . . 0.0 111.278 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.904 HG22 ' O ' ' A' ' 46' ' ' LYS . 9.9 m -80.45 -28.02 11.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.133 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.31 -22.53 59.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.303 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.3 -28.35 41.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.406 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.586 HG23 ' HB2' ' A' ' 55' ' ' ASP . 7.2 t -135.29 24.01 3.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.175 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 53.31 24.54 22.99 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.729 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.586 ' HB2' HG23 ' A' ' 53' ' ' THR . 9.4 t0 -74.67 -30.14 61.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.885 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.67 -150.47 0.64 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.543 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.413 ' HB3' ' CG ' ' A' ' 10' ' ' TRP . 59.2 Cg_endo -71.97 177.69 6.78 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.597 2.198 . . . . 0.0 112.36 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.58 -31.57 7.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.804 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.684 HG21 HD21 ' A' ' 280' ' ' LEU . 30.3 mt -128.32 139.83 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.048 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.715 HD11 ' HE3' ' A' ' 62' ' ' TRP . 2.5 tt -140.34 160.14 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.062 0.458 . . . . 0.0 110.962 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.482 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 9.0 m-85 -132.58 136.02 46.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.078 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.715 ' HE3' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -176.08 152.01 1.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.756 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.61 157.76 3.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.231 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.723 ' HD2' HG12 ' A' ' 261' ' ' VAL . 12.5 p80 -54.89 -29.65 56.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.085 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -58.86 -34.33 71.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.099 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.81 17.14 12.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.345 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.457 ' HB3' HD11 ' A' ' 104' ' ' ILE . 2.0 m-85 -113.29 -24.23 9.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.655 0.264 . . . . 0.0 111.28 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -83.05 55.49 5.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.466 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -153.15 -42.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.574 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -82.86 -14.4 54.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.628 0.251 . . . . 0.0 111.258 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.47 -35.35 24.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.78 0.324 . . . . 0.0 111.205 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -62.28 -30.02 70.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.9 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.4 t -83.61 -23.12 32.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.057 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.5 28.26 13.21 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.479 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.0 mt -88.81 -34.3 17.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.801 0.334 . . . . 0.0 110.955 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 27.6 mt -79.11 167.01 21.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.417 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -106.7 126.23 52.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.083 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.457 ' CG ' ' N ' ' A' ' 79' ' ' ILE . 19.2 tt0 -65.42 164.05 14.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.795 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.542 HG21 ' CE1' ' A' ' 106' ' ' TYR . 40.6 pt -139.8 -179.65 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.208 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.447 HG23 ' O ' ' A' ' 79' ' ' ILE . 0.9 OUTLIER -158.89 77.86 3.11 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.45 ' HD2' HD12 ' A' ' 103' ' ' LEU . 37.2 Cg_endo -65.61 119.17 6.15 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.593 2.196 . . . . 0.0 112.27 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.35 177.92 0.33 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.824 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 11.2 mtmm -60.21 -45.45 93.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.52 -31.56 69.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.001 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -72.26 -52.21 17.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.871 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -64.37 -25.88 68.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.951 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.8 -28.36 67.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.157 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.522 ' O ' HD12 ' A' ' 304' ' ' LEU . 0.0 OUTLIER -97.86 34.26 1.93 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.118 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.517 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 94.2 mt -153.37 174.22 14.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.91 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.438 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . 44.7 m-85 -99.83 142.25 24.27 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.989 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -56.17 -55.88 2.53 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.617 2.211 . . . . 0.0 112.932 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.544 ' CE1' HG22 ' A' ' 93' ' ' THR . 38.2 p90 -52.98 -37.86 61.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.892 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.544 HG22 ' CE1' ' A' ' 92' ' ' PHE . 30.0 p -64.25 -27.88 69.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.722 0.296 . . . . 0.0 111.115 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.517 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 11.2 m95 -73.26 -24.52 60.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.218 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.42 11.31 19.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.466 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -101.83 -31.39 10.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.812 0.339 . . . . 0.0 111.257 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.669 ' CG1' ' HB3' ' A' ' 105' ' ' ALA . 9.0 m -87.92 -35.5 8.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.312 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.93 117.98 9.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.926 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -97.93 -67.24 0.86 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -99.62 30.74 3.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.922 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.02 -24.63 27.75 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.564 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.4 133.04 42.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 0.0 110.944 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.45 HD12 ' HD2' ' A' ' 81' ' ' PRO . 88.8 mt -66.35 150.0 49.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.868 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.664 ' O ' HD12 ' A' ' 104' ' ' ILE . 2.5 pp -155.02 36.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.145 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.702 ' HB1' ' HB2' ' A' ' 263' ' ' SER . . . -172.73 157.43 3.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.131 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.542 ' CE1' HG21 ' A' ' 79' ' ' ILE . 72.8 m-85 -118.01 80.85 15.3 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.455 ' HB3' HG21 ' A' ' 261' ' ' VAL . 48.4 Cg_exo -55.98 138.79 83.46 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.564 2.176 . . . . 0.0 112.233 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.703 HD13 ' O ' ' A' ' 284' ' ' LEU . 24.7 mt -134.46 -51.73 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.121 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.685 ' CB ' HD22 ' A' ' 299' ' ' LEU . . . -108.67 171.56 7.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.123 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.5 t -141.5 129.05 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.126 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.448 ' O ' HG13 ' A' ' 259' ' ' VAL . 0.1 OUTLIER -115.97 144.59 43.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -162.79 151.78 14.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.576 HD22 HG22 ' A' ' 226' ' ' ILE . 13.8 mt -61.22 124.56 20.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.1 m -115.66 165.28 13.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.0 tp -105.47 101.26 10.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.858 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 32.8 mt -91.45 119.77 39.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.109 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.525 ' CD1' HG22 ' A' ' 245' ' ' THR . 43.0 p90 -118.79 148.1 43.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.931 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -73.68 165.23 25.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.881 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.32 -31.13 6.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.02 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -74.8 -39.4 61.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.023 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.7 mt -109.53 28.61 8.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.076 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.8 tp -176.96 89.44 0.25 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.97 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -69.03 -30.51 25.56 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.516 2.144 . . . . 0.0 112.248 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -133.99 120.98 15.49 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.22 153.84 41.05 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.47 2.113 . . . . 0.0 112.379 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.05 122.11 8.15 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.587 2.191 . . . . 0.0 112.289 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 128' ' ' THR . 2.1 mmmp? -93.75 18.13 10.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 127' ' ' LYS . 5.4 p -156.99 141.96 17.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.8 0.334 . . . . 0.0 110.81 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.684 ' CE3' HD12 ' A' ' 132' ' ' ILE . 27.9 m95 -61.77 -31.78 72.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -68.89 -15.88 63.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.336 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.98 0.52 57.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.551 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.684 HD12 ' CE3' ' A' ' 129' ' ' TRP . 16.6 mt -85.37 -46.24 0.63 Allowed Pre-proline 0 C--N 1.332 -0.184 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 72.0 Cg_exo -48.74 -57.49 2.33 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.369 2.046 . . . . 0.0 112.447 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.28 -36.97 83.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.995 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.2 mt -58.39 -52.29 66.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.997 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.437 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 4.9 t0 -46.08 -31.75 2.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.436 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -85.61 -27.02 25.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.232 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -57.93 -64.18 1.0 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.289 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.646 ' H ' HD13 ' A' ' 139' ' ' LEU . 0.0 OUTLIER -68.49 -16.32 63.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.567 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.407 ' H ' HD22 ' A' ' 139' ' ' LEU . 2.6 ttmt -63.4 -21.57 66.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.884 0.373 . . . . 0.0 110.461 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.51 -41.74 81.39 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.672 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.404 ' HD2' ' HA ' ' A' ' 139' ' ' LEU . 0.0 OUTLIER -81.85 -26.28 34.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.784 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 119.52 21.48 3.63 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.615 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -116.0 -174.98 2.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.775 0.322 . . . . 0.0 110.943 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.2 p -130.17 158.38 39.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.913 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.483 ' HB2' HD11 ' A' ' 139' ' ' LEU . . . -76.76 -62.72 1.54 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.179 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.831 HD11 HG13 ' A' ' 226' ' ' ILE . 4.0 tp -148.66 143.44 26.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.015 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.48 ' SD ' HG21 ' A' ' 222' ' ' THR . 0.0 OUTLIER -129.26 -177.83 4.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.778 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.9 p90 179.63 145.99 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.9 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -62.9 126.97 29.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.952 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.7 mt -98.48 31.62 2.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.848 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -101.51 -31.33 10.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -119.71 146.5 41.76 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.905 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.1 -3.41 13.71 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.553 2.168 . . . . 0.0 112.677 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.5 ' CZ ' ' CH2' ' A' ' 340' ' ' TRP . 0.4 OUTLIER -57.8 -32.12 67.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.826 0.346 . . . . 0.0 110.954 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -94.69 4.04 54.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.544 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.532 HG21 HG11 ' A' ' 347' ' ' VAL . 55.8 p -106.77 -28.12 10.35 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.796 0.332 . . . . 0.0 111.049 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.483 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 11.7 t-105 -55.94 -46.66 99.73 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.308 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.76 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 77.2 Cg_exo -50.35 -25.51 13.95 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.377 2.051 . . . . 0.0 112.479 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.701 HD21 ' HB3' ' A' ' 194' ' ' PHE . 3.6 tp -94.06 -38.84 10.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.018 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.646 HG12 HD12 ' A' ' 192' ' ' LEU . 21.4 mt -76.04 -55.45 11.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.179 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.09 -25.97 68.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.243 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.76 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -57.17 -56.09 26.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.239 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -96.05 -20.1 18.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.231 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -77.06 -104.65 0.15 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.525 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -150.49 -86.98 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.531 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -172.83 -179.6 2.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.837 0.351 . . . . 0.0 110.897 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.02 -48.8 6.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.066 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -141.86 140.61 32.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.965 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -77.5 136.83 38.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.848 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.487 ' CE2' ' CE2' ' A' ' 176' ' ' TYR . 0.3 OUTLIER -101.69 110.64 22.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.779 179.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -133.96 145.02 49.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.126 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 48.69 32.09 3.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.249 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 68.0 26.61 73.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.424 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.23 -171.32 2.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.359 . . . . 0.0 110.839 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.487 ' CE2' ' CE2' ' A' ' 171' ' ' TYR . 1.1 m-85 -130.54 131.7 45.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.848 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.73 139.4 32.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.633 HG21 ' OE1' ' A' ' 335' ' ' GLN . 19.9 pt -95.03 -18.4 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.334 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.91 26.01 4.37 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.113 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -140.52 78.58 1.66 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.882 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.669 HG12 ' H ' ' A' ' 183' ' ' VAL . 21.7 t -94.24 137.71 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.162 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.29 0.3 40.6 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.857 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.669 ' H ' HG12 ' A' ' 181' ' ' VAL . 0.3 OUTLIER -54.05 -42.67 55.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.921 0.391 . . . . 0.0 111.31 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.418 ' N ' ' CG1' ' A' ' 183' ' ' VAL . 22.9 t0 -96.09 61.51 2.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.971 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -91.57 165.47 13.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.84 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -59.87 -38.71 82.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.14 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -85.92 -25.11 38.93 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.565 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.15 -30.56 66.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 0.0 111.163 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -61.03 -38.2 85.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -87.56 -30.06 20.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -59.31 -51.05 61.44 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.555 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.852 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.3 OUTLIER -60.24 -41.01 92.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.805 0.336 . . . . 0.0 110.904 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.8 m -54.07 -25.5 22.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.161 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.701 ' HB3' HD21 ' A' ' 160' ' ' LEU . 1.3 t80 -65.28 -60.57 2.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.784 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.762 ' HA ' HD12 ' A' ' 198' ' ' LEU . 3.9 tp -63.86 -33.47 75.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.68 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.852 HG23 ' O ' ' A' ' 192' ' ' LEU . 46.2 t -65.9 -44.68 92.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.941 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.5 -28.11 60.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.938 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.762 HD12 ' HA ' ' A' ' 195' ' ' LEU . 16.6 mt -57.82 -53.72 55.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.005 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 14.9 mt -68.81 -29.86 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.003 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.685 ' HD2' HG12 ' A' ' 196' ' ' VAL . 24.1 mtpt -75.8 -29.86 58.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.968 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -95.32 22.76 6.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.177 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.49 75.27 0.33 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.931 0.396 . . . . 0.0 111.156 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.4 -41.97 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.74 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . 0.7 ' CE ' HD13 ' A' ' 198' ' ' LEU . 0.1 OUTLIER -103.01 145.56 29.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.846 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -90.03 113.96 25.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.867 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.19 -26.72 66.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.154 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -92.98 46.49 1.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.931 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 51.9 m -113.36 138.75 49.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.784 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.519 ' HB2' HD11 ' A' ' 212' ' ' ILE . 1.8 m-20 -151.35 176.3 11.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.945 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -42.67 -62.98 0.86 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.38 -59.25 4.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.004 0.43 . . . . 0.0 111.591 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 209' ' ' ASP . 0.0 OUTLIER -52.96 -31.9 17.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.183 -179.53 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -81.98 -28.3 32.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.763 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -82.36 -56.15 4.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.026 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.08 -31.26 61.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.334 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.46 -36.0 73.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.122 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.72 ' CG ' HG21 ' A' ' 225' ' ' THR . 29.0 t80 -82.24 -31.75 30.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.994 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -63.97 -46.94 82.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.99 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.09 -36.76 58.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.95 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 110.33 56.92 0.51 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.506 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -108.66 -29.71 8.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.801 0.334 . . . . 0.0 110.949 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.48 HG21 ' SD ' ' A' ' 148' ' ' MET . 9.8 t -117.38 140.1 50.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.937 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.06 -31.14 68.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.095 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 9.8 mtp -134.43 163.29 30.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.72 HG21 ' CG ' ' A' ' 217' ' ' PHE . 4.7 t -166.62 132.49 2.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.831 HG13 HD11 ' A' ' 147' ' ' LEU . 25.6 mt -96.62 116.81 39.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.087 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -156.29 165.3 36.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.428 ' HA3' ' CZ3' ' A' ' 230' ' ' TRP . . . -82.53 170.77 50.77 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.478 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.81 -25.59 27.64 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.661 2.241 . . . . 0.0 112.325 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . 0.428 ' CZ3' ' HA3' ' A' ' 228' ' ' GLY . 28.5 p90 -59.29 -30.97 68.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.965 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -59.46 -29.95 68.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.152 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 27.9 m0 -59.61 -28.91 67.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.049 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.9 m -57.81 -31.07 66.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.003 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -72.16 -59.61 2.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 4.5 mt -78.49 116.66 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.082 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -168.66 -47.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.934 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 22.2 p -76.48 -38.71 54.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 11.8 t -66.16 -29.41 69.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.957 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 62.16 81.72 0.19 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.35 143.8 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.104 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -85.25 87.47 7.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.932 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -104.64 167.61 9.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.06 174.28 21.99 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.523 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 20.9 t -140.01 127.52 24.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.793 0.33 . . . . 0.0 111.076 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.525 HG22 ' CD1' ' A' ' 117' ' ' TYR . 8.7 t -143.53 151.34 40.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.967 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.417 ' CG2' ' N ' ' A' ' 247' ' ' LEU . 0.7 OUTLIER -54.51 152.3 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.292 0.568 . . . . 0.0 111.295 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.417 ' N ' ' CG2' ' A' ' 246' ' ' VAL . 9.2 mt -71.45 146.6 91.87 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.977 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.419 ' HG2' ' CD1' ' A' ' 129' ' ' TRP . 50.8 Cg_endo -69.18 177.17 5.44 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.541 2.16 . . . . 0.0 112.265 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 44.6 p -121.12 175.47 6.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -142.85 121.94 12.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 20.7 mttm 60.1 31.67 20.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 74.35 27.03 66.62 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.52 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -136.48 128.99 17.43 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.554 0.216 . . . . 0.0 110.821 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.07 163.09 35.86 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.505 2.137 . . . . 0.0 112.354 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.82 -172.95 3.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.786 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -134.72 63.87 60.77 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.952 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -56.88 127.78 27.25 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.554 2.169 . . . . 0.0 112.182 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . 0.425 ' CD2' ' CD1' ' A' ' 155' ' ' TYR . 98.5 m-85 -60.65 139.96 57.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.739 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 111' ' ' GLU . 25.5 t -120.32 146.25 25.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.294 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -134.65 86.57 0.26 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.294 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.723 HG12 ' HD2' ' A' ' 64' ' ' HIS . 7.5 p -60.52 128.85 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.843 0.354 . . . . 0.0 111.326 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.3 tp -89.9 106.9 18.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.702 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 0.5 OUTLIER -117.56 174.32 6.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.961 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . . . -109.44 154.51 22.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.03 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.0 129.77 8.11 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.515 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.438 HD12 ' CE1' ' A' ' 106' ' ' TYR . 4.4 mt -125.74 100.53 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.803 0.335 . . . . 0.0 110.998 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.19 162.63 4.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.956 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.417 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -70.78 -28.36 64.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -90.51 49.94 1.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.132 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.5 m -109.1 102.76 50.17 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.782 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.81 -23.91 47.51 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.419 2.079 . . . . 0.0 112.366 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -98.37 31.11 2.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.934 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.99 -38.35 90.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.886 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -61.7 -49.52 76.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.96 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.446 HD13 HD13 ' A' ' 33' ' ' ILE . 78.2 mt -77.7 -31.02 52.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.942 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.67 -55.4 20.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.178 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -44.82 74.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.045 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.415 ' HG3' ' ND2' ' A' ' 282' ' ' ASN . 14.5 tt0 -63.89 -43.38 96.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -66.83 -37.11 83.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.766 HD23 ' CD2' ' A' ' 284' ' ' LEU . 2.8 mt -78.71 -22.24 46.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.445 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.55 -29.94 15.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.505 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.415 ' ND2' ' HG3' ' A' ' 278' ' ' GLU . 22.9 m-80 -94.67 -58.09 2.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.728 0.299 . . . . 0.0 111.494 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -106.49 58.12 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.94 0.4 . . . . 0.0 111.319 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.766 ' CD2' HD23 ' A' ' 280' ' ' LEU . 2.0 tp 177.64 38.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.942 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.78 HD23 HD13 ' A' ' 304' ' ' LEU . 0.4 OUTLIER 179.3 38.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.872 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 44.7 p -153.48 172.37 17.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.947 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -63.15 -29.28 70.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.018 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -78.22 -30.15 48.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.019 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -92.2 -51.8 2.33 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.624 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.603 HD21 HG22 ' A' ' 108' ' ' ILE . 1.5 mt -59.03 -30.59 68.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.764 0.316 . . . . 0.0 110.999 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -72.81 -31.45 64.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.937 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.459 ' HB3' HG22 ' A' ' 23' ' ' VAL . . . -59.25 -40.49 86.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.138 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.2 t -83.53 -30.81 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.138 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -63.31 -29.72 70.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.977 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -58.77 -33.66 70.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.96 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -102.61 -35.82 8.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.0 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 4.2 mmtm -146.61 90.36 5.57 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.932 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.2 104.79 1.44 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.53 2.154 . . . . 0.0 112.265 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.685 HD22 ' CB ' ' A' ' 109' ' ' ALA . 2.2 mp -58.42 -26.75 63.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.994 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 90.13 -94.72 2.01 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.523 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -79.05 122.01 25.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.784 0.326 . . . . 0.0 111.073 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.528 HG11 ' CD2' ' A' ' 307' ' ' TYR . 21.3 m -111.59 165.98 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.18 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -92.13 -29.24 16.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.167 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.78 HD13 HD23 ' A' ' 285' ' ' LEU . 5.0 tp -58.16 120.91 9.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.936 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -65.22 -31.63 72.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.9 -31.75 51.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.617 ' CE2' HD11 ' A' ' 311' ' ' LEU . 5.4 t80 -84.68 -28.26 26.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.021 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -59.4 -31.79 69.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.84 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -73.08 -58.91 2.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.853 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -51.53 -32.21 27.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.771 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.785 ' HB3' HG21 ' A' ' 317' ' ' ILE . 13.3 mt -85.78 -26.14 25.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.667 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.7 -16.48 62.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.343 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -47.82 -32.62 6.29 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.931 0.396 . . . . 0.0 110.832 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -108.67 138.53 20.3 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.345 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 11.8 Cg_endo -55.89 -30.67 78.26 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.418 2.078 . . . . 0.0 112.374 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -49.68 -39.32 36.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.001 0.429 . . . . 0.0 110.299 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.785 HG21 ' HB3' ' A' ' 311' ' ' LEU . 18.5 mm -85.57 -33.58 7.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.964 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -69.2 -57.48 5.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.205 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.19 -49.58 75.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.258 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 73.8 m -58.73 -31.02 67.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.987 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 9.1 tpt -79.98 -32.13 39.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -61.43 -56.13 23.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.94 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -65.12 -30.44 71.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.942 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.09 -56.54 20.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.134 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -64.09 -37.52 87.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.875 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 12.0 tttp -67.52 -31.92 72.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -76.97 -162.02 14.3 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.501 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -129.27 160.46 32.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.762 0.315 . . . . 0.0 110.949 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.492 HG22 ' N ' ' A' ' 330' ' ' MET . 29.8 mt -86.78 158.81 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.127 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.492 ' N ' HG22 ' A' ' 329' ' ' ILE . 6.1 mtp -80.13 131.07 63.83 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.899 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -57.3 158.36 18.82 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.392 2.061 . . . . 0.0 112.181 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -110.23 -26.53 9.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.087 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 34.9 pt -55.59 150.44 25.49 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.248 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.71 -25.42 24.22 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.594 2.196 . . . . 0.0 112.417 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.633 ' OE1' HG21 ' A' ' 178' ' ' ILE . 0.9 OUTLIER -56.57 -28.36 60.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.062 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -27.86 66.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.061 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 4.9 m -55.87 -56.2 23.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.01 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.59 -30.8 71.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.09 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.778 ' O ' HG23 ' A' ' 343' ' ' VAL . 47.1 t80 -59.7 -40.49 88.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.946 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.5 ' CH2' ' CZ ' ' A' ' 155' ' ' TYR . 96.7 m95 -63.6 -55.75 21.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.024 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -58.8 -44.3 90.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.082 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -59.17 -58.73 7.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.19 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 339' ' ' PHE . 24.4 t -59.21 -28.43 39.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.228 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.71 -53.89 49.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.073 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.67 -30.61 68.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.959 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -59.26 -52.83 63.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.212 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 343' ' ' VAL . 21.2 t -59.19 -36.74 64.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.198 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 29.3 mt -76.37 -37.15 30.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.158 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -58.93 -30.95 68.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.95 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -87.6 -46.68 9.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.053 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.13 -40.53 96.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.123 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 8.1 m -67.92 -22.43 65.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.104 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 85.12 27.6 33.3 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.564 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.19 -30.28 21.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.852 0.358 . . . . 0.0 110.918 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -146.09 -173.92 4.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 4.4 p -104.48 156.12 18.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.951 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.529 HG13 HD22 ' A' ' 192' ' ' LEU . 43.1 t -59.12 -29.93 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.977 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.12 -49.29 70.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.23 -34.88 71.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.995 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -65.98 -52.85 45.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.98 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.591 HD22 ' O ' ' A' ' 183' ' ' VAL . 89.9 mt -61.75 -28.72 69.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -81.19 -41.16 22.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.871 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -73.72 -46.98 42.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.14 -43.65 87.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.145 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -62.95 -36.17 82.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.933 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.573 HG22 ' HG2' ' A' ' 370' ' ' LYS . 21.3 m -60.34 -42.99 96.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -59.71 -29.82 68.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.924 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.563 HD12 ' CD2' ' A' ' 339' ' ' PHE . 26.2 mm -71.02 -35.66 60.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.076 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 1.4 t -152.77 78.64 1.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.573 ' HG2' HG22 ' A' ' 366' ' ' THR . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.92 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.55 HG21 ' HD2' ' A' ' 271' ' ' PRO . 7.5 t . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.798 0.332 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.26 173.54 10.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.883 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 58.24 174.63 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.983 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -84.98 55.92 4.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.494 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -125.15 173.29 8.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.861 0.362 . . . . 0.0 110.887 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.455 HD11 ' HB3' ' A' ' 275' ' ' LEU . 6.1 mt -141.9 115.82 9.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.2 t -89.61 146.99 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.212 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.902 HG21 HD21 ' A' ' 20' ' ' LEU . 5.4 mt -128.16 107.47 16.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.925 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.449 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 8.6 m0 -93.78 106.7 18.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.854 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.3 tt -123.29 145.81 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.081 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -60.13 170.56 1.22 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.79 47.91 2.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.52 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -157.23 31.4 0.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.856 0.36 . . . . 0.0 110.907 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.33 -172.3 3.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.92 93.84 1.53 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.501 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -85.97 -37.5 18.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.816 0.341 . . . . 0.0 110.923 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -75.73 -32.72 60.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.976 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.9 -28.21 59.22 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.507 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.902 HD21 HG21 ' A' ' 9' ' ' ILE . 18.5 tp -80.05 -32.4 39.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.76 0.314 . . . . 0.0 110.931 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.77 -31.81 71.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.175 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -60.23 -31.05 69.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.965 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.8 t -64.62 -41.14 91.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.088 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.99 -34.96 88.64 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.499 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.0 mttp -60.03 -28.59 67.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.826 0.346 . . . . 0.0 110.934 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -83.0 -38.5 22.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.849 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -55.82 -45.69 78.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.096 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -60.36 -38.35 83.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.937 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.39 -28.81 66.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.901 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -83.76 -32.66 25.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.311 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.462 HG23 HG12 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -139.06 -44.15 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.391 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.98 20.9 5.5 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.721 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.613 HG21 HD13 ' A' ' 275' ' ' LEU . 29.4 mm -80.67 114.9 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.814 0.34 . . . . 0.0 110.985 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -57.65 145.48 33.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.003 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.4 t -138.96 109.31 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.111 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.2 m -104.14 128.54 51.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.911 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.572 HG22 HD12 ' A' ' 9' ' ' ILE . 21.5 t -114.74 113.86 44.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.149 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -114.78 156.8 24.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.9 p-80 -122.47 71.49 37.22 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.855 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.573 ' HG2' HD22 ' A' ' 43' ' ' LEU . 57.1 Cg_endo -70.77 165.84 30.82 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.603 2.202 . . . . 0.0 112.377 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -126.0 141.21 52.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.815 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.5 mmtm 59.68 36.96 22.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.839 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.573 HD22 ' HG2' ' A' ' 40' ' ' PRO . 0.6 OUTLIER -78.19 -3.51 42.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.48 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -58.29 -36.91 74.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.84 0.352 . . . . 0.0 110.964 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.47 -19.75 23.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.172 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.777 ' O ' HG22 ' A' ' 50' ' ' VAL . 2.5 mtpp -87.41 -19.0 28.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.344 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.451 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 7.0 t80 -70.91 -48.52 14.41 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.361 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 2.9 Cg_exo -76.04 -31.32 5.02 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.791 2.327 . . . . 0.0 112.688 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.602 ' HG3' HG13 ' A' ' 50' ' ' VAL . 7.8 pt20 -60.28 -50.69 72.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.834 0.35 . . . . 0.0 111.239 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 46' ' ' LYS . 7.4 m -97.17 27.09 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.434 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.19 -29.98 31.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.184 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.55 -32.49 25.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.207 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.483 HG22 ' HA ' ' A' ' 50' ' ' VAL . 2.2 t -82.75 -29.65 29.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.944 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.71 26.96 23.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.517 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.42 -26.02 24.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.829 0.347 . . . . 0.0 111.009 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.4 -178.52 0.4 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.554 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.449 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 60.9 Cg_endo -72.59 -168.23 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.609 2.206 . . . . 0.0 112.364 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.29 -46.22 3.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.814 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.9 mt -117.88 138.88 47.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.596 HD11 ' CE3' ' A' ' 62' ' ' TRP . 2.6 tt -139.02 159.69 29.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.12 0.486 . . . . 0.0 110.952 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.481 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 28.1 m-85 -127.62 136.17 51.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.942 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.596 ' CE3' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -172.01 157.69 4.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.913 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.36 156.1 30.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.094 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.719 ' CD2' HG12 ' A' ' 261' ' ' VAL . 4.2 p80 -56.48 -41.93 77.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.085 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -59.26 -31.35 69.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.08 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.418 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 8.6 mmm180 -94.25 17.19 13.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.334 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.402 ' CE2' ' O ' ' A' ' 62' ' ' TRP . 0.8 OUTLIER -109.65 -13.33 14.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.285 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -92.5 21.89 35.93 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.739 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.42 -23.83 4.65 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.559 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.46 ' O ' HD12 ' A' ' 75' ' ' LEU . 29.3 m-85 -100.47 -28.08 13.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.737 0.303 . . . . 0.0 110.972 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.0 -25.78 53.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.11 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -59.29 -29.3 67.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.155 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 m -96.65 24.99 5.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.13 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.49 29.46 39.31 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.791 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.46 HD12 ' O ' ' A' ' 70' ' ' TYR . 7.3 mt -87.81 -40.61 13.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 0.0 110.944 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.4 mt -83.33 148.52 27.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.931 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.546 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -82.31 165.33 20.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.128 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.475 ' OE1' HG22 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -88.03 -165.63 1.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.935 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.665 HD11 ' HB3' ' A' ' 103' ' ' LEU . 33.8 pt -157.33 164.62 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.968 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 47.0 p -156.31 77.43 4.36 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.837 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.64 161.16 46.15 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.646 2.231 . . . . 0.0 112.269 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.38 165.07 16.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.809 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.35 -38.28 76.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.884 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.37 -29.31 61.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.063 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.428 ' CZ ' HD13 ' A' ' 285' ' ' LEU . 7.4 t80 -78.54 -32.01 47.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.434 ' HG2' ' CE2' ' A' ' 94' ' ' TRP . 0.0 OUTLIER -82.21 -29.62 31.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.994 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -73.74 -36.42 65.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.048 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.466 ' HG3' HD12 ' A' ' 89' ' ' LEU . 2.6 pttt -59.87 -30.28 68.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.012 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.532 HD11 HD11 ' A' ' 285' ' ' LEU . 1.1 mp -88.45 162.54 16.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.849 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.424 ' HB3' ' CE1' ' A' ' 92' ' ' PHE . 15.2 m-85 -75.09 141.09 74.07 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.064 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -54.31 -55.88 3.0 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.658 2.239 . . . . 0.0 113.022 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.476 ' CE2' HG23 ' A' ' 93' ' ' THR . 42.4 p90 -56.16 -42.21 76.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.734 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.476 HG23 ' CE2' ' A' ' 92' ' ' PHE . 30.6 p -59.46 -28.06 66.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.754 0.312 . . . . 0.0 111.103 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.434 ' CE2' ' HG2' ' A' ' 86' ' ' GLN . 7.2 m95 -75.01 -25.82 59.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.113 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.405 ' HA ' ' CG ' ' A' ' 98' ' ' ARG . 5.9 m-20 -90.55 12.42 18.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.398 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -101.9 -48.26 4.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.779 0.324 . . . . 0.0 111.289 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.879 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 7.2 m -78.98 -33.14 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.387 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 0.9 OUTLIER -66.09 121.17 14.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.99 -179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -122.96 142.68 50.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.727 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 69.59 25.31 5.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.071 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.57 7.27 88.13 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.109 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.04 141.64 47.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.846 0.355 . . . . 0.0 111.006 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.665 ' HB3' HD11 ' A' ' 79' ' ' ILE . 1.2 mp -75.85 149.82 37.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.953 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.475 HG22 ' OE1' ' A' ' 78' ' ' GLU . 2.5 pp -157.14 26.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.387 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.879 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -161.59 179.09 8.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.073 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -137.66 89.97 14.99 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.939 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.695 ' HB3' HG21 ' A' ' 261' ' ' VAL . 44.2 Cg_exo -56.23 131.47 46.06 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.524 2.149 . . . . 0.0 112.228 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.672 ' CG2' HD21 ' A' ' 290' ' ' LEU . 4.0 mt -127.24 -48.06 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 262' ' ' LEU . . . -113.34 138.44 50.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.089 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.34 128.92 67.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.1 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -109.2 148.17 31.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.958 ' HB3' HG23 ' A' ' 320' ' ' THR . . . -157.93 137.05 11.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.405 HD11 ' HE1' ' A' ' 155' ' ' TYR . 8.6 mt -66.85 109.08 2.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.864 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.85 161.14 14.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.931 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.726 HD22 ' HD3' ' A' ' 248' ' ' PRO . 6.8 tp -96.78 111.79 23.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.8 mt -97.98 132.09 43.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.1 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.436 ' CD1' ' HB3' ' A' ' 125' ' ' PRO . 34.7 p90 -129.74 159.33 36.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.001 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.557 ' HB3' HD12 ' A' ' 121' ' ' LEU . 5.3 m120 -86.39 120.93 28.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.0 mtpp -77.93 -27.97 49.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.037 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -65.46 -30.48 71.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.1 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.557 HD12 ' HB3' ' A' ' 118' ' ' ASN . 1.9 mp -110.42 -35.7 5.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.114 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 16.2 tp -110.43 101.92 49.98 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.97 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.82 -27.79 37.08 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.37 2.047 . . . . 0.0 112.303 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -137.98 130.34 16.33 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.436 ' HB3' ' CD1' ' A' ' 117' ' ' TYR . 71.7 Cg_endo -76.99 151.55 30.94 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.538 2.159 . . . . 0.0 112.326 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.438 ' HB2' HD11 ' A' ' 132' ' ' ILE . 72.4 Cg_endo -76.26 103.03 1.68 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.54 2.16 . . . . 0.0 112.328 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -24.28 59.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.092 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.39 143.69 35.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.902 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.441 ' CE3' HG13 ' A' ' 132' ' ' ILE . 18.4 m95 -78.1 -30.82 49.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -67.64 -15.82 63.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.314 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.81 -11.11 43.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.609 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.476 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 25.6 mm -70.96 -46.56 15.15 Favored Pre-proline 0 CA--C 1.53 0.197 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.476 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 75.3 Cg_exo -48.12 -57.94 2.04 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.396 2.064 . . . . 0.0 112.489 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.32 -35.18 79.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.061 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.2 mt -58.44 -51.02 71.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.052 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.545 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 4.8 t70 -46.74 -28.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.508 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -85.58 -27.97 25.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.312 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.56 -63.71 1.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.302 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.666 ' H ' HD13 ' A' ' 139' ' ' LEU . 0.0 OUTLIER -68.96 -16.4 63.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.646 -179.597 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.418 ' N ' HD22 ' A' ' 139' ' ' LEU . 0.0 OUTLIER -64.54 -21.58 66.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.804 0.335 . . . . 0.0 110.495 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.44 -41.61 80.82 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.126 0.489 . . . . 0.0 110.581 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.4 ' HD2' ' HA ' ' A' ' 139' ' ' LEU . 0.0 OUTLIER -83.01 -26.75 30.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.784 179.711 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.34 18.6 3.36 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.76 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -111.4 -174.96 2.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.826 0.345 . . . . 0.0 110.893 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.6 t -132.12 163.9 27.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.878 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.545 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -79.26 -64.47 1.18 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.303 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.5 ' CD1' HD11 ' A' ' 115' ' ' LEU . 1.0 OUTLIER -153.28 148.44 26.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.102 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.474 ' SD ' HG21 ' A' ' 222' ' ' THR . 0.0 OUTLIER -137.05 -177.87 4.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.754 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -179.26 152.74 0.55 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.954 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.405 ' OD1' ' CD2' ' A' ' 156' ' ' PHE . 12.9 p-10 -67.95 113.11 5.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.679 ' CD2' HD21 ' A' ' 195' ' ' LEU . 8.8 mt -94.1 45.26 1.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.854 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -110.44 -30.29 7.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.008 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -125.14 125.86 25.24 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.885 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.84 -22.32 29.32 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.446 2.098 . . . . 0.0 112.341 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.405 ' HE1' HD11 ' A' ' 113' ' ' LEU . 44.4 t80 -54.19 -31.1 51.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.091 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.405 ' CD2' ' OD1' ' A' ' 150' ' ' ASN . 0.2 OUTLIER -89.16 -31.25 18.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.4 HG21 HD22 ' A' ' 195' ' ' LEU . 0.1 OUTLIER -94.93 12.43 28.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.241 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.55 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 29.7 t-105 -68.23 -54.85 14.04 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.433 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 17.4 Cg_endo -57.82 -20.26 42.88 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.238 1.959 . . . . 0.0 112.413 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.678 HD23 HD13 ' A' ' 195' ' ' LEU . 21.3 tp -78.8 -27.41 44.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.945 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 18.3 mt -101.67 -47.72 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.127 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -60.07 -36.48 77.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.214 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.42 84.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.232 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.05 -20.16 56.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.252 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 130.9 71.74 0.11 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.509 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 188' ' ' ALA . . . -171.77 172.67 44.78 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.489 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -162.39 173.57 13.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.82 0.343 . . . . 0.0 110.946 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.71 -53.34 4.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.052 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -127.72 146.22 50.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.784 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.85 108.12 17.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.049 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -73.51 110.95 8.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.577 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -159.38 145.6 16.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.935 0.398 . . . . 0.0 111.099 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 62.11 29.19 17.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.18 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.41 -37.27 3.36 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.14 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 5.1 pttm -102.04 179.61 4.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 111.139 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 176' ' ' TYR . 1.3 m-85 -110.19 115.21 29.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.801 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -58.45 134.83 57.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.899 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.8 pt -95.05 -16.63 7.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.415 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.04 25.96 4.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.024 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -150.13 110.05 4.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.817 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.775 HG12 ' H ' ' A' ' 183' ' ' VAL . 22.0 t -124.49 139.67 50.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.173 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -96.5 -5.58 58.93 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.831 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.775 ' H ' HG12 ' A' ' 181' ' ' VAL . 0.3 OUTLIER -51.85 -42.6 33.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.927 0.394 . . . . 0.0 111.36 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.417 ' N ' ' CG1' ' A' ' 183' ' ' VAL . 37.2 t0 -105.2 65.55 0.73 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.91 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.421 ' H ' ' HB3' ' A' ' 188' ' ' ALA . 0.5 OUTLIER -118.11 -168.84 1.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -74.81 -39.22 61.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.142 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -85.89 -37.85 9.05 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.468 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.442 ' HB2' ' HA3' ' A' ' 166' ' ' GLY . . . -60.21 -30.61 69.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.809 0.337 . . . . 0.0 111.163 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.44 -49.82 76.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.919 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.23 -27.88 66.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.201 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -58.18 -56.59 24.36 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.545 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.868 ' O ' HG23 ' A' ' 196' ' ' VAL . 6.9 tp -59.57 -50.44 73.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.77 0.319 . . . . 0.0 110.893 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.39 -24.72 57.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.07 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -66.84 -60.5 2.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.824 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.679 HD21 ' CD2' ' A' ' 151' ' ' LEU . 4.8 tp -57.55 -31.85 66.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.657 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 192' ' ' LEU . 48.8 t -61.73 -61.58 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.983 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.62 -27.73 68.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.848 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mt -60.28 -46.6 89.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.99 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.527 HG23 ' O ' ' A' ' 204' ' ' MET . 5.1 mt -64.35 -30.02 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.171 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.87 -30.33 26.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.367 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -98.65 -6.44 29.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.8 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -117.58 -9.82 10.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.588 0.232 . . . . 0.0 111.546 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 24.9 m80 62.96 41.48 8.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.873 0.368 . . . . 0.0 110.61 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . 0.527 ' O ' HG23 ' A' ' 199' ' ' ILE . 0.0 OUTLIER -82.96 134.73 35.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.88 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -74.47 122.73 23.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -73.09 -13.84 61.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.449 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -83.93 3.96 31.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.537 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.457 ' HA ' HD12 ' A' ' 212' ' ' ILE . 56.5 m -52.53 144.6 13.2 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.769 0.319 . . . . 0.0 111.12 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.514 ' HB2' HD11 ' A' ' 212' ' ' ILE . 1.5 m-20 -153.65 176.39 12.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.048 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.409 ' OH ' ' CZ2' ' A' ' 230' ' ' TRP . 0.8 OUTLIER -46.0 -62.95 1.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.406 -179.506 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.23 -59.04 6.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.599 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.514 HD11 ' HB2' ' A' ' 209' ' ' ASP . 0.0 OUTLIER -55.81 -33.46 34.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.21 -179.428 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -81.91 -25.54 34.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.779 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.34 -47.2 12.62 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.975 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.23 -32.16 62.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.253 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.47 -25.18 50.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.217 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.59 ' CD2' HG21 ' A' ' 225' ' ' THR . 1.1 t80 -69.3 -62.66 1.29 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.991 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -68.94 -45.57 70.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.03 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.41 -29.4 66.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.959 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.57 41.28 10.04 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.514 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -89.19 -31.31 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.794 0.33 . . . . 0.0 110.893 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.474 HG21 ' SD ' ' A' ' 148' ' ' MET . 11.0 t -124.64 163.17 22.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.934 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -90.26 -35.24 15.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.032 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -130.5 163.22 27.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.818 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.59 HG21 ' CD2' ' A' ' 217' ' ' PHE . 1.8 t -166.72 162.67 16.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.97 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.9 mt -111.61 118.8 58.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.021 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -144.27 165.42 27.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.924 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -98.59 -174.76 32.46 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.536 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.12 -24.67 27.77 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.562 2.175 . . . . 0.0 112.415 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . 0.409 ' CZ2' ' OH ' ' A' ' 210' ' ' TYR . 24.7 p90 -59.03 -30.83 68.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.91 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -71.33 -26.68 62.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.191 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 27.6 m0 -55.83 -39.62 71.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.981 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.6 m -69.47 -31.7 70.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -69.67 -35.85 75.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.924 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 22.7 mt -75.83 116.52 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.079 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -173.31 -42.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.933 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.41 -55.51 13.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 20.9 t -63.67 -28.68 70.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.941 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt 60.84 76.01 0.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.902 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 22.6 t -121.08 112.21 34.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.045 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.04 108.87 1.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.942 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -117.3 145.13 44.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.844 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -117.63 179.15 17.22 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.513 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.56 128.84 74.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 0.0 111.13 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.9 t -143.03 159.28 42.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.956 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.62 152.06 7.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.01 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.85 145.25 91.68 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.833 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.726 ' HD3' HD22 ' A' ' 115' ' ' LEU . 51.0 Cg_exo -53.7 137.29 66.91 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.477 2.118 . . . . 0.0 112.267 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 1.3 p -77.08 160.6 28.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -145.37 126.62 14.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt 62.26 18.01 9.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.287 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.24 38.66 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.888 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.84 149.29 37.01 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.731 0.3 . . . . 0.0 110.873 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.66 162.07 42.62 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.509 2.139 . . . . 0.0 112.229 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 39.7 p -71.14 179.59 2.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.832 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -128.84 58.07 33.91 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.84 136.47 32.88 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.548 2.165 . . . . 0.0 112.316 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . 0.497 ' CZ ' ' CD1' ' A' ' 158' ' ' TRP . 85.9 m-85 -59.51 140.1 56.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.978 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.68 145.76 12.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -134.81 108.42 0.71 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.469 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.719 HG12 ' CD2' ' A' ' 64' ' ' HIS . 7.4 p -88.74 160.84 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 0.0 111.152 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.462 ' N ' HG22 ' A' ' 261' ' ' VAL . 9.6 tp -121.62 131.43 54.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.77 169.43 19.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.964 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -105.4 127.36 52.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.058 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -90.44 148.21 19.5 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.537 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.648 HD11 HD12 ' A' ' 280' ' ' LEU . 31.3 mt -127.3 115.76 41.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.861 0.362 . . . . 0.0 111.125 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -77.05 135.88 38.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.912 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.546 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -64.77 -30.43 71.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.132 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -58.98 -30.98 68.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.7 111.18 8.12 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.87 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.55 ' HD2' HG21 ' A' ' 2' ' ' THR . 46.8 Cg_endo -68.27 -14.05 39.39 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.402 2.068 . . . . 0.0 112.583 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -84.47 57.22 4.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.939 0.4 . . . . 0.0 110.942 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.6 tppm? -82.77 -36.75 25.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -59.95 -49.18 78.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.613 HD13 HG21 ' A' ' 33' ' ' ILE . 37.4 mt -71.08 -33.33 70.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.968 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.34 93.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.044 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -63.14 -54.17 41.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -62.9 -33.28 74.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -69.64 -46.74 65.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.047 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.773 HD22 HD22 ' A' ' 284' ' ' LEU . 79.9 mt -81.42 -21.67 38.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.383 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -93.66 -48.21 6.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.765 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -103.77 18.05 22.77 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.605 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -163.47 52.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.879 0.371 . . . . 0.0 111.213 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.773 HD22 HD22 ' A' ' 280' ' ' LEU . 7.1 tp -174.83 -65.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.897 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.809 ' CD2' HD13 ' A' ' 304' ' ' LEU . 1.0 OUTLIER -84.95 58.41 5.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.947 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.23 -179.09 5.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.881 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.75 -36.97 31.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -75.76 -31.05 59.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.907 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -79.42 -52.1 4.95 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.532 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.672 HD21 ' CG2' ' A' ' 108' ' ' ILE . 10.1 mt -60.04 -35.35 74.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.819 0.342 . . . . 0.0 110.958 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -59.96 -44.02 94.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.29 -53.68 51.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.12 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.8 t -59.64 -47.14 92.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.128 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -66.44 -31.6 72.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.914 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 2.4 mtmm -63.1 -33.9 76.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.942 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -98.82 -32.43 11.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.024 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.4 ' HA ' ' HD2' ' A' ' 298' ' ' PRO . 4.1 mmtt -154.49 95.12 2.72 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.915 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 297' ' ' LYS . 36.6 Cg_endo -65.81 123.65 11.63 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.488 2.125 . . . . 0.0 112.314 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.455 ' H ' HD12 ' A' ' 299' ' ' LEU . 1.0 OUTLIER -93.38 17.44 11.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.133 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 81.78 -142.8 22.87 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.59 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -58.41 174.94 0.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 111.192 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.594 HG21 ' HB3' ' A' ' 307' ' ' TYR . 13.4 m -140.47 133.14 32.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.111 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -59.46 -33.79 71.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.208 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.829 HD23 ' HB2' ' A' ' 307' ' ' TYR . 14.0 tp -60.16 114.86 3.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -60.14 -30.67 69.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.951 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 32.6 m -70.36 -39.39 74.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.935 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.829 ' HB2' HD23 ' A' ' 304' ' ' LEU . 1.0 OUTLIER -86.22 -26.76 24.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.014 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -59.89 -31.7 70.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.807 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -69.76 -54.51 13.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.862 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.73 -34.74 19.82 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.788 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.578 ' HB3' HG21 ' A' ' 317' ' ' ILE . 88.3 mt -85.72 -26.63 25.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.697 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -70.53 -12.3 61.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.439 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -47.76 -31.77 5.21 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.925 0.393 . . . . 0.0 110.81 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -116.11 140.26 26.13 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.35 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.475 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 12.6 Cg_endo -56.52 -24.82 55.25 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.384 2.056 . . . . 0.0 112.414 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -50.96 -41.48 59.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.008 0.433 . . . . 0.0 110.302 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.578 HG21 ' HB3' ' A' ' 311' ' ' LEU . 30.1 mm -85.55 -32.72 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.882 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.475 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -69.11 -29.63 67.74 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.233 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.33 -30.65 66.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.151 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.958 HG23 ' HB3' ' A' ' 112' ' ' ALA . 56.6 m -84.61 -36.35 22.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 6.8 tpt -64.41 -40.21 95.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -59.92 -43.73 94.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.931 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -79.26 -29.13 42.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.023 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.6 -39.96 94.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.19 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -71.65 -55.01 8.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.994 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.13 -47.33 74.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.836 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -58.99 147.71 40.9 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.482 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -86.22 149.85 24.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.337 . . . . 0.0 110.911 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.535 HG22 ' HE1' ' A' ' 64' ' ' HIS . 28.4 mt -87.98 141.96 13.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.085 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 71.6 mtm -63.84 124.16 84.06 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.944 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -56.38 -164.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.38 2.053 . . . . 0.0 112.261 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -150.61 30.82 0.66 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 31.5 pt -117.86 153.73 51.01 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.108 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.51 -20.36 70.38 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.606 2.204 . . . . 0.0 112.445 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -60.39 -27.46 67.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.099 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 1.4 tpt -74.78 -30.21 61.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.074 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.84 -44.98 86.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.001 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -63.52 -29.93 71.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.108 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.856 ' CE1' HG21 ' A' ' 343' ' ' VAL . 11.9 t80 -59.45 -48.6 81.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.973 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 24.2 m95 -59.01 -30.27 67.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.044 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -81.31 -44.17 18.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.046 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.698 ' HB1' ' HA ' ' A' ' 364' ' ' ALA . . . -61.83 -61.66 2.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.269 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.856 HG21 ' CE1' ' A' ' 339' ' ' PHE . 21.9 t -58.39 -23.73 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.427 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.84 -57.41 12.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.093 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . 0.587 HG22 ' ND2' ' A' ' 349' ' ' ASN . 26.4 m -72.18 -30.27 64.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.107 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.27 -50.79 66.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.289 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 343' ' ' VAL . 33.3 t -62.91 -45.27 99.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.249 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 27.6 mt -67.85 -42.59 86.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.113 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.587 ' ND2' HG22 ' A' ' 345' ' ' THR . 55.7 m-20 -58.13 -45.71 86.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.985 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -74.57 -28.71 61.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.197 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.19 -35.98 76.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.268 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.09 20.76 9.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.185 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 55.82 26.0 46.11 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.602 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -82.03 -30.44 31.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.866 0.365 . . . . 0.0 110.941 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -145.42 174.75 10.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 41.0 p -100.47 151.64 21.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.566 HG22 HD23 ' A' ' 192' ' ' LEU . 40.5 t -55.91 -27.41 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.053 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -73.81 -47.71 36.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.82 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -35.4 62.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.051 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.0 -56.7 13.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.971 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 92.1 mt -61.63 -29.81 70.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.818 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -56.14 25.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.887 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -63.78 -47.62 80.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.932 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.698 ' HA ' ' HB1' ' A' ' 342' ' ' ALA . . . -61.61 -52.84 62.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.151 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.85 ' HA ' HD12 ' A' ' 368' ' ' ILE . 15.6 tm0? -57.36 -30.49 64.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.005 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 60.5 m -82.62 -33.41 27.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.952 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -66.99 -33.81 76.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.936 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.85 HD12 ' HA ' ' A' ' 365' ' ' GLN . 5.2 mt -65.92 -30.13 49.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.04 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.7 p -80.14 -29.94 38.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 34.3 mttp . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.895 180.0 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.482 HG21 ' HB3' ' A' ' 58' ' ' ASP . 8.5 t . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.832 0.348 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -170.68 35.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.914 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -143.9 -166.37 2.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.785 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -84.91 56.02 5.0 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.463 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.51 ' HE2' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -142.08 -178.38 5.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.754 0.312 . . . . 0.0 110.938 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.403 HD21 ' HB3' ' A' ' 275' ' ' LEU . 15.2 mt -145.83 118.38 8.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.51 HG22 ' HE2' ' A' ' 6' ' ' LYS . 30.1 t -92.2 132.46 36.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.118 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.622 HG21 ' CD2' ' A' ' 20' ' ' LEU . 34.3 mt -121.56 107.2 19.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.46 ' CG ' ' HG2' ' A' ' 57' ' ' PRO . 0.9 OUTLIER -94.89 112.98 24.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.871 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.455 HD11 ' HD2' ' A' ' 15' ' ' LYS . 2.8 tt -144.93 146.16 20.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.105 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -66.26 161.57 21.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.858 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.13 55.99 4.97 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.512 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -153.34 36.03 0.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.795 0.331 . . . . 0.0 110.897 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.455 ' HD2' HD11 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -148.44 179.94 7.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.92 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.2 66.92 3.11 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.505 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 12.2 p90 -79.47 -31.4 42.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.821 0.344 . . . . 0.0 110.911 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.445 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 51.7 t-20 -60.49 -32.92 71.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.944 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.65 -28.59 51.06 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.493 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.622 ' CD2' HG21 ' A' ' 9' ' ' ILE . 14.0 tp -69.27 -33.46 73.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.865 0.364 . . . . 0.0 110.906 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.23 -40.83 91.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.119 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.4 -33.1 70.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.035 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.1 t -70.91 -32.74 49.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.11 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.63 -33.07 63.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.489 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -66.86 -29.44 69.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.845 0.355 . . . . 0.0 110.937 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.14 -40.13 46.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -58.3 -54.67 44.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.959 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -37.56 77.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.941 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -72.01 -26.3 62.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.975 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -82.95 -31.79 27.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.523 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 17.3 p -138.14 -44.22 0.51 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.611 0.243 . . . . 0.0 111.594 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.53 -20.2 2.95 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.689 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.3 mm -59.94 114.68 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.807 0.337 . . . . 0.0 111.047 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.3 mttp -82.69 170.13 15.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.988 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.28 125.51 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.104 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 m -116.6 125.1 51.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -105.15 127.95 59.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -115.49 153.68 30.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.861 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -117.83 70.27 7.19 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.425 ' HG3' ' CD2' ' A' ' 10' ' ' TRP . 88.0 Cg_endo -77.07 174.53 12.68 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.685 2.256 . . . . 0.0 112.475 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -60.94 -156.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.474 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.474 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -46.95 -26.49 1.01 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.516 0.198 . . . . 0.0 111.457 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.474 HD23 ' O ' ' A' ' 42' ' ' LYS . 0.3 OUTLIER 54.77 18.11 2.0 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.879 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -79.17 -55.78 4.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.834 0.349 . . . . 0.0 110.782 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -93.67 -7.8 42.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.363 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.478 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -80.71 -19.17 45.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.385 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.425 ' CB ' ' HD3' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -84.46 -53.36 0.51 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.197 -179.762 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.425 ' HD3' ' CB ' ' A' ' 47' ' ' PHE . 32.6 Cg_exo -57.84 -32.44 94.97 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.485 2.123 . . . . 0.0 112.37 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.488 ' HG3' HG13 ' A' ' 50' ' ' VAL . 11.4 pt20 -61.31 -47.07 87.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.058 0.456 . . . . 0.0 111.016 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.488 HG13 ' HG3' ' A' ' 49' ' ' GLN . 4.1 m -95.1 27.05 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.484 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.16 -32.18 30.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.348 . . . . 0.0 111.2 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.52 -32.82 19.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.171 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 51.6 p -72.73 -31.4 64.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.93 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.89 26.08 46.79 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.563 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -96.24 -28.66 14.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.808 0.337 . . . . 0.0 110.895 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.97 166.14 3.98 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.665 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.46 ' HG2' ' CG ' ' A' ' 10' ' ' TRP . 50.0 Cg_exo -53.38 -172.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.681 2.254 . . . . 0.0 112.38 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.482 ' HB3' HG21 ' A' ' 2' ' ' THR . 8.2 p30 -109.48 -29.02 8.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.953 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.484 HG21 HD21 ' A' ' 280' ' ' LEU . 30.9 mt -132.13 157.08 43.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.205 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.481 ' CG1' ' N ' ' A' ' 61' ' ' PHE . 2.0 tt -163.35 159.36 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.133 0.492 . . . . 0.0 110.897 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.481 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 3.9 m-85 -132.73 124.95 29.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.835 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.6 t-105 -159.41 171.43 19.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.851 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.7 134.04 55.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.163 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.434 ' CD2' HG23 ' A' ' 261' ' ' VAL . 13.2 p80 -58.56 -31.0 67.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.97 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -59.89 -29.97 68.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.988 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -88.48 -30.27 19.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.923 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -58.36 -30.12 66.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.968 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.81 -27.47 61.83 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.578 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.33 -28.45 71.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.488 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -87.22 -30.16 21.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.815 0.34 . . . . 0.0 110.947 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.18 -29.08 42.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.123 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -57.91 -29.55 65.19 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.063 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.55 -23.15 17.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.085 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.02 28.4 9.36 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.515 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.5 mt -81.81 -32.63 31.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.852 0.358 . . . . 0.0 110.913 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 76' ' ' LEU . 38.5 mt -76.0 160.68 29.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.502 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -101.77 133.0 47.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.453 ' CG ' ' N ' ' A' ' 79' ' ' ILE . 19.3 tt0 -61.36 164.01 6.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.722 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.498 ' O ' HG23 ' A' ' 80' ' ' THR . 43.1 pt -141.22 177.6 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.145 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 79' ' ' ILE . 0.7 OUTLIER -162.03 77.9 2.08 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.802 179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.51 135.92 41.02 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.555 2.17 . . . . 0.0 112.318 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.39 173.42 0.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -62.39 -48.47 79.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.64 -31.3 69.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.121 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -71.08 -44.26 66.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.89 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -64.08 -44.76 91.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.904 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -65.8 -29.75 70.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.94 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -59.62 -45.35 92.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.945 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.837 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 46.3 mt -88.23 173.64 8.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.879 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.435 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . 10.6 m-85 -81.57 149.55 64.83 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.063 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.33 -55.93 2.45 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.637 2.225 . . . . 0.0 112.706 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.454 ' CE1' ' CG2' ' A' ' 93' ' ' THR . 50.8 p90 -56.55 -44.12 80.58 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.771 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.454 ' CG2' ' CE1' ' A' ' 92' ' ' PHE . 39.3 p -54.49 -28.07 42.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.74 0.305 . . . . 0.0 111.116 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.837 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 49.6 m95 -76.83 -46.09 26.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.821 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.73 -26.53 67.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.069 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.401 ' HB2' HD13 ' A' ' 329' ' ' ILE . . . -71.71 -28.74 63.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.279 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 11.2 m -107.42 64.58 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.22 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -156.06 120.07 4.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.98 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -118.93 136.48 54.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.781 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 62.64 17.94 10.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.18 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.79 21.9 56.75 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.947 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.05 156.43 48.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.832 0.349 . . . . 0.0 110.994 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.547 ' O ' HG23 ' A' ' 104' ' ' ILE . 5.8 mt -93.8 142.67 27.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.547 HG23 ' O ' ' A' ' 103' ' ' LEU . 2.6 pp -159.0 36.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.206 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.589 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -160.79 176.91 10.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.186 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.425 ' CE1' HG21 ' A' ' 79' ' ' ILE . 39.3 m-85 -139.34 87.4 13.63 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.81 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.553 ' CG ' HG21 ' A' ' 97' ' ' VAL . 61.3 Cg_exo -51.77 102.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.571 2.18 . . . . 0.0 112.327 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.742 HD12 HD23 ' A' ' 284' ' ' LEU . 20.7 mm -76.67 -64.27 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.095 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.581 ' O ' HG12 ' A' ' 261' ' ' VAL . . . -131.88 171.63 13.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.078 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.28 148.11 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.055 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.77 159.8 37.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.961 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -169.07 145.25 3.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.107 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.2 mt -62.56 108.39 1.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.1 m -92.56 161.83 14.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.0 tp -109.3 102.12 11.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.907 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.7 mp -91.94 131.46 38.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.131 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.45 ' CD1' ' HG2' ' A' ' 125' ' ' PRO . 46.1 p90 -113.51 165.51 12.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.949 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -109.84 106.16 15.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.821 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -58.58 -22.86 57.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.612 ' HB3' HD23 ' A' ' 121' ' ' LEU . 2.5 t0 -55.04 -32.81 62.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.113 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.612 HD23 ' HB3' ' A' ' 120' ' ' ASP . 0.1 OUTLIER -128.86 -42.03 1.43 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.201 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 122' ' ' LEU . 14.4 tp -104.85 90.67 3.68 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.009 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.84 -43.83 2.37 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.532 2.155 . . . . 0.0 112.283 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -126.51 91.37 47.69 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.45 ' HG2' ' CD1' ' A' ' 117' ' ' TYR . 75.6 Cg_exo -50.58 151.83 9.9 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.586 2.191 . . . . 0.0 112.357 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.76 119.5 5.46 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.566 2.178 . . . . 0.0 112.366 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.05 -21.22 62.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.036 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 12.0 p -100.86 146.1 27.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.903 0.382 . . . . 0.0 111.058 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.88 ' CE3' HD12 ' A' ' 132' ' ' ILE . 4.4 m95 -77.36 -28.44 52.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.958 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.96 -15.74 60.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.526 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -89.19 -21.94 23.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.528 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.88 HD12 ' CE3' ' A' ' 129' ' ' TRP . 41.4 mt -59.76 -46.99 98.44 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.592 ' HG3' HD21 ' A' ' 198' ' ' LEU . 75.7 Cg_exo -49.5 -45.17 32.06 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.412 2.075 . . . . 0.0 112.416 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.26 -38.71 92.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.05 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.499 HD23 ' CD1' ' A' ' 139' ' ' LEU . 0.2 OUTLIER -65.34 -33.59 76.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.865 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.528 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 41.9 t0 -63.77 -24.4 67.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.1 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -85.53 -31.67 22.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.115 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -85.01 -47.11 10.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.208 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.779 HD22 ' HB2' ' A' ' 223' ' ' ALA . 0.3 OUTLIER -62.14 -17.87 59.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.394 -179.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.32 -27.92 53.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.736 0.303 . . . . 0.0 110.879 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.6 -41.69 90.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.05 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.7 mtpt -72.59 -27.11 61.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.017 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 114.51 29.4 2.71 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.504 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt -141.75 166.99 23.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.844 0.354 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.0 t -97.71 159.13 15.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.871 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.618 ' HA ' HD13 ' A' ' 139' ' ' LEU . . . -85.45 -32.07 22.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.17 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.824 HD12 ' CB ' ' A' ' 224' ' ' MET . 1.0 OUTLIER -169.98 124.1 0.75 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.018 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.413 ' HB2' HG21 ' A' ' 208' ' ' THR . 0.4 OUTLIER -129.43 166.65 19.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.59 179.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.8 p90 179.01 -170.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.803 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -89.14 109.64 20.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.905 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.674 HD21 HD11 ' A' ' 195' ' ' LEU . 13.7 mt -88.97 -29.13 19.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.952 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -59.17 -31.46 69.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.885 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.38 111.28 59.45 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.6 -23.48 19.8 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.428 2.085 . . . . 0.0 112.318 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.496 ' CE1' ' CD1' ' A' ' 258' ' ' PHE . 0.3 OUTLIER -50.6 -27.41 6.78 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.232 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -96.81 -22.47 16.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.219 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.839 ' O ' HD12 ' A' ' 161' ' ' ILE . 17.2 p -92.35 11.75 24.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.398 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.467 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 22.8 t-105 -87.58 -47.45 0.48 Allowed Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.309 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 53.7 Cg_exo -52.52 -23.32 18.95 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.374 2.049 . . . . 0.0 112.574 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.679 HD11 ' CD2' ' A' ' 194' ' ' PHE . 5.6 tp -86.02 -67.38 0.81 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.103 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.839 HD12 ' O ' ' A' ' 157' ' ' THR . 5.4 mt -57.73 -41.69 80.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.237 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.499 ' HB1' ' HB2' ' A' ' 256' ' ' LYS . . . -59.8 -38.27 81.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.197 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.673 ' HB2' ' HA ' ' A' ' 255' ' ' SER . . . -57.79 -36.17 71.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.229 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.94 -20.18 56.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.169 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 130.04 -22.0 4.86 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.636 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.562 ' HA3' ' HB2' ' A' ' 188' ' ' ALA . . . -69.32 154.65 53.25 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.496 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.442 ' CD1' ' HA3' ' A' ' 182' ' ' GLY . 25.6 p90 -148.85 -175.13 4.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 0.0 110.926 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.474 ' HB1' ' CE1' ' A' ' 339' ' ' PHE . . . -111.31 -48.9 3.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.024 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -130.28 127.53 39.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.828 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 167' ' ' TYR . 11.1 tttm -94.65 112.79 24.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.092 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.403 ' HB2' ' CE1' ' A' ' 176' ' ' TYR . 62.5 t80 -68.93 110.89 4.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.544 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -172.48 156.06 3.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.961 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 62.73 46.23 5.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.007 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 104.09 -62.27 0.4 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.723 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -151.09 -171.47 3.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 111.009 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.403 ' CE1' ' HB2' ' A' ' 171' ' ' TYR . 88.2 m-85 -59.49 125.9 25.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.9 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -82.19 127.51 33.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.876 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.2 pt -73.18 -27.6 24.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.202 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -97.25 26.04 5.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.052 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -125.44 96.35 4.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.921 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.796 HG21 ' HA ' ' A' ' 365' ' ' GLN . 23.5 t -96.29 146.01 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.111 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . 0.442 ' HA3' ' CD1' ' A' ' 167' ' ' TYR . . . -114.71 -7.04 18.57 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.995 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.662 HG12 HD22 ' A' ' 361' ' ' LEU . 11.1 t -56.51 -43.31 77.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.866 0.333 . . . . 0.0 111.181 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.06 57.26 4.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.919 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -104.61 -178.87 3.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.75 -52.15 22.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.108 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -76.82 -29.59 57.2 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.561 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.562 ' HB2' ' HA3' ' A' ' 166' ' ' GLY . . . -58.29 -33.93 69.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.829 0.347 . . . . 0.0 111.122 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.59 -31.2 72.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -87.47 -36.86 17.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.137 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -60.29 -46.85 93.52 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.461 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.939 HD12 HG22 ' A' ' 357' ' ' VAL . 3.1 tm? -60.33 -45.93 91.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.831 0.348 . . . . 0.0 110.854 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.554 ' OG1' HG21 ' A' ' 357' ' ' VAL . 91.7 m -67.02 -24.28 66.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.977 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.679 ' CD2' HD11 ' A' ' 160' ' ' LEU . 24.7 t80 -59.27 -60.67 3.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.812 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.674 HD11 HD21 ' A' ' 151' ' ' LEU . 3.7 tp -61.18 -30.29 70.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.554 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 192' ' ' LEU . 49.1 t -69.86 -43.28 79.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.005 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.34 -24.32 34.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.133 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.592 HD21 ' HG3' ' A' ' 133' ' ' PRO . 0.7 OUTLIER -63.87 -35.21 79.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.033 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.517 HG23 ' O ' ' A' ' 204' ' ' MET . 12.4 mt -77.75 -33.74 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.3 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 4.0 mtpp -85.07 -28.99 25.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.146 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -91.39 -10.18 42.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.558 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.569 ' HG3' HD23 ' A' ' 198' ' ' LEU . 13.1 mmtm -130.83 9.02 4.9 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.5 0.191 . . . . 0.0 111.49 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . 0.424 ' CG ' ' O ' ' A' ' 202' ' ' LYS . 40.1 p-80 43.67 52.96 6.16 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.888 0.375 . . . . 0.0 111.426 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . 0.517 ' O ' HG23 ' A' ' 199' ' ' ILE . 48.0 mtp -82.76 133.51 35.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -59.37 119.75 8.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.073 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -80.07 -29.77 39.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.059 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.74 -20.85 52.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.222 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.413 HG21 ' HB2' ' A' ' 148' ' ' MET . 7.2 m -45.16 149.31 0.5 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.916 0.388 . . . . 0.0 111.398 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.527 ' OD2' HD11 ' A' ' 212' ' ' ILE . 11.2 m-20 -154.07 176.28 12.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.661 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 211' ' ' SER . 0.3 OUTLIER -62.96 -30.48 71.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.93 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.454 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 0.7 OUTLIER -68.78 -59.21 3.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.953 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.527 HD11 ' OD2' ' A' ' 209' ' ' ASP . 0.0 OUTLIER -58.83 -28.85 38.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.358 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -74.07 -33.61 63.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.781 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.75 -28.63 30.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.53 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.37 -36.42 83.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.474 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.433 ' HA ' ' HA3' ' A' ' 220' ' ' GLY . . . -52.46 -25.22 9.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.307 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -66.92 -53.9 27.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.979 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -90.06 -13.96 34.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.03 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -176.84 101.85 0.05 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.979 0.419 . . . . 0.0 111.275 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 216' ' ' ALA . . . 149.73 -46.85 0.64 Allowed Glycine 0 N--CA 1.453 -0.229 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.049 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 63.97 101.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.944 0.402 . . . . 0.0 111.561 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.564 HG21 ' HB ' ' A' ' 225' ' ' THR . 13.3 t -116.05 124.89 51.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.374 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.779 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -45.92 -32.64 2.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.604 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.824 ' CB ' HD12 ' A' ' 147' ' ' LEU . 26.3 mtm -156.89 142.54 17.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.914 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.564 ' HB ' HG21 ' A' ' 222' ' ' THR . 4.1 t -164.3 126.24 2.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.444 HG12 HD21 ' A' ' 247' ' ' LEU . 4.0 mt -95.71 126.99 48.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.096 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -141.28 165.49 27.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -82.48 -170.94 46.06 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.496 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.406 ' HD2' ' CE3' ' A' ' 230' ' ' TRP . 74.1 Cg_endo -74.99 -2.89 13.13 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.638 2.225 . . . . 0.0 112.751 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . 0.406 ' CE3' ' HD2' ' A' ' 229' ' ' PRO . 39.0 p90 -95.97 34.08 1.6 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.694 0.283 . . . . 0.0 111.104 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -136.86 11.29 3.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.557 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 8.7 m0 -81.19 -39.43 25.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.808 0.337 . . . . 0.0 110.965 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.45 -29.92 68.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.024 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.71 -30.45 65.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.993 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.548 HG21 ' CE1' ' A' ' 242' ' ' TYR . 4.4 mt -88.63 84.67 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.071 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . 0.603 ' O ' HG23 ' A' ' 237' ' ' THR . 33.9 p-10 -160.76 37.19 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.915 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . 0.603 HG23 ' O ' ' A' ' 236' ' ' ASP . 0.8 OUTLIER -165.71 -43.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.957 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 82.8 p -63.08 -30.68 71.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.964 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 7.4 mmtm 61.09 36.05 18.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 20.8 t -95.41 121.73 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.105 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -61.98 111.97 2.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.868 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.548 ' CE1' HG21 ' A' ' 235' ' ' ILE . 50.8 p90 -109.26 146.96 33.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.91 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -126.14 147.19 16.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.492 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 20.8 t -110.18 127.05 67.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.814 0.34 . . . . 0.0 111.126 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.3 t -143.61 146.81 33.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.419 ' CG2' ' N ' ' A' ' 247' ' ' LEU . 0.7 OUTLIER -55.17 152.31 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.217 0.532 . . . . 0.0 111.32 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.55 HD12 HD21 ' A' ' 323' ' ' ASN . 13.5 mt -72.08 147.62 91.04 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.946 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.561 ' HG3' HD11 ' A' ' 132' ' ' ILE . 36.1 Cg_endo -65.43 166.45 19.47 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.535 2.157 . . . . 0.0 112.282 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 254' ' ' PRO . 4.5 p -110.32 162.2 14.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.943 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -117.24 110.58 18.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.913 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 9.1 mttm 59.84 25.3 14.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.042 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 92.93 -21.07 41.61 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.714 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -80.48 126.59 78.26 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.539 0.209 . . . . 0.0 110.832 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.462 ' HA ' HG22 ' A' ' 249' ' ' THR . 71.4 Cg_endo -74.76 143.88 30.5 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.433 2.089 . . . . 0.0 112.34 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.673 ' HA ' ' HB2' ' A' ' 163' ' ' ALA . 89.7 p -60.64 -178.29 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.777 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.499 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . 11.6 mttp -136.99 62.25 38.82 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.014 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.414 ' HD3' ' N ' ' A' ' 256' ' ' LYS . 35.7 Cg_exo -57.43 -161.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.497 2.131 . . . . 0.0 112.207 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . 0.496 ' CD1' ' CE1' ' A' ' 155' ' ' TYR . 63.1 m-85 -122.3 136.89 54.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.821 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 25.8 t -97.15 117.82 42.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.178 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -114.61 114.23 3.2 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.405 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -112.84 142.34 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.849 0.357 . . . . 0.0 111.151 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 14.8 tp -101.76 81.44 2.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.724 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.545 ' OG ' ' HB1' ' A' ' 105' ' ' ALA . 14.9 p -85.32 166.2 16.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.971 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -99.72 148.37 24.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.055 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -125.26 131.4 7.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.521 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 3.9 mp -124.13 102.4 10.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.789 0.328 . . . . 0.0 111.064 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -59.59 148.33 33.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.993 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.502 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -60.74 -30.55 70.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.092 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.83 57.1 4.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.014 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 8.0 m -145.56 93.29 5.35 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.84 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -48.64 -26.72 9.67 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.585 2.19 . . . . 0.0 112.464 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.481 ' ND2' HD12 ' A' ' 275' ' ' LEU . 4.9 m120 -86.21 56.24 3.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.835 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.27 -49.64 9.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.905 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -60.04 -43.72 95.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.864 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.481 HD12 ' ND2' ' A' ' 272' ' ' ASN . 46.6 mt -66.06 -32.18 73.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.8 -44.27 86.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.074 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.11 -49.39 74.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -63.05 -32.31 73.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.89 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.402 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 84.1 t80 -69.57 -47.59 63.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.97 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.507 HD23 HD22 ' A' ' 284' ' ' LEU . 1.6 mt -81.49 -21.17 38.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.383 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -93.61 -48.25 6.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.793 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -102.99 17.72 23.39 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.519 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.402 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 21.4 m-85 -163.81 44.59 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.884 0.373 . . . . 0.0 111.193 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.742 HD23 HD12 ' A' ' 108' ' ' ILE . 3.1 tp -177.95 -55.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 3.0 mt -89.99 52.56 2.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.7 p -138.31 -178.17 5.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -71.54 -43.27 66.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.888 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -82.72 -33.62 27.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -60.55 -61.88 6.59 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.563 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.566 HD13 ' CD2' ' A' ' 307' ' ' TYR . 2.8 mt -60.96 -34.27 74.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.333 . . . . 0.0 110.917 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.94 -41.99 93.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.94 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -59.5 -36.4 75.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.14 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.6 t -85.4 -30.67 6.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -59.77 -36.0 75.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -66.88 -32.72 74.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -89.46 -32.75 17.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.961 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -162.65 91.53 1.27 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.983 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.66 123.68 10.72 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.499 2.133 . . . . 0.0 112.315 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.468 ' H ' HD12 ' A' ' 299' ' ' LEU . 3.1 mp -93.33 16.87 12.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.11 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 59.09 -116.93 9.51 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.542 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -59.58 155.71 14.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.861 0.362 . . . . 0.0 111.093 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.544 HG11 ' CD2' ' A' ' 307' ' ' TYR . 16.7 m -141.1 156.16 21.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.162 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.49 ' HB3' HD22 ' A' ' 89' ' ' LEU . . . -69.87 -36.2 75.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.098 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.638 HD23 ' HB2' ' A' ' 307' ' ' TYR . 9.2 tp -61.35 122.32 14.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -70.05 -27.28 64.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.009 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 69.0 m -81.25 -27.61 35.11 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.149 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.638 ' HB2' HD23 ' A' ' 304' ' ' LEU . 8.3 t80 -83.06 -31.24 27.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.24 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -30.71 69.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.881 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -69.8 -50.23 45.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.891 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -51.22 -39.46 56.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.75 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.765 ' HB3' HG21 ' A' ' 317' ' ' ILE . 72.4 mt -85.68 -23.05 27.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.866 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.99 -14.95 61.66 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.491 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -46.41 -30.61 2.22 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.891 0.377 . . . . 0.0 110.912 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.89 142.04 27.79 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.339 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.42 -33.52 96.43 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.476 2.117 . . . . 0.0 112.521 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -49.18 -37.15 21.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.007 0.432 . . . . 0.0 110.364 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.765 HG21 ' HB3' ' A' ' 311' ' ' LEU . 33.1 mm -85.56 -34.33 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.876 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.3 -31.81 72.84 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.154 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.09 -45.75 83.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.175 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 60.3 m -61.34 -35.24 76.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 2.9 tpt -66.38 -46.62 76.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -62.76 -33.68 75.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.55 HD21 HD12 ' A' ' 247' ' ' LEU . 2.8 t-20 -75.33 -32.19 60.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.45 -45.38 72.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.045 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -59.67 -31.54 69.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.854 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -96.59 21.12 9.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.145 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -117.15 135.95 12.29 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.524 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -79.27 143.03 35.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.781 0.324 . . . . 0.0 110.886 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.401 HD13 ' HB2' ' A' ' 96' ' ' ALA . 26.0 mt -75.76 133.88 30.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.142 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 27.4 mtm -60.29 125.63 82.16 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.778 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.77 172.06 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.352 2.035 . . . . 0.0 112.245 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -132.35 41.03 3.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 31.7 pt -117.56 143.98 33.29 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.108 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.49 -23.84 49.91 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.595 2.196 . . . . 0.0 112.426 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.13 -22.46 40.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.203 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 37.8 mtp -54.66 -24.2 20.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.288 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 44.7 m -57.14 -36.89 71.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.085 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -82.41 -28.19 31.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.189 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.778 ' CZ ' HG21 ' A' ' 343' ' ' VAL . 79.7 t80 -57.4 -31.22 65.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.979 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -62.74 -61.0 2.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.018 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -63.2 -27.96 69.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.131 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -73.44 -38.24 65.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.351 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.831 ' O ' HG23 ' A' ' 347' ' ' VAL . 25.9 t -88.58 -46.35 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.299 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.563 ' HG2' HD11 ' A' ' 348' ' ' ILE . 7.1 ttt180 -55.75 -57.36 12.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.129 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 29.8 m -61.97 -27.25 68.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.115 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 350' ' ' ALA . . . -76.3 -32.66 58.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.322 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 343' ' ' VAL . 33.0 t -82.71 -42.68 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.282 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.563 HD11 ' HG2' ' A' ' 344' ' ' ARG . 17.4 mt -62.31 -59.05 4.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.125 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -59.6 -30.36 68.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.935 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 346' ' ' ALA . . . -73.56 -52.06 14.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.112 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.26 -32.2 72.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.137 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.25 -22.4 64.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.092 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 103.45 -27.21 20.85 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.573 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -58.97 -77.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.882 0.372 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -65.55 140.89 58.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.844 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 78.2 p -87.92 178.02 6.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.787 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.939 HG22 HD12 ' A' ' 192' ' ' LEU . 23.3 t -77.62 -55.11 11.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.945 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -47.69 -33.0 6.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.319 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -82.08 -45.79 14.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.143 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -57.43 -60.46 3.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.052 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.662 HD22 HG12 ' A' ' 183' ' ' VAL . 7.3 mt -58.7 -27.29 64.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.074 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -81.2 -37.06 29.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.955 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -70.36 -45.53 65.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.863 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.404 ' O ' HD12 ' A' ' 368' ' ' ILE . . . -58.2 -30.78 66.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.11 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.796 ' HA ' HG21 ' A' ' 181' ' ' VAL . 3.5 tt0 -69.39 -30.46 68.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 7.0 m -85.05 -30.14 24.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.051 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -74.19 -41.99 60.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.0 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 364' ' ' ALA . 12.4 mt -73.48 -28.92 26.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.218 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 365' ' ' GLN . 79.6 p -90.98 -46.09 8.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.867 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.932 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 40.4 tttt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.796 0.331 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.7 t -80.45 166.42 21.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -120.97 178.24 4.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.917 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -93.04 168.73 10.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.79 36.43 87.12 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.481 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.8 170.32 21.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.848 0.356 . . . . 0.0 110.949 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.6 mt -140.38 124.51 17.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.88 106.97 21.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.059 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.706 HG21 HD21 ' A' ' 20' ' ' LEU . 4.0 mp -99.26 121.23 49.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.578 ' CE3' HD13 ' A' ' 43' ' ' LEU . 1.4 m0 -91.23 133.7 35.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.984 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.535 HG23 ' HB3' ' A' ' 39' ' ' HIS . 9.4 tp -125.01 159.56 31.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.962 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.404 ' N ' HG13 ' A' ' 11' ' ' ILE . 26.6 m-20 -93.49 31.71 1.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.159 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.45 ' H ' HG23 ' A' ' 11' ' ' ILE . . . 47.46 37.77 12.97 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.06 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -178.64 53.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.846 0.355 . . . . 0.0 111.004 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.401 ' CB ' HD11 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -179.75 78.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.865 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.47 49.8 73.17 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.534 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 36.3 p90 -78.99 -38.83 35.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.813 0.339 . . . . 0.0 110.919 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.438 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 2.6 t30 -86.92 -31.68 20.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.949 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.57 -37.44 68.41 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.531 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.706 HD21 HG21 ' A' ' 9' ' ' ILE . 4.9 tp -63.75 -32.23 73.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.856 0.36 . . . . 0.0 110.949 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.67 -31.23 72.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.081 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -63.51 -43.64 96.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.912 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.87 -35.44 60.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.109 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.412 ' HA2' HG21 ' A' ' 35' ' ' VAL . . . -65.96 -43.73 93.05 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.445 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -59.73 -25.62 64.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.772 0.32 . . . . 0.0 111.002 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -82.58 -38.95 22.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.991 0.424 . . . . 0.0 110.882 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.34 -50.13 73.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.029 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -38.39 81.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.93 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.06 -25.12 64.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.095 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -88.38 -32.49 18.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.372 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.0 p -136.65 -44.14 0.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.375 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.67 20.61 4.94 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.657 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.56 HG21 HD13 ' A' ' 275' ' ' LEU . 32.9 mm -85.78 126.72 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.852 0.358 . . . . 0.0 111.043 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -65.45 148.68 51.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.412 HG21 ' HA2' ' A' ' 24' ' ' GLY . 21.5 t -143.38 104.36 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.09 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.6 m -109.54 150.6 27.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.999 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 9' ' ' ILE . 21.6 t -133.15 127.83 55.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.064 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -126.26 155.56 41.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.91 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.535 ' HB3' HG23 ' A' ' 11' ' ' ILE . 7.6 p80 -135.96 70.22 63.92 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.851 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.523 ' HG2' HD22 ' A' ' 43' ' ' LEU . 44.4 Cg_endo -68.77 170.27 15.73 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.584 2.189 . . . . 0.0 112.468 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -108.34 141.42 40.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.717 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.98 32.94 19.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.663 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.623 HD11 ' HZ3' ' A' ' 62' ' ' TRP . 2.3 pp -77.34 -0.78 26.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.699 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -56.98 -57.09 14.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.784 0.326 . . . . 0.0 111.16 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -88.41 -25.64 22.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.185 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.532 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -74.0 -18.97 60.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.295 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.462 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 78.4 t80 -74.07 -56.33 2.72 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.504 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 40.6 Cg_endo -67.0 -23.91 46.05 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.298 1.998 . . . . 0.0 112.883 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -65.12 -46.03 82.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.873 0.368 . . . . 0.0 111.155 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.532 HG22 ' O ' ' A' ' 46' ' ' LYS . 5.8 m -87.06 -28.99 5.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.314 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.463 ' HB1' ' OD1' ' A' ' 267' ' ' ASN . . . -56.9 -29.61 63.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.261 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.59 -33.37 71.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.13 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.2 p -93.87 -30.78 14.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.949 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.73 25.61 24.77 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.59 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -94.44 -32.97 13.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.869 0.366 . . . . 0.0 110.867 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.27 -143.94 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.534 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.422 ' HG3' ' CD2' ' A' ' 10' ' ' TRP . 43.6 Cg_endo -68.09 -167.78 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.538 2.159 . . . . 0.0 112.329 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -123.75 -51.9 1.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.0 mt -109.77 138.46 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.092 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.469 ' CG1' ' N ' ' A' ' 61' ' ' PHE . 3.0 tt -125.82 159.72 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.069 0.461 . . . . 0.0 111.029 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.469 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 46.4 m-85 -135.08 125.63 26.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.932 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.623 ' HZ3' HD11 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -160.27 175.95 12.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.52 157.01 37.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.142 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.755 ' HD2' HG12 ' A' ' 261' ' ' VAL . 32.2 p80 -57.98 -34.11 69.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.994 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -60.59 -48.82 80.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.08 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.416 ' HG3' ' CD1' ' A' ' 62' ' ' TRP . 30.5 mmm180 -74.87 -27.85 60.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.021 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.402 ' CE2' ' HB2' ' A' ' 263' ' ' SER . 1.0 OUTLIER -57.65 -22.37 45.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.147 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -94.6 33.7 5.18 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.576 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -118.4 -32.49 1.35 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.51 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -88.41 -27.52 21.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.775 0.322 . . . . 0.0 110.98 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.33 -30.72 38.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.053 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.422 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 3.5 pt20 -61.05 -36.4 79.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.962 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 m -89.75 -23.06 21.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.126 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.74 59.2 0.87 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.452 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.0 mt -138.31 31.69 2.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.362 . . . . 0.0 110.961 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' A' ' 268' ' ' ALA . 14.1 mt -138.88 161.45 37.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.792 ' HB2' ' O ' ' A' ' 267' ' ' ASN . . . -97.8 151.21 20.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.058 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.469 ' CD ' HG22 ' A' ' 104' ' ' ILE . 1.0 OUTLIER -77.06 -165.37 0.55 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.93 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.441 HD13 ' N ' ' A' ' 105' ' ' ALA . 33.4 pt -157.64 171.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.085 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 79' ' ' ILE . 41.8 p -158.1 77.42 3.52 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.741 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.48 160.16 47.39 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.631 2.221 . . . . 0.0 112.347 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.35 -176.94 3.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.753 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.3 mttp -59.89 -38.94 83.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.81 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.18 -28.04 61.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.075 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -79.19 -37.69 37.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.935 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -82.14 -25.95 33.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.085 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -79.19 -40.83 29.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.163 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.452 ' NZ ' HD13 ' A' ' 285' ' ' LEU . 32.5 pttt -58.37 -39.45 79.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.083 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.707 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 24.9 mt -83.01 162.1 21.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.872 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.499 ' HB2' HG23 ' A' ' 93' ' ' THR . 26.1 m-85 -88.26 147.63 40.72 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.03 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -54.21 -55.71 3.18 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.567 2.178 . . . . 0.0 112.736 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.547 ' CE1' HG22 ' A' ' 93' ' ' THR . 40.2 p90 -54.09 -39.62 66.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.808 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.547 HG22 ' CE1' ' A' ' 92' ' ' PHE . 27.8 p -61.42 -32.98 72.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.745 0.307 . . . . 0.0 110.826 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.707 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 45.3 m95 -67.75 -32.0 72.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.793 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -60.35 -26.98 67.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.055 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.622 ' HB1' ' CB ' ' A' ' 64' ' ' HIS . . . -73.12 -28.67 62.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.258 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.612 ' CG1' ' HB3' ' A' ' 105' ' ' ALA . 3.8 m -104.05 56.24 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.936 0.398 . . . . 0.0 111.245 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -156.08 130.45 8.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.422 ' CE2' ' HB3' ' A' ' 72' ' ' GLN . 1.8 t80 -96.23 -64.74 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.838 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -127.69 45.78 2.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.795 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.16 -26.8 19.4 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.526 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.2 141.8 33.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.841 0.353 . . . . 0.0 110.88 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 32.1 mt -97.01 132.05 43.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.843 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.547 ' O ' HD12 ' A' ' 104' ' ' ILE . 2.6 pp -138.31 30.47 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.196 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.612 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . . . -173.8 178.73 2.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.152 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.806 ' OH ' HD11 ' A' ' 266' ' ' ILE . 1.1 p90 -155.74 96.09 2.4 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.807 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.63 ' HB3' HG21 ' A' ' 261' ' ' VAL . 54.0 Cg_exo -52.54 144.99 39.39 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.504 2.136 . . . . 0.0 112.424 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.612 HG23 ' CD2' ' A' ' 285' ' ' LEU . 5.4 mt -128.31 -59.3 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.047 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.526 ' HA ' HG12 ' A' ' 302' ' ' VAL . . . -105.86 145.75 30.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.096 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.478 HG22 HG23 ' A' ' 261' ' ' VAL . 32.7 t -121.18 138.36 51.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.136 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -139.47 160.08 40.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.863 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -172.31 152.74 2.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.083 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.512 HD23 ' HA2' ' A' ' 228' ' ' GLY . 5.3 mt -71.02 101.94 2.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.44 -176.52 3.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.6 tp -96.81 114.61 26.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.919 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.7 mt -108.9 114.01 45.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.004 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -124.88 165.53 17.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.906 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.39 144.51 34.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.926 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.5 mtmm -98.5 33.39 2.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.961 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -93.13 -48.12 6.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.949 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.96 -35.26 5.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.008 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.464 HD21 ' O ' ' A' ' 124' ' ' ASN . 1.6 tt -108.53 95.32 15.95 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.979 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.48 -45.24 1.26 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.484 2.123 . . . . 0.0 112.353 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.464 ' O ' HD21 ' A' ' 122' ' ' LEU . 6.3 m120 -100.34 114.71 65.81 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.51 153.01 39.11 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.416 2.077 . . . . 0.0 112.364 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.52 116.24 4.64 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.576 2.184 . . . . 0.0 112.289 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.93 -23.73 38.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.027 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 73.2 p -118.01 149.7 40.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.895 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.895 ' CE3' HD12 ' A' ' 132' ' ' ILE . 26.5 m95 -69.63 -31.27 69.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.854 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -68.8 -15.65 63.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.427 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -85.5 -16.95 37.87 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.895 HD12 ' CE3' ' A' ' 129' ' ' TRP . 24.0 mt -71.78 -49.42 10.78 Favored Pre-proline 0 C--N 1.331 -0.204 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.53 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 83.3 Cg_exo -44.99 -46.58 12.96 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.499 2.132 . . . . 0.0 112.509 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.07 -40.07 92.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.997 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.926 HD23 HD12 ' A' ' 139' ' ' LEU . 0.2 OUTLIER -64.73 -36.84 85.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.797 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.706 ' OD1' ' HB3' ' A' ' 146' ' ' ALA . 1.6 m-20 -57.76 -27.51 63.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.067 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.433 ' HE2' ' CE1' ' A' ' 203' ' ' HIS . 50.1 mttm -85.6 -31.6 22.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.069 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -85.1 -56.46 3.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.171 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.926 HD12 HD23 ' A' ' 135' ' ' LEU . 0.2 OUTLIER -55.42 -26.77 43.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.272 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -77.67 -28.26 51.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.804 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.42 -38.28 83.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.951 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 41.3 mttt -73.64 -27.12 61.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.073 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.2 32.4 1.83 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.599 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.2 mtmt -149.82 159.7 44.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 0.0 110.874 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.608 ' O ' HD22 ' A' ' 139' ' ' LEU . 84.7 p -82.33 170.11 15.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.975 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.72 ' HA ' HD13 ' A' ' 139' ' ' LEU . . . -102.67 -56.69 2.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.169 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.666 HD22 HD13 ' A' ' 132' ' ' ILE . 4.0 tp -153.54 136.32 15.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.92 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.588 ' SD ' HG21 ' A' ' 222' ' ' THR . 0.0 OUTLIER -133.87 -177.91 4.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.82 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.518 ' HZ ' HD11 ' A' ' 195' ' ' LEU . 51.1 p90 -177.25 -172.78 0.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.875 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.424 ' HB3' ' CD1' ' A' ' 156' ' ' PHE . 60.2 t-20 -83.59 114.21 21.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.941 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.4 mt -98.57 30.8 3.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.911 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -127.54 30.33 5.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -168.49 111.42 0.55 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.627 ' CB ' HG12 ' A' ' 343' ' ' VAL . 78.0 Cg_exo -50.26 -25.74 14.07 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.453 2.102 . . . . 0.0 112.353 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.494 ' CD2' ' CD2' ' A' ' 258' ' ' PHE . 0.8 OUTLIER -58.4 -31.5 67.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.424 ' CD1' ' HB3' ' A' ' 150' ' ' ASN . 13.6 m-85 -74.43 -30.53 61.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.44 ' O ' HD12 ' A' ' 161' ' ' ILE . 21.1 p -102.56 30.34 4.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.067 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.468 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 1.4 t-105 -83.59 -48.45 0.73 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.093 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.512 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 32.4 Cg_exo -58.13 -18.83 38.49 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.417 2.078 . . . . 0.0 112.497 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 15.6 tp -92.66 -32.13 14.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.155 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.661 HD13 HD12 ' A' ' 192' ' ' LEU . 15.6 mt -95.79 -58.02 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.222 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.463 ' HB1' ' HE3' ' A' ' 256' ' ' LYS . . . -56.15 -31.1 63.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.252 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -59.08 -44.82 91.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.135 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -63.73 -20.08 65.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.185 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 131.71 71.26 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.56 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -158.2 142.9 8.84 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.493 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -147.48 179.47 7.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.332 . . . . 0.0 110.999 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.635 ' HB2' ' CZ ' ' A' ' 339' ' ' PHE . . . -103.55 -33.01 9.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.983 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -141.25 155.31 46.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.793 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 9.1 tttm -103.35 111.32 23.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.057 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.437 ' CD1' ' CZ ' ' A' ' 176' ' ' TYR . 57.4 t80 -73.81 110.91 8.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.412 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -158.76 150.92 21.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.08 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 61.51 29.93 18.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.059 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 90.78 -38.54 3.2 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.014 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -108.05 -177.11 3.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.918 0.389 . . . . 0.0 111.079 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.437 ' CZ ' ' CD1' ' A' ' 171' ' ' TYR . 4.9 m-85 -108.1 121.14 44.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.921 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -58.75 132.5 54.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.7 pt -91.02 -23.63 5.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.385 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.39 26.05 4.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.15 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -141.53 90.12 2.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.919 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.72 HG11 HD13 ' A' ' 368' ' ' ILE . 16.2 t -100.75 146.01 10.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.079 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -111.0 66.55 0.23 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.652 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.947 HG12 ' CD2' ' A' ' 361' ' ' LEU . 1.5 t -103.13 -60.52 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.91 0.386 . . . . 0.0 111.064 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.498 ' HA ' HD13 ' A' ' 361' ' ' LEU . 35.1 p-10 -83.46 56.7 3.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.11 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -95.77 168.43 10.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.814 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -59.83 -34.17 72.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.113 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -85.93 -45.51 5.67 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.611 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 183' ' ' VAL . . . -58.9 -38.69 79.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.785 0.326 . . . . 0.0 111.17 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -60.07 -34.7 73.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -87.55 -30.99 20.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.168 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -58.45 -50.5 66.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.57 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.888 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.2 OUTLIER -60.77 -43.08 98.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.806 0.336 . . . . 0.0 110.931 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 9.9 m -50.19 -27.37 5.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.252 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -67.93 -58.67 4.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.811 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.518 HD11 ' HZ ' ' A' ' 149' ' ' PHE . 4.1 tp -64.76 -30.1 71.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 192' ' ' LEU . 47.6 t -66.18 -56.92 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.062 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.84 -28.41 61.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.146 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 195' ' ' LEU . 26.2 mt -59.69 -58.22 9.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.012 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 9.0 mt -61.39 -28.8 44.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.057 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.33 -35.4 66.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -90.2 16.46 8.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.44 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.84 39.12 27.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.821 0.343 . . . . 0.0 111.216 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . 0.433 ' CE1' ' HE2' ' A' ' 137' ' ' LYS . 2.8 m-70 -90.2 -23.86 21.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.888 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 13.9 mtt -132.91 -177.51 4.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.777 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -115.59 147.86 40.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.918 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -78.8 -30.52 45.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.041 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.37 60.04 4.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.783 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.587 ' HA ' HD12 ' A' ' 212' ' ' ILE . 0.2 OUTLIER -117.43 138.55 51.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.928 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.444 ' OD2' HD11 ' A' ' 212' ' ' ILE . 57.3 m-20 -154.19 176.16 12.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.732 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -64.68 -39.84 94.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.231 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.03 -59.08 3.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.876 0.369 . . . . 0.0 110.988 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.587 HD12 ' HA ' ' A' ' 208' ' ' THR . 0.3 OUTLIER -57.63 -29.11 33.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.656 179.805 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.405 ' CB ' ' HG3' ' A' ' 148' ' ' MET . . . -80.61 -22.63 40.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.961 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -77.88 -36.62 49.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.866 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -72.47 -38.2 68.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.037 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.66 -30.8 67.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.121 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -81.71 -36.88 28.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.93 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -68.28 -46.85 69.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.52 -30.1 71.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.13 43.79 1.99 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.49 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -100.3 -74.49 0.6 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.882 0.373 . . . . 0.0 110.903 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.588 HG21 ' SD ' ' A' ' 148' ' ' MET . 11.3 t -74.34 142.81 45.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.72 -30.98 46.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.049 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.422 ' SD ' HD13 ' A' ' 122' ' ' LEU . 2.1 mpp? -128.34 156.24 43.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.929 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 9.4 t -166.64 147.36 6.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.47 HD12 ' HB3' ' A' ' 149' ' ' PHE . 4.5 mt -109.85 126.51 67.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.029 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -144.92 165.43 28.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.512 ' HA2' HD23 ' A' ' 113' ' ' LEU . . . -80.96 -169.44 41.46 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.533 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.419 ' HD2' ' CZ3' ' A' ' 230' ' ' TRP . 55.1 Cg_endo -69.81 -8.98 24.99 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.562 2.175 . . . . 0.0 112.699 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . 0.427 ' CZ3' ' HA3' ' A' ' 228' ' ' GLY . 41.0 p90 -94.36 39.25 1.09 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.758 0.314 . . . . 0.0 111.09 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -113.47 -33.19 5.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.129 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 22.4 m0 -63.14 -31.42 72.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.862 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 49.6 m -60.8 -33.69 73.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.96 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.35 -50.89 72.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 18.1 pt -75.58 134.81 28.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.123 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -176.26 -40.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.69 -36.05 9.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.35 -32.69 58.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.923 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt 60.06 74.65 0.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.27 122.0 56.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.063 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -63.18 107.3 1.02 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -98.13 157.65 16.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.3 120.68 2.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.463 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.5 t -94.39 123.04 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 111.1 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 58.9 m -143.52 136.18 27.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.409 ' CG2' ' N ' ' A' ' 247' ' ' LEU . 0.7 OUTLIER -54.62 152.34 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.241 0.543 . . . . 0.0 111.328 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.409 ' N ' ' CG2' ' A' ' 246' ' ' VAL . 4.7 mt -59.62 139.47 89.5 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.884 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.423 ' HB2' ' CD1' ' A' ' 129' ' ' TRP . 51.2 Cg_exo -54.0 -172.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.504 2.136 . . . . 0.0 112.276 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 2.7 p -122.65 165.48 16.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.883 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.416 ' CD2' ' HG3' ' A' ' 251' ' ' LYS . 14.6 t80 -129.0 117.54 21.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.416 ' HG3' ' CD2' ' A' ' 250' ' ' PHE . 6.2 mtpp 59.96 31.99 20.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 73.8 27.02 67.81 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.564 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -118.85 147.81 43.16 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.7 0.286 . . . . 0.0 110.859 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.7 149.89 55.53 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.538 2.159 . . . . 0.0 112.286 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 66.9 p -73.81 159.19 33.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.463 ' HE3' ' HB1' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -121.39 54.59 4.56 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.876 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.19 155.27 64.92 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.575 2.183 . . . . 0.0 112.281 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.494 ' CD2' ' CD2' ' A' ' 155' ' ' TYR . 67.0 m-85 -74.17 166.21 23.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.894 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.488 HG23 ' C ' ' A' ' 328' ' ' GLU . 22.0 t -116.7 134.95 58.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.24 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -128.93 96.24 0.4 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.388 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.755 HG12 ' HD2' ' A' ' 64' ' ' HIS . 10.2 p -98.8 159.96 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.819 0.342 . . . . 0.0 111.216 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.464 ' N ' HG22 ' A' ' 261' ' ' VAL . 12.2 tp -122.21 104.67 9.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.903 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.402 ' HB2' ' CE2' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -109.07 170.3 8.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.924 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.555 ' HB3' ' CE1' ' A' ' 106' ' ' TYR . . . -101.95 143.6 31.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.058 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -116.05 152.43 17.97 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.56 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.806 HD11 ' OH ' ' A' ' 106' ' ' TYR . 30.2 mt -135.15 144.37 34.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.833 0.349 . . . . 0.0 110.983 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.792 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -82.49 153.69 25.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 76' ' ' LEU . . . -84.08 -22.8 31.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.355 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -53.66 -82.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.226 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . 0.418 ' N ' ' HD3' ' A' ' 271' ' ' PRO . 0.3 OUTLIER 179.58 65.56 0.13 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.94 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' A' ' 270' ' ' SER . 4.9 Cg_exo -76.67 -71.44 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.812 2.341 . . . . 0.0 112.088 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.635 ' ND2' HD12 ' A' ' 275' ' ' LEU . 0.6 OUTLIER 174.88 68.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.625 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.26 -28.13 69.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.086 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -77.07 -49.35 15.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.146 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.635 HD12 ' ND2' ' A' ' 272' ' ' ASN . 99.3 mt -76.04 -44.44 39.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.096 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -58.46 -53.38 59.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.155 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 24.6 tttp -59.97 -30.67 69.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.959 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -81.04 -38.51 27.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.943 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.431 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 49.8 t80 -72.55 -34.93 67.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.951 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.987 HD23 HD22 ' A' ' 284' ' ' LEU . 7.8 mt -81.46 -20.77 39.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.396 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -91.08 -48.7 6.81 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.434 ' O ' ' CG ' ' A' ' 283' ' ' TYR . 0.0 OUTLIER -114.16 28.37 8.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.073 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.434 ' CG ' ' O ' ' A' ' 282' ' ' ASN . 32.3 m-85 -164.39 32.75 0.07 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.856 0.36 . . . . 0.0 111.005 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.987 HD22 HD23 ' A' ' 280' ' ' LEU . 10.6 tp -168.66 -42.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.898 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.612 ' CD2' HG23 ' A' ' 108' ' ' ILE . 1.9 mt -98.16 30.38 3.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.897 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 65.8 p -138.95 164.52 29.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.853 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.27 -27.81 62.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.077 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -67.03 -41.88 85.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.022 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.4 ' O ' HG23 ' A' ' 293' ' ' VAL . . . -92.41 -46.47 3.5 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.678 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.505 ' CD2' HG11 ' A' ' 302' ' ' VAL . 0.6 OUTLIER -57.67 -53.61 56.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.801 0.334 . . . . 0.0 111.09 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -58.83 -32.49 69.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.965 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -66.6 -42.51 86.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.141 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 289' ' ' GLY . 21.8 t -81.84 -30.3 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.175 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -69.83 -30.78 68.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 7.9 mtpp -63.58 -33.6 75.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.952 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -98.3 -39.99 8.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.99 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -144.25 89.17 7.1 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.856 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.47 98.08 0.83 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.523 2.149 . . . . 0.0 112.34 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.511 ' H ' HD12 ' A' ' 299' ' ' LEU . 1.7 mp -58.78 -22.88 59.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.094 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 110.04 -118.16 4.98 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.45 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.429 ' HB2' ' HB ' ' A' ' 320' ' ' THR . . . -81.22 163.26 23.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 111.038 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 109' ' ' ALA . 15.5 m -141.59 176.04 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.142 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -87.49 -30.32 20.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.16 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.452 HD23 ' HB2' ' A' ' 307' ' ' TYR . 5.4 tp -58.1 122.22 12.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.975 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -64.51 -41.45 96.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.947 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.5 m -60.01 -53.3 59.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.93 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.452 ' HB2' HD23 ' A' ' 304' ' ' LEU . 2.5 t80 -67.4 -23.2 65.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.162 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.03 -31.24 66.81 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 110.85 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -76.24 -58.04 3.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -50.11 -32.44 15.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.766 ' O ' HD12 ' A' ' 317' ' ' ILE . 32.9 mt -85.76 -26.63 25.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.704 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -74.89 -6.05 47.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.515 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.47 -31.76 4.51 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.986 0.422 . . . . 0.0 110.82 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.87 134.8 24.39 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.317 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.494 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 11.2 Cg_endo -55.15 -27.14 54.48 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.42 2.08 . . . . 0.0 112.373 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -49.82 -42.02 46.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.037 0.446 . . . . 0.0 110.294 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.766 HD12 ' O ' ' A' ' 311' ' ' LEU . 30.8 mt -85.63 -33.55 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.851 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.494 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -58.8 -30.71 67.81 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.129 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.59 -31.98 70.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.082 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.429 ' HB ' ' HB2' ' A' ' 301' ' ' ALA . 25.3 m -62.49 -51.15 68.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.911 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 5.6 tpt -61.5 -37.51 83.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -64.77 -31.87 73.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -67.01 -38.28 85.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -78.7 -35.35 45.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -67.07 -43.65 82.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.928 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.31 -31.35 26.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.84 -164.07 1.82 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.528 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . 0.488 ' C ' HG23 ' A' ' 259' ' ' VAL . 7.4 mm-40 -137.34 129.11 28.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.37 . . . . 0.0 110.892 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.461 HG23 ' NE2' ' A' ' 64' ' ' HIS . 31.2 mt -77.22 138.98 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.113 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 30.4 mtm -76.77 130.47 76.11 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.919 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.44 175.55 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.378 2.052 . . . . 0.0 112.271 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -114.17 32.1 6.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.819 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.482 HD12 ' HB2' ' A' ' 335' ' ' GLN . 42.3 pt -99.63 153.59 37.7 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.2 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.66 -25.2 34.44 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.583 2.188 . . . . 0.0 112.382 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.482 ' HB2' HD12 ' A' ' 333' ' ' ILE . 3.9 mp0 -58.62 -25.16 62.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.096 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 23.3 mmm -56.19 -32.47 64.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.052 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.3 m -59.52 -48.68 80.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.0 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -59.14 -31.55 69.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.06 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.743 ' CZ ' HG21 ' A' ' 343' ' ' VAL . 85.0 t80 -69.34 -32.25 71.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.489 ' CZ2' ' CZ ' ' A' ' 155' ' ' TYR . 68.9 m95 -66.38 -30.63 71.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.961 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -84.71 -51.73 6.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.178 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -55.23 -54.41 43.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.43 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.743 HG21 ' CZ ' ' A' ' 339' ' ' PHE . 28.8 t -59.03 -30.66 44.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.228 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.436 ' O ' HD12 ' A' ' 348' ' ' ILE . 0.2 OUTLIER -59.44 -57.48 12.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.975 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . 0.44 HG22 ' CG ' ' A' ' 349' ' ' ASN . 3.6 m -68.66 -27.29 65.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.108 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -57.14 -61.74 2.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.397 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 23.3 t -61.8 -43.15 96.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.309 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.436 HD12 ' O ' ' A' ' 344' ' ' ARG . 27.7 mt -63.56 -44.98 98.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.109 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.44 ' CG ' HG22 ' A' ' 345' ' ' THR . 28.9 m-20 -59.79 -30.95 69.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -77.96 -51.06 10.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.108 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -60.17 -40.15 88.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.087 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 14.9 m -71.65 -22.42 61.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.122 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 86.5 27.52 29.74 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.453 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -89.59 -30.39 18.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.784 0.326 . . . . 0.0 110.9 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -145.37 145.07 31.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.888 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.7 p -62.37 169.51 2.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.795 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.612 HG23 HD22 ' A' ' 192' ' ' LEU . 1.5 p -62.51 -47.3 93.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.893 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . 0.5 ' HA ' HD12 ' A' ' 361' ' ' LEU . 3.2 m-20 -66.78 -31.42 72.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.987 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -72.19 -43.13 64.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.975 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -60.59 -40.6 92.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.162 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.947 ' CD2' HG12 ' A' ' 183' ' ' VAL . 0.5 OUTLIER -77.35 -31.82 54.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.806 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.6 -52.88 40.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -61.17 -47.28 86.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.408 ' O ' HD12 ' A' ' 368' ' ' ILE . . . -57.96 -37.73 74.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.072 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.834 ' O ' HG22 ' A' ' 369' ' ' THR . 0.8 OUTLIER -60.67 -42.15 96.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.794 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 31.6 m -71.68 -31.5 66.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.862 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 36.1 mtt180 -69.41 -42.02 75.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.72 HD13 HG11 ' A' ' 181' ' ' VAL . 4.8 mt -67.19 -51.96 47.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.834 HG22 ' O ' ' A' ' 365' ' ' GLN . 9.8 t -95.44 43.59 1.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.994 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 1.2 tttm . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.245 -0.884 . . . . 0.0 110.92 179.986 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 47.3 mttt . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.838 0.351 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.694 HG23 ' HA ' ' A' ' 57' ' ' PRO . 0.6 OUTLIER -89.47 -175.75 4.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -151.64 154.34 36.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -83.62 139.89 32.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.925 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.38 26.51 43.16 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.539 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.0 159.74 32.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.78 0.324 . . . . 0.0 110.915 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.42 HD11 ' HB3' ' A' ' 275' ' ' LEU . 7.4 mt -128.09 109.98 12.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.5 t -83.6 147.01 6.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.15 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.74 HD13 HD12 ' A' ' 20' ' ' LEU . 29.6 mt -127.42 107.5 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.949 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.468 ' CE3' HD12 ' A' ' 43' ' ' LEU . 3.6 m0 -97.98 106.76 19.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.798 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.648 HD11 ' HE3' ' A' ' 15' ' ' LYS . 15.7 tt -140.67 158.19 24.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.085 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -59.1 146.51 38.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.26 -26.13 74.16 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.598 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.24 46.45 1.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.914 0.388 . . . . 0.0 111.006 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.648 ' HE3' HD11 ' A' ' 11' ' ' ILE . 1.6 mtmt -141.34 -176.13 4.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.833 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.78 80.33 0.12 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.516 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 19.2 p90 -83.65 -35.61 24.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.868 0.366 . . . . 0.0 110.942 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.4 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 6.9 t-20 -60.31 -31.17 70.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.548 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -67.61 -58.1 8.17 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.476 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.74 HD12 HD13 ' A' ' 9' ' ' ILE . 4.0 mm? -60.79 -30.41 70.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.81 0.338 . . . . 0.0 110.885 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.51 -43.89 95.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.059 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -75.64 -51.96 11.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 19' ' ' GLY . 23.9 t -59.05 -31.21 45.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.055 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.42 -34.41 84.73 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.424 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.8 mmtm -72.46 -28.16 62.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.824 0.345 . . . . 0.0 110.957 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -46.1 89.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.989 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -62.48 -41.21 98.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.956 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -69.79 -30.89 68.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.941 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.8 mttp -82.66 -26.66 31.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.086 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -91.78 -24.98 19.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.726 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.6 p -125.4 -44.19 1.87 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.692 0.282 . . . . 0.0 111.59 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.3 -26.82 5.17 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.585 -0.816 . . . . 0.0 112.467 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.6 mm -59.96 124.33 14.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.826 0.346 . . . . 0.0 111.058 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.3 mtmt -72.23 153.7 41.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.948 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.5 t -140.54 110.58 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.106 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.4 m -105.53 130.25 53.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.933 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.596 HG22 HD12 ' A' ' 9' ' ' ILE . 21.7 t -97.94 110.52 25.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.051 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -103.35 141.18 36.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.974 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -136.57 70.17 59.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.813 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.655 ' HG2' HD22 ' A' ' 43' ' ' LEU . 73.7 Cg_endo -75.63 156.06 40.16 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.629 2.219 . . . . 0.0 112.503 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.69 140.69 37.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.506 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? 56.39 41.72 28.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.675 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.655 HD22 ' HG2' ' A' ' 40' ' ' PRO . 0.9 OUTLIER -89.1 16.87 6.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.554 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -60.99 -42.18 97.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.876 0.369 . . . . 0.0 110.694 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -85.45 -6.3 59.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.252 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.565 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -82.85 -20.07 36.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.376 -179.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.59 ' CE2' HD12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -78.86 -52.58 1.25 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.617 0.246 . . . . 0.0 111.224 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.424 ' HD3' ' CB ' ' A' ' 47' ' ' PHE . 35.2 Cg_exo -59.94 -40.07 65.56 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.47 2.113 . . . . 0.0 112.366 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.442 ' CG ' ' N ' ' A' ' 50' ' ' VAL . 1.7 pt20 -60.12 -49.08 79.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.01 0.433 . . . . 0.0 111.058 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.728 ' O ' HG22 ' A' ' 53' ' ' THR . 34.2 m -79.28 -23.92 12.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.212 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.14 -27.79 48.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.19 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.13 -34.85 75.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.197 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.728 HG22 ' O ' ' A' ' 50' ' ' VAL . 11.8 t -69.52 -26.8 64.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.972 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.34 32.52 4.87 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.602 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.32 -81.25 0.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.789 0.328 . . . . 0.0 110.933 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 54.3 -170.85 1.11 Allowed Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.605 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.694 ' HA ' HG23 ' A' ' 2' ' ' THR . 55.2 Cg_endo -69.59 -179.57 2.93 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.577 2.185 . . . . 0.0 112.253 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -110.2 -31.3 7.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.976 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.8 mt -143.75 137.41 24.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.235 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.59 HD12 ' CE2' ' A' ' 47' ' ' PHE . 2.6 tt -142.36 159.72 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.887 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.48 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 41.7 m-85 -130.46 135.83 48.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.065 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -176.04 161.79 2.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.863 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.92 148.97 28.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.201 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.805 ' CD2' ' HB1' ' A' ' 96' ' ' ALA . 45.4 p-80 -60.7 -36.03 77.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.867 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -60.34 -30.28 69.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -93.85 17.17 12.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.208 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -112.2 29.24 8.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.854 0.359 . . . . 0.0 110.87 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.83 25.35 6.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.535 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -120.53 -36.4 0.79 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.483 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -83.07 -27.59 30.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.745 0.307 . . . . 0.0 111.036 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.538 ' HB2' HD12 ' A' ' 76' ' ' LEU . . . -84.03 -36.88 22.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.165 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -59.19 -32.54 70.02 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.078 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 m -90.1 -23.14 21.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.141 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.96 57.87 0.76 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.45 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.2 mt -139.25 32.36 2.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.793 0.33 . . . . 0.0 110.916 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.538 HD12 ' HB2' ' A' ' 71' ' ' ALA . 13.0 mt -144.4 160.57 40.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.56 163.28 12.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.066 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.453 ' HA ' HG22 ' A' ' 104' ' ' ILE . 1.1 tp10 -93.56 -165.48 1.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.643 HD11 ' CB ' ' A' ' 103' ' ' LEU . 44.6 pt -157.49 172.87 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.957 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 48.1 p -156.54 77.48 4.24 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.802 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.42 134.29 26.27 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.641 2.227 . . . . 0.0 112.348 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.71 174.26 10.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.758 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -59.66 -37.05 77.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.825 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.72 -30.05 69.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.064 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -77.58 -47.72 18.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.895 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -65.64 -30.89 71.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.954 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.04 -27.07 64.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.053 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -95.94 39.83 1.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.03 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.464 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 8.3 mt -157.99 173.74 16.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.861 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.5 ' CZ ' ' HE2' ' A' ' 321' ' ' MET . 27.2 m-85 -89.34 150.78 45.38 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.057 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -67.79 -56.39 0.21 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.454 2.103 . . . . 0.0 112.441 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.83 ' CE1' HG23 ' A' ' 93' ' ' THR . 44.2 p90 -55.68 -41.01 73.09 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.4 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.83 HG23 ' CE1' ' A' ' 92' ' ' PHE . 13.8 p -56.89 -29.62 63.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.068 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.464 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 55.0 m95 -74.52 -30.85 61.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.914 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.85 -28.43 64.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.0 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.805 ' HB1' ' CD2' ' A' ' 64' ' ' HIS . . . -72.26 -29.57 64.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.226 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.0 m -100.46 50.82 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.259 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.707 ' HB3' HD23 ' A' ' 103' ' ' LEU . 7.0 ptm180 -156.08 142.27 18.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -93.69 -47.97 6.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.927 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -151.48 58.71 0.88 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.842 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.08 -27.88 14.96 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.611 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.22 152.47 21.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 110.891 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.707 HD23 ' HB3' ' A' ' 98' ' ' ARG . 13.7 mt -110.59 150.38 29.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.453 HG22 ' HA ' ' A' ' 78' ' ' GLU . 2.2 pp -146.68 30.37 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.221 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.597 ' HB1' ' HB2' ' A' ' 263' ' ' SER . . . -164.34 -176.87 4.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.168 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -142.02 89.35 8.85 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.922 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.717 ' HB3' HG21 ' A' ' 261' ' ' VAL . 51.4 Cg_exo -52.86 129.92 35.12 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.551 2.167 . . . . 0.0 112.214 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.496 ' CG2' HD21 ' A' ' 290' ' ' LEU . 30.4 mt -112.91 -61.34 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.226 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.44 ' CB ' HD13 ' A' ' 299' ' ' LEU . . . -127.34 150.6 49.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.175 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.658 HG13 ' O ' ' A' ' 260' ' ' GLY . 21.5 t -120.72 137.39 54.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.033 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -116.36 161.66 18.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.952 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -169.17 158.44 8.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.098 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.8 mt -67.71 -178.28 0.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.936 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 226' ' ' ILE . 0.3 OUTLIER -169.95 169.27 8.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.929 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.456 ' HB2' HD23 ' A' ' 247' ' ' LEU . 8.4 tp -101.24 142.8 32.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.89 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.7 mt -127.72 131.94 69.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.077 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -134.97 161.18 36.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -115.74 117.76 31.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.024 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -66.64 -28.46 68.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -56.82 -40.78 76.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.928 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.458 HD22 ' NZ ' ' A' ' 144' ' ' LYS . 81.7 mt -88.06 -80.15 0.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.83 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.802 HD22 ' HB1' ' A' ' 223' ' ' ALA . 1.0 OUTLIER -81.21 144.46 54.24 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.84 -43.06 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.477 2.118 . . . . 0.0 112.295 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -139.42 142.77 33.36 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.853 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.61 150.94 36.25 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.566 2.177 . . . . 0.0 112.337 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.28 120.02 6.32 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.56 2.173 . . . . 0.0 112.309 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -94.88 20.59 8.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.95 142.0 29.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.914 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.669 ' CE3' HD12 ' A' ' 132' ' ' ILE . 2.1 m95 -72.54 -25.95 61.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.017 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.1 -21.93 56.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.213 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.407 ' O ' HD12 ' A' ' 135' ' ' LEU . 14.1 mt-10 -77.5 -26.28 51.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.203 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.794 HD13 HD22 ' A' ' 147' ' ' LEU . 36.8 mt -62.26 -54.45 49.26 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.534 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.615 ' HB3' HD21 ' A' ' 198' ' ' LEU . 18.7 Cg_endo -60.23 -28.32 86.67 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.185 1.923 . . . . 0.0 112.131 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.59 -30.21 41.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 131' ' ' GLU . 0.2 OUTLIER -73.74 -35.78 65.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.814 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.37 -27.92 39.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -85.65 -28.21 24.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.072 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -84.45 -37.27 21.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.11 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.709 HD13 ' HA ' ' A' ' 146' ' ' ALA . 0.5 OUTLIER -75.4 -17.21 60.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.487 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.09 -29.54 57.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.876 0.369 . . . . 0.0 110.656 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.46 -37.12 82.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.928 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -78.46 -27.11 46.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.022 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 113.66 45.11 0.73 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.509 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.458 ' NZ ' HD22 ' A' ' 121' ' ' LEU . 11.8 mtmt -162.03 -178.24 6.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.814 0.34 . . . . 0.0 110.937 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.2 t -112.0 176.99 4.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.848 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.709 ' HA ' HD13 ' A' ' 139' ' ' LEU . . . -101.96 -68.42 0.82 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.199 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.794 HD22 HD13 ' A' ' 132' ' ' ILE . 6.3 tp -140.42 145.72 37.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.963 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.664 ' CG ' ' HB2' ' A' ' 213' ' ' ALA . 0.0 OUTLIER -141.21 -177.82 5.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.805 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.434 ' CZ ' ' CE ' ' A' ' 204' ' ' MET . 22.6 p90 -179.4 170.93 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.818 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.405 ' OD1' ' CG ' ' A' ' 156' ' ' PHE . 4.4 p-10 -79.47 131.06 35.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.476 HD23 HG21 ' A' ' 157' ' ' THR . 11.2 mt -105.91 29.13 6.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.992 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -104.41 -30.48 10.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.944 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -119.78 120.69 30.3 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.935 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.05 -21.94 29.18 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.509 2.139 . . . . 0.0 112.434 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.5 ' CD1' ' CE2' ' A' ' 258' ' ' PHE . 2.5 m-85 -53.91 -30.02 44.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.129 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.405 ' CG ' ' OD1' ' A' ' 150' ' ' ASN . 4.3 m-85 -89.81 -30.24 18.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.902 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.479 ' O ' HD12 ' A' ' 161' ' ' ILE . 17.3 p -95.03 18.42 12.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.263 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.471 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 13.4 t-105 -87.44 -46.86 0.49 Allowed Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.313 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.592 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 59.2 Cg_exo -51.72 -25.38 20.39 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.329 2.02 . . . . 0.0 112.438 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 49.6 tp -76.73 -61.95 1.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.001 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.479 HD12 ' O ' ' A' ' 157' ' ' THR . 4.3 mt -69.33 -46.42 76.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.224 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -57.65 -34.05 68.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.25 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -60.09 -41.33 92.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.681 ' OD2' ' HB3' ' A' ' 190' ' ' ALA . 16.5 t0 -68.21 -20.09 64.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.187 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 121.44 41.72 0.49 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.467 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.614 ' HA2' ' HB2' ' A' ' 188' ' ' ALA . . . -119.54 103.6 0.98 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.507 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.44 ' CD2' ' HA3' ' A' ' 182' ' ' GLY . 30.3 p90 -114.15 -177.4 3.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.796 0.332 . . . . 0.0 110.882 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.437 ' HB2' ' CE1' ' A' ' 339' ' ' PHE . . . -108.19 -35.09 6.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.087 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.415 ' CE2' HD11 ' A' ' 333' ' ' ILE . 34.6 m-85 -136.39 152.97 51.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.88 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.27 118.93 37.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.061 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.42 ' CE1' ' HA ' ' A' ' 175' ' ' LYS . 6.5 t80 -79.53 121.24 24.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.489 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -170.41 147.32 2.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.969 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 63.4 42.36 6.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.863 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.4 ' O ' ' CZ ' ' A' ' 171' ' ' TYR . . . 102.83 -63.16 0.44 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.694 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.42 ' HA ' ' CE1' ' A' ' 171' ' ' TYR . 35.9 pttt -128.7 -166.92 1.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.805 0.336 . . . . 0.0 110.994 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -94.09 174.0 7.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -131.31 158.61 40.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.975 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.539 HG21 ' HG2' ' A' ' 335' ' ' GLN . 44.9 pt -92.76 -6.44 10.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.601 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.33 25.89 4.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.755 0.312 . . . . 0.0 111.073 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -152.91 102.53 2.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.859 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.586 HG12 ' H ' ' A' ' 183' ' ' VAL . 24.2 t -93.96 145.95 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.104 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 0.44 ' HA3' ' CD2' ' A' ' 167' ' ' TYR . . . -96.88 -20.46 23.88 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.734 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.65 ' CG1' HD22 ' A' ' 361' ' ' LEU . 21.4 t -55.17 -40.76 56.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.822 0.344 . . . . 0.0 111.346 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -84.29 57.19 4.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.974 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -118.82 168.56 10.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.834 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.59 -32.97 70.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.133 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -83.47 -38.41 10.87 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.534 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.614 ' HB2' ' HA2' ' A' ' 166' ' ' GLY . . . -59.16 -34.35 72.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.866 0.365 . . . . 0.0 111.168 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.526 ' HA ' HD11 ' A' ' 361' ' ' LEU . 9.5 ttmt -59.95 -54.54 44.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.681 ' HB3' ' OD2' ' A' ' 164' ' ' ASP . . . -60.89 -30.14 69.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.177 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -57.9 -54.23 39.04 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.557 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.815 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.1 OUTLIER -65.26 -44.86 86.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.1 m -53.5 -25.22 15.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.203 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -69.49 -60.59 2.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.801 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.503 ' HA ' HD12 ' A' ' 198' ' ' LEU . 2.1 tp -62.3 -33.2 74.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.662 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 192' ' ' LEU . 47.3 t -69.04 -34.57 64.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.975 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -74.06 -38.34 63.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.615 HD21 ' HB3' ' A' ' 133' ' ' PRO . 5.5 mt -57.94 -54.15 50.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.001 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 8.6 mt -68.38 -24.86 30.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.135 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -64.35 -40.89 96.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.022 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -95.81 22.07 7.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.232 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.03 79.22 0.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.844 0.354 . . . . 0.0 111.027 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -149.82 25.44 0.84 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.886 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . 0.434 ' CE ' ' CZ ' ' A' ' 149' ' ' PHE . 23.1 mtp -160.77 -178.78 7.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.822 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -130.05 114.01 15.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.842 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -67.66 -32.58 73.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.89 46.75 1.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.976 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.492 HG23 HG21 ' A' ' 212' ' ' ILE . 57.2 m -98.41 138.17 36.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.923 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -106.15 176.05 5.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.828 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -75.77 -33.56 60.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.938 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.4 m -82.79 -28.18 30.47 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.092 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.492 HG21 HG23 ' A' ' 208' ' ' THR . 0.3 OUTLIER -45.66 -47.47 4.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.218 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.767 ' HB1' HG23 ' A' ' 225' ' ' THR . . . -71.73 -28.09 63.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.16 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.428 ' HA ' ' CE2' ' A' ' 217' ' ' PHE . 0.4 OUTLIER -61.86 -63.0 1.4 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.937 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.77 -21.45 66.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.365 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.444 ' HB1' ' HB2' ' A' ' 221' ' ' GLU . . . -54.09 -61.11 2.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.274 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.431 ' CD1' ' N ' ' A' ' 218' ' ' ASN . 11.2 p90 -68.8 -30.72 69.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.925 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.431 ' N ' ' CD1' ' A' ' 217' ' ' PHE . 5.5 t-20 -60.18 -30.68 69.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.28 28.76 7.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.921 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 58.57 95.92 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.53 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.444 ' HB2' ' HB1' ' A' ' 216' ' ' ALA . 40.2 mt-10 -150.46 -46.89 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.337 . . . . 0.0 110.88 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.3 t -124.71 171.97 9.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.802 ' HB1' HD22 ' A' ' 122' ' ' LEU . . . -93.12 -54.05 3.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.084 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.428 ' HE2' ' HB2' ' A' ' 147' ' ' LEU . 2.9 mpp? -111.08 163.53 13.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.767 HG23 ' HB1' ' A' ' 213' ' ' ALA . 78.4 m -163.99 152.62 13.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.434 HG23 ' O ' ' A' ' 114' ' ' SER . 4.8 mt -126.7 129.56 71.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.018 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.835 ' ND2' ' HB2' ' A' ' 231' ' ' ALA . 2.0 t30 -145.43 159.31 43.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -75.86 -156.44 6.21 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.54 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.417 ' HD2' ' CZ3' ' A' ' 230' ' ' TRP . 43.3 Cg_endo -68.14 -24.22 38.71 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.554 2.169 . . . . 0.0 112.473 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . 0.417 ' CZ3' ' HD2' ' A' ' 229' ' ' PRO . 44.9 p90 -84.06 57.02 3.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.403 . . . . 0.0 110.92 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.835 ' HB2' ' ND2' ' A' ' 227' ' ' ASN . . . -143.0 -44.79 0.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.199 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . 0.522 ' HA ' HD12 ' A' ' 235' ' ' ILE . 20.3 m0 -52.98 -40.84 64.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.058 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 13.0 m -61.71 -30.85 71.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.864 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -64.78 -31.71 73.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.929 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.817 HG21 ' CD1' ' A' ' 242' ' ' TYR . 4.8 mt -84.23 57.77 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.056 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.67 -48.51 2.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.816 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 2.5 m -108.98 31.23 5.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.888 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 3.4 t -100.37 -29.73 12.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp 64.04 40.57 7.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.07 117.62 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.042 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -62.02 124.19 20.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.817 ' CD1' HG21 ' A' ' 235' ' ' ILE . 21.1 p90 -118.94 132.04 56.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.876 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -109.14 131.3 10.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.517 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.472 HG21 ' CZ2' ' A' ' 232' ' ' TRP . 21.3 t -99.21 117.42 44.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.809 0.338 . . . . 0.0 111.085 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.7 t -135.8 149.66 49.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 247' ' ' LEU . 0.7 OUTLIER -55.09 152.22 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.257 0.551 . . . . 0.0 111.311 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.456 HD23 ' HB2' ' A' ' 115' ' ' LEU . 40.7 mt -72.35 152.15 92.1 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.077 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.73 177.15 2.43 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.619 2.213 . . . . 0.0 112.258 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.429 HG22 ' HA ' ' A' ' 254' ' ' PRO . 57.5 p -115.57 152.76 32.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -100.37 116.48 32.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.76 25.97 15.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.038 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 93.64 -21.09 43.04 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.695 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -87.74 142.18 32.38 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.685 0.278 . . . . 0.0 110.901 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.429 ' HA ' HG22 ' A' ' 249' ' ' THR . 73.3 Cg_endo -75.8 163.26 33.87 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.578 2.185 . . . . 0.0 112.339 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.4 p -88.18 179.52 6.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.892 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.421 ' N ' ' HD3' ' A' ' 257' ' ' PRO . 5.5 mtmm -136.55 62.86 44.92 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.939 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 256' ' ' LYS . 32.3 Cg_exo -57.94 -173.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.537 2.158 . . . . 0.0 112.242 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.5 ' CE2' ' CD1' ' A' ' 155' ' ' TYR . 43.4 m-85 -103.91 126.22 50.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.729 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.2 t -108.63 138.53 35.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.378 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.658 ' O ' HG13 ' A' ' 110' ' ' VAL . . . -119.78 156.3 15.89 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.258 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.717 HG21 ' HB3' ' A' ' 107' ' ' PRO . 10.9 p -139.65 152.2 22.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.819 0.342 . . . . 0.0 111.238 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 20.3 tp -105.25 110.28 22.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.597 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 0.9 OUTLIER -125.74 155.95 40.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.933 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -100.85 133.46 45.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.113 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -101.38 161.74 18.05 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.489 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 31.5 mt -135.14 152.0 31.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.822 0.344 . . . . 0.0 111.146 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -91.47 149.27 21.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.952 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.98 -28.38 68.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.189 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -55.82 -30.0 60.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.268 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 5.9 t 59.09 62.5 4.11 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.55 -32.84 14.6 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.583 2.188 . . . . 0.0 112.297 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.433 ' OD1' HD12 ' A' ' 275' ' ' LEU . 4.5 t-20 -162.33 46.86 0.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.891 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 34.0 mttt -59.62 -31.83 69.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -60.15 -54.97 39.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.897 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.433 HD12 ' OD1' ' A' ' 272' ' ' ASN . 77.8 mt -75.24 -31.06 60.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -59.87 -45.86 91.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.34 -51.26 70.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.906 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -61.81 -45.39 94.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -66.09 -37.85 86.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.972 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 55.3 mt -81.33 -21.01 39.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.376 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -93.52 -43.32 8.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.796 0.331 . . . . 0.0 111.334 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -92.08 -48.92 6.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.211 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.485 ' HB3' HG12 ' A' ' 23' ' ' VAL . 10.4 m-85 -96.96 38.56 1.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.166 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.567 HD21 HD11 ' A' ' 20' ' ' LEU . 0.2 OUTLIER 179.96 38.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.888 179.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -177.77 37.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.825 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 38.3 p -140.79 167.28 22.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.921 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -64.91 -30.43 71.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.969 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -76.24 -30.64 57.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.981 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -90.71 -50.76 2.83 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.588 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.496 HD21 ' CG2' ' A' ' 108' ' ' ILE . 3.5 mt -59.28 -41.1 88.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.991 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -62.37 -37.06 84.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.959 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.41 -47.57 83.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.043 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.514 HG22 ' HA3' ' A' ' 19' ' ' GLY . 25.3 t -72.94 -30.92 33.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.027 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -71.81 -31.25 66.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 9.9 mtmt -63.41 -34.84 78.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.99 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -99.53 -34.74 10.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.078 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.4 tptt -148.43 91.33 4.76 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.98 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.5 108.54 2.24 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.495 2.13 . . . . 0.0 112.296 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.44 HD13 ' CB ' ' A' ' 109' ' ' ALA . 4.9 mt -59.53 -28.4 67.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.013 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 107.37 -125.83 8.15 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.461 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.83 94.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.846 0.355 . . . . 0.0 111.039 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.788 HG21 ' HB3' ' A' ' 307' ' ' TYR . 30.1 m -67.65 158.08 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.184 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 108' ' ' ILE . . . -87.94 -26.45 22.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.141 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 10.0 tp -55.97 127.63 31.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.963 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -67.31 -29.49 69.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.048 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.26 -26.09 36.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.226 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.788 ' HB3' HG21 ' A' ' 302' ' ' VAL . 0.1 OUTLIER -96.54 -22.98 16.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.396 -179.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.38 -33.4 69.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.859 0.362 . . . . 0.0 110.948 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -75.48 -53.49 8.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.907 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -49.66 -34.13 17.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.767 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.722 ' HB3' HG21 ' A' ' 317' ' ' ILE . 12.4 mt -85.8 -26.46 25.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.641 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -71.56 -14.12 61.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.433 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -48.0 -34.1 8.85 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.965 0.412 . . . . 0.0 110.83 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.52 138.1 21.34 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.381 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.464 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 11.4 Cg_endo -55.3 -23.56 38.23 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.407 2.071 . . . . 0.0 112.432 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.05 -41.58 59.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.961 0.41 . . . . 0.0 110.34 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.722 HG21 ' HB3' ' A' ' 311' ' ' LEU . 33.8 mm -85.57 -33.65 7.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.952 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -68.67 -30.08 68.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.223 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -73.64 -51.71 15.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.178 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 8.8 t -58.94 -30.73 68.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.995 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.5 ' HE2' ' CZ ' ' A' ' 90' ' ' TYR . 4.9 ttt -85.47 -31.03 23.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.983 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -59.27 -46.96 87.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.912 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -66.05 -31.52 72.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -72.06 -49.21 38.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.088 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -59.97 -35.64 75.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.919 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -96.27 21.07 9.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.085 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -133.3 -179.11 16.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.514 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.09 137.2 42.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.819 0.343 . . . . 0.0 110.929 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.585 HG22 ' HE2' ' A' ' 64' ' ' HIS . 12.2 mt -80.29 144.28 10.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.055 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 15.1 ttm -57.21 113.32 5.95 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.941 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.83 -172.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.459 2.106 . . . . 0.0 112.315 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -152.76 38.6 0.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.923 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.637 HD12 ' HB2' ' A' ' 335' ' ' GLN . 10.2 pt -107.2 155.75 38.8 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.129 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.34 -27.75 47.42 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.535 2.157 . . . . 0.0 112.336 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.637 ' HB2' HD12 ' A' ' 333' ' ' ILE . 1.4 mp0 -59.44 -22.59 61.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.091 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 9.5 mtp -54.63 -28.3 45.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.127 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.1 m -56.91 -53.96 52.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.014 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -59.66 -30.29 68.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.041 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.72 ' CZ ' HG21 ' A' ' 343' ' ' VAL . 51.6 t80 -58.95 -34.11 71.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.885 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.497 ' CH2' ' CE1' ' A' ' 155' ' ' TYR . 97.3 m95 -76.24 -21.86 55.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.175 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -84.83 -34.74 22.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.419 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -87.05 -57.95 2.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.85 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.849 ' O ' HG23 ' A' ' 347' ' ' VAL . 47.3 t -48.98 -56.55 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.804 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -52.89 -29.98 31.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.394 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 10.7 m -84.1 -55.71 4.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.113 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.889 ' HB1' ' HB1' ' A' ' 360' ' ' ALA . . . -51.44 -26.47 8.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.615 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 343' ' ' VAL . 31.3 t -82.75 -55.32 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.234 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 59.4 mt -64.94 -41.85 93.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.335 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -57.59 -39.29 76.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.001 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -86.32 -30.55 22.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.108 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -76.18 -29.03 57.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.233 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 72.7 m -95.6 20.74 9.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.175 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 56.04 25.39 46.12 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.644 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.82 -31.55 20.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.87 0.366 . . . . 0.0 110.869 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -144.71 -168.82 3.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.859 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 19.3 p -121.52 160.4 24.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 30.2 t -58.06 -56.31 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.063 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.49 -29.71 1.88 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.185 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -84.25 -42.75 15.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.889 ' HB1' ' HB1' ' A' ' 346' ' ' ALA . . . -60.3 -59.72 4.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.736 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.65 HD22 ' CG1' ' A' ' 183' ' ' VAL . 3.3 mt -58.39 -26.77 63.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.03 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 30.9 tttt -80.89 -59.18 2.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.782 0.325 . . . . 0.0 110.965 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -61.16 -44.76 96.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.83 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -52.49 -37.8 58.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.253 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.616 ' O ' HG23 ' A' ' 369' ' ' THR . 19.9 tt0 -59.42 -43.36 93.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.471 HG22 ' HD2' ' A' ' 370' ' ' LYS . 69.3 m -63.57 -39.92 95.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.984 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 31.9 mtt180 -67.06 -42.51 84.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.991 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 19.0 mt -75.45 -31.37 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.174 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 365' ' ' GLN . 63.6 p -81.91 -31.42 31.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.877 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.471 ' HD2' HG22 ' A' ' 366' ' ' THR . 3.5 mtpp . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.889 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.821 0.343 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.544 ' O ' HG23 ' A' ' 2' ' ' THR . 6.7 t -150.52 91.23 1.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -133.81 87.63 2.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.921 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -133.42 20.2 3.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.188 0.518 . . . . 0.0 111.207 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.466 ' O ' HG23 ' A' ' 33' ' ' ILE . . . 75.52 34.61 49.44 Favored Glycine 0 C--N 1.317 -0.503 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.509 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.78 -177.23 4.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.832 0.349 . . . . 0.0 110.931 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.3 mt -133.51 118.2 18.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.94 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.49 147.0 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.193 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.453 HD13 ' CD1' ' A' ' 20' ' ' LEU . 31.4 mt -132.59 107.44 12.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.947 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.425 ' CE3' ' HB3' ' A' ' 57' ' ' PRO . 19.7 m0 -92.95 106.65 18.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.873 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.8 tt -137.97 158.98 33.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.046 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -54.84 174.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.049 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.22 -23.99 49.53 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.68 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -137.6 81.42 1.86 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.849 0.357 . . . . 0.0 110.961 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.81 36.71 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.811 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.58 43.37 4.88 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.504 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -85.22 -31.33 23.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 0.0 110.904 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -32.58 70.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.923 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -80.83 -38.69 15.39 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.501 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.453 ' CD1' HD13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -61.48 -30.65 70.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.808 0.337 . . . . 0.0 110.896 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.36 -42.98 99.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -68.2 -44.18 76.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 19' ' ' GLY . 21.7 t -62.03 -33.46 58.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.213 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.11 -27.86 73.56 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.558 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -83.21 -27.74 29.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.759 0.314 . . . . 0.0 111.011 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -45.5 89.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.947 0.403 . . . . 0.0 110.956 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.434 ' CD2' ' HB ' ' A' ' 33' ' ' ILE . 10.4 t80 -61.51 -38.87 88.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.016 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.41 ' O ' ' HA2' ' A' ' 32' ' ' GLY . 28.3 mt-10 -60.75 -32.57 71.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.877 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.4 tttm -82.67 -24.36 33.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.918 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -90.8 -26.14 19.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.68 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.1 p -137.29 -44.28 0.56 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 28' ' ' GLU . . . 121.23 -17.82 9.01 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.687 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.466 HG23 ' O ' ' A' ' 5' ' ' GLY . 37.3 mm -59.94 105.43 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.872 0.368 . . . . 0.0 110.96 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -58.67 141.89 51.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.95 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.6 130.12 74.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.117 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.0 m -121.94 150.61 41.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.5 t -133.73 116.55 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.156 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -104.37 161.94 13.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.49 70.29 32.17 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.951 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.16 168.55 24.48 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.56 2.173 . . . . 0.0 112.215 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -89.94 140.13 29.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.935 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.477 ' O ' HD23 ' A' ' 43' ' ' LEU . 12.8 mmtt 74.91 -57.2 0.61 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.98 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.837 HD11 ' CZ3' ' A' ' 62' ' ' TRP . 0.4 OUTLIER 51.17 18.41 0.58 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.051 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.22 -57.03 3.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.796 0.331 . . . . 0.0 110.949 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -83.17 -6.84 59.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.45 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.54 -20.08 65.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.325 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.533 ' CZ ' HG21 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -87.21 -58.43 0.29 Allowed Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.189 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.508 ' HD3' ' CB ' ' A' ' 47' ' ' PHE . 52.0 Cg_exo -55.24 -30.71 73.05 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.33 2.02 . . . . 0.0 112.412 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.53 ' HG3' HG13 ' A' ' 50' ' ' VAL . 5.9 pt20 -60.08 -48.99 79.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.984 0.421 . . . . 0.0 111.084 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.53 HG13 ' HG3' ' A' ' 49' ' ' GLN . 5.5 m -93.18 17.63 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.762 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.656 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -91.06 -35.63 14.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.826 0.346 . . . . 0.0 111.164 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.21 -26.66 26.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.213 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.402 HG22 ' C ' ' A' ' 50' ' ' VAL . 10.1 t -59.96 -27.54 66.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.005 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.75 36.29 5.35 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.492 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.53 -78.2 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.894 0.378 . . . . 0.0 110.863 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.41 173.74 26.91 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.475 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.457 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 44.4 Cg_endo -68.49 -167.55 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.542 2.161 . . . . 0.0 112.242 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.75 -45.72 3.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.027 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.85 HD13 HD21 ' A' ' 280' ' ' LEU . 19.3 mt -149.39 159.06 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.29 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.533 HG21 ' CZ ' ' A' ' 47' ' ' PHE . 2.4 tt -159.02 159.47 2.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.866 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.511 ' HE2' HD21 ' A' ' 284' ' ' LEU . 4.1 m-85 -128.59 137.96 51.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.914 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.837 ' CZ3' HD11 ' A' ' 43' ' ' LEU . 2.9 t-105 -176.03 163.31 2.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.854 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.24 140.16 53.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.11 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.421 ' HE1' HG22 ' A' ' 329' ' ' ILE . 6.0 p80 -57.62 -30.9 65.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.963 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.67 -42.05 98.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.958 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.06 17.27 12.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.291 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.45 -26.02 13.03 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.735 0.302 . . . . 0.0 110.992 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.29 49.61 3.75 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.54 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -120.96 -34.08 0.93 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.583 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -93.38 -23.48 18.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.715 0.293 . . . . 0.0 111.096 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.529 ' HB2' HD12 ' A' ' 76' ' ' LEU . . . -75.59 -24.66 56.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.121 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -56.75 -38.18 72.05 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.033 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.4 t -90.52 -23.08 21.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.016 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.23 34.57 3.13 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.487 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.656 HD22 ' HB1' ' A' ' 51' ' ' ALA . 11.2 mt -85.57 -46.11 11.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 0.0 110.847 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.529 HD12 ' HB2' ' A' ' 71' ' ' ALA . 7.2 mt -74.1 170.64 15.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.834 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.623 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -100.7 155.03 18.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.032 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.12 -165.02 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.845 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.788 HD11 ' HB3' ' A' ' 103' ' ' LEU . 37.6 pt -157.02 166.82 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.044 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.0 p -156.53 77.45 4.25 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.779 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.39 154.53 60.85 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.641 2.228 . . . . 0.0 112.314 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.7 175.94 8.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.793 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 28.2 mttm -59.59 -45.34 92.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.85 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.08 -30.51 69.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.01 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -73.41 -35.15 65.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -81.6 -29.86 33.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.944 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.57 -40.2 70.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.012 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.3 pttt -59.22 -35.2 73.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.004 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.635 HD23 ' HB1' ' A' ' 303' ' ' ALA . 4.0 mt -90.6 148.84 22.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.865 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.437 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . 83.2 m-85 -78.42 144.61 66.32 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.966 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -49.35 -55.71 3.87 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.695 2.263 . . . . 0.0 112.844 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 93' ' ' THR . 21.7 p90 -49.33 -37.28 23.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.436 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.46 HG21 ' HB1' ' A' ' 303' ' ' ALA . 0.3 OUTLIER -59.71 -42.22 92.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.896 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.573 ' CZ2' HD13 ' A' ' 89' ' ' LEU . 61.4 m95 -69.65 -34.81 74.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.905 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.98 -25.82 67.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.007 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.45 ' HB2' HD13 ' A' ' 329' ' ' ILE . . . -74.67 -33.9 62.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.16 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.494 ' O ' HD23 ' A' ' 103' ' ' LEU . 5.6 m -103.52 64.2 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.198 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -156.01 123.64 5.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.32 -52.95 6.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.81 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -143.38 48.69 1.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.73 -25.34 25.42 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.597 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -91.24 135.12 34.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.366 . . . . 0.0 110.95 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.788 ' HB3' HD11 ' A' ' 79' ' ' ILE . 78.7 mt -88.71 150.46 22.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.83 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.584 ' O ' HD12 ' A' ' 104' ' ' ILE . 2.8 pp -157.14 34.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.193 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.693 ' HB1' ' HB2' ' A' ' 263' ' ' SER . . . -159.54 174.23 14.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.11 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.48 ' OH ' HG22 ' A' ' 79' ' ' ILE . 72.3 m-85 -133.42 82.24 52.85 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.807 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.65 119.39 4.64 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.625 2.216 . . . . 0.0 112.392 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.5 mt -101.69 -66.56 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.146 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.418 ' O ' HG12 ' A' ' 261' ' ' VAL . . . -108.58 148.94 29.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.096 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.77 125.26 66.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.141 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.67 148.9 24.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.908 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.509 ' HB1' ' HB3' ' A' ' 323' ' ' ASN . . . -169.94 153.77 4.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.049 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.2 mt -65.22 164.98 12.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.1 178.91 8.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.783 HD11 HD11 ' A' ' 147' ' ' LEU . 63.3 tp -137.62 114.22 10.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.939 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.929 HD12 ' HB2' ' A' ' 227' ' ' ASN . 5.1 mt -106.97 150.1 9.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.067 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.403 ' CE2' ' O ' ' A' ' 243' ' ' GLY . 45.1 p90 -148.55 165.45 31.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.955 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -91.58 121.26 33.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.59 -17.42 61.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.171 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.24 -50.84 68.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.76 0.314 . . . . 0.0 111.132 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.474 ' CD1' ' HB2' ' A' ' 223' ' ' ALA . 0.6 OUTLIER -110.89 -31.06 7.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.086 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.539 ' HB2' ' HB1' ' A' ' 223' ' ' ALA . 7.5 tp -104.39 89.35 2.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.964 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.13 -46.94 1.93 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.563 2.175 . . . . 0.0 112.295 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -119.24 128.92 25.67 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.826 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.914 ' CB ' HG21 ' A' ' 245' ' ' THR . 72.4 Cg_endo -76.58 147.76 28.62 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.424 2.083 . . . . 0.0 112.38 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.33 120.47 5.98 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.546 2.164 . . . . 0.0 112.335 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.96 20.57 8.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.1 p -136.5 141.96 43.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.93 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.644 ' CH2' HD13 ' A' ' 160' ' ' LEU . 12.6 m95 -81.68 -29.27 33.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -74.87 -15.84 60.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.378 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.79 -14.84 33.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.531 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.501 HD12 ' CE3' ' A' ' 129' ' ' TRP . 25.4 mt -65.88 -46.3 65.14 Favored Pre-proline 0 C--N 1.331 -0.214 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.484 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 50.9 Cg_exo -53.95 -49.98 15.27 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.293 1.995 . . . . 0.0 112.304 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.0 -35.28 76.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.134 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 135' ' ' LEU . 6.3 mt -63.97 -46.05 86.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.96 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.446 ' N ' ' HB2' ' A' ' 146' ' ' ALA . 11.8 t70 -52.08 -29.56 22.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.983 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -85.53 -27.76 25.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.044 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -85.05 -31.64 23.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.087 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.432 HD13 ' O ' ' A' ' 145' ' ' SER . 2.0 mt -83.87 -17.25 41.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.375 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -76.66 -29.11 56.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.808 0.337 . . . . 0.0 110.607 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.4 -37.35 85.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.892 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -80.57 -27.02 37.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.973 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 117.48 33.92 1.26 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.579 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.71 172.56 13.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.826 0.346 . . . . 0.0 110.882 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.432 ' O ' HD13 ' A' ' 139' ' ' LEU . 13.3 t -107.37 172.68 6.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.926 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.446 ' HB2' ' N ' ' A' ' 136' ' ' ASP . . . -73.19 -78.18 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.111 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.783 HD11 HD11 ' A' ' 115' ' ' LEU . 5.2 tp -137.86 115.98 11.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.922 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.669 ' SD ' HG23 ' A' ' 208' ' ' THR . 0.0 OUTLIER -84.55 158.2 21.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.229 0.538 . . . . 0.0 111.539 -179.726 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.445 ' H ' HG21 ' A' ' 208' ' ' THR . 38.1 p90 178.35 144.06 0.12 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.876 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -59.38 121.2 10.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.065 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.619 HD22 HD21 ' A' ' 195' ' ' LEU . 11.2 mt -107.32 32.94 4.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.891 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -95.61 -69.82 0.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.97 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -77.27 149.36 79.03 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.002 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.451 ' CB ' HG12 ' A' ' 343' ' ' VAL . 63.5 Cg_endo -73.16 -9.0 22.91 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.652 2.235 . . . . 0.0 112.618 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 258' ' ' PHE . 5.2 t80 -59.67 -26.51 65.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.746 0.308 . . . . 0.0 111.117 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -91.17 -36.1 14.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.056 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 43.9 p -81.48 -22.22 38.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.226 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.564 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 64.9 t-105 -53.03 -54.36 45.09 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.642 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 12.7 Cg_endo -56.29 -21.02 34.46 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.233 1.955 . . . . 0.0 112.431 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.644 HD13 ' CH2' ' A' ' 129' ' ' TRP . 1.9 tp -87.67 -42.57 12.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.853 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.856 HD13 HD12 ' A' ' 192' ' ' LEU . 20.0 mt -77.9 -46.21 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.147 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -59.98 -27.85 67.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.237 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.598 ' HB2' ' HA ' ' A' ' 255' ' ' SER . . . -56.65 -39.12 73.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.236 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.83 -20.14 55.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.162 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 136.02 -28.31 2.95 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.49 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.684 ' HA3' ' HB2' ' A' ' 188' ' ' ALA . . . -59.61 151.07 37.36 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.43 ' CG ' ' HA3' ' A' ' 182' ' ' GLY . 41.6 p90 -141.58 -176.16 4.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 110.916 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.405 ' HB2' ' CZ ' ' A' ' 339' ' ' PHE . . . -97.75 -49.0 4.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.053 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.466 ' CE2' HD11 ' A' ' 333' ' ' ILE . 92.1 m-85 -133.22 154.77 50.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.914 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.13 134.13 40.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -101.14 110.88 22.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.657 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -162.79 146.19 11.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.867 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 61.46 30.38 18.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 64.84 13.7 57.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.009 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.96 160.08 38.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.848 0.356 . . . . 0.0 111.01 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -101.5 102.11 12.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.816 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -59.01 136.63 58.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.986 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.521 HG21 ' NE2' ' A' ' 335' ' ' GLN . 3.0 pt -93.59 -29.05 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.186 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -69.44 -16.44 63.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.296 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -102.43 150.32 23.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.783 0.325 . . . . 0.0 111.01 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 183' ' ' VAL . 21.4 t -131.81 146.05 33.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.048 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 0.43 ' HA3' ' CG ' ' A' ' 167' ' ' TYR . . . -103.06 -18.3 15.59 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.783 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.669 HG12 HD22 ' A' ' 361' ' ' LEU . 21.3 t -56.65 -44.38 81.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.81 0.338 . . . . 0.0 111.25 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -84.16 57.38 4.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.906 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -120.25 -177.3 3.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.868 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -76.21 -29.61 57.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.191 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -82.26 -47.19 6.2 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.556 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.684 ' HB2' ' HA3' ' A' ' 166' ' ' GLY . . . -57.31 -29.97 64.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.82 0.343 . . . . 0.0 111.197 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -67.92 -49.28 62.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.906 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -74.22 -30.15 62.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.163 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -58.85 -53.91 42.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.557 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.856 HD12 HD13 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -59.43 -43.96 92.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.86 0.362 . . . . 0.0 110.997 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 61.0 m -57.39 -21.79 38.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.257 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.617 ' CZ ' HD11 ' A' ' 198' ' ' LEU . 14.2 t80 -68.21 -60.53 2.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.824 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.619 HD21 HD22 ' A' ' 151' ' ' LEU . 4.2 tp -63.11 -35.59 80.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.626 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 192' ' ' LEU . 43.8 t -66.19 -56.81 12.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.983 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -67.63 -26.83 66.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.999 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.617 HD11 ' CZ ' ' A' ' 194' ' ' PHE . 4.9 mt -61.26 -58.42 8.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.003 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 195' ' ' LEU . 5.6 mt -57.65 -21.24 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.439 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -84.86 -35.71 22.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.407 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -113.08 19.43 17.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.703 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.34 -17.21 3.81 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 14.1 m80 64.22 43.8 4.72 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.884 0.373 . . . . 0.0 110.671 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.89 146.68 28.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.85 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -81.99 116.77 21.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.96 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.16 -10.15 59.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.413 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.6 56.93 4.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.875 0.369 . . . . 0.0 111.008 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.669 HG23 ' SD ' ' A' ' 148' ' ' MET . 0.6 OUTLIER -117.0 133.08 56.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.802 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.858 ' OD2' HD11 ' A' ' 212' ' ' ILE . 55.0 m-20 -154.11 176.1 12.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.029 0.442 . . . . 0.0 111.106 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.401 ' CD2' ' OE2' ' A' ' 214' ' ' GLU . 1.1 t80 -41.87 -61.64 1.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.81 -59.21 3.24 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.858 HD11 ' OD2' ' A' ' 209' ' ' ASP . 0.2 OUTLIER -53.81 -34.03 24.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.507 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.456 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -81.78 -24.14 36.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.712 0.291 . . . . 0.0 110.915 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.401 ' OE2' ' CD2' ' A' ' 210' ' ' TYR . 4.0 mt-10 -82.29 -46.08 14.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.939 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.13 -31.22 66.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.131 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.33 -35.74 78.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.023 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.421 ' CD1' HG22 ' A' ' 225' ' ' THR . 42.1 t80 -82.24 -36.53 27.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -59.11 -46.77 87.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.973 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -76.41 -27.98 56.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.958 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.35 31.2 6.58 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.521 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -77.94 -71.33 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.808 0.337 . . . . 0.0 110.86 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.4 t -68.0 129.0 38.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.539 ' HB1' ' HB2' ' A' ' 122' ' ' LEU . . . -59.18 -36.81 75.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.14 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.518 ' C ' HD12 ' A' ' 147' ' ' LEU . 9.7 ptt? -141.37 153.89 45.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.553 ' O ' HD12 ' A' ' 115' ' ' LEU . 9.0 t -151.42 157.89 42.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.43 HD12 ' CB ' ' A' ' 149' ' ' PHE . 30.2 mt -94.97 121.82 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.109 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.929 ' HB2' HD12 ' A' ' 116' ' ' ILE . 0.8 OUTLIER -137.84 165.44 26.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.822 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -124.39 -162.31 11.37 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.617 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.81 -10.28 26.14 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.846 2.364 . . . . 0.0 112.71 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -92.56 28.28 2.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.651 0.262 . . . . 0.0 111.386 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.05 19.18 1.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.371 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 9.6 m95 -81.2 -55.84 4.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.851 0.358 . . . . 0.0 110.919 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.7 m -57.3 -26.5 60.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.177 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -54.66 -29.27 52.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.092 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.803 HG21 ' CD1' ' A' ' 242' ' ' TYR . 3.2 mt -86.71 98.53 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.046 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -169.98 -49.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.1 t -73.35 -33.51 65.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . 0.517 ' HB3' HG23 ' A' ' 240' ' ' VAL . 71.1 m -90.88 -30.26 17.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt 62.13 31.4 17.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.517 HG23 ' HB3' ' A' ' 238' ' ' SER . 21.6 t -74.43 124.2 31.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.083 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -61.93 94.24 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.827 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.803 ' CD1' HG21 ' A' ' 235' ' ' ILE . 50.3 p90 -89.99 123.02 33.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.924 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.403 ' O ' ' CE2' ' A' ' 117' ' ' TYR . . . -108.99 95.32 0.9 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.469 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 27.0 t -68.95 127.96 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.815 0.34 . . . . 0.0 111.088 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.914 HG21 ' CB ' ' A' ' 125' ' ' PRO . 9.9 t -134.0 159.33 41.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.7 t -66.65 152.02 9.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.97 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.2 mp -67.63 151.19 97.39 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.944 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.426 ' HG3' HD11 ' A' ' 132' ' ' ILE . 39.5 Cg_endo -67.14 162.98 35.92 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.543 2.162 . . . . 0.0 112.211 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 36.9 p -102.14 144.99 30.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.968 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.49 ' CE1' ' CZ ' ' A' ' 194' ' ' PHE . 26.9 t80 -129.31 132.06 47.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.06 18.44 8.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.282 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 91.21 -21.27 35.48 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.942 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.66 145.74 31.19 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.701 0.286 . . . . 0.0 110.926 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.66 164.04 34.58 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.589 2.192 . . . . 0.0 112.299 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.598 ' HA ' ' HB2' ' A' ' 163' ' ' ALA . 0.3 OUTLIER -62.15 -176.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 15.7 mttp -137.0 66.61 54.91 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.7 176.19 9.21 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.561 2.174 . . . . 0.0 112.324 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 155' ' ' TYR . 95.1 m-85 -95.26 166.12 12.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.99 136.4 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.293 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -131.15 121.68 3.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.349 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -113.67 133.64 58.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 111.233 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 12.9 tp -92.07 90.17 7.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.568 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.693 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 0.9 OUTLIER -84.87 167.01 16.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.08 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -98.97 114.99 27.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.997 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -81.92 149.8 28.59 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.529 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 31.3 mt -142.41 152.0 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 0.0 111.098 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -98.93 149.93 22.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.962 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.623 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -68.6 -36.68 79.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.065 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -97.35 36.54 1.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.14 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.3 m -69.27 146.5 96.77 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.888 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.51 -49.32 17.76 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.524 2.149 . . . . 0.0 112.264 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -141.76 83.4 1.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.82 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? -63.08 -34.33 77.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.82 -53.94 52.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.876 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 68.7 mt -59.78 -32.52 70.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.9 -40.69 96.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -52.3 25.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.9 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -60.34 -42.35 95.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.415 ' CE2' ' HB2' ' A' ' 27' ' ' PHE . 11.9 t80 -60.26 -64.28 1.01 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.123 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.978 HD22 HD22 ' A' ' 284' ' ' LEU . 26.2 mt -57.25 -21.65 35.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.411 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -90.48 -32.93 16.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.704 0.288 . . . . 0.0 111.375 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.402 ' O ' ' CD1' ' A' ' 283' ' ' TYR . 35.2 m-80 -104.34 20.39 18.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.285 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.558 ' O ' HG22 ' A' ' 286' ' ' THR . 96.1 m-85 -157.75 -66.25 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.825 0.345 . . . . 0.0 111.042 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.978 HD22 HD22 ' A' ' 280' ' ' LEU . 17.6 tp -60.84 -30.14 69.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.935 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 99.6 mt -121.89 82.28 1.93 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.964 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.56 HG23 ' HA3' ' A' ' 289' ' ' GLY . 0.6 OUTLIER -160.96 170.01 21.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.835 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.2 -57.07 8.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -69.26 -42.77 75.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.049 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.56 ' HA3' HG23 ' A' ' 286' ' ' THR . . . -57.77 -57.2 21.03 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.615 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.488 HD22 HG11 ' A' ' 302' ' ' VAL . 30.4 mt -58.59 -29.85 66.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.802 0.334 . . . . 0.0 110.976 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -60.05 -43.82 95.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.001 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -59.53 -53.67 55.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.142 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.1 t -59.65 -32.17 48.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.22 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -71.68 -31.21 66.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.944 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 49.1 mttm -65.69 -34.66 78.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.955 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.62 -35.04 11.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.5 90.71 4.55 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.889 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.91 112.61 2.75 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.548 2.165 . . . . 0.0 112.238 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 1.2 mt -97.4 25.82 5.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.003 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . 0.589 ' O ' HD13 ' A' ' 311' ' ' LEU . . . 58.29 -125.5 39.66 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.553 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.572 ' HB2' ' CG ' ' A' ' 321' ' ' MET . . . -64.97 156.05 32.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.78 0.324 . . . . 0.0 111.099 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.488 HG11 HD22 ' A' ' 290' ' ' LEU . 9.6 m -128.36 24.89 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.234 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.635 ' HB1' HD23 ' A' ' 89' ' ' LEU . . . 52.92 27.37 5.45 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.343 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.479 ' HB2' HG23 ' A' ' 302' ' ' VAL . 0.5 OUTLIER -116.0 125.24 52.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.862 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -67.01 -31.78 72.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.01 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.8 m -81.2 -29.8 34.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.164 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.422 ' CE2' ' HB2' ' A' ' 290' ' ' LEU . 1.9 t80 -87.91 -28.24 21.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.202 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 0.0 OUTLIER -54.09 -29.63 45.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.814 0.34 . . . . 0.0 111.062 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -67.79 -61.51 1.85 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -50.86 -33.7 24.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.77 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.78 ' HB3' HG21 ' A' ' 317' ' ' ILE . 46.9 mt -85.76 -25.83 26.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.781 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 308' ' ' GLU . . . -73.39 -7.44 51.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.558 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -47.21 -30.59 3.06 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.95 0.405 . . . . 0.0 110.895 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.33 133.81 24.31 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.283 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.512 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 10.8 Cg_endo -54.55 -29.04 58.27 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.421 2.081 . . . . 0.0 112.422 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -49.35 -41.76 39.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.095 0.474 . . . . 0.0 110.296 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.78 HG21 ' HB3' ' A' ' 311' ' ' LEU . 27.8 mt -85.6 -33.26 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.939 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.512 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -62.66 -30.83 71.67 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.11 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -79.31 -31.38 43.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.118 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.37 -35.47 80.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.572 ' CG ' ' HB2' ' A' ' 301' ' ' ALA . 45.8 mtp -81.88 -32.79 30.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.933 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.24 -31.34 70.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.943 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.509 ' HB3' ' HB1' ' A' ' 112' ' ' ALA . 6.3 m-80 -67.99 -38.77 83.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -71.17 -39.89 71.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.132 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -59.85 -35.03 73.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.957 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 6.7 mmtm -117.81 21.11 13.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.033 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -114.03 142.27 17.42 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.501 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -75.61 135.57 40.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.791 0.329 . . . . 0.0 110.884 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.45 HD13 ' HB2' ' A' ' 96' ' ' ALA . 30.8 mt -79.19 148.96 5.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.14 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 6.6 mtp -76.51 113.49 29.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.37 152.5 15.43 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.489 2.126 . . . . 0.0 112.312 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -106.01 39.15 1.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.854 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.466 HD11 ' CE2' ' A' ' 169' ' ' PHE . 22.7 pt -108.15 148.87 38.37 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.177 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.95 -27.71 30.08 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.559 2.172 . . . . 0.0 112.339 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.521 ' NE2' HG21 ' A' ' 178' ' ' ILE . 3.6 mp0 -59.33 -24.14 63.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.055 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 1.7 tpt -54.53 -26.8 34.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.188 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 38.3 m -58.23 -55.26 37.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.015 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -60.43 -29.61 69.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.166 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.711 ' O ' HG23 ' A' ' 343' ' ' VAL . 68.7 t80 -58.98 -51.71 68.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.026 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 40.3 m95 -56.47 -23.52 39.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.356 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -79.38 -61.38 2.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.125 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -59.63 -48.32 82.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.404 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 339' ' ' PHE . 31.7 t -58.18 -32.52 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.292 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 -68.11 -57.46 6.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.914 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 30.9 m -65.83 -28.32 68.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.137 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.581 ' HB1' ' HB1' ' A' ' 360' ' ' ALA . . . -60.09 -51.39 69.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.342 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 32.8 t -70.83 -47.31 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.272 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 57.8 mt -59.31 -43.29 89.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.054 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -60.36 -30.61 69.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.012 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -79.31 -52.51 8.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.34 -38.72 90.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.03 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 16.8 m -70.98 -22.35 62.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.139 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 87.5 26.79 29.18 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.589 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 30.4 mtt180 -91.27 -30.74 16.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.854 0.359 . . . . 0.0 110.915 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -146.45 -176.51 5.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.846 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 19.8 p -116.28 170.74 8.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.525 HG22 ' CD2' ' A' ' 192' ' ' LEU . 47.9 t -59.5 -55.29 24.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.005 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -47.42 -29.83 2.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.157 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -84.29 -41.97 16.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.965 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.581 ' HB1' ' HB1' ' A' ' 346' ' ' ALA . . . -60.08 -60.46 3.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.931 0.395 . . . . 0.0 110.765 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.669 HD22 HG12 ' A' ' 183' ' ' VAL . 3.1 mt -58.29 -27.02 63.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.978 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.94 -53.46 6.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.831 0.348 . . . . 0.0 111.007 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -59.36 -48.55 81.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.857 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.466 ' O ' HD12 ' A' ' 368' ' ' ILE . . . -58.57 -36.42 73.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.994 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.611 ' O ' HG23 ' A' ' 369' ' ' THR . 0.1 OUTLIER -59.78 -45.24 92.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.831 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -52.32 66.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.002 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -59.05 -48.38 81.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.998 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.466 HD12 ' O ' ' A' ' 364' ' ' ALA . 10.6 mt -65.88 -28.96 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.188 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.611 HG23 ' O ' ' A' ' 365' ' ' GLN . 32.6 p -83.37 -31.3 26.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.922 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.884 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 32.2 mttt . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.788 0.327 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.512 HG23 ' HG2' ' A' ' 271' ' ' PRO . 2.7 t -80.12 98.07 7.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.91 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -98.75 31.76 2.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.42 ' HB3' ' CD ' ' A' ' 6' ' ' LYS . 2.2 tt0 -92.83 -163.87 1.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.794 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -134.15 52.47 0.81 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.771 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.42 ' CD ' ' HB3' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -146.25 -174.93 4.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.793 0.33 . . . . 0.0 110.94 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 21.6 mt -130.56 123.62 29.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.5 t -91.27 142.04 13.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.156 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.848 HG21 ' CD2' ' A' ' 20' ' ' LEU . 29.5 mm -119.66 107.53 21.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.952 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.41 ' CD2' ' HG3' ' A' ' 57' ' ' PRO . 5.2 m0 -104.07 106.74 17.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.6 tt -150.84 150.52 13.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.11 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -64.36 158.91 22.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.916 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.87 57.74 3.68 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.522 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -125.86 -44.51 1.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.862 0.363 . . . . 0.0 110.912 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.75 -179.29 6.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.874 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.18 83.83 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.486 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -71.91 -35.5 69.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.809 0.338 . . . . 0.0 110.902 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -72.31 -31.18 65.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.85 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.25 -41.49 96.75 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.495 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.848 ' CD2' HG21 ' A' ' 9' ' ' ILE . 8.4 tp -67.23 -29.52 69.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.0 110.952 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.74 -42.29 79.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.101 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.67 -26.14 68.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.019 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.65 HG12 ' CZ ' ' A' ' 279' ' ' PHE . 17.5 t -76.71 -25.94 16.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -81.39 -42.54 9.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.599 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -27.69 69.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.767 0.318 . . . . 0.0 110.988 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -73.9 -41.52 62.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -60.43 -57.15 14.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.931 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.32 -21.19 48.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.295 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.42 -25.81 33.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.334 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -102.48 -33.74 9.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.583 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.68 -44.15 3.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.766 0.317 . . . . 0.0 111.402 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.31 -26.4 7.04 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.528 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.577 HG21 HD13 ' A' ' 275' ' ' LEU . 35.7 mm -62.25 122.65 13.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.338 . . . . 0.0 111.108 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -70.71 166.77 20.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.967 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.2 t -147.45 102.57 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.087 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.8 m -98.29 144.67 27.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.5 t -114.53 110.18 31.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.113 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -97.56 176.46 5.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.789 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -159.32 70.24 3.36 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.018 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.29 144.41 46.0 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.549 2.166 . . . . 0.0 112.171 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.21 139.13 48.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.966 0.412 . . . . 0.0 111.04 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.538 ' C ' HD23 ' A' ' 43' ' ' LEU . 4.4 mtmt 73.48 -58.39 0.6 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.873 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.538 HD23 ' C ' ' A' ' 42' ' ' LYS . 0.5 OUTLIER 49.18 18.69 0.25 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.114 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -83.29 -57.02 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -91.57 -7.4 50.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.354 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.546 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.5 tptt -67.75 -25.1 65.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.264 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.477 ' CB ' ' HD3' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -85.16 -57.68 0.36 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.179 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.477 ' HD3' ' CB ' ' A' ' 47' ' ' PHE . 54.0 Cg_exo -52.07 -35.8 63.2 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.416 2.077 . . . . 0.0 112.531 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.612 ' HG3' HG13 ' A' ' 50' ' ' VAL . 11.5 pt20 -60.09 -49.64 76.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.01 0.433 . . . . 0.0 111.053 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.612 HG13 ' HG3' ' A' ' 49' ' ' GLN . 6.2 m -96.68 27.0 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.418 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 1.037 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -88.55 -42.15 12.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.107 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.33 -33.65 76.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.098 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 55' ' ' ASP . 11.5 t -88.12 -31.31 19.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.52 39.61 68.38 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.518 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.417 ' H ' HG23 ' A' ' 53' ' ' THR . 8.8 t0 -97.73 -29.58 13.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.98 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.52 -160.5 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.551 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.442 ' HG2' ' CZ ' ' A' ' 47' ' ' PHE . 41.4 Cg_endo -67.54 -167.79 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.549 2.166 . . . . 0.0 112.263 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -124.12 -42.48 2.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.006 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 60' ' ' ILE . 16.7 mt -102.1 158.29 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.242 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.563 HG22 ' O ' ' A' ' 265' ' ' GLY . 2.4 tt -166.86 159.48 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.811 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.477 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 73.6 m-85 -119.85 140.58 50.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.987 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.505 ' HZ3' HD11 ' A' ' 43' ' ' LEU . 4.9 t-105 -174.07 151.11 1.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.64 134.54 57.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.091 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -53.26 -28.37 27.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.195 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -64.55 -35.06 79.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.005 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.438 ' HB3' ' CD1' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -94.41 17.18 13.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.296 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -106.84 30.62 5.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.827 0.346 . . . . 0.0 110.907 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -122.29 35.91 3.34 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.544 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -128.43 -41.7 0.27 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.51 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -80.62 -9.03 59.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.608 0.242 . . . . 0.0 111.364 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.22 -25.98 47.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.728 0.299 . . . . 0.0 111.144 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -60.72 -51.05 71.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.948 0.404 . . . . 0.0 110.661 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.7 m -72.04 -23.1 61.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.047 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.4 31.63 9.43 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.526 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.037 HD22 ' HB1' ' A' ' 51' ' ' ALA . 35.7 mt -72.5 -37.97 68.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.785 0.326 . . . . 0.0 110.952 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.674 HD13 HD13 ' A' ' 104' ' ' ILE . 6.7 mt -77.35 146.28 36.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.986 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.797 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -93.08 116.39 28.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.078 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -60.79 155.83 18.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.833 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.475 ' O ' HG23 ' A' ' 80' ' ' THR . 42.6 pt -124.68 179.19 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.131 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 79' ' ' ILE . 0.9 OUTLIER -159.82 77.81 2.79 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.893 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.31 163.45 34.42 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.613 2.209 . . . . 0.0 112.207 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -94.8 -179.43 4.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -59.18 -48.92 79.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.883 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.51 -31.16 72.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.104 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -74.59 -35.73 62.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.917 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.427 ' HA ' ' CZ2' ' A' ' 94' ' ' TRP . 15.5 mt-30 -79.87 -30.13 40.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.947 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -74.05 -39.26 63.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.985 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.83 -36.21 76.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.978 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.515 HD13 ' CZ2' ' A' ' 94' ' ' TRP . 0.4 OUTLIER -84.48 178.07 7.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.834 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.42 ' HB3' ' CE1' ' A' ' 92' ' ' PHE . 24.4 m-85 -86.79 142.38 34.4 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.039 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 63.7 Cg_exo -54.27 -55.85 3.03 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.581 2.188 . . . . 0.0 112.657 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.541 ' CE2' HG23 ' A' ' 93' ' ' THR . 50.0 p90 -60.32 -46.63 89.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.429 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.541 HG23 ' CE2' ' A' ' 92' ' ' PHE . 70.9 p -53.21 -27.6 22.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.797 0.332 . . . . 0.0 111.233 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.515 ' CZ2' HD13 ' A' ' 89' ' ' LEU . 22.8 m95 -74.68 -36.44 62.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.822 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -74.56 -7.7 53.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.342 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.76 -27.9 22.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.822 0.344 . . . . 0.0 111.183 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.516 ' CG1' ' HB3' ' A' ' 105' ' ' ALA . 27.5 m -93.0 47.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.288 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.9 124.31 13.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -108.94 -65.2 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.844 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -98.59 30.66 3.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.808 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.92 -25.96 21.1 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.558 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -92.17 170.55 9.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.333 . . . . 0.0 110.99 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.514 ' O ' HG23 ' A' ' 104' ' ' ILE . 5.9 mt -96.17 141.11 29.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.79 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.685 ' O ' HD12 ' A' ' 104' ' ' ILE . 1.8 pp -158.08 58.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.239 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.805 ' HB1' ' HB3' ' A' ' 263' ' ' SER . . . -177.33 172.25 1.89 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.229 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.732 ' CE1' HD12 ' A' ' 266' ' ' ILE . 26.0 m-85 -138.53 94.01 10.82 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.821 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.52 116.96 3.65 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.648 2.232 . . . . 0.0 112.381 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.0 mt -119.06 -64.39 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.118 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.588 ' CB ' HD22 ' A' ' 299' ' ' LEU . . . -113.7 142.84 45.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.147 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.676 HG22 HG13 ' A' ' 261' ' ' VAL . 21.5 t -106.86 151.88 8.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.116 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -130.94 149.14 52.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -171.72 146.36 2.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.2 mt -66.53 114.87 5.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.915 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.681 ' HB3' HG13 ' A' ' 244' ' ' VAL . 1.3 m -93.72 163.23 13.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.925 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 50.1 tp -100.72 101.54 12.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.766 HG22 ' CZ ' ' A' ' 217' ' ' PHE . 28.7 mt -86.16 119.91 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.119 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -137.84 148.9 45.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.943 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -81.42 156.75 25.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.6 mtmm -110.88 -30.25 7.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.978 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -61.17 -31.61 71.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.035 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.669 HD11 ' HA ' ' A' ' 223' ' ' ALA . 3.8 pp -111.6 -33.71 6.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.974 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.561 ' HB2' HD12 ' A' ' 121' ' ' LEU . 8.3 tp -119.25 88.98 38.83 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.995 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.26 -28.42 33.65 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.535 2.157 . . . . 0.0 112.283 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -140.26 112.58 7.31 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.836 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -78.82 167.59 22.05 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.586 2.191 . . . . 0.0 112.422 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.408 ' HD2' ' HE3' ' A' ' 224' ' ' MET . 56.2 Cg_endo -70.34 111.81 3.02 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.603 2.202 . . . . 0.0 112.322 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.45 -27.1 65.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.963 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 29.5 p -120.34 158.53 26.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.964 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.425 ' CE3' HD12 ' A' ' 132' ' ' ILE . 34.5 m95 -72.44 -30.06 64.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.967 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -72.2 -16.05 61.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.405 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.733 ' O ' HD12 ' A' ' 135' ' ' LEU . 2.6 mt-10 -89.76 0.05 57.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.581 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.48 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 12.2 mt -85.44 -46.5 0.62 Allowed Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 73.2 Cg_exo -49.25 -28.35 14.76 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.378 2.052 . . . . 0.0 112.44 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.27 -34.61 28.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.197 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.733 HD12 ' O ' ' A' ' 131' ' ' GLU . 0.2 OUTLIER -62.23 -42.55 99.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.092 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.406 ' OD2' ' HA ' ' A' ' 133' ' ' PRO . 7.5 p30 -57.09 -22.24 38.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.216 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -85.62 -33.71 21.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.079 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -85.1 -61.74 1.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.296 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.421 HD13 ' HB2' ' A' ' 223' ' ' ALA . 6.6 mt -53.79 -24.85 16.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.545 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -76.87 -24.77 52.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.742 0.306 . . . . 0.0 110.959 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.12 -33.75 69.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.903 0.383 . . . . 0.0 110.97 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.08 -27.12 39.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.029 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.44 42.16 0.77 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.491 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -144.99 -177.3 5.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 0.0 110.861 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.57 147.82 40.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.868 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -68.33 -68.82 0.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.201 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.698 HD13 ' HB2' ' A' ' 224' ' ' MET . 18.8 tp -148.79 132.92 17.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.043 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.777 ' HB2' HG21 ' A' ' 208' ' ' THR . 0.0 OUTLIER -126.17 179.61 5.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.712 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.428 ' HB2' ' CD2' ' A' ' 156' ' ' PHE . 50.6 p90 -178.28 -176.04 0.49 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.018 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -79.37 118.8 21.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.905 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.4 mt -98.93 29.2 3.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -112.09 -33.34 6.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.842 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -101.04 135.27 19.99 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.419 ' CB ' HG12 ' A' ' 343' ' ' VAL . 72.0 Cg_endo -76.56 -13.36 18.3 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.532 2.155 . . . . 0.0 112.612 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.495 ' CZ ' ' CH2' ' A' ' 340' ' ' TRP . 3.0 m-85 -57.37 -32.62 66.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.12 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.428 ' CD2' ' HB2' ' A' ' 149' ' ' PHE . 1.8 m-85 -77.44 -36.72 52.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.896 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.652 HG21 HG11 ' A' ' 347' ' ' VAL . 40.1 p -81.55 -23.07 37.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.045 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.545 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 64.5 t-105 -50.9 -54.15 40.03 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.572 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.611 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 14.9 Cg_endo -57.24 -22.02 46.61 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.196 1.931 . . . . 0.0 112.3 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.4 tp -80.44 -54.48 5.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.813 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.991 HG21 HD12 ' A' ' 192' ' ' LEU . 12.3 pt -71.16 -34.03 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.434 ' HB1' ' HG3' ' A' ' 256' ' ' LYS . . . -75.08 -28.9 60.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.175 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -56.5 -28.87 60.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.233 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -76.16 -20.04 57.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.222 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 139.55 -26.37 2.67 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.658 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.488 ' HA3' ' HB2' ' A' ' 188' ' ' ALA . . . -57.0 145.32 37.64 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.565 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -134.81 -176.35 4.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.801 0.334 . . . . 0.0 110.986 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.45 ' HB2' ' CZ2' ' A' ' 158' ' ' TRP . . . -107.58 -49.64 3.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.12 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.911 ' CE2' HD11 ' A' ' 333' ' ' ILE . 24.9 m-85 -127.83 158.73 36.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -99.44 118.58 36.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.017 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.404 ' CE1' ' O ' ' A' ' 174' ' ' GLY . 7.7 t80 -85.59 111.15 19.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.487 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.04 146.33 23.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.153 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 63.11 29.45 16.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.095 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 171' ' ' TYR . . . 90.55 -37.0 3.44 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.021 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.91 -177.24 3.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 0.0 111.067 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -98.92 -177.48 3.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.954 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -133.46 134.76 43.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.8 pt -87.12 -29.68 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.119 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -74.54 -16.33 60.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.219 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -104.96 117.35 33.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.807 0.337 . . . . 0.0 110.976 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.725 HG12 HG23 ' A' ' 183' ' ' VAL . 16.9 t -124.51 146.05 30.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.006 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -117.04 61.37 0.42 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.782 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.725 HG23 HG12 ' A' ' 181' ' ' VAL . 2.3 t -96.55 -61.58 2.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.846 0.355 . . . . 0.0 110.973 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -84.4 57.23 4.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.922 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -95.74 167.84 11.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.849 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -58.64 -31.14 67.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.178 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -85.98 -49.13 4.38 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.55 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.488 ' HB2' ' HA3' ' A' ' 166' ' ' GLY . . . -59.0 -31.59 68.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 0.0 111.182 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -60.02 -45.81 91.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.834 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -86.95 -28.2 22.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.154 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -57.81 -53.61 43.96 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.608 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.991 HD12 HG21 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -61.22 -32.65 72.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.339 . . . . 0.0 110.981 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.3 m -53.67 -25.15 16.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.091 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -65.89 -59.08 4.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.786 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.493 ' HA ' HD12 ' A' ' 198' ' ' LEU . 8.0 tt -64.78 -29.78 70.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.735 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.87 HG23 ' O ' ' A' ' 192' ' ' LEU . 41.2 t -69.49 -59.84 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.062 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -58.48 -29.55 66.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.051 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 195' ' ' LEU . 12.5 mt -60.06 -47.88 84.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 22.4 mt -76.53 -28.41 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.167 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.789 ' HD2' HG12 ' A' ' 196' ' ' VAL . 18.2 mtpt -62.06 -30.48 71.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.966 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -91.07 13.58 16.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.423 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt 56.13 44.04 25.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.956 0.407 . . . . 0.0 111.028 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.83 -28.1 12.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.904 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 87.7 mtp -113.69 176.74 4.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.932 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 19.8 m-20 -124.22 133.57 53.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -79.77 -38.99 31.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.094 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -59.25 -27.39 65.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.982 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.777 HG21 ' HB2' ' A' ' 148' ' ' MET . 1.6 m -49.45 146.74 3.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.227 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -154.23 176.08 12.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.858 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -61.08 -29.02 69.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.257 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.13 -59.36 2.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.84 0.352 . . . . 0.0 110.986 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -28.65 44.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.309 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.582 ' O ' HG21 ' A' ' 225' ' ' THR . . . -77.74 -21.75 51.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.769 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.16 -50.2 11.36 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.835 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.76 -30.61 68.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.127 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.3 -32.98 70.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.144 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.766 ' CZ ' HG22 ' A' ' 116' ' ' ILE . 19.4 t80 -79.42 -41.1 28.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.961 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -67.12 -36.11 81.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.5 mttm -83.73 -34.0 24.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.863 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 98.12 59.33 0.94 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.491 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -109.27 -72.69 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.803 0.335 . . . . 0.0 110.825 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.592 HG21 ' SD ' ' A' ' 148' ' ' MET . 10.6 t -74.36 169.12 18.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.924 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.669 ' HA ' HD11 ' A' ' 121' ' ' LEU . . . -81.53 -54.66 5.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.171 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.698 ' HB2' HD13 ' A' ' 147' ' ' LEU . 0.5 OUTLIER -125.78 163.59 22.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.004 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.582 HG21 ' O ' ' A' ' 213' ' ' ALA . 66.3 m -159.83 137.75 10.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 29.3 mt -112.98 135.22 53.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.163 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.523 ' HB3' ' HB2' ' A' ' 231' ' ' ALA . 33.5 t30 -150.47 155.78 40.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -62.47 -162.25 0.27 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.551 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.427 ' HD2' ' CZ3' ' A' ' 230' ' ' TRP . 34.5 Cg_endo -64.56 -23.09 64.48 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.649 2.233 . . . . 0.0 112.499 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . 0.427 ' CZ3' ' HD2' ' A' ' 229' ' ' PRO . 46.6 p90 -84.5 57.31 4.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.958 0.409 . . . . 0.0 110.875 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.523 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . . . -141.76 -44.94 0.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.18 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . 0.551 ' HA ' HD12 ' A' ' 235' ' ' ILE . 20.8 m0 -54.26 -30.59 51.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.086 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.5 m -62.71 -36.58 83.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.944 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -60.39 -34.39 73.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.919 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.551 HD12 ' HA ' ' A' ' 232' ' ' TRP . 10.6 mt -74.96 70.4 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.03 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -153.28 -46.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.871 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 62.4 m -61.29 -44.1 97.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.84 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 2.7 t -101.58 -34.13 9.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.93 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.97 104.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.6 t -135.01 142.32 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.122 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.05 95.66 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.627 ' HB2' HG23 ' A' ' 116' ' ' ILE . 55.0 p90 -100.54 135.6 41.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -100.53 148.16 18.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.466 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.681 HG13 ' HB3' ' A' ' 114' ' ' SER . 21.3 t -128.55 123.27 59.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.838 0.351 . . . . 0.0 111.119 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 10.0 t -143.45 153.78 43.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.864 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.502 HG11 ' CD ' ' A' ' 322' ' ' GLU . 0.8 OUTLIER -54.85 152.35 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.245 0.545 . . . . 0.0 111.381 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.412 ' N ' ' CG2' ' A' ' 246' ' ' VAL . 89.9 mt -67.68 136.24 92.68 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.855 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.422 ' HB2' ' CD1' ' A' ' 129' ' ' TRP . 52.3 Cg_exo -54.58 -170.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.412 2.075 . . . . 0.0 112.279 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.511 HG22 ' HA ' ' A' ' 254' ' ' PRO . 1.3 p -127.89 163.04 25.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -111.05 108.24 17.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.93 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 17.1 mttt 59.44 30.72 20.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.958 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 83.1 27.03 42.06 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.541 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.431 ' O ' HG22 ' A' ' 249' ' ' THR . 2.9 mm-40 -122.22 141.27 34.14 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.59 0.233 . . . . 0.0 110.852 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.511 ' HA ' HG22 ' A' ' 249' ' ' THR . 72.6 Cg_endo -76.37 145.34 26.82 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.544 2.163 . . . . 0.0 112.42 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.22 -172.64 1.77 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.769 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.434 ' HG3' ' HB1' ' A' ' 162' ' ' ALA . 12.3 mmmt -132.88 58.69 37.45 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.128 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.433 ' HD3' ' N ' ' A' ' 256' ' ' LYS . 62.3 Cg_exo -50.9 -179.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.406 2.071 . . . . 0.0 112.291 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.494 ' CE2' ' CD2' ' A' ' 155' ' ' TYR . 10.9 m-85 -110.53 134.9 51.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.826 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 328' ' ' GLU . 23.8 t -97.17 132.13 42.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.203 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -145.57 106.13 0.37 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.307 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.676 HG13 HG22 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -106.21 149.53 9.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.881 0.372 . . . . 0.0 111.323 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 262' ' ' LEU . 11.9 tp -85.75 80.88 8.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.975 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.805 ' HB3' ' HB1' ' A' ' 105' ' ' ALA . 2.1 m -75.81 137.44 40.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.033 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.713 ' HB3' ' HB2' ' A' ' 106' ' ' TYR . . . -82.04 114.98 20.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.053 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.563 ' O ' HG22 ' A' ' 60' ' ' ILE . . . -83.38 117.82 4.51 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.565 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.732 HD12 ' CE1' ' A' ' 106' ' ' TYR . 29.2 mt -119.48 121.94 67.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.818 0.342 . . . . 0.0 110.998 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -79.59 148.64 31.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.953 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.797 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -67.51 -27.13 66.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.176 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -90.98 48.81 1.56 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.152 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 58.5 p -116.45 108.11 45.93 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.794 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.512 ' HG2' HG23 ' A' ' 2' ' ' THR . 38.3 Cg_endo -66.73 -24.37 47.54 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.418 2.079 . . . . 0.0 112.312 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -97.64 37.21 1.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.841 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -66.36 -41.09 89.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -59.58 -56.15 25.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.961 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.577 HD13 HG21 ' A' ' 33' ' ' ILE . 19.1 mt -60.32 -35.04 74.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.81 -50.72 40.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.075 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -44.62 95.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.873 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -63.07 -61.97 2.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.65 ' CZ ' HG12 ' A' ' 23' ' ' VAL . 72.8 t80 -55.09 -27.18 43.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.143 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.64 HD23 HD22 ' A' ' 284' ' ' LEU . 24.8 mt -76.95 -37.83 54.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.109 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.465 ' HG3' HD12 ' A' ' 285' ' ' LEU . 1.1 mp0 -93.62 -7.32 44.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.643 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -103.29 -35.8 8.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.653 0.263 . . . . 0.0 111.367 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -116.96 -35.77 4.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.406 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.64 HD22 HD23 ' A' ' 280' ' ' LEU . 1.5 tp -95.21 41.1 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.799 0.333 . . . . 0.0 111.134 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.465 HD12 ' HG3' ' A' ' 281' ' ' GLU . 2.7 mt -177.18 37.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.878 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.2 p -142.91 164.49 29.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -72.28 -30.21 64.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -79.45 -30.49 42.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.004 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -89.63 -50.92 3.01 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.589 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 87.2 mt -59.68 -31.0 69.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.363 . . . . 0.0 111.021 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -69.64 -31.21 69.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.46 -30.73 67.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.164 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.12 -30.02 9.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.39 -30.71 71.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.959 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -68.99 -33.62 73.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.027 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.55 -36.69 12.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.015 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -169.2 100.3 0.49 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.922 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.28 115.12 3.69 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.428 2.085 . . . . 0.0 112.32 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.588 HD22 ' CB ' ' A' ' 109' ' ' ALA . 0.8 OUTLIER -56.9 -24.63 53.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.026 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 109.76 -32.66 6.58 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.573 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -157.36 176.83 12.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 0.0 111.126 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.629 HG21 ' CD2' ' A' ' 307' ' ' TYR . 5.8 m -152.92 156.08 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.089 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.458 ' HB1' HD23 ' A' ' 89' ' ' LEU . . . -84.42 -30.32 25.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.135 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 304' ' ' LEU . 14.0 tp -59.67 123.97 18.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.908 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -72.66 -24.14 60.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.12 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.6 m -81.27 -24.13 37.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.179 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.629 ' CD2' HG21 ' A' ' 302' ' ' VAL . 26.3 t80 -95.33 -31.97 13.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.306 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -57.23 -29.72 63.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.343 . . . . 0.0 110.948 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -64.27 -59.87 3.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -50.89 -33.26 23.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.827 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.799 ' HB3' HG21 ' A' ' 317' ' ' ILE . 7.8 mt -85.76 -24.99 26.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.798 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -67.13 -13.82 62.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.494 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -47.48 -32.16 4.91 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.972 0.415 . . . . 0.0 110.941 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -112.69 140.65 24.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.37 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.483 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 11.6 Cg_endo -55.76 -26.99 59.59 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.425 2.083 . . . . 0.0 112.341 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -50.51 -41.24 53.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.079 0.466 . . . . 0.0 110.313 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.799 HG21 ' HB3' ' A' ' 311' ' ' LEU . 32.2 mm -85.58 -32.0 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.957 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.483 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -69.39 -30.69 68.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.171 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -74.42 -46.18 41.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.204 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 63.4 m -59.7 -31.35 69.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.925 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.91 -41.82 25.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.946 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.502 ' CD ' HG11 ' A' ' 246' ' ' VAL . 18.1 tt0 -60.0 -47.06 87.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.958 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -60.14 -54.27 47.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.966 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.79 -50.55 73.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.148 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -59.71 -33.29 71.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -96.59 21.15 9.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.123 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -128.18 161.88 21.97 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.521 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . 0.408 ' O ' HG23 ' A' ' 259' ' ' VAL . 0.4 OUTLIER -79.58 156.24 27.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.804 0.335 . . . . 0.0 110.873 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 25.3 mt -88.02 138.39 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.141 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.441 ' HG2' ' CD1' ' A' ' 258' ' ' PHE . 12.8 mtm -60.35 140.27 91.74 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.43 ' HG2' ' HE3' ' A' ' 336' ' ' MET . 72.6 Cg_endo -76.41 138.79 20.1 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.549 2.166 . . . . 0.0 112.333 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -101.87 30.98 4.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.911 HD11 ' CE2' ' A' ' 169' ' ' PHE . 9.4 pt -107.2 148.52 37.23 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.108 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.56 -24.47 18.77 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.584 2.19 . . . . 0.0 112.446 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.15 -26.34 38.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.184 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.43 ' HE3' ' HG2' ' A' ' 331' ' ' PRO . 17.3 ptm -57.31 -22.27 40.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.215 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 67.1 m -50.24 -48.8 54.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.175 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.52 -28.02 60.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.15 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.73 ' CZ ' HG21 ' A' ' 343' ' ' VAL . 78.0 t80 -58.25 -29.1 65.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.009 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.495 ' CH2' ' CZ ' ' A' ' 155' ' ' TYR . 94.2 m95 -60.28 -61.06 2.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.034 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.86 -30.72 71.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.091 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -62.04 -56.28 20.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.339 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.73 HG21 ' CZ ' ' A' ' 339' ' ' PHE . 21.4 t -78.62 -33.76 17.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.417 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -57.16 -57.45 12.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.15 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . 0.637 HG22 ' OD1' ' A' ' 349' ' ' ASN . 21.0 m -66.71 -29.53 69.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.01 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -59.78 -56.84 16.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.24 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.652 HG11 HG21 ' A' ' 157' ' ' THR . 21.2 t -59.05 -40.57 81.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.284 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 26.2 mt -68.22 -41.6 84.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.064 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.637 ' OD1' HG22 ' A' ' 345' ' ' THR . 2.0 m120 -59.58 -30.2 68.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.967 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -91.1 -34.84 14.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.236 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -76.52 -33.33 58.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.228 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 5.6 t -66.27 -22.42 66.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.118 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 80.0 61.7 2.22 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.539 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 18.9 mtt-85 -140.29 -79.33 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.83 0.348 . . . . 0.0 110.836 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -77.55 177.55 7.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.758 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 65.8 p -106.57 145.13 32.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.776 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.41 HG12 ' HG ' ' A' ' 361' ' ' LEU . 40.3 t -51.44 -40.14 23.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.108 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -50.73 -38.51 47.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.62 -30.65 29.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -65.96 -58.17 6.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.062 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.673 HD22 HG12 ' A' ' 183' ' ' VAL . 12.1 mt -60.04 -25.29 65.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.037 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -72.83 -51.07 20.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.834 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -57.76 -48.46 79.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.85 -39.19 80.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.073 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.602 ' O ' HG23 ' A' ' 369' ' ' THR . 7.1 tm0? -58.86 -33.99 71.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.963 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 90.0 m -87.11 -40.36 14.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.925 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -59.07 -44.87 91.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.718 HD12 HG11 ' A' ' 181' ' ' VAL . 17.1 mt -69.45 -30.4 45.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.175 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.602 HG23 ' O ' ' A' ' 365' ' ' GLN . 76.2 p -82.97 -29.64 28.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.942 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 26.3 tttm . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.918 179.998 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 22.2 tttt . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.826 0.346 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.3 t -102.17 125.78 48.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.894 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -105.21 99.45 9.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 58.87 162.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.967 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.59 -58.4 0.53 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.506 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -142.14 174.6 10.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.815 0.34 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 33.7 mt -128.69 133.8 48.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.7 t -109.6 147.05 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.115 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.592 HG21 ' CD2' ' A' ' 20' ' ' LEU . 28.7 mm -120.49 107.51 20.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.968 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.419 ' CG ' ' HG3' ' A' ' 57' ' ' PRO . 0.5 OUTLIER -93.41 106.77 18.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.833 HD11 ' HD3' ' A' ' 15' ' ' LYS . 17.3 tt -163.15 123.02 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.006 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -142.53 162.68 34.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.928 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 109.57 58.81 0.52 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.984 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.6 t70 59.48 28.9 18.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.96 0.409 . . . . 0.0 110.556 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.833 ' HD3' HD11 ' A' ' 11' ' ' ILE . 3.3 mmpt? -83.16 173.56 11.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.8 54.67 4.62 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.527 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -72.62 -31.05 64.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.827 0.346 . . . . 0.0 110.909 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -74.53 -32.3 62.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.39 -37.85 8.67 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.512 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.592 ' CD2' HG21 ' A' ' 9' ' ' ILE . 6.2 tp -65.77 -31.22 72.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.783 0.325 . . . . 0.0 110.92 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.92 -31.02 70.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.128 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -66.59 -36.65 83.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.563 HG12 ' HB3' ' A' ' 283' ' ' TYR . 25.4 t -65.38 -31.39 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.074 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.97 -27.63 73.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.512 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.3 mmtt -59.24 -30.55 68.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.776 0.322 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.3 -40.48 58.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.881 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.632 ' CE1' HG21 ' A' ' 31' ' ' THR . 38.5 t80 -57.98 -52.89 63.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.017 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -68.94 -23.91 64.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.174 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -78.84 -25.83 44.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.22 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -103.89 -36.98 7.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.41 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.632 HG21 ' CE1' ' A' ' 27' ' ' PHE . 8.9 p -99.98 -44.11 6.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.225 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.06 -27.09 8.38 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.45 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.424 ' HB ' ' CE2' ' A' ' 27' ' ' PHE . 35.8 mm -64.32 118.83 7.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.779 0.323 . . . . 0.0 111.091 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -59.71 152.37 22.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.914 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.29 108.78 12.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.045 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.5 m -115.36 144.67 43.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.409 HG13 ' HB ' ' A' ' 9' ' ' ILE . 29.6 t -118.98 119.07 59.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.052 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -100.85 151.4 21.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -117.21 73.41 7.1 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.973 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.95 -179.99 5.51 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.646 2.231 . . . . 0.0 112.359 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -60.3 -158.88 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.416 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.466 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -47.13 -27.39 1.4 Allowed 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.598 0.237 . . . . 0.0 111.485 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 42' ' ' LYS . 0.3 OUTLIER 52.45 17.95 0.86 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.979 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -83.19 -57.04 3.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 0.0 110.972 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -92.77 -5.62 50.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.44 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.1 -18.94 29.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.557 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.679 ' CE2' HG21 ' A' ' 60' ' ' ILE . 13.3 t80 -83.37 -47.92 0.77 Allowed Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 116.762 -0.199 . . . . 0.0 111.49 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.545 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 41.9 Cg_exo -57.11 -38.23 96.14 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.336 2.024 . . . . 0.0 112.327 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.441 ' CG ' ' N ' ' A' ' 50' ' ' VAL . 4.6 pt20 -60.9 -47.31 86.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.044 0.45 . . . . 0.0 110.923 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.441 ' N ' ' CG ' ' A' ' 49' ' ' GLN . 20.3 m -76.99 -27.95 16.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.229 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 75' ' ' LEU . . . -56.7 -26.78 57.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.39 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.76 -35.73 71.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.237 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.0 t -110.8 -29.65 7.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.031 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.39 35.53 6.56 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.536 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.27 -27.45 20.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.785 0.326 . . . . 0.0 111.029 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.73 -156.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.544 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.419 ' HG3' ' CG ' ' A' ' 10' ' ' TRP . 46.0 Cg_endo -68.06 -167.84 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.623 2.215 . . . . 0.0 112.301 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -109.45 -31.27 7.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.894 HD13 HD21 ' A' ' 280' ' ' LEU . 22.2 mt -136.81 129.03 44.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.135 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.679 HG21 ' CE2' ' A' ' 47' ' ' PHE . 2.3 tt -114.88 159.07 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.093 0.473 . . . . 0.0 111.018 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.47 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 6.2 m-85 -130.56 113.14 13.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.784 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.3 t-105 -152.71 173.73 14.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.959 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.45 139.27 58.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.495 ' HB3' HG23 ' A' ' 261' ' ' VAL . 1.5 p80 -58.0 -33.69 69.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.038 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -59.67 -39.39 84.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.981 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -94.14 17.18 13.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.273 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.43 -4.71 37.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.416 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -94.82 26.4 18.74 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.56 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -124.5 4.42 8.74 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.84 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.521 ' O ' HD12 ' A' ' 75' ' ' LEU . 4.7 m-85 -112.59 -32.32 6.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.845 0.355 . . . . 0.0 110.998 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.51 -26.07 50.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.09 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -32.82 70.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.963 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.57 24.95 6.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.079 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 54.84 40.48 72.3 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.756 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.528 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 4.0 mt -100.32 -48.19 4.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.808 0.337 . . . . 0.0 110.934 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 20.5 mt -73.35 142.0 47.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.987 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.754 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -92.6 169.77 10.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.095 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.35 -164.9 1.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.942 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.748 HD11 ' CB ' ' A' ' 103' ' ' LEU . 35.8 pt -157.02 168.82 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.089 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 48.9 p -156.65 77.49 4.17 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.831 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.77 154.59 63.67 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.603 2.202 . . . . 0.0 112.315 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -78.08 164.77 24.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.813 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -59.74 -38.48 81.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.815 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.94 -44.39 85.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.005 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.674 ' CZ ' HD22 ' A' ' 285' ' ' LEU . 31.4 t80 -66.44 -37.37 85.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -69.07 -30.48 68.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.51 -28.32 62.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.969 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.66 43.19 1.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.024 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.455 HD13 ' CZ2' ' A' ' 94' ' ' TRP . 8.1 mt -151.93 139.04 19.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.876 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.438 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . 12.9 m-85 -73.31 129.77 85.39 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -49.06 -55.54 4.05 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.657 2.238 . . . . 0.0 112.996 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.699 ' HB2' HD11 ' A' ' 329' ' ' ILE . 10.7 p90 -49.78 -25.13 2.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.077 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.613 HG22 ' CE1' ' A' ' 92' ' ' PHE . 10.4 p -74.73 -30.57 61.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.819 0.342 . . . . 0.0 110.804 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.498 ' CZ3' HD13 ' A' ' 103' ' ' LEU . 12.2 m95 -73.1 -39.48 65.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.922 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -62.09 -27.34 68.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.999 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.53 ' HB2' HG21 ' A' ' 329' ' ' ILE . . . -64.98 -25.67 67.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.332 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 97' ' ' VAL . 27.6 m -121.09 72.81 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.911 0.386 . . . . 0.0 111.266 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -156.06 144.2 19.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.874 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -106.09 -64.53 1.15 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -123.8 41.76 3.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.824 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.84 25.58 29.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.522 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.99 145.35 49.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.765 0.317 . . . . 0.0 110.896 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.748 ' CB ' HD11 ' A' ' 79' ' ' ILE . 13.4 mt -87.93 140.41 29.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.939 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.0 pt -144.86 29.87 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.227 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -166.68 -177.11 3.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.153 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.431 ' OH ' HG22 ' A' ' 79' ' ' ILE . 5.9 m-85 -135.31 85.97 31.47 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.89 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.32 97.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.584 2.19 . . . . 0.0 112.321 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.7 mm -75.31 -66.16 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.204 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.748 ' HB2' HD12 ' A' ' 299' ' ' LEU . . . -112.74 164.41 13.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.181 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.451 HG22 ' CG1' ' A' ' 261' ' ' VAL . 21.3 t -130.51 106.96 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.07 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -91.44 163.55 14.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.933 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.465 ' HB2' ' HB2' ' A' ' 324' ' ' ALA . . . -163.02 144.3 9.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.061 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.437 HD12 ' H ' ' A' ' 258' ' ' PHE . 3.8 mt -62.05 145.22 53.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.1 p -140.35 -177.19 4.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.942 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.451 HD23 HG23 ' A' ' 245' ' ' THR . 35.2 tp -122.48 129.38 51.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.871 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.1 mp -110.51 125.83 67.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.064 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.433 ' CG ' ' HB3' ' A' ' 125' ' ' PRO . 28.2 p90 -125.72 160.42 29.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -92.38 -176.36 4.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.886 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.9 mttm -125.13 -45.31 1.86 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.869 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.16 -31.65 72.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 70.6 mt -98.98 -31.06 12.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.957 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.638 HD22 ' SD ' ' A' ' 224' ' ' MET . 9.9 tp -132.53 108.0 13.23 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.853 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.63 -45.84 3.1 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.377 2.051 . . . . 0.0 112.263 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -128.17 128.95 23.68 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.83 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.593 ' HA ' HD21 ' A' ' 122' ' ' LEU . 66.8 Cg_endo -74.11 144.18 33.36 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.448 2.099 . . . . 0.0 112.416 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.54 123.07 7.33 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.52 2.147 . . . . 0.0 112.315 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.0 mmtp -93.42 17.87 10.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.105 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.41 149.93 51.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.846 0.355 . . . . 0.0 110.795 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.603 ' CE3' HD12 ' A' ' 132' ' ' ILE . 3.7 m95 -78.52 -22.47 47.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.111 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.26 -18.4 36.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.362 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.54 -30.68 52.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.8 0.334 . . . . 0.0 111.113 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.742 HD13 HD22 ' A' ' 147' ' ' LEU . 24.5 mt -63.68 -54.79 39.41 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.673 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 12.2 Cg_endo -55.98 -30.63 78.8 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.205 1.937 . . . . 0.0 112.084 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.2 -29.16 57.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.808 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 135' ' ' LEU . 6.9 mt -72.74 -33.14 66.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.762 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.69 -22.9 38.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.202 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -85.35 -32.31 22.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.026 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -85.09 -48.44 9.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.138 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.854 HD13 ' HA ' ' A' ' 146' ' ' ALA . 1.2 mt -63.33 -17.45 62.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.403 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.42 -29.9 42.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.845 0.355 . . . . 0.0 110.814 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.34 -34.39 78.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.91 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -75.9 -27.09 57.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.97 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 113.11 40.21 1.08 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.48 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.66 -175.97 5.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.787 0.327 . . . . 0.0 110.862 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.9 t -115.34 159.12 21.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.854 ' HA ' HD13 ' A' ' 139' ' ' LEU . . . -84.57 -66.08 0.94 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.128 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.742 HD22 HD13 ' A' ' 132' ' ' ILE . 6.0 tp -154.02 141.62 19.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.939 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.854 ' HB2' HG21 ' A' ' 208' ' ' THR . 0.0 OUTLIER -135.46 -177.86 4.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.594 ' CZ ' HD11 ' A' ' 195' ' ' LEU . 8.2 p90 -177.22 175.0 1.57 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.867 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -69.0 111.17 4.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.851 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.654 HD13 ' HA ' ' A' ' 206' ' ' ALA . 6.6 mt -98.0 27.02 4.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.057 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -119.83 -40.0 2.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.822 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -99.37 146.42 31.73 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.813 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.502 ' HB3' HG12 ' A' ' 343' ' ' VAL . 87.7 Cg_endo -82.08 9.45 3.96 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.722 2.281 . . . . 0.0 113.028 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -75.41 -32.3 60.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.739 0.304 . . . . 0.0 111.13 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -94.98 -16.58 22.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.437 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 30.8 p -92.42 -24.41 18.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.69 0.281 . . . . 0.0 111.28 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.773 ' CE2' ' HB2' ' A' ' 162' ' ' ALA . 27.3 t-105 -53.4 -45.78 98.33 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.526 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.544 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 52.6 Cg_exo -52.67 -25.61 26.85 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.334 2.022 . . . . 0.0 112.28 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.493 HD11 ' CE1' ' A' ' 250' ' ' PHE . 4.8 tp -92.56 -42.96 9.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.933 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 21.0 mt -72.79 -54.66 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.773 ' HB2' ' CE2' ' A' ' 158' ' ' TRP . . . -60.2 -33.21 71.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.176 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -62.07 -33.48 74.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.142 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.28 -20.14 57.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.153 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 141.09 -26.9 2.45 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.561 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.7 158.01 53.35 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.537 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -146.8 171.26 15.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.327 . . . . 0.0 110.85 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -90.96 -67.55 0.85 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.078 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -120.83 121.14 37.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.788 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -63.69 123.99 20.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.931 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -86.36 115.28 23.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.483 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -165.04 148.38 8.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.106 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 64.73 29.22 12.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.162 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.7 -37.25 3.37 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.087 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.73 -173.35 2.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.886 0.374 . . . . 0.0 111.063 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -105.25 173.98 6.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.85 127.85 49.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.1 pt -79.34 -22.55 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.349 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.34 26.02 4.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.132 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -145.06 94.2 2.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.836 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.7 HG12 ' H ' ' A' ' 183' ' ' VAL . 21.6 t -114.27 131.75 65.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.163 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -87.88 -9.04 71.82 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.853 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.7 ' H ' HG12 ' A' ' 181' ' ' VAL . 0.3 OUTLIER -48.47 -41.8 11.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.892 0.377 . . . . 0.0 111.332 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.416 ' N ' ' CG1' ' A' ' 183' ' ' VAL . 25.8 t0 -84.61 57.17 4.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.915 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -118.26 -173.75 2.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.944 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.07 -34.77 57.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.113 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.57 -43.74 84.9 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.569 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.43 -30.62 67.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.833 0.349 . . . . 0.0 111.189 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.86 -38.68 82.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.869 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -86.96 -28.51 22.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.199 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -57.47 -54.62 35.79 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.607 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.871 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.7 OUTLIER -60.63 -53.11 61.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.829 0.347 . . . . 0.0 110.932 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.417 ' OG1' HG21 ' A' ' 357' ' ' VAL . 62.1 m -54.1 -24.93 19.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.121 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -70.86 -59.99 2.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.815 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.594 HD11 ' CZ ' ' A' ' 149' ' ' PHE . 2.6 tp -58.73 -33.07 69.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.669 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 192' ' ' LEU . 49.5 t -63.43 -54.52 31.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.902 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -66.06 -32.69 74.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.735 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.5 HD22 ' HB3' ' A' ' 133' ' ' PRO . 14.5 mt -57.11 -19.27 18.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.224 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 196' ' ' VAL . 4.7 mt -88.99 -60.11 2.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.803 0.335 . . . . 0.0 111.565 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -85.19 -47.27 10.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.008 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -71.0 -10.0 58.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.014 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -114.71 -82.98 0.61 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.808 0.337 . . . . 0.0 111.189 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 171.01 16.27 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.374 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . 0.486 ' O ' HG23 ' A' ' 199' ' ' ILE . 0.2 OUTLIER -82.96 146.12 28.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.784 0.326 . . . . 0.0 110.77 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -102.04 137.42 40.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.031 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.654 ' HA ' HD13 ' A' ' 151' ' ' LEU . . . -79.99 -25.28 40.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.259 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -55.09 -31.1 60.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.132 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.854 HG21 ' HB2' ' A' ' 148' ' ' MET . 3.8 m -49.89 147.23 3.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.174 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.503 ' OD2' HD11 ' A' ' 212' ' ' ILE . 69.8 m-20 -154.15 176.22 12.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.015 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -41.59 -61.66 1.03 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.77 -59.26 3.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.833 0.349 . . . . 0.0 111.921 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.622 HD12 ' HA ' ' A' ' 208' ' ' THR . 0.2 OUTLIER -53.88 -30.67 19.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.342 -179.357 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.562 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -81.89 -25.76 34.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.801 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -82.31 -53.0 6.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.71 -25.75 63.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.323 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 221' ' ' GLU . . . -56.86 -32.27 65.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.239 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.515 ' CG ' HG21 ' A' ' 225' ' ' THR . 58.2 t80 -82.15 -34.0 29.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -75.46 -40.39 57.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -77.64 -31.92 53.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.928 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 103.01 72.13 0.91 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.546 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.412 ' HB2' ' HB1' ' A' ' 216' ' ' ALA . 6.7 mt-10 -128.39 -62.92 1.01 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.835 0.35 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.438 HG21 ' SD ' ' A' ' 148' ' ' MET . 8.9 t -93.5 135.88 34.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.939 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.92 -31.25 70.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.06 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.638 ' SD ' HD22 ' A' ' 122' ' ' LEU . 3.3 mpp? -120.8 151.21 39.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.942 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.515 HG21 ' CG ' ' A' ' 217' ' ' PHE . 9.0 t -157.67 159.58 37.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 24.8 mt -120.46 130.35 74.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.174 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.444 ' HB3' ' HB2' ' A' ' 231' ' ' ALA . 72.7 m-20 -160.95 165.34 30.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -105.99 -153.16 20.6 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.566 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.98 -26.19 24.38 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.629 2.22 . . . . 0.0 112.364 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 41.1 p90 -84.87 57.51 4.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.839 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.444 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . . . -156.45 -44.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.166 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -54.88 -48.01 73.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.021 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.3 m -66.77 -31.7 72.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.01 -32.2 73.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 4.8 mt -94.13 113.66 29.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.031 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -165.46 -49.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 7.0 m -65.87 -39.98 91.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.923 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . 0.646 ' HB3' HG23 ' A' ' 240' ' ' VAL . 1.9 t -69.25 -29.5 67.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.921 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt 61.82 36.55 16.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.918 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.646 HG23 ' HB3' ' A' ' 238' ' ' SER . 26.8 t -79.01 108.29 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.043 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.42 92.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.924 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -97.58 160.05 14.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.23 137.86 9.43 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.445 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.28 124.15 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.784 0.326 . . . . 0.0 111.155 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.451 HG23 HD23 ' A' ' 115' ' ' LEU . 9.1 t -130.52 159.3 37.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.5 t -73.61 151.92 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.001 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.2 mt -74.22 149.82 87.22 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.884 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.441 ' HG2' ' CE2' ' A' ' 129' ' ' TRP . 50.9 Cg_endo -69.14 165.97 28.44 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.554 2.169 . . . . 0.0 112.341 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 4.0 p -92.33 163.64 13.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.963 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.493 ' CE1' HD11 ' A' ' 160' ' ' LEU . 8.3 t80 -128.89 111.12 12.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 8.8 mttt 60.28 28.23 17.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.023 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 93.79 -21.16 42.99 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.731 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -94.3 148.99 36.01 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.704 0.288 . . . . 0.0 110.945 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.2 154.36 66.06 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.594 2.196 . . . . 0.0 112.334 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.16 -174.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.837 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 2.0 mmtt -135.04 63.83 59.02 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.973 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -56.19 -177.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.532 2.154 . . . . 0.0 112.251 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.437 ' H ' HD12 ' A' ' 113' ' ' LEU . 32.2 m-85 -118.83 116.59 26.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.766 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.2 t -85.8 123.4 39.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.288 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -121.92 117.64 3.45 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.271 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.614 HG12 ' O ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -109.48 127.47 66.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.37 . . . . 0.0 111.318 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 29.3 tp -91.11 85.38 5.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.297 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 1.4 m -86.33 175.19 8.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.134 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.449 ' HB1' ' CG2' ' A' ' 59' ' ' ILE . . . -107.06 114.99 29.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.006 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -85.9 128.8 8.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.553 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.435 HD11 HD13 ' A' ' 280' ' ' LEU . 28.0 mt -115.63 135.18 56.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.361 . . . . 0.0 111.08 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -85.49 140.62 30.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.754 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -70.39 -41.57 72.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.081 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -61.85 -28.95 69.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.149 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 3.7 m -58.17 109.48 1.85 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.979 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.57 -18.2 43.06 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.467 2.112 . . . . 0.0 112.499 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -92.88 46.27 1.22 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.03 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 16.3 mtmt -84.05 -31.96 25.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -62.11 -57.44 11.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 50.1 mt -62.51 -31.53 72.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.722 ' HB1' HD11 ' A' ' 59' ' ' ILE . . . -69.85 -46.62 65.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . 0.468 ' HA ' HD12 ' A' ' 280' ' ' LEU . 1.0 OUTLIER -57.68 -29.12 64.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.012 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -73.7 -52.96 11.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.043 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.416 ' CD1' ' HB2' ' A' ' 283' ' ' TYR . 79.1 t80 -59.93 -28.21 67.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.325 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.894 HD21 HD13 ' A' ' 59' ' ' ILE . 5.1 mt -80.31 -30.7 38.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.182 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.44 ' HG2' ' CE1' ' A' ' 85' ' ' PHE . 7.3 tt0 -93.65 -24.46 17.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.449 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -97.51 -50.16 4.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.445 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.563 ' HB3' HG12 ' A' ' 23' ' ' VAL . 4.4 m-85 -117.47 71.41 0.81 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.37 . . . . 0.0 111.296 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.824 ' CD2' HD23 ' A' ' 280' ' ' LEU . 5.6 tp -178.54 -39.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.91 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.674 HD22 ' CZ ' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -115.26 38.35 3.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.869 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.19 -176.38 2.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -80.87 -38.7 27.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -82.68 -36.28 26.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -65.67 -44.19 92.96 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.519 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 9.2 mt -70.14 -31.08 68.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 0.0 110.915 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -70.33 -36.96 74.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.994 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -59.27 -38.22 79.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.131 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.56 -29.45 20.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.111 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -74.06 -30.92 62.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.983 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 33.1 mttt -65.87 -35.41 80.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.959 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -99.0 -30.96 12.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.969 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.411 ' HA ' ' HD2' ' A' ' 298' ' ' PRO . 3.7 mmtt -152.97 95.18 3.02 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.931 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 297' ' ' LYS . 26.2 Cg_endo -62.29 119.52 6.66 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.513 2.142 . . . . 0.0 112.248 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.748 HD12 ' HB2' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -96.72 22.01 8.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.963 179.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . 0.662 ' O ' HD13 ' A' ' 311' ' ' LEU . . . 58.37 -133.96 52.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.664 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -58.71 174.68 0.31 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.816 0.341 . . . . 0.0 111.223 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.746 HG21 ' HB3' ' A' ' 307' ' ' TYR . 14.2 m -143.18 -179.7 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.07 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -93.86 -29.55 15.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.146 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.5 tp -58.89 152.27 19.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.916 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -77.01 -61.19 2.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.019 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 7.2 p -57.17 -49.79 74.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.079 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.746 ' HB3' HG21 ' A' ' 302' ' ' VAL . 0.1 OUTLIER -57.81 -25.04 60.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.027 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.46 -31.78 71.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.736 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -83.83 -42.1 16.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.865 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -52.44 -33.22 43.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.774 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.691 ' O ' HD12 ' A' ' 317' ' ' ILE . 83.7 mt -85.74 -21.37 28.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.919 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -76.47 -2.65 33.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.711 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 22.1 mmtt -47.26 -31.83 4.09 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 121.043 0.449 . . . . 0.0 110.856 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -117.41 140.22 27.08 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.309 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.565 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 14.4 Cg_endo -57.46 -32.4 94.01 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.349 2.033 . . . . 0.0 112.416 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 11.2 mtm-85 -48.58 -42.57 34.14 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.116 0.484 . . . . 0.0 110.243 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.691 HD12 ' O ' ' A' ' 311' ' ' LEU . 34.4 mt -85.56 -30.78 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.791 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.565 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -64.66 -33.92 77.07 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.125 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -74.97 -31.46 61.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.152 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 7.1 m -64.05 -48.48 76.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 10.8 tpt -60.96 -31.62 71.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -61.11 -43.77 98.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -62.35 -41.91 98.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . 0.465 ' HB2' ' HB2' ' A' ' 112' ' ' ALA . . . -60.03 -55.0 39.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.082 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -60.1 -30.03 68.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.931 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -95.84 21.08 8.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.145 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -131.38 -179.6 16.28 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.486 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.1 133.77 52.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.825 0.345 . . . . 0.0 110.906 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.699 HD11 ' HB2' ' A' ' 92' ' ' PHE . 22.9 mt -81.53 133.53 29.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.107 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 10.7 mtm -62.41 137.42 96.15 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.92 -172.38 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.522 2.148 . . . . 0.0 112.326 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -110.05 -26.07 9.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.027 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.701 HD12 ' HB2' ' A' ' 335' ' ' GLN . 33.5 pt -56.25 147.99 44.31 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.319 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.26 -8.91 22.65 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.636 2.224 . . . . 0.0 112.645 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.701 ' HB2' HD12 ' A' ' 333' ' ' ILE . 3.3 mp0 -54.53 -26.18 30.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.741 0.305 . . . . 0.0 111.103 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.404 ' O ' ' CD1' ' A' ' 340' ' ' TRP . 0.7 OUTLIER -56.8 -30.91 64.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.934 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.5 m -60.75 -57.31 13.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.971 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.97 -30.35 71.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.133 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.757 ' O ' HG23 ' A' ' 343' ' ' VAL . 39.0 t80 -59.73 -36.76 77.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.977 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.404 ' CD1' ' O ' ' A' ' 336' ' ' MET . 25.8 m95 -66.28 -51.01 61.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.945 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.89 -47.84 84.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.074 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -57.22 -44.63 83.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.301 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.844 ' O ' HG23 ' A' ' 347' ' ' VAL . 23.9 t -77.39 -28.55 16.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.27 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -57.43 13.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.945 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 3.7 m -60.57 -41.37 94.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.586 ' HB1' ' HB1' ' A' ' 360' ' ' ALA . . . -57.29 -34.92 69.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.23 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 343' ' ' VAL . 28.7 t -82.69 -45.91 19.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.188 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 9.4 mt -61.26 -57.59 11.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.162 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -58.77 -43.66 90.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.971 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.39 -29.87 70.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.082 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -78.51 -29.45 46.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.174 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 10.6 m -95.75 20.74 9.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.18 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 56.32 27.02 52.24 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.617 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 6.8 mtt-85 -89.86 -29.69 18.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.79 0.329 . . . . 0.0 110.963 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -143.86 162.27 36.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.899 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 30.6 p -97.96 156.85 16.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.844 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.543 HG22 HD23 ' A' ' 192' ' ' LEU . 25.6 t -56.88 -28.66 28.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.159 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -70.26 -56.5 6.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -61.88 -46.08 90.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.021 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.586 ' HB1' ' HB1' ' A' ' 346' ' ' ALA . . . -60.02 -50.37 73.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.139 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.424 ' CD1' HG12 ' A' ' 357' ' ' VAL . 28.0 mt -62.04 -30.18 70.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.47 -45.44 25.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.961 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -69.13 -45.59 69.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.99 -46.03 89.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -59.8 -43.25 94.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 10.0 m -64.66 -31.53 72.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.92 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 13.6 mtp85 -68.57 -35.71 77.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.943 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.699 HD13 ' CE2' ' A' ' 339' ' ' PHE . 19.3 mt -73.26 -28.86 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.177 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 2.2 p -82.62 -31.47 28.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.899 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.901 179.969 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.804 0.335 . . . . 0.0 111.254 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 55' ' ' ASP . 10.0 t -154.27 146.66 23.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.2 165.24 12.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -82.59 154.85 24.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.568 ' O ' HG23 ' A' ' 33' ' ' ILE . . . 113.26 -35.9 4.33 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.455 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -113.76 169.86 8.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 0.0 110.871 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' A' ' 275' ' ' LEU . 44.7 mt -124.24 118.78 27.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.9 147.05 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.208 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.826 HG21 HD21 ' A' ' 20' ' ' LEU . 31.8 mt -137.32 107.34 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.927 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -96.81 109.36 22.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.84 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.458 HD11 ' CD ' ' A' ' 15' ' ' LYS . 14.9 tt -123.52 158.14 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.029 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -60.56 166.58 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.19 43.36 2.39 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.498 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -161.18 31.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.458 ' CD ' HD11 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -130.46 177.67 7.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.94 73.49 0.27 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.52 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -86.02 -33.06 21.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 0.0 110.947 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -60.43 -33.17 72.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.739 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -75.96 -28.46 60.61 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.531 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.826 HD21 HG21 ' A' ' 9' ' ' ILE . 3.7 tp -72.66 -30.99 64.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.811 0.338 . . . . 0.0 110.932 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.52 -37.94 83.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.103 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -70.39 -32.23 69.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 19' ' ' GLY . 26.8 t -72.2 -30.72 36.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.104 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.32 -38.6 33.4 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.538 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -59.88 -29.51 68.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.817 0.341 . . . . 0.0 110.94 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -74.78 -41.19 60.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.937 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.484 ' CD2' ' CE1' ' A' ' 283' ' ' TYR . 1.5 t80 -59.75 -52.62 64.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.907 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -58.53 -43.13 89.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.902 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -71.83 -25.39 61.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.83 -32.85 40.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.371 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.53 -44.23 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.473 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.16 -23.27 2.58 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.762 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.568 HG23 ' O ' ' A' ' 5' ' ' GLY . 33.1 mm -59.92 110.16 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.828 0.347 . . . . 0.0 111.037 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.6 mtmt -78.63 156.75 28.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.955 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.4 t -134.82 117.96 24.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.091 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.0 m -99.5 143.86 29.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.4 t -137.84 110.71 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.139 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -110.28 176.21 5.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.86 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -133.11 74.31 73.44 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.86 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.18 -179.13 4.07 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.64 2.227 . . . . 0.0 112.415 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -60.05 -159.43 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.53 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.476 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -46.46 -27.45 1.1 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.604 0.24 . . . . 0.0 111.53 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.567 HD12 ' CD1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 52.44 19.68 1.23 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.852 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.73 -57.12 4.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.829 0.347 . . . . 0.0 110.655 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -95.49 -7.72 37.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.002 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.87 -19.24 57.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.256 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.567 ' CD1' HD12 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -85.58 -55.94 0.39 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.045 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.444 ' HD3' ' CB ' ' A' ' 47' ' ' PHE . 72.6 Cg_exo -50.54 -35.63 46.79 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.589 2.193 . . . . 0.0 112.61 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.581 ' HG3' HG13 ' A' ' 50' ' ' VAL . 11.2 pt20 -59.49 -49.68 76.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.947 0.403 . . . . 0.0 111.004 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.581 HG13 ' HG3' ' A' ' 49' ' ' GLN . 6.6 m -95.29 18.05 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.552 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.09 -38.01 13.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.825 0.345 . . . . 0.0 111.216 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.51 -33.77 68.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.164 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.449 HG23 ' H ' ' A' ' 55' ' ' ASP . 3.3 t -96.43 -29.53 13.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.934 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.53 28.1 72.71 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.431 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.691 ' O ' HG22 ' A' ' 2' ' ' THR . 5.3 t0 -94.5 -28.26 15.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.74 0.305 . . . . 0.0 111.01 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.97 -105.11 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.597 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.444 ' CG ' ' CE2' ' A' ' 47' ' ' PHE . 61.4 Cg_endo -73.18 -169.12 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.49 2.127 . . . . 0.0 112.407 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -150.55 -46.86 0.12 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.813 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.2 mt -127.19 133.37 68.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.058 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.477 ' CG1' ' N ' ' A' ' 61' ' ' PHE . 1.9 tt -139.49 159.69 28.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.111 0.481 . . . . 0.0 110.942 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.6 ' CE2' HD21 ' A' ' 284' ' ' LEU . 65.2 m-85 -138.1 122.35 18.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.873 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -158.26 169.26 24.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.882 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.13 143.87 47.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -60.49 -31.52 70.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -59.74 -36.04 75.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.902 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.3 mmt-85 -94.69 17.18 13.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.231 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -105.71 -31.14 9.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.849 0.357 . . . . 0.0 110.858 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.5 -28.14 64.53 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.555 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.34 -28.83 74.01 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.559 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -91.89 -27.91 17.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.73 0.3 . . . . 0.0 110.982 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.589 ' HB2' HD12 ' A' ' 76' ' ' LEU . . . -79.53 -28.03 41.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.244 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.36 -31.71 69.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.063 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.6 m -88.09 -23.17 23.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.09 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.4 27.98 10.17 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.442 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.9 mt -81.25 -34.25 32.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.77 0.319 . . . . 0.0 110.868 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.589 HD12 ' HB2' ' A' ' 71' ' ' ALA . 25.5 mt -81.86 146.55 29.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.71 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -87.29 135.27 33.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.068 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.696 ' HA ' HG22 ' A' ' 104' ' ' ILE . 17.5 tp10 -69.57 159.72 32.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.09 0.472 . . . . 0.0 110.739 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.59 HG21 ' CE1' ' A' ' 106' ' ' TYR . 35.4 pt -135.29 -178.57 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.176 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 t -163.22 78.0 1.75 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.804 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.08 123.4 11.83 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.643 2.229 . . . . 0.0 112.282 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.5 -177.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.852 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -60.09 -40.56 90.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.913 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.79 -50.5 73.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.094 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -66.28 -35.31 80.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.46 -31.14 63.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.794 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -75.64 -36.51 60.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 57.19 4.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.885 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.514 HD13 ' CZ2' ' A' ' 94' ' ' TRP . 0.1 OUTLIER -173.61 162.02 4.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.774 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.48 ' CD1' ' CZ ' ' A' ' 92' ' ' PHE . 22.0 m-85 -78.51 136.22 60.09 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.077 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 53.3 Cg_exo -55.24 -55.72 2.91 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.526 2.15 . . . . 0.0 112.662 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.908 ' CE1' HG23 ' A' ' 93' ' ' THR . 25.0 p90 -54.87 -44.83 74.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.549 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.908 HG23 ' CE1' ' A' ' 92' ' ' PHE . 40.2 p -61.31 -27.6 68.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.189 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.514 ' CZ2' HD13 ' A' ' 89' ' ' LEU . 8.4 m95 -69.52 -29.29 66.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.941 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.401 ' HA ' ' CG ' ' A' ' 98' ' ' ARG . 1.3 m-20 -93.66 17.32 11.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.362 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -101.89 -29.69 11.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.76 0.314 . . . . 0.0 111.214 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.687 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 12.0 m -90.63 -35.73 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.446 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.401 ' CG ' ' HA ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -65.95 132.37 48.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.012 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.407 ' CE1' ' OD1' ' A' ' 332' ' ' ASN . 0.4 OUTLIER -82.0 -49.59 10.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.865 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -148.6 54.67 1.01 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.929 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.12 -27.27 20.01 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.645 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.51 158.9 20.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.782 0.325 . . . . 0.0 110.965 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 54.9 mt -117.5 131.03 56.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.884 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.696 HG22 ' HA ' ' A' ' 78' ' ' GLU . 2.8 pp -142.65 27.21 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.342 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.89 ' HB1' ' HB2' ' A' ' 263' ' ' SER . . . -158.25 179.33 9.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.869 0.366 . . . . 0.0 111.173 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.59 ' CE1' HG21 ' A' ' 79' ' ' ILE . 39.2 m-85 -140.87 89.49 9.96 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.833 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.462 ' HG3' HG13 ' A' ' 97' ' ' VAL . 52.6 Cg_exo -53.09 99.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.57 2.18 . . . . 0.0 112.269 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.62 ' HA ' HD21 ' A' ' 285' ' ' LEU . 25.2 mm -74.01 -66.23 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.161 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.423 ' O ' HG12 ' A' ' 261' ' ' VAL . . . -120.8 166.36 13.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.066 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 301' ' ' ALA . 10.9 p -123.22 139.07 51.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.092 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -116.74 147.93 41.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -161.85 149.62 14.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.141 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 113' ' ' LEU . 28.9 mt -68.27 126.02 28.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.9 m -124.9 147.29 48.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.503 HD12 HG12 ' A' ' 226' ' ' ILE . 5.2 tp -82.94 136.0 34.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.898 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.535 HG23 ' O ' ' A' ' 243' ' ' GLY . 4.3 mt -116.4 131.38 69.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.049 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -122.24 154.95 36.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.32 144.31 31.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.36 29.77 3.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.959 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.731 ' HB3' HD23 ' A' ' 121' ' ' LEU . 1.8 t70 -97.39 -61.17 1.44 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.895 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.731 HD23 ' HB3' ' A' ' 120' ' ' ASP . 0.2 OUTLIER -110.33 -32.83 6.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.849 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.517 HD21 ' HD3' ' A' ' 126' ' ' PRO . 14.1 tp -93.39 104.16 11.62 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.821 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.83 -47.21 2.0 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.405 2.07 . . . . 0.0 112.275 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -123.38 135.44 26.04 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.822 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.09 139.11 21.21 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.529 2.152 . . . . 0.0 112.32 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.517 ' HD3' HD21 ' A' ' 122' ' ' LEU . 74.5 Cg_endo -75.2 116.77 4.65 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.447 2.098 . . . . 0.0 112.394 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.01 23.41 6.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.03 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.5 p -134.77 141.95 46.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.865 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.804 ' CE3' HD12 ' A' ' 132' ' ' ILE . 2.4 m95 -79.94 -22.56 42.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.103 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.52 -24.72 53.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.181 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -81.18 -26.56 35.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.143 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.804 HD12 ' CE3' ' A' ' 129' ' ' TRP . 31.7 mt -57.28 -54.56 53.49 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.625 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 15.6 Cg_endo -57.47 -27.32 75.75 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.239 1.959 . . . . 0.0 112.089 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.0 -29.31 35.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.5 mt -73.92 -39.68 63.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.859 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.12 -26.35 11.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.058 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -85.58 -27.86 25.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.122 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.98 -48.62 9.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.153 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.808 HD13 ' HA ' ' A' ' 146' ' ' ALA . 0.2 OUTLIER -62.89 -17.32 61.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.411 -179.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -28.11 55.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.845 0.355 . . . . 0.0 110.847 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.88 -41.64 87.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.02 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 46.7 mttt -77.22 -27.01 53.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.02 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 116.07 31.48 1.88 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.488 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.72 -178.31 5.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 0.0 110.868 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.2 t -115.65 171.76 7.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.861 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.808 ' HA ' HD13 ' A' ' 139' ' ' LEU . . . -87.28 -57.59 2.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.155 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.479 ' HB2' ' HE2' ' A' ' 224' ' ' MET . 6.2 tp -161.21 143.83 12.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.987 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.455 ' SD ' HG21 ' A' ' 222' ' ' THR . 0.0 OUTLIER -132.29 -178.99 5.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -179.29 151.73 0.5 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -62.52 121.33 13.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.857 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.4 mt -98.26 28.6 3.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.938 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -112.63 -33.59 6.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.24 107.51 60.54 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.887 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -51.32 -24.13 15.14 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.485 2.123 . . . . 0.0 112.398 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.483 ' CE1' ' CD2' ' A' ' 258' ' ' PHE . 54.0 t80 -52.33 -27.79 16.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.199 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -87.11 -35.1 18.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.9 p -94.86 18.3 12.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.2 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.552 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 27.4 t-105 -73.76 -50.51 5.65 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.531 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 43.2 Cg_endo -68.2 -24.79 37.67 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.116 1.878 . . . . 0.0 112.508 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.673 ' CD2' HD13 ' A' ' 195' ' ' LEU . 52.1 tp -59.23 -37.47 77.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.841 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 4.8 mp -105.06 -33.28 2.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.991 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.52 -29.15 70.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.241 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.403 ' HB2' ' HA ' ' A' ' 255' ' ' SER . . . -56.64 -46.77 80.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.144 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -61.06 -20.07 62.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.124 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 125.63 53.55 0.17 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.489 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -134.53 123.64 3.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.512 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.433 ' CD2' ' HA3' ' A' ' 182' ' ' GLY . 20.7 p90 -117.99 -178.25 3.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.848 0.356 . . . . 0.0 110.871 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -100.07 -44.48 5.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.083 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -131.87 141.95 49.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.7 tptp -68.38 137.24 54.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.976 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.429 ' CE1' ' HA2' ' A' ' 174' ' ' GLY . 19.8 t80 -128.11 110.7 12.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.74 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.407 ' CG ' ' N ' ' A' ' 173' ' ' ASN . 9.7 pt-20 -139.01 -47.24 0.48 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.308 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.407 ' N ' ' CG ' ' A' ' 172' ' ' GLU . 49.4 m-80 -95.72 41.85 1.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.073 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.429 ' HA2' ' CE1' ' A' ' 171' ' ' TYR . . . 57.78 20.55 40.54 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.706 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.406 ' O ' ' CD2' ' A' ' 171' ' ' TYR . 11.3 mttt -133.3 -171.37 2.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.337 . . . . 0.0 110.866 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -126.44 86.81 2.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.59 127.67 33.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.911 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.9 pt -81.46 -12.3 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.472 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -96.01 26.0 4.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.719 0.295 . . . . 0.0 111.149 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -148.4 116.16 6.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.935 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.715 HG12 ' H ' ' A' ' 183' ' ' VAL . 21.3 t -104.53 146.08 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.042 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 0.433 ' HA3' ' CD2' ' A' ' 167' ' ' TYR . . . -96.97 -12.64 49.08 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.029 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.898 HG12 HD22 ' A' ' 361' ' ' LEU . 6.1 t -62.89 -43.5 98.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.815 0.34 . . . . 0.0 111.18 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -83.85 57.23 4.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.07 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -110.74 -172.78 2.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.12 -44.78 29.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.171 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.16 -34.78 28.84 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.583 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.62 -30.16 68.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.337 . . . . 0.0 111.179 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -60.51 -56.62 19.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.32 -26.53 55.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.225 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -56.14 -40.7 84.29 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.706 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.832 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.4 OUTLIER -76.77 -30.13 56.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.752 0.311 . . . . 0.0 110.94 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 66.2 m -56.35 -23.27 36.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.943 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -65.58 -60.53 2.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.791 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.673 HD13 ' CD2' ' A' ' 160' ' ' LEU . 5.2 tp -60.31 -30.96 69.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.703 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 192' ' ' LEU . 40.0 t -66.07 -48.41 81.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.007 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -82.43 -23.12 34.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.095 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.605 HD23 ' HG3' ' A' ' 202' ' ' LYS . 6.3 mt -64.25 -24.38 67.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.228 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 204' ' ' MET . 13.5 mt -88.96 -42.22 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.646 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 23.4 mtpt -85.02 -29.35 25.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.829 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -91.65 -10.18 41.28 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.605 ' HG3' HD23 ' A' ' 198' ' ' LEU . 13.4 mmtt -133.96 9.71 3.86 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.191 -0.204 . . . . 0.0 111.516 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . 0.424 ' CG ' ' O ' ' A' ' 202' ' ' LYS . 56.2 p-80 43.89 53.15 6.38 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.942 0.401 . . . . 0.0 111.376 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . 0.432 ' O ' HG23 ' A' ' 199' ' ' ILE . 0.0 OUTLIER -82.84 128.42 34.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.844 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -59.94 119.89 8.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.991 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -80.04 -28.06 39.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.077 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -56.47 -24.36 45.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.182 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.653 ' HA ' HD12 ' A' ' 212' ' ' ILE . 7.6 m -36.29 145.91 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.94 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.476 ' OD2' HD11 ' A' ' 212' ' ' ILE . 59.4 m-20 -153.55 176.21 12.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.75 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -34.84 79.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.032 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.99 -59.13 2.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 0.0 111.226 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' A' ' 208' ' ' THR . 0.3 OUTLIER -58.88 -29.59 41.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.848 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -81.75 -21.23 37.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.995 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -75.47 -56.9 4.25 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.837 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.37 -29.53 68.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.136 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.524 ' HB1' ' HB2' ' A' ' 221' ' ' GLU . . . -58.94 -41.91 88.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.141 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.679 ' CG ' HG21 ' A' ' 225' ' ' THR . 19.1 t80 -75.65 -33.16 60.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -74.9 -38.39 61.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.956 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.35 -31.55 33.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.894 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.66 63.8 0.72 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.48 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.524 ' HB2' ' HB1' ' A' ' 216' ' ' ALA . 39.9 mm-40 -111.07 -32.99 6.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.342 . . . . 0.0 110.949 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.455 HG21 ' SD ' ' A' ' 148' ' ' MET . 9.6 t -121.05 162.26 20.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -84.08 -39.86 19.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.102 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.479 ' HE2' ' HB2' ' A' ' 147' ' ' LEU . 1.3 mpp? -126.71 165.81 18.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.897 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.679 HG21 ' CG ' ' A' ' 217' ' ' PHE . 9.8 t -166.65 139.52 3.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.503 HG12 HD12 ' A' ' 115' ' ' LEU . 22.9 mt -101.08 128.27 53.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.466 ' ND2' ' HB3' ' A' ' 231' ' ' ALA . 1.7 p-10 -165.3 144.74 6.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -63.84 -175.05 3.5 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.508 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.52 -20.91 35.34 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.662 2.241 . . . . 0.0 112.457 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . 0.428 ' CD1' ' N ' ' A' ' 231' ' ' ALA . 5.4 p90 -56.3 -30.7 62.86 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.001 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.466 ' HB3' ' ND2' ' A' ' 227' ' ' ASN . . . -72.92 -32.78 65.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.102 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . 0.881 ' HA ' HD12 ' A' ' 235' ' ' ILE . 50.6 m0 -57.29 -27.42 62.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.074 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.3 m -59.59 -55.42 34.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.024 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -62.59 -30.63 71.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.011 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.881 HD12 ' HA ' ' A' ' 232' ' ' TRP . 23.2 mt -70.78 96.69 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.085 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -160.48 -53.2 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.77 -33.92 74.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.917 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . 0.458 ' HB2' HG23 ' A' ' 240' ' ' VAL . 99.1 p -60.19 -32.84 71.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.906 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm 60.69 33.34 20.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.458 HG23 ' HB2' ' A' ' 238' ' ' SER . 21.5 t -91.44 131.18 39.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.12 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.97 93.52 3.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.589 ' CE1' HG21 ' A' ' 235' ' ' ILE . 52.7 p90 -103.43 135.13 45.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.967 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.535 ' O ' HG23 ' A' ' 116' ' ' ILE . . . -101.97 -164.55 26.84 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.5 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.4 t -148.19 133.99 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 111.128 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 63.3 m -143.5 159.3 42.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.86 151.88 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.971 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.447 HD12 ' OD1' ' A' ' 323' ' ' ASN . 9.9 mt -59.64 141.05 88.94 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.874 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.43 ' HB2' ' CD1' ' A' ' 129' ' ' TRP . 50.3 Cg_exo -53.67 146.1 45.78 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.506 2.137 . . . . 0.0 112.242 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 67.6 p -81.19 -177.3 6.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -156.8 109.95 2.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 24.1 mtpt 59.57 31.04 20.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 83.84 27.12 39.1 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.549 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -138.16 142.2 34.69 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.667 0.27 . . . . 0.0 110.915 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.09 163.88 34.29 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.572 2.181 . . . . 0.0 112.342 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.403 ' HA ' ' HB2' ' A' ' 163' ' ' ALA . 8.5 m -74.25 153.05 39.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.845 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.35 72.62 0.93 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.868 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.8 -168.26 0.31 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.597 2.198 . . . . 0.0 112.335 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.496 ' CE2' ' CD1' ' A' ' 158' ' ' TRP . 13.9 m-85 -101.99 165.6 11.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.924 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 328' ' ' GLU . 26.5 t -127.98 126.4 66.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.103 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -126.92 116.9 2.59 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.386 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -112.6 130.56 66.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.824 0.345 . . . . 0.0 111.078 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 7.3 tp -90.58 84.01 5.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.791 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.89 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 0.3 OUTLIER -83.53 166.27 18.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.966 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.581 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . . . -99.51 131.38 45.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.068 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -95.53 103.04 2.92 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.507 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.507 HD11 ' CD1' ' A' ' 280' ' ' LEU . 32.8 mt -100.5 103.05 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.797 0.332 . . . . 0.0 111.098 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -62.07 165.49 5.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.997 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.71 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -84.02 -24.97 30.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.279 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -96.4 30.25 2.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.301 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.44 125.05 90.59 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.83 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.23 -27.71 39.25 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.385 2.057 . . . . 0.0 112.339 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -145.9 85.51 1.69 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.883 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -64.85 -36.32 83.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.855 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.25 -57.69 9.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.459 ' HB3' HD11 ' A' ' 7' ' ' LEU . 10.1 mt -60.01 -31.53 70.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.957 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.92 -60.4 3.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.099 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . 0.515 ' HA ' HD12 ' A' ' 280' ' ' LEU . 0.3 OUTLIER -61.86 -29.16 70.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.964 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -59.47 -60.91 3.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.021 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.458 ' HE1' HD13 ' A' ' 284' ' ' LEU . 52.6 t80 -54.12 -24.27 17.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.403 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.913 HD23 HD22 ' A' ' 284' ' ' LEU . 95.1 mt -76.74 -40.72 47.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.265 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -93.56 -16.38 24.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.601 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.444 ' HB3' ' CD1' ' A' ' 283' ' ' TYR . 2.8 m-80 -91.91 -58.06 2.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.639 0.257 . . . . 0.0 111.362 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.484 ' CE1' ' CD2' ' A' ' 27' ' ' PHE . 7.0 m-85 -126.83 75.86 1.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.37 . . . . 0.0 111.227 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.913 HD22 HD23 ' A' ' 280' ' ' LEU . 5.1 tp -177.99 -57.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.924 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.62 HD21 ' HA ' ' A' ' 108' ' ' ILE . 13.7 mt -94.41 47.29 1.18 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.891 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 18.0 p -128.53 176.98 7.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.891 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.425 ' HA ' ' CD1' ' A' ' 307' ' ' TYR . 9.2 p-10 -81.0 -34.98 32.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.933 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -82.69 -31.21 28.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.929 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.79 -56.64 5.8 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.583 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.444 HD21 HG22 ' A' ' 108' ' ' ILE . 0.9 OUTLIER -59.83 -30.7 69.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.76 0.314 . . . . 0.0 110.97 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -59.76 -41.06 90.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.036 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.72 -54.44 47.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.143 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.3 t -58.4 -28.31 35.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.282 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -71.08 -27.16 63.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.046 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 18.5 mttm -60.28 -34.19 73.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.189 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -110.73 -34.68 6.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.207 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 2.8 tppt? -133.41 83.71 48.73 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.062 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.42 119.32 6.26 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.579 2.186 . . . . 0.0 112.284 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 4.6 mp -95.71 20.95 9.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.07 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 57.09 -106.56 0.74 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.603 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.525 ' HB3' HG13 ' A' ' 110' ' ' VAL . . . -71.59 175.29 5.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 111.12 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 15.4 m -143.14 160.12 17.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.165 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 108' ' ' ILE . . . -79.96 -34.51 38.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.072 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.46 HD23 ' HB2' ' A' ' 307' ' ' TYR . 2.7 tp -71.37 110.65 6.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.891 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -60.59 -31.54 70.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.861 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.4 m -70.21 -33.23 71.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.561 ' CE2' HD11 ' A' ' 311' ' ' LEU . 12.5 t80 -83.78 -27.14 29.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.024 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -58.75 -30.62 67.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.878 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -63.19 -55.32 26.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.809 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.94 -35.25 45.31 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.749 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.678 ' CB ' HG21 ' A' ' 317' ' ' ILE . 15.8 mt -85.73 -23.97 27.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.756 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.46 -14.74 61.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.457 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -46.66 -31.37 2.85 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 120.921 0.391 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -116.64 137.89 24.05 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.302 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.77 -28.48 67.09 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.432 2.088 . . . . 0.0 112.459 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -51.72 -36.31 46.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.001 0.429 . . . . 0.0 110.37 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.678 HG21 ' CB ' ' A' ' 311' ' ' LEU . 35.7 mm -85.43 -35.45 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.85 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -69.83 -29.69 67.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.189 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -70.66 -56.01 7.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.148 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 8.7 m -60.1 -37.23 79.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.954 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.486 ' SD ' ' HB1' ' A' ' 301' ' ' ALA . 7.0 tpt -63.98 -31.34 72.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.951 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -69.45 -53.65 18.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.992 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.447 ' OD1' HD12 ' A' ' 247' ' ' LEU . 0.3 OUTLIER -60.2 -31.34 70.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.887 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.68 -31.33 72.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.14 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -75.43 -55.02 6.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.94 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -68.55 -30.29 69.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -58.43 142.56 45.05 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.529 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . 0.754 ' O ' HG23 ' A' ' 259' ' ' VAL . 26.8 tt0 -74.53 154.12 38.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.869 0.366 . . . . 0.0 110.872 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.532 HD11 ' HB2' ' A' ' 92' ' ' PHE . 23.3 mt -101.69 132.52 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.064 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.428 ' HG3' ' CD1' ' A' ' 258' ' ' PHE . 29.5 mtm -69.58 135.87 88.3 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.49 168.55 24.26 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.501 2.134 . . . . 0.0 112.347 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.407 ' OD1' ' CE1' ' A' ' 99' ' ' TYR . 9.3 p30 -113.03 36.81 3.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.839 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.855 HD12 ' HB2' ' A' ' 335' ' ' GLN . 2.1 pt -105.98 154.29 39.59 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.158 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.26 -28.1 28.08 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.564 2.176 . . . . 0.0 112.308 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.855 ' HB2' HD12 ' A' ' 333' ' ' ILE . 3.0 mp0 -58.86 -26.26 64.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.047 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.4 ' O ' ' CD1' ' A' ' 340' ' ' TRP . 0.0 OUTLIER -56.08 -29.9 61.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.04 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.8 m -66.66 -41.65 87.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.936 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.85 -26.09 60.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.233 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.845 ' O ' HG23 ' A' ' 343' ' ' VAL . 87.5 t80 -57.95 -30.43 65.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.07 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.4 ' CD1' ' O ' ' A' ' 336' ' ' MET . 89.0 m95 -67.43 -53.28 30.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.004 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.89 -24.75 59.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.172 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -84.77 -29.13 25.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.397 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.853 ' O ' HG23 ' A' ' 347' ' ' VAL . 25.4 t -91.97 -50.27 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.259 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.404 ' O ' HD12 ' A' ' 348' ' ' ILE . 0.0 OUTLIER -52.66 -28.5 21.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.281 -179.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 19.5 m -85.72 -48.67 8.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.077 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.784 ' HB1' ' HB1' ' A' ' 360' ' ' ALA . . . -58.78 -29.12 66.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.388 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 343' ' ' VAL . 24.8 t -77.13 -52.26 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.293 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 344' ' ' ARG . 40.4 mt -61.38 -50.92 78.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.127 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -58.57 -30.18 66.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.925 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -82.68 -29.42 29.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.207 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -76.44 -27.08 56.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.272 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 3.3 m -95.83 20.77 9.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.224 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 55.75 24.7 41.65 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.703 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.87 -29.72 18.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.832 0.349 . . . . 0.0 110.887 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -138.69 153.26 48.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.817 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.14 165.08 20.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.805 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 358' ' ' ASP . 1.6 p -63.97 -45.4 96.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.154 0.502 . . . . 0.0 110.774 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . 0.468 ' N ' ' CG1' ' A' ' 357' ' ' VAL . 66.4 m-20 -60.02 -53.87 52.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.172 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -57.18 -31.24 65.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.177 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.784 ' HB1' ' HB1' ' A' ' 346' ' ' ALA . . . -61.07 -60.41 3.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.973 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.898 HD22 HG12 ' A' ' 183' ' ' VAL . 0.3 OUTLIER -63.31 -32.93 74.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.606 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.65 -59.05 3.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -59.17 -46.37 88.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.795 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -57.13 -37.16 71.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.076 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.411 ' HA ' HG21 ' A' ' 181' ' ' VAL . 5.4 tt0 -60.59 -45.4 94.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 6.5 m -61.03 -40.61 94.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.956 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 44.4 mtm180 -62.95 -43.52 98.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.937 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 15.8 mt -72.47 -32.19 40.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.047 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.491 HG23 ' O ' ' A' ' 369' ' ' THR . 4.8 t -160.76 91.83 0.92 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.912 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.827 0.346 . . . . 0.0 111.172 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.461 HG21 ' OD2' ' A' ' 58' ' ' ASP . 1.5 m -79.11 104.81 9.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -72.73 149.96 43.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.911 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -69.46 137.23 52.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 107.76 29.4 4.4 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.474 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.443 ' HA ' HG22 ' A' ' 33' ' ' ILE . 2.3 ptpt -157.14 -177.94 6.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.817 0.341 . . . . 0.0 110.91 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 mt -150.09 112.49 4.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.8 t -100.58 131.07 48.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.162 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.638 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.3 mp -113.2 107.36 22.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.817 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.445 ' CD2' ' HG2' ' A' ' 57' ' ' PRO . 0.3 OUTLIER -95.22 106.7 18.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.842 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.9 tt -137.12 157.22 35.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.104 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -69.45 -179.59 1.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.51 61.02 0.31 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.558 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.41 31.11 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.815 0.34 . . . . 0.0 110.917 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -150.37 -176.73 5.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.854 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.75 64.79 1.84 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.536 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -78.92 -31.56 45.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.824 0.345 . . . . 0.0 110.921 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -63.1 -32.04 73.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.844 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.85 -30.82 57.14 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.46 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.516 HD21 HG21 ' A' ' 9' ' ' ILE . 14.1 tp -60.98 -30.68 70.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 110.887 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.89 -48.62 80.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.131 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -59.03 -30.66 68.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.966 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 36.5 t -69.04 -34.89 66.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.029 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.3 -35.71 83.1 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.465 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -59.63 -27.82 66.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.81 0.338 . . . . 0.0 111.014 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.42 -41.58 76.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.894 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.84 -51.26 67.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.0 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -64.66 -23.1 67.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.158 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -82.64 -25.45 33.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.309 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -101.22 -32.58 10.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.629 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.8 p -119.0 -44.18 2.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.781 0.325 . . . . 0.0 111.446 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.93 27.23 6.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.526 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.443 HG22 ' HA ' ' A' ' 6' ' ' LYS . 27.9 mm -94.19 130.49 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.761 0.315 . . . . 0.0 111.104 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -59.64 152.16 23.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.942 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.33 104.64 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.115 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.0 m -103.41 147.87 26.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -141.16 110.63 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -115.61 161.11 19.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.928 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -132.51 70.3 79.6 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.865 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.562 ' HG2' HD22 ' A' ' 43' ' ' LEU . 40.9 Cg_endo -68.13 161.14 45.71 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.59 2.193 . . . . 0.0 112.362 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -103.36 141.01 36.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.651 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.09 37.57 24.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.817 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.562 HD22 ' HG2' ' A' ' 40' ' ' PRO . 2.4 pp -79.07 5.57 11.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.747 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.4 -46.69 66.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.795 0.331 . . . . 0.0 111.173 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -90.03 -9.84 47.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.478 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.607 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -89.03 -18.91 26.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.649 0.261 . . . . 0.0 111.338 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.441 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -78.18 -50.86 1.71 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.682 0.277 . . . . 0.0 111.317 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 52.7 Cg_exo -55.31 -20.43 25.31 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.632 2.221 . . . . 0.0 112.944 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.429 ' CG ' ' N ' ' A' ' 50' ' ' VAL . 0.9 OUTLIER -85.71 -47.95 9.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.896 0.379 . . . . 0.0 111.327 -179.61 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 46' ' ' LYS . 11.2 m -79.57 -28.6 13.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.304 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.28 -41.69 89.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.88 -32.21 73.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.148 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.2 p -83.52 -30.83 26.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.937 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.443 ' HA3' ' HB1' ' A' ' 269' ' ' ALA . . . 75.5 25.85 66.97 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.559 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.26 -31.07 10.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.864 0.364 . . . . 0.0 110.892 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.38 -147.72 2.29 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.523 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.445 ' HG2' ' CD2' ' A' ' 10' ' ' TRP . 52.9 Cg_exo -52.57 -175.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.56 2.173 . . . . 0.0 112.314 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.461 ' OD2' HG21 ' A' ' 2' ' ' THR . 63.8 m-20 -135.25 -46.77 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.957 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.67 HG21 HD11 ' A' ' 280' ' ' LEU . 6.7 pt -117.24 130.65 71.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.25 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.758 HD11 ' CE3' ' A' ' 62' ' ' TRP . 2.8 tt -127.4 159.84 37.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.83 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.482 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 6.2 m-85 -119.65 140.52 50.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.139 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.758 ' CE3' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -176.07 153.76 1.34 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.724 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.89 158.44 6.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.09 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -55.99 -36.23 67.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.127 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -65.03 -29.68 70.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.066 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.7 17.25 12.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.365 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.867 ' CD2' ' HB2' ' A' ' 105' ' ' ALA . 2.6 m-85 -110.99 -31.8 7.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.8 0.333 . . . . 0.0 110.909 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.33 -28.3 61.68 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.519 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.06 -25.9 63.24 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.61 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -85.42 -19.32 31.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.627 0.251 . . . . 0.0 111.279 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.53 -39.47 16.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.759 0.314 . . . . 0.0 111.166 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -30.63 71.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.012 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.1 m -73.64 -23.09 59.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.08 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.81 26.79 30.96 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.561 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 mt -94.59 -30.12 14.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.84 0.353 . . . . 0.0 110.976 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 80.5 mt -83.09 160.86 21.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.032 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.482 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -109.17 -172.69 2.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.04 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.408 ' O ' ' CG2' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -88.57 -168.16 2.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.002 0.429 . . . . 0.0 110.958 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.778 HD11 ' CB ' ' A' ' 103' ' ' LEU . 7.6 pt -158.53 179.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.851 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 61.7 p -157.46 78.74 3.59 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.138 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.631 ' HD3' HD12 ' A' ' 79' ' ' ILE . 28.6 Cg_endo -62.22 113.2 1.8 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.575 2.183 . . . . 0.0 112.128 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.54 176.98 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.965 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -50.05 75.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.863 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 88' ' ' LYS . . . -56.66 -22.06 31.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.405 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.706 ' CZ ' HD22 ' A' ' 285' ' ' LEU . 0.3 OUTLIER -83.75 -54.52 4.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.898 0.38 . . . . 0.0 111.006 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.475 ' HG2' ' CZ2' ' A' ' 94' ' ' TRP . 17.3 mt-30 -69.79 -21.18 63.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.539 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -91.62 -9.07 45.39 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.449 ' HG2' HD12 ' A' ' 304' ' ' LEU . 0.0 OUTLIER -117.07 -23.01 8.13 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.497 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 85' ' ' PHE . 0.4 OUTLIER -82.72 135.13 35.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.868 0.366 . . . . 0.0 110.988 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.45 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . 33.1 m-85 -63.25 131.97 94.95 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.073 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.13 -55.57 3.74 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.682 2.255 . . . . 0.0 112.867 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.657 ' HD1' HD11 ' A' ' 329' ' ' ILE . 10.5 p90 -46.35 -28.02 1.21 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.908 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.477 HG22 ' CE1' ' A' ' 92' ' ' PHE . 11.7 p -72.95 -31.28 64.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.83 0.348 . . . . 0.0 110.858 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.736 ' CZ3' HD11 ' A' ' 103' ' ' LEU . 6.6 m95 -63.57 -31.42 72.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.817 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.26 -18.21 64.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.359 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.665 ' HB2' HG21 ' A' ' 329' ' ' ILE . . . -88.77 -18.11 28.44 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.574 HG23 ' CD2' ' A' ' 103' ' ' LEU . 4.8 m -103.82 -36.0 3.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.653 0.263 . . . . 0.0 111.541 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.9 116.92 7.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.885 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -99.85 -33.33 10.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.809 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -155.23 40.68 0.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.767 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.73 -22.37 40.78 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.658 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.7 pttp -104.21 179.77 4.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 111.018 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.778 ' CB ' HD11 ' A' ' 79' ' ' ILE . 17.6 mt -124.96 169.36 12.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.022 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.501 HD12 ' HD2' ' A' ' 67' ' ' PHE . 1.2 pp -156.61 -41.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.393 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.867 ' HB2' ' CD2' ' A' ' 67' ' ' PHE . . . -89.8 162.84 15.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 111.301 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.468 ' OH ' HG22 ' A' ' 79' ' ' ILE . 58.9 m-85 -120.14 79.93 27.0 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.551 ' O ' HD21 ' A' ' 285' ' ' LEU . 50.5 Cg_exo -54.19 137.47 70.51 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.607 2.205 . . . . 0.0 112.352 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.664 HD12 ' O ' ' A' ' 262' ' ' LEU . 3.1 mp -118.51 -60.15 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.126 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.61 ' HB2' HD13 ' A' ' 299' ' ' LEU . . . -125.37 150.42 47.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.141 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.518 HG23 ' HB2' ' A' ' 303' ' ' ALA . 21.4 t -122.02 101.15 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.33 174.69 9.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.974 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -169.97 124.59 0.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.07 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.467 HD23 ' HA2' ' A' ' 228' ' ' GLY . 2.9 mt -64.35 96.59 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.962 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.2 t -100.3 154.17 18.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.887 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.3 tt -83.24 128.57 34.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.907 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.681 HD12 ' HB2' ' A' ' 227' ' ' ASN . 4.1 mt -114.53 130.52 68.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.096 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -109.79 165.55 11.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -106.68 154.05 21.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.94 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -98.92 31.07 3.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -94.06 -45.78 7.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.89 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -144.04 38.96 1.32 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 20.1 tp -172.5 89.35 0.41 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.07 -44.79 2.31 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.527 2.151 . . . . 0.0 112.29 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -108.91 120.45 45.96 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.834 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.92 151.1 44.83 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.408 2.072 . . . . 0.0 112.389 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.63 119.03 5.71 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.587 2.192 . . . . 0.0 112.344 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.24 21.69 7.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.036 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.38 141.94 25.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.838 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.678 ' CE3' HD12 ' A' ' 132' ' ' ILE . 45.9 m95 -68.29 -27.99 66.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.001 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -73.47 -15.75 61.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.402 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.772 ' O ' HD12 ' A' ' 135' ' ' LEU . 0.5 OUTLIER -87.12 -3.91 59.1 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.678 HD12 ' CE3' ' A' ' 129' ' ' TRP . 11.3 mt -85.47 -48.13 0.59 Allowed Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.599 ' HG3' HD21 ' A' ' 198' ' ' LEU . 71.5 Cg_exo -48.51 -49.83 13.7 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.383 2.055 . . . . 0.0 112.411 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.45 -42.83 98.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.088 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.772 HD12 ' O ' ' A' ' 131' ' ' GLU . 0.2 OUTLIER -58.19 -48.61 79.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.595 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 1.4 t70 -53.4 -27.8 26.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -85.71 -28.91 24.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -84.96 -52.01 6.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.331 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.53 HD13 ' HA ' ' A' ' 146' ' ' ALA . 2.1 mt -58.88 -19.75 44.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.493 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.19 -29.56 48.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.823 0.344 . . . . 0.0 110.803 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.74 -36.72 77.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.66 -27.04 40.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.878 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.45 31.26 2.03 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.508 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -140.27 173.57 11.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.751 0.31 . . . . 0.0 110.924 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.493 ' O ' HD13 ' A' ' 139' ' ' LEU . 10.1 t -101.21 171.99 7.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.595 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -101.33 -68.4 0.82 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.267 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.674 HD22 HD13 ' A' ' 132' ' ' ILE . 4.0 tp -148.42 143.25 26.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.034 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.78 -177.81 5.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.808 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.572 ' O ' HG22 ' A' ' 208' ' ' THR . 32.1 p90 -178.54 -178.52 0.6 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -84.92 111.9 20.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.972 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.443 HD23 HG21 ' A' ' 157' ' ' THR . 9.9 mt -99.91 41.67 1.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.779 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -104.25 -32.5 9.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.06 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -134.59 143.92 48.64 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.018 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -57.55 -19.47 37.01 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.577 2.185 . . . . 0.0 112.491 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -48.13 -28.24 2.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.428 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -100.57 -29.95 12.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.081 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.443 HG21 HD23 ' A' ' 151' ' ' LEU . 16.2 p -96.83 17.66 16.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.354 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.543 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 11.8 t-105 -73.63 -50.37 5.9 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.538 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.588 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 47.2 Cg_endo -68.79 -15.82 41.05 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.153 1.902 . . . . 0.0 112.535 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 23.0 tp -77.27 -35.2 55.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 0.0 110.809 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.918 HD13 HD12 ' A' ' 192' ' ' LEU . 10.2 mt -105.1 -47.27 9.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.144 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -57.94 -28.68 64.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.312 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -56.51 -28.85 60.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.27 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.46 ' OD2' ' HB3' ' A' ' 190' ' ' ALA . 1.5 t0 -74.58 -20.1 60.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.212 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 139.01 -24.42 2.85 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.694 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.428 ' HA3' ' HB2' ' A' ' 188' ' ' ALA . . . -56.52 144.65 36.94 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.663 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.438 ' CD2' ' HA3' ' A' ' 182' ' ' GLY . 25.7 p90 -140.96 -177.01 4.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.337 . . . . 0.0 110.84 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -101.26 -34.49 9.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.14 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.778 ' CD2' HD11 ' A' ' 333' ' ' ILE . 90.0 m-85 -144.37 153.67 42.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.933 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.5 140.01 39.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.976 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.439 ' CZ ' ' HA2' ' A' ' 174' ' ' GLY . 57.7 t80 -143.99 110.81 5.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.685 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -135.03 -47.54 0.72 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.385 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -103.21 50.24 0.81 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 0.0 111.123 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.439 ' HA2' ' CZ ' ' A' ' 171' ' ' TYR . . . 57.71 19.77 36.91 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.735 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -125.22 170.79 10.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.793 0.33 . . . . 0.0 110.969 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -128.17 95.87 4.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.871 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.03 129.45 42.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.942 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.434 HG22 ' HG3' ' A' ' 335' ' ' GLN . 3.1 pt -82.75 -26.34 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.254 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.8 25.97 4.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.144 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -130.52 108.04 9.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.916 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.841 ' CG1' HG23 ' A' ' 183' ' ' VAL . 21.4 t -97.88 146.06 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.089 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 0.438 ' HA3' ' CD2' ' A' ' 167' ' ' TYR . . . -117.17 33.2 5.13 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.738 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.841 HG23 ' CG1' ' A' ' 181' ' ' VAL . 3.4 t -92.5 -50.52 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.345 . . . . 0.0 110.92 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -83.98 57.06 3.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.963 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -102.98 -178.92 3.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.766 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -74.06 -32.1 63.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.019 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -85.96 -42.61 6.67 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.571 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 183' ' ' VAL . . . -58.33 -39.88 80.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.817 0.342 . . . . 0.0 111.227 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -59.25 -31.25 68.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.864 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.46 ' HB3' ' OD2' ' A' ' 164' ' ' ASP . . . -87.48 -30.25 20.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.096 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.4 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -64.73 -49.01 66.17 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.544 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.918 HD12 HD13 ' A' ' 161' ' ' ILE . 0.4 OUTLIER -60.43 -43.57 96.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.834 0.35 . . . . 0.0 110.848 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 17.0 m -58.13 -27.43 63.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.928 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.539 ' CE2' HD11 ' A' ' 198' ' ' LEU . 19.4 t80 -60.27 -60.58 3.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.766 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.421 ' O ' HD12 ' A' ' 199' ' ' ILE . 4.8 tp -60.56 -31.65 70.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.541 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.863 HG23 ' O ' ' A' ' 192' ' ' LEU . 45.6 t -65.03 -61.64 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.936 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.61 -28.28 69.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.778 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.599 HD21 ' HG3' ' A' ' 133' ' ' PRO . 3.3 mt -58.57 -55.59 33.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.953 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.421 HD12 ' O ' ' A' ' 195' ' ' LEU . 4.7 mt -55.26 -30.01 24.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.072 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -82.16 -34.09 29.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.937 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -106.49 29.98 6.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -144.92 -36.06 0.31 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.275 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 10.4 m80 76.28 41.64 0.21 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.925 0.393 . . . . 0.0 110.811 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.97 -175.38 5.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.759 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -108.16 126.76 53.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.963 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -79.44 -30.22 42.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.012 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.96 -15.98 62.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.22 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.701 ' HA ' HD12 ' A' ' 212' ' ' ILE . 30.0 m -36.81 148.43 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.974 0.416 . . . . 0.0 111.878 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.4 ' OD2' HD11 ' A' ' 212' ' ' ILE . 63.7 m-20 -154.05 176.19 12.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.808 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -64.79 -28.73 69.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.47 -59.17 2.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.812 0.339 . . . . 0.0 111.12 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 208' ' ' THR . 0.2 OUTLIER -59.18 -27.48 36.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.833 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -80.1 -20.43 45.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.838 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.59 -49.99 13.47 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.885 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.89 -32.44 69.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.104 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.68 -30.19 68.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.077 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -75.24 -47.73 26.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -59.54 -44.9 93.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -61.65 -29.0 69.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.826 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.59 37.67 5.49 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.473 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -94.52 -76.43 0.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 110.923 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 10.5 t -70.07 123.39 21.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.46 -31.71 68.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.047 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.446 ' HE1' ' HB2' ' A' ' 147' ' ' LEU . 1.5 mpp? -119.87 151.16 39.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 6.6 t -166.69 147.56 6.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 24.0 mt -95.66 116.81 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.085 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.681 ' HB2' HD12 ' A' ' 116' ' ' ILE . 9.9 m120 -119.26 165.43 14.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.852 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.467 ' HA2' HD23 ' A' ' 113' ' ' LEU . . . -119.64 -175.14 15.79 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.548 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.1 -20.29 30.22 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.648 2.232 . . . . 0.0 112.533 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 36.5 p90 -94.31 26.02 3.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.284 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.408 ' HB3' ' HB3' ' A' ' 227' ' ' ASN . . . -124.62 -1.66 7.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.685 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -81.02 -21.73 39.95 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.763 0.316 . . . . 0.0 111.226 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.6 m -72.97 -28.86 62.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.113 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . 0.736 ' OD1' HG23 ' A' ' 235' ' ' ILE . 23.9 p30 -78.98 -32.88 45.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.075 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.736 HG23 ' OD1' ' A' ' 234' ' ' ASN . 2.1 pt -88.91 87.32 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.125 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -171.23 -46.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.862 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 63.3 p -93.54 -30.97 14.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.91 -26.3 64.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.023 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 62.68 67.21 0.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.87 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.97 128.6 56.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.013 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -62.01 104.88 0.51 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -106.49 148.73 27.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -137.85 113.71 1.01 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.499 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 26.9 t -78.68 120.49 29.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.791 0.329 . . . . 0.0 111.119 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 5.6 t -131.18 159.29 38.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.65 151.91 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.019 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 11.4 mt -72.21 152.75 92.46 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.881 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.44 164.34 31.2 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.508 2.139 . . . . 0.0 112.274 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.538 HG22 ' HA ' ' A' ' 254' ' ' PRO . 18.8 p -106.52 152.07 24.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.963 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -102.55 111.74 24.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt 60.42 28.1 17.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.971 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 93.83 -21.04 43.73 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.671 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -83.67 149.12 56.47 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.689 0.281 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.538 ' HA ' HG22 ' A' ' 249' ' ' THR . 56.5 Cg_endo -70.6 154.92 64.11 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.544 2.162 . . . . 0.0 112.304 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 91.1 p -65.29 166.33 10.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.417 ' N ' ' CD ' ' A' ' 257' ' ' PRO . 0.1 OUTLIER -133.59 52.8 8.95 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.951 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 256' ' ' LYS . 73.2 Cg_endo -76.28 -172.98 1.52 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.583 2.189 . . . . 0.0 112.385 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.435 ' CD1' ' HG2' ' A' ' 330' ' ' MET . 13.5 m-85 -92.22 158.44 16.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.81 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 20.4 t -144.01 119.28 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.227 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -99.16 155.53 19.95 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.297 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.532 ' O ' HG13 ' A' ' 261' ' ' VAL . 14.9 p -144.0 116.74 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.815 0.34 . . . . 0.0 111.286 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.664 ' O ' HD12 ' A' ' 108' ' ' ILE . 52.0 tp -68.42 127.03 31.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.794 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.706 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 79.6 p -140.93 154.56 46.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.056 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -102.07 138.65 38.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.958 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -109.59 130.2 9.83 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.598 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 23.4 mt -109.58 119.01 58.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.754 0.312 . . . . 0.0 111.02 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -76.91 150.45 35.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.965 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.482 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -60.28 -31.65 70.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.027 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.443 ' HB1' ' HA3' ' A' ' 54' ' ' GLY . . . -92.55 48.02 1.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.083 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.0 t -108.89 97.39 24.19 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.869 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.57 -30.2 21.0 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.537 2.158 . . . . 0.0 112.38 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -101.19 56.87 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.82 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 9.2 tptp -70.55 -55.08 9.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -62.25 -34.36 76.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.939 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 275' ' ' LEU . 20.6 mt -73.66 -31.75 63.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.02 -48.42 81.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.102 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -60.54 -56.33 22.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.814 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 18.6 tt0 -57.19 -22.12 38.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.136 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -86.63 -60.65 1.93 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.165 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.67 HD11 HG21 ' A' ' 59' ' ' ILE . 2.3 mt -81.46 -56.39 4.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.433 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.28 -18.2 47.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.917 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 6.5 m-20 -120.11 -58.2 1.88 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.668 0.271 . . . . 0.0 111.609 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -86.97 57.54 4.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.954 0.406 . . . . 0.0 111.143 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 7.1 tp -172.51 -41.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.964 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.706 HD22 ' CZ ' ' A' ' 85' ' ' PHE . 1.9 mp -97.62 38.21 1.3 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.926 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.8 p -117.83 165.42 13.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.853 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -62.38 -30.4 71.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.934 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -82.46 -49.62 9.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -59.34 -49.56 77.16 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.572 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.435 HD21 HG22 ' A' ' 108' ' ' ILE . 2.8 mt -60.1 -30.89 69.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.815 0.34 . . . . 0.0 110.916 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -64.09 -41.89 97.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.951 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.08 -58.15 9.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.147 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.39 -29.45 42.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.204 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -70.51 -31.88 69.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.899 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -65.66 -34.63 78.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.954 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.61 -31.39 12.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.951 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.9 95.56 1.98 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.935 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.53 108.98 1.95 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.455 2.104 . . . . 0.0 112.291 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.61 HD13 ' HB2' ' A' ' 109' ' ' ALA . 5.0 mt -58.96 -28.26 66.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.003 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 99.64 -109.37 3.73 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.56 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.575 ' HB2' ' HB ' ' A' ' 320' ' ' THR . . . -75.23 93.73 2.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.82 0.343 . . . . 0.0 111.072 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.2 134.0 30.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.518 ' HB2' HG23 ' A' ' 110' ' ' VAL . . . -65.6 -27.4 68.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.023 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.488 HD23 ' HB2' ' A' ' 307' ' ' TYR . 24.6 tp -59.25 111.16 1.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.432 ' CG ' ' CE2' ' A' ' 90' ' ' TYR . 3.9 mttm -64.98 -45.07 87.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.974 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 17.2 m -54.74 -27.12 38.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.102 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.62 ' CE2' HD11 ' A' ' 311' ' ' LEU . 4.9 t80 -99.95 -25.31 14.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.12 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 0.2 OUTLIER -58.11 -34.4 70.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.86 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.41 -62.8 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.863 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -52.18 -31.8 33.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.789 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.801 ' HB3' HG21 ' A' ' 317' ' ' ILE . 12.3 mt -85.7 -25.05 26.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.793 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' A' ' 308' ' ' GLU . . . -67.25 -13.47 62.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.526 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 4.3 mtmm -46.51 -32.91 3.65 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.906 0.384 . . . . 0.0 110.925 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.64 140.16 24.95 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.354 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.435 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 12.0 Cg_endo -56.02 -25.59 54.71 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.393 2.062 . . . . 0.0 112.352 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -50.87 -40.21 55.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.038 0.447 . . . . 0.0 110.316 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.801 HG21 ' HB3' ' A' ' 311' ' ' LEU . 32.1 mm -85.5 -33.79 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.014 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -69.29 -29.72 67.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.241 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -72.08 -48.97 40.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.205 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.575 ' HB ' ' HB2' ' A' ' 301' ' ' ALA . 1.7 m -59.98 -38.62 83.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 5.3 tpt -72.58 -43.09 63.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.948 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -60.77 -31.87 71.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -69.5 -31.84 70.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.932 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -73.16 -50.18 24.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.143 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -61.39 -51.47 68.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 29.5 mtpt -59.97 -30.72 69.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.993 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -97.19 164.34 22.38 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.493 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -97.56 150.59 20.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.775 0.321 . . . . 0.0 110.897 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.665 HG21 ' HB2' ' A' ' 96' ' ' ALA . 32.1 mt -84.37 142.77 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.435 ' HG2' ' CD1' ' A' ' 258' ' ' PHE . 32.4 mtm -58.85 131.81 86.47 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.894 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.65 -174.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.367 2.045 . . . . 0.0 112.305 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -132.65 30.76 4.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.878 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.778 HD11 ' CD2' ' A' ' 169' ' ' PHE . 27.2 pt -106.11 147.31 34.6 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.35 -25.56 21.56 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.56 2.174 . . . . 0.0 112.437 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.434 ' HG3' HG22 ' A' ' 178' ' ' ILE . 75.1 mm-40 -55.15 -29.5 57.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.071 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 13.9 ttt -58.75 -24.49 61.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.055 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . 0.402 ' O ' ' CE2' ' A' ' 341' ' ' TYR . 8.0 m -56.66 -38.93 72.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.047 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -86.16 -33.3 20.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.1 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.721 ' CZ ' HG21 ' A' ' 343' ' ' VAL . 48.6 t80 -59.76 -26.29 65.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.115 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 20.8 m95 -56.36 -52.45 64.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.17 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 0.402 ' CE2' ' O ' ' A' ' 337' ' ' SER . 0.2 OUTLIER -84.89 -31.79 23.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.666 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 339' ' ' PHE . . . -50.49 -40.16 50.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.478 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.721 HG21 ' CZ ' ' A' ' 339' ' ' PHE . 17.5 t -95.93 -26.19 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.259 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -52.37 -56.35 15.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.162 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 12.4 m -64.3 -29.63 70.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.011 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -67.14 -55.32 14.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.248 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 343' ' ' VAL . 21.9 t -57.24 -43.2 81.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.278 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 22.7 mt -67.04 -53.74 31.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.089 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -59.95 -30.69 69.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -82.91 -38.38 22.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.131 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -67.84 -30.57 69.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.094 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 17.4 t -71.18 -22.38 62.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.111 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 96.24 -21.6 44.43 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.66 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -57.76 -31.34 66.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.856 0.36 . . . . 0.0 110.928 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -122.46 151.57 41.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 30.2 p -85.44 169.36 13.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.772 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.465 HG13 HD22 ' A' ' 192' ' ' LEU . 29.2 t -72.55 -51.68 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.969 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -47.1 -32.53 4.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.353 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.22 -44.69 14.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.996 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -56.45 -60.46 3.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.061 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.659 HD22 HG12 ' A' ' 183' ' ' VAL . 7.9 mt -56.98 -26.13 59.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.813 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.6 -35.92 33.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.85 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -57.85 -49.4 76.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.948 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -59.3 -39.11 81.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.082 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.832 ' HA ' HG21 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -59.08 -41.9 89.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.96 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 28.3 m -63.38 -49.59 73.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -43.44 94.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.998 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 13.9 mt -73.81 -40.4 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.082 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 365' ' ' GLN . 13.1 p -98.26 30.72 3.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.952 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.88 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.827 0.346 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.72 125.3 25.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.917 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -136.12 32.32 2.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -151.09 166.33 31.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.8 -16.49 76.29 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.718 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.418 ' HA ' HG22 ' A' ' 33' ' ' ILE . 1.2 pptp? -69.87 153.45 43.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.807 0.337 . . . . 0.0 110.935 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 mt -102.28 138.8 38.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.953 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 t -106.94 147.03 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.168 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.776 HD12 HG22 ' A' ' 37' ' ' VAL . 25.8 mt -125.43 107.51 18.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.967 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.413 ' CG ' ' HB3' ' A' ' 57' ' ' PRO . 0.9 OUTLIER -92.27 109.67 21.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.83 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.3 tt -153.89 148.02 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.05 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -60.4 170.29 1.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.927 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.16 29.56 9.9 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.566 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -90.88 -52.97 4.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.361 . . . . 0.0 110.943 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -79.9 -175.61 5.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -59.06 87.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.516 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 36.9 p90 -83.57 -44.24 14.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.343 . . . . 0.0 110.867 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.428 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 12.9 t30 -70.62 -31.72 68.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.1 -32.77 51.73 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.525 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.607 HD12 HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -60.18 -41.86 93.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.861 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.81 -30.22 68.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.089 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -59.5 -33.99 72.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.985 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.459 HG22 ' HB3' ' A' ' 292' ' ' ALA . 30.1 t -62.22 -31.26 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.11 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.57 -29.56 72.91 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.517 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 mmtt -59.85 -33.35 71.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.331 . . . . 0.0 110.944 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -42.04 72.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.854 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.642 ' CE1' HG21 ' A' ' 31' ' ' THR . 12.7 t80 -59.37 -59.22 5.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.939 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -57.8 -21.92 44.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.35 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -69.5 -26.31 64.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.512 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -117.74 -39.01 3.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.78 0.324 . . . . 0.0 111.49 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.642 HG21 ' CE1' ' A' ' 27' ' ' PHE . 15.1 p -90.68 -32.99 15.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.183 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.67 -22.39 35.98 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.663 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.446 HD13 HD13 ' A' ' 275' ' ' LEU . 38.8 mt -66.17 139.34 21.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.821 0.343 . . . . 0.0 111.046 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.0 170.01 17.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.982 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.6 t -146.99 111.06 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.042 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.1 m -101.85 150.63 22.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.948 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.776 HG22 HD12 ' A' ' 9' ' ' ILE . 21.9 t -130.14 110.19 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.117 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.408 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 60.2 mm-40 -96.52 165.7 12.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.562 ' CE1' HG12 ' A' ' 37' ' ' VAL . 50.9 m-70 -149.6 72.31 9.79 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.843 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.62 -179.75 3.54 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.601 2.201 . . . . 0.0 112.347 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -118.58 143.77 46.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.74 28.95 18.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.604 ' H ' HD23 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -59.27 -26.92 65.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.099 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.447 ' CG ' ' CH2' ' A' ' 62' ' ' TRP . 26.1 mt-10 -56.99 -30.59 64.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.013 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -95.89 -19.02 19.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.203 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.904 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.4 mtmp? -88.68 -29.6 19.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.803 0.335 . . . . 0.0 111.16 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.453 ' CZ ' HG21 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -52.83 -50.63 80.27 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.344 -179.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 38.4 Cg_exo -61.1 -23.64 77.73 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.573 2.182 . . . . 0.0 112.741 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.28 -40.38 11.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.835 0.35 . . . . 0.0 111.278 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.904 HG22 ' O ' ' A' ' 46' ' ' LYS . 9.9 m -80.45 -28.02 11.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.133 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.31 -22.53 59.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.303 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.3 -28.35 41.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.406 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.586 HG23 ' HB2' ' A' ' 55' ' ' ASP . 7.2 t -135.29 24.01 3.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.175 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 53.31 24.54 22.99 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.729 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.586 ' HB2' HG23 ' A' ' 53' ' ' THR . 9.4 t0 -74.67 -30.14 61.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.885 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.67 -150.47 0.64 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.543 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.413 ' HB3' ' CG ' ' A' ' 10' ' ' TRP . 59.2 Cg_endo -71.97 177.69 6.78 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.597 2.198 . . . . 0.0 112.36 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.58 -31.57 7.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.804 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.684 HG21 HD21 ' A' ' 280' ' ' LEU . 30.3 mt -128.32 139.83 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.048 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.715 HD11 ' HE3' ' A' ' 62' ' ' TRP . 2.5 tt -140.34 160.14 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.062 0.458 . . . . 0.0 110.962 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.482 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 9.0 m-85 -132.58 136.02 46.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.078 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.715 ' HE3' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -176.08 152.01 1.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.756 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.61 157.76 3.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.231 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.723 ' HD2' HG12 ' A' ' 261' ' ' VAL . 12.5 p80 -54.89 -29.65 56.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.085 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -58.86 -34.33 71.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.099 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.81 17.14 12.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.345 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.457 ' HB3' HD11 ' A' ' 104' ' ' ILE . 2.0 m-85 -113.29 -24.23 9.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.655 0.264 . . . . 0.0 111.28 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -83.05 55.49 5.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.466 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -153.15 -42.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.574 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -82.86 -14.4 54.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.628 0.251 . . . . 0.0 111.258 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.47 -35.35 24.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.78 0.324 . . . . 0.0 111.205 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -62.28 -30.02 70.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.9 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.4 t -83.61 -23.12 32.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.057 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.5 28.26 13.21 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.479 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.0 mt -88.81 -34.3 17.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.801 0.334 . . . . 0.0 110.955 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 27.6 mt -79.11 167.01 21.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.417 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -106.7 126.23 52.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.083 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.457 ' CG ' ' N ' ' A' ' 79' ' ' ILE . 19.2 tt0 -65.42 164.05 14.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.795 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.542 HG21 ' CE1' ' A' ' 106' ' ' TYR . 40.6 pt -139.8 -179.65 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.208 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.447 HG23 ' O ' ' A' ' 79' ' ' ILE . 0.9 OUTLIER -158.89 77.86 3.11 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.45 ' HD2' HD12 ' A' ' 103' ' ' LEU . 37.2 Cg_endo -65.61 119.17 6.15 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.593 2.196 . . . . 0.0 112.27 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.35 177.92 0.33 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.824 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 11.2 mtmm -60.21 -45.45 93.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.52 -31.56 69.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.001 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -72.26 -52.21 17.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.871 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -64.37 -25.88 68.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.951 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.8 -28.36 67.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.157 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.522 ' O ' HD12 ' A' ' 304' ' ' LEU . 0.0 OUTLIER -97.86 34.26 1.93 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.118 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.517 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 94.2 mt -153.37 174.22 14.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.91 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.438 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . 44.7 m-85 -99.83 142.25 24.27 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.989 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -56.17 -55.88 2.53 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.617 2.211 . . . . 0.0 112.932 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.544 ' CE1' HG22 ' A' ' 93' ' ' THR . 38.2 p90 -52.98 -37.86 61.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.892 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.544 HG22 ' CE1' ' A' ' 92' ' ' PHE . 30.0 p -64.25 -27.88 69.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.722 0.296 . . . . 0.0 111.115 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.517 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 11.2 m95 -73.26 -24.52 60.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.218 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.42 11.31 19.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.466 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -101.83 -31.39 10.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.812 0.339 . . . . 0.0 111.257 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.669 ' CG1' ' HB3' ' A' ' 105' ' ' ALA . 9.0 m -87.92 -35.5 8.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.312 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.93 117.98 9.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.926 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -97.93 -67.24 0.86 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -99.62 30.74 3.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.922 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.02 -24.63 27.75 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.564 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.4 133.04 42.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 0.0 110.944 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.45 HD12 ' HD2' ' A' ' 81' ' ' PRO . 88.8 mt -66.35 150.0 49.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.868 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.664 ' O ' HD12 ' A' ' 104' ' ' ILE . 2.5 pp -155.02 36.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.145 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.702 ' HB1' ' HB2' ' A' ' 263' ' ' SER . . . -172.73 157.43 3.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.131 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.542 ' CE1' HG21 ' A' ' 79' ' ' ILE . 72.8 m-85 -118.01 80.85 15.3 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.455 ' HB3' HG21 ' A' ' 261' ' ' VAL . 48.4 Cg_exo -55.98 138.79 83.46 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.564 2.176 . . . . 0.0 112.233 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.703 HD13 ' O ' ' A' ' 284' ' ' LEU . 24.7 mt -134.46 -51.73 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.121 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.685 ' CB ' HD22 ' A' ' 299' ' ' LEU . . . -108.67 171.56 7.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.123 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.5 t -141.5 129.05 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.126 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.448 ' O ' HG13 ' A' ' 259' ' ' VAL . 0.1 OUTLIER -115.97 144.59 43.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -162.79 151.78 14.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.576 HD22 HG22 ' A' ' 226' ' ' ILE . 13.8 mt -61.22 124.56 20.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.1 m -115.66 165.28 13.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.0 tp -105.47 101.26 10.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.858 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 32.8 mt -91.45 119.77 39.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.109 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.525 ' CD1' HG22 ' A' ' 245' ' ' THR . 43.0 p90 -118.79 148.1 43.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.931 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -73.68 165.23 25.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.881 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.32 -31.13 6.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.02 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -74.8 -39.4 61.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.023 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.7 mt -109.53 28.61 8.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.076 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.8 tp -176.96 89.44 0.25 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.97 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -69.03 -30.51 25.56 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.516 2.144 . . . . 0.0 112.248 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -133.99 120.98 15.49 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.22 153.84 41.05 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.47 2.113 . . . . 0.0 112.379 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.05 122.11 8.15 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.587 2.191 . . . . 0.0 112.289 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 128' ' ' THR . 2.1 mmmp? -93.75 18.13 10.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 127' ' ' LYS . 5.4 p -156.99 141.96 17.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.8 0.334 . . . . 0.0 110.81 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.684 ' CE3' HD12 ' A' ' 132' ' ' ILE . 27.9 m95 -61.77 -31.78 72.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -68.89 -15.88 63.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.336 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.98 0.52 57.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.551 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.684 HD12 ' CE3' ' A' ' 129' ' ' TRP . 16.6 mt -85.37 -46.24 0.63 Allowed Pre-proline 0 C--N 1.332 -0.184 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 72.0 Cg_exo -48.74 -57.49 2.33 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.369 2.046 . . . . 0.0 112.447 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.28 -36.97 83.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.995 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.2 mt -58.39 -52.29 66.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.997 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.437 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 4.9 t0 -46.08 -31.75 2.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.436 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -85.61 -27.02 25.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.232 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -57.93 -64.18 1.0 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.289 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.646 ' H ' HD13 ' A' ' 139' ' ' LEU . 0.0 OUTLIER -68.49 -16.32 63.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.567 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.407 ' H ' HD22 ' A' ' 139' ' ' LEU . 2.6 ttmt -63.4 -21.57 66.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.884 0.373 . . . . 0.0 110.461 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.51 -41.74 81.39 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.672 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.404 ' HD2' ' HA ' ' A' ' 139' ' ' LEU . 0.0 OUTLIER -81.85 -26.28 34.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.784 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 119.52 21.48 3.63 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.615 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -116.0 -174.98 2.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.775 0.322 . . . . 0.0 110.943 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.2 p -130.17 158.38 39.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.913 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.483 ' HB2' HD11 ' A' ' 139' ' ' LEU . . . -76.76 -62.72 1.54 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.179 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.831 HD11 HG13 ' A' ' 226' ' ' ILE . 4.0 tp -148.66 143.44 26.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.015 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.48 ' SD ' HG21 ' A' ' 222' ' ' THR . 0.0 OUTLIER -129.26 -177.83 4.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.778 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.9 p90 179.63 145.99 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.9 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -62.9 126.97 29.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.952 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.7 mt -98.48 31.62 2.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.848 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -101.51 -31.33 10.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -119.71 146.5 41.76 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.905 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.1 -3.41 13.71 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.553 2.168 . . . . 0.0 112.677 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.5 ' CZ ' ' CH2' ' A' ' 340' ' ' TRP . 0.4 OUTLIER -57.8 -32.12 67.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.826 0.346 . . . . 0.0 110.954 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -94.69 4.04 54.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.544 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.532 HG21 HG11 ' A' ' 347' ' ' VAL . 55.8 p -106.77 -28.12 10.35 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.796 0.332 . . . . 0.0 111.049 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.483 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 11.7 t-105 -55.94 -46.66 99.73 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.308 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.76 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 77.2 Cg_exo -50.35 -25.51 13.95 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.377 2.051 . . . . 0.0 112.479 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.701 HD21 ' HB3' ' A' ' 194' ' ' PHE . 3.6 tp -94.06 -38.84 10.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.018 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.646 HG12 HD12 ' A' ' 192' ' ' LEU . 21.4 mt -76.04 -55.45 11.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.179 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.09 -25.97 68.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.243 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.76 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -57.17 -56.09 26.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.239 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -96.05 -20.1 18.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.231 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -77.06 -104.65 0.15 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.525 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -150.49 -86.98 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.531 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -172.83 -179.6 2.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.837 0.351 . . . . 0.0 110.897 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.02 -48.8 6.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.066 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -141.86 140.61 32.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.965 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -77.5 136.83 38.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.848 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.487 ' CE2' ' CE2' ' A' ' 176' ' ' TYR . 0.3 OUTLIER -101.69 110.64 22.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.779 179.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -133.96 145.02 49.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.126 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 48.69 32.09 3.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.249 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 68.0 26.61 73.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.424 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.23 -171.32 2.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.359 . . . . 0.0 110.839 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.487 ' CE2' ' CE2' ' A' ' 171' ' ' TYR . 1.1 m-85 -130.54 131.7 45.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.848 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.73 139.4 32.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.633 HG21 ' OE1' ' A' ' 335' ' ' GLN . 19.9 pt -95.03 -18.4 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.334 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.91 26.01 4.37 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.113 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -140.52 78.58 1.66 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.882 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.669 HG12 ' H ' ' A' ' 183' ' ' VAL . 21.7 t -94.24 137.71 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.162 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.29 0.3 40.6 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.857 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.669 ' H ' HG12 ' A' ' 181' ' ' VAL . 0.3 OUTLIER -54.05 -42.67 55.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.921 0.391 . . . . 0.0 111.31 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.418 ' N ' ' CG1' ' A' ' 183' ' ' VAL . 22.9 t0 -96.09 61.51 2.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.971 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -91.57 165.47 13.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.84 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -59.87 -38.71 82.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.14 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -85.92 -25.11 38.93 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.565 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.15 -30.56 66.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 0.0 111.163 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -61.03 -38.2 85.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -87.56 -30.06 20.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -59.31 -51.05 61.44 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.555 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.852 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.3 OUTLIER -60.24 -41.01 92.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.805 0.336 . . . . 0.0 110.904 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.8 m -54.07 -25.5 22.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.161 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.701 ' HB3' HD21 ' A' ' 160' ' ' LEU . 1.3 t80 -65.28 -60.57 2.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.784 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.762 ' HA ' HD12 ' A' ' 198' ' ' LEU . 3.9 tp -63.86 -33.47 75.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.68 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.852 HG23 ' O ' ' A' ' 192' ' ' LEU . 46.2 t -65.9 -44.68 92.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.941 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.5 -28.11 60.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.938 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.762 HD12 ' HA ' ' A' ' 195' ' ' LEU . 16.6 mt -57.82 -53.72 55.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.005 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 14.9 mt -68.81 -29.86 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.003 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.685 ' HD2' HG12 ' A' ' 196' ' ' VAL . 24.1 mtpt -75.8 -29.86 58.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.968 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -95.32 22.76 6.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.177 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.49 75.27 0.33 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.931 0.396 . . . . 0.0 111.156 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.4 -41.97 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.74 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . 0.7 ' CE ' HD13 ' A' ' 198' ' ' LEU . 0.1 OUTLIER -103.01 145.56 29.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.846 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -90.03 113.96 25.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.867 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.19 -26.72 66.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.154 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -92.98 46.49 1.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.931 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 51.9 m -113.36 138.75 49.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.784 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.519 ' HB2' HD11 ' A' ' 212' ' ' ILE . 1.8 m-20 -151.35 176.3 11.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.945 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -42.67 -62.98 0.86 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.38 -59.25 4.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.004 0.43 . . . . 0.0 111.591 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 209' ' ' ASP . 0.0 OUTLIER -52.96 -31.9 17.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.183 -179.53 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -81.98 -28.3 32.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.763 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -82.36 -56.15 4.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.026 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.08 -31.26 61.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.334 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.46 -36.0 73.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.122 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.72 ' CG ' HG21 ' A' ' 225' ' ' THR . 29.0 t80 -82.24 -31.75 30.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.994 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -63.97 -46.94 82.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.99 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.09 -36.76 58.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.95 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 110.33 56.92 0.51 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.506 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -108.66 -29.71 8.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.801 0.334 . . . . 0.0 110.949 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.48 HG21 ' SD ' ' A' ' 148' ' ' MET . 9.8 t -117.38 140.1 50.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.937 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.06 -31.14 68.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.095 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 9.8 mtp -134.43 163.29 30.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.72 HG21 ' CG ' ' A' ' 217' ' ' PHE . 4.7 t -166.62 132.49 2.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.831 HG13 HD11 ' A' ' 147' ' ' LEU . 25.6 mt -96.62 116.81 39.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.087 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -156.29 165.3 36.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.428 ' HA3' ' CZ3' ' A' ' 230' ' ' TRP . . . -82.53 170.77 50.77 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.478 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.81 -25.59 27.64 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.661 2.241 . . . . 0.0 112.325 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . 0.428 ' CZ3' ' HA3' ' A' ' 228' ' ' GLY . 28.5 p90 -59.29 -30.97 68.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.965 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -59.46 -29.95 68.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.152 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 27.9 m0 -59.61 -28.91 67.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.049 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.9 m -57.81 -31.07 66.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.003 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -72.16 -59.61 2.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 4.5 mt -78.49 116.66 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.082 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -168.66 -47.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.934 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 22.2 p -76.48 -38.71 54.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 11.8 t -66.16 -29.41 69.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.957 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 62.16 81.72 0.19 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.35 143.8 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.104 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -85.25 87.47 7.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.932 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -104.64 167.61 9.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.06 174.28 21.99 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.523 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 20.9 t -140.01 127.52 24.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.793 0.33 . . . . 0.0 111.076 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.525 HG22 ' CD1' ' A' ' 117' ' ' TYR . 8.7 t -143.53 151.34 40.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.967 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.417 ' CG2' ' N ' ' A' ' 247' ' ' LEU . 0.7 OUTLIER -54.51 152.3 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.292 0.568 . . . . 0.0 111.295 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.417 ' N ' ' CG2' ' A' ' 246' ' ' VAL . 9.2 mt -71.45 146.6 91.87 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.977 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.419 ' HG2' ' CD1' ' A' ' 129' ' ' TRP . 50.8 Cg_endo -69.18 177.17 5.44 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.541 2.16 . . . . 0.0 112.265 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 44.6 p -121.12 175.47 6.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -142.85 121.94 12.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 20.7 mttm 60.1 31.67 20.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 74.35 27.03 66.62 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.52 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -136.48 128.99 17.43 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.554 0.216 . . . . 0.0 110.821 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.07 163.09 35.86 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.505 2.137 . . . . 0.0 112.354 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.82 -172.95 3.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.786 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -134.72 63.87 60.77 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.952 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -56.88 127.78 27.25 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.554 2.169 . . . . 0.0 112.182 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.425 ' CD2' ' CD1' ' A' ' 155' ' ' TYR . 98.5 m-85 -60.65 139.96 57.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.739 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 111' ' ' GLU . 25.5 t -120.32 146.25 25.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.294 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -134.65 86.57 0.26 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.294 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.723 HG12 ' HD2' ' A' ' 64' ' ' HIS . 7.5 p -60.52 128.85 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.843 0.354 . . . . 0.0 111.326 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.3 tp -89.9 106.9 18.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.702 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 0.5 OUTLIER -117.56 174.32 6.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.961 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . . . -109.44 154.51 22.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.03 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.0 129.77 8.11 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.515 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.438 HD12 ' CE1' ' A' ' 106' ' ' TYR . 4.4 mt -125.74 100.53 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.803 0.335 . . . . 0.0 110.998 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.19 162.63 4.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.956 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.417 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -70.78 -28.36 64.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -90.51 49.94 1.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.132 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.5 m -109.1 102.76 50.17 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.782 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.81 -23.91 47.51 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.419 2.079 . . . . 0.0 112.366 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -98.37 31.11 2.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.934 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.99 -38.35 90.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.886 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -61.7 -49.52 76.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.96 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.446 HD13 HD13 ' A' ' 33' ' ' ILE . 78.2 mt -77.7 -31.02 52.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.942 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.67 -55.4 20.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.178 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -44.82 74.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.045 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.415 ' HG3' ' ND2' ' A' ' 282' ' ' ASN . 14.5 tt0 -63.89 -43.38 96.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -66.83 -37.11 83.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.766 HD23 ' CD2' ' A' ' 284' ' ' LEU . 2.8 mt -78.71 -22.24 46.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.445 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.55 -29.94 15.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.505 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.415 ' ND2' ' HG3' ' A' ' 278' ' ' GLU . 22.9 m-80 -94.67 -58.09 2.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.728 0.299 . . . . 0.0 111.494 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -106.49 58.12 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.94 0.4 . . . . 0.0 111.319 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.766 ' CD2' HD23 ' A' ' 280' ' ' LEU . 2.0 tp 177.64 38.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.942 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.78 HD23 HD13 ' A' ' 304' ' ' LEU . 0.4 OUTLIER 179.3 38.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.872 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 44.7 p -153.48 172.37 17.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.947 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -63.15 -29.28 70.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.018 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -78.22 -30.15 48.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.019 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -92.2 -51.8 2.33 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.624 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.603 HD21 HG22 ' A' ' 108' ' ' ILE . 1.5 mt -59.03 -30.59 68.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.764 0.316 . . . . 0.0 110.999 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -72.81 -31.45 64.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.937 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.459 ' HB3' HG22 ' A' ' 23' ' ' VAL . . . -59.25 -40.49 86.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.138 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.2 t -83.53 -30.81 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.138 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -63.31 -29.72 70.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.977 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -58.77 -33.66 70.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.96 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -102.61 -35.82 8.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.0 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 4.2 mmtm -146.61 90.36 5.57 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.932 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.2 104.79 1.44 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.53 2.154 . . . . 0.0 112.265 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.685 HD22 ' CB ' ' A' ' 109' ' ' ALA . 2.2 mp -58.42 -26.75 63.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.994 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 90.13 -94.72 2.01 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.523 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -79.05 122.01 25.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.784 0.326 . . . . 0.0 111.073 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.528 HG11 ' CD2' ' A' ' 307' ' ' TYR . 21.3 m -111.59 165.98 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.18 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -92.13 -29.24 16.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.167 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.78 HD13 HD23 ' A' ' 285' ' ' LEU . 5.0 tp -58.16 120.91 9.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.936 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -65.22 -31.63 72.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.9 -31.75 51.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.617 ' CE2' HD11 ' A' ' 311' ' ' LEU . 5.4 t80 -84.68 -28.26 26.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.021 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -59.4 -31.79 69.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.84 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -73.08 -58.91 2.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.853 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -51.53 -32.21 27.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.771 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.785 ' HB3' HG21 ' A' ' 317' ' ' ILE . 13.3 mt -85.78 -26.14 25.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.667 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.7 -16.48 62.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.343 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -47.82 -32.62 6.29 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.931 0.396 . . . . 0.0 110.832 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -108.67 138.53 20.3 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.345 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 11.8 Cg_endo -55.89 -30.67 78.26 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.418 2.078 . . . . 0.0 112.374 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -49.68 -39.32 36.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.001 0.429 . . . . 0.0 110.299 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.785 HG21 ' HB3' ' A' ' 311' ' ' LEU . 18.5 mm -85.57 -33.58 7.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.964 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -69.2 -57.48 5.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.205 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.19 -49.58 75.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.258 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 73.8 m -58.73 -31.02 67.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.987 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 9.1 tpt -79.98 -32.13 39.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -61.43 -56.13 23.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.94 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -65.12 -30.44 71.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.942 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.09 -56.54 20.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.134 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -64.09 -37.52 87.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.875 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 12.0 tttp -67.52 -31.92 72.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -76.97 -162.02 14.3 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.501 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -129.27 160.46 32.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.762 0.315 . . . . 0.0 110.949 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.492 HG22 ' N ' ' A' ' 330' ' ' MET . 29.8 mt -86.78 158.81 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.127 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.492 ' N ' HG22 ' A' ' 329' ' ' ILE . 6.1 mtp -80.13 131.07 63.83 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.899 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -57.3 158.36 18.82 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.392 2.061 . . . . 0.0 112.181 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -110.23 -26.53 9.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.087 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 34.9 pt -55.59 150.44 25.49 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.248 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.71 -25.42 24.22 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.594 2.196 . . . . 0.0 112.417 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.633 ' OE1' HG21 ' A' ' 178' ' ' ILE . 0.9 OUTLIER -56.57 -28.36 60.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.062 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -27.86 66.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.061 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 4.9 m -55.87 -56.2 23.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.01 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.59 -30.8 71.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.09 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.778 ' O ' HG23 ' A' ' 343' ' ' VAL . 47.1 t80 -59.7 -40.49 88.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.946 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.5 ' CH2' ' CZ ' ' A' ' 155' ' ' TYR . 96.7 m95 -63.6 -55.75 21.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.024 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -58.8 -44.3 90.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.082 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -59.17 -58.73 7.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.19 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 339' ' ' PHE . 24.4 t -59.21 -28.43 39.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.228 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.71 -53.89 49.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.073 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.67 -30.61 68.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.959 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -59.26 -52.83 63.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.212 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 343' ' ' VAL . 21.2 t -59.19 -36.74 64.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.198 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 29.3 mt -76.37 -37.15 30.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.158 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -58.93 -30.95 68.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.95 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -87.6 -46.68 9.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.053 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.13 -40.53 96.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.123 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 8.1 m -67.92 -22.43 65.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.104 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 85.12 27.6 33.3 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.564 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.19 -30.28 21.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.852 0.358 . . . . 0.0 110.918 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -146.09 -173.92 4.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 4.4 p -104.48 156.12 18.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.951 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.529 HG13 HD22 ' A' ' 192' ' ' LEU . 43.1 t -59.12 -29.93 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.977 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.12 -49.29 70.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.23 -34.88 71.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.995 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -65.98 -52.85 45.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.98 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.591 HD22 ' O ' ' A' ' 183' ' ' VAL . 89.9 mt -61.75 -28.72 69.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -81.19 -41.16 22.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.871 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -73.72 -46.98 42.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.14 -43.65 87.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.145 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -62.95 -36.17 82.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.933 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.573 HG22 ' HG2' ' A' ' 370' ' ' LYS . 21.3 m -60.34 -42.99 96.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -59.71 -29.82 68.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.924 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.563 HD12 ' CD2' ' A' ' 339' ' ' PHE . 26.2 mm -71.02 -35.66 60.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.076 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 1.4 t -152.77 78.64 1.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.573 ' HG2' HG22 ' A' ' 366' ' ' THR . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.92 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.799 0.333 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.55 HG21 ' HD2' ' A' ' 271' ' ' PRO . 7.5 t -58.93 99.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.94 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.26 173.54 10.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.883 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 58.24 174.63 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.983 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -84.98 55.92 4.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.494 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -125.15 173.29 8.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.861 0.362 . . . . 0.0 110.887 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.455 HD11 ' HB3' ' A' ' 275' ' ' LEU . 6.1 mt -141.9 115.82 9.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.2 t -89.61 146.99 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.212 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.902 HG21 HD21 ' A' ' 20' ' ' LEU . 5.4 mt -128.16 107.47 16.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.925 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.449 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 8.6 m0 -93.78 106.7 18.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.854 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.3 tt -123.29 145.81 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.081 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -60.13 170.56 1.22 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.79 47.91 2.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.52 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -157.23 31.4 0.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.856 0.36 . . . . 0.0 110.907 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.33 -172.3 3.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.92 93.84 1.53 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.501 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -85.97 -37.5 18.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.816 0.341 . . . . 0.0 110.923 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -75.73 -32.72 60.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.976 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.9 -28.21 59.22 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.507 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.902 HD21 HG21 ' A' ' 9' ' ' ILE . 18.5 tp -80.05 -32.4 39.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.76 0.314 . . . . 0.0 110.931 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.77 -31.81 71.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.175 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -60.23 -31.05 69.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.965 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.8 t -64.62 -41.14 91.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.088 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.99 -34.96 88.64 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.499 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.0 mttp -60.03 -28.59 67.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.826 0.346 . . . . 0.0 110.934 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -83.0 -38.5 22.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.849 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -55.82 -45.69 78.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.096 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -60.36 -38.35 83.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.937 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.39 -28.81 66.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.901 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -83.76 -32.66 25.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.311 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.462 HG23 HG12 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -139.06 -44.15 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.391 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.98 20.9 5.5 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.721 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.613 HG21 HD13 ' A' ' 275' ' ' LEU . 29.4 mm -80.67 114.9 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.814 0.34 . . . . 0.0 110.985 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -57.65 145.48 33.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.003 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.4 t -138.96 109.31 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.111 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.2 m -104.14 128.54 51.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.911 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.572 HG22 HD12 ' A' ' 9' ' ' ILE . 21.5 t -114.74 113.86 44.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.149 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -114.78 156.8 24.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.9 p-80 -122.47 71.49 37.22 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.855 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.573 ' HG2' HD22 ' A' ' 43' ' ' LEU . 57.1 Cg_endo -70.77 165.84 30.82 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.603 2.202 . . . . 0.0 112.377 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -126.0 141.21 52.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.815 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.5 mmtm 59.68 36.96 22.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.839 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.573 HD22 ' HG2' ' A' ' 40' ' ' PRO . 0.6 OUTLIER -78.19 -3.51 42.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.48 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -58.29 -36.91 74.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.84 0.352 . . . . 0.0 110.964 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.47 -19.75 23.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.172 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.777 ' O ' HG22 ' A' ' 50' ' ' VAL . 2.5 mtpp -87.41 -19.0 28.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.344 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.451 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 7.0 t80 -70.91 -48.52 14.41 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.361 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 2.9 Cg_exo -76.04 -31.32 5.02 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.791 2.327 . . . . 0.0 112.688 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.602 ' HG3' HG13 ' A' ' 50' ' ' VAL . 7.8 pt20 -60.28 -50.69 72.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.834 0.35 . . . . 0.0 111.239 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 46' ' ' LYS . 7.4 m -97.17 27.09 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.434 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.19 -29.98 31.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.184 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.55 -32.49 25.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.207 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.483 HG22 ' HA ' ' A' ' 50' ' ' VAL . 2.2 t -82.75 -29.65 29.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.944 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.71 26.96 23.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.517 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.42 -26.02 24.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.829 0.347 . . . . 0.0 111.009 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.4 -178.52 0.4 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.554 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.449 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 60.9 Cg_endo -72.59 -168.23 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.609 2.206 . . . . 0.0 112.364 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.29 -46.22 3.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.814 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.9 mt -117.88 138.88 47.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.596 HD11 ' CE3' ' A' ' 62' ' ' TRP . 2.6 tt -139.02 159.69 29.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.12 0.486 . . . . 0.0 110.952 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.481 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 28.1 m-85 -127.62 136.17 51.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.942 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.596 ' CE3' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -172.01 157.69 4.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.913 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.36 156.1 30.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.094 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.719 ' CD2' HG12 ' A' ' 261' ' ' VAL . 4.2 p80 -56.48 -41.93 77.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.085 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -59.26 -31.35 69.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.08 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.418 ' HB2' ' CD1' ' A' ' 62' ' ' TRP . 8.6 mmm180 -94.25 17.19 13.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.334 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.402 ' CE2' ' O ' ' A' ' 62' ' ' TRP . 0.8 OUTLIER -109.65 -13.33 14.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.285 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -92.5 21.89 35.93 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.739 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.42 -23.83 4.65 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.559 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.46 ' O ' HD12 ' A' ' 75' ' ' LEU . 29.3 m-85 -100.47 -28.08 13.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.737 0.303 . . . . 0.0 110.972 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.0 -25.78 53.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.11 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -59.29 -29.3 67.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.155 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 m -96.65 24.99 5.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.13 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.49 29.46 39.31 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.791 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.46 HD12 ' O ' ' A' ' 70' ' ' TYR . 7.3 mt -87.81 -40.61 13.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 0.0 110.944 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.4 mt -83.33 148.52 27.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.931 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.546 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -82.31 165.33 20.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.128 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.475 ' OE1' HG22 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -88.03 -165.63 1.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.935 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.665 HD11 ' HB3' ' A' ' 103' ' ' LEU . 33.8 pt -157.33 164.62 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.968 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 47.0 p -156.31 77.43 4.36 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.837 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.64 161.16 46.15 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.646 2.231 . . . . 0.0 112.269 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.38 165.07 16.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.809 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.35 -38.28 76.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.884 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.37 -29.31 61.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.063 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.428 ' CZ ' HD13 ' A' ' 285' ' ' LEU . 7.4 t80 -78.54 -32.01 47.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.434 ' HG2' ' CE2' ' A' ' 94' ' ' TRP . 0.0 OUTLIER -82.21 -29.62 31.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.994 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -73.74 -36.42 65.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.048 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.466 ' HG3' HD12 ' A' ' 89' ' ' LEU . 2.6 pttt -59.87 -30.28 68.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.012 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.532 HD11 HD11 ' A' ' 285' ' ' LEU . 1.1 mp -88.45 162.54 16.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.849 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.424 ' HB3' ' CE1' ' A' ' 92' ' ' PHE . 15.2 m-85 -75.09 141.09 74.07 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.064 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -54.31 -55.88 3.0 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.658 2.239 . . . . 0.0 113.022 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.476 ' CE2' HG23 ' A' ' 93' ' ' THR . 42.4 p90 -56.16 -42.21 76.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.734 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.476 HG23 ' CE2' ' A' ' 92' ' ' PHE . 30.6 p -59.46 -28.06 66.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.754 0.312 . . . . 0.0 111.103 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.434 ' CE2' ' HG2' ' A' ' 86' ' ' GLN . 7.2 m95 -75.01 -25.82 59.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.113 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.405 ' HA ' ' CG ' ' A' ' 98' ' ' ARG . 5.9 m-20 -90.55 12.42 18.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.398 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -101.9 -48.26 4.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.779 0.324 . . . . 0.0 111.289 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.879 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 7.2 m -78.98 -33.14 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.387 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 0.9 OUTLIER -66.09 121.17 14.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.99 -179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -122.96 142.68 50.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.727 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 69.59 25.31 5.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.071 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.57 7.27 88.13 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.109 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.04 141.64 47.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.846 0.355 . . . . 0.0 111.006 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.665 ' HB3' HD11 ' A' ' 79' ' ' ILE . 1.2 mp -75.85 149.82 37.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.953 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.475 HG22 ' OE1' ' A' ' 78' ' ' GLU . 2.5 pp -157.14 26.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.387 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.879 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -161.59 179.09 8.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.073 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -137.66 89.97 14.99 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.939 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.695 ' HB3' HG21 ' A' ' 261' ' ' VAL . 44.2 Cg_exo -56.23 131.47 46.06 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.524 2.149 . . . . 0.0 112.228 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.672 ' CG2' HD21 ' A' ' 290' ' ' LEU . 4.0 mt -127.24 -48.06 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 262' ' ' LEU . . . -113.34 138.44 50.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.089 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.34 128.92 67.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.1 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -109.2 148.17 31.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.958 ' HB3' HG23 ' A' ' 320' ' ' THR . . . -157.93 137.05 11.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.405 HD11 ' HE1' ' A' ' 155' ' ' TYR . 8.6 mt -66.85 109.08 2.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.864 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.85 161.14 14.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.931 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.726 HD22 ' HD3' ' A' ' 248' ' ' PRO . 6.8 tp -96.78 111.79 23.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.8 mt -97.98 132.09 43.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.1 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.436 ' CD1' ' HB3' ' A' ' 125' ' ' PRO . 34.7 p90 -129.74 159.33 36.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.001 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.557 ' HB3' HD12 ' A' ' 121' ' ' LEU . 5.3 m120 -86.39 120.93 28.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.0 mtpp -77.93 -27.97 49.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.037 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -65.46 -30.48 71.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.1 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.557 HD12 ' HB3' ' A' ' 118' ' ' ASN . 1.9 mp -110.42 -35.7 5.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.114 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 16.2 tp -110.43 101.92 49.98 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.97 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.82 -27.79 37.08 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.37 2.047 . . . . 0.0 112.303 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -137.98 130.34 16.33 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.436 ' HB3' ' CD1' ' A' ' 117' ' ' TYR . 71.7 Cg_endo -76.99 151.55 30.94 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.538 2.159 . . . . 0.0 112.326 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.438 ' HB2' HD11 ' A' ' 132' ' ' ILE . 72.4 Cg_endo -76.26 103.03 1.68 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.54 2.16 . . . . 0.0 112.328 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -24.28 59.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.092 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.39 143.69 35.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.902 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.441 ' CE3' HG13 ' A' ' 132' ' ' ILE . 18.4 m95 -78.1 -30.82 49.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -67.64 -15.82 63.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.314 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.81 -11.11 43.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.609 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.476 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 25.6 mm -70.96 -46.56 15.15 Favored Pre-proline 0 CA--C 1.53 0.197 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.476 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 75.3 Cg_exo -48.12 -57.94 2.04 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.396 2.064 . . . . 0.0 112.489 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.32 -35.18 79.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.061 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.2 mt -58.44 -51.02 71.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.052 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.545 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 4.8 t70 -46.74 -28.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.508 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -85.58 -27.97 25.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.312 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.56 -63.71 1.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.302 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.666 ' H ' HD13 ' A' ' 139' ' ' LEU . 0.0 OUTLIER -68.96 -16.4 63.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.646 -179.597 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.418 ' N ' HD22 ' A' ' 139' ' ' LEU . 0.0 OUTLIER -64.54 -21.58 66.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.804 0.335 . . . . 0.0 110.495 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.44 -41.61 80.82 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.126 0.489 . . . . 0.0 110.581 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.4 ' HD2' ' HA ' ' A' ' 139' ' ' LEU . 0.0 OUTLIER -83.01 -26.75 30.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.784 179.711 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.34 18.6 3.36 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.76 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -111.4 -174.96 2.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.826 0.345 . . . . 0.0 110.893 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.6 t -132.12 163.9 27.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.878 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.545 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -79.26 -64.47 1.18 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.303 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.5 ' CD1' HD11 ' A' ' 115' ' ' LEU . 1.0 OUTLIER -153.28 148.44 26.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.102 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.474 ' SD ' HG21 ' A' ' 222' ' ' THR . 0.0 OUTLIER -137.05 -177.87 4.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.754 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -179.26 152.74 0.55 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.954 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.405 ' OD1' ' CD2' ' A' ' 156' ' ' PHE . 12.9 p-10 -67.95 113.11 5.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.679 ' CD2' HD21 ' A' ' 195' ' ' LEU . 8.8 mt -94.1 45.26 1.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.854 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -110.44 -30.29 7.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.008 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -125.14 125.86 25.24 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.885 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.84 -22.32 29.32 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.446 2.098 . . . . 0.0 112.341 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.405 ' HE1' HD11 ' A' ' 113' ' ' LEU . 44.4 t80 -54.19 -31.1 51.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.091 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.405 ' CD2' ' OD1' ' A' ' 150' ' ' ASN . 0.2 OUTLIER -89.16 -31.25 18.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.4 HG21 HD22 ' A' ' 195' ' ' LEU . 0.1 OUTLIER -94.93 12.43 28.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.241 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.55 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 29.7 t-105 -68.23 -54.85 14.04 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.433 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 17.4 Cg_endo -57.82 -20.26 42.88 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.238 1.959 . . . . 0.0 112.413 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.678 HD23 HD13 ' A' ' 195' ' ' LEU . 21.3 tp -78.8 -27.41 44.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.945 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 18.3 mt -101.67 -47.72 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.127 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -60.07 -36.48 77.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.214 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.42 84.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.232 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.05 -20.16 56.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.252 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 130.9 71.74 0.11 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.509 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 188' ' ' ALA . . . -171.77 172.67 44.78 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.489 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -162.39 173.57 13.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.82 0.343 . . . . 0.0 110.946 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.71 -53.34 4.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.052 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -127.72 146.22 50.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.784 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.85 108.12 17.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.049 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -73.51 110.95 8.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.577 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -159.38 145.6 16.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.935 0.398 . . . . 0.0 111.099 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 62.11 29.19 17.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.18 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.41 -37.27 3.36 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.14 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 5.1 pttm -102.04 179.61 4.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 111.139 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 176' ' ' TYR . 1.3 m-85 -110.19 115.21 29.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.801 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -58.45 134.83 57.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.899 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.8 pt -95.05 -16.63 7.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.415 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.04 25.96 4.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.024 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -150.13 110.05 4.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.817 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.775 HG12 ' H ' ' A' ' 183' ' ' VAL . 22.0 t -124.49 139.67 50.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.173 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -96.5 -5.58 58.93 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.831 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.775 ' H ' HG12 ' A' ' 181' ' ' VAL . 0.3 OUTLIER -51.85 -42.6 33.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.927 0.394 . . . . 0.0 111.36 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.417 ' N ' ' CG1' ' A' ' 183' ' ' VAL . 37.2 t0 -105.2 65.55 0.73 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.91 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.421 ' H ' ' HB3' ' A' ' 188' ' ' ALA . 0.5 OUTLIER -118.11 -168.84 1.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -74.81 -39.22 61.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.142 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -85.89 -37.85 9.05 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.468 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.442 ' HB2' ' HA3' ' A' ' 166' ' ' GLY . . . -60.21 -30.61 69.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.809 0.337 . . . . 0.0 111.163 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.44 -49.82 76.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.919 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.23 -27.88 66.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.201 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -58.18 -56.59 24.36 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.545 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.868 ' O ' HG23 ' A' ' 196' ' ' VAL . 6.9 tp -59.57 -50.44 73.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.77 0.319 . . . . 0.0 110.893 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.39 -24.72 57.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.07 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -66.84 -60.5 2.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.824 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.679 HD21 ' CD2' ' A' ' 151' ' ' LEU . 4.8 tp -57.55 -31.85 66.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.657 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 192' ' ' LEU . 48.8 t -61.73 -61.58 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.983 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.62 -27.73 68.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.848 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.5 mt -60.28 -46.6 89.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.99 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.527 HG23 ' O ' ' A' ' 204' ' ' MET . 5.1 mt -64.35 -30.02 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.171 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.87 -30.33 26.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.367 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -98.65 -6.44 29.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.8 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -117.58 -9.82 10.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.588 0.232 . . . . 0.0 111.546 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 24.9 m80 62.96 41.48 8.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.873 0.368 . . . . 0.0 110.61 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . 0.527 ' O ' HG23 ' A' ' 199' ' ' ILE . 0.0 OUTLIER -82.96 134.73 35.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.88 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -74.47 122.73 23.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -73.09 -13.84 61.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.449 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -83.93 3.96 31.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.537 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.457 ' HA ' HD12 ' A' ' 212' ' ' ILE . 56.5 m -52.53 144.6 13.2 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.769 0.319 . . . . 0.0 111.12 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.514 ' HB2' HD11 ' A' ' 212' ' ' ILE . 1.5 m-20 -153.65 176.39 12.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.048 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.409 ' OH ' ' CZ2' ' A' ' 230' ' ' TRP . 0.8 OUTLIER -46.0 -62.95 1.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.406 -179.506 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.23 -59.04 6.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.599 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.514 HD11 ' HB2' ' A' ' 209' ' ' ASP . 0.0 OUTLIER -55.81 -33.46 34.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.21 -179.428 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -81.91 -25.54 34.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.779 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.34 -47.2 12.62 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.975 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.23 -32.16 62.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.253 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.47 -25.18 50.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.217 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.59 ' CD2' HG21 ' A' ' 225' ' ' THR . 1.1 t80 -69.3 -62.66 1.29 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.991 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -68.94 -45.57 70.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.03 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.41 -29.4 66.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.959 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.57 41.28 10.04 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.514 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -89.19 -31.31 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.794 0.33 . . . . 0.0 110.893 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.474 HG21 ' SD ' ' A' ' 148' ' ' MET . 11.0 t -124.64 163.17 22.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.934 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -90.26 -35.24 15.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.032 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -130.5 163.22 27.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.818 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.59 HG21 ' CD2' ' A' ' 217' ' ' PHE . 1.8 t -166.72 162.67 16.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.97 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.9 mt -111.61 118.8 58.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.021 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -144.27 165.42 27.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.924 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -98.59 -174.76 32.46 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.536 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.12 -24.67 27.77 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.562 2.175 . . . . 0.0 112.415 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . 0.409 ' CZ2' ' OH ' ' A' ' 210' ' ' TYR . 24.7 p90 -59.03 -30.83 68.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.91 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -71.33 -26.68 62.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.191 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 27.6 m0 -55.83 -39.62 71.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.981 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.6 m -69.47 -31.7 70.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -69.67 -35.85 75.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.924 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 22.7 mt -75.83 116.52 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.079 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -173.31 -42.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.933 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.41 -55.51 13.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 20.9 t -63.67 -28.68 70.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.941 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt 60.84 76.01 0.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.902 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 22.6 t -121.08 112.21 34.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.045 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.04 108.87 1.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.942 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -117.3 145.13 44.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.844 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -117.63 179.15 17.22 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.513 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.56 128.84 74.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 0.0 111.13 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.9 t -143.03 159.28 42.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.956 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.62 152.06 7.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.01 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.85 145.25 91.68 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.833 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.726 ' HD3' HD22 ' A' ' 115' ' ' LEU . 51.0 Cg_exo -53.7 137.29 66.91 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.477 2.118 . . . . 0.0 112.267 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 1.3 p -77.08 160.6 28.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -145.37 126.62 14.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt 62.26 18.01 9.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.287 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 92.25 -21.24 38.66 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.888 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.84 149.29 37.01 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.731 0.3 . . . . 0.0 110.873 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.66 162.07 42.62 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.509 2.139 . . . . 0.0 112.229 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 39.7 p -71.14 179.59 2.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.832 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -128.84 58.07 33.91 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.84 136.47 32.88 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.548 2.165 . . . . 0.0 112.316 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.497 ' CZ ' ' CD1' ' A' ' 158' ' ' TRP . 85.9 m-85 -59.51 140.1 56.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.978 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.68 145.76 12.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -134.81 108.42 0.71 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.469 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.719 HG12 ' CD2' ' A' ' 64' ' ' HIS . 7.4 p -88.74 160.84 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 0.0 111.152 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.462 ' N ' HG22 ' A' ' 261' ' ' VAL . 9.6 tp -121.62 131.43 54.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.77 169.43 19.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.964 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -105.4 127.36 52.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.058 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -90.44 148.21 19.5 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.537 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.648 HD11 HD12 ' A' ' 280' ' ' LEU . 31.3 mt -127.3 115.76 41.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.861 0.362 . . . . 0.0 111.125 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -77.05 135.88 38.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.912 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.546 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -64.77 -30.43 71.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.132 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -58.98 -30.98 68.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.7 111.18 8.12 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.87 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.55 ' HD2' HG21 ' A' ' 2' ' ' THR . 46.8 Cg_endo -68.27 -14.05 39.39 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.402 2.068 . . . . 0.0 112.583 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -84.47 57.22 4.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.939 0.4 . . . . 0.0 110.942 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.6 tppm? -82.77 -36.75 25.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -59.95 -49.18 78.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.613 HD13 HG21 ' A' ' 33' ' ' ILE . 37.4 mt -71.08 -33.33 70.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.968 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.34 93.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.044 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -63.14 -54.17 41.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -62.9 -33.28 74.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -69.64 -46.74 65.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.047 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.773 HD22 HD22 ' A' ' 284' ' ' LEU . 79.9 mt -81.42 -21.67 38.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.383 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -93.66 -48.21 6.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.765 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -103.77 18.05 22.77 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.605 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -163.47 52.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.879 0.371 . . . . 0.0 111.213 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.773 HD22 HD22 ' A' ' 280' ' ' LEU . 7.1 tp -174.83 -65.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.897 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.809 ' CD2' HD13 ' A' ' 304' ' ' LEU . 1.0 OUTLIER -84.95 58.41 5.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.947 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.23 -179.09 5.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.881 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.75 -36.97 31.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -75.76 -31.05 59.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.907 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -79.42 -52.1 4.95 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.532 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.672 HD21 ' CG2' ' A' ' 108' ' ' ILE . 10.1 mt -60.04 -35.35 74.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.819 0.342 . . . . 0.0 110.958 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -59.96 -44.02 94.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.29 -53.68 51.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.12 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.8 t -59.64 -47.14 92.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.128 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -66.44 -31.6 72.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.914 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 2.4 mtmm -63.1 -33.9 76.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.942 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -98.82 -32.43 11.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.024 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.4 ' HA ' ' HD2' ' A' ' 298' ' ' PRO . 4.1 mmtt -154.49 95.12 2.72 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.915 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 297' ' ' LYS . 36.6 Cg_endo -65.81 123.65 11.63 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.488 2.125 . . . . 0.0 112.314 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.455 ' H ' HD12 ' A' ' 299' ' ' LEU . 1.0 OUTLIER -93.38 17.44 11.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.133 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 81.78 -142.8 22.87 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.59 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -58.41 174.94 0.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 111.192 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.594 HG21 ' HB3' ' A' ' 307' ' ' TYR . 13.4 m -140.47 133.14 32.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.111 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -59.46 -33.79 71.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.208 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.829 HD23 ' HB2' ' A' ' 307' ' ' TYR . 14.0 tp -60.16 114.86 3.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -60.14 -30.67 69.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.951 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 32.6 m -70.36 -39.39 74.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.935 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.829 ' HB2' HD23 ' A' ' 304' ' ' LEU . 1.0 OUTLIER -86.22 -26.76 24.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.014 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -59.89 -31.7 70.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.807 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -69.76 -54.51 13.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.862 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.73 -34.74 19.82 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.788 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.578 ' HB3' HG21 ' A' ' 317' ' ' ILE . 88.3 mt -85.72 -26.63 25.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.697 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -70.53 -12.3 61.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.439 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -47.76 -31.77 5.21 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.925 0.393 . . . . 0.0 110.81 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -116.11 140.26 26.13 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.35 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.475 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 12.6 Cg_endo -56.52 -24.82 55.25 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.384 2.056 . . . . 0.0 112.414 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -50.96 -41.48 59.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.008 0.433 . . . . 0.0 110.302 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.578 HG21 ' HB3' ' A' ' 311' ' ' LEU . 30.1 mm -85.55 -32.72 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.882 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.475 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -69.11 -29.63 67.74 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.233 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.33 -30.65 66.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.151 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.958 HG23 ' HB3' ' A' ' 112' ' ' ALA . 56.6 m -84.61 -36.35 22.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 6.8 tpt -64.41 -40.21 95.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -59.92 -43.73 94.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.931 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -79.26 -29.13 42.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.023 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.6 -39.96 94.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.19 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -71.65 -55.01 8.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.994 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.13 -47.33 74.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.836 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -58.99 147.71 40.9 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.482 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -86.22 149.85 24.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.337 . . . . 0.0 110.911 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.535 HG22 ' HE1' ' A' ' 64' ' ' HIS . 28.4 mt -87.98 141.96 13.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.085 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 71.6 mtm -63.84 124.16 84.06 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.944 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -56.38 -164.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.38 2.053 . . . . 0.0 112.261 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -150.61 30.82 0.66 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 31.5 pt -117.86 153.73 51.01 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.108 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.51 -20.36 70.38 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.606 2.204 . . . . 0.0 112.445 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -60.39 -27.46 67.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.099 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 1.4 tpt -74.78 -30.21 61.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.074 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.84 -44.98 86.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.001 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -63.52 -29.93 71.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.108 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.856 ' CE1' HG21 ' A' ' 343' ' ' VAL . 11.9 t80 -59.45 -48.6 81.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.973 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 24.2 m95 -59.01 -30.27 67.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.044 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -81.31 -44.17 18.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.046 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.698 ' HB1' ' HA ' ' A' ' 364' ' ' ALA . . . -61.83 -61.66 2.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.269 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.856 HG21 ' CE1' ' A' ' 339' ' ' PHE . 21.9 t -58.39 -23.73 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.427 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.84 -57.41 12.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.093 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . 0.587 HG22 ' ND2' ' A' ' 349' ' ' ASN . 26.4 m -72.18 -30.27 64.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.107 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.27 -50.79 66.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.289 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 343' ' ' VAL . 33.3 t -62.91 -45.27 99.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.249 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 27.6 mt -67.85 -42.59 86.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.113 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.587 ' ND2' HG22 ' A' ' 345' ' ' THR . 55.7 m-20 -58.13 -45.71 86.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.985 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -74.57 -28.71 61.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.197 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.19 -35.98 76.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.268 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.09 20.76 9.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.185 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 55.82 26.0 46.11 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.602 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -82.03 -30.44 31.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.866 0.365 . . . . 0.0 110.941 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -145.42 174.75 10.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 41.0 p -100.47 151.64 21.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.566 HG22 HD23 ' A' ' 192' ' ' LEU . 40.5 t -55.91 -27.41 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.053 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -73.81 -47.71 36.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.82 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -35.4 62.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.051 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.0 -56.7 13.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.971 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 92.1 mt -61.63 -29.81 70.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.818 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -56.14 25.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.887 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -63.78 -47.62 80.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.932 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.698 ' HA ' ' HB1' ' A' ' 342' ' ' ALA . . . -61.61 -52.84 62.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.151 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.85 ' HA ' HD12 ' A' ' 368' ' ' ILE . 15.6 tm0? -57.36 -30.49 64.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.005 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 60.5 m -82.62 -33.41 27.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.952 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -66.99 -33.81 76.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.936 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.85 HD12 ' HA ' ' A' ' 365' ' ' GLN . 5.2 mt -65.92 -30.13 49.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.04 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.7 p -80.14 -29.94 38.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 34.3 mttp . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.895 180.0 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.86 0.362 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.482 HG21 ' HB3' ' A' ' 58' ' ' ASP . 8.5 t -118.24 133.31 56.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.94 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -170.68 35.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.914 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -143.9 -166.37 2.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.785 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -84.91 56.02 5.0 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.463 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.51 ' HE2' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -142.08 -178.38 5.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.754 0.312 . . . . 0.0 110.938 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.403 HD21 ' HB3' ' A' ' 275' ' ' LEU . 15.2 mt -145.83 118.38 8.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.51 HG22 ' HE2' ' A' ' 6' ' ' LYS . 30.1 t -92.2 132.46 36.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.118 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.622 HG21 ' CD2' ' A' ' 20' ' ' LEU . 34.3 mt -121.56 107.2 19.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.46 ' CG ' ' HG2' ' A' ' 57' ' ' PRO . 0.9 OUTLIER -94.89 112.98 24.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.871 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.455 HD11 ' HD2' ' A' ' 15' ' ' LYS . 2.8 tt -144.93 146.16 20.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.105 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -66.26 161.57 21.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.858 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.13 55.99 4.97 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.512 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -153.34 36.03 0.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.795 0.331 . . . . 0.0 110.897 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.455 ' HD2' HD11 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -148.44 179.94 7.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.92 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.2 66.92 3.11 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.505 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 12.2 p90 -79.47 -31.4 42.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.821 0.344 . . . . 0.0 110.911 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.445 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 51.7 t-20 -60.49 -32.92 71.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.944 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.65 -28.59 51.06 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.493 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.622 ' CD2' HG21 ' A' ' 9' ' ' ILE . 14.0 tp -69.27 -33.46 73.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.865 0.364 . . . . 0.0 110.906 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.23 -40.83 91.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.119 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.4 -33.1 70.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.035 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.1 t -70.91 -32.74 49.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.11 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.63 -33.07 63.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.489 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -66.86 -29.44 69.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.845 0.355 . . . . 0.0 110.937 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.14 -40.13 46.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -58.3 -54.67 44.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.959 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -37.56 77.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.941 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -72.01 -26.3 62.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.975 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -82.95 -31.79 27.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.523 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 17.3 p -138.14 -44.22 0.51 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.611 0.243 . . . . 0.0 111.594 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.53 -20.2 2.95 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.689 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.3 mm -59.94 114.68 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.807 0.337 . . . . 0.0 111.047 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.3 mttp -82.69 170.13 15.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.988 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.28 125.51 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.104 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 m -116.6 125.1 51.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -105.15 127.95 59.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -115.49 153.68 30.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.861 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -117.83 70.27 7.19 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.425 ' HG3' ' CD2' ' A' ' 10' ' ' TRP . 88.0 Cg_endo -77.07 174.53 12.68 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.685 2.256 . . . . 0.0 112.475 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -60.94 -156.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.474 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.474 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -46.95 -26.49 1.01 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.516 0.198 . . . . 0.0 111.457 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.474 HD23 ' O ' ' A' ' 42' ' ' LYS . 0.3 OUTLIER 54.77 18.11 2.0 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.879 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -79.17 -55.78 4.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.834 0.349 . . . . 0.0 110.782 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -93.67 -7.8 42.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.363 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.478 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -80.71 -19.17 45.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.385 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.425 ' CB ' ' HD3' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -84.46 -53.36 0.51 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.197 -179.762 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.425 ' HD3' ' CB ' ' A' ' 47' ' ' PHE . 32.6 Cg_exo -57.84 -32.44 94.97 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.485 2.123 . . . . 0.0 112.37 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.488 ' HG3' HG13 ' A' ' 50' ' ' VAL . 11.4 pt20 -61.31 -47.07 87.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.058 0.456 . . . . 0.0 111.016 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.488 HG13 ' HG3' ' A' ' 49' ' ' GLN . 4.1 m -95.1 27.05 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.484 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.16 -32.18 30.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.348 . . . . 0.0 111.2 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.52 -32.82 19.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.171 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 51.6 p -72.73 -31.4 64.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.93 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.89 26.08 46.79 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.563 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -96.24 -28.66 14.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.808 0.337 . . . . 0.0 110.895 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.97 166.14 3.98 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.665 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.46 ' HG2' ' CG ' ' A' ' 10' ' ' TRP . 50.0 Cg_exo -53.38 -172.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.681 2.254 . . . . 0.0 112.38 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.482 ' HB3' HG21 ' A' ' 2' ' ' THR . 8.2 p30 -109.48 -29.02 8.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.953 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.484 HG21 HD21 ' A' ' 280' ' ' LEU . 30.9 mt -132.13 157.08 43.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.205 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.481 ' CG1' ' N ' ' A' ' 61' ' ' PHE . 2.0 tt -163.35 159.36 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.133 0.492 . . . . 0.0 110.897 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.481 ' N ' ' CG1' ' A' ' 60' ' ' ILE . 3.9 m-85 -132.73 124.95 29.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.835 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.6 t-105 -159.41 171.43 19.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.851 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.7 134.04 55.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.163 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.434 ' CD2' HG23 ' A' ' 261' ' ' VAL . 13.2 p80 -58.56 -31.0 67.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.97 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -59.89 -29.97 68.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.988 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -88.48 -30.27 19.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.923 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -58.36 -30.12 66.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.968 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.81 -27.47 61.83 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.578 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.33 -28.45 71.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.488 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -87.22 -30.16 21.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.815 0.34 . . . . 0.0 110.947 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.18 -29.08 42.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.123 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -57.91 -29.55 65.19 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.063 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.55 -23.15 17.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.085 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.02 28.4 9.36 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.515 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.5 mt -81.81 -32.63 31.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.852 0.358 . . . . 0.0 110.913 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 76' ' ' LEU . 38.5 mt -76.0 160.68 29.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.502 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -101.77 133.0 47.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.453 ' CG ' ' N ' ' A' ' 79' ' ' ILE . 19.3 tt0 -61.36 164.01 6.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.722 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.498 ' O ' HG23 ' A' ' 80' ' ' THR . 43.1 pt -141.22 177.6 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.145 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 79' ' ' ILE . 0.7 OUTLIER -162.03 77.9 2.08 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.802 179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.51 135.92 41.02 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.555 2.17 . . . . 0.0 112.318 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.39 173.42 0.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -62.39 -48.47 79.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.64 -31.3 69.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.121 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -71.08 -44.26 66.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.89 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -64.08 -44.76 91.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.904 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -65.8 -29.75 70.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.94 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -59.62 -45.35 92.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.945 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.837 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 46.3 mt -88.23 173.64 8.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.879 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.435 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . 10.6 m-85 -81.57 149.55 64.83 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.063 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.33 -55.93 2.45 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.637 2.225 . . . . 0.0 112.706 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.454 ' CE1' ' CG2' ' A' ' 93' ' ' THR . 50.8 p90 -56.55 -44.12 80.58 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.771 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.454 ' CG2' ' CE1' ' A' ' 92' ' ' PHE . 39.3 p -54.49 -28.07 42.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.74 0.305 . . . . 0.0 111.116 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.837 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 49.6 m95 -76.83 -46.09 26.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.821 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.73 -26.53 67.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.069 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.401 ' HB2' HD13 ' A' ' 329' ' ' ILE . . . -71.71 -28.74 63.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.279 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 11.2 m -107.42 64.58 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.22 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -156.06 120.07 4.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.98 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -118.93 136.48 54.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.781 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 62.64 17.94 10.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.18 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.79 21.9 56.75 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.947 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.05 156.43 48.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.832 0.349 . . . . 0.0 110.994 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.547 ' O ' HG23 ' A' ' 104' ' ' ILE . 5.8 mt -93.8 142.67 27.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.547 HG23 ' O ' ' A' ' 103' ' ' LEU . 2.6 pp -159.0 36.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.206 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.589 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -160.79 176.91 10.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.186 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.425 ' CE1' HG21 ' A' ' 79' ' ' ILE . 39.3 m-85 -139.34 87.4 13.63 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.81 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.553 ' CG ' HG21 ' A' ' 97' ' ' VAL . 61.3 Cg_exo -51.77 102.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.571 2.18 . . . . 0.0 112.327 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.742 HD12 HD23 ' A' ' 284' ' ' LEU . 20.7 mm -76.67 -64.27 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.095 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.581 ' O ' HG12 ' A' ' 261' ' ' VAL . . . -131.88 171.63 13.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.078 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.28 148.11 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.055 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.77 159.8 37.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.961 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -169.07 145.25 3.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.107 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.2 mt -62.56 108.39 1.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.1 m -92.56 161.83 14.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.0 tp -109.3 102.12 11.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.907 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.7 mp -91.94 131.46 38.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.131 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.45 ' CD1' ' HG2' ' A' ' 125' ' ' PRO . 46.1 p90 -113.51 165.51 12.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.949 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -109.84 106.16 15.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.821 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -58.58 -22.86 57.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.612 ' HB3' HD23 ' A' ' 121' ' ' LEU . 2.5 t0 -55.04 -32.81 62.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.113 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.612 HD23 ' HB3' ' A' ' 120' ' ' ASP . 0.1 OUTLIER -128.86 -42.03 1.43 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.201 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 122' ' ' LEU . 14.4 tp -104.85 90.67 3.68 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.009 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.84 -43.83 2.37 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.532 2.155 . . . . 0.0 112.283 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -126.51 91.37 47.69 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.45 ' HG2' ' CD1' ' A' ' 117' ' ' TYR . 75.6 Cg_exo -50.58 151.83 9.9 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.586 2.191 . . . . 0.0 112.357 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.76 119.5 5.46 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.566 2.178 . . . . 0.0 112.366 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.05 -21.22 62.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.036 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 12.0 p -100.86 146.1 27.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.903 0.382 . . . . 0.0 111.058 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.88 ' CE3' HD12 ' A' ' 132' ' ' ILE . 4.4 m95 -77.36 -28.44 52.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.958 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.96 -15.74 60.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.526 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -89.19 -21.94 23.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.528 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.88 HD12 ' CE3' ' A' ' 129' ' ' TRP . 41.4 mt -59.76 -46.99 98.44 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.592 ' HG3' HD21 ' A' ' 198' ' ' LEU . 75.7 Cg_exo -49.5 -45.17 32.06 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.412 2.075 . . . . 0.0 112.416 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.26 -38.71 92.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.05 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.499 HD23 ' CD1' ' A' ' 139' ' ' LEU . 0.2 OUTLIER -65.34 -33.59 76.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.865 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.528 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 41.9 t0 -63.77 -24.4 67.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.1 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -85.53 -31.67 22.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.115 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -85.01 -47.11 10.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.208 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.779 HD22 ' HB2' ' A' ' 223' ' ' ALA . 0.3 OUTLIER -62.14 -17.87 59.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.394 -179.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.32 -27.92 53.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.736 0.303 . . . . 0.0 110.879 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.6 -41.69 90.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.05 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.7 mtpt -72.59 -27.11 61.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.017 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 114.51 29.4 2.71 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.504 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt -141.75 166.99 23.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.844 0.354 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.0 t -97.71 159.13 15.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.871 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.618 ' HA ' HD13 ' A' ' 139' ' ' LEU . . . -85.45 -32.07 22.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.17 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.824 HD12 ' CB ' ' A' ' 224' ' ' MET . 1.0 OUTLIER -169.98 124.1 0.75 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.018 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.413 ' HB2' HG21 ' A' ' 208' ' ' THR . 0.4 OUTLIER -129.43 166.65 19.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.59 179.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.8 p90 179.01 -170.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.803 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -89.14 109.64 20.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.905 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.674 HD21 HD11 ' A' ' 195' ' ' LEU . 13.7 mt -88.97 -29.13 19.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.952 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -59.17 -31.46 69.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.885 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.38 111.28 59.45 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.6 -23.48 19.8 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.428 2.085 . . . . 0.0 112.318 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.496 ' CE1' ' CD1' ' A' ' 258' ' ' PHE . 0.3 OUTLIER -50.6 -27.41 6.78 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.232 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -96.81 -22.47 16.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.219 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.839 ' O ' HD12 ' A' ' 161' ' ' ILE . 17.2 p -92.35 11.75 24.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.398 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.467 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 22.8 t-105 -87.58 -47.45 0.48 Allowed Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.309 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 53.7 Cg_exo -52.52 -23.32 18.95 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.374 2.049 . . . . 0.0 112.574 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.679 HD11 ' CD2' ' A' ' 194' ' ' PHE . 5.6 tp -86.02 -67.38 0.81 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.103 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.839 HD12 ' O ' ' A' ' 157' ' ' THR . 5.4 mt -57.73 -41.69 80.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.237 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.499 ' HB1' ' HB2' ' A' ' 256' ' ' LYS . . . -59.8 -38.27 81.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.197 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.673 ' HB2' ' HA ' ' A' ' 255' ' ' SER . . . -57.79 -36.17 71.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.229 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.94 -20.18 56.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.169 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 130.04 -22.0 4.86 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.636 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.562 ' HA3' ' HB2' ' A' ' 188' ' ' ALA . . . -69.32 154.65 53.25 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.496 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.442 ' CD1' ' HA3' ' A' ' 182' ' ' GLY . 25.6 p90 -148.85 -175.13 4.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 0.0 110.926 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.474 ' HB1' ' CE1' ' A' ' 339' ' ' PHE . . . -111.31 -48.9 3.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.024 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -130.28 127.53 39.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.828 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 167' ' ' TYR . 11.1 tttm -94.65 112.79 24.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.092 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.403 ' HB2' ' CE1' ' A' ' 176' ' ' TYR . 62.5 t80 -68.93 110.89 4.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.544 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -172.48 156.06 3.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.961 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 62.73 46.23 5.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.007 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 104.09 -62.27 0.4 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.723 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -151.09 -171.47 3.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 111.009 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.403 ' CE1' ' HB2' ' A' ' 171' ' ' TYR . 88.2 m-85 -59.49 125.9 25.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.9 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -82.19 127.51 33.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.876 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.2 pt -73.18 -27.6 24.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.202 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -97.25 26.04 5.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.052 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -125.44 96.35 4.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.921 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.796 HG21 ' HA ' ' A' ' 365' ' ' GLN . 23.5 t -96.29 146.01 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.111 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 0.442 ' HA3' ' CD1' ' A' ' 167' ' ' TYR . . . -114.71 -7.04 18.57 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.995 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.662 HG12 HD22 ' A' ' 361' ' ' LEU . 11.1 t -56.51 -43.31 77.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.866 0.333 . . . . 0.0 111.181 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.06 57.26 4.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.919 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -104.61 -178.87 3.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.75 -52.15 22.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.108 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -76.82 -29.59 57.2 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.561 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.562 ' HB2' ' HA3' ' A' ' 166' ' ' GLY . . . -58.29 -33.93 69.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.829 0.347 . . . . 0.0 111.122 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.59 -31.2 72.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -87.47 -36.86 17.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.137 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -60.29 -46.85 93.52 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.461 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.939 HD12 HG22 ' A' ' 357' ' ' VAL . 3.1 tm? -60.33 -45.93 91.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.831 0.348 . . . . 0.0 110.854 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.554 ' OG1' HG21 ' A' ' 357' ' ' VAL . 91.7 m -67.02 -24.28 66.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.977 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.679 ' CD2' HD11 ' A' ' 160' ' ' LEU . 24.7 t80 -59.27 -60.67 3.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.812 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.674 HD11 HD21 ' A' ' 151' ' ' LEU . 3.7 tp -61.18 -30.29 70.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.554 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 192' ' ' LEU . 49.1 t -69.86 -43.28 79.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.005 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.34 -24.32 34.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.133 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.592 HD21 ' HG3' ' A' ' 133' ' ' PRO . 0.7 OUTLIER -63.87 -35.21 79.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.033 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.517 HG23 ' O ' ' A' ' 204' ' ' MET . 12.4 mt -77.75 -33.74 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.3 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 4.0 mtpp -85.07 -28.99 25.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.146 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -91.39 -10.18 42.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.558 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.569 ' HG3' HD23 ' A' ' 198' ' ' LEU . 13.1 mmtm -130.83 9.02 4.9 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.5 0.191 . . . . 0.0 111.49 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . 0.424 ' CG ' ' O ' ' A' ' 202' ' ' LYS . 40.1 p-80 43.67 52.96 6.16 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.888 0.375 . . . . 0.0 111.426 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . 0.517 ' O ' HG23 ' A' ' 199' ' ' ILE . 48.0 mtp -82.76 133.51 35.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -59.37 119.75 8.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.073 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -80.07 -29.77 39.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.059 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.74 -20.85 52.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.222 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.413 HG21 ' HB2' ' A' ' 148' ' ' MET . 7.2 m -45.16 149.31 0.5 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.916 0.388 . . . . 0.0 111.398 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.527 ' OD2' HD11 ' A' ' 212' ' ' ILE . 11.2 m-20 -154.07 176.28 12.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.661 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 211' ' ' SER . 0.3 OUTLIER -62.96 -30.48 71.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.93 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.454 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 0.7 OUTLIER -68.78 -59.21 3.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.953 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.527 HD11 ' OD2' ' A' ' 209' ' ' ASP . 0.0 OUTLIER -58.83 -28.85 38.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.358 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -74.07 -33.61 63.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.781 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.75 -28.63 30.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.53 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.37 -36.42 83.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.474 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.433 ' HA ' ' HA3' ' A' ' 220' ' ' GLY . . . -52.46 -25.22 9.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.307 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -66.92 -53.9 27.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.979 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -90.06 -13.96 34.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.03 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -176.84 101.85 0.05 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.979 0.419 . . . . 0.0 111.275 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 216' ' ' ALA . . . 149.73 -46.85 0.64 Allowed Glycine 0 N--CA 1.453 -0.229 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.049 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 63.97 101.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.944 0.402 . . . . 0.0 111.561 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.564 HG21 ' HB ' ' A' ' 225' ' ' THR . 13.3 t -116.05 124.89 51.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.374 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.779 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -45.92 -32.64 2.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.604 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.824 ' CB ' HD12 ' A' ' 147' ' ' LEU . 26.3 mtm -156.89 142.54 17.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.914 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.564 ' HB ' HG21 ' A' ' 222' ' ' THR . 4.1 t -164.3 126.24 2.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.444 HG12 HD21 ' A' ' 247' ' ' LEU . 4.0 mt -95.71 126.99 48.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.096 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -141.28 165.49 27.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -82.48 -170.94 46.06 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.496 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.406 ' HD2' ' CE3' ' A' ' 230' ' ' TRP . 74.1 Cg_endo -74.99 -2.89 13.13 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.638 2.225 . . . . 0.0 112.751 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . 0.406 ' CE3' ' HD2' ' A' ' 229' ' ' PRO . 39.0 p90 -95.97 34.08 1.6 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.694 0.283 . . . . 0.0 111.104 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -136.86 11.29 3.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.557 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 8.7 m0 -81.19 -39.43 25.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.808 0.337 . . . . 0.0 110.965 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.45 -29.92 68.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.024 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.71 -30.45 65.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.993 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.548 HG21 ' CE1' ' A' ' 242' ' ' TYR . 4.4 mt -88.63 84.67 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.071 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.603 ' O ' HG23 ' A' ' 237' ' ' THR . 33.9 p-10 -160.76 37.19 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.915 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.603 HG23 ' O ' ' A' ' 236' ' ' ASP . 0.8 OUTLIER -165.71 -43.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.957 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 82.8 p -63.08 -30.68 71.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.964 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 7.4 mmtm 61.09 36.05 18.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 20.8 t -95.41 121.73 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.105 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -61.98 111.97 2.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.868 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.548 ' CE1' HG21 ' A' ' 235' ' ' ILE . 50.8 p90 -109.26 146.96 33.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.91 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -126.14 147.19 16.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.492 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 20.8 t -110.18 127.05 67.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.814 0.34 . . . . 0.0 111.126 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.3 t -143.61 146.81 33.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.419 ' CG2' ' N ' ' A' ' 247' ' ' LEU . 0.7 OUTLIER -55.17 152.31 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.217 0.532 . . . . 0.0 111.32 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.55 HD12 HD21 ' A' ' 323' ' ' ASN . 13.5 mt -72.08 147.62 91.04 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.946 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.561 ' HG3' HD11 ' A' ' 132' ' ' ILE . 36.1 Cg_endo -65.43 166.45 19.47 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.535 2.157 . . . . 0.0 112.282 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 254' ' ' PRO . 4.5 p -110.32 162.2 14.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.943 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -117.24 110.58 18.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.913 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 9.1 mttm 59.84 25.3 14.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.042 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 92.93 -21.07 41.61 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.714 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -80.48 126.59 78.26 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.539 0.209 . . . . 0.0 110.832 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.462 ' HA ' HG22 ' A' ' 249' ' ' THR . 71.4 Cg_endo -74.76 143.88 30.5 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.433 2.089 . . . . 0.0 112.34 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.673 ' HA ' ' HB2' ' A' ' 163' ' ' ALA . 89.7 p -60.64 -178.29 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.777 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.499 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . 11.6 mttp -136.99 62.25 38.82 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.014 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.414 ' HD3' ' N ' ' A' ' 256' ' ' LYS . 35.7 Cg_exo -57.43 -161.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.497 2.131 . . . . 0.0 112.207 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.496 ' CD1' ' CE1' ' A' ' 155' ' ' TYR . 63.1 m-85 -122.3 136.89 54.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.821 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 25.8 t -97.15 117.82 42.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.178 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -114.61 114.23 3.2 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.405 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -112.84 142.34 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.849 0.357 . . . . 0.0 111.151 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 14.8 tp -101.76 81.44 2.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.724 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.545 ' OG ' ' HB1' ' A' ' 105' ' ' ALA . 14.9 p -85.32 166.2 16.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.971 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -99.72 148.37 24.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.055 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -125.26 131.4 7.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.521 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 3.9 mp -124.13 102.4 10.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.789 0.328 . . . . 0.0 111.064 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -59.59 148.33 33.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.993 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.502 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -60.74 -30.55 70.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.092 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.83 57.1 4.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.014 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 8.0 m -145.56 93.29 5.35 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.84 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -48.64 -26.72 9.67 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.585 2.19 . . . . 0.0 112.464 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.481 ' ND2' HD12 ' A' ' 275' ' ' LEU . 4.9 m120 -86.21 56.24 3.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.835 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.27 -49.64 9.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.905 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -60.04 -43.72 95.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.864 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.481 HD12 ' ND2' ' A' ' 272' ' ' ASN . 46.6 mt -66.06 -32.18 73.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.8 -44.27 86.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.074 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.11 -49.39 74.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -63.05 -32.31 73.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.89 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.402 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 84.1 t80 -69.57 -47.59 63.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.97 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.507 HD23 HD22 ' A' ' 284' ' ' LEU . 1.6 mt -81.49 -21.17 38.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.383 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -93.61 -48.25 6.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.793 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -102.99 17.72 23.39 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.519 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.402 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 21.4 m-85 -163.81 44.59 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.884 0.373 . . . . 0.0 111.193 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.742 HD23 HD12 ' A' ' 108' ' ' ILE . 3.1 tp -177.95 -55.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 3.0 mt -89.99 52.56 2.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.7 p -138.31 -178.17 5.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -71.54 -43.27 66.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.888 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -82.72 -33.62 27.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -60.55 -61.88 6.59 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.563 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.566 HD13 ' CD2' ' A' ' 307' ' ' TYR . 2.8 mt -60.96 -34.27 74.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.333 . . . . 0.0 110.917 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.94 -41.99 93.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.94 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -59.5 -36.4 75.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.14 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.6 t -85.4 -30.67 6.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -59.77 -36.0 75.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -66.88 -32.72 74.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -89.46 -32.75 17.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.961 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -162.65 91.53 1.27 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.983 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.66 123.68 10.72 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.499 2.133 . . . . 0.0 112.315 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.468 ' H ' HD12 ' A' ' 299' ' ' LEU . 3.1 mp -93.33 16.87 12.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.11 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 59.09 -116.93 9.51 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.542 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -59.58 155.71 14.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.861 0.362 . . . . 0.0 111.093 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.544 HG11 ' CD2' ' A' ' 307' ' ' TYR . 16.7 m -141.1 156.16 21.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.162 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.49 ' HB3' HD22 ' A' ' 89' ' ' LEU . . . -69.87 -36.2 75.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.098 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.638 HD23 ' HB2' ' A' ' 307' ' ' TYR . 9.2 tp -61.35 122.32 14.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -70.05 -27.28 64.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.009 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 69.0 m -81.25 -27.61 35.11 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.149 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.638 ' HB2' HD23 ' A' ' 304' ' ' LEU . 8.3 t80 -83.06 -31.24 27.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.24 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -30.71 69.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.881 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -69.8 -50.23 45.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.891 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -51.22 -39.46 56.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.75 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.765 ' HB3' HG21 ' A' ' 317' ' ' ILE . 72.4 mt -85.68 -23.05 27.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.866 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.99 -14.95 61.66 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.491 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -46.41 -30.61 2.22 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.891 0.377 . . . . 0.0 110.912 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.89 142.04 27.79 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.339 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.42 -33.52 96.43 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.476 2.117 . . . . 0.0 112.521 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -49.18 -37.15 21.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.007 0.432 . . . . 0.0 110.364 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.765 HG21 ' HB3' ' A' ' 311' ' ' LEU . 33.1 mm -85.56 -34.33 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.876 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.3 -31.81 72.84 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.154 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.09 -45.75 83.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.175 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 60.3 m -61.34 -35.24 76.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 2.9 tpt -66.38 -46.62 76.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -62.76 -33.68 75.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.55 HD21 HD12 ' A' ' 247' ' ' LEU . 2.8 t-20 -75.33 -32.19 60.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.45 -45.38 72.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.045 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -59.67 -31.54 69.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.854 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -96.59 21.12 9.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.145 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -117.15 135.95 12.29 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.524 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -79.27 143.03 35.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.781 0.324 . . . . 0.0 110.886 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.401 HD13 ' HB2' ' A' ' 96' ' ' ALA . 26.0 mt -75.76 133.88 30.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.142 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 27.4 mtm -60.29 125.63 82.16 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.778 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.77 172.06 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.352 2.035 . . . . 0.0 112.245 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -132.35 41.03 3.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 31.7 pt -117.56 143.98 33.29 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.108 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.49 -23.84 49.91 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.595 2.196 . . . . 0.0 112.426 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.13 -22.46 40.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.203 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 37.8 mtp -54.66 -24.2 20.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.288 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 44.7 m -57.14 -36.89 71.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.085 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -82.41 -28.19 31.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.189 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.778 ' CZ ' HG21 ' A' ' 343' ' ' VAL . 79.7 t80 -57.4 -31.22 65.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.979 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -62.74 -61.0 2.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.018 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -63.2 -27.96 69.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.131 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -73.44 -38.24 65.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.351 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.831 ' O ' HG23 ' A' ' 347' ' ' VAL . 25.9 t -88.58 -46.35 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.299 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.563 ' HG2' HD11 ' A' ' 348' ' ' ILE . 7.1 ttt180 -55.75 -57.36 12.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.129 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 29.8 m -61.97 -27.25 68.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.115 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 350' ' ' ALA . . . -76.3 -32.66 58.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.322 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 343' ' ' VAL . 33.0 t -82.71 -42.68 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.282 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.563 HD11 ' HG2' ' A' ' 344' ' ' ARG . 17.4 mt -62.31 -59.05 4.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.125 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -59.6 -30.36 68.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.935 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 346' ' ' ALA . . . -73.56 -52.06 14.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.112 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.26 -32.2 72.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.137 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.25 -22.4 64.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.092 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 103.45 -27.21 20.85 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.573 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -58.97 -77.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.882 0.372 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -65.55 140.89 58.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.844 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 78.2 p -87.92 178.02 6.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.787 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.939 HG22 HD12 ' A' ' 192' ' ' LEU . 23.3 t -77.62 -55.11 11.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.945 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -47.69 -33.0 6.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.319 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -82.08 -45.79 14.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.143 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -57.43 -60.46 3.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.052 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.662 HD22 HG12 ' A' ' 183' ' ' VAL . 7.3 mt -58.7 -27.29 64.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.074 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -81.2 -37.06 29.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.955 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -70.36 -45.53 65.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.863 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.404 ' O ' HD12 ' A' ' 368' ' ' ILE . . . -58.2 -30.78 66.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.11 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.796 ' HA ' HG21 ' A' ' 181' ' ' VAL . 3.5 tt0 -69.39 -30.46 68.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 7.0 m -85.05 -30.14 24.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.051 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -74.19 -41.99 60.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.0 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 364' ' ' ALA . 12.4 mt -73.48 -28.92 26.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.218 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 365' ' ' GLN . 79.6 p -90.98 -46.09 8.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.867 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.932 -179.996 . . . . . . . . 1 1 . 1 stop_ save_